data_2ksr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ksr _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.859 0.275 . . . . 71.02 112.367 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.4 pp -52.0 -30.96 27.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 72.23 110.905 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -78.54 -33.58 47.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 74.14 110.865 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -72.5 -45.96 56.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 74.32 110.905 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -60.23 -40.03 88.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 74.53 111.129 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -29.11 21.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 75.31 111.138 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.87 -27.06 49.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 73.53 110.869 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.35 -19.18 23.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 75.33 110.922 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.6 mm -76.73 -34.84 23.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.453 . . . . 74.34 111.137 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.535 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.2 mt -55.7 -57.13 23.0 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.621 0.724 . . . . 74.34 111.139 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.3 Cg_endo -69.81 -20.47 34.56 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.696 2.264 . . . . 75.11 112.32 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 48.7 t -75.88 -44.59 39.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 63.23 110.867 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.53 -28.96 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 74.52 111.163 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 mt -51.0 -33.97 27.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 74.43 110.922 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.1 tp -58.73 -34.65 52.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 73.25 111.153 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.73 -40.9 92.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 73.24 111.167 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.25 -43.45 67.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 64.21 110.816 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 tp -76.46 -39.32 53.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.453 . . . . 74.32 110.908 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.88 -36.29 72.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 63.05 111.102 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.97 -32.32 57.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 73.43 111.112 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.29 -33.78 63.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 74.22 110.901 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.0 m -101.66 -36.82 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 75.25 111.086 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -71.6 -64.81 0.85 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 74.15 110.927 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.63 -61.77 1.65 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 73.23 110.948 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.77 160.63 60.22 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.656 0.741 . . . . 74.12 110.907 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 136.37 32.85 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.709 2.272 . . . . 72.43 112.355 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.65 44.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 70.23 110.862 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -53.06 109.58 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 64.44 110.877 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -179.16 159.06 0.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 75.21 110.886 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.48 -26.71 31.52 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.748 . . . . 75.34 112.487 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -72.58 -35.0 67.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 75.0 110.85 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.0 -49.25 66.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 75.41 110.896 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -70.51 -48.08 57.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 65.14 110.913 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.2 m -54.27 -27.02 32.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 74.2 111.18 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.86 -38.92 66.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.446 . . . . 73.14 110.913 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 26.3 m -66.87 -45.59 77.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 71.53 110.861 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.9 tt -71.26 -35.0 56.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 64.44 111.101 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.6 m -58.43 -26.36 63.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 65.01 110.861 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.3 t -61.73 -40.06 85.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.477 . . . . 74.24 111.063 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.89 -28.88 25.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 72.34 110.902 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.13 -39.17 79.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 72.14 110.914 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.39 -29.99 70.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 71.4 111.116 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.8 mt -65.11 -54.7 25.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 75.4 110.915 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.81 -38.26 87.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 71.5 111.172 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.6 t -71.5 -32.98 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 75.41 111.12 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -54.58 -30.01 53.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.481 . . . . 74.51 110.866 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.78 -50.54 64.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 74.51 110.954 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.4 mt -73.23 -33.09 65.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 75.02 110.949 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -55.08 22.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 75.42 110.909 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -64.93 -30.48 50.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 63.21 111.152 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.8 t -80.47 -19.12 46.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 72.33 110.839 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -78.16 -10.26 59.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 74.54 110.931 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.1 pp -55.62 -25.19 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 75.23 111.12 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.1 t 62.89 76.21 0.38 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.654 0.74 . . . . 73.4 111.155 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 167.5 24.29 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.685 2.257 . . . . 71.42 112.317 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -48.85 0.64 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.623 2.215 . . . . 73.24 112.37 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.3 t -133.65 14.43 4.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 74.14 111.122 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.3 p 51.65 37.96 21.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 74.14 110.856 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.15 -11.81 61.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 74.14 110.922 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -95.28 23.36 5.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 73.32 110.835 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.525 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.8 -57.91 9.01 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.603 0.716 . . . . 75.11 111.128 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 54.7 Cg_endo -69.68 -19.99 35.78 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.698 2.265 . . . . 74.24 112.391 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.15 -50.36 19.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 74.41 110.897 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.7 t -78.54 -47.35 23.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 75.41 111.138 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.87 -40.77 50.42 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.695 -0.764 . . . . 61.34 112.504 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.5 tttp -74.25 -23.5 59.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.797 0.332 . . . . 75.32 110.879 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -74.68 -34.34 62.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 74.15 110.971 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.9 mt -53.0 -29.67 30.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.079 -0.509 . . . . 75.32 110.939 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.56 -43.65 72.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 74.13 110.831 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.4 ' O ' HG23 ' A' ' 100' ' ' VAL . 47.0 t80 -75.18 -51.14 14.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 74.4 110.877 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 t -53.08 -29.95 33.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 73.22 111.132 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 8.9 mmt -66.54 -30.09 70.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 72.11 110.928 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.83 -30.12 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 74.43 111.088 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.88 -33.29 62.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 74.2 110.916 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.2 m -76.86 -38.06 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 75.32 111.128 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 76.5 m -72.51 -38.41 68.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 73.43 111.153 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -66.81 -32.0 72.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 74.02 110.911 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.5 t -71.5 -36.44 71.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 65.11 110.877 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 38.4 mt -70.78 -52.0 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 71.32 111.077 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 p -54.0 -35.96 29.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 74.24 111.114 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.3 m -52.42 -32.42 39.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 75.14 111.188 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 t -50.45 -31.36 14.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 72.32 110.874 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.4 p -52.42 -32.85 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 74.11 111.13 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 14.9 m -64.49 -46.59 82.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 72.41 110.912 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 95.0 t -73.97 -38.93 50.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 74.51 111.111 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.5 mt -69.11 -30.92 69.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 73.15 110.931 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -58.18 -33.51 69.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 74.11 110.872 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.27 -24.79 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 72.55 111.156 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -58.84 -69.89 0.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 75.44 110.837 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 72.34 110.847 179.984 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 N-CA-C 112.455 -0.258 . . . . 64.41 112.455 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -77.62 -26.14 50.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.963 0.411 . . . . 73.22 110.955 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.1 m -60.58 -37.48 75.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 71.04 111.087 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.7 -25.02 68.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 60.01 111.078 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 13.2 mmt -52.97 -30.98 38.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 74.0 110.909 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.9 t -56.97 -57.03 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 75.54 111.154 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 64.1 mt -74.02 -38.37 49.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 74.13 111.1 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -61.23 -29.96 70.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 74.35 110.896 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.02 -30.17 24.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 73.25 110.871 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.66 -50.83 70.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 55.3 110.935 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -74.04 -44.23 55.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 73.33 110.885 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.06 -33.86 40.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 73.34 110.88 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -53.76 -46.51 70.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 71.12 110.905 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 43.3 mm -76.9 -31.96 19.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 74.33 111.117 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -56.09 -56.82 16.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 74.33 110.865 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.9 m -54.9 -35.0 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 75.41 111.171 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -63.38 -32.95 74.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 73.44 110.9 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 31.7 t -66.56 -37.74 80.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 74.34 111.129 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 91.8 m -58.93 -51.94 67.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 74.54 110.882 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.48 -32.99 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 71.01 111.125 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -52.71 -52.0 57.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 74.44 110.887 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.85 -19.38 75.51 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.757 . . . . 51.42 112.484 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.6 m -74.72 -52.83 10.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.81 0.338 . . . . 63.53 111.18 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.7 mt -76.52 -29.77 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 64.31 111.105 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -55.43 -49.95 62.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.725 -0.75 . . . . 55.4 112.491 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.4 mmt -71.13 -32.03 68.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.877 0.37 . . . . 70.13 110.923 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 15.1 t80 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 74.01 110.905 -179.98 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.232 0.193 0 CA-C-O 120.827 0.261 . . . . 72.21 112.352 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 pp -52.08 -30.93 28.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 72.12 110.932 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -78.43 -33.34 48.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 72.24 110.828 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -72.61 -45.81 57.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 75.14 110.936 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -60.28 -39.95 88.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 72.1 111.109 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -29.03 21.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 74.5 111.146 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -26.72 52.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 73.3 110.857 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.57 -19.46 22.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 75.54 110.955 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.4 mm -76.68 -34.78 24.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 75.33 111.159 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.536 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.2 mt -55.74 -57.18 22.83 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.681 0.753 . . . . 74.12 111.14 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 54.1 Cg_endo -69.73 -20.97 34.29 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.673 2.249 . . . . 75.11 112.354 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 48.5 t -75.89 -44.92 38.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.251 -0.431 . . . . 62.02 110.873 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.2 p -81.59 -28.89 10.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 74.4 111.166 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.2 mt -50.95 -33.94 26.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 74.24 110.89 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.2 tp -58.77 -34.65 52.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 75.54 111.164 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 p -65.73 -34.74 78.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 74.53 111.164 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.14 -46.8 79.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 71.23 110.883 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.64 -41.6 60.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 75.12 110.896 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.52 -51.42 69.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 73.3 111.095 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.03 -32.09 56.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 65.02 111.166 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.4 tp -51.62 -37.93 52.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 73.0 110.905 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.0 p -101.64 -35.79 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 75.22 111.153 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -66.28 -62.06 1.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 75.53 110.877 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.52 -53.73 52.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 74.43 110.935 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.9 mp -51.96 160.53 1.13 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.585 0.707 . . . . 71.15 110.968 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -170.97 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.688 2.259 . . . . 74.33 112.343 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 55.1 91.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 75.44 110.848 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -152.24 147.31 26.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 70.42 110.845 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -173.97 -74.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 75.44 110.877 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -85.95 -50.81 3.79 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.756 -0.735 . . . . 61.21 112.491 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -61.57 -44.34 97.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.899 0.38 . . . . 73.42 110.908 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.08 -48.9 67.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 74.33 110.931 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -66.02 -37.53 86.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 74.35 110.923 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.5 m -66.91 -29.14 68.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 72.42 111.17 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.66 -50.69 28.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 75.31 110.937 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -51.21 62.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 74.01 110.86 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.5 tt -66.85 -35.02 73.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 74.12 111.154 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 m -65.79 -25.12 67.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 64.13 110.858 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 64.0 t -58.02 -36.64 57.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 65.11 111.13 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.92 -28.95 25.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 75.23 110.898 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.29 -38.94 78.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 71.31 110.917 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.51 -30.0 70.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 70.54 111.133 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.5 mt -64.99 -54.78 25.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 75.44 110.904 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.68 -38.46 87.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 71.25 111.196 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.3 t -71.43 -32.89 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.22 111.12 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -51.82 -30.14 22.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 75.11 110.895 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.9 -41.62 61.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 73.42 110.928 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.0 mt -73.27 -34.6 65.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 74.52 110.873 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.6 -55.07 11.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 73.44 110.916 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.22 -24.59 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 74.14 111.083 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.5 -16.43 60.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 74.34 110.813 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? -64.05 -15.54 59.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 75.13 110.896 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -51.73 -28.68 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 75.03 111.106 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 58.6 t 61.01 76.72 0.4 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.664 0.745 . . . . 75.33 111.12 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 167.41 24.46 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.702 2.268 . . . . 75.14 112.377 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -49.05 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.661 2.241 . . . . 75.3 112.365 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.9 t -134.48 18.37 3.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 71.02 111.125 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.2 p 50.09 46.51 24.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 74.15 110.856 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mt -94.68 22.12 6.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 74.2 110.94 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -99.07 24.53 7.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 75.11 110.854 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.14 -57.78 10.34 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.634 0.731 . . . . 75.04 111.142 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.4 Cg_endo -69.77 -20.53 34.68 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.721 2.281 . . . . 72.2 112.341 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.16 -53.12 10.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 75.23 110.926 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.05 -40.39 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 75.14 111.116 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -53.17 -33.69 45.81 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.774 -0.727 . . . . 51.43 112.481 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.0 -23.25 44.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.831 0.348 . . . . 73.12 110.911 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -76.57 -35.19 58.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 74.4 110.942 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.3 mt -52.28 -29.9 25.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 61.51 110.916 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -43.15 79.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 75.3 110.92 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -75.37 -52.09 11.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 73.53 110.852 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -53.14 -29.76 33.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 75.22 111.169 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.9 mmt -66.83 -30.06 70.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 73.54 110.916 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.77 -30.07 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 72.14 111.122 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.89 -33.19 62.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 74.44 110.927 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.6 m -76.87 -38.1 28.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 71.11 111.131 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 73.6 m -72.45 -40.39 67.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 70.32 111.151 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -64.11 -31.95 73.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 72.33 110.902 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.7 m -73.89 -33.77 64.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 73.12 110.892 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 30.4 mt -75.1 -50.94 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 74.43 111.142 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 34.5 m -53.9 -33.98 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 75.45 111.124 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.4 m -52.48 -32.46 40.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 75.42 111.09 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 t -50.48 -31.49 15.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 73.42 110.851 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.5 p -52.5 -32.77 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 73.22 111.158 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 42.6 m -66.86 -49.04 66.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 73.24 110.884 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 67.8 t -70.16 -35.67 64.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 74.35 111.159 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.8 mt -72.08 -38.97 69.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 74.25 110.887 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -53.9 -31.33 49.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 72.43 110.885 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.7 p -102.31 -23.68 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 74.21 111.167 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -52.87 -51.07 62.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 71.4 110.873 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 62.43 110.868 179.998 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.535 -0.226 . . . . 74.33 112.535 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -83.43 -26.59 30.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.892 0.377 . . . . 64.03 110.917 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.1 m -64.47 -30.04 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 74.4 111.131 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.14 -25.09 61.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.53 111.071 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 38.8 mmt -53.02 -30.86 37.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 74.43 110.902 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 71.6 t -56.98 -58.59 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 71.34 111.127 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.8 mt -74.03 -37.79 47.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 73.33 111.099 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.98 -30.88 70.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 75.13 110.883 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.26 -28.74 29.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 74.55 110.888 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.52 -43.36 63.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 73.13 110.94 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -73.96 -52.48 12.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 74.32 110.888 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.01 -32.09 32.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 72.45 110.903 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -67.3 -42.53 83.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 72.21 110.876 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 69.6 mt -76.85 -32.22 19.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.416 . . . . 74.42 111.103 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -56.0 -56.99 14.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 65.03 110.871 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.5 m -54.94 -35.05 32.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 72.43 111.123 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -68.32 -33.03 73.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 75.31 110.888 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 46.0 t -69.17 -34.0 61.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 73.13 111.146 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.48 -52.04 60.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 73.34 110.922 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.0 m -73.1 -35.41 47.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 74.13 111.149 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -52.46 -40.16 61.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 75.11 110.878 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -76.6 -20.3 76.81 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.71 -0.757 . . . . 65.41 112.499 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 35.0 m -72.08 -52.86 14.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.755 0.312 . . . . 75.42 111.172 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 19.7 mt -76.58 -24.82 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 72.33 111.098 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.35 -49.63 76.45 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.734 -0.745 . . . . 42.44 112.503 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -32.05 55.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.843 0.354 . . . . 74.43 110.893 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 14.7 t80 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 63.34 110.859 -179.927 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.84 0.267 . . . . 61.22 112.377 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 pp -53.37 -31.0 42.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 75.14 110.921 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -77.39 -30.2 53.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 71.1 110.902 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -77.02 -44.46 30.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.15 -0.477 . . . . 74.41 110.932 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -60.34 -40.06 89.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 71.45 111.129 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.83 -28.86 31.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 72.12 111.146 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.37 -26.58 68.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 70.44 110.921 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.27 -24.44 20.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 63.25 110.899 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.8 mm -79.4 -29.41 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 74.05 111.121 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.522 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.65 -57.15 22.76 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.634 0.731 . . . . 73.11 111.123 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.3 Cg_endo -69.74 -19.69 35.88 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.696 2.264 . . . . 74.35 112.328 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 47.5 t -76.04 -44.65 38.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 75.32 110.864 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 p -81.64 -28.89 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 64.41 111.128 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 mt -50.99 -33.94 26.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 75.23 110.943 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.2 tp -58.72 -34.62 52.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 74.32 111.153 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 p -65.88 -41.53 91.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 74.33 111.105 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.8 t -52.92 -42.91 65.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 74.44 110.864 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.0 tp -76.71 -39.69 51.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 74.12 110.89 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.85 -51.35 70.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 72.33 111.082 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.4 mp -49.7 -31.46 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 73.54 111.09 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.74 -42.3 57.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 72.35 110.912 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.47 -37.52 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 74.4 111.093 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -63.61 -64.48 0.89 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 72.11 110.853 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.68 -56.06 5.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 75.11 110.978 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.5 mp -95.71 160.55 30.04 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.602 0.715 . . . . 74.02 110.898 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 141.24 44.44 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.617 2.211 . . . . 75.31 112.351 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.5 m -161.98 105.85 1.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 62.41 110.849 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.02 -170.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 74.54 110.838 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 78.8 m -110.9 -73.71 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 75.24 110.894 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.35 -26.81 72.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.744 -0.741 . . . . 60.24 112.514 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.08 -35.05 46.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.946 0.403 . . . . 75.24 110.877 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -54.22 -51.42 64.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 73.43 110.938 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.5 tpt -60.43 -51.31 70.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 74.32 110.917 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 30.0 p -54.8 -31.33 58.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 74.44 111.14 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.96 -41.34 59.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 74.22 110.926 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 81.5 m -66.84 -50.94 60.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 64.23 110.93 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 15.9 tt -62.27 -35.0 66.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 72.12 111.14 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.2 t -63.58 -27.08 69.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 75.24 110.874 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 63.6 t -59.38 -39.37 78.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 65.15 111.124 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 tp -53.11 -29.03 28.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 75.25 110.879 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -74.16 -46.81 39.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 64.11 110.888 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.76 -29.59 19.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 74.03 111.112 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 30.0 mt -58.04 -54.58 45.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 74.32 110.909 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 t -63.12 -27.26 69.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 71.54 111.134 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.2 t -71.23 -32.94 49.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 75.23 111.107 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -52.08 -50.02 62.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 74.4 110.869 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.0 tp -61.54 -32.5 72.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 74.42 110.91 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 mp -73.04 -44.24 60.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.452 . . . . 71.13 110.941 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.2 tt -67.73 -50.22 58.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 74.31 110.912 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -57.43 -25.51 24.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 64.34 111.106 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.04 -18.58 49.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 74.01 110.904 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -69.07 -11.71 61.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 71.33 110.876 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -54.17 -26.33 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 74.21 111.097 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 44.6 t 62.12 75.72 0.42 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.629 0.728 . . . . 74.43 111.149 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 167.61 23.91 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.646 2.231 . . . . 64.51 112.381 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -48.91 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.676 2.25 . . . . 73.53 112.361 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.8 t -133.1 13.29 4.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 75.13 111.175 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.1 m 51.55 65.23 1.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 74.34 110.882 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 tp -117.19 25.93 10.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 72.44 110.899 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.5 22.47 14.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 75.21 110.907 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -68.2 -57.94 8.31 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.649 0.738 . . . . 75.44 111.131 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.6 Cg_endo -69.72 -19.61 36.08 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.664 2.243 . . . . 75.0 112.385 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.15 -53.01 10.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 72.53 110.874 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.24 -23.79 11.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 73.54 111.146 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.68 -50.67 42.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.76 -0.733 . . . . 73.44 112.445 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.42 -35.06 78.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.757 0.313 . . . . 74.22 110.883 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -61.27 -42.46 98.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 75.3 110.943 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.7 mt -51.94 -29.83 22.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 71.14 110.938 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.0 mmt -67.77 -42.87 81.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 63.33 110.868 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -75.24 -52.41 10.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 73.11 110.919 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -53.17 -29.77 33.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 70.24 111.185 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.2 mmt -66.86 -29.92 69.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.479 . . . . 70.05 110.883 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.84 -30.05 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 73.04 111.128 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.87 -33.38 62.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 64.32 110.918 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.4 m -76.89 -38.0 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 71.31 111.106 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 63.2 m -72.44 -42.23 65.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 74.22 111.15 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -60.65 -31.96 71.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 63.44 110.929 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.1 t -75.08 -36.05 61.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 73.3 110.881 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 39.4 mt -74.87 -49.31 29.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.489 . . . . 74.14 111.16 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 34.0 m -53.89 -33.91 24.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 75.42 111.158 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.8 m -52.34 -32.5 38.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 75.43 111.194 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.9 m -50.52 -31.48 15.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 73.3 110.856 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.5 p -52.41 -32.77 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 71.43 111.111 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 20.5 m -64.3 -42.81 96.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 65.24 110.943 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 75.7 t -78.07 -35.37 20.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 71.51 111.134 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.4 mt -71.83 -30.99 66.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.901 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -60.15 -32.28 70.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 74.4 110.907 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.31 -24.67 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 70.41 111.136 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -89.1 -71.79 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 74.12 110.842 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 72.51 110.879 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.495 -0.242 . . . . 73.43 112.495 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -87.49 -26.86 22.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 75.5 110.88 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.6 m -64.96 -34.94 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 70.52 111.08 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.72 -25.01 61.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 73.12 111.077 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.96 -31.1 38.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 72.34 110.872 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.6 t -56.94 -58.73 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 70.41 111.121 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.5 mp -73.99 -37.52 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 72.31 111.157 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -61.42 -29.97 70.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 72.24 110.819 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.0 -30.51 25.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.269 -0.423 . . . . 74.03 110.871 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.3 mt -71.76 -40.85 69.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 74.42 110.958 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -73.61 -53.06 11.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 72.43 110.92 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.8 mp -52.42 -32.02 37.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 75.43 110.851 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -61.37 -43.61 98.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.234 -0.439 . . . . 73.22 110.906 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 68.2 mt -76.97 -33.49 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 74.14 111.152 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -56.36 -56.67 18.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 70.23 110.893 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 28.2 t -55.2 -35.12 34.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 72.4 111.126 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.18 -32.99 74.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 73.14 110.852 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 46.0 t -61.2 -51.78 69.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 74.23 111.09 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.1 m -52.05 -32.06 32.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 71.33 110.86 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.5 t -57.72 -50.89 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.229 -0.441 . . . . 75.41 111.101 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -72.06 -26.86 62.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 71.53 110.912 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -52.21 -58.98 9.48 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.715 -0.755 . . . . 64.51 112.468 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.5 t -60.82 -31.95 71.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.766 0.317 . . . . 75.31 111.119 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 43.9 mm -72.65 -24.94 21.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 72.14 111.151 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -65.65 -49.9 57.28 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.722 -0.751 . . . . 51.3 112.504 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.24 -32.01 43.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.781 0.324 . . . . 75.04 110.885 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 32.6 t80 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 75.41 110.83 -179.883 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.167 0 CA-C-O 120.853 0.272 . . . . 64.14 112.313 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.05 -30.96 65.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 72.21 110.961 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -78.34 -32.15 48.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 71.13 110.879 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.08 -45.01 59.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 75.24 110.927 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -60.53 -39.95 89.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 75.42 111.132 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -29.12 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 74.34 111.117 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.95 -26.84 49.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 72.43 110.913 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.54 -19.22 23.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 74.33 110.917 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.6 mm -76.6 -35.01 24.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 73.11 111.108 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.541 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.76 -57.15 23.07 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.574 0.702 . . . . 73.15 111.131 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.77 -22.12 32.49 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.645 2.23 . . . . 64.33 112.376 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 45.9 t -76.04 -45.67 33.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 72.15 110.871 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.1 p -81.53 -28.83 10.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 73.13 111.165 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mt -50.92 -34.01 26.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 74.24 110.89 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.2 tp -58.72 -34.65 52.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 64.21 111.103 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.7 p -65.89 -35.29 80.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 74.44 111.121 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.73 -51.22 66.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 72.54 110.858 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 tp -70.64 -42.23 71.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 75.52 110.915 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.06 -48.76 75.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 70.35 111.094 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.09 -32.25 57.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 64.01 111.093 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.6 tp -51.62 -37.73 51.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 74.24 110.89 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -101.52 -35.95 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 74.31 111.144 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -66.44 -62.45 1.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 64.0 110.909 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.51 -43.44 75.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 74.12 110.919 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.3 mp -54.45 160.63 2.49 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.617 0.722 . . . . 73.55 110.911 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 179.91 3.37 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.669 2.246 . . . . 73.5 112.334 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 62.99 162.04 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 72.45 110.864 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -179.18 84.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 75.33 110.85 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.7 m -80.64 -170.63 2.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 75.42 110.911 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.82 -27.17 27.91 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.709 -0.758 . . . . 51.51 112.463 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -57.1 -34.96 68.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.924 0.392 . . . . 75.41 110.894 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.24 -51.36 64.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 73.32 110.882 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.7 ttm -53.05 -51.96 60.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 71.41 110.896 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.2 p -60.93 -35.53 76.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 70.41 111.15 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.87 -47.19 75.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.425 . . . . 65.12 110.939 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 75.6 m -57.73 -51.98 67.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 72.21 110.888 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.8 tt -66.54 -34.96 73.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 74.12 111.1 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.5 m -59.76 -25.08 64.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 73.31 110.832 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.3 t -57.92 -38.02 64.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 75.12 111.12 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mt -52.89 -28.9 25.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 74.45 110.894 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.63 -38.74 77.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 70.35 110.886 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.57 -30.07 70.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 74.54 111.137 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.4 mt -64.95 -54.72 26.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 74.34 110.954 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.72 -38.43 87.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.469 . . . . 74.15 111.139 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.9 t -71.48 -32.82 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 72.42 111.135 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -51.59 -30.56 21.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 75.25 110.877 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.6 tp -75.02 -38.84 61.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 72.44 110.937 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.0 mp -73.26 -40.32 64.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 74.22 110.923 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.2 tt -65.05 -54.07 35.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 75.44 110.893 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.06 -23.59 18.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 73.13 111.143 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.5 m -80.26 -21.95 42.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 71.21 110.845 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -59.81 -20.44 56.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.481 . . . . 74.15 110.849 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.7 pt -51.92 -29.06 10.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 75.43 111.156 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 59.1 t 61.17 76.81 0.39 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.654 0.74 . . . . 72.04 111.162 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 167.47 24.29 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.666 2.244 . . . . 72.23 112.35 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -48.78 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.683 2.255 . . . . 65.33 112.324 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.0 t -117.23 -20.16 9.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 72.51 111.134 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.74 45.51 4.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 73.31 110.882 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 tp -95.73 25.8 4.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 73.11 110.897 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -102.94 23.72 11.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 73.14 110.886 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.522 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -66.74 -57.72 11.23 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.594 0.711 . . . . 65.51 111.128 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 54.0 Cg_endo -69.72 -37.32 9.43 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.741 2.294 . . . . 64.24 112.342 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.7 mp -53.95 -52.96 58.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 71.12 110.899 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.24 -26.37 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 70.14 111.089 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.72 -51.32 39.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 75.31 112.532 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.54 -35.39 80.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.813 0.339 . . . . 72.32 110.9 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -60.52 -38.2 83.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 74.34 110.946 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.2 mt -51.79 -29.75 20.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 72.3 110.923 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.04 -42.99 79.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 73.5 110.876 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.401 ' O ' HG22 ' A' ' 100' ' ' VAL . 57.8 t80 -75.25 -52.2 11.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 75.43 110.887 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 t -53.15 -29.88 33.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 75.02 111.131 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.6 mmt -66.66 -30.1 70.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 74.44 110.846 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.76 -30.05 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 71.31 111.135 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.97 -33.19 61.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 74.33 110.918 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.8 m -76.85 -37.94 28.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.51 111.158 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 60.9 m -72.51 -41.9 65.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 65.13 111.135 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -60.91 -31.89 71.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 71.52 110.895 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.7 t -74.8 -35.52 62.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 71.51 110.868 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.7 mt -74.97 -49.65 27.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 75.4 111.124 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 34.2 m -53.99 -33.86 24.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 75.53 111.143 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.5 m -52.44 -32.43 39.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 72.34 111.173 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.7 m -50.45 -31.59 15.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 74.44 110.87 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.7 p -52.6 -32.68 17.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 64.35 111.144 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 49.4 m -66.7 -47.05 73.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 75.41 110.848 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 88.4 t -72.35 -35.37 51.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 65.24 111.143 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 89.5 mt -72.08 -39.69 68.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 73.55 110.964 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -54.1 -30.67 49.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 72.04 110.879 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.4 p -102.32 -23.23 4.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 75.02 111.126 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -53.82 -61.61 2.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 75.15 110.839 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 75.12 110.844 -179.979 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.491 -0.244 . . . . 75.31 112.491 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -71.52 -26.8 62.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.94 0.4 . . . . 74.41 110.909 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.8 m -64.58 -27.01 41.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 74.11 111.142 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.23 -24.95 45.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 70.23 111.135 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.0 -30.9 38.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 75.15 110.871 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 58.9 t -56.99 -59.0 3.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 71.51 111.13 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.7 mt -74.05 -37.72 47.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 73.21 111.121 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -61.28 -29.96 70.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 72.5 110.827 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.37 -29.69 25.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 73.42 110.912 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.93 -50.41 23.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 73.35 110.929 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -66.37 -53.99 29.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 71.51 110.876 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.0 -32.23 32.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 75.21 110.937 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -71.74 -38.1 70.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 75.23 110.913 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 55.9 mt -76.87 -32.03 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 73.1 111.132 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -56.11 -56.31 22.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 72.34 110.875 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.26 -34.99 45.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 74.4 111.153 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -59.64 -47.53 85.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 73.52 110.914 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 91.8 t -69.38 -34.1 60.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 73.1 111.129 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.95 -51.47 56.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 55.1 110.916 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 40.8 t -75.87 -33.11 24.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 74.21 111.121 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.36 -42.99 83.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 72.24 110.896 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.02 -19.32 67.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 73.1 112.436 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 94.9 m -63.02 -51.94 64.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.756 0.312 . . . . 70.11 111.145 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 20.5 tt -55.94 -25.64 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 74.43 111.162 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -51.87 -49.54 47.75 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.707 -0.759 . . . . 62.42 112.524 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 1.3 mmt -61.82 -31.79 72.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.834 0.349 . . . . 53.51 110.916 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 73.22 110.886 -179.929 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.232 0.198 0 CA-C-O 120.785 0.244 . . . . 73.21 112.334 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 pp -53.31 -30.98 41.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 73.1 110.95 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -79.94 -29.34 39.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 73.11 110.865 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -77.07 -45.4 27.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.468 . . . . 74.15 110.938 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.2 t -59.45 -40.33 86.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 73.21 111.093 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -28.84 32.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 73.22 111.123 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.37 -25.89 68.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 73.54 110.896 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -91.24 -23.08 20.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 75.34 110.872 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.6 mm -78.55 -31.2 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.447 . . . . 72.04 111.107 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.532 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.7 -57.16 22.82 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.615 0.721 . . . . 70.32 111.123 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 54.2 Cg_endo -69.76 -20.79 34.36 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.676 2.251 . . . . 72.44 112.378 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 7.6 t -76.01 -43.27 45.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 63.32 110.876 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.61 -28.89 10.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 73.45 111.126 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 mt -50.97 -33.95 26.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 64.04 110.912 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.1 tp -58.8 -34.62 52.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 72.13 111.123 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.81 -38.62 89.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 74.02 111.177 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.6 m -53.04 -45.04 67.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 71.2 110.86 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.2 tp -76.93 -40.1 48.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 60.04 110.899 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.63 -38.34 74.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 73.31 111.091 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.22 -31.98 55.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 75.21 111.142 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 tp -51.45 -38.74 55.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 73.21 110.896 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.8 p -101.47 -36.66 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 64.42 111.187 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -67.1 -64.65 0.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 74.42 110.876 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.24 -25.94 62.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 74.1 110.9 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.1 mp -124.84 72.0 61.82 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.616 0.722 . . . . 73.54 110.961 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -173.0 0.64 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.651 2.234 . . . . 72.52 112.34 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.2 p -158.71 27.48 0.23 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 74.22 110.878 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 57.2 93.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 71.21 110.822 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.03 141.77 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 64.51 110.874 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.19 -22.97 45.55 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 52.53 112.469 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -52.06 -34.99 45.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 71.24 110.908 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.07 -37.47 61.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 74.12 110.914 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.19 -50.86 35.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 70.02 110.848 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.1 p -60.24 -29.3 68.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 73.23 111.121 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.55 -37.31 60.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.439 . . . . 74.43 110.893 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 62.4 m -66.27 -44.86 82.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 72.4 110.929 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.6 tt -75.59 -33.14 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 75.31 111.149 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 t -51.74 -25.81 8.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 74.02 110.827 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.9 p -57.08 -32.55 40.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 73.5 111.111 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.9 -28.93 25.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 73.32 110.925 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.25 -38.88 78.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 71.42 110.92 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.64 -30.03 70.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 74.52 111.054 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.2 mt -65.38 -54.63 26.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 74.54 110.94 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.59 -38.57 88.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 75.42 111.151 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 83.4 t -71.56 -32.89 47.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 75.22 111.152 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -52.0 -30.14 23.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 74.44 110.867 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.73 -45.93 67.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 74.5 110.937 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.7 mt -73.1 -34.14 65.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 72.32 110.906 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.43 -54.99 15.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 74.52 110.925 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.4 tt -61.45 -30.02 47.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 75.34 111.135 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.6 m -80.07 -23.71 41.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 73.13 110.862 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -66.8 -15.64 63.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 75.22 110.924 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.2 pp -56.08 -24.84 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 75.13 111.121 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.3 t 63.52 75.42 0.4 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.57 0.7 . . . . 72.31 111.112 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 167.65 23.83 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.708 2.272 . . . . 75.43 112.363 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -22.13 32.52 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.649 2.233 . . . . 73.52 112.366 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.9 t -95.24 -31.41 13.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 64.33 111.139 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 55.47 26.12 8.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 74.52 110.849 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 tp -141.84 51.89 1.51 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 71.14 110.918 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -97.91 27.34 4.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 75.04 110.87 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.513 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.12 -57.75 10.42 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.607 0.717 . . . . 64.54 111.132 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.8 Cg_endo -69.83 -20.67 34.2 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.683 2.255 . . . . 73.15 112.289 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.19 -52.3 12.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 71.24 110.933 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.2 -22.81 11.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 72.5 111.096 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.65 -47.55 52.06 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.755 -0.736 . . . . 54.14 112.474 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -34.94 76.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.755 0.312 . . . . 75.43 110.859 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -60.62 -34.57 74.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.268 -0.423 . . . . 75.34 110.904 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.7 mt -51.7 -29.79 19.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 64.45 110.924 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -43.22 78.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 74.02 110.873 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -75.27 -52.0 11.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 74.24 110.84 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 t -53.05 -29.94 32.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 73.21 111.137 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.5 mmt -66.41 -30.42 70.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 75.14 110.898 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.59 -29.94 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 75.44 111.139 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.26 -33.43 61.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 74.2 110.859 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.5 m -77.54 -39.51 27.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 64.45 111.14 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.5 t -72.58 -32.14 65.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 74.34 111.161 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -57.74 -33.89 68.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 75.11 110.88 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.4 t -74.95 -33.98 62.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 62.32 110.848 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.4 mt -75.11 -50.56 24.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 72.34 111.138 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.5 m -53.91 -35.73 28.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 74.23 111.149 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.6 m -52.61 -32.29 40.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 74.11 111.132 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 51.8 p -50.33 -31.56 14.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.43 . . . . 70.13 110.854 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.4 p -52.5 -32.75 17.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 73.13 111.123 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 44.1 m -67.08 -49.02 66.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 73.13 110.846 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 65.4 t -70.08 -35.49 64.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 72.53 111.109 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.1 mt -72.11 -41.09 67.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 71.21 110.928 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -51.94 -31.34 28.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 74.51 110.924 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.6 p -102.27 -23.97 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 71.23 111.135 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -53.18 -74.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 74.4 110.864 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 70.42 110.869 179.987 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.544 -0.222 . . . . 72.02 112.544 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -76.55 -37.47 56.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.947 0.403 . . . . 72.04 110.916 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.2 m -65.18 -34.7 72.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 72.2 111.097 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -68.33 -25.13 64.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 73.31 111.108 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 23.4 mmt -53.01 -30.96 38.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 75.01 110.894 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.0 -57.66 8.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 73.32 111.161 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.8 mm -74.01 -37.37 47.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.486 . . . . 73.04 111.157 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.82 -29.96 70.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 73.43 110.871 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -52.09 -30.2 25.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 75.35 110.87 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.2 tt -72.1 -50.38 28.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 71.1 110.931 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -63.03 -52.07 64.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 73.11 110.861 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.94 -35.16 45.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 74.51 110.917 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -60.81 -40.27 92.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 73.3 110.918 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 45.6 mm -76.85 -31.98 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 73.12 111.166 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -56.02 -56.76 16.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.486 . . . . 70.03 110.906 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.6 m -56.67 -35.32 45.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 75.13 111.153 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.4 -34.1 77.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 74.52 110.879 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 67.4 t -54.06 -35.93 30.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 72.13 111.146 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -52.82 -49.78 65.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 73.13 110.852 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.36 -33.04 57.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 73.53 111.125 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.19 -54.99 23.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 75.44 110.877 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.58 -19.48 71.0 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 64.55 112.484 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 32.7 m -55.95 -52.83 62.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.77 0.319 . . . . 75.12 111.123 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 29.8 mt -76.52 -27.99 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 73.33 111.126 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -53.71 -50.03 55.6 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.788 -0.72 . . . . 70.05 112.494 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -71.37 -31.99 67.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 75.52 110.844 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 27.6 t80 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 70.21 110.929 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.825 0.261 . . . . 73.23 112.344 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.0 pp -52.26 -31.02 30.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 73.32 110.926 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -80.86 -31.69 35.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 75.43 110.853 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -72.98 -46.27 53.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.127 -0.488 . . . . 74.22 110.956 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 t -59.57 -39.89 85.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.483 . . . . 73.21 111.133 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.16 -29.08 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 70.35 111.156 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.73 -27.5 50.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.152 -0.477 . . . . 73.43 110.863 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.89 -18.75 24.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 75.01 110.903 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.6 mm -76.76 -34.82 23.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 72.03 111.106 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.53 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.68 -57.17 22.76 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.575 0.702 . . . . 74.54 111.057 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.8 Cg_endo -69.78 -19.3 36.2 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.686 2.258 . . . . 74.13 112.347 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 48.7 t -73.02 -43.91 61.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 71.13 110.881 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.53 -28.93 10.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 75.33 111.115 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.1 mt -50.96 -33.94 26.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 74.03 110.874 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.78 -34.71 52.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 54.12 111.095 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.82 -41.19 92.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 75.21 111.138 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.09 -43.16 66.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 71.12 110.867 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 tp -76.29 -39.74 53.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 72.22 110.904 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.66 -51.46 69.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 73.42 111.125 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.4 mp -49.8 -31.36 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 75.35 111.134 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.1 tp -50.83 -42.17 58.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 63.41 110.912 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.53 -37.38 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 75.11 111.151 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -63.77 -64.45 0.89 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 72.14 110.856 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.67 -62.05 1.59 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.457 . . . . 74.25 110.947 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 mp -67.83 160.64 72.52 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.633 0.73 . . . . 74.43 110.921 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 154.0 68.62 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.713 2.276 . . . . 74.14 112.329 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 t -175.79 65.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 74.33 110.835 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -62.23 95.03 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 74.14 110.819 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.2 145.82 0.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 74.14 110.871 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.19 -28.26 25.99 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.672 -0.775 . . . . 71.5 112.47 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -53.42 -34.95 59.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.951 0.405 . . . . 75.23 110.894 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.94 -51.97 59.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 71.23 110.863 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.67 -48.95 78.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 65.03 110.88 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.6 p -60.73 -34.16 74.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 74.32 111.154 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.4 mt -67.0 -51.07 59.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 75.51 110.903 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 79.6 m -53.79 -51.06 64.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 71.31 110.89 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.0 tt -68.86 -34.96 67.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 75.24 111.151 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.1 -29.91 23.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 63.52 110.84 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.22 -40.54 88.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 72.35 111.126 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.93 -28.96 25.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 75.33 110.921 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.08 -39.0 79.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 73.23 110.928 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.46 -30.03 70.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 71.42 111.087 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.6 mt -65.8 -54.78 22.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.263 -0.426 . . . . 74.42 110.893 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.14 -38.41 86.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 72.15 111.121 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 80.5 t -71.38 -32.92 48.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 62.11 111.153 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -60.06 -29.79 68.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 73.43 110.896 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.21 -55.03 28.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 70.24 110.927 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.15 -31.93 64.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 73.42 110.905 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tt -60.96 -54.44 44.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 74.14 110.88 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 tt -66.15 -27.02 39.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 74.54 111.112 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.7 t -83.23 -14.75 52.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 73.41 110.812 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -93.7 -9.76 36.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 73.54 110.878 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 10.5 pt -54.26 -28.22 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 71.5 111.158 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.5 t 63.07 74.75 0.44 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.624 0.726 . . . . 73.44 111.127 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 166.34 27.94 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.682 2.255 . . . . 74.22 112.359 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -49.15 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.664 2.243 . . . . 75.21 112.354 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.1 t -115.93 -41.7 3.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 74.3 111.115 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.61 -42.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 73.5 110.824 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 63.56 70.48 0.52 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.139 -0.482 . . . . 73.43 110.922 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 51.05 64.14 1.96 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 74.15 110.838 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.522 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -69.17 -58.09 6.61 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.645 0.736 . . . . 71.21 111.177 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.2 Cg_endo -69.83 -24.21 29.63 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.692 2.261 . . . . 64.04 112.301 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -74.21 -53.09 10.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 64.15 110.913 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.07 -48.93 81.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 74.42 111.111 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.83 -46.58 54.67 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.773 -0.727 . . . . 63.45 112.446 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -72.08 -24.93 61.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.819 0.342 . . . . 73.22 110.909 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -71.21 -30.93 66.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 73.54 110.939 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.1 mt -54.83 -29.66 55.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 73.12 110.917 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.51 -42.41 71.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 71.4 110.849 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -75.13 -51.16 14.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 75.12 110.866 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 t -53.04 -29.96 32.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 75.51 111.125 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.8 mmt -66.58 -30.11 70.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 73.32 110.867 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.82 -30.11 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.427 . . . . 71.4 111.118 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.97 -33.12 61.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 72.3 110.913 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.47 -37.64 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 70.24 111.143 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 55.1 m -72.86 -46.47 52.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 73.34 111.134 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -52.59 -31.64 37.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 73.44 110.898 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 53.2 p -74.68 -49.0 22.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 72.41 110.85 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.8 mt -55.77 -34.56 36.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 74.04 111.131 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.0 t -53.7 -45.78 61.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 74.43 111.159 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.1 m -52.38 -32.49 38.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.099 -0.501 . . . . 74.04 111.147 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.7 m -50.35 -31.39 14.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 74.45 110.855 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.7 p -52.44 -32.76 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 74.51 111.112 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 34.4 m -66.72 -47.04 73.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 71.25 110.88 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 82.8 t -72.4 -35.05 50.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 65.33 111.126 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 87.8 mt -72.04 -42.8 65.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 64.54 110.88 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -52.11 -30.3 25.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 71.03 110.917 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.9 p -102.22 -22.25 4.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.142 -0.481 . . . . 75.41 111.114 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -58.65 -71.72 0.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 70.43 110.84 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.439 . . . . 72.14 110.842 -179.937 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.443 -0.263 . . . . 62.21 112.443 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -88.03 -30.34 20.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.926 0.393 . . . . 71.4 110.939 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.8 m -73.94 -30.33 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 72.21 111.096 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.33 -24.94 47.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 61.44 111.111 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.96 -30.97 37.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 74.1 110.872 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 64.5 t -56.83 -62.33 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 73.21 111.158 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 41.8 mm -71.64 -38.15 65.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 74.43 111.104 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -60.65 -30.46 69.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 74.52 110.859 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.18 -25.74 48.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 72.4 110.824 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 7.6 tt -68.87 -50.93 45.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 74.15 110.925 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -73.97 -36.08 64.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 64.55 110.849 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.9 mt -52.21 -33.76 42.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 70.22 110.948 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -61.21 -48.38 81.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.451 . . . . 74.43 110.895 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.0 mt -75.6 -31.98 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 75.32 111.128 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -56.0 -56.72 17.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 75.03 110.888 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 22.8 t -57.65 -35.7 51.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 75.03 111.089 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -66.79 -32.98 74.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 75.55 110.892 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 90.5 t -61.99 -34.0 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 74.42 111.151 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 49.7 m -63.24 -52.02 63.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 72.02 110.861 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.3 m -71.48 -35.56 57.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 73.03 111.119 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -67.45 -41.15 85.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 74.32 110.889 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.44 -33.25 39.76 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.754 -0.736 . . . . 72.33 112.485 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.7 m -76.48 -52.86 8.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.738 0.304 . . . . 73.51 111.141 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.9 mt -76.48 -24.5 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 72.13 111.185 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.01 -49.39 78.99 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.698 -0.763 . . . . 73.05 112.434 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -31.96 55.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.813 0.34 . . . . 73.23 110.853 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 20.4 t80 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 62.03 110.871 -179.958 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.188 0 CA-C-O 120.845 0.269 . . . . 62.12 112.335 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 pp -51.97 -30.88 26.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 65.43 110.873 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -79.28 -33.35 43.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 71.52 110.885 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -72.33 -46.44 55.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 75.43 110.913 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -59.78 -40.12 87.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 72.44 111.186 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.21 -29.06 21.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 75.05 111.149 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -55.66 -27.14 48.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 54.33 110.884 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.31 -18.74 23.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 73.31 110.913 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.8 mm -76.43 -35.25 26.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 70.13 111.125 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.538 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.76 -57.14 23.16 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.626 0.727 . . . . 75.11 111.153 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.6 Cg_endo -69.75 -21.94 32.82 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.705 2.27 . . . . 75.43 112.306 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.7 t -76.01 -45.59 33.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 63.43 110.9 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.52 -28.91 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 73.02 111.149 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mt -51.02 -33.92 27.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 74.5 110.923 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.2 tp -58.71 -34.68 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 73.44 111.103 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 p -65.69 -40.68 92.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 72.31 111.141 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.01 -44.38 67.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 75.41 110.9 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.9 tp -75.3 -40.41 58.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 74.45 110.949 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.97 -36.53 70.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 73.23 111.1 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.93 -32.31 57.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 73.4 111.112 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 tp -55.28 -33.82 63.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 75.44 110.893 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.1 m -101.64 -36.66 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 72.02 111.138 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -71.7 -64.93 0.83 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 74.1 110.87 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.46 -58.74 3.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.486 . . . . 75.43 110.903 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 mp -77.03 160.69 75.65 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.629 0.728 . . . . 74.44 110.873 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 146.69 61.07 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.722 2.281 . . . . 71.44 112.329 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -178.22 74.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 73.14 110.841 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 53.91 -172.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.154 -0.475 . . . . 74.45 110.861 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 95.5 m -120.45 -54.8 2.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 72.55 110.904 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.32 -57.43 13.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.743 . . . . 74.53 112.502 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -52.08 -34.97 46.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.361 . . . . 74.34 110.846 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.97 -48.21 67.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 74.34 110.92 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 29.4 ttm -62.34 -52.06 65.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 74.25 110.866 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.7 p -58.02 -27.06 63.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 63.34 111.107 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.87 -34.19 60.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.29 -0.413 . . . . 73.21 110.886 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 90.2 m -70.96 -51.89 23.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 71.52 110.845 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 15.8 tt -63.24 -35.29 71.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 65.33 111.134 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.5 t -63.54 -25.46 68.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 74.33 110.847 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 83.6 t -57.95 -36.15 54.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 75.15 111.08 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.87 -28.83 24.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 74.45 110.926 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.24 -38.98 78.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 73.34 110.924 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.56 -29.95 70.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 54.34 111.136 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.4 mt -65.16 -54.71 25.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 73.32 110.945 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.7 -38.56 88.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 74.12 111.149 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 82.2 t -71.5 -32.91 47.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 75.22 111.105 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -51.86 -30.55 24.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 72.12 110.859 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.02 -39.24 61.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 74.33 110.892 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.07 -39.38 65.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 73.43 110.901 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.4 tt -66.46 -55.06 17.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 72.13 110.918 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 tt -57.04 -30.6 34.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 73.43 111.13 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.5 t -80.22 -23.36 40.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 74.03 110.83 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.63 -12.9 62.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 75.25 110.895 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.2 pp -56.41 -24.53 18.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 75.21 111.088 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.8 t 63.68 75.21 0.4 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.649 0.737 . . . . 64.34 111.173 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 167.55 24.2 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.638 2.226 . . . . 75.41 112.352 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -48.63 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.694 2.263 . . . . 61.53 112.356 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.4 t -117.22 -19.88 9.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 70.02 111.07 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.76 47.02 3.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 74.12 110.858 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 tp -99.27 26.05 6.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 71.23 110.91 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.91 23.68 9.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 74.52 110.845 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.529 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.74 -57.79 9.32 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.66 0.743 . . . . 73.45 111.152 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.7 Cg_endo -69.81 -20.0 35.18 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.664 2.243 . . . . 73.42 112.35 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.19 -53.09 10.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 71.1 110.911 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.9 t -80.68 -33.69 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 74.3 111.125 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.82 -52.21 35.63 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.734 -0.746 . . . . 75.03 112.466 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -35.35 80.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 73.41 110.882 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -60.32 -36.98 79.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.438 . . . . 75.1 110.923 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.5 mt -51.91 -29.75 21.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 75.03 110.915 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 4.1 mmt -67.67 -42.86 81.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 73.43 110.921 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -75.29 -52.47 10.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 61.2 110.849 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -53.1 -29.87 33.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 75.11 111.135 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.71 -30.08 70.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.913 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.73 -30.05 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 73.45 111.103 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.96 -33.25 61.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 73.24 110.893 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.1 m -76.93 -37.96 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 73.12 111.095 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 61.3 m -72.45 -41.37 66.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 72.4 111.116 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -61.67 -32.02 72.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 74.34 110.873 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -32.58 69.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 63.33 110.843 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 12.3 mt -74.41 -51.77 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 74.31 111.165 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.3 p -53.95 -33.93 24.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 73.33 111.158 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 91.8 m -52.36 -32.4 38.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 63.44 111.131 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.34 -31.74 15.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 74.12 110.874 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.5 p -52.72 -32.83 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.492 . . . . 71.34 111.114 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 47.5 m -65.23 -43.53 91.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 64.23 110.881 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.5 t -76.82 -35.77 24.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 73.11 111.161 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.3 mt -72.14 -31.13 65.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 75.11 110.882 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -64.73 -29.46 70.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 64.23 110.87 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.8 p -102.24 -20.91 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 73.12 111.102 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -79.18 -74.55 0.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 72.14 110.853 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 74.41 110.876 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.391 0 N-CA-C 112.523 -0.231 . . . . 74.34 112.523 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -71.43 -26.93 62.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.897 0.379 . . . . 73.01 110.915 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.8 m -55.8 -26.96 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 63.45 111.139 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.99 -24.84 41.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 72.22 111.069 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.1 mtt -52.66 -31.0 34.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 72.13 110.889 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 17.7 m -59.55 -30.55 44.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 74.22 111.156 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 28.2 mt -74.15 -47.38 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 73.32 111.163 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -69.66 -29.95 67.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 65.31 110.839 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.1 mtm-85 -55.87 -25.64 43.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 74.52 110.838 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.6 mt -71.02 -50.99 28.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 72.45 110.887 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -73.82 -27.13 60.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 55.32 110.853 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.93 -36.8 50.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.17 -0.468 . . . . 65.01 110.884 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -53.03 -52.01 59.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 73.01 110.905 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 3.4 mt -77.02 -37.74 26.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 72.11 111.17 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -56.01 -56.96 14.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 73.11 110.915 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 42.7 t -56.67 -34.97 43.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 74.03 111.165 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -68.48 -34.95 76.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 75.44 110.882 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 93.5 t -55.58 -41.62 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 73.31 111.133 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 98.6 m -52.02 -48.23 64.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 74.34 110.9 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 43.6 t -75.69 -36.9 34.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 74.34 111.122 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.31 -26.85 61.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 75.2 110.903 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.15 -59.07 2.48 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.696 -0.764 . . . . 50.11 112.455 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 4.6 t -55.3 -41.78 72.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.741 0.305 . . . . 73.15 111.092 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 18.7 tt -63.06 -26.29 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 74.42 111.141 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -51.98 -49.82 47.36 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.767 -0.73 . . . . 70.44 112.47 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 22.7 mmt -71.57 -31.9 67.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.828 0.347 . . . . 74.53 110.878 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 75.31 110.903 -179.959 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo . . . . . 0 C--O 1.232 0.188 0 CA-C-O 120.883 0.285 . . . . 70.2 112.376 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.92 -30.94 65.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 74.31 110.873 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -78.18 -31.84 49.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 74.2 110.84 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.66 -44.91 55.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 74.51 110.926 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.6 t -60.56 -39.78 89.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 72.14 111.14 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.12 -29.12 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 74.01 111.118 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.13 -27.05 52.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 73.54 110.909 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.25 -19.28 23.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 70.35 110.925 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.3 mm -76.84 -34.58 22.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 74.24 111.118 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.536 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.75 -57.18 22.9 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.629 0.728 . . . . 74.12 111.112 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.8 Cg_endo -69.74 -20.47 34.9 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.663 2.242 . . . . 60.13 112.356 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 49.3 t -75.94 -44.42 40.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 61.33 110.87 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.2 p -81.57 -28.93 10.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 73.01 111.104 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.5 mt -50.99 -33.94 26.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 75.23 110.917 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.2 tp -58.74 -34.69 52.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 70.1 111.1 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.82 -36.79 84.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 71.21 111.121 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.07 -52.65 60.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 71.51 110.862 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.1 tp -68.91 -40.51 79.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 73.24 110.922 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.93 -51.38 69.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 74.22 111.101 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.13 -31.85 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 74.25 111.141 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.68 -38.1 53.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 73.24 110.926 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.7 p -101.6 -37.17 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 75.51 111.175 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -67.43 -63.28 1.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 72.13 110.86 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.39 -26.01 38.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 75.42 110.946 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.2 mp -76.78 160.65 76.29 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.596 0.712 . . . . 65.0 110.907 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 78.84 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.704 2.27 . . . . 73.02 112.339 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.7 t -165.8 151.69 9.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 54.52 110.848 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -161.16 26.14 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 74.31 110.85 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 30.3 p -65.97 -170.24 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 72.33 110.86 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.99 -43.73 72.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.723 -0.751 . . . . 64.2 112.488 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -53.04 -41.27 64.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.93 0.395 . . . . 75.53 110.929 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -59.28 -45.21 91.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 73.51 110.894 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 33.4 ttm -63.92 -51.68 63.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 75.21 110.902 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 80.8 p -54.08 -34.82 61.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 73.11 111.135 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.64 -50.33 65.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 74.31 110.921 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 59.4 m -53.87 -51.96 62.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 74.1 110.886 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.6 tt -67.37 -35.06 72.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 73.33 111.095 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 m -60.26 -26.01 66.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 75.02 110.911 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.6 t -57.97 -38.52 67.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 73.34 111.139 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.88 -28.9 25.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 72.43 110.913 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.03 -39.34 79.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 74.04 110.945 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.27 -29.98 70.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 74.5 111.081 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.1 mt -64.82 -54.74 26.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 74.12 110.908 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.97 -38.08 87.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 74.44 111.127 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 75.0 t -71.45 -32.91 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 71.2 111.094 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -60.13 -29.88 68.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 75.41 110.901 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 tt -73.25 -44.17 59.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.124 -0.489 . . . . 74.45 110.89 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.4 mt -73.35 -33.04 64.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 74.21 110.918 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.6 tt -68.87 -55.14 12.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 73.32 110.882 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -56.93 -23.38 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 74.25 111.16 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.5 t -70.03 -14.69 62.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 72.31 110.882 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -62.17 -17.04 56.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 74.21 110.893 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 24.7 pt -50.37 -31.4 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 75.35 111.099 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 66.7 t 56.73 80.33 0.29 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.635 0.731 . . . . 63.42 111.137 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 166.8 26.3 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.735 2.29 . . . . 75.33 112.358 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -49.14 0.59 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.658 2.239 . . . . 74.05 112.374 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.1 t -135.67 22.2 3.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 71.21 111.153 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.7 t 52.17 48.57 22.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 64.2 110.856 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tp -95.55 24.65 5.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 74.24 110.915 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -110.92 25.85 11.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 73.23 110.894 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.517 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.03 -57.82 10.45 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.664 0.745 . . . . 75.04 111.092 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.9 Cg_endo -69.72 -20.59 34.84 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.661 2.241 . . . . 72.41 112.392 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.19 -53.07 10.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 74.1 110.978 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.07 -36.54 16.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 74.54 111.096 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.21 -40.43 52.35 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.768 -0.729 . . . . 72.51 112.475 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -67.66 -24.6 65.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 73.33 110.865 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -78.04 -44.3 26.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 75.34 110.971 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.0 mt -55.45 -29.72 59.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 75.01 110.923 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.38 -43.26 77.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 74.24 110.847 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.401 ' O ' HG22 ' A' ' 100' ' ' VAL . 39.1 t80 -75.29 -51.85 12.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 75.32 110.941 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 t -53.12 -29.87 33.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 72.2 111.165 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.1 mmt -66.69 -30.11 70.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 73.11 110.875 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.76 -30.09 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 75.05 111.116 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.89 -33.27 62.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 75.43 110.884 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.1 m -76.87 -38.1 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 75.41 111.159 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 73.9 m -72.46 -39.77 67.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 74.23 111.143 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -64.87 -31.99 73.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 73.51 110.843 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.9 t -72.57 -35.25 67.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 60.21 110.857 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 36.8 mt -72.55 -51.36 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 75.11 111.099 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 p -53.97 -36.41 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 74.54 111.097 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 94.7 m -52.42 -32.4 39.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 74.31 111.099 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.9 p -50.44 -31.4 14.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 72.35 110.826 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.4 p -52.45 -32.82 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 71.11 111.106 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 31.0 m -65.81 -43.17 89.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 74.53 110.895 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.8 t -77.02 -35.45 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 74.44 111.145 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 87.5 mt -71.99 -32.98 67.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 75.11 110.906 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -59.71 -31.24 69.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 65.4 110.881 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.7 p -102.29 -23.96 4.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 74.51 111.135 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -77.04 -26.17 53.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 72.12 110.833 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 75.31 110.827 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.524 -0.23 . . . . 65.23 112.524 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -86.37 -26.79 24.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 70.02 110.882 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.6 m -54.4 -26.91 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 72.13 111.124 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.22 -26.04 36.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 74.44 111.066 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 6.4 ptm -52.99 -30.94 38.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 74.44 110.89 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 62.8 t -56.96 -58.95 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 74.42 111.092 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.8 mt -73.96 -37.78 48.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 71.32 111.14 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -61.25 -30.01 70.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 73.22 110.851 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.01 -29.02 26.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 61.42 110.9 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.52 -48.3 70.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 74.11 110.925 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -73.69 -41.77 62.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 74.23 110.824 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.07 -32.7 35.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 64.42 110.933 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 23.7 m0 -61.85 -51.98 65.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 72.24 110.906 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 66.6 mt -71.21 -32.05 46.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 75.21 111.175 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -56.33 -40.76 74.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 73.21 110.858 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 21.8 t -73.63 -44.97 52.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 72.02 111.101 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.4 -40.73 62.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 72.22 110.851 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 65.5 t -54.34 -33.96 27.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 73.22 111.119 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 72.0 m -52.06 -51.96 54.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.191 -0.459 . . . . 60.02 110.871 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.91 -33.7 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 75.34 111.143 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -52.38 -40.57 62.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 74.11 110.902 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.76 -44.24 8.52 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.771 -0.728 . . . . 72.35 112.506 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 35.1 m -51.85 -52.85 46.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 64.12 111.163 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 47.5 mm -76.52 -24.92 16.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 65.11 111.16 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -53.92 -49.9 56.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 74.44 112.513 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -31.95 73.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.825 0.345 . . . . 65.45 110.894 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 23.1 t80 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 73.34 110.881 -179.971 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.839 0.266 . . . . 72.33 112.343 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 pp -52.06 -30.91 27.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 74.25 110.92 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -79.08 -33.17 44.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 61.02 110.9 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.45 -46.0 56.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 74.41 110.938 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -60.03 -39.97 87.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 71.14 111.182 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -29.05 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 72.51 111.132 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.87 -27.19 50.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 73.42 110.89 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.23 -19.14 23.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 75.01 110.894 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.7 mm -76.77 -34.73 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 75.0 111.138 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.7 -57.15 22.91 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.62 0.724 . . . . 75.34 111.09 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.9 Cg_endo -69.73 -22.83 31.68 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.655 2.237 . . . . 50.21 112.377 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 49.6 t -76.08 -46.49 28.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 74.35 110.825 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.7 p -81.6 -28.78 10.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 74.31 111.117 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.6 mt -50.93 -33.99 26.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 72.23 110.932 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.2 tp -58.68 -34.71 52.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 74.4 111.119 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.7 p -66.04 -38.55 88.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 74.53 111.147 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.8 m -52.92 -53.77 44.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.229 -0.442 . . . . 75.44 110.897 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tp -67.55 -39.47 84.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 63.1 110.954 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.99 74.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 73.34 111.142 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.93 -32.47 58.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 74.21 111.104 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.6 tp -53.76 -34.61 59.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 75.32 110.887 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -102.26 -36.59 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 74.44 111.145 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.48 -64.92 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 74.54 110.891 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.27 -62.3 1.44 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.099 -0.5 . . . . 74.02 110.956 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.6 mp -63.47 160.09 45.54 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.587 0.708 . . . . 61.24 110.932 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -168.54 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.687 2.258 . . . . 73.52 112.349 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.88 154.53 0.07 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 75.02 110.856 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 53.01 88.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 73.13 110.813 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 94.5 m -88.71 -69.61 0.7 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 62.43 110.831 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.95 -32.0 59.0 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.708 -0.758 . . . . 53.12 112.493 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -51.97 -34.97 44.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.9 0.381 . . . . 75.41 110.924 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -52.98 -48.79 67.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 73.03 110.906 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.4 ttm -57.83 -51.78 68.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 75.1 110.892 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.4 p -61.95 -28.34 69.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 73.41 111.111 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.81 -50.78 14.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 74.24 110.931 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 71.4 m -52.96 -42.19 65.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 73.33 110.895 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.7 tt -73.37 -34.95 44.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 71.41 111.127 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.9 t -69.14 -25.85 64.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 71.32 110.841 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.5 t -57.95 -34.6 49.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 72.42 111.12 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -52.89 -28.91 25.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 72.11 110.891 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.37 -38.92 78.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 74.13 110.95 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.6 -29.94 70.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 72.5 111.105 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.5 mt -65.08 -54.79 24.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 74.15 110.86 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.71 -38.38 87.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 75.33 111.173 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.3 t -71.48 -32.83 47.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 63.45 111.109 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -51.94 -30.0 22.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 74.42 110.855 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.08 -41.71 61.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 75.31 110.88 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.9 mt -73.2 -34.78 66.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 72.01 110.91 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.31 -55.09 11.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 74.32 110.885 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.19 -25.0 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 64.22 111.117 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.6 -14.9 63.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 73.43 110.851 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -59.23 -20.76 56.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 72.33 110.884 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.8 pt -51.55 -29.38 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 74.32 111.108 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.2 t 60.87 77.54 0.36 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.589 0.709 . . . . 62.13 111.112 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 167.57 24.06 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.714 2.276 . . . . 75.31 112.356 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -48.76 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.657 2.238 . . . . 73.21 112.33 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.5 t -131.73 9.89 4.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 73.42 111.179 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.73 52.74 13.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 75.11 110.82 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.89 25.65 4.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 73.25 110.91 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.3 23.71 12.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 75.44 110.87 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.528 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.37 -57.84 9.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.63 0.728 . . . . 73.34 111.133 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.3 Cg_endo -69.75 -20.35 35.01 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.716 2.277 . . . . 74.4 112.337 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.17 -53.02 10.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 73.22 110.937 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.6 t -80.75 -32.87 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 75.54 111.114 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.72 -52.1 35.69 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.707 -0.759 . . . . 61.03 112.476 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -35.01 79.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.778 0.323 . . . . 75.13 110.883 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -61.22 -36.61 80.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 75.13 110.906 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.2 mt -51.82 -29.87 21.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 71.25 110.924 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -69.25 -43.63 73.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 75.04 110.864 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -75.26 -51.26 13.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 75.14 110.867 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 t -53.05 -29.86 32.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 75.04 111.157 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.8 mmt -66.6 -30.24 70.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 74.41 110.859 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.67 -29.97 13.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 71.24 111.097 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.23 -33.49 61.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 72.15 110.903 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.3 m -77.53 -39.65 27.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 74.52 111.104 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.9 t -72.55 -32.3 65.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 70.33 111.082 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -56.83 -35.14 68.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 71.53 110.861 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.4 t -75.02 -32.59 61.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 73.12 110.882 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.3 mt -75.16 -51.3 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 75.02 111.092 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 p -53.99 -35.87 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 75.43 111.101 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.7 m -52.42 -32.36 38.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 74.32 111.135 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.2 t -50.33 -31.58 14.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 74.45 110.822 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.2 p -52.5 -32.77 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 73.32 111.124 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 35.5 m -66.2 -47.55 73.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 73.01 110.915 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.2 t -72.1 -36.09 55.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.475 . . . . 75.23 111.137 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.5 mt -72.04 -33.31 67.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 75.33 110.927 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -59.82 -30.72 69.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 75.22 110.906 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.4 p -102.26 -23.83 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 73.33 111.15 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 -85.44 -70.37 0.59 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 64.35 110.858 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.1 t60 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 73.23 110.869 179.965 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.478 -0.249 . . . . 75.5 112.478 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -87.89 -26.07 22.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.964 0.412 . . . . 73.42 110.947 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.3 m -54.35 -26.93 16.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.077 -0.511 . . . . 75.33 111.083 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.96 -25.05 41.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 73.34 111.091 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.94 -30.84 36.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 71.12 110.912 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 91.5 t -57.09 -59.31 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 75.45 111.08 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 65.1 mt -73.97 -35.26 41.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 73.14 111.137 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -62.98 -30.16 71.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 54.14 110.843 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -53.78 -28.23 33.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 73.2 110.881 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.8 mp -67.36 -48.91 66.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 73.12 110.888 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -73.67 -47.47 39.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 73.32 110.892 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.92 -49.74 62.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.483 . . . . 74.25 110.944 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -53.22 -32.3 47.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 75.42 110.94 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.8 mt -76.99 -42.33 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 74.44 111.118 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -56.17 -57.01 13.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 75.1 110.938 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 31.1 t -54.15 -37.08 34.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 75.23 111.118 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -70.01 -44.04 70.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 75.11 110.854 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 91.1 t -63.52 -34.09 65.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 73.15 111.158 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 17.2 m -51.85 -44.23 63.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 72.41 110.907 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 26.5 t -75.84 -33.19 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 72.42 111.097 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -58.8 -54.63 44.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 73.44 110.882 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -68.42 -19.4 72.58 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 64.21 112.512 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.1 m -75.64 -52.83 9.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.754 0.311 . . . . 74.34 111.172 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 49.3 mt -76.5 -27.5 17.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 73.5 111.132 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -53.65 -49.55 57.27 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.725 -0.75 . . . . 62.1 112.533 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -31.89 67.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 75.13 110.906 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 71.6 t80 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 74.1 110.877 -179.96 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.232 0.19 0 CA-C-O 120.828 0.262 . . . . 75.11 112.358 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 pp -52.16 -31.0 29.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 70.23 110.93 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -81.0 -31.95 34.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 75.14 110.865 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -72.51 -46.1 56.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 75.21 110.896 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 t -59.83 -40.17 87.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 73.41 111.146 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -29.11 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 72.32 111.105 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -55.59 -27.0 46.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 74.21 110.899 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.51 -18.95 23.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 75.42 110.947 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.8 mm -76.53 -35.17 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 72.43 111.103 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.52 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.3 mm -55.68 -57.15 22.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.609 0.718 . . . . 72.21 111.125 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.78 -21.4 33.45 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.67 2.247 . . . . 73.03 112.323 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.0 t -71.33 -45.36 63.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 65.4 110.912 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 p -81.62 -28.94 10.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 74.25 111.091 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 mt -50.95 -33.91 26.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 74.44 110.915 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.2 tp -58.77 -34.68 52.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 74.41 111.145 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.72 -39.81 91.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 54.23 111.145 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.95 -51.23 62.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 62.34 110.885 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.7 tp -70.68 -35.96 73.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 74.43 110.908 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.73 -38.84 82.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 73.23 111.075 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.25 -32.03 55.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 64.15 111.15 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 tp -51.42 -38.74 55.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 74.03 110.944 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.8 p -101.48 -36.79 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 73.21 111.145 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -66.97 -64.59 0.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 75.53 110.926 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.22 -25.98 62.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 74.44 110.924 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.6 mp -125.08 71.65 63.22 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.622 0.725 . . . . 74.42 110.9 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 173.27 11.19 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.748 2.299 . . . . 65.33 112.3 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.0 p -167.8 -170.27 1.34 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 75.42 110.876 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.0 95.71 10.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 72.14 110.839 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -179.1 138.78 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 71.11 110.841 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.33 -22.96 77.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.741 -0.743 . . . . 64.32 112.452 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -52.06 -34.94 45.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.932 0.396 . . . . 71.41 110.87 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.98 -51.57 61.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 72.42 110.905 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.8 ttm -65.41 -28.02 68.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 73.33 110.835 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.4 m -75.49 -31.65 60.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 73.11 111.148 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.45 -51.07 47.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 70.31 110.912 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -53.88 -48.01 70.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 65.11 110.887 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.6 tt -70.68 -34.95 58.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 72.15 111.119 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -61.52 -27.96 68.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 64.41 110.885 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.2 t -57.93 -39.48 71.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 74.41 111.099 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -29.13 27.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 71.44 110.915 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -74.56 -45.77 43.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 73.55 110.94 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.91 -29.59 20.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 72.32 111.086 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 37.3 mt -58.69 -54.46 46.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 73.45 110.91 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.31 -27.21 68.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 71.01 111.126 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 97.8 t -70.69 -33.05 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 75.4 111.154 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -64.7 -31.97 73.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 74.12 110.886 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.3 tp -75.1 -50.73 15.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 73.41 110.897 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.2 mp -65.84 -37.58 86.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 74.44 110.908 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.4 tt -62.63 -55.07 30.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 74.44 110.93 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.6 tt -66.31 -29.51 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 71.51 111.097 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.3 t -81.55 -14.78 56.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.822 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -93.67 -9.72 36.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 74.35 110.89 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.52 -16.88 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 74.55 111.122 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.2 t 64.28 78.01 0.29 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.561 0.696 . . . . 64.44 111.118 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 164.11 35.84 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.659 2.24 . . . . 73.01 112.355 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -49.3 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.745 2.296 . . . . 74.03 112.36 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 t -124.9 -35.32 2.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 75.43 111.153 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.24 -39.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 72.55 110.865 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.2 tp 64.53 70.6 0.49 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 74.13 110.917 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 50.15 60.17 4.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 72.22 110.894 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.521 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -68.62 -58.21 7.26 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.625 0.726 . . . . 71.23 111.114 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.4 Cg_endo -69.77 -26.02 27.98 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.673 2.248 . . . . 72.43 112.342 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.83 -39.81 69.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 75.33 110.916 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.3 t -80.53 -41.85 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 73.1 111.164 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.0 -46.39 55.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.769 -0.729 . . . . 53.51 112.464 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -32.95 69.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.816 0.341 . . . . 73.25 110.896 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -62.25 -31.97 72.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 72.41 110.879 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.3 mt -53.17 -29.8 33.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 71.42 110.903 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -42.48 86.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 74.42 110.859 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -75.26 -53.19 9.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 74.34 110.892 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -53.03 -29.93 32.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 75.4 111.165 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.1 mmt -66.61 -30.13 70.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 74.11 110.901 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.76 -30.1 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 64.41 111.116 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.92 -33.12 61.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 74.14 110.953 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.6 m -76.96 -37.99 27.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 73.3 111.118 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 70.5 m -72.53 -39.68 67.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 74.4 111.153 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -64.73 -31.93 73.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 64.05 110.847 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.6 t -74.3 -33.92 63.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.461 . . . . 73.33 110.852 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.3 mt -74.93 -50.65 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 72.5 111.151 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 34.7 m -54.15 -34.12 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 71.42 111.111 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.0 m -52.41 -32.45 39.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 74.01 111.188 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.4 m -50.42 -31.54 15.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 73.43 110.857 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.4 p -52.47 -32.8 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.496 . . . . 73.42 111.143 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 31.5 m -65.46 -43.17 91.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.143 -0.481 . . . . 63.04 110.846 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.3 t -77.12 -34.81 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 74.24 111.106 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.1 mt -72.05 -33.11 67.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 73.1 110.917 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -59.68 -31.03 69.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 73.31 110.888 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.8 p -102.32 -24.24 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 74.44 111.139 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -94.24 -74.68 0.53 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.472 . . . . 75.13 110.897 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 74.41 110.897 179.998 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.47 -0.252 . . . . 71.51 112.47 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -87.87 -26.11 22.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.914 0.388 . . . . 75.1 110.932 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.8 -36.92 77.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 74.34 111.08 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -67.04 -25.8 66.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 75.31 111.123 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 30.4 mmt -52.96 -30.95 37.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 71.42 110.91 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 74.8 t -56.97 -59.02 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 73.53 111.134 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.6 mp -74.01 -37.74 47.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 72.53 111.136 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -61.26 -29.94 70.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 73.42 110.896 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.08 -30.14 24.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 73.43 110.872 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.42 -42.24 68.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 74.32 110.933 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -74.0 -51.43 15.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 75.51 110.881 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.03 -33.31 38.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 73.33 110.893 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 45.6 t-105 -61.8 -45.42 93.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.236 -0.438 . . . . 71.03 110.924 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 50.8 mm -76.96 -32.87 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 72.13 111.135 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -56.07 -56.96 14.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 72.13 110.867 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.7 m -55.6 -35.0 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 72.24 111.146 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -69.72 -33.11 72.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 74.15 110.883 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 82.0 t -67.62 -33.99 65.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 64.44 111.144 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 67.9 m -66.32 -46.41 77.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 75.31 110.874 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 43.4 t -76.03 -36.82 32.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 74.43 111.104 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -71.87 -28.6 63.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 74.5 110.861 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -52.24 -27.75 24.81 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.754 -0.736 . . . . 71.25 112.468 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.8 t -53.81 -32.01 51.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 74.32 111.155 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 20.0 tt -55.89 -25.7 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 75.0 111.163 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -51.9 -49.93 46.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.723 -0.751 . . . . 61.02 112.507 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -73.92 -31.8 63.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.785 0.326 . . . . 72.45 110.825 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 77.4 t80 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.429 . . . . 75.11 110.906 -179.937 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.232 0.224 0 CA-C-O 120.794 0.248 . . . . 73.25 112.292 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 pp -52.0 -30.96 27.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 74.42 110.904 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -78.98 -33.31 45.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 71.55 110.901 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -72.5 -46.19 55.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 74.51 110.922 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -59.98 -40.03 87.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.511 . . . . 75.24 111.125 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.11 -29.1 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 75.23 111.141 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.1 -26.87 51.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 71.22 110.866 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.51 -19.2 23.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 73.13 110.9 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mm -76.76 -34.86 23.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 74.33 111.087 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.526 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.1 mt -55.72 -57.12 23.15 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.6 0.714 . . . . 74.25 111.109 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.4 Cg_endo -69.8 -20.34 34.77 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.683 2.255 . . . . 75.24 112.337 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 48.4 t -75.51 -44.26 44.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 62.13 110.869 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 p -81.54 -28.95 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 74.31 111.144 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.3 mt -50.97 -33.97 26.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 75.12 110.872 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.76 -34.66 52.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 64.51 111.121 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.83 -38.43 88.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.19 -0.459 . . . . 75.4 111.132 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.07 -49.08 67.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 72.54 110.849 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.0 tp -74.31 -36.02 63.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 73.44 110.938 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.48 -37.99 76.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 72.4 111.106 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.9 -32.49 58.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 73.24 111.108 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 tp -55.07 -33.77 63.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 75.01 110.882 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.76 -36.73 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 73.32 111.126 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -71.43 -64.91 0.83 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 71.1 110.903 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.98 -23.27 64.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 74.32 110.875 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.7 mp -128.05 73.6 79.3 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.634 0.73 . . . . 73.51 110.889 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 133.18 24.89 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.721 2.28 . . . . 75.33 112.351 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.2 m -87.08 -67.73 0.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 71.41 110.824 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.53 -75.14 0.59 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 73.03 110.841 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.45 -62.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 72.22 110.859 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.16 -62.93 5.26 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.751 -0.737 . . . . 71.2 112.477 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -51.94 -36.93 50.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 64.35 110.881 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -62.93 -44.06 97.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 75.11 110.882 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.0 tpt -72.06 -48.47 44.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 74.22 110.842 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 82.0 p -54.99 -26.15 34.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.424 . . . . 71.4 111.101 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.65 -37.4 59.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 73.52 110.874 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 35.0 m -74.01 -48.19 31.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 74.54 110.914 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.6 pt -54.92 -32.21 26.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 73.52 111.115 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.0 t -70.84 -25.14 62.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 71.24 110.838 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.1 t -57.94 -37.13 59.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 75.51 111.137 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mt -55.37 -29.7 58.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 64.21 110.907 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -69.85 -45.44 67.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 73.42 110.872 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.07 -29.7 22.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 74.42 111.082 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 23.9 mt -59.81 -54.53 45.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 73.34 110.932 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.76 -27.16 67.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 64.11 111.148 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.1 t -70.32 -32.94 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 72.3 111.127 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -61.66 -29.84 70.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 74.51 110.911 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.73 -50.3 63.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 74.43 110.903 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.4 -38.25 65.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 75.34 110.866 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.5 tt -58.03 -55.05 40.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 74.31 110.969 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 tt -66.62 -23.95 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 75.03 111.162 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.6 t -80.32 -17.96 50.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 70.11 110.817 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -12.18 60.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 74.34 110.925 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 47.7 pt -52.77 -28.04 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 75.24 111.151 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 57.5 t 61.48 77.14 0.37 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.664 0.745 . . . . 73.51 111.117 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 167.28 24.89 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.681 2.254 . . . . 74.52 112.318 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -48.99 0.6 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.656 2.237 . . . . 72.44 112.369 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 t -134.82 18.49 3.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 73.14 111.106 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.2 m 51.73 64.55 1.8 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 52.42 110.845 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.15 24.96 11.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 74.43 110.877 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -115.05 25.48 10.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 71.21 110.861 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.521 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -65.15 -57.61 14.92 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.643 0.735 . . . . 74.52 111.121 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.6 Cg_endo -69.76 -21.4 33.53 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.676 2.25 . . . . 70.01 112.326 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.0 mp -73.41 -52.97 11.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 75.15 110.935 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.1 t -80.03 -42.86 22.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.458 . . . . 63.03 111.14 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.41 -38.05 49.83 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.784 -0.722 . . . . 74.22 112.46 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.35 -23.7 60.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.789 0.328 . . . . 73.04 110.9 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -76.15 -39.34 55.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 72.34 110.951 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.0 mt -55.68 -29.74 59.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.108 -0.496 . . . . 72.24 110.924 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.9 mmt -70.23 -42.57 72.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 74.21 110.896 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -75.26 -51.09 14.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 74.21 110.863 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -53.23 -29.84 34.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 74.13 111.127 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.6 mmt -66.77 -30.01 70.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 75.44 110.877 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.81 -30.01 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 73.04 111.137 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.91 -33.12 61.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 74.03 110.916 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.2 m -76.55 -37.73 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 75.25 111.118 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 53.7 m -72.7 -46.6 52.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 72.12 111.097 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -51.86 -31.26 27.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 74.33 110.894 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 m -73.86 -51.09 17.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 70.41 110.842 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.6 mt -54.76 -34.68 30.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 65.43 111.117 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.6 t -54.02 -45.73 64.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 74.53 111.103 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.6 m -52.3 -32.45 37.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 74.13 111.152 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.1 p -50.41 -31.36 14.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 71.13 110.855 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.6 p -52.45 -32.86 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 70.3 111.154 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 28.9 m -65.86 -47.35 75.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.468 . . . . 71.25 110.897 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 84.6 t -72.46 -36.28 54.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 73.34 111.121 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.1 mt -72.05 -32.72 67.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 73.43 110.93 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -60.98 -30.59 70.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 73.53 110.852 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.8 p -102.3 -23.2 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 72.12 111.126 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -109.37 117.7 34.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 73.51 110.886 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 16.7 t60 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.456 . . . . 74.42 110.855 -179.979 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.501 -0.24 . . . . 63.32 112.501 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -66.29 -39.96 89.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.944 0.402 . . . . 74.22 110.952 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.7 m -54.72 -27.04 17.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 73.41 111.079 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.31 -25.33 48.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 62.32 111.094 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 37.1 mmt -53.01 -30.98 38.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 73.34 110.849 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 52.6 t -56.94 -58.26 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 64.11 111.114 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 45.5 mm -74.06 -37.94 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 75.14 111.101 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.73 -32.86 69.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 61.41 110.869 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.07 -26.02 59.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 73.35 110.895 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 16.1 tp -68.51 -50.88 48.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 75.54 110.939 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -73.23 -37.01 66.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 73.44 110.895 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.5 mt -52.02 -33.31 37.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 75.41 110.885 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -74.31 -34.53 63.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.213 -0.449 . . . . 75.44 110.905 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 36.0 mt -76.94 -32.01 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 75.15 111.101 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -56.05 -56.96 14.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 74.13 110.861 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.3 m -54.19 -34.99 28.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 64.54 111.132 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -67.34 -41.18 85.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 74.41 110.895 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 87.9 t -62.18 -34.04 61.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 52.23 111.121 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 98.9 m -53.8 -39.07 65.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.14 -0.482 . . . . 74.45 110.89 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.9 t -75.46 -33.0 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 74.51 111.122 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.98 -54.7 26.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 63.14 110.92 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.42 -19.35 79.87 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.794 -0.717 . . . . 73.04 112.461 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 34.6 m -73.61 -52.83 12.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.806 0.336 . . . . 70.52 111.176 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 45.4 mm -76.51 -24.26 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 73.52 111.128 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -53.95 -48.51 62.26 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.767 -0.73 . . . . 73.53 112.472 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.21 -33.14 50.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.762 0.315 . . . . 74.23 110.881 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 74.42 110.867 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.797 0.249 . . . . 74.11 112.388 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.99 -30.94 65.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 72.35 110.886 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -77.7 -32.24 52.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 74.33 110.873 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -73.45 -44.98 56.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 73.4 110.91 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 t -60.71 -39.71 89.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.102 -0.499 . . . . 71.21 111.183 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -29.07 21.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 71.34 111.097 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -56.0 -27.58 53.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 75.43 110.892 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.69 -18.42 25.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 75.31 110.908 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mm -76.79 -34.79 23.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 74.53 111.165 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.539 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.73 -57.16 22.94 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.61 0.719 . . . . 75.54 111.092 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.8 Cg_endo -69.75 -20.85 34.35 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.718 2.279 . . . . 62.24 112.335 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 48.6 t -76.0 -44.69 38.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 73.13 110.859 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.5 -28.88 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 75.45 111.183 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mt -51.01 -34.01 27.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 73.43 110.909 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.64 -34.73 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 72.32 111.143 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.75 -41.15 92.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 74.52 111.13 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.01 -43.01 66.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 72.01 110.865 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 tp -76.59 -40.03 50.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 74.3 110.938 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.72 -51.46 69.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 61.44 111.075 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.4 mp -49.73 -31.44 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 73.54 111.136 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.0 tp -50.76 -42.22 57.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 74.22 110.943 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.49 -37.48 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 75.23 111.145 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.68 -64.53 0.87 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 70.41 110.871 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.85 -62.0 1.61 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.484 . . . . 75.33 110.907 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.2 mp -67.89 160.67 72.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.599 0.714 . . . . 72.14 110.874 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 143.68 51.77 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.73 2.287 . . . . 64.42 112.329 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.17 -176.83 6.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 71.02 110.846 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -173.41 -169.99 0.57 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.5 . . . . 73.23 110.872 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 63.35 172.5 0.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 74.33 110.893 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.4 -22.93 39.91 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.712 -0.756 . . . . 65.0 112.48 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -51.97 -35.01 44.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.917 0.389 . . . . 73.41 110.887 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.3 ttpp -52.96 -52.0 59.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 75.14 110.897 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 6.8 tpt -72.01 -42.09 66.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 75.23 110.87 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.6 m -53.08 -28.4 24.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 62.42 111.13 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.53 -40.21 70.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 74.43 110.899 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 28.7 m -66.04 -45.65 80.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 75.31 110.908 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 12.4 tt -72.37 -35.05 50.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 73.13 111.145 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.14 -43.25 70.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 72.43 110.898 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.7 t -58.01 -34.83 49.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 73.31 111.134 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.87 -28.98 25.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 71.44 110.895 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -68.99 -39.25 79.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 74.31 110.896 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.39 -30.05 70.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 64.5 111.086 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.9 mt -64.85 -54.67 27.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 73.44 110.947 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.97 -38.22 87.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 72.45 111.172 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.5 t -71.37 -32.9 48.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 74.51 111.151 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -66.68 -29.88 69.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 75.25 110.853 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.3 tt -72.06 -47.61 50.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 61.41 110.896 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.5 mt -73.04 -39.63 65.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 75.41 110.915 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.9 tt -58.22 -51.3 70.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 73.41 110.932 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.6 tt -71.68 -26.2 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 70.21 111.145 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 25.5 t -80.53 -13.8 58.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 62.14 110.868 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.5 mmmt -50.71 -29.21 10.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 74.33 110.878 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.9 pt -50.53 -37.43 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 63.11 111.111 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.0 t 51.37 81.68 0.26 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.59 0.709 . . . . 74.35 111.178 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 167.47 24.43 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.657 2.238 . . . . 73.43 112.335 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -49.96 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.701 2.267 . . . . 73.04 112.342 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.2 t -136.75 -38.92 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 75.14 111.179 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.64 83.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 73.2 110.886 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.8 -18.04 16.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 72.5 110.893 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -153.7 24.1 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 72.35 110.873 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -66.9 -57.9 10.56 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.649 0.738 . . . . 73.04 111.159 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 54.1 Cg_endo -69.75 -21.54 33.38 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.709 2.273 . . . . 74.43 112.372 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.12 -53.17 10.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 65.34 110.938 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.7 -46.65 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 74.42 111.134 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.87 -39.46 47.94 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.754 -0.736 . . . . 32.22 112.47 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -73.22 -24.37 60.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.331 . . . . 70.31 110.922 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -74.43 -37.95 63.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 70.52 110.916 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.6 mt -57.38 -29.71 64.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.076 -0.511 . . . . 74.41 110.938 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 5.2 mmt -69.51 -43.57 72.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 74.13 110.866 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -75.16 -51.22 13.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 72.51 110.854 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 t -53.08 -29.9 33.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 74.4 111.097 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 9.0 mmt -66.65 -30.13 70.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 72.02 110.887 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.77 -30.18 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 72.11 111.114 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.79 -33.29 62.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 74.44 110.931 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.9 m -76.93 -38.06 28.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 74.11 111.097 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 76.7 m -72.4 -38.91 68.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 75.12 111.162 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -66.17 -31.93 73.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 72.31 110.874 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.0 t -73.41 -37.12 66.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 63.33 110.841 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.0 mt -70.29 -51.45 38.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 72.0 111.157 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.1 p -54.06 -35.53 29.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 63.22 111.15 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.3 m -52.41 -32.42 39.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 72.14 111.162 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.6 m -50.36 -31.54 14.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 74.04 110.847 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.3 p -52.51 -32.83 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 74.35 111.092 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 33.6 m -65.69 -43.56 88.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.199 -0.455 . . . . 73.22 110.863 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.9 t -76.74 -35.64 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 65.34 111.11 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 89.6 mt -72.1 -31.57 66.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 75.41 110.903 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -62.51 -30.26 71.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 64.21 110.896 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.9 p -102.31 -22.78 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 74.24 111.173 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -60.91 -74.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 73.32 110.903 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 73.15 110.86 179.97 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.481 -0.248 . . . . 63.32 112.481 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -87.9 -43.0 12.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.919 0.39 . . . . 72.41 110.951 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.2 m -54.97 -31.84 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 75.43 111.119 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.81 -24.99 61.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 65.52 111.069 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 18.2 mmt -52.93 -31.05 38.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 71.31 110.894 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 32.2 t -57.0 -49.44 79.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 63.55 111.105 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 30.8 mm -74.03 -40.65 52.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 74.4 111.121 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -61.97 -30.02 70.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 64.52 110.848 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.0 mtm-85 -54.32 -27.53 36.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 73.2 110.857 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 tp -67.66 -50.85 55.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 73.4 110.931 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -74.05 -31.44 62.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 75.31 110.847 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.15 -32.04 33.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 70.42 110.906 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -35.16 61.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 73.1 110.923 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 36.9 mm -76.91 -32.16 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 65.22 111.11 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -56.02 -56.74 17.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 74.44 110.923 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.27 -35.46 62.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 65.14 111.142 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.32 -33.07 67.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 75.31 110.851 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 28.8 t -65.96 -37.04 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 75.14 111.118 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.1 t -57.09 -51.69 68.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 73.41 110.854 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.9 t -69.17 -33.47 58.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 73.51 111.094 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -52.32 -53.5 43.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 75.33 110.895 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.04 -19.63 77.06 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.702 -0.761 . . . . 60.41 112.486 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 35.1 m -65.82 -52.83 47.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.74 0.305 . . . . 71.25 111.174 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 20.6 mt -76.58 -25.26 16.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 71.21 111.142 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -58.5 -49.92 72.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 62.01 112.462 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 9.6 mmt -70.13 -31.99 69.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.782 0.325 . . . . 75.02 110.854 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 75.3 t80 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 73.31 110.882 -179.972 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.232 0.197 0 CA-C-O 120.748 0.228 . . . . 73.4 112.3 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 pp -52.36 -30.98 31.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 74.11 110.905 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -80.99 -31.69 34.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.468 . . . . 75.22 110.902 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -72.88 -46.29 53.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 74.11 110.951 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 t -59.49 -40.09 85.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 65.23 111.145 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.16 -29.05 21.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 74.15 111.149 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.0 -26.87 50.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 71.21 110.91 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.5 -19.24 23.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 73.12 110.891 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mm -76.66 -34.95 24.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 74.01 111.131 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.526 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.65 -57.16 22.74 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.62 0.724 . . . . 74.1 111.12 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.4 Cg_endo -69.73 -20.45 34.95 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.743 2.295 . . . . 73.43 112.318 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 48.0 t -75.98 -44.54 39.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 73.54 110.885 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.2 p -81.57 -28.93 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 74.12 111.131 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 mt -50.98 -33.94 26.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.459 . . . . 75.12 110.93 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.1 tp -58.76 -34.64 52.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 74.32 111.122 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 p -65.79 -38.8 90.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 72.34 111.111 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 t -53.0 -46.46 68.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 75.33 110.866 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.63 -41.41 60.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 74.41 110.938 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.4 -35.74 68.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 75.51 111.089 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.81 -32.54 58.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 71.43 111.122 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.8 tp -55.04 -33.64 62.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 72.22 110.916 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.7 m -102.04 -35.57 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 75.53 111.102 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -72.58 -64.87 0.87 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 71.11 110.87 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.76 -41.14 96.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 74.21 110.911 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.49 74.78 2.29 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.639 0.733 . . . . 74.0 110.942 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 125.89 12.67 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.723 2.282 . . . . 74.4 112.312 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.8 t -116.31 -26.78 7.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 61.43 110.826 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -161.96 125.87 3.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.107 -0.497 . . . . 75.43 110.853 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.7 p -57.72 -26.0 61.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 73.21 110.871 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.95 -62.97 5.43 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.76 -0.733 . . . . 75.01 112.462 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -74.89 -35.46 62.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.889 0.376 . . . . 74.32 110.876 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -55.76 -50.49 70.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 73.42 110.869 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.5 ttm -64.96 -51.7 60.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 72.43 110.877 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 70.9 p -56.22 -28.63 59.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 73.05 111.175 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -72.78 -51.0 20.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 74.44 110.908 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.01 -49.67 65.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 71.54 110.887 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.6 tt -68.29 -35.01 69.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 72.43 111.125 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 m -65.71 -25.07 67.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 63.52 110.837 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.0 t -57.96 -37.57 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.494 . . . . 61.42 111.107 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -28.95 26.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 75.41 110.884 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.36 -38.86 78.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 74.32 110.917 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.53 -30.02 70.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 65.13 111.128 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.6 mt -65.08 -54.7 26.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 65.34 110.897 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.69 -38.49 88.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 73.21 111.152 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 80.0 t -71.43 -32.93 48.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 72.42 111.127 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -51.84 -30.18 22.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 74.34 110.917 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.22 -42.36 62.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.491 . . . . 75.04 110.936 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.6 mt -73.21 -33.91 65.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 74.11 110.897 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 tt -70.22 -55.07 10.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 73.21 110.973 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 tt -57.08 -30.43 34.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 74.32 111.104 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.1 m -80.17 -23.42 41.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 72.25 110.858 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.79 -12.75 61.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.477 . . . . 74.13 110.895 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.2 pp -56.31 -24.57 18.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 73.14 111.123 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 22.0 t 63.7 75.27 0.4 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.641 0.734 . . . . 72.22 111.151 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 167.53 24.22 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.658 2.238 . . . . 65.04 112.342 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 -48.66 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.69 2.26 . . . . 71.2 112.354 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.0 t -117.2 -19.79 9.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 74.54 111.143 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.69 45.08 4.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 73.54 110.872 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.6 tp -95.7 25.9 4.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 75.35 110.909 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -104.57 24.39 11.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 72.2 110.862 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.513 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.19 -57.79 10.23 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.642 0.735 . . . . 74.15 111.145 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 54.3 Cg_endo -69.79 -20.48 34.62 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.696 2.264 . . . . 74.41 112.359 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.12 -45.6 47.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 75.4 110.955 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.4 t -80.67 -37.85 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 62.21 111.121 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.92 -52.1 36.66 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.724 -0.751 . . . . 74.4 112.542 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -35.19 79.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.828 0.347 . . . . 72.14 110.895 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -60.77 -36.75 79.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 73.52 110.952 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.7 mt -51.89 -29.8 21.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 71.42 110.934 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 13.4 mmt -67.85 -43.12 80.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 74.51 110.916 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -75.28 -52.25 11.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 74.22 110.888 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -53.02 -29.91 32.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 74.51 111.165 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.72 -30.05 70.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 74.2 110.858 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.8 -30.04 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 65.13 111.134 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.91 -33.21 61.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 75.41 110.929 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.91 -38.09 28.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 74.53 111.156 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 73.0 m -72.46 -40.73 66.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 74.41 111.203 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -63.51 -32.17 73.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 63.33 110.88 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.0 t -71.38 -32.04 68.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 74.3 110.828 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.3 mt -75.01 -52.1 19.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 72.41 111.163 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.1 p -54.16 -36.65 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 75.24 111.139 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.7 m -52.38 -32.4 38.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 62.31 111.173 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.7 m -50.46 -31.29 14.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.463 . . . . 71.1 110.835 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.2 p -52.51 -32.73 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 75.53 111.109 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 17.9 m -64.15 -43.87 93.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 64.13 110.878 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 84.1 t -76.89 -34.74 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 63.42 111.087 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.4 mt -71.99 -32.25 67.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 72.2 110.895 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -59.18 -31.97 69.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 72.32 110.858 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.0 p -102.32 -24.84 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 75.41 111.166 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 -90.25 -73.73 0.51 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.123 -0.49 . . . . 74.43 110.828 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 75.32 110.816 -179.961 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.464 -0.254 . . . . 65.04 112.464 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -87.97 -29.81 20.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.987 0.422 . . . . 74.15 110.922 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.9 m -66.44 -35.93 76.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 63.21 111.105 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.46 -25.02 67.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 75.04 111.094 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 39.1 mmt -53.0 -31.02 38.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 73.02 110.872 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 64.5 t -56.99 -58.17 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.281 -0.418 . . . . 74.52 111.082 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.9 mt -73.95 -36.93 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 73.22 111.12 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -62.09 -29.94 70.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 63.5 110.884 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.18 -29.86 24.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 73.41 110.886 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.31 -39.48 74.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 74.2 110.879 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -73.86 -53.38 10.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 64.03 110.897 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.39 -33.6 44.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 74.24 110.913 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 20.7 t90 -55.51 -50.6 69.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 75.2 110.937 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 57.8 mt -76.01 -33.49 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 73.41 111.121 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -56.16 -56.02 25.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 63.11 110.867 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 23.2 t -59.95 -35.01 58.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 71.12 111.089 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -66.06 -33.27 75.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 70.21 110.895 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 78.7 t -54.25 -50.64 54.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 74.51 111.155 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.39 -47.7 66.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 74.44 110.921 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.7 t -63.67 -33.03 59.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 74.33 111.132 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -52.07 -54.94 24.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 74.42 110.893 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.32 -19.55 74.05 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 54.52 112.486 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.2 m -60.11 -52.82 63.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.733 0.301 . . . . 74.13 111.136 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 47.3 mm -76.48 -33.65 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 73.21 111.132 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -55.2 -49.98 61.31 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.741 -0.742 . . . . 61.51 112.51 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 3.3 mmt -72.43 -31.99 65.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.822 0.344 . . . . 75.32 110.91 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 17.5 t80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 74.43 110.856 -179.949 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.209 0 CA-C-O 120.843 0.268 . . . . 74.43 112.375 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.0 pp -52.08 -30.99 28.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 71.31 110.913 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -78.04 -33.59 50.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 73.24 110.882 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -72.64 -45.89 56.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 74.23 110.904 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -60.31 -39.96 88.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 64.31 111.14 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.17 -29.08 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 64.52 111.145 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.88 -27.26 51.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.42 110.861 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.1 -18.8 23.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 70.42 110.957 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.7 mm -76.54 -34.97 25.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 73.22 111.173 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.535 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.72 -57.15 22.97 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.583 0.706 . . . . 74.31 111.107 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.5 Cg_endo -69.77 -21.35 33.54 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.683 2.255 . . . . 72.53 112.285 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 47.3 t -75.87 -44.52 40.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 72.52 110.882 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.7 p -81.57 -28.93 10.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 71.23 111.139 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 mt -50.97 -34.01 27.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 74.41 110.907 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.1 tp -58.68 -34.68 52.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 65.25 111.141 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 p -65.69 -40.48 92.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.458 . . . . 72.34 111.138 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.97 -43.08 66.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 71.42 110.876 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.9 tp -76.96 -40.79 45.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.12 -0.491 . . . . 73.21 110.914 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.1 -36.52 68.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 61.24 111.103 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.28 -32.02 55.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 75.51 111.112 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.9 tp -51.43 -38.76 55.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 75.1 110.916 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -101.47 -36.69 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 74.34 111.154 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -67.02 -64.65 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 74.34 110.871 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.34 -60.8 2.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 74.13 110.907 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.0 mp -71.0 160.63 81.85 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.598 0.713 . . . . 74.33 110.921 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 144.63 54.77 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.701 2.267 . . . . 75.54 112.313 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.76 95.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 72.4 110.877 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 53.85 -172.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 73.1 110.862 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.4 m -114.81 -74.49 0.61 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 63.11 110.862 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.41 -27.74 66.18 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.726 . . . . 73.42 112.515 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -52.1 -34.92 46.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.852 0.358 . . . . 72.24 110.821 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.6 mttt -52.98 -51.92 59.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 71.35 110.894 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 9.7 ttm -64.3 -45.44 87.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 73.4 110.882 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.7 m -58.28 -36.96 74.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.446 . . . . 75.25 111.177 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.62 -32.6 60.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 73.02 110.939 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 6.8 m -65.26 -52.01 57.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 73.24 110.897 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.4 tt -60.26 -34.95 59.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 70.23 111.112 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -24.98 66.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 74.01 110.853 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.3 t -57.95 -35.59 52.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 74.4 111.137 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mp -52.98 -28.88 25.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 71.51 110.893 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.37 -38.99 78.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 71.34 110.925 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.45 -30.05 70.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 75.22 111.093 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.9 mt -64.7 -54.72 27.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 64.11 110.944 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.97 -38.17 87.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 72.25 111.112 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 76.4 t -71.44 -32.83 47.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 70.11 111.111 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -51.51 -30.67 21.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 73.33 110.909 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.9 tp -75.0 -40.06 60.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 75.51 110.915 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.9 mt -73.22 -34.8 66.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 72.01 110.916 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.11 -53.87 13.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.456 . . . . 73.32 110.906 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.6 tt -56.43 -26.17 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 74.34 111.104 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.5 m -80.15 -22.4 42.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 71.11 110.862 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -70.77 -10.5 59.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 74.33 110.873 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.4 pp -56.61 -23.72 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 72.24 111.133 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.4 t 64.11 75.49 0.38 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.598 0.713 . . . . 65.22 111.127 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 167.26 24.93 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.656 2.237 . . . . 63.25 112.348 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -48.8 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.713 2.275 . . . . 73.32 112.331 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.4 t -116.6 -19.93 9.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 74.44 111.148 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 p 63.46 23.27 13.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 64.54 110.873 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.72 31.21 2.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 75.22 110.915 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -94.63 47.16 1.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.457 . . . . 72.33 110.875 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.527 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -66.74 -57.72 11.22 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.586 0.708 . . . . 73.33 111.142 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.7 Cg_endo -69.77 -20.0 35.34 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.679 2.252 . . . . 74.35 112.322 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.15 -53.16 10.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.246 -0.434 . . . . 72.01 110.875 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.11 -38.01 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 72.12 111.085 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.1 -43.43 56.18 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.752 -0.737 . . . . 75.3 112.448 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -21.92 64.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.806 0.336 . . . . 74.11 110.911 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -78.13 -41.88 33.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 74.54 110.902 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.9 mt -55.69 -29.71 59.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 73.35 110.875 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -43.42 76.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 74.45 110.876 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.4 ' O ' HG22 ' A' ' 100' ' ' VAL . 50.9 t80 -75.27 -51.69 12.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 75.23 110.871 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 t -53.16 -29.88 33.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 74.34 111.113 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.8 mmt -66.63 -30.12 70.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 75.13 110.878 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.7 -30.08 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 75.43 111.153 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.0 -33.2 61.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 74.11 110.906 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.2 m -76.91 -38.12 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 74.43 111.155 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 74.1 m -72.47 -40.05 67.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.472 . . . . 74.33 111.135 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -64.49 -31.92 73.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 71.13 110.852 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.6 t -74.4 -34.51 63.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 61.2 110.859 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.5 mt -74.43 -50.72 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 72.41 111.135 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 34.5 m -54.05 -33.99 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 73.31 111.111 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.0 m -52.41 -32.53 39.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 63.23 111.164 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.1 m -50.45 -31.46 15.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 73.24 110.891 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.4 p -52.5 -32.73 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 72.15 111.115 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 35.5 m -66.94 -48.74 67.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 64.53 110.868 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 77.7 t -70.49 -35.37 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 74.43 111.124 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.0 mt -72.09 -40.31 68.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 74.32 110.911 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -52.12 -31.66 31.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 74.3 110.863 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.3 p -102.31 -24.18 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 73.21 111.139 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -54.02 -74.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 72.51 110.879 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 75.54 110.857 179.956 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.518 -0.233 . . . . 71.32 112.518 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -69.32 -26.35 64.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.969 0.414 . . . . 75.25 110.946 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.1 m -54.72 -27.1 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.054 -0.521 . . . . 75.31 111.113 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.83 -27.66 43.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 75.34 111.117 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 37.0 mmt -53.0 -31.01 38.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 71.42 110.876 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 62.4 t -56.94 -56.02 16.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.267 -0.424 . . . . 73.43 111.105 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.8 mp -73.94 -38.66 50.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 73.11 111.116 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -61.13 -30.46 70.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 73.35 110.899 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.76 -27.28 40.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.478 . . . . 71.15 110.88 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.01 -50.63 21.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 72.04 110.909 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -69.06 -53.59 19.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 74.4 110.887 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.08 -32.4 34.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 74.54 110.907 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -61.45 -51.48 68.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 74.54 110.884 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.1 mt -74.35 -32.0 29.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 75.12 111.156 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -56.0 -56.46 20.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 71.44 110.847 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 30.6 t -54.3 -35.56 30.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 73.31 111.138 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -69.96 -37.86 75.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 72.02 110.884 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 63.0 t -54.9 -34.06 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 72.41 111.145 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.78 -47.99 67.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 72.5 110.91 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.5 -36.69 42.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 73.2 111.126 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -54.89 -26.92 38.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 72.34 110.92 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.58 -59.05 4.26 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 73.35 112.423 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 4.4 t -54.59 -34.09 61.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.788 0.328 . . . . 70.23 111.162 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 47.6 mt -70.24 -25.21 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 74.14 111.091 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.83 -49.92 32.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.704 -0.76 . . . . 61.32 112.514 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.65 -32.01 57.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.345 . . . . 73.42 110.928 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 20.3 t80 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 74.01 110.879 -179.964 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.83 0.263 . . . . 71.12 112.313 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.0 pp -52.29 -30.95 30.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 75.41 110.923 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -80.26 -32.01 38.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 74.42 110.914 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -73.12 -46.16 52.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 75.04 110.926 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 t -59.67 -39.99 86.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 72.43 111.157 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.19 -29.1 21.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 74.44 111.132 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -55.58 -27.24 48.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 75.3 110.869 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.27 -19.08 23.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.201 -0.454 . . . . 75.44 110.93 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.8 mm -76.51 -35.03 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 74.22 111.138 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.535 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.68 -57.14 22.91 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.609 0.719 . . . . 74.52 111.127 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.9 Cg_endo -69.75 -21.58 33.32 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.683 2.255 . . . . 72.04 112.308 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.2 t -73.09 -46.91 48.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 73.24 110.871 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.5 p -81.53 -29.01 10.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 70.21 111.117 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.1 mt -50.89 -34.01 26.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 73.31 110.949 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.2 tp -58.76 -34.64 52.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 74.55 111.113 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.3 p -65.66 -34.53 78.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 64.42 111.141 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.06 -49.01 72.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 75.33 110.864 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.0 tp -73.17 -43.21 61.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 61.01 110.922 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.94 -39.99 75.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 73.41 111.13 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.07 -32.45 58.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 73.31 111.102 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.0 tp -51.57 -37.15 48.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 65.2 110.915 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.01 -35.78 4.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 71.31 111.09 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -67.08 -62.86 1.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 74.24 110.881 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.23 -40.33 70.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 75.43 110.922 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.43 159.18 85.73 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.602 0.715 . . . . 73.02 110.887 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -172.28 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.615 2.21 . . . . 74.41 112.389 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.9 t 63.28 87.75 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 71.33 110.865 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -89.86 50.4 1.88 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 73.03 110.875 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.7 p -63.21 -173.38 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 71.32 110.898 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.2 -30.02 30.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.754 -0.736 . . . . 71.53 112.492 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -60.89 -34.88 75.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.977 0.417 . . . . 73.1 110.932 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -46.07 82.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 71.44 110.873 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 23.9 ttm -71.64 -46.49 58.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 72.32 110.889 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 30.4 p -54.38 -27.18 34.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 72.43 111.109 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.24 -51.0 34.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 74.24 110.906 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 7.3 m -54.66 -46.53 74.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.429 . . . . 71.21 110.931 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 15.8 tt -71.22 -34.96 56.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 74.21 111.148 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 m -53.85 -28.07 33.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 70.41 110.898 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.0 t -58.08 -38.37 67.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.487 . . . . 72.22 111.169 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.91 -28.87 25.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 72.54 110.962 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.01 -39.04 79.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 75.31 110.927 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.48 -29.97 70.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 71.23 111.084 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.5 mt -66.04 -54.81 21.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 63.31 110.903 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -60.94 -38.37 85.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 71.14 111.148 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 81.9 t -71.5 -37.19 63.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 73.32 111.124 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -68.55 -31.87 71.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 73.31 110.853 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.8 tt -75.03 -43.62 52.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 75.24 110.904 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.8 mp -73.32 -44.06 59.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 74.45 110.893 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.3 tt -55.55 -55.16 35.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 72.44 110.936 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.4 tt -62.91 -25.08 37.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 75.31 111.074 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.4 m -80.14 -14.62 58.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 75.33 110.848 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -54.43 -26.42 30.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 72.13 110.891 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.423 ' O ' ' C ' ' A' ' 81' ' ' VAL . 1.0 OUTLIER -62.42 -16.78 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 75.34 111.084 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' A' ' 80' ' ' ILE . 2.4 p 35.53 80.95 0.25 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.601 0.715 . . . . 73.34 111.097 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 165.76 29.87 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.714 2.276 . . . . 73.12 112.376 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 -50.13 0.5 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.704 2.269 . . . . 75.42 112.388 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.5 t -136.98 -38.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 71.53 111.14 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 178.7 82.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 74.35 110.85 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.21 -17.82 20.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 64.54 110.914 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -152.56 23.88 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 74.24 110.879 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -66.86 -57.8 10.82 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.63 0.728 . . . . 73.33 111.113 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.4 Cg_endo -69.79 -21.55 33.21 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.67 2.247 . . . . 72.33 112.322 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.15 -53.1 10.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.44 . . . . 75.24 110.934 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.32 -44.89 24.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 74.23 111.164 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.04 -39.2 48.83 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.736 -0.745 . . . . 53.21 112.446 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -73.75 -23.56 59.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.798 0.333 . . . . 73.45 110.936 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -75.35 -37.82 60.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 75.42 110.931 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.9 mt -54.45 -29.85 50.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 73.51 110.89 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.36 -43.65 73.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 55.21 110.885 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -75.17 -51.12 14.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 73.03 110.884 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 t -53.15 -29.74 33.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 73.12 111.129 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.78 -30.18 70.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.44 . . . . 73.52 110.909 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.85 -29.95 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 72.31 111.154 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.06 -33.22 61.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 73.43 110.915 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.1 m -76.91 -38.06 28.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 73.32 111.164 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 74.5 m -72.51 -38.54 68.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 75.11 111.113 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -66.41 -31.84 72.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 73.3 110.87 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.01 -34.76 64.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 73.24 110.872 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.3 mt -73.83 -51.03 25.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 73.01 111.177 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.2 m -53.94 -34.21 25.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 65.32 111.133 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.3 m -52.39 -32.51 39.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 74.02 111.144 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.0 p -50.41 -31.45 14.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 75.43 110.862 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.5 p -52.56 -32.8 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 75.21 111.118 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 27.3 m -66.2 -48.14 71.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 74.12 110.905 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.6 t -71.44 -35.98 59.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 63.22 111.144 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.8 mt -72.03 -34.68 68.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 75.11 110.912 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -55.44 -32.73 62.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 74.02 110.886 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.6 p -102.34 -24.28 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 64.54 111.121 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -81.48 -70.08 0.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 75.4 110.812 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 75.23 110.871 -179.965 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.518 -0.233 . . . . 73.11 112.518 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -87.17 -30.78 20.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.893 0.378 . . . . 72.15 110.882 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 23.4 m -73.66 -28.26 24.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 71.13 111.16 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.95 -25.12 42.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 54.42 111.146 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -52.96 -30.88 37.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 63.24 110.89 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 64.9 t -56.97 -56.66 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 74.12 111.141 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 31.9 mm -74.09 -36.42 44.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 75.22 111.133 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -62.84 -29.88 71.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 71.32 110.864 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.18 -27.6 35.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 74.03 110.909 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.9 tt -70.47 -50.22 40.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 75.34 110.928 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -72.09 -28.95 63.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 74.54 110.925 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.8 tt -56.77 -40.74 76.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 71.01 110.918 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -72.44 -51.07 21.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 74.33 110.976 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 51.0 mm -57.96 -32.21 42.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 73.22 111.164 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -56.27 -57.14 13.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 73.44 110.878 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 21.7 t -66.73 -36.31 76.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.48 . . . . 74.44 111.108 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.34 -36.13 68.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 75.11 110.851 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 94.4 t -58.82 -53.22 50.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 75.24 111.117 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -56.23 -32.6 64.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 75.54 110.893 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 67.5 t -71.07 -34.2 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 74.33 111.097 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -71.88 -27.44 62.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 73.22 110.939 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.07 -48.58 5.99 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.705 -0.76 . . . . 71.33 112.482 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.4 t -51.81 -39.39 58.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.751 0.31 . . . . 73.1 111.14 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 41.1 mt -63.09 -43.18 98.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 71.43 111.135 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -52.88 -48.55 57.27 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.747 -0.74 . . . . 74.05 112.495 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -31.94 66.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.792 0.329 . . . . 74.42 110.887 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 1.5 t80 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.443 . . . . 72.41 110.902 -179.944 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.821 0.259 . . . . 71.51 112.369 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 pp -51.99 -30.95 27.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 73.32 110.927 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -78.82 -33.49 46.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 75.1 110.879 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -72.46 -46.23 55.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 72.51 110.94 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -60.08 -40.02 88.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.511 . . . . 64.21 111.11 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.19 -29.11 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 74.2 111.101 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -55.8 -27.12 49.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 72.04 110.856 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.29 -19.19 23.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 71.31 110.942 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.6 mm -76.6 -34.94 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 65.03 111.134 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.53 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.3 mm -55.61 -57.21 22.35 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.659 0.742 . . . . 64.12 111.136 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.6 Cg_endo -69.82 -20.91 33.95 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.661 2.24 . . . . 64.11 112.336 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 48.6 t -75.98 -44.65 38.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 75.41 110.908 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.61 -28.86 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 71.41 111.128 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.3 mt -50.97 -33.97 26.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 73.24 110.919 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.76 -34.65 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 64.5 111.131 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 p -65.81 -39.73 91.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 64.41 111.188 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.99 -51.11 62.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 74.31 110.809 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.9 tp -69.48 -38.81 77.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 75.13 110.896 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.7 -39.64 77.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 54.01 111.106 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.33 -31.93 55.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 70.14 111.125 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.5 -38.7 55.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 74.21 110.927 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -101.45 -36.73 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 73.22 111.139 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -67.1 -64.62 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 74.34 110.894 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.22 -61.96 1.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 74.13 110.944 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.2 mp -67.62 160.65 71.58 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.617 0.723 . . . . 75.22 110.928 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 161.53 45.56 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.722 2.282 . . . . 64.41 112.336 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -174.88 -69.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 72.1 110.895 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -178.37 -171.73 0.27 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 71.11 110.887 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 50.2 t -94.83 -74.39 0.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 73.13 110.892 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.75 -47.1 59.2 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 70.41 112.506 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.56 -35.54 70.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.916 0.389 . . . . 65.22 110.862 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -66.02 -44.58 84.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 75.41 110.885 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.35 -45.76 71.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 72.43 110.863 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 77.3 p -62.45 -26.09 68.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 73.41 111.131 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.24 -37.34 61.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 73.22 110.913 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 82.5 m -74.0 -48.65 28.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 74.32 110.839 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.7 pt -54.85 -32.26 25.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 73.41 111.121 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.1 -28.45 67.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 70.01 110.9 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.13 -38.25 66.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 74.05 111.141 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tp -52.89 -28.92 25.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 72.34 110.876 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.23 -38.94 78.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 74.42 110.933 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.65 -30.01 70.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 74.3 111.093 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.2 mt -65.31 -54.81 23.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 72.21 110.87 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.47 -38.63 87.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 71.24 111.151 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.2 t -71.52 -32.96 47.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 65.24 111.13 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -52.03 -34.09 41.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 74.42 110.889 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.1 tp -60.96 -51.11 70.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 74.41 110.939 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.5 mt -73.14 -32.13 64.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.47 . . . . 74.21 110.87 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.7 tt -66.69 -52.33 45.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 71.24 110.895 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.5 tt -69.17 -30.55 46.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 74.13 111.117 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.0 m -80.19 -21.3 43.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 72.2 110.862 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -60.38 -19.95 57.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.107 -0.497 . . . . 74.33 110.947 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -59.17 -20.71 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 72.13 111.132 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.8 t 51.56 76.62 0.52 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.609 0.719 . . . . 71.41 111.118 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 112.08 2.99 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.711 2.274 . . . . 72.52 112.35 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 -48.61 0.67 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.716 2.277 . . . . 72.31 112.309 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.5 t -117.05 -21.86 8.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 73.12 111.13 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.18 -48.74 61.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 73.43 110.86 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.3 tp 51.0 56.14 8.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.108 -0.496 . . . . 74.13 110.918 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -95.36 24.03 5.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 75.31 110.875 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.523 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.2 -57.82 10.16 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.609 0.719 . . . . 60.42 111.132 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.9 Cg_endo -69.76 -20.8 34.35 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.706 2.27 . . . . 74.34 112.324 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.07 -53.13 10.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 75.43 110.939 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.6 t -65.37 -36.43 77.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 61.21 111.135 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.94 -41.46 52.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.761 -0.733 . . . . 52.12 112.464 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.6 mmpm? -75.21 -22.07 58.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.748 0.308 . . . . 74.24 110.867 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -75.68 -33.4 60.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.259 -0.428 . . . . 75.14 110.954 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.2 mt -53.39 -29.83 36.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 72.3 110.937 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.26 -43.65 73.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 65.4 110.923 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -75.23 -51.16 14.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 74.42 110.901 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 t -53.17 -29.93 34.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 72.14 111.126 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.0 mmt -66.53 -30.15 70.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 75.24 110.892 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.85 -30.07 13.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 74.43 111.135 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.88 -33.2 62.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 74.2 110.94 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.1 m -76.92 -38.08 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 74.12 111.129 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 78.8 m -72.48 -38.55 68.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 75.33 111.107 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -66.86 -32.03 73.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 74.14 110.888 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.0 t -71.56 -35.55 70.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 75.23 110.831 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.4 mt -71.7 -51.92 29.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 74.44 111.112 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 p -54.05 -36.36 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 72.25 111.139 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.1 m -52.34 -32.41 37.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 75.33 111.182 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.0 m -50.46 -31.32 14.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 72.51 110.836 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.3 p -52.49 -32.83 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 75.13 111.089 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 23.6 m -65.51 -44.35 87.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 73.32 110.926 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 82.1 t -75.96 -35.83 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 75.34 111.067 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.0 mt -71.95 -31.79 66.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 75.22 110.95 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -60.03 -31.71 70.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 74.51 110.919 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.3 p -102.32 -24.77 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 75.41 111.151 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -90.47 -74.14 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 71.51 110.869 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 74.02 110.896 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.516 -0.234 . . . . 73.15 112.516 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -87.9 -26.48 22.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.924 0.392 . . . . 73.54 110.911 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.5 m -55.59 -30.79 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 65.12 111.122 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.02 -26.08 63.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 51.0 111.101 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 31.8 mmt -52.95 -30.99 37.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 74.55 110.904 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 52.4 t -57.01 -58.43 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 73.2 111.109 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 44.5 mm -73.98 -37.77 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 71.14 111.135 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -61.17 -30.4 70.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 71.14 110.9 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.78 -28.19 33.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 74.32 110.903 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.0 tp -65.4 -50.81 64.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 75.24 110.916 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -73.78 -42.89 60.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 74.33 110.876 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 tt -52.01 -32.78 35.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 73.31 110.892 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -66.63 -43.01 85.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 74.03 110.931 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.9 mt -76.43 -32.15 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 75.34 111.099 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -55.96 -56.41 21.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 74.34 110.884 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.2 m -60.72 -35.22 62.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 63.23 111.072 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -64.68 -41.52 95.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 74.03 110.855 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 88.9 t -58.39 -34.23 49.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 75.55 111.106 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 89.8 m -57.79 -51.98 67.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 43.11 110.842 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 57.0 t -75.99 -35.23 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 72.13 111.089 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -63.42 -37.73 88.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 74.3 110.919 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.25 -46.14 9.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.792 -0.718 . . . . 71.34 112.445 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 95.4 m -59.96 -51.99 67.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.785 0.326 . . . . 73.41 111.16 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 20.4 tt -55.9 -26.63 21.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 73.52 111.129 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -52.0 -49.99 46.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.764 -0.732 . . . . 63.22 112.447 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.2 mmt -71.65 -31.81 67.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 73.23 110.919 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 50.0 t80 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 75.04 110.904 -179.952 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.231 0.147 0 CA-C-O 120.822 0.259 . . . . 74.01 112.354 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.07 -30.96 65.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 72.31 110.86 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -78.26 -31.82 49.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 74.21 110.917 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -73.63 -44.87 55.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 75.54 110.876 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -60.55 -39.86 89.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 62.21 111.156 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -29.07 21.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 75.44 111.135 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.03 -27.08 51.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 72.23 110.898 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.31 -19.19 23.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 71.14 110.904 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.4 mm -76.87 -34.62 22.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 75.13 111.112 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.525 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.78 -57.08 23.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.614 0.721 . . . . 70.01 111.13 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.4 Cg_endo -69.77 -19.34 36.21 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.709 2.273 . . . . 64.22 112.348 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 37.4 t -70.12 -46.29 65.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 74.42 110.872 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 p -81.53 -28.91 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 75.53 111.16 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.5 mt -51.04 -33.91 27.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 70.24 110.902 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.2 tp -58.73 -34.64 52.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 75.34 111.146 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 p -65.73 -36.56 83.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 72.42 111.096 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.37 -44.77 72.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 74.54 110.881 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.01 -42.3 39.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 62.22 110.91 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.11 -34.63 66.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 73.3 111.126 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.1 mp -64.54 -32.39 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 75.04 111.121 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.4 tp -51.55 -37.43 49.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 74.2 110.932 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -101.98 -36.13 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 65.35 111.144 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -68.31 -64.96 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 75.42 110.885 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -56.36 -39.15 72.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.148 -0.478 . . . . 74.33 110.916 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.7 tp -57.61 139.0 81.79 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.613 0.72 . . . . 74.41 110.871 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 178.81 4.21 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.663 2.242 . . . . 50.24 112.349 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.23 161.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 64.23 110.859 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -160.88 175.9 12.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.102 -0.499 . . . . 74.55 110.87 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.5 p -176.19 -174.36 0.62 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 63.55 110.892 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.52 -31.45 63.32 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.737 -0.744 . . . . 62.41 112.486 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -75.09 -54.74 6.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.882 0.372 . . . . 74.51 110.904 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -53.2 -45.33 68.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 74.44 110.919 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -57.68 -51.74 68.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 73.45 110.844 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 60.4 p -65.37 -28.43 69.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.264 -0.425 . . . . 75.35 111.136 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.51 -34.57 67.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 74.45 110.934 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 80.2 m -72.78 -51.99 16.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 74.21 110.913 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.5 tt -54.39 -33.06 25.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 74.14 111.112 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.69 -25.24 6.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 74.05 110.858 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.9 p -57.13 -32.62 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.485 . . . . 75.31 111.127 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.93 -35.36 61.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 72.41 110.917 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -68.96 -46.7 67.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 63.2 110.891 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.8 -29.53 19.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 75.12 111.089 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 40.9 mt -57.83 -54.51 46.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 75.45 110.918 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.2 t -63.45 -27.28 69.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 74.2 111.156 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.6 t -71.35 -34.11 52.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 74.44 111.169 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -52.07 -30.11 24.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 75.1 110.865 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.93 -39.49 61.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 72.45 110.923 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.0 mp -73.24 -40.13 64.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 73.52 110.902 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.6 -55.05 22.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 73.24 110.937 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 tt -56.22 -24.69 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 73.21 111.17 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.1 p -68.1 -15.0 63.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 74.32 110.876 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -19.83 55.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 74.24 110.94 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pt -53.57 -27.17 14.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 64.34 111.134 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 50.2 t 61.41 75.23 0.45 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.661 0.743 . . . . 71.43 111.101 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 167.46 24.35 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.663 2.242 . . . . 75.04 112.395 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -48.64 0.67 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.671 2.247 . . . . 71.42 112.35 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.6 t -117.26 -19.63 9.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 71.01 111.15 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.3 t 63.72 38.37 9.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.451 . . . . 72.43 110.822 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 tp -99.72 35.33 2.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.144 -0.48 . . . . 71.0 110.94 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -95.58 24.37 5.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 64.45 110.887 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.514 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.31 -57.73 10.13 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.623 0.725 . . . . 62.3 111.195 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.6 Cg_endo -69.82 -20.32 34.71 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.664 2.242 . . . . 71.04 112.329 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.14 -53.09 10.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 72.25 110.949 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.7 t -80.31 -20.53 11.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 75.2 111.116 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.28 -31.49 27.45 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.775 -0.726 . . . . 75.23 112.494 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -35.39 59.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.8 0.333 . . . . 75.53 110.883 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -65.69 -44.84 84.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 75.13 110.872 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.5 mt -51.94 -29.81 21.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 73.55 110.953 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -43.38 76.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 72.21 110.892 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.401 ' O ' HG23 ' A' ' 100' ' ' VAL . 33.7 t80 -75.22 -51.83 12.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 74.42 110.9 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -53.07 -29.97 33.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 74.25 111.185 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.2 mmt -66.61 -30.04 70.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 75.54 110.923 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.83 -30.04 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 73.23 111.111 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.92 -33.31 61.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 74.44 110.947 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.8 -38.07 29.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 74.33 111.115 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 71.4 m -72.49 -39.81 67.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 74.14 111.149 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -64.69 -31.96 73.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 74.13 110.898 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.4 t -71.54 -35.75 70.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 64.14 110.859 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.7 mt -71.58 -51.83 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 73.5 111.116 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 p -53.97 -35.1 27.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 74.01 111.13 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.6 m -52.34 -32.43 38.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 75.25 111.146 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.4 m -50.42 -31.52 15.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 60.21 110.871 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.5 p -52.49 -32.79 17.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.102 -0.499 . . . . 71.43 111.153 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 42.1 m -66.59 -45.66 78.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 75.42 110.868 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 88.4 t -73.91 -34.7 40.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 75.42 111.128 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.07 -42.02 66.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 75.11 110.906 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -52.02 -30.71 26.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 75.32 110.901 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.4 p -102.31 -23.07 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 71.34 111.13 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -52.49 -66.22 0.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 74.42 110.896 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 74.31 110.876 179.994 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.467 -0.253 . . . . 74.24 112.467 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -63.29 -26.12 68.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.961 0.41 . . . . 75.32 110.953 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.8 m -56.9 -33.68 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.116 -0.493 . . . . 75.52 111.15 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.2 -25.22 67.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 74.2 111.091 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 16.7 mmt -53.0 -30.92 38.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 74.22 110.833 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 49.2 t -56.96 -63.86 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 75.4 111.11 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.0 mp -70.46 -38.35 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 73.44 111.134 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -60.56 -30.02 69.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 73.41 110.879 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.5 mtt-85 -56.18 -26.03 49.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 75.41 110.881 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.01 -50.99 35.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 74.14 110.941 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -73.97 -28.44 61.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 64.43 110.862 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.02 -36.4 83.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 71.42 110.913 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -58.99 -48.74 80.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 73.11 110.883 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 58.5 mt -77.04 -32.29 19.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 75.01 111.159 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.0 -56.88 15.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 75.03 110.89 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.42 -35.06 60.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 74.35 111.155 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.06 -32.97 74.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 71.54 110.892 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.9 t -53.98 -34.11 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 75.42 111.139 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 4.8 t -52.03 -42.98 63.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 73.14 110.878 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 25.5 t -75.99 -33.03 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 73.53 111.124 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -52.44 -49.9 63.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 73.23 110.93 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.2 -19.78 73.87 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.71 -0.757 . . . . 74.41 112.53 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.4 m -63.46 -52.85 59.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.783 0.325 . . . . 52.41 111.167 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 89.2 mt -76.49 -25.89 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 73.02 111.149 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -52.19 -29.39 29.15 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 74.51 112.502 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.92 -31.9 51.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.737 0.303 . . . . 64.03 110.883 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 74.1 110.843 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.192 0 CA-C-O 120.835 0.265 . . . . 73.54 112.319 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 pp -52.08 -30.99 28.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 73.21 110.933 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -80.08 -32.52 39.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 72.24 110.838 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -72.66 -46.25 54.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.206 -0.452 . . . . 71.42 110.892 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -59.81 -39.95 86.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.492 . . . . 65.23 111.148 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.13 -29.06 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 73.15 111.135 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.65 -27.59 50.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 74.43 110.886 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.78 -18.14 25.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 73.44 110.896 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.9 mm -76.33 -35.31 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 71.01 111.083 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.533 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.77 -57.13 23.23 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.605 0.717 . . . . 75.23 111.098 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.9 Cg_endo -69.8 -21.83 32.74 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.689 2.259 . . . . 75.44 112.374 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.6 t -73.86 -44.43 55.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 73.54 110.826 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.57 -28.91 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 74.32 111.138 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mt -50.97 -33.93 26.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 74.32 110.948 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.2 tp -58.73 -34.68 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 74.54 111.122 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.2 p -65.69 -42.84 90.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 72.33 111.093 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.99 -41.74 64.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.425 . . . . 74.35 110.829 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.4 tp -77.03 -38.43 52.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 73.14 110.946 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.8 -52.14 67.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 73.33 111.056 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.4 mp -49.72 -31.44 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 72.41 111.079 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.2 tp -50.79 -42.3 57.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 74.21 110.926 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -101.46 -37.5 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 63.1 111.12 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -63.68 -64.46 0.89 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 75.4 110.85 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.89 -60.73 2.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 75.32 110.897 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -78.39 159.22 75.35 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.549 0.69 . . . . 75.42 110.943 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 138.68 38.31 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.657 2.238 . . . . 73.45 112.321 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.3 112.67 0.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 65.12 110.854 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 56.32 -176.06 0.05 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.145 -0.479 . . . . 74.22 110.859 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 50.0 t -113.7 -74.51 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 74.25 110.859 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.71 -23.01 62.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.742 . . . . 60.15 112.493 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -52.11 -34.96 46.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.914 0.387 . . . . 73.52 110.932 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -51.96 60.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 73.53 110.911 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -48.56 68.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 71.22 110.852 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 29.3 p -53.07 -31.88 44.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 74.43 111.134 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -50.84 43.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 63.42 110.93 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 68.1 m -52.97 -47.75 67.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 74.55 110.861 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.3 tt -72.31 -35.04 51.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 72.45 111.141 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.67 -25.61 60.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 64.33 110.879 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.09 -41.39 92.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.101 -0.5 . . . . 74.21 111.119 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 tt -52.88 -28.87 25.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 63.12 110.991 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.26 -39.1 78.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 72.33 110.872 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.41 -30.03 70.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 75.21 111.099 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.8 mt -64.78 -54.7 27.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 74.05 110.957 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.94 -38.26 87.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 64.33 111.147 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.0 t -71.44 -32.82 47.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 65.2 111.134 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -61.85 -29.85 70.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 72.45 110.89 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 tt -71.99 -44.93 62.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 75.11 110.941 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.7 mp -73.22 -39.31 65.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 75.03 110.931 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.28 -51.67 67.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.51 110.907 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.8 tt -68.17 -30.2 47.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 75.2 111.092 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.1 t -80.53 -14.93 57.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 75.15 110.821 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.29 -9.9 58.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.151 -0.477 . . . . 75.22 110.903 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.413 ' O ' ' C ' ' A' ' 81' ' ' VAL . 1.1 pp -63.84 -15.37 16.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.422 . . . . 73.34 111.147 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 80' ' ' ILE . 2.4 p 35.79 81.21 0.25 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.609 0.718 . . . . 71.02 111.137 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 167.3 24.78 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.704 2.269 . . . . 74.02 112.364 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 -48.61 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.657 2.238 . . . . 73.51 112.313 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.0 t -117.26 -19.48 9.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 74.32 111.125 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.54 46.99 3.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 74.24 110.866 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.1 -11.1 60.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 75.21 110.901 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -95.36 23.96 5.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 75.22 110.892 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.515 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.58 -57.8 9.56 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.626 0.727 . . . . 71.12 111.161 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.5 Cg_endo -69.77 -20.02 35.31 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.679 2.253 . . . . 64.2 112.358 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.22 -53.1 10.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 75.15 110.863 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.3 t -68.6 -43.42 83.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 73.12 111.146 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.07 -38.86 48.43 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.76 . . . . 72.21 112.497 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.66 -24.39 59.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.783 0.325 . . . . 74.44 110.902 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -74.5 -37.92 62.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 73.12 110.897 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.5 mt -54.79 -29.57 54.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 75.14 110.927 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.0 mmt -71.28 -41.56 69.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 72.44 110.884 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -75.28 -51.06 14.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 74.4 110.888 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -53.09 -29.87 32.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.474 . . . . 74.11 111.18 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.68 -30.09 70.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 63.33 110.85 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.8 -30.05 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.443 . . . . 72.32 111.113 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.93 -32.99 61.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 75.11 110.924 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.4 m -76.6 -37.46 29.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 72.44 111.091 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 55.3 m -72.98 -46.6 51.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 75.24 111.154 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -51.96 -31.7 30.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 74.35 110.916 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.8 p -74.59 -48.73 24.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 72.23 110.813 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.8 mt -56.15 -34.52 39.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 75.55 111.148 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.1 t -53.85 -45.55 62.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 71.35 111.083 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.9 m -52.3 -32.38 37.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 70.11 111.153 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.5 t -50.28 -31.49 14.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 74.34 110.857 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.5 p -52.51 -32.83 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 74.34 111.159 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 34.7 m -65.89 -44.52 85.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 73.22 110.874 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 83.8 t -75.52 -35.78 33.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 74.44 111.154 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.8 mt -72.21 -33.62 67.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 73.15 110.916 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -62.6 -28.95 70.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 64.54 110.93 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.2 p -102.39 -20.94 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 72.22 111.084 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -76.08 73.69 2.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 73.24 110.833 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 73.23 110.836 179.964 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.543 -0.223 . . . . 42.23 112.543 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -62.14 -26.39 68.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.968 0.413 . . . . 74.24 110.945 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.4 m -54.14 -27.2 16.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 74.11 111.147 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.62 -26.25 55.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 75.02 111.136 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 11.3 ptm -53.04 -30.79 37.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 64.32 110.846 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 58.6 t -56.9 -61.55 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 73.14 111.159 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.5 mp -74.06 -25.96 20.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 74.11 111.136 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -58.5 -29.96 66.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.462 . . . . 72.43 110.884 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -30.1 23.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 74.02 110.863 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 7.0 tp -63.22 -50.73 69.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 65.41 110.916 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -74.03 -41.22 62.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 71.3 110.882 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.93 -31.98 31.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 73.22 110.915 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.18 -46.25 84.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.192 -0.458 . . . . 73.31 110.913 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 3.9 mt -76.98 -31.96 19.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 75.43 111.155 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -56.01 -55.89 27.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 72.51 110.873 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 31.8 t -54.01 -36.68 32.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 73.44 111.153 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -70.05 -41.38 74.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 73.21 110.867 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 96.7 t -54.07 -34.45 26.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 74.21 111.087 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 95.6 m -51.9 -52.08 52.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 74.13 110.873 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 31.5 t -76.06 -33.26 24.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 74.14 111.14 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.72 -27.05 37.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 75.14 110.846 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.97 -57.67 3.42 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.733 -0.746 . . . . 71.01 112.485 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 92.5 m -61.35 -45.01 96.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.779 0.323 . . . . 72.14 111.185 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 20.3 tt -55.9 -25.86 19.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 73.51 111.128 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -51.93 -50.07 45.99 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.746 -0.74 . . . . 74.1 112.454 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.66 -31.84 63.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.773 0.32 . . . . 72.13 110.85 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 75.54 110.9 -179.92 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.822 0.259 . . . . 71.35 112.354 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 pp -53.57 -30.93 44.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 75.41 110.917 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -80.58 -28.56 37.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 73.22 110.898 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -76.74 -44.79 31.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 74.42 110.913 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.4 t -62.87 -39.54 94.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 74.23 111.182 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.79 -29.03 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 74.3 111.12 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -68.87 -25.31 64.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 74.45 110.922 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -92.0 -27.81 17.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 74.2 110.884 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.2 mm -79.51 -28.38 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 74.35 111.145 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.533 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.96 -57.15 23.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.575 0.702 . . . . 72.3 111.086 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.79 -24.82 29.1 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.676 2.251 . . . . 72.41 112.356 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.1 t -74.57 -45.4 45.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 65.21 110.892 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.9 p -81.45 -28.91 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 72.25 111.161 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mt -51.02 -33.96 27.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 75.21 110.898 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -58.68 -34.6 52.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 72.11 111.138 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.69 -34.98 79.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 74.53 111.094 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 m -57.33 -52.6 64.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 75.14 110.836 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.8 tp -70.16 -34.45 73.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 73.23 110.922 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.24 -44.89 90.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.452 . . . . 62.4 111.11 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.26 -31.98 55.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 72.55 111.137 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mp -51.39 -38.88 55.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 73.45 110.916 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -101.45 -36.7 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 63.03 111.107 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -67.05 -64.65 0.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 74.51 110.861 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.4 -60.08 2.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 62.45 110.936 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.1 mp -78.2 160.67 72.82 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.609 0.719 . . . . 64.02 110.92 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 157.25 61.14 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.711 2.274 . . . . 75.23 112.329 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.32 -170.19 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 71.43 110.845 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.33 171.21 1.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 71.21 110.859 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 5.6 t -81.51 -68.11 0.72 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 73.21 110.922 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.53 -23.64 43.66 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.782 -0.723 . . . . 75.11 112.495 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -52.36 -42.89 64.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.933 0.397 . . . . 72.43 110.908 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -53.53 -43.45 68.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 73.0 110.868 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.93 -50.77 26.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 71.15 110.867 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.2 p -53.39 -44.64 68.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 64.54 111.136 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.93 -28.93 64.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 71.3 110.93 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 1.3 m -71.43 -44.96 63.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 63.25 110.889 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.8 tt -72.41 -35.09 50.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 75.43 111.118 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -55.96 -26.25 47.27 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.174 -0.466 . . . . 72.33 110.809 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.2 t -58.68 -38.63 72.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 74.22 111.113 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.89 -28.93 25.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 73.14 110.918 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.16 -39.14 78.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 75.13 110.893 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.4 -30.12 70.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 55.11 111.079 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.7 mt -64.93 -54.66 27.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.448 . . . . 72.24 110.93 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.92 -38.25 87.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 70.01 111.139 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.3 t -71.44 -32.85 47.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 72.25 111.165 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -51.87 -38.39 55.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 74.41 110.864 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.3 tp -75.12 -30.87 60.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.487 . . . . 72.31 110.905 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 65.5 mt -73.26 -54.03 9.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 74.13 110.888 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.61 -54.16 47.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 75.31 110.928 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.4 tt -55.49 -27.59 21.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 71.54 111.135 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.5 m -80.03 -24.8 40.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 64.42 110.895 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.7 mttp -64.74 -15.27 61.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 74.44 110.853 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.2 pp -56.16 -24.38 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 64.4 111.136 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 22.1 t 63.81 75.11 0.4 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.595 0.712 . . . . 73.43 111.118 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 166.69 26.77 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.71 2.273 . . . . 74.53 112.302 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -49.1 0.6 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.679 2.253 . . . . 72.12 112.347 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.9 t -118.88 -25.61 6.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 70.33 111.136 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 64.26 47.99 3.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 73.14 110.831 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.18 37.15 1.59 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 72.14 110.902 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.44 22.76 14.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 72.11 110.856 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.527 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -68.05 -57.89 8.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.578 0.704 . . . . 64.44 111.106 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.7 Cg_endo -69.74 -19.93 35.6 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.653 2.236 . . . . 75.24 112.341 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.09 -51.54 15.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 74.54 110.964 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.1 t -80.17 -24.38 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 75.03 111.089 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.7 -50.0 44.86 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.729 -0.748 . . . . 74.14 112.496 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -35.46 80.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.78 0.324 . . . . 75.22 110.879 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -60.51 -40.1 90.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.218 -0.446 . . . . 71.43 110.906 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.5 mt -51.79 -29.87 20.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 72.15 110.918 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.21 -43.62 73.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 73.14 110.859 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -75.19 -51.34 13.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 75.0 110.863 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 t -53.07 -29.91 32.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 74.22 111.169 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.9 mmt -66.69 -30.11 70.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 74.54 110.834 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.73 -30.12 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 75.32 111.123 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.89 -33.26 62.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 75.52 110.944 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.9 m -76.95 -38.04 27.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 71.22 111.141 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 69.8 m -72.51 -40.67 66.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 73.21 111.158 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -63.41 -31.98 73.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 72.13 110.87 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.29 -32.98 69.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 71.3 110.841 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.3 mt -73.96 -51.69 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 74.44 111.131 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -54.21 -34.29 27.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 71.23 111.164 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.5 m -53.0 -34.97 58.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 71.25 111.119 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.0 t -52.24 -48.34 65.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 73.24 110.845 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.7 t -52.91 -33.83 19.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.493 . . . . 72.42 111.155 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 31.2 m -65.09 -39.9 93.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 55.14 110.875 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 65.6 t -79.98 -36.14 16.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 74.41 111.175 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 87.6 mt -72.86 -51.7 17.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 74.43 110.886 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -51.73 -29.5 18.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 72.3 110.901 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.9 p -99.43 -16.81 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 63.45 111.157 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -54.26 -52.53 61.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 73.45 110.924 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 74.14 110.86 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.503 -0.239 . . . . 61.24 112.503 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -76.37 -27.0 56.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.938 0.399 . . . . 73.45 110.911 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.8 m -58.62 -37.39 64.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 74.52 111.158 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -72.8 -29.3 63.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 73.25 111.074 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 14.6 mmt -56.66 -31.02 63.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 73.34 110.806 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 65.9 t -56.99 -65.9 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 74.12 111.146 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 38.9 mm -69.17 -33.07 56.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 74.33 111.12 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -64.27 -29.97 71.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 74.23 110.859 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.09 -29.1 39.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 73.1 110.873 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.96 -44.54 61.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 64.1 110.926 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -74.0 -53.96 8.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 63.54 110.895 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.23 -36.98 53.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 73.13 110.96 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 32.9 t-105 -52.98 -51.48 61.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 74.24 110.905 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 74.3 mt -76.99 -38.81 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 75.15 111.127 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -56.14 -57.15 13.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 64.54 110.839 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 46.2 t -56.74 -34.96 44.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 73.03 111.128 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -66.58 -32.95 74.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.864 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 94.5 t -53.99 -33.96 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 73.34 111.128 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.97 -36.77 50.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 73.23 110.845 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 83.1 t -75.95 -35.93 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 71.51 111.102 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -71.9 -27.01 62.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 75.44 110.863 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -52.2 -58.9 9.67 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.753 -0.737 . . . . 71.31 112.462 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.5 t -54.06 -35.08 61.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.78 0.324 . . . . 75.43 111.192 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 51.0 mm -66.67 -57.98 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 74.32 111.158 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -54.13 -26.07 34.15 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.764 -0.731 . . . . 63.21 112.488 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -32.0 73.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 73.25 110.903 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 18.3 t80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 73.35 110.89 -179.966 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.808 0.253 . . . . 63.25 112.312 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 pp -52.9 -31.5 40.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 74.13 110.927 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -80.35 -29.88 37.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 73.23 110.896 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -76.81 -42.35 40.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.13 -0.486 . . . . 74.11 110.935 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.1 t -62.21 -38.52 89.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 73.04 111.179 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -29.12 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 75.51 111.124 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -57.53 -27.73 62.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 74.23 110.887 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.55 -20.13 22.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 64.23 110.924 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.4 mm -76.96 -34.22 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 72.32 111.131 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.528 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.3 mm -54.95 -57.32 20.08 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.634 0.731 . . . . 74.12 111.143 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.5 Cg_endo -69.72 -11.8 31.65 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.657 2.238 . . . . 72.41 112.363 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.1 t -62.07 -43.41 98.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 73.12 110.895 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.3 p -79.47 -27.28 12.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 71.13 111.073 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -50.39 -34.31 23.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 74.21 110.909 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -58.7 -34.94 53.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 74.32 111.115 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.3 p -64.95 -36.59 84.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 72.2 111.105 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.1 t -54.17 -46.35 72.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 71.23 110.847 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tp -77.13 -38.08 52.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 75.21 110.936 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.65 -52.12 67.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 65.35 111.07 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.4 mp -49.82 -31.51 6.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 74.3 111.11 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 tt -50.78 -41.91 57.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 74.32 110.92 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.61 -36.77 4.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 75.14 111.117 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -64.47 -64.56 0.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 73.53 110.888 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.71 -62.01 1.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 74.24 110.965 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.4 mp -67.04 160.75 68.51 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.61 0.719 . . . . 74.11 110.896 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 143.12 49.55 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.692 2.262 . . . . 74.34 112.316 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.42 -170.1 3.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 73.51 110.816 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.14 172.67 11.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 73.51 110.851 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 22.5 m -68.29 -62.07 1.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 71.32 110.869 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.25 -22.94 38.82 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.709 -0.757 . . . . 71.03 112.526 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -35.01 41.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.919 0.39 . . . . 71.02 110.915 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -56.24 -46.48 79.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 75.54 110.93 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -52.01 51.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 75.55 110.923 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 55.3 p -55.28 -25.95 37.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 75.31 111.129 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 tp -72.99 -37.27 67.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 74.14 110.896 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 39.4 t -73.85 -48.52 30.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 65.11 110.893 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.6 pt -58.09 -32.59 44.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 73.35 111.096 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.13 -57.15 4.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 75.3 110.848 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.2 p -60.64 -33.61 55.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 63.34 111.128 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 tt -52.67 -31.08 35.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 75.14 110.906 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -68.36 -37.78 80.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 75.22 110.944 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.0 -29.96 69.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 75.24 111.07 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.4 mt -66.78 -54.86 18.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.236 -0.438 . . . . 75.21 110.928 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 t -59.95 -38.81 83.54 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.17 -0.468 . . . . 75.25 111.167 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.6 t -71.42 -33.0 48.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 75.13 111.124 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -65.46 -38.44 89.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 71.33 110.916 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.6 mp -74.99 -35.41 62.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.117 -0.492 . . . . 75.43 110.932 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.1 mp -73.42 -47.84 38.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 75.42 110.902 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.98 -48.33 80.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 74.53 110.924 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 tt -65.96 -28.83 44.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 73.14 111.122 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 t -80.85 -23.87 38.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 73.25 110.833 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -58.81 -22.04 57.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.484 . . . . 74.21 110.914 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 26.0 pt -51.25 -30.87 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 74.24 111.097 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 58.4 t 55.71 80.13 0.31 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.655 0.74 . . . . 74.32 111.158 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 112.11 3.0 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.652 2.235 . . . . 75.02 112.359 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -48.56 0.7 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.713 2.275 . . . . 74.32 112.363 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.0 t -116.84 -22.07 8.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 74.42 111.131 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.71 -47.5 63.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 62.44 110.841 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.6 tp 51.73 49.8 20.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 74.11 110.951 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -95.99 29.19 2.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 75.12 110.893 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -66.98 -57.77 10.65 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.612 0.72 . . . . 72.53 111.136 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.5 Cg_endo -69.78 -20.87 34.19 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.663 2.242 . . . . 73.21 112.337 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.25 -43.87 55.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 75.44 110.959 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.7 t -80.7 -38.84 17.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 73.12 111.106 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.89 -51.21 40.97 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.689 -0.767 . . . . 71.02 112.509 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -34.71 78.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.81 0.338 . . . . 73.42 110.891 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -61.26 -36.03 78.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 72.14 110.913 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.4 mt -51.82 -33.0 33.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 75.11 110.894 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.85 -28.05 33.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 73.35 110.891 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -72.98 -54.68 7.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 72.12 110.89 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.4 -28.54 30.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.494 . . . . 73.33 111.142 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 27.4 mmt -68.59 -30.04 68.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 75.14 110.875 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.91 -29.74 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 73.03 111.107 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.74 -32.73 62.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 73.31 110.876 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.7 m -77.08 -38.18 27.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 70.5 111.178 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 84.4 m -72.66 -37.7 67.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 72.23 111.126 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -68.54 -32.19 71.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 75.5 110.851 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.0 t -70.42 -33.62 71.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 74.21 110.833 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 30.8 mt -72.6 -51.39 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 74.32 111.127 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.3 p -56.18 -35.35 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 75.34 111.121 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 98.3 m -52.48 -32.32 39.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.156 -0.475 . . . . 71.2 111.104 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.41 -31.54 15.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 74.41 110.875 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.3 p -52.57 -32.87 17.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 73.13 111.129 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 43.0 m -66.11 -47.67 73.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 62.21 110.877 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.7 t -71.99 -36.04 56.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 71.35 111.141 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.5 mt -72.02 -33.48 68.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 63.12 110.961 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -59.64 -30.73 68.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 73.41 110.907 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.5 p -102.34 -24.21 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 75.5 111.127 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -90.72 -73.23 0.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 72.45 110.857 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 72.44 110.833 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.261 0 N-CA-C 112.455 -0.258 . . . . 72.22 112.455 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -87.87 -24.93 23.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.912 0.387 . . . . 73.33 110.901 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 23.8 m -53.98 -30.51 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 72.12 111.066 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.25 -25.05 58.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 73.44 111.082 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.8 ptm -52.94 -30.94 37.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 73.34 110.892 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 59.1 t -56.92 -53.64 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.284 -0.416 . . . . 73.42 111.128 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 64.9 mt -73.93 -38.56 50.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 71.21 111.156 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.97 -30.03 70.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 74.12 110.909 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -30.14 23.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 74.2 110.863 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.4 tt -63.47 -50.91 67.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 74.4 110.868 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -73.99 -36.97 64.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 71.54 110.901 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.0 -34.33 42.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 72.15 110.957 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 21.4 t90 -64.17 -50.68 67.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 74.31 110.915 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 51.2 mm -68.35 -32.12 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 72.31 111.148 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -56.02 -56.72 17.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 75.44 110.859 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 21.7 t -65.95 -35.91 76.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 65.03 111.147 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.51 -33.2 65.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 74.24 110.842 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 58.0 t -54.07 -34.11 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 61.32 111.126 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 71.8 m -51.95 -43.55 63.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.167 -0.47 . . . . 71.51 110.849 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 64.3 t -75.22 -35.06 32.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 54.42 111.112 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -54.74 -28.71 50.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 75.43 110.873 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -70.8 -22.43 78.19 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.734 -0.745 . . . . 63.03 112.493 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.1 m -79.46 -52.8 7.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.76 0.314 . . . . 75.3 111.15 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 47.6 mm -76.5 -24.15 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 73.22 111.147 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -52.13 -50.04 47.37 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.728 -0.748 . . . . 44.21 112.463 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -31.98 67.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 74.04 110.899 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 73.21 110.899 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.78 0.324 . . . . 75.24 110.853 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.13 -69.97 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 65.13 110.891 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.56 158.68 0.12 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.556 0.693 . . . . 74.22 110.947 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -12.68 33.36 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.729 2.286 . . . . 71.02 112.367 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.4 pp -52.0 -30.96 27.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 72.23 110.905 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -78.54 -33.58 47.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 74.14 110.865 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -72.5 -45.96 56.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 74.32 110.905 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -60.23 -40.03 88.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 74.53 111.129 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -29.11 21.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 75.31 111.138 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.87 -27.06 49.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 73.53 110.869 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.35 -19.18 23.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 75.33 110.922 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.6 mm -76.73 -34.84 23.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.453 . . . . 74.34 111.137 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.535 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.2 mt -55.7 -57.13 23.0 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.621 0.724 . . . . 74.34 111.139 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.3 Cg_endo -69.81 -20.47 34.56 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.696 2.264 . . . . 75.11 112.32 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 48.7 t -75.88 -44.59 39.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 63.23 110.867 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.53 -28.96 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 74.52 111.163 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 mt -51.0 -33.97 27.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 74.43 110.922 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.1 tp -58.73 -34.65 52.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 73.25 111.153 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.73 -40.9 92.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 73.24 111.167 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.25 -43.45 67.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 64.21 110.816 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 tp -76.46 -39.32 53.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.453 . . . . 74.32 110.908 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.88 -36.29 72.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 63.05 111.102 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.97 -32.32 57.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 73.43 111.112 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.29 -33.78 63.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 74.22 110.901 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.0 m -101.66 -36.82 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 75.25 111.086 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -71.6 -64.81 0.85 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 74.15 110.927 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.63 -61.77 1.65 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 73.23 110.948 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.77 160.63 60.22 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.656 0.741 . . . . 74.12 110.907 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 136.37 32.85 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.709 2.272 . . . . 72.43 112.355 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.65 44.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 70.23 110.862 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -53.06 109.58 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 64.44 110.877 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -179.16 159.06 0.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 75.21 110.886 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.48 -26.71 31.52 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.748 . . . . 75.34 112.487 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -72.58 -35.0 67.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 75.0 110.85 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.0 -49.25 66.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 75.41 110.896 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -70.51 -48.08 57.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 65.14 110.913 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.2 m -54.27 -27.02 32.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 74.2 111.18 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.86 -38.92 66.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.446 . . . . 73.14 110.913 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 26.3 m -66.87 -45.59 77.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 71.53 110.861 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.9 tt -71.26 -35.0 56.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 64.44 111.101 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.6 m -58.43 -26.36 63.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 65.01 110.861 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.3 t -61.73 -40.06 85.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.477 . . . . 74.24 111.063 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.89 -28.88 25.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 72.34 110.902 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.13 -39.17 79.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 72.14 110.914 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.39 -29.99 70.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 71.4 111.116 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.8 mt -65.11 -54.7 25.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 75.4 110.915 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.81 -38.26 87.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 71.5 111.172 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.6 t -71.5 -32.98 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 75.41 111.12 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -54.58 -30.01 53.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.481 . . . . 74.51 110.866 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.78 -50.54 64.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 74.51 110.954 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.4 mt -73.23 -33.09 65.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 75.02 110.949 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -55.08 22.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 75.42 110.909 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -64.93 -30.48 50.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 63.21 111.152 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.8 t -80.47 -19.12 46.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 72.33 110.839 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -78.16 -10.26 59.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 74.54 110.931 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.1 pp -55.62 -25.19 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 75.23 111.12 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.1 t 62.89 76.21 0.38 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.654 0.74 . . . . 73.4 111.155 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 167.5 24.29 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.685 2.257 . . . . 71.42 112.317 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -48.85 0.64 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.623 2.215 . . . . 73.24 112.37 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.3 t -133.65 14.43 4.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 74.14 111.122 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.3 p 51.65 37.96 21.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 74.14 110.856 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.15 -11.81 61.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 74.14 110.922 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -95.28 23.36 5.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 73.32 110.835 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.525 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.8 -57.91 9.01 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.603 0.716 . . . . 75.11 111.128 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 54.7 Cg_endo -69.68 -19.99 35.78 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.698 2.265 . . . . 74.24 112.391 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.15 -50.36 19.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 74.41 110.897 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.7 t -78.54 -47.35 23.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 75.41 111.138 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.87 -40.77 50.42 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.695 -0.764 . . . . 61.34 112.504 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.5 tttp -74.25 -23.5 59.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.797 0.332 . . . . 75.32 110.879 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -74.68 -34.34 62.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 74.15 110.971 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.9 mt -53.0 -29.67 30.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.079 -0.509 . . . . 75.32 110.939 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.56 -43.65 72.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 74.13 110.831 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.4 ' O ' HG23 ' A' ' 100' ' ' VAL . 47.0 t80 -75.18 -51.14 14.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 74.4 110.877 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 t -53.08 -29.95 33.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 73.22 111.132 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 8.9 mmt -66.54 -30.09 70.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 72.11 110.928 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.83 -30.12 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 74.43 111.088 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.88 -33.29 62.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 74.2 110.916 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.2 m -76.86 -38.06 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 75.32 111.128 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 76.5 m -72.51 -38.41 68.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 73.43 111.153 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -66.81 -32.0 72.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 74.02 110.911 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.5 t -71.5 -36.44 71.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 65.11 110.877 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 38.4 mt -70.78 -52.0 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 71.32 111.077 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 p -54.0 -35.96 29.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 74.24 111.114 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.3 m -52.42 -32.42 39.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 75.14 111.188 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 t -50.45 -31.36 14.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 72.32 110.874 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.4 p -52.42 -32.85 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 74.11 111.13 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 14.9 m -64.49 -46.59 82.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 72.41 110.912 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 95.0 t -73.97 -38.93 50.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 74.51 111.111 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.5 mt -69.11 -30.92 69.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 73.15 110.931 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -58.18 -33.51 69.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 74.11 110.872 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.27 -24.79 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 72.55 111.156 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -58.84 -69.89 0.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 75.44 110.837 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -168.91 48.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 72.34 110.847 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.5 mtp85 -153.76 92.13 1.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 73.12 110.901 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.8 t 63.03 73.37 0.51 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.686 0.755 . . . . 74.32 110.899 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 124.28 10.95 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.673 2.249 . . . . 72.22 112.341 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.45 -24.69 14.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 64.03 111.141 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.42 98.87 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 74.33 111.108 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -131.42 -40.4 1.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.462 . . . . 75.22 110.839 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.98 159.66 40.05 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.615 0.721 . . . . 75.51 111.139 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 -172.55 0.6 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.689 2.259 . . . . 72.23 112.297 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.3 mtp85 60.95 173.43 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 72.04 110.869 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -169.94 -134.63 1.77 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.751 . . . . 73.11 112.451 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.8 -58.84 4.5 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.757 -0.735 . . . . 54.43 112.522 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -128.98 -149.92 7.01 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.724 -0.75 . . . . 74.15 112.479 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -111.39 19.72 24.01 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.741 -0.742 . . . . 64.41 112.455 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -77.62 -26.14 50.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.963 0.411 . . . . 73.22 110.955 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.1 m -60.58 -37.48 75.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 71.04 111.087 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.7 -25.02 68.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 60.01 111.078 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 13.2 mmt -52.97 -30.98 38.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 74.0 110.909 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.9 t -56.97 -57.03 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 75.54 111.154 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 64.1 mt -74.02 -38.37 49.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 74.13 111.1 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -61.23 -29.96 70.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 74.35 110.896 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.02 -30.17 24.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 73.25 110.871 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.66 -50.83 70.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 55.3 110.935 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -74.04 -44.23 55.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 73.33 110.885 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.06 -33.86 40.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 73.34 110.88 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -53.76 -46.51 70.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 71.12 110.905 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 43.3 mm -76.9 -31.96 19.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 74.33 111.117 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -56.09 -56.82 16.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 74.33 110.865 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.9 m -54.9 -35.0 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 75.41 111.171 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -63.38 -32.95 74.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 73.44 110.9 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 31.7 t -66.56 -37.74 80.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 74.34 111.129 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 91.8 m -58.93 -51.94 67.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 74.54 110.882 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.48 -32.99 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 71.01 111.125 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -52.71 -52.0 57.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 74.44 110.887 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.85 -19.38 75.51 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.757 . . . . 51.42 112.484 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.6 m -74.72 -52.83 10.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.81 0.338 . . . . 63.53 111.18 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.7 mt -76.52 -29.77 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 64.31 111.105 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -55.43 -49.95 62.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.725 -0.75 . . . . 55.4 112.491 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.4 mmt -71.13 -32.03 68.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.877 0.37 . . . . 70.13 110.923 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -71.82 -24.93 61.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 74.01 110.905 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 14.9 mt -75.48 -26.45 58.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 63.24 110.932 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.478 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.3 OUTLIER -51.9 -60.53 5.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.594 0.711 . . . . 71.15 110.917 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.5 Cg_endo -69.8 -16.34 37.34 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.669 2.246 . . . . 74.41 112.298 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.8 tp -93.93 40.85 1.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 75.44 110.92 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.97 -62.63 1.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 64.52 110.897 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -176.46 -74.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 74.34 110.928 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 60.53 99.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 74.52 110.885 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 16.1 t80 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 74.3 110.894 -179.914 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.82 0.343 . . . . 75.13 110.853 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.1 mtt-85 -65.17 91.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 72.21 110.911 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -114.03 73.01 2.32 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.548 0.69 . . . . 74.52 110.873 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -12.88 33.93 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.689 2.259 . . . . 72.21 112.352 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 pp -52.08 -30.93 28.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 72.12 110.932 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -78.43 -33.34 48.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 72.24 110.828 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -72.61 -45.81 57.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 75.14 110.936 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -60.28 -39.95 88.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 72.1 111.109 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -29.03 21.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 74.5 111.146 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -26.72 52.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 73.3 110.857 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.57 -19.46 22.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 75.54 110.955 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.4 mm -76.68 -34.78 24.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 75.33 111.159 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.536 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.2 mt -55.74 -57.18 22.83 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.681 0.753 . . . . 74.12 111.14 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 54.1 Cg_endo -69.73 -20.97 34.29 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.673 2.249 . . . . 75.11 112.354 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 48.5 t -75.89 -44.92 38.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.251 -0.431 . . . . 62.02 110.873 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.2 p -81.59 -28.89 10.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 74.4 111.166 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.2 mt -50.95 -33.94 26.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 74.24 110.89 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.2 tp -58.77 -34.65 52.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 75.54 111.164 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 p -65.73 -34.74 78.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 74.53 111.164 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.14 -46.8 79.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 71.23 110.883 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.64 -41.6 60.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 75.12 110.896 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.52 -51.42 69.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 73.3 111.095 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.03 -32.09 56.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 65.02 111.166 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.4 tp -51.62 -37.93 52.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 73.0 110.905 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.0 p -101.64 -35.79 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 75.22 111.153 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -66.28 -62.06 1.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 75.53 110.877 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.52 -53.73 52.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 74.43 110.935 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.9 mp -51.96 160.53 1.13 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.585 0.707 . . . . 71.15 110.968 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -170.97 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.688 2.259 . . . . 74.33 112.343 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 55.1 91.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 75.44 110.848 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -152.24 147.31 26.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 70.42 110.845 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -173.97 -74.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 75.44 110.877 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -85.95 -50.81 3.79 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.756 -0.735 . . . . 61.21 112.491 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -61.57 -44.34 97.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.899 0.38 . . . . 73.42 110.908 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.08 -48.9 67.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 74.33 110.931 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -66.02 -37.53 86.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 74.35 110.923 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.5 m -66.91 -29.14 68.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 72.42 111.17 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.66 -50.69 28.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 75.31 110.937 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -51.21 62.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 74.01 110.86 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.5 tt -66.85 -35.02 73.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 74.12 111.154 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 m -65.79 -25.12 67.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 64.13 110.858 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 64.0 t -58.02 -36.64 57.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 65.11 111.13 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.92 -28.95 25.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 75.23 110.898 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.29 -38.94 78.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 71.31 110.917 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.51 -30.0 70.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 70.54 111.133 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.5 mt -64.99 -54.78 25.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 75.44 110.904 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.68 -38.46 87.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 71.25 111.196 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.3 t -71.43 -32.89 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.22 111.12 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -51.82 -30.14 22.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 75.11 110.895 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.9 -41.62 61.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 73.42 110.928 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.0 mt -73.27 -34.6 65.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 74.52 110.873 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.6 -55.07 11.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 73.44 110.916 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.22 -24.59 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 74.14 111.083 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.5 -16.43 60.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 74.34 110.813 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? -64.05 -15.54 59.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 75.13 110.896 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -51.73 -28.68 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 75.03 111.106 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 58.6 t 61.01 76.72 0.4 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.664 0.745 . . . . 75.33 111.12 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 167.41 24.46 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.702 2.268 . . . . 75.14 112.377 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -49.05 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.661 2.241 . . . . 75.3 112.365 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.9 t -134.48 18.37 3.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 71.02 111.125 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.2 p 50.09 46.51 24.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 74.15 110.856 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mt -94.68 22.12 6.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 74.2 110.94 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -99.07 24.53 7.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 75.11 110.854 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.14 -57.78 10.34 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.634 0.731 . . . . 75.04 111.142 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.4 Cg_endo -69.77 -20.53 34.68 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.721 2.281 . . . . 72.2 112.341 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.16 -53.12 10.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 75.23 110.926 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.05 -40.39 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 75.14 111.116 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -53.17 -33.69 45.81 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.774 -0.727 . . . . 51.43 112.481 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.0 -23.25 44.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.831 0.348 . . . . 73.12 110.911 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -76.57 -35.19 58.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 74.4 110.942 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.3 mt -52.28 -29.9 25.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 61.51 110.916 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -43.15 79.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 75.3 110.92 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -75.37 -52.09 11.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 73.53 110.852 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -53.14 -29.76 33.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 75.22 111.169 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.9 mmt -66.83 -30.06 70.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 73.54 110.916 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.77 -30.07 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 72.14 111.122 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.89 -33.19 62.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 74.44 110.927 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.6 m -76.87 -38.1 28.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 71.11 111.131 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 73.6 m -72.45 -40.39 67.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 70.32 111.151 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -64.11 -31.95 73.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 72.33 110.902 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.7 m -73.89 -33.77 64.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 73.12 110.892 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 30.4 mt -75.1 -50.94 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 74.43 111.142 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 34.5 m -53.9 -33.98 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 75.45 111.124 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.4 m -52.48 -32.46 40.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 75.42 111.09 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 t -50.48 -31.49 15.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 73.42 110.851 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.5 p -52.5 -32.77 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 73.22 111.158 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 42.6 m -66.86 -49.04 66.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 73.24 110.884 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 67.8 t -70.16 -35.67 64.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 74.35 111.159 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.8 mt -72.08 -38.97 69.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 74.25 110.887 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -53.9 -31.33 49.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 72.43 110.885 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.7 p -102.31 -23.68 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 74.21 111.167 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -52.87 -51.07 62.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 71.4 110.873 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -173.32 39.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 62.43 110.868 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.7 mtt85 -133.24 176.67 8.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 75.43 110.879 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.74 160.59 18.81 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.659 0.742 . . . . 74.22 110.879 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 146.4 59.83 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.671 2.247 . . . . 74.12 112.33 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.65 -174.46 5.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 72.11 111.167 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.6 m -134.13 68.88 1.47 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 74.22 111.174 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -177.1 -48.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 75.02 110.894 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -159.99 68.2 2.89 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.607 0.718 . . . . 75.24 111.174 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -171.06 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.64 2.227 . . . . 75.4 112.339 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.92 -71.06 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 72.54 110.915 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 177.8 -93.47 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.758 -0.734 . . . . 73.23 112.506 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -162.57 167.44 37.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.779 -0.724 . . . . 74.05 112.472 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 110.67 -76.76 0.22 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.765 -0.731 . . . . 74.54 112.512 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 137.21 -28.43 2.8 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.762 -0.733 . . . . 74.33 112.535 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -83.43 -26.59 30.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.892 0.377 . . . . 64.03 110.917 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.1 m -64.47 -30.04 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 74.4 111.131 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.14 -25.09 61.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.53 111.071 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 38.8 mmt -53.02 -30.86 37.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 74.43 110.902 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 71.6 t -56.98 -58.59 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 71.34 111.127 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.8 mt -74.03 -37.79 47.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 73.33 111.099 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.98 -30.88 70.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 75.13 110.883 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.26 -28.74 29.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 74.55 110.888 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.52 -43.36 63.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 73.13 110.94 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -73.96 -52.48 12.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 74.32 110.888 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.01 -32.09 32.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 72.45 110.903 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -67.3 -42.53 83.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 72.21 110.876 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 69.6 mt -76.85 -32.22 19.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.416 . . . . 74.42 111.103 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -56.0 -56.99 14.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 65.03 110.871 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.5 m -54.94 -35.05 32.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 72.43 111.123 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -68.32 -33.03 73.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 75.31 110.888 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 46.0 t -69.17 -34.0 61.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 73.13 111.146 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.48 -52.04 60.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 73.34 110.922 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.0 m -73.1 -35.41 47.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 74.13 111.149 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -52.46 -40.16 61.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 75.11 110.878 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -76.6 -20.3 76.81 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.71 -0.757 . . . . 65.41 112.499 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 35.0 m -72.08 -52.86 14.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.755 0.312 . . . . 75.42 111.172 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 19.7 mt -76.58 -24.82 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 72.33 111.098 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.35 -49.63 76.45 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.734 -0.745 . . . . 42.44 112.503 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -32.05 55.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.843 0.354 . . . . 74.43 110.893 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -71.09 -24.04 62.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 63.34 110.859 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 13.2 mt -75.26 -27.17 59.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 74.11 110.916 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.468 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.8 OUTLIER -51.81 -60.59 5.71 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.62 0.724 . . . . 74.42 110.92 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 54.2 Cg_endo -69.74 -16.32 37.59 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.673 2.249 . . . . 74.01 112.364 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 52.3 mt -92.9 43.44 1.12 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 72.13 110.938 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.39 -68.94 0.68 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 73.42 110.898 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.43 -26.1 7.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 61.04 110.883 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -51.97 -62.19 1.79 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 62.54 110.949 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 71.44 110.925 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.795 0.331 . . . . 73.42 110.833 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -70.52 -26.2 63.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 74.44 110.858 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.72 73.04 0.8 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.566 0.698 . . . . 74.42 110.919 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 -12.17 32.47 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.742 2.294 . . . . 61.22 112.377 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 pp -53.37 -31.0 42.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 75.14 110.921 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -77.39 -30.2 53.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 71.1 110.902 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -77.02 -44.46 30.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.15 -0.477 . . . . 74.41 110.932 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -60.34 -40.06 89.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 71.45 111.129 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.83 -28.86 31.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 72.12 111.146 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.37 -26.58 68.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 70.44 110.921 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.27 -24.44 20.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 63.25 110.899 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.8 mm -79.4 -29.41 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 74.05 111.121 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.522 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.65 -57.15 22.76 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.634 0.731 . . . . 73.11 111.123 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.3 Cg_endo -69.74 -19.69 35.88 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.696 2.264 . . . . 74.35 112.328 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 47.5 t -76.04 -44.65 38.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 75.32 110.864 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 p -81.64 -28.89 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 64.41 111.128 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 mt -50.99 -33.94 26.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 75.23 110.943 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.2 tp -58.72 -34.62 52.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 74.32 111.153 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 p -65.88 -41.53 91.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 74.33 111.105 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.8 t -52.92 -42.91 65.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 74.44 110.864 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.0 tp -76.71 -39.69 51.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 74.12 110.89 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.85 -51.35 70.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 72.33 111.082 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.4 mp -49.7 -31.46 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 73.54 111.09 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.74 -42.3 57.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 72.35 110.912 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.47 -37.52 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 74.4 111.093 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -63.61 -64.48 0.89 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 72.11 110.853 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.68 -56.06 5.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 75.11 110.978 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.5 mp -95.71 160.55 30.04 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.602 0.715 . . . . 74.02 110.898 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 141.24 44.44 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.617 2.211 . . . . 75.31 112.351 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.5 m -161.98 105.85 1.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 62.41 110.849 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.02 -170.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 74.54 110.838 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 78.8 m -110.9 -73.71 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 75.24 110.894 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.35 -26.81 72.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.744 -0.741 . . . . 60.24 112.514 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.08 -35.05 46.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.946 0.403 . . . . 75.24 110.877 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -54.22 -51.42 64.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 73.43 110.938 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.5 tpt -60.43 -51.31 70.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 74.32 110.917 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 30.0 p -54.8 -31.33 58.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 74.44 111.14 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.96 -41.34 59.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 74.22 110.926 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 81.5 m -66.84 -50.94 60.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 64.23 110.93 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 15.9 tt -62.27 -35.0 66.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 72.12 111.14 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.2 t -63.58 -27.08 69.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 75.24 110.874 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 63.6 t -59.38 -39.37 78.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 65.15 111.124 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 tp -53.11 -29.03 28.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 75.25 110.879 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -74.16 -46.81 39.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 64.11 110.888 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.76 -29.59 19.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 74.03 111.112 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 30.0 mt -58.04 -54.58 45.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 74.32 110.909 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 t -63.12 -27.26 69.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 71.54 111.134 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.2 t -71.23 -32.94 49.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 75.23 111.107 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -52.08 -50.02 62.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 74.4 110.869 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.0 tp -61.54 -32.5 72.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 74.42 110.91 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 mp -73.04 -44.24 60.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.452 . . . . 71.13 110.941 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.2 tt -67.73 -50.22 58.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 74.31 110.912 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -57.43 -25.51 24.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 64.34 111.106 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.04 -18.58 49.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 74.01 110.904 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -69.07 -11.71 61.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 71.33 110.876 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -54.17 -26.33 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 74.21 111.097 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 44.6 t 62.12 75.72 0.42 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.629 0.728 . . . . 74.43 111.149 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 167.61 23.91 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.646 2.231 . . . . 64.51 112.381 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -48.91 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.676 2.25 . . . . 73.53 112.361 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.8 t -133.1 13.29 4.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 75.13 111.175 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.1 m 51.55 65.23 1.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 74.34 110.882 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 tp -117.19 25.93 10.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 72.44 110.899 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.5 22.47 14.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 75.21 110.907 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -68.2 -57.94 8.31 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.649 0.738 . . . . 75.44 111.131 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.6 Cg_endo -69.72 -19.61 36.08 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.664 2.243 . . . . 75.0 112.385 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.15 -53.01 10.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 72.53 110.874 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.24 -23.79 11.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 73.54 111.146 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.68 -50.67 42.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.76 -0.733 . . . . 73.44 112.445 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.42 -35.06 78.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.757 0.313 . . . . 74.22 110.883 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -61.27 -42.46 98.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 75.3 110.943 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.7 mt -51.94 -29.83 22.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 71.14 110.938 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.0 mmt -67.77 -42.87 81.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 63.33 110.868 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -75.24 -52.41 10.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 73.11 110.919 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -53.17 -29.77 33.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 70.24 111.185 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.2 mmt -66.86 -29.92 69.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.479 . . . . 70.05 110.883 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.84 -30.05 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 73.04 111.128 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.87 -33.38 62.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 64.32 110.918 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.4 m -76.89 -38.0 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 71.31 111.106 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 63.2 m -72.44 -42.23 65.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 74.22 111.15 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -60.65 -31.96 71.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 63.44 110.929 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.1 t -75.08 -36.05 61.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 73.3 110.881 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 39.4 mt -74.87 -49.31 29.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.489 . . . . 74.14 111.16 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 34.0 m -53.89 -33.91 24.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 75.42 111.158 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.8 m -52.34 -32.5 38.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 75.43 111.194 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.9 m -50.52 -31.48 15.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 73.3 110.856 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.5 p -52.41 -32.77 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 71.43 111.111 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 20.5 m -64.3 -42.81 96.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 65.24 110.943 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 75.7 t -78.07 -35.37 20.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 71.51 111.134 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.4 mt -71.83 -30.99 66.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.901 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -60.15 -32.28 70.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 74.4 110.907 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.31 -24.67 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 70.41 111.136 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -89.1 -71.79 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 74.12 110.842 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -178.63 111.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 72.51 110.879 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 29.3 ttp85 -117.82 -34.34 4.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.453 . . . . 74.53 110.871 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.08 160.5 1.55 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.657 0.741 . . . . 74.11 110.854 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 175.08 8.56 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.683 2.255 . . . . 73.11 112.353 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -170.88 -73.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 73.25 111.163 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.6 -172.83 4.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 75.33 111.088 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -77.62 60.09 2.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 72.21 110.854 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.92 159.67 68.84 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.567 0.699 . . . . 62.43 111.157 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -12.55 33.15 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.741 2.294 . . . . 75.4 112.324 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 52.06 88.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.457 . . . . 74.24 110.882 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -129.86 -176.75 14.55 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.785 -0.721 . . . . 61.15 112.502 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 159.8 -116.68 0.73 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 74.11 112.514 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -110.35 -114.61 3.58 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.781 -0.724 . . . . 62.44 112.473 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.54 39.61 2.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 73.43 112.495 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -87.49 -26.86 22.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 75.5 110.88 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.6 m -64.96 -34.94 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 70.52 111.08 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.72 -25.01 61.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 73.12 111.077 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.96 -31.1 38.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 72.34 110.872 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.6 t -56.94 -58.73 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 70.41 111.121 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.5 mp -73.99 -37.52 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 72.31 111.157 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -61.42 -29.97 70.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 72.24 110.819 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.0 -30.51 25.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.269 -0.423 . . . . 74.03 110.871 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.3 mt -71.76 -40.85 69.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 74.42 110.958 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -73.61 -53.06 11.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 72.43 110.92 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.8 mp -52.42 -32.02 37.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 75.43 110.851 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -61.37 -43.61 98.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.234 -0.439 . . . . 73.22 110.906 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 68.2 mt -76.97 -33.49 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 74.14 111.152 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -56.36 -56.67 18.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 70.23 110.893 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 28.2 t -55.2 -35.12 34.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 72.4 111.126 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.18 -32.99 74.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 73.14 110.852 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 46.0 t -61.2 -51.78 69.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 74.23 111.09 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.1 m -52.05 -32.06 32.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 71.33 110.86 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.5 t -57.72 -50.89 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.229 -0.441 . . . . 75.41 111.101 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -72.06 -26.86 62.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 71.53 110.912 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -52.21 -58.98 9.48 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.715 -0.755 . . . . 64.51 112.468 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.5 t -60.82 -31.95 71.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.766 0.317 . . . . 75.31 111.119 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 43.9 mm -72.65 -24.94 21.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 72.14 111.151 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -65.65 -49.9 57.28 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.722 -0.751 . . . . 51.3 112.504 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.24 -32.01 43.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.781 0.324 . . . . 75.04 110.885 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -71.09 -23.81 62.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 75.41 110.83 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 8.7 mt -75.11 -27.5 59.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 75.01 110.91 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.476 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.9 OUTLIER -51.79 -60.64 5.6 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.618 0.723 . . . . 74.45 110.921 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.9 Cg_endo -69.69 -16.27 37.76 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.681 2.254 . . . . 75.33 112.392 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.5 tp -93.97 40.73 1.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 72.33 110.931 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -90.22 -30.59 17.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 75.14 110.887 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.49 -52.63 2.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 73.3 110.946 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -72.62 79.01 1.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 70.55 110.921 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 71.02 110.934 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 62.1 mtt-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.773 0.32 . . . . 72.34 110.89 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -99.76 54.64 0.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 74.05 110.915 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.4 71.33 12.84 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.609 0.718 . . . . 73.43 110.893 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 78.59 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.667 2.245 . . . . 64.14 112.313 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.05 -30.96 65.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 72.21 110.961 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -78.34 -32.15 48.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 71.13 110.879 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.08 -45.01 59.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 75.24 110.927 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -60.53 -39.95 89.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 75.42 111.132 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -29.12 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 74.34 111.117 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.95 -26.84 49.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 72.43 110.913 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.54 -19.22 23.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 74.33 110.917 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.6 mm -76.6 -35.01 24.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 73.11 111.108 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.541 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.76 -57.15 23.07 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.574 0.702 . . . . 73.15 111.131 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.77 -22.12 32.49 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.645 2.23 . . . . 64.33 112.376 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 45.9 t -76.04 -45.67 33.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 72.15 110.871 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.1 p -81.53 -28.83 10.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 73.13 111.165 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mt -50.92 -34.01 26.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 74.24 110.89 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.2 tp -58.72 -34.65 52.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 64.21 111.103 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.7 p -65.89 -35.29 80.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 74.44 111.121 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.73 -51.22 66.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 72.54 110.858 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 tp -70.64 -42.23 71.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 75.52 110.915 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.06 -48.76 75.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 70.35 111.094 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.09 -32.25 57.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 64.01 111.093 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.6 tp -51.62 -37.73 51.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 74.24 110.89 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -101.52 -35.95 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 74.31 111.144 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -66.44 -62.45 1.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 64.0 110.909 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.51 -43.44 75.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 74.12 110.919 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.3 mp -54.45 160.63 2.49 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.617 0.722 . . . . 73.55 110.911 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 179.91 3.37 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.669 2.246 . . . . 73.5 112.334 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 62.99 162.04 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 72.45 110.864 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -179.18 84.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 75.33 110.85 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.7 m -80.64 -170.63 2.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 75.42 110.911 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.82 -27.17 27.91 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.709 -0.758 . . . . 51.51 112.463 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -57.1 -34.96 68.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.924 0.392 . . . . 75.41 110.894 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.24 -51.36 64.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 73.32 110.882 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.7 ttm -53.05 -51.96 60.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 71.41 110.896 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.2 p -60.93 -35.53 76.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 70.41 111.15 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.87 -47.19 75.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.425 . . . . 65.12 110.939 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 75.6 m -57.73 -51.98 67.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 72.21 110.888 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.8 tt -66.54 -34.96 73.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 74.12 111.1 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.5 m -59.76 -25.08 64.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 73.31 110.832 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.3 t -57.92 -38.02 64.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 75.12 111.12 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mt -52.89 -28.9 25.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 74.45 110.894 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.63 -38.74 77.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 70.35 110.886 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.57 -30.07 70.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 74.54 111.137 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.4 mt -64.95 -54.72 26.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 74.34 110.954 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.72 -38.43 87.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.469 . . . . 74.15 111.139 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.9 t -71.48 -32.82 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 72.42 111.135 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -51.59 -30.56 21.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 75.25 110.877 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.6 tp -75.02 -38.84 61.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 72.44 110.937 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.0 mp -73.26 -40.32 64.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 74.22 110.923 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.2 tt -65.05 -54.07 35.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 75.44 110.893 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.06 -23.59 18.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 73.13 111.143 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.5 m -80.26 -21.95 42.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 71.21 110.845 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -59.81 -20.44 56.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.481 . . . . 74.15 110.849 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.7 pt -51.92 -29.06 10.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 75.43 111.156 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 59.1 t 61.17 76.81 0.39 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.654 0.74 . . . . 72.04 111.162 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 167.47 24.29 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.666 2.244 . . . . 72.23 112.35 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -48.78 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.683 2.255 . . . . 65.33 112.324 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.0 t -117.23 -20.16 9.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 72.51 111.134 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.74 45.51 4.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 73.31 110.882 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 tp -95.73 25.8 4.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 73.11 110.897 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -102.94 23.72 11.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 73.14 110.886 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.522 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -66.74 -57.72 11.23 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.594 0.711 . . . . 65.51 111.128 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 54.0 Cg_endo -69.72 -37.32 9.43 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.741 2.294 . . . . 64.24 112.342 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.7 mp -53.95 -52.96 58.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 71.12 110.899 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.24 -26.37 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 70.14 111.089 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.72 -51.32 39.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 75.31 112.532 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.54 -35.39 80.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.813 0.339 . . . . 72.32 110.9 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -60.52 -38.2 83.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 74.34 110.946 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.2 mt -51.79 -29.75 20.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 72.3 110.923 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.04 -42.99 79.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 73.5 110.876 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.401 ' O ' HG22 ' A' ' 100' ' ' VAL . 57.8 t80 -75.25 -52.2 11.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 75.43 110.887 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 t -53.15 -29.88 33.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 75.02 111.131 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.6 mmt -66.66 -30.1 70.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 74.44 110.846 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.76 -30.05 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 71.31 111.135 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.97 -33.19 61.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 74.33 110.918 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.8 m -76.85 -37.94 28.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.51 111.158 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 60.9 m -72.51 -41.9 65.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 65.13 111.135 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -60.91 -31.89 71.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 71.52 110.895 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.7 t -74.8 -35.52 62.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 71.51 110.868 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.7 mt -74.97 -49.65 27.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 75.4 111.124 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 34.2 m -53.99 -33.86 24.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 75.53 111.143 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.5 m -52.44 -32.43 39.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 72.34 111.173 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.7 m -50.45 -31.59 15.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 74.44 110.87 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.7 p -52.6 -32.68 17.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 64.35 111.144 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 49.4 m -66.7 -47.05 73.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 75.41 110.848 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 88.4 t -72.35 -35.37 51.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 65.24 111.143 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 89.5 mt -72.08 -39.69 68.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 73.55 110.964 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -54.1 -30.67 49.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 72.04 110.879 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.4 p -102.32 -23.23 4.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 75.02 111.126 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -53.82 -61.61 2.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 75.15 110.839 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -156.1 28.32 0.36 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 75.12 110.844 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -123.22 -177.79 3.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 74.14 110.851 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.33 160.55 25.8 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.658 0.742 . . . . 65.41 110.845 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.76 149.19 66.54 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.671 2.248 . . . . 60.41 112.316 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.56 -73.55 0.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 71.34 111.11 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.9 26.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 73.33 111.137 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -137.65 -60.15 0.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 73.25 110.898 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 34.2 m -113.84 73.92 2.4 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.567 0.699 . . . . 63.53 111.151 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 175.85 7.54 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.69 2.26 . . . . 74.1 112.38 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.1 mtt180 63.21 104.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 75.15 110.873 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -52.25 147.05 13.9 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.703 -0.761 . . . . 51.52 112.495 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -151.22 -147.02 4.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.734 -0.746 . . . . 74.31 112.487 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -112.49 -75.5 0.74 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.736 -0.745 . . . . 53.2 112.51 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -175.84 -44.35 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.739 -0.743 . . . . 75.31 112.491 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -71.52 -26.8 62.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.94 0.4 . . . . 74.41 110.909 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.8 m -64.58 -27.01 41.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 74.11 111.142 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.23 -24.95 45.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 70.23 111.135 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.0 -30.9 38.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 75.15 110.871 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 58.9 t -56.99 -59.0 3.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 71.51 111.13 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.7 mt -74.05 -37.72 47.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 73.21 111.121 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -61.28 -29.96 70.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 72.5 110.827 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.37 -29.69 25.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 73.42 110.912 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.93 -50.41 23.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 73.35 110.929 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -66.37 -53.99 29.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 71.51 110.876 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.0 -32.23 32.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 75.21 110.937 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -71.74 -38.1 70.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 75.23 110.913 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 55.9 mt -76.87 -32.03 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 73.1 111.132 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -56.11 -56.31 22.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 72.34 110.875 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.26 -34.99 45.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 74.4 111.153 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -59.64 -47.53 85.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 73.52 110.914 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 91.8 t -69.38 -34.1 60.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 73.1 111.129 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.95 -51.47 56.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 55.1 110.916 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 40.8 t -75.87 -33.11 24.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 74.21 111.121 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.36 -42.99 83.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 72.24 110.896 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.02 -19.32 67.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 73.1 112.436 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 94.9 m -63.02 -51.94 64.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.756 0.312 . . . . 70.11 111.145 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 20.5 tt -55.94 -25.64 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 74.43 111.162 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -51.87 -49.54 47.75 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.707 -0.759 . . . . 62.42 112.524 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 1.3 mmt -61.82 -31.79 72.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.834 0.349 . . . . 53.51 110.916 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -73.83 -22.8 59.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 73.22 110.886 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.1 mt -79.75 -25.55 41.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 72.42 110.898 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.519 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 15.1 tp60 -51.95 -58.07 12.63 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.558 0.694 . . . . 75.02 110.933 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.6 Cg_endo -69.77 -19.07 36.54 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.647 2.231 . . . . 74.44 112.346 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 9.8 tp -52.21 -58.23 7.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 71.14 110.935 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 5.6 t80 64.42 14.38 8.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 73.01 110.876 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 -88.91 54.02 2.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 71.41 110.925 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -80.21 -26.31 39.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 73.32 110.887 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 74.34 110.894 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.845 0.355 . . . . 73.55 110.86 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.0 mtt180 -90.55 -25.96 19.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 74.52 110.889 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -125.15 79.08 66.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.608 0.718 . . . . 75.24 110.924 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -5.06 15.29 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.724 2.283 . . . . 73.21 112.334 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 pp -53.31 -30.98 41.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 73.1 110.95 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -79.94 -29.34 39.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 73.11 110.865 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -77.07 -45.4 27.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.468 . . . . 74.15 110.938 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.2 t -59.45 -40.33 86.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 73.21 111.093 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -28.84 32.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 73.22 111.123 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.37 -25.89 68.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 73.54 110.896 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -91.24 -23.08 20.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 75.34 110.872 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.6 mm -78.55 -31.2 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.447 . . . . 72.04 111.107 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.532 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.7 -57.16 22.82 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.615 0.721 . . . . 70.32 111.123 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 54.2 Cg_endo -69.76 -20.79 34.36 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.676 2.251 . . . . 72.44 112.378 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 7.6 t -76.01 -43.27 45.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 63.32 110.876 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.61 -28.89 10.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 73.45 111.126 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 mt -50.97 -33.95 26.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 64.04 110.912 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.1 tp -58.8 -34.62 52.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 72.13 111.123 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.81 -38.62 89.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 74.02 111.177 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.6 m -53.04 -45.04 67.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 71.2 110.86 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.2 tp -76.93 -40.1 48.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 60.04 110.899 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.63 -38.34 74.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 73.31 111.091 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.22 -31.98 55.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 75.21 111.142 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 tp -51.45 -38.74 55.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 73.21 110.896 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.8 p -101.47 -36.66 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 64.42 111.187 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -67.1 -64.65 0.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 74.42 110.876 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.24 -25.94 62.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 74.1 110.9 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.1 mp -124.84 72.0 61.82 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.616 0.722 . . . . 73.54 110.961 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -173.0 0.64 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.651 2.234 . . . . 72.52 112.34 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.2 p -158.71 27.48 0.23 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 74.22 110.878 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 57.2 93.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 71.21 110.822 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.03 141.77 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 64.51 110.874 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.19 -22.97 45.55 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 52.53 112.469 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -52.06 -34.99 45.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 71.24 110.908 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.07 -37.47 61.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 74.12 110.914 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.19 -50.86 35.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 70.02 110.848 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.1 p -60.24 -29.3 68.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 73.23 111.121 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.55 -37.31 60.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.439 . . . . 74.43 110.893 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 62.4 m -66.27 -44.86 82.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 72.4 110.929 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.6 tt -75.59 -33.14 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 75.31 111.149 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 t -51.74 -25.81 8.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 74.02 110.827 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.9 p -57.08 -32.55 40.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 73.5 111.111 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.9 -28.93 25.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 73.32 110.925 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.25 -38.88 78.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 71.42 110.92 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.64 -30.03 70.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 74.52 111.054 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.2 mt -65.38 -54.63 26.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 74.54 110.94 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.59 -38.57 88.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 75.42 111.151 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 83.4 t -71.56 -32.89 47.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 75.22 111.152 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -52.0 -30.14 23.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 74.44 110.867 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.73 -45.93 67.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 74.5 110.937 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.7 mt -73.1 -34.14 65.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 72.32 110.906 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.43 -54.99 15.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 74.52 110.925 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.4 tt -61.45 -30.02 47.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 75.34 111.135 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.6 m -80.07 -23.71 41.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 73.13 110.862 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -66.8 -15.64 63.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 75.22 110.924 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.2 pp -56.08 -24.84 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 75.13 111.121 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.3 t 63.52 75.42 0.4 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.57 0.7 . . . . 72.31 111.112 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 167.65 23.83 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.708 2.272 . . . . 75.43 112.363 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -22.13 32.52 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.649 2.233 . . . . 73.52 112.366 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.9 t -95.24 -31.41 13.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 64.33 111.139 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 55.47 26.12 8.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 74.52 110.849 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 tp -141.84 51.89 1.51 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 71.14 110.918 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -97.91 27.34 4.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 75.04 110.87 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.513 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.12 -57.75 10.42 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.607 0.717 . . . . 64.54 111.132 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.8 Cg_endo -69.83 -20.67 34.2 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.683 2.255 . . . . 73.15 112.289 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.19 -52.3 12.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 71.24 110.933 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.2 -22.81 11.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 72.5 111.096 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.65 -47.55 52.06 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.755 -0.736 . . . . 54.14 112.474 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -34.94 76.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.755 0.312 . . . . 75.43 110.859 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -60.62 -34.57 74.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.268 -0.423 . . . . 75.34 110.904 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.7 mt -51.7 -29.79 19.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 64.45 110.924 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -43.22 78.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 74.02 110.873 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -75.27 -52.0 11.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 74.24 110.84 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 t -53.05 -29.94 32.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 73.21 111.137 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.5 mmt -66.41 -30.42 70.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 75.14 110.898 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.59 -29.94 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 75.44 111.139 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.26 -33.43 61.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 74.2 110.859 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.5 m -77.54 -39.51 27.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 64.45 111.14 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.5 t -72.58 -32.14 65.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 74.34 111.161 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -57.74 -33.89 68.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 75.11 110.88 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.4 t -74.95 -33.98 62.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 62.32 110.848 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.4 mt -75.11 -50.56 24.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 72.34 111.138 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.5 m -53.91 -35.73 28.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 74.23 111.149 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.6 m -52.61 -32.29 40.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 74.11 111.132 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 51.8 p -50.33 -31.56 14.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.43 . . . . 70.13 110.854 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.4 p -52.5 -32.75 17.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 73.13 111.123 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 44.1 m -67.08 -49.02 66.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 73.13 110.846 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 65.4 t -70.08 -35.49 64.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 72.53 111.109 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.1 mt -72.11 -41.09 67.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 71.21 110.928 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -51.94 -31.34 28.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 74.51 110.924 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.6 p -102.27 -23.97 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 71.23 111.135 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -53.18 -74.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 74.4 110.864 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -153.35 -44.08 0.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 70.42 110.869 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -67.8 120.14 13.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 72.14 110.914 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 49.3 m 52.29 71.9 1.34 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.665 0.745 . . . . 75.22 110.829 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 163.61 37.62 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.693 2.262 . . . . 71.5 112.356 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.11 24.94 10.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 74.43 111.172 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.6 m 63.17 45.32 5.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 72.44 111.149 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -167.98 114.45 0.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 71.52 110.848 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -156.89 68.38 4.39 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.538 0.685 . . . . 75.13 111.133 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 92.88 0.51 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.696 2.264 . . . . 70.5 112.301 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 61.4 -170.35 0.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 71.32 110.86 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 111.89 169.01 18.27 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.752 -0.737 . . . . 61.54 112.496 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -128.95 -50.31 0.13 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.783 -0.722 . . . . 65.41 112.492 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -129.32 19.64 5.37 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 51.35 112.496 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.11 45.54 0.87 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.769 -0.729 . . . . 72.02 112.544 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -76.55 -37.47 56.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.947 0.403 . . . . 72.04 110.916 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.2 m -65.18 -34.7 72.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 72.2 111.097 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -68.33 -25.13 64.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 73.31 111.108 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 23.4 mmt -53.01 -30.96 38.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 75.01 110.894 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.0 -57.66 8.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 73.32 111.161 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.8 mm -74.01 -37.37 47.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.486 . . . . 73.04 111.157 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.82 -29.96 70.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 73.43 110.871 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -52.09 -30.2 25.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 75.35 110.87 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.2 tt -72.1 -50.38 28.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 71.1 110.931 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -63.03 -52.07 64.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 73.11 110.861 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.94 -35.16 45.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 74.51 110.917 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -60.81 -40.27 92.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 73.3 110.918 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 45.6 mm -76.85 -31.98 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 73.12 111.166 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -56.02 -56.76 16.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.486 . . . . 70.03 110.906 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.6 m -56.67 -35.32 45.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 75.13 111.153 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.4 -34.1 77.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 74.52 110.879 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 67.4 t -54.06 -35.93 30.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 72.13 111.146 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -52.82 -49.78 65.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 73.13 110.852 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.36 -33.04 57.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 73.53 111.125 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.19 -54.99 23.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 75.44 110.877 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.58 -19.48 71.0 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 64.55 112.484 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 32.7 m -55.95 -52.83 62.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.77 0.319 . . . . 75.12 111.123 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 29.8 mt -76.52 -27.99 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 73.33 111.126 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -53.71 -50.03 55.6 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.788 -0.72 . . . . 70.05 112.494 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -71.37 -31.99 67.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 75.52 110.844 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -71.24 -24.03 62.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 70.21 110.929 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 8.8 mt -75.27 -27.13 59.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 72.03 110.939 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.468 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -51.95 -60.58 5.81 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.584 0.707 . . . . 74.41 110.907 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.4 Cg_endo -69.78 -15.39 37.0 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.656 2.238 . . . . 70.33 112.349 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.96 40.86 1.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 74.44 110.946 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.62 -26.28 32.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 74.33 110.853 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 63.26 105.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.484 . . . . 75.44 110.945 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -111.6 26.21 10.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 75.14 110.865 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 8.2 t80 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 75.2 110.928 -179.885 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.826 0.346 . . . . 74.52 110.895 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.34 91.73 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 74.23 110.859 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.9 79.09 50.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.587 0.708 . . . . 74.33 110.882 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -5.0 15.17 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.67 2.247 . . . . 73.23 112.344 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.0 pp -52.26 -31.02 30.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 73.32 110.926 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -80.86 -31.69 35.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 75.43 110.853 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -72.98 -46.27 53.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.127 -0.488 . . . . 74.22 110.956 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 t -59.57 -39.89 85.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.483 . . . . 73.21 111.133 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.16 -29.08 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 70.35 111.156 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.73 -27.5 50.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.152 -0.477 . . . . 73.43 110.863 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.89 -18.75 24.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 75.01 110.903 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.6 mm -76.76 -34.82 23.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 72.03 111.106 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.53 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.68 -57.17 22.76 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.575 0.702 . . . . 74.54 111.057 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.8 Cg_endo -69.78 -19.3 36.2 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.686 2.258 . . . . 74.13 112.347 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 48.7 t -73.02 -43.91 61.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 71.13 110.881 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.53 -28.93 10.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 75.33 111.115 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.1 mt -50.96 -33.94 26.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 74.03 110.874 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.78 -34.71 52.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 54.12 111.095 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.82 -41.19 92.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 75.21 111.138 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.09 -43.16 66.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 71.12 110.867 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 tp -76.29 -39.74 53.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 72.22 110.904 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.66 -51.46 69.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 73.42 111.125 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.4 mp -49.8 -31.36 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 75.35 111.134 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.1 tp -50.83 -42.17 58.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 63.41 110.912 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.53 -37.38 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 75.11 111.151 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -63.77 -64.45 0.89 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 72.14 110.856 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.67 -62.05 1.59 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.457 . . . . 74.25 110.947 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 mp -67.83 160.64 72.52 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.633 0.73 . . . . 74.43 110.921 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 154.0 68.62 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.713 2.276 . . . . 74.14 112.329 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 t -175.79 65.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 74.33 110.835 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -62.23 95.03 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 74.14 110.819 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.2 145.82 0.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 74.14 110.871 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.19 -28.26 25.99 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.672 -0.775 . . . . 71.5 112.47 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -53.42 -34.95 59.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.951 0.405 . . . . 75.23 110.894 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.94 -51.97 59.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 71.23 110.863 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.67 -48.95 78.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 65.03 110.88 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.6 p -60.73 -34.16 74.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 74.32 111.154 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.4 mt -67.0 -51.07 59.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 75.51 110.903 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 79.6 m -53.79 -51.06 64.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 71.31 110.89 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.0 tt -68.86 -34.96 67.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 75.24 111.151 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.1 -29.91 23.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 63.52 110.84 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.22 -40.54 88.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 72.35 111.126 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.93 -28.96 25.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 75.33 110.921 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.08 -39.0 79.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 73.23 110.928 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.46 -30.03 70.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 71.42 111.087 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.6 mt -65.8 -54.78 22.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.263 -0.426 . . . . 74.42 110.893 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.14 -38.41 86.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 72.15 111.121 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 80.5 t -71.38 -32.92 48.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 62.11 111.153 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -60.06 -29.79 68.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 73.43 110.896 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.21 -55.03 28.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 70.24 110.927 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.15 -31.93 64.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 73.42 110.905 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tt -60.96 -54.44 44.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 74.14 110.88 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 tt -66.15 -27.02 39.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 74.54 111.112 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.7 t -83.23 -14.75 52.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 73.41 110.812 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -93.7 -9.76 36.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 73.54 110.878 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 10.5 pt -54.26 -28.22 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 71.5 111.158 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.5 t 63.07 74.75 0.44 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.624 0.726 . . . . 73.44 111.127 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 166.34 27.94 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.682 2.255 . . . . 74.22 112.359 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -49.15 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.664 2.243 . . . . 75.21 112.354 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.1 t -115.93 -41.7 3.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 74.3 111.115 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.61 -42.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 73.5 110.824 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 63.56 70.48 0.52 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.139 -0.482 . . . . 73.43 110.922 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 51.05 64.14 1.96 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 74.15 110.838 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.522 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -69.17 -58.09 6.61 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.645 0.736 . . . . 71.21 111.177 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.2 Cg_endo -69.83 -24.21 29.63 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.692 2.261 . . . . 64.04 112.301 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -74.21 -53.09 10.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 64.15 110.913 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.07 -48.93 81.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 74.42 111.111 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.83 -46.58 54.67 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.773 -0.727 . . . . 63.45 112.446 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -72.08 -24.93 61.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.819 0.342 . . . . 73.22 110.909 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -71.21 -30.93 66.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 73.54 110.939 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.1 mt -54.83 -29.66 55.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 73.12 110.917 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.51 -42.41 71.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 71.4 110.849 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -75.13 -51.16 14.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 75.12 110.866 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 t -53.04 -29.96 32.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 75.51 111.125 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.8 mmt -66.58 -30.11 70.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 73.32 110.867 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.82 -30.11 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.427 . . . . 71.4 111.118 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.97 -33.12 61.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 72.3 110.913 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.47 -37.64 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 70.24 111.143 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 55.1 m -72.86 -46.47 52.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 73.34 111.134 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -52.59 -31.64 37.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 73.44 110.898 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 53.2 p -74.68 -49.0 22.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 72.41 110.85 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.8 mt -55.77 -34.56 36.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 74.04 111.131 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.0 t -53.7 -45.78 61.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 74.43 111.159 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.1 m -52.38 -32.49 38.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.099 -0.501 . . . . 74.04 111.147 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.7 m -50.35 -31.39 14.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 74.45 110.855 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.7 p -52.44 -32.76 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 74.51 111.112 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 34.4 m -66.72 -47.04 73.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 71.25 110.88 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 82.8 t -72.4 -35.05 50.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 65.33 111.126 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 87.8 mt -72.04 -42.8 65.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 64.54 110.88 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -52.11 -30.3 25.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 71.03 110.917 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.9 p -102.22 -22.25 4.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.142 -0.481 . . . . 75.41 111.114 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -58.65 -71.72 0.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 70.43 110.84 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -177.99 36.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.439 . . . . 72.14 110.842 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -151.88 122.79 7.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 74.42 110.897 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 68.4 m 56.15 68.6 2.21 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.651 0.738 . . . . 73.44 110.851 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 102.79 1.07 Allowed 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.723 2.282 . . . . 74.43 112.312 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -169.9 83.53 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 64.04 111.111 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.8 t -160.23 173.13 16.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.264 -0.426 . . . . 72.53 111.107 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -100.34 74.42 1.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 73.52 110.858 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.22 159.67 46.55 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.577 0.703 . . . . 73.41 111.172 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 85.58 0.61 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.688 2.259 . . . . 74.23 112.329 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.25 105.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 74.31 110.878 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -52.33 102.99 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.733 -0.746 . . . . 75.23 112.497 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -168.34 131.63 2.36 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.725 -0.75 . . . . 72.4 112.488 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 58.37 174.32 0.47 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.77 -0.729 . . . . 64.22 112.461 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -112.7 18.71 22.12 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.678 -0.772 . . . . 62.21 112.443 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -88.03 -30.34 20.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.926 0.393 . . . . 71.4 110.939 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.8 m -73.94 -30.33 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 72.21 111.096 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.33 -24.94 47.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 61.44 111.111 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.96 -30.97 37.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 74.1 110.872 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 64.5 t -56.83 -62.33 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 73.21 111.158 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 41.8 mm -71.64 -38.15 65.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 74.43 111.104 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -60.65 -30.46 69.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 74.52 110.859 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.18 -25.74 48.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 72.4 110.824 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 7.6 tt -68.87 -50.93 45.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 74.15 110.925 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -73.97 -36.08 64.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 64.55 110.849 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.9 mt -52.21 -33.76 42.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 70.22 110.948 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -61.21 -48.38 81.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.451 . . . . 74.43 110.895 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.0 mt -75.6 -31.98 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 75.32 111.128 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -56.0 -56.72 17.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 75.03 110.888 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 22.8 t -57.65 -35.7 51.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 75.03 111.089 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -66.79 -32.98 74.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 75.55 110.892 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 90.5 t -61.99 -34.0 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 74.42 111.151 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 49.7 m -63.24 -52.02 63.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 72.02 110.861 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.3 m -71.48 -35.56 57.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 73.03 111.119 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -67.45 -41.15 85.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 74.32 110.889 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.44 -33.25 39.76 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.754 -0.736 . . . . 72.33 112.485 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.7 m -76.48 -52.86 8.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.738 0.304 . . . . 73.51 111.141 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.9 mt -76.48 -24.5 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 72.13 111.185 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.01 -49.39 78.99 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.698 -0.763 . . . . 73.05 112.434 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -31.96 55.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.813 0.34 . . . . 73.23 110.853 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -71.17 -24.07 62.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 62.03 110.871 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 13.4 mt -75.23 -27.22 59.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 71.45 110.935 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.474 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -51.77 -60.58 5.72 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.624 0.726 . . . . 74.14 110.938 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 54.2 Cg_endo -69.76 -27.36 26.56 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.695 2.263 . . . . 75.42 112.36 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.1 tp -52.06 -55.45 20.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 71.35 110.938 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 5.0 t80 64.48 14.38 8.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 75.32 110.857 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -171.51 112.39 0.34 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.495 . . . . 74.43 110.956 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -64.18 -62.49 1.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 73.14 110.841 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 9.5 t80 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 75.22 110.97 -179.883 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.862 0.363 . . . . 74.31 110.885 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -143.82 -167.89 2.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 73.34 110.861 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.68 108.17 0.93 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.569 0.7 . . . . 74.24 110.867 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -11.65 31.29 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.698 2.266 . . . . 62.12 112.335 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 pp -51.97 -30.88 26.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 65.43 110.873 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -79.28 -33.35 43.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 71.52 110.885 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -72.33 -46.44 55.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 75.43 110.913 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -59.78 -40.12 87.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 72.44 111.186 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.21 -29.06 21.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 75.05 111.149 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -55.66 -27.14 48.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 54.33 110.884 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.31 -18.74 23.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 73.31 110.913 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.8 mm -76.43 -35.25 26.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 70.13 111.125 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.538 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.76 -57.14 23.16 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.626 0.727 . . . . 75.11 111.153 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.6 Cg_endo -69.75 -21.94 32.82 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.705 2.27 . . . . 75.43 112.306 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.7 t -76.01 -45.59 33.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 63.43 110.9 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.52 -28.91 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 73.02 111.149 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mt -51.02 -33.92 27.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 74.5 110.923 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.2 tp -58.71 -34.68 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 73.44 111.103 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 p -65.69 -40.68 92.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 72.31 111.141 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.01 -44.38 67.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 75.41 110.9 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.9 tp -75.3 -40.41 58.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 74.45 110.949 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.97 -36.53 70.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 73.23 111.1 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.93 -32.31 57.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 73.4 111.112 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 tp -55.28 -33.82 63.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 75.44 110.893 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.1 m -101.64 -36.66 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 72.02 111.138 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -71.7 -64.93 0.83 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 74.1 110.87 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.46 -58.74 3.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.486 . . . . 75.43 110.903 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 mp -77.03 160.69 75.65 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.629 0.728 . . . . 74.44 110.873 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 146.69 61.07 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.722 2.281 . . . . 71.44 112.329 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -178.22 74.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 73.14 110.841 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 53.91 -172.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.154 -0.475 . . . . 74.45 110.861 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 95.5 m -120.45 -54.8 2.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 72.55 110.904 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.32 -57.43 13.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.743 . . . . 74.53 112.502 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -52.08 -34.97 46.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.361 . . . . 74.34 110.846 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.97 -48.21 67.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 74.34 110.92 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 29.4 ttm -62.34 -52.06 65.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 74.25 110.866 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.7 p -58.02 -27.06 63.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 63.34 111.107 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.87 -34.19 60.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.29 -0.413 . . . . 73.21 110.886 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 90.2 m -70.96 -51.89 23.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 71.52 110.845 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 15.8 tt -63.24 -35.29 71.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 65.33 111.134 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.5 t -63.54 -25.46 68.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 74.33 110.847 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 83.6 t -57.95 -36.15 54.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 75.15 111.08 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.87 -28.83 24.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 74.45 110.926 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.24 -38.98 78.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 73.34 110.924 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.56 -29.95 70.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 54.34 111.136 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.4 mt -65.16 -54.71 25.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 73.32 110.945 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.7 -38.56 88.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 74.12 111.149 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 82.2 t -71.5 -32.91 47.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 75.22 111.105 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -51.86 -30.55 24.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 72.12 110.859 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.02 -39.24 61.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 74.33 110.892 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.07 -39.38 65.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 73.43 110.901 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.4 tt -66.46 -55.06 17.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 72.13 110.918 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 tt -57.04 -30.6 34.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 73.43 111.13 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.5 t -80.22 -23.36 40.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 74.03 110.83 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.63 -12.9 62.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 75.25 110.895 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.2 pp -56.41 -24.53 18.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 75.21 111.088 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.8 t 63.68 75.21 0.4 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.649 0.737 . . . . 64.34 111.173 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 167.55 24.2 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.638 2.226 . . . . 75.41 112.352 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -48.63 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.694 2.263 . . . . 61.53 112.356 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.4 t -117.22 -19.88 9.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 70.02 111.07 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.76 47.02 3.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 74.12 110.858 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 tp -99.27 26.05 6.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 71.23 110.91 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.91 23.68 9.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 74.52 110.845 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.529 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.74 -57.79 9.32 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.66 0.743 . . . . 73.45 111.152 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.7 Cg_endo -69.81 -20.0 35.18 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.664 2.243 . . . . 73.42 112.35 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.19 -53.09 10.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 71.1 110.911 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.9 t -80.68 -33.69 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 74.3 111.125 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.82 -52.21 35.63 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.734 -0.746 . . . . 75.03 112.466 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -35.35 80.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 73.41 110.882 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -60.32 -36.98 79.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.438 . . . . 75.1 110.923 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.5 mt -51.91 -29.75 21.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 75.03 110.915 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 4.1 mmt -67.67 -42.86 81.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 73.43 110.921 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -75.29 -52.47 10.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 61.2 110.849 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -53.1 -29.87 33.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 75.11 111.135 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.71 -30.08 70.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.913 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.73 -30.05 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 73.45 111.103 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.96 -33.25 61.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 73.24 110.893 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.1 m -76.93 -37.96 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 73.12 111.095 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 61.3 m -72.45 -41.37 66.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 72.4 111.116 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -61.67 -32.02 72.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 74.34 110.873 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -32.58 69.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 63.33 110.843 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 12.3 mt -74.41 -51.77 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 74.31 111.165 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.3 p -53.95 -33.93 24.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 73.33 111.158 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 91.8 m -52.36 -32.4 38.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 63.44 111.131 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.34 -31.74 15.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 74.12 110.874 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.5 p -52.72 -32.83 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.492 . . . . 71.34 111.114 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 47.5 m -65.23 -43.53 91.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 64.23 110.881 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.5 t -76.82 -35.77 24.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 73.11 111.161 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.3 mt -72.14 -31.13 65.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 75.11 110.882 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -64.73 -29.46 70.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 64.23 110.87 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.8 p -102.24 -20.91 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 73.12 111.102 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -79.18 -74.55 0.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 72.14 110.853 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -177.26 110.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 74.41 110.876 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.03 -178.55 0.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 71.1 110.876 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.1 160.63 1.15 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.699 0.761 . . . . 65.41 110.855 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 79.61 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.67 2.247 . . . . 71.44 112.342 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.78 -179.42 5.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 74.52 111.135 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.98 128.74 15.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 75.42 111.126 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.61 -58.52 0.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 73.04 110.884 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.88 159.64 39.98 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.554 0.692 . . . . 74.45 111.117 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -12.47 32.88 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.725 2.284 . . . . 75.42 112.318 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -63.54 151.5 41.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 73.21 110.897 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -176.6 -164.53 30.72 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.741 -0.742 . . . . 74.41 112.496 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 129.26 -136.7 9.12 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 73.33 112.457 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.58 -133.07 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.756 -0.735 . . . . 74.55 112.505 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -112.43 -51.62 0.54 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.732 -0.746 . . . . 74.34 112.523 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -71.43 -26.93 62.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.897 0.379 . . . . 73.01 110.915 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.8 m -55.8 -26.96 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 63.45 111.139 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.99 -24.84 41.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 72.22 111.069 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.1 mtt -52.66 -31.0 34.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 72.13 110.889 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 17.7 m -59.55 -30.55 44.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 74.22 111.156 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 28.2 mt -74.15 -47.38 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 73.32 111.163 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -69.66 -29.95 67.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 65.31 110.839 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.1 mtm-85 -55.87 -25.64 43.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 74.52 110.838 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.6 mt -71.02 -50.99 28.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 72.45 110.887 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -73.82 -27.13 60.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 55.32 110.853 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.93 -36.8 50.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.17 -0.468 . . . . 65.01 110.884 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -53.03 -52.01 59.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 73.01 110.905 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 3.4 mt -77.02 -37.74 26.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 72.11 111.17 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -56.01 -56.96 14.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 73.11 110.915 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 42.7 t -56.67 -34.97 43.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 74.03 111.165 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -68.48 -34.95 76.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 75.44 110.882 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 93.5 t -55.58 -41.62 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 73.31 111.133 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 98.6 m -52.02 -48.23 64.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 74.34 110.9 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 43.6 t -75.69 -36.9 34.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 74.34 111.122 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.31 -26.85 61.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 75.2 110.903 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.15 -59.07 2.48 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.696 -0.764 . . . . 50.11 112.455 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 4.6 t -55.3 -41.78 72.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.741 0.305 . . . . 73.15 111.092 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 18.7 tt -63.06 -26.29 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 74.42 111.141 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -51.98 -49.82 47.36 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.767 -0.73 . . . . 70.44 112.47 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 22.7 mmt -71.57 -31.9 67.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.828 0.347 . . . . 74.53 110.878 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -67.97 -20.28 65.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 75.31 110.903 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.6 mt -74.43 -28.96 61.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 74.32 110.849 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.477 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 1.0 OUTLIER -53.27 -60.56 6.58 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.618 0.723 . . . . 72.41 110.952 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.4 Cg_endo -69.82 -21.56 33.04 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.674 2.249 . . . . 63.51 112.31 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.82 -25.65 42.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 73.45 110.903 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -51.99 -30.3 24.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 74.3 110.88 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.16 104.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 75.3 110.905 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -115.92 27.36 9.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 71.43 110.918 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 78.2 t80 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 72.45 110.888 -179.913 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.81 0.338 . . . . 72.22 110.852 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.2 mmt-85 -68.2 -60.75 2.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 73.14 110.876 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -120.64 68.3 15.09 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.63 0.729 . . . . 74.01 110.904 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.74 78.47 1.0 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.688 2.258 . . . . 70.2 112.376 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.92 -30.94 65.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 74.31 110.873 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -78.18 -31.84 49.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 74.2 110.84 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.66 -44.91 55.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 74.51 110.926 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.6 t -60.56 -39.78 89.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 72.14 111.14 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.12 -29.12 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 74.01 111.118 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.13 -27.05 52.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 73.54 110.909 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.25 -19.28 23.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 70.35 110.925 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.3 mm -76.84 -34.58 22.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 74.24 111.118 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.536 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.75 -57.18 22.9 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.629 0.728 . . . . 74.12 111.112 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.8 Cg_endo -69.74 -20.47 34.9 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.663 2.242 . . . . 60.13 112.356 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 49.3 t -75.94 -44.42 40.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 61.33 110.87 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.2 p -81.57 -28.93 10.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 73.01 111.104 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.5 mt -50.99 -33.94 26.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 75.23 110.917 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.2 tp -58.74 -34.69 52.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 70.1 111.1 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.82 -36.79 84.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 71.21 111.121 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.07 -52.65 60.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 71.51 110.862 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.1 tp -68.91 -40.51 79.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 73.24 110.922 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.93 -51.38 69.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 74.22 111.101 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.13 -31.85 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 74.25 111.141 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.68 -38.1 53.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 73.24 110.926 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.7 p -101.6 -37.17 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 75.51 111.175 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -67.43 -63.28 1.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 72.13 110.86 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.39 -26.01 38.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 75.42 110.946 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.2 mp -76.78 160.65 76.29 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.596 0.712 . . . . 65.0 110.907 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 78.84 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.704 2.27 . . . . 73.02 112.339 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.7 t -165.8 151.69 9.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 54.52 110.848 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -161.16 26.14 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 74.31 110.85 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 30.3 p -65.97 -170.24 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 72.33 110.86 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.99 -43.73 72.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.723 -0.751 . . . . 64.2 112.488 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -53.04 -41.27 64.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.93 0.395 . . . . 75.53 110.929 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -59.28 -45.21 91.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 73.51 110.894 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 33.4 ttm -63.92 -51.68 63.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 75.21 110.902 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 80.8 p -54.08 -34.82 61.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 73.11 111.135 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.64 -50.33 65.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 74.31 110.921 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 59.4 m -53.87 -51.96 62.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 74.1 110.886 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.6 tt -67.37 -35.06 72.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 73.33 111.095 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 m -60.26 -26.01 66.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 75.02 110.911 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.6 t -57.97 -38.52 67.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 73.34 111.139 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.88 -28.9 25.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 72.43 110.913 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.03 -39.34 79.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 74.04 110.945 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.27 -29.98 70.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 74.5 111.081 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.1 mt -64.82 -54.74 26.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 74.12 110.908 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.97 -38.08 87.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 74.44 111.127 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 75.0 t -71.45 -32.91 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 71.2 111.094 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -60.13 -29.88 68.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 75.41 110.901 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 tt -73.25 -44.17 59.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.124 -0.489 . . . . 74.45 110.89 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.4 mt -73.35 -33.04 64.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 74.21 110.918 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.6 tt -68.87 -55.14 12.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 73.32 110.882 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -56.93 -23.38 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 74.25 111.16 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.5 t -70.03 -14.69 62.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 72.31 110.882 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -62.17 -17.04 56.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 74.21 110.893 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 24.7 pt -50.37 -31.4 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 75.35 111.099 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 66.7 t 56.73 80.33 0.29 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.635 0.731 . . . . 63.42 111.137 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 166.8 26.3 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.735 2.29 . . . . 75.33 112.358 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -49.14 0.59 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.658 2.239 . . . . 74.05 112.374 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.1 t -135.67 22.2 3.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 71.21 111.153 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.7 t 52.17 48.57 22.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 64.2 110.856 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tp -95.55 24.65 5.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 74.24 110.915 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -110.92 25.85 11.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 73.23 110.894 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.517 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.03 -57.82 10.45 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.664 0.745 . . . . 75.04 111.092 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.9 Cg_endo -69.72 -20.59 34.84 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.661 2.241 . . . . 72.41 112.392 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.19 -53.07 10.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 74.1 110.978 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.07 -36.54 16.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 74.54 111.096 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.21 -40.43 52.35 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.768 -0.729 . . . . 72.51 112.475 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -67.66 -24.6 65.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 73.33 110.865 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -78.04 -44.3 26.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 75.34 110.971 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.0 mt -55.45 -29.72 59.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 75.01 110.923 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.38 -43.26 77.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 74.24 110.847 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.401 ' O ' HG22 ' A' ' 100' ' ' VAL . 39.1 t80 -75.29 -51.85 12.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 75.32 110.941 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 t -53.12 -29.87 33.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 72.2 111.165 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.1 mmt -66.69 -30.11 70.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 73.11 110.875 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.76 -30.09 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 75.05 111.116 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.89 -33.27 62.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 75.43 110.884 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.1 m -76.87 -38.1 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 75.41 111.159 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 73.9 m -72.46 -39.77 67.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 74.23 111.143 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -64.87 -31.99 73.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 73.51 110.843 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.9 t -72.57 -35.25 67.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 60.21 110.857 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 36.8 mt -72.55 -51.36 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 75.11 111.099 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 p -53.97 -36.41 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 74.54 111.097 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 94.7 m -52.42 -32.4 39.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 74.31 111.099 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.9 p -50.44 -31.4 14.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 72.35 110.826 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.4 p -52.45 -32.82 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 71.11 111.106 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 31.0 m -65.81 -43.17 89.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 74.53 110.895 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.8 t -77.02 -35.45 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 74.44 111.145 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 87.5 mt -71.99 -32.98 67.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 75.11 110.906 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -59.71 -31.24 69.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 65.4 110.881 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.7 p -102.29 -23.96 4.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 74.51 111.135 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -77.04 -26.17 53.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 72.12 110.833 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -173.27 -169.94 0.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 75.31 110.827 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 56.71 -174.24 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 74.51 110.903 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.5 160.62 29.74 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.665 0.745 . . . . 64.12 110.844 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 125.3 11.97 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.68 2.253 . . . . 74.33 112.33 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.97 -73.22 0.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 73.13 111.127 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 48.8 m -93.54 -42.89 8.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 63.44 111.147 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -91.24 -169.93 2.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 73.43 110.841 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.36 147.55 43.47 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.577 0.704 . . . . 74.14 111.141 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -173.93 0.81 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.667 2.245 . . . . 74.22 112.372 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.04 120.15 1.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 75.41 110.866 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -53.98 102.52 0.12 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.746 -0.74 . . . . 45.3 112.479 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -176.21 -109.24 0.24 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.771 -0.728 . . . . 45.1 112.496 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -166.68 -37.24 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.701 -0.761 . . . . 73.01 112.449 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 167.63 -30.59 0.18 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.768 -0.73 . . . . 65.23 112.524 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -86.37 -26.79 24.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 70.02 110.882 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.6 m -54.4 -26.91 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 72.13 111.124 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.22 -26.04 36.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 74.44 111.066 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 6.4 ptm -52.99 -30.94 38.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 74.44 110.89 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 62.8 t -56.96 -58.95 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 74.42 111.092 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.8 mt -73.96 -37.78 48.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 71.32 111.14 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -61.25 -30.01 70.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 73.22 110.851 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.01 -29.02 26.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 61.42 110.9 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.52 -48.3 70.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 74.11 110.925 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -73.69 -41.77 62.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 74.23 110.824 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.07 -32.7 35.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 64.42 110.933 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 23.7 m0 -61.85 -51.98 65.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 72.24 110.906 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 66.6 mt -71.21 -32.05 46.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 75.21 111.175 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -56.33 -40.76 74.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 73.21 110.858 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 21.8 t -73.63 -44.97 52.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 72.02 111.101 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.4 -40.73 62.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 72.22 110.851 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 65.5 t -54.34 -33.96 27.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 73.22 111.119 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 72.0 m -52.06 -51.96 54.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.191 -0.459 . . . . 60.02 110.871 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.91 -33.7 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 75.34 111.143 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -52.38 -40.57 62.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 74.11 110.902 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.76 -44.24 8.52 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.771 -0.728 . . . . 72.35 112.506 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 35.1 m -51.85 -52.85 46.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 64.12 111.163 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 47.5 mm -76.52 -24.92 16.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 65.11 111.16 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -53.92 -49.9 56.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 74.44 112.513 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -31.95 73.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.825 0.345 . . . . 65.45 110.894 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -76.97 -23.77 52.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 73.34 110.881 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.3 mt -78.51 -26.79 45.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 73.31 110.889 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.515 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 4.6 tt0 -51.98 -58.69 10.36 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.577 0.703 . . . . 73.25 110.854 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.9 Cg_endo -69.79 -17.17 37.59 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.697 2.265 . . . . 75.11 112.327 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.0 tp -83.76 -26.45 29.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 75.02 110.879 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -53.86 -71.63 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 72.14 110.904 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 63.06 104.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 73.4 110.911 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -75.9 79.74 2.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 73.1 110.887 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 13.2 p90 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 75.13 110.956 -179.898 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.83 0.348 . . . . 75.22 110.829 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.97 -167.89 2.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 74.21 110.894 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.9 mtpp 55.83 73.62 0.82 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.564 0.697 . . . . 74.12 110.894 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 -11.64 31.36 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.735 2.29 . . . . 72.33 112.343 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 pp -52.06 -30.91 27.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 74.25 110.92 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -79.08 -33.17 44.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 61.02 110.9 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.45 -46.0 56.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 74.41 110.938 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -60.03 -39.97 87.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 71.14 111.182 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -29.05 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 72.51 111.132 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.87 -27.19 50.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 73.42 110.89 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.23 -19.14 23.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 75.01 110.894 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.7 mm -76.77 -34.73 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 75.0 111.138 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.7 -57.15 22.91 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.62 0.724 . . . . 75.34 111.09 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.9 Cg_endo -69.73 -22.83 31.68 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.655 2.237 . . . . 50.21 112.377 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 49.6 t -76.08 -46.49 28.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 74.35 110.825 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.7 p -81.6 -28.78 10.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 74.31 111.117 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.6 mt -50.93 -33.99 26.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 72.23 110.932 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.2 tp -58.68 -34.71 52.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 74.4 111.119 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.7 p -66.04 -38.55 88.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 74.53 111.147 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.8 m -52.92 -53.77 44.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.229 -0.442 . . . . 75.44 110.897 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tp -67.55 -39.47 84.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 63.1 110.954 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.99 74.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 73.34 111.142 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.93 -32.47 58.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 74.21 111.104 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.6 tp -53.76 -34.61 59.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 75.32 110.887 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -102.26 -36.59 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 74.44 111.145 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.48 -64.92 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 74.54 110.891 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.27 -62.3 1.44 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.099 -0.5 . . . . 74.02 110.956 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.6 mp -63.47 160.09 45.54 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.587 0.708 . . . . 61.24 110.932 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -168.54 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.687 2.258 . . . . 73.52 112.349 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.88 154.53 0.07 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 75.02 110.856 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 53.01 88.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 73.13 110.813 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 94.5 m -88.71 -69.61 0.7 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 62.43 110.831 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.95 -32.0 59.0 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.708 -0.758 . . . . 53.12 112.493 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -51.97 -34.97 44.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.9 0.381 . . . . 75.41 110.924 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -52.98 -48.79 67.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 73.03 110.906 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.4 ttm -57.83 -51.78 68.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 75.1 110.892 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.4 p -61.95 -28.34 69.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 73.41 111.111 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.81 -50.78 14.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 74.24 110.931 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 71.4 m -52.96 -42.19 65.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 73.33 110.895 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.7 tt -73.37 -34.95 44.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 71.41 111.127 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.9 t -69.14 -25.85 64.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 71.32 110.841 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.5 t -57.95 -34.6 49.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 72.42 111.12 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -52.89 -28.91 25.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 72.11 110.891 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.37 -38.92 78.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 74.13 110.95 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.6 -29.94 70.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 72.5 111.105 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.5 mt -65.08 -54.79 24.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 74.15 110.86 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.71 -38.38 87.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 75.33 111.173 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.3 t -71.48 -32.83 47.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 63.45 111.109 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -51.94 -30.0 22.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 74.42 110.855 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.08 -41.71 61.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 75.31 110.88 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.9 mt -73.2 -34.78 66.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 72.01 110.91 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.31 -55.09 11.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 74.32 110.885 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.19 -25.0 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 64.22 111.117 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.6 -14.9 63.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 73.43 110.851 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -59.23 -20.76 56.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 72.33 110.884 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.8 pt -51.55 -29.38 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 74.32 111.108 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.2 t 60.87 77.54 0.36 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.589 0.709 . . . . 62.13 111.112 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 167.57 24.06 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.714 2.276 . . . . 75.31 112.356 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -48.76 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.657 2.238 . . . . 73.21 112.33 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.5 t -131.73 9.89 4.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 73.42 111.179 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.73 52.74 13.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 75.11 110.82 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.89 25.65 4.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 73.25 110.91 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.3 23.71 12.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 75.44 110.87 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.528 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.37 -57.84 9.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.63 0.728 . . . . 73.34 111.133 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.3 Cg_endo -69.75 -20.35 35.01 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.716 2.277 . . . . 74.4 112.337 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.17 -53.02 10.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 73.22 110.937 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.6 t -80.75 -32.87 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 75.54 111.114 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.72 -52.1 35.69 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.707 -0.759 . . . . 61.03 112.476 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -35.01 79.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.778 0.323 . . . . 75.13 110.883 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -61.22 -36.61 80.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 75.13 110.906 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.2 mt -51.82 -29.87 21.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 71.25 110.924 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -69.25 -43.63 73.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 75.04 110.864 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -75.26 -51.26 13.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 75.14 110.867 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 t -53.05 -29.86 32.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 75.04 111.157 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.8 mmt -66.6 -30.24 70.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 74.41 110.859 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.67 -29.97 13.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 71.24 111.097 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.23 -33.49 61.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 72.15 110.903 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.3 m -77.53 -39.65 27.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 74.52 111.104 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.9 t -72.55 -32.3 65.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 70.33 111.082 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -56.83 -35.14 68.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 71.53 110.861 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.4 t -75.02 -32.59 61.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 73.12 110.882 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.3 mt -75.16 -51.3 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 75.02 111.092 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 p -53.99 -35.87 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 75.43 111.101 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.7 m -52.42 -32.36 38.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 74.32 111.135 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.2 t -50.33 -31.58 14.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 74.45 110.822 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.2 p -52.5 -32.77 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 73.32 111.124 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 35.5 m -66.2 -47.55 73.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 73.01 110.915 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.2 t -72.1 -36.09 55.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.475 . . . . 75.23 111.137 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.5 mt -72.04 -33.31 67.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 75.33 110.927 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -59.82 -30.72 69.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 75.22 110.906 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.4 p -102.26 -23.83 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 73.33 111.15 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 -85.44 -70.37 0.59 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 64.35 110.858 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -178.88 121.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 73.23 110.869 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.3 ttp85 -153.45 159.12 42.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 73.11 110.849 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.11 160.62 0.99 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.646 0.736 . . . . 74.54 110.862 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 78.7 1.0 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.709 2.273 . . . . 63.3 112.315 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.11 177.55 3.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 65.12 111.172 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.55 69.29 1.4 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 71.24 111.102 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -81.48 -74.44 0.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.456 . . . . 73.01 110.888 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.56 159.69 4.9 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.607 0.718 . . . . 72.13 111.131 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 -12.45 32.82 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.642 2.228 . . . . 71.11 112.34 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -52.35 127.48 22.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 74.21 110.89 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.36 133.25 1.57 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.771 -0.728 . . . . 50.34 112.529 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -135.8 151.68 20.74 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.733 . . . . 71.12 112.487 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 112.38 94.45 2.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.769 -0.729 . . . . 61.31 112.506 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 156.26 51.27 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.733 -0.746 . . . . 75.5 112.478 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -87.89 -26.07 22.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.964 0.412 . . . . 73.42 110.947 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.3 m -54.35 -26.93 16.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.077 -0.511 . . . . 75.33 111.083 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.96 -25.05 41.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 73.34 111.091 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.94 -30.84 36.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 71.12 110.912 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 91.5 t -57.09 -59.31 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 75.45 111.08 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 65.1 mt -73.97 -35.26 41.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 73.14 111.137 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -62.98 -30.16 71.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 54.14 110.843 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -53.78 -28.23 33.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 73.2 110.881 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.8 mp -67.36 -48.91 66.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 73.12 110.888 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -73.67 -47.47 39.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 73.32 110.892 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.92 -49.74 62.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.483 . . . . 74.25 110.944 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -53.22 -32.3 47.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 75.42 110.94 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.8 mt -76.99 -42.33 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 74.44 111.118 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -56.17 -57.01 13.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 75.1 110.938 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 31.1 t -54.15 -37.08 34.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 75.23 111.118 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -70.01 -44.04 70.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 75.11 110.854 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 91.1 t -63.52 -34.09 65.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 73.15 111.158 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 17.2 m -51.85 -44.23 63.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 72.41 110.907 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 26.5 t -75.84 -33.19 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 72.42 111.097 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -58.8 -54.63 44.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 73.44 110.882 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -68.42 -19.4 72.58 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 64.21 112.512 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.1 m -75.64 -52.83 9.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.754 0.311 . . . . 74.34 111.172 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 49.3 mt -76.5 -27.5 17.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 73.5 111.132 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -53.65 -49.55 57.27 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.725 -0.75 . . . . 62.1 112.533 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -31.89 67.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 75.13 110.906 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -72.75 -20.98 61.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 74.1 110.877 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 20.1 mt -79.37 -26.79 41.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 74.51 110.942 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.519 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 14.4 tp60 -52.0 -58.17 12.28 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.577 0.703 . . . . 71.31 110.88 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 54.1 Cg_endo -69.68 -15.73 37.53 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.695 2.263 . . . . 54.5 112.348 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.91 40.84 1.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 75.1 110.94 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -73.3 -26.17 60.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 74.42 110.874 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 63.27 105.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 75.43 110.905 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -91.05 -64.5 1.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 72.31 110.909 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 69.0 t80 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 72.45 110.942 -179.921 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.817 0.341 . . . . 73.0 110.921 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.6 mtm-85 -59.29 -28.41 66.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 75.45 110.865 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -123.06 79.01 51.47 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.532 0.682 . . . . 74.22 110.882 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 -5.07 15.28 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.688 2.258 . . . . 75.11 112.358 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 pp -52.16 -31.0 29.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 70.23 110.93 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -81.0 -31.95 34.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 75.14 110.865 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -72.51 -46.1 56.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 75.21 110.896 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 t -59.83 -40.17 87.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 73.41 111.146 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -29.11 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 72.32 111.105 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -55.59 -27.0 46.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 74.21 110.899 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.51 -18.95 23.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 75.42 110.947 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.8 mm -76.53 -35.17 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 72.43 111.103 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.52 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.3 mm -55.68 -57.15 22.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.609 0.718 . . . . 72.21 111.125 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.78 -21.4 33.45 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.67 2.247 . . . . 73.03 112.323 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.0 t -71.33 -45.36 63.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 65.4 110.912 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 p -81.62 -28.94 10.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 74.25 111.091 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 mt -50.95 -33.91 26.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 74.44 110.915 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.2 tp -58.77 -34.68 52.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 74.41 111.145 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.72 -39.81 91.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 54.23 111.145 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.95 -51.23 62.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 62.34 110.885 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.7 tp -70.68 -35.96 73.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 74.43 110.908 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.73 -38.84 82.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 73.23 111.075 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.25 -32.03 55.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 64.15 111.15 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 tp -51.42 -38.74 55.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 74.03 110.944 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.8 p -101.48 -36.79 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 73.21 111.145 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -66.97 -64.59 0.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 75.53 110.926 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.22 -25.98 62.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 74.44 110.924 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.6 mp -125.08 71.65 63.22 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.622 0.725 . . . . 74.42 110.9 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 173.27 11.19 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.748 2.299 . . . . 65.33 112.3 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.0 p -167.8 -170.27 1.34 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 75.42 110.876 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.0 95.71 10.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 72.14 110.839 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -179.1 138.78 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 71.11 110.841 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.33 -22.96 77.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.741 -0.743 . . . . 64.32 112.452 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -52.06 -34.94 45.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.932 0.396 . . . . 71.41 110.87 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.98 -51.57 61.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 72.42 110.905 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.8 ttm -65.41 -28.02 68.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 73.33 110.835 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.4 m -75.49 -31.65 60.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 73.11 111.148 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.45 -51.07 47.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 70.31 110.912 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -53.88 -48.01 70.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 65.11 110.887 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.6 tt -70.68 -34.95 58.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 72.15 111.119 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -61.52 -27.96 68.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 64.41 110.885 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.2 t -57.93 -39.48 71.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 74.41 111.099 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -29.13 27.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 71.44 110.915 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -74.56 -45.77 43.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 73.55 110.94 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.91 -29.59 20.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 72.32 111.086 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 37.3 mt -58.69 -54.46 46.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 73.45 110.91 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.31 -27.21 68.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 71.01 111.126 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 97.8 t -70.69 -33.05 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 75.4 111.154 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -64.7 -31.97 73.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 74.12 110.886 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.3 tp -75.1 -50.73 15.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 73.41 110.897 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.2 mp -65.84 -37.58 86.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 74.44 110.908 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.4 tt -62.63 -55.07 30.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 74.44 110.93 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.6 tt -66.31 -29.51 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 71.51 111.097 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.3 t -81.55 -14.78 56.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.822 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -93.67 -9.72 36.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 74.35 110.89 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.52 -16.88 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 74.55 111.122 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.2 t 64.28 78.01 0.29 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.561 0.696 . . . . 64.44 111.118 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 164.11 35.84 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.659 2.24 . . . . 73.01 112.355 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -49.3 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.745 2.296 . . . . 74.03 112.36 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 t -124.9 -35.32 2.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 75.43 111.153 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.24 -39.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 72.55 110.865 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.2 tp 64.53 70.6 0.49 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 74.13 110.917 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 50.15 60.17 4.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 72.22 110.894 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.521 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -68.62 -58.21 7.26 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.625 0.726 . . . . 71.23 111.114 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.4 Cg_endo -69.77 -26.02 27.98 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.673 2.248 . . . . 72.43 112.342 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.83 -39.81 69.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 75.33 110.916 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.3 t -80.53 -41.85 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 73.1 111.164 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.0 -46.39 55.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.769 -0.729 . . . . 53.51 112.464 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -32.95 69.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.816 0.341 . . . . 73.25 110.896 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -62.25 -31.97 72.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 72.41 110.879 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.3 mt -53.17 -29.8 33.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 71.42 110.903 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -42.48 86.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 74.42 110.859 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -75.26 -53.19 9.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 74.34 110.892 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -53.03 -29.93 32.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 75.4 111.165 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.1 mmt -66.61 -30.13 70.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 74.11 110.901 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.76 -30.1 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 64.41 111.116 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.92 -33.12 61.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 74.14 110.953 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.6 m -76.96 -37.99 27.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 73.3 111.118 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 70.5 m -72.53 -39.68 67.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 74.4 111.153 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -64.73 -31.93 73.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 64.05 110.847 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.6 t -74.3 -33.92 63.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.461 . . . . 73.33 110.852 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.3 mt -74.93 -50.65 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 72.5 111.151 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 34.7 m -54.15 -34.12 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 71.42 111.111 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.0 m -52.41 -32.45 39.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 74.01 111.188 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.4 m -50.42 -31.54 15.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 73.43 110.857 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.4 p -52.47 -32.8 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.496 . . . . 73.42 111.143 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 31.5 m -65.46 -43.17 91.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.143 -0.481 . . . . 63.04 110.846 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.3 t -77.12 -34.81 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 74.24 111.106 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.1 mt -72.05 -33.11 67.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 73.1 110.917 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -59.68 -31.03 69.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 73.31 110.888 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.8 p -102.32 -24.24 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 74.44 111.139 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -94.24 -74.68 0.53 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.472 . . . . 75.13 110.897 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -158.94 96.58 1.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 74.41 110.897 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.36 -26.0 13.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 74.1 110.877 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.13 160.59 1.17 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.711 0.767 . . . . 74.35 110.806 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 134.94 29.23 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.687 2.258 . . . . 70.34 112.385 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.07 83.67 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 64.02 111.13 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.6 p -95.53 25.5 4.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.436 . . . . 73.15 111.142 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -135.3 -51.44 0.76 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 73.41 110.814 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 30.6 m -144.78 68.44 14.42 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.57 0.7 . . . . 75.53 111.156 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -12.45 32.85 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.638 2.225 . . . . 72.2 112.356 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.12 136.67 29.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 73.53 110.887 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.7 110.54 0.78 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 71.53 112.471 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 112.14 -159.16 13.87 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.78 -0.724 . . . . 65.13 112.525 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.91 -84.21 0.17 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.745 -0.741 . . . . 71.53 112.494 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.12 19.88 7.4 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 71.51 112.47 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -87.87 -26.11 22.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.914 0.388 . . . . 75.1 110.932 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.8 -36.92 77.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 74.34 111.08 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -67.04 -25.8 66.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 75.31 111.123 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 30.4 mmt -52.96 -30.95 37.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 71.42 110.91 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 74.8 t -56.97 -59.02 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 73.53 111.134 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.6 mp -74.01 -37.74 47.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 72.53 111.136 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -61.26 -29.94 70.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 73.42 110.896 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.08 -30.14 24.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 73.43 110.872 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.42 -42.24 68.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 74.32 110.933 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -74.0 -51.43 15.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 75.51 110.881 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.03 -33.31 38.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 73.33 110.893 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 45.6 t-105 -61.8 -45.42 93.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.236 -0.438 . . . . 71.03 110.924 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 50.8 mm -76.96 -32.87 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 72.13 111.135 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -56.07 -56.96 14.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 72.13 110.867 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.7 m -55.6 -35.0 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 72.24 111.146 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -69.72 -33.11 72.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 74.15 110.883 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 82.0 t -67.62 -33.99 65.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 64.44 111.144 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 67.9 m -66.32 -46.41 77.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 75.31 110.874 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 43.4 t -76.03 -36.82 32.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 74.43 111.104 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -71.87 -28.6 63.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 74.5 110.861 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -52.24 -27.75 24.81 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.754 -0.736 . . . . 71.25 112.468 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.8 t -53.81 -32.01 51.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 74.32 111.155 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 20.0 tt -55.89 -25.7 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 75.0 111.163 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -51.9 -49.93 46.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.723 -0.751 . . . . 61.02 112.507 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -73.92 -31.8 63.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.785 0.326 . . . . 72.45 110.825 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -68.91 -21.49 64.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.429 . . . . 75.11 110.906 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.4 mt -74.74 -29.05 61.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 75.43 110.884 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.47 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.7 OUTLIER -51.95 -60.62 5.74 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.592 0.71 . . . . 74.43 110.877 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.9 Cg_endo -69.7 -16.53 37.84 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.753 2.302 . . . . 74.24 112.331 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.96 40.72 1.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 73.4 110.925 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -72.76 -26.32 61.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.442 . . . . 71.33 110.903 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 63.32 103.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.487 . . . . 73.3 110.867 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -78.88 -72.27 0.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 74.21 110.897 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 16.5 t80 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 73.44 110.88 -179.898 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 27.3 mmt-85 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.814 0.34 . . . . 74.13 110.845 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -96.16 26.16 4.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 75.33 110.848 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.97 73.73 2.46 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.536 0.684 . . . . 75.54 110.896 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -11.84 31.6 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.661 2.24 . . . . 73.25 112.292 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 pp -52.0 -30.96 27.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 74.42 110.904 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -78.98 -33.31 45.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 71.55 110.901 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -72.5 -46.19 55.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 74.51 110.922 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -59.98 -40.03 87.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.511 . . . . 75.24 111.125 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.11 -29.1 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 75.23 111.141 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.1 -26.87 51.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 71.22 110.866 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.51 -19.2 23.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 73.13 110.9 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mm -76.76 -34.86 23.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 74.33 111.087 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.526 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.1 mt -55.72 -57.12 23.15 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.6 0.714 . . . . 74.25 111.109 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.4 Cg_endo -69.8 -20.34 34.77 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.683 2.255 . . . . 75.24 112.337 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 48.4 t -75.51 -44.26 44.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 62.13 110.869 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 p -81.54 -28.95 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 74.31 111.144 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.3 mt -50.97 -33.97 26.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 75.12 110.872 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.76 -34.66 52.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 64.51 111.121 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.83 -38.43 88.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.19 -0.459 . . . . 75.4 111.132 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.07 -49.08 67.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 72.54 110.849 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.0 tp -74.31 -36.02 63.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 73.44 110.938 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.48 -37.99 76.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 72.4 111.106 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.9 -32.49 58.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 73.24 111.108 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 tp -55.07 -33.77 63.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 75.01 110.882 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.76 -36.73 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 73.32 111.126 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -71.43 -64.91 0.83 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 71.1 110.903 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.98 -23.27 64.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 74.32 110.875 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.7 mp -128.05 73.6 79.3 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.634 0.73 . . . . 73.51 110.889 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 133.18 24.89 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.721 2.28 . . . . 75.33 112.351 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.2 m -87.08 -67.73 0.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 71.41 110.824 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.53 -75.14 0.59 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 73.03 110.841 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.45 -62.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 72.22 110.859 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.16 -62.93 5.26 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.751 -0.737 . . . . 71.2 112.477 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -51.94 -36.93 50.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 64.35 110.881 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -62.93 -44.06 97.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 75.11 110.882 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.0 tpt -72.06 -48.47 44.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 74.22 110.842 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 82.0 p -54.99 -26.15 34.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.424 . . . . 71.4 111.101 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.65 -37.4 59.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 73.52 110.874 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 35.0 m -74.01 -48.19 31.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 74.54 110.914 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.6 pt -54.92 -32.21 26.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 73.52 111.115 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.0 t -70.84 -25.14 62.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 71.24 110.838 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.1 t -57.94 -37.13 59.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 75.51 111.137 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mt -55.37 -29.7 58.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 64.21 110.907 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -69.85 -45.44 67.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 73.42 110.872 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.07 -29.7 22.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 74.42 111.082 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 23.9 mt -59.81 -54.53 45.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 73.34 110.932 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.76 -27.16 67.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 64.11 111.148 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.1 t -70.32 -32.94 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 72.3 111.127 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -61.66 -29.84 70.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 74.51 110.911 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.73 -50.3 63.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 74.43 110.903 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.4 -38.25 65.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 75.34 110.866 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.5 tt -58.03 -55.05 40.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 74.31 110.969 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 tt -66.62 -23.95 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 75.03 111.162 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.6 t -80.32 -17.96 50.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 70.11 110.817 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -12.18 60.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 74.34 110.925 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 47.7 pt -52.77 -28.04 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 75.24 111.151 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 57.5 t 61.48 77.14 0.37 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.664 0.745 . . . . 73.51 111.117 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 167.28 24.89 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.681 2.254 . . . . 74.52 112.318 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -48.99 0.6 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.656 2.237 . . . . 72.44 112.369 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 t -134.82 18.49 3.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 73.14 111.106 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.2 m 51.73 64.55 1.8 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 52.42 110.845 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.15 24.96 11.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 74.43 110.877 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -115.05 25.48 10.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 71.21 110.861 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.521 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -65.15 -57.61 14.92 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.643 0.735 . . . . 74.52 111.121 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.6 Cg_endo -69.76 -21.4 33.53 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.676 2.25 . . . . 70.01 112.326 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.0 mp -73.41 -52.97 11.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 75.15 110.935 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.1 t -80.03 -42.86 22.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.458 . . . . 63.03 111.14 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.41 -38.05 49.83 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.784 -0.722 . . . . 74.22 112.46 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.35 -23.7 60.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.789 0.328 . . . . 73.04 110.9 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -76.15 -39.34 55.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 72.34 110.951 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.0 mt -55.68 -29.74 59.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.108 -0.496 . . . . 72.24 110.924 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.9 mmt -70.23 -42.57 72.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 74.21 110.896 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -75.26 -51.09 14.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 74.21 110.863 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -53.23 -29.84 34.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 74.13 111.127 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.6 mmt -66.77 -30.01 70.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 75.44 110.877 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.81 -30.01 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 73.04 111.137 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.91 -33.12 61.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 74.03 110.916 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.2 m -76.55 -37.73 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 75.25 111.118 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 53.7 m -72.7 -46.6 52.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 72.12 111.097 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -51.86 -31.26 27.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 74.33 110.894 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 m -73.86 -51.09 17.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 70.41 110.842 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.6 mt -54.76 -34.68 30.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 65.43 111.117 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.6 t -54.02 -45.73 64.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 74.53 111.103 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.6 m -52.3 -32.45 37.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 74.13 111.152 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.1 p -50.41 -31.36 14.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 71.13 110.855 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.6 p -52.45 -32.86 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 70.3 111.154 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 28.9 m -65.86 -47.35 75.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.468 . . . . 71.25 110.897 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 84.6 t -72.46 -36.28 54.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 73.34 111.121 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.1 mt -72.05 -32.72 67.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 73.43 110.93 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -60.98 -30.59 70.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 73.53 110.852 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.8 p -102.3 -23.2 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 72.12 111.126 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -109.37 117.7 34.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 73.51 110.886 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -52.96 169.98 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.456 . . . . 74.42 110.855 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -173.1 -173.88 0.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 73.51 110.861 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.04 160.61 1.14 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.654 0.74 . . . . 75.43 110.833 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 78.95 0.98 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.662 2.241 . . . . 74.33 112.319 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.11 -172.68 3.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 72.32 111.159 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.8 t -116.81 -24.58 7.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 74.51 111.178 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -51.88 -74.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 74.31 110.864 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 64.4 m -160.62 73.8 2.82 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.588 0.708 . . . . 72.55 111.145 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 100.05 0.79 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.667 2.245 . . . . 75.12 112.37 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -146.2 156.09 43.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 74.21 110.855 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -136.1 -162.5 9.57 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.762 -0.733 . . . . 75.31 112.491 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 103.41 57.42 0.75 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.714 -0.755 . . . . 64.4 112.46 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 130.38 -164.9 22.8 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.752 -0.737 . . . . 64.2 112.471 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 176.14 -64.01 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 63.32 112.501 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -66.29 -39.96 89.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.944 0.402 . . . . 74.22 110.952 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.7 m -54.72 -27.04 17.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 73.41 111.079 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.31 -25.33 48.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 62.32 111.094 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 37.1 mmt -53.01 -30.98 38.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 73.34 110.849 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 52.6 t -56.94 -58.26 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 64.11 111.114 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 45.5 mm -74.06 -37.94 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 75.14 111.101 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.73 -32.86 69.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 61.41 110.869 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.07 -26.02 59.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 73.35 110.895 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 16.1 tp -68.51 -50.88 48.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 75.54 110.939 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -73.23 -37.01 66.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 73.44 110.895 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.5 mt -52.02 -33.31 37.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 75.41 110.885 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -74.31 -34.53 63.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.213 -0.449 . . . . 75.44 110.905 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 36.0 mt -76.94 -32.01 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 75.15 111.101 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -56.05 -56.96 14.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 74.13 110.861 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.3 m -54.19 -34.99 28.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 64.54 111.132 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -67.34 -41.18 85.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 74.41 110.895 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 87.9 t -62.18 -34.04 61.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 52.23 111.121 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 98.9 m -53.8 -39.07 65.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.14 -0.482 . . . . 74.45 110.89 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.9 t -75.46 -33.0 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 74.51 111.122 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.98 -54.7 26.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 63.14 110.92 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.42 -19.35 79.87 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.794 -0.717 . . . . 73.04 112.461 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 34.6 m -73.61 -52.83 12.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.806 0.336 . . . . 70.52 111.176 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 45.4 mm -76.51 -24.26 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 73.52 111.128 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -53.95 -48.51 62.26 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.767 -0.73 . . . . 73.53 112.472 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.21 -33.14 50.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.762 0.315 . . . . 74.23 110.881 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.69 -21.14 64.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 74.42 110.867 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.9 mt -74.85 -29.18 60.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 75.43 110.868 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.475 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -51.93 -60.55 5.86 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.645 0.735 . . . . 75.44 110.879 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.5 Cg_endo -69.76 -31.12 21.13 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.668 2.246 . . . . 74.4 112.345 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.1 -53.5 41.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 72.12 110.933 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 5.1 t80 64.75 14.05 8.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 73.23 110.885 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -56.13 -65.38 0.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 72.4 110.905 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 62.6 t30 53.07 30.98 10.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 75.21 110.876 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 3.3 t80 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 73.32 110.946 -179.887 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.801 0.334 . . . . 75.32 110.836 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.95 -67.98 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 74.24 110.891 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? -119.56 68.44 11.07 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.551 0.691 . . . . 73.54 110.909 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 78.7 0.99 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.716 2.278 . . . . 74.11 112.388 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.99 -30.94 65.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 72.35 110.886 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -77.7 -32.24 52.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 74.33 110.873 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -73.45 -44.98 56.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 73.4 110.91 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 t -60.71 -39.71 89.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.102 -0.499 . . . . 71.21 111.183 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -29.07 21.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 71.34 111.097 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -56.0 -27.58 53.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 75.43 110.892 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.69 -18.42 25.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 75.31 110.908 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mm -76.79 -34.79 23.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 74.53 111.165 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.539 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.73 -57.16 22.94 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.61 0.719 . . . . 75.54 111.092 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.8 Cg_endo -69.75 -20.85 34.35 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.718 2.279 . . . . 62.24 112.335 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 48.6 t -76.0 -44.69 38.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 73.13 110.859 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.5 -28.88 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 75.45 111.183 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mt -51.01 -34.01 27.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 73.43 110.909 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.64 -34.73 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 72.32 111.143 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.75 -41.15 92.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 74.52 111.13 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.01 -43.01 66.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 72.01 110.865 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 tp -76.59 -40.03 50.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 74.3 110.938 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.72 -51.46 69.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 61.44 111.075 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.4 mp -49.73 -31.44 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 73.54 111.136 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.0 tp -50.76 -42.22 57.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 74.22 110.943 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.49 -37.48 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 75.23 111.145 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.68 -64.53 0.87 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 70.41 110.871 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.85 -62.0 1.61 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.484 . . . . 75.33 110.907 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.2 mp -67.89 160.67 72.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.599 0.714 . . . . 72.14 110.874 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 143.68 51.77 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.73 2.287 . . . . 64.42 112.329 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.17 -176.83 6.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 71.02 110.846 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -173.41 -169.99 0.57 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.5 . . . . 73.23 110.872 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 63.35 172.5 0.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 74.33 110.893 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.4 -22.93 39.91 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.712 -0.756 . . . . 65.0 112.48 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -51.97 -35.01 44.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.917 0.389 . . . . 73.41 110.887 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.3 ttpp -52.96 -52.0 59.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 75.14 110.897 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 6.8 tpt -72.01 -42.09 66.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 75.23 110.87 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.6 m -53.08 -28.4 24.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 62.42 111.13 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.53 -40.21 70.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 74.43 110.899 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 28.7 m -66.04 -45.65 80.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 75.31 110.908 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 12.4 tt -72.37 -35.05 50.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 73.13 111.145 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.14 -43.25 70.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 72.43 110.898 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.7 t -58.01 -34.83 49.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 73.31 111.134 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.87 -28.98 25.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 71.44 110.895 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -68.99 -39.25 79.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 74.31 110.896 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.39 -30.05 70.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 64.5 111.086 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.9 mt -64.85 -54.67 27.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 73.44 110.947 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.97 -38.22 87.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 72.45 111.172 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.5 t -71.37 -32.9 48.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 74.51 111.151 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -66.68 -29.88 69.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 75.25 110.853 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.3 tt -72.06 -47.61 50.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 61.41 110.896 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.5 mt -73.04 -39.63 65.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 75.41 110.915 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.9 tt -58.22 -51.3 70.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 73.41 110.932 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.6 tt -71.68 -26.2 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 70.21 111.145 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 25.5 t -80.53 -13.8 58.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 62.14 110.868 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.5 mmmt -50.71 -29.21 10.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 74.33 110.878 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.9 pt -50.53 -37.43 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 63.11 111.111 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.0 t 51.37 81.68 0.26 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.59 0.709 . . . . 74.35 111.178 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 167.47 24.43 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.657 2.238 . . . . 73.43 112.335 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -49.96 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.701 2.267 . . . . 73.04 112.342 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.2 t -136.75 -38.92 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 75.14 111.179 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.64 83.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 73.2 110.886 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.8 -18.04 16.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 72.5 110.893 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -153.7 24.1 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 72.35 110.873 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -66.9 -57.9 10.56 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.649 0.738 . . . . 73.04 111.159 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 54.1 Cg_endo -69.75 -21.54 33.38 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.709 2.273 . . . . 74.43 112.372 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.12 -53.17 10.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 65.34 110.938 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.7 -46.65 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 74.42 111.134 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.87 -39.46 47.94 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.754 -0.736 . . . . 32.22 112.47 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -73.22 -24.37 60.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.331 . . . . 70.31 110.922 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -74.43 -37.95 63.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 70.52 110.916 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.6 mt -57.38 -29.71 64.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.076 -0.511 . . . . 74.41 110.938 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 5.2 mmt -69.51 -43.57 72.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 74.13 110.866 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -75.16 -51.22 13.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 72.51 110.854 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 t -53.08 -29.9 33.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 74.4 111.097 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 9.0 mmt -66.65 -30.13 70.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 72.02 110.887 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.77 -30.18 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 72.11 111.114 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.79 -33.29 62.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 74.44 110.931 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.9 m -76.93 -38.06 28.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 74.11 111.097 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 76.7 m -72.4 -38.91 68.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 75.12 111.162 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -66.17 -31.93 73.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 72.31 110.874 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.0 t -73.41 -37.12 66.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 63.33 110.841 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.0 mt -70.29 -51.45 38.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 72.0 111.157 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.1 p -54.06 -35.53 29.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 63.22 111.15 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.3 m -52.41 -32.42 39.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 72.14 111.162 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.6 m -50.36 -31.54 14.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 74.04 110.847 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.3 p -52.51 -32.83 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 74.35 111.092 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 33.6 m -65.69 -43.56 88.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.199 -0.455 . . . . 73.22 110.863 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.9 t -76.74 -35.64 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 65.34 111.11 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 89.6 mt -72.1 -31.57 66.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 75.41 110.903 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -62.51 -30.26 71.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 64.21 110.896 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.9 p -102.31 -22.78 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 74.24 111.173 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -60.91 -74.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 73.32 110.903 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -174.97 76.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 73.15 110.86 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.12 -170.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 72.44 110.862 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 63.2 69.12 0.86 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.65 0.738 . . . . 64.44 110.814 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -170.97 0.43 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.703 2.269 . . . . 74.31 112.332 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.93 -73.53 0.58 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 74.44 111.163 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.68 150.2 49.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 73.04 111.146 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 56.46 -169.87 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 73.43 110.853 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.0 t -114.07 72.4 2.24 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.55 0.691 . . . . 74.01 111.129 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 139.55 40.55 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.667 2.245 . . . . 62.0 112.309 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.8 158.36 44.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 74.45 110.866 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 109.54 156.44 16.66 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.797 -0.716 . . . . 75.34 112.472 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 132.23 -158.06 22.77 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.729 -0.748 . . . . 65.11 112.471 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.84 -146.64 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.724 -0.75 . . . . 74.15 112.469 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.04 45.69 0.8 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.714 -0.755 . . . . 63.32 112.481 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -87.9 -43.0 12.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.919 0.39 . . . . 72.41 110.951 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.2 m -54.97 -31.84 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 75.43 111.119 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.81 -24.99 61.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 65.52 111.069 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 18.2 mmt -52.93 -31.05 38.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 71.31 110.894 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 32.2 t -57.0 -49.44 79.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 63.55 111.105 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 30.8 mm -74.03 -40.65 52.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 74.4 111.121 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -61.97 -30.02 70.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 64.52 110.848 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.0 mtm-85 -54.32 -27.53 36.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 73.2 110.857 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 tp -67.66 -50.85 55.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 73.4 110.931 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -74.05 -31.44 62.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 75.31 110.847 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.15 -32.04 33.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 70.42 110.906 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -35.16 61.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 73.1 110.923 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 36.9 mm -76.91 -32.16 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 65.22 111.11 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -56.02 -56.74 17.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 74.44 110.923 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.27 -35.46 62.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 65.14 111.142 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.32 -33.07 67.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 75.31 110.851 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 28.8 t -65.96 -37.04 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 75.14 111.118 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.1 t -57.09 -51.69 68.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 73.41 110.854 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.9 t -69.17 -33.47 58.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 73.51 111.094 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -52.32 -53.5 43.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 75.33 110.895 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.04 -19.63 77.06 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.702 -0.761 . . . . 60.41 112.486 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 35.1 m -65.82 -52.83 47.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.74 0.305 . . . . 71.25 111.174 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 20.6 mt -76.58 -25.26 16.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 71.21 111.142 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -58.5 -49.92 72.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 62.01 112.462 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 9.6 mmt -70.13 -31.99 69.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.782 0.325 . . . . 75.02 110.854 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -71.64 -24.32 61.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 73.31 110.882 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 10.7 mt -75.35 -26.74 58.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 75.44 110.932 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.467 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.9 OUTLIER -52.13 -60.61 5.83 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.592 0.71 . . . . 75.44 110.894 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 54.0 Cg_endo -69.71 -36.26 11.26 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.705 2.27 . . . . 75.14 112.38 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.407 ' O ' ' CB ' ' A' ' 161' ' ' PHE . 4.5 tp 48.72 34.96 5.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 74.3 110.91 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.407 ' CB ' ' O ' ' A' ' 160' ' ' LEU . 8.9 t80 76.39 -52.22 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 72.32 110.868 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -170.4 -72.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 74.25 110.933 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -174.92 118.07 0.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 65.13 110.917 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 3.7 t80 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 74.3 110.917 -179.873 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.824 0.345 . . . . 72.32 110.859 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.471 ' O ' ' C ' ' A' ' 27' ' ' LYS . 8.6 mtt-85 -78.74 67.3 4.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 71.25 110.85 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER 31.85 77.0 0.36 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.622 0.725 . . . . 73.0 110.902 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -3.32 11.79 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.714 2.276 . . . . 73.4 112.3 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 pp -52.36 -30.98 31.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 74.11 110.905 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -80.99 -31.69 34.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.468 . . . . 75.22 110.902 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -72.88 -46.29 53.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 74.11 110.951 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 t -59.49 -40.09 85.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 65.23 111.145 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.16 -29.05 21.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 74.15 111.149 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.0 -26.87 50.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 71.21 110.91 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.5 -19.24 23.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 73.12 110.891 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mm -76.66 -34.95 24.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 74.01 111.131 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.526 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.65 -57.16 22.74 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.62 0.724 . . . . 74.1 111.12 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.4 Cg_endo -69.73 -20.45 34.95 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.743 2.295 . . . . 73.43 112.318 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 48.0 t -75.98 -44.54 39.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 73.54 110.885 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.2 p -81.57 -28.93 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 74.12 111.131 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 mt -50.98 -33.94 26.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.459 . . . . 75.12 110.93 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.1 tp -58.76 -34.64 52.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 74.32 111.122 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 p -65.79 -38.8 90.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 72.34 111.111 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 t -53.0 -46.46 68.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 75.33 110.866 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.63 -41.41 60.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 74.41 110.938 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.4 -35.74 68.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 75.51 111.089 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.81 -32.54 58.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 71.43 111.122 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.8 tp -55.04 -33.64 62.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 72.22 110.916 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.7 m -102.04 -35.57 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 75.53 111.102 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -72.58 -64.87 0.87 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 71.11 110.87 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.76 -41.14 96.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 74.21 110.911 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.49 74.78 2.29 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.639 0.733 . . . . 74.0 110.942 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 125.89 12.67 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.723 2.282 . . . . 74.4 112.312 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.8 t -116.31 -26.78 7.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 61.43 110.826 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -161.96 125.87 3.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.107 -0.497 . . . . 75.43 110.853 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.7 p -57.72 -26.0 61.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 73.21 110.871 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.95 -62.97 5.43 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.76 -0.733 . . . . 75.01 112.462 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -74.89 -35.46 62.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.889 0.376 . . . . 74.32 110.876 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -55.76 -50.49 70.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 73.42 110.869 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.5 ttm -64.96 -51.7 60.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 72.43 110.877 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 70.9 p -56.22 -28.63 59.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 73.05 111.175 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -72.78 -51.0 20.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 74.44 110.908 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.01 -49.67 65.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 71.54 110.887 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.6 tt -68.29 -35.01 69.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 72.43 111.125 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 m -65.71 -25.07 67.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 63.52 110.837 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.0 t -57.96 -37.57 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.494 . . . . 61.42 111.107 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -28.95 26.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 75.41 110.884 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.36 -38.86 78.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 74.32 110.917 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.53 -30.02 70.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 65.13 111.128 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.6 mt -65.08 -54.7 26.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 65.34 110.897 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.69 -38.49 88.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 73.21 111.152 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 80.0 t -71.43 -32.93 48.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 72.42 111.127 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -51.84 -30.18 22.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 74.34 110.917 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.22 -42.36 62.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.491 . . . . 75.04 110.936 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.6 mt -73.21 -33.91 65.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 74.11 110.897 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 tt -70.22 -55.07 10.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 73.21 110.973 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 tt -57.08 -30.43 34.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 74.32 111.104 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.1 m -80.17 -23.42 41.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 72.25 110.858 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.79 -12.75 61.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.477 . . . . 74.13 110.895 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.2 pp -56.31 -24.57 18.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 73.14 111.123 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 22.0 t 63.7 75.27 0.4 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.641 0.734 . . . . 72.22 111.151 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 167.53 24.22 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.658 2.238 . . . . 65.04 112.342 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 -48.66 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.69 2.26 . . . . 71.2 112.354 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.0 t -117.2 -19.79 9.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 74.54 111.143 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.69 45.08 4.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 73.54 110.872 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.6 tp -95.7 25.9 4.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 75.35 110.909 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -104.57 24.39 11.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 72.2 110.862 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.513 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.19 -57.79 10.23 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.642 0.735 . . . . 74.15 111.145 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 54.3 Cg_endo -69.79 -20.48 34.62 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.696 2.264 . . . . 74.41 112.359 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.12 -45.6 47.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 75.4 110.955 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.4 t -80.67 -37.85 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 62.21 111.121 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.92 -52.1 36.66 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.724 -0.751 . . . . 74.4 112.542 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -35.19 79.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.828 0.347 . . . . 72.14 110.895 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -60.77 -36.75 79.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 73.52 110.952 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.7 mt -51.89 -29.8 21.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 71.42 110.934 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 13.4 mmt -67.85 -43.12 80.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 74.51 110.916 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -75.28 -52.25 11.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 74.22 110.888 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -53.02 -29.91 32.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 74.51 111.165 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.72 -30.05 70.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 74.2 110.858 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.8 -30.04 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 65.13 111.134 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.91 -33.21 61.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 75.41 110.929 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.91 -38.09 28.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 74.53 111.156 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 73.0 m -72.46 -40.73 66.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 74.41 111.203 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -63.51 -32.17 73.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 63.33 110.88 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.0 t -71.38 -32.04 68.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 74.3 110.828 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.3 mt -75.01 -52.1 19.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 72.41 111.163 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.1 p -54.16 -36.65 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 75.24 111.139 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.7 m -52.38 -32.4 38.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 62.31 111.173 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.7 m -50.46 -31.29 14.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.463 . . . . 71.1 110.835 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.2 p -52.51 -32.73 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 75.53 111.109 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 17.9 m -64.15 -43.87 93.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 64.13 110.878 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 84.1 t -76.89 -34.74 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 63.42 111.087 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.4 mt -71.99 -32.25 67.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 72.2 110.895 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -59.18 -31.97 69.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 72.32 110.858 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.0 p -102.32 -24.84 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 75.41 111.166 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 -90.25 -73.73 0.51 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.123 -0.49 . . . . 74.43 110.828 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -172.72 99.14 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 75.32 110.816 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.412 HH11 ' N ' ' A' ' 119' ' ' SER . 52.3 tpt85 -98.76 118.1 34.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 74.13 110.909 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.412 ' N ' HH11 ' A' ' 118' ' ' ARG . 0.1 OUTLIER -179.12 160.59 0.99 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.689 0.757 . . . . 73.4 110.826 -179.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 135.93 31.75 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.647 2.231 . . . . 72.02 112.384 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -170.4 145.85 2.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 71.03 111.18 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.5 m -160.47 69.02 0.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 74.23 111.132 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -156.28 26.21 0.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 72.21 110.879 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 27.2 m 60.62 73.95 0.58 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.574 0.702 . . . . 75.12 111.173 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -170.99 0.43 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.702 2.268 . . . . 71.11 112.349 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.0 mmt-85 -126.04 -74.29 0.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 74.45 110.862 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 52.4 -144.38 20.26 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.759 -0.734 . . . . 74.44 112.49 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 144.83 125.89 1.85 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.768 -0.73 . . . . 71.24 112.525 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 131.04 -154.53 20.84 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.747 -0.74 . . . . 71.32 112.495 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 90.31 28.75 16.26 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 65.04 112.464 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -87.97 -29.81 20.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.987 0.422 . . . . 74.15 110.922 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.9 m -66.44 -35.93 76.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 63.21 111.105 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.46 -25.02 67.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 75.04 111.094 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 39.1 mmt -53.0 -31.02 38.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 73.02 110.872 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 64.5 t -56.99 -58.17 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.281 -0.418 . . . . 74.52 111.082 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.9 mt -73.95 -36.93 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 73.22 111.12 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -62.09 -29.94 70.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 63.5 110.884 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.18 -29.86 24.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 73.41 110.886 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.31 -39.48 74.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 74.2 110.879 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -73.86 -53.38 10.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 64.03 110.897 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.39 -33.6 44.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 74.24 110.913 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 20.7 t90 -55.51 -50.6 69.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 75.2 110.937 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 57.8 mt -76.01 -33.49 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 73.41 111.121 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -56.16 -56.02 25.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 63.11 110.867 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 23.2 t -59.95 -35.01 58.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 71.12 111.089 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -66.06 -33.27 75.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 70.21 110.895 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 78.7 t -54.25 -50.64 54.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 74.51 111.155 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.39 -47.7 66.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 74.44 110.921 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.7 t -63.67 -33.03 59.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 74.33 111.132 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -52.07 -54.94 24.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 74.42 110.893 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.32 -19.55 74.05 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 54.52 112.486 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.2 m -60.11 -52.82 63.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.733 0.301 . . . . 74.13 111.136 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 47.3 mm -76.48 -33.65 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 73.21 111.132 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -55.2 -49.98 61.31 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.741 -0.742 . . . . 61.51 112.51 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 3.3 mmt -72.43 -31.99 65.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.822 0.344 . . . . 75.32 110.91 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -71.22 -24.18 62.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 74.43 110.856 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.8 mt -75.28 -26.97 59.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 65.03 110.963 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.463 ' CB ' ' CD ' ' A' ' 159' ' ' PRO . 0.8 OUTLIER -52.0 -60.55 5.91 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.629 0.728 . . . . 75.51 110.915 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' A' ' 158' ' ' GLN . 53.4 Cg_endo -69.81 -15.61 36.96 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.701 2.267 . . . . 65.23 112.339 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.96 40.87 1.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 73.1 110.949 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -67.93 -26.09 65.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 73.15 110.854 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 72.21 -69.01 0.2 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 74.32 110.968 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 22.8 t30 52.02 87.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 75.12 110.904 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 35.1 t80 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 73.12 110.927 -179.9 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.819 0.342 . . . . 73.44 110.865 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -146.96 -168.0 2.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 74.12 110.876 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -49.66 108.1 0.92 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.583 0.706 . . . . 75.51 110.933 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -13.46 34.82 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.652 2.235 . . . . 74.43 112.375 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.0 pp -52.08 -30.99 28.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 71.31 110.913 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -78.04 -33.59 50.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 73.24 110.882 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -72.64 -45.89 56.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 74.23 110.904 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -60.31 -39.96 88.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 64.31 111.14 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.17 -29.08 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 64.52 111.145 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.88 -27.26 51.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.42 110.861 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.1 -18.8 23.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 70.42 110.957 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.7 mm -76.54 -34.97 25.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 73.22 111.173 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.535 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.72 -57.15 22.97 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.583 0.706 . . . . 74.31 111.107 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.5 Cg_endo -69.77 -21.35 33.54 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.683 2.255 . . . . 72.53 112.285 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 47.3 t -75.87 -44.52 40.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 72.52 110.882 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.7 p -81.57 -28.93 10.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 71.23 111.139 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 mt -50.97 -34.01 27.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 74.41 110.907 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.1 tp -58.68 -34.68 52.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 65.25 111.141 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 p -65.69 -40.48 92.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.458 . . . . 72.34 111.138 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.97 -43.08 66.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 71.42 110.876 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.9 tp -76.96 -40.79 45.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.12 -0.491 . . . . 73.21 110.914 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.1 -36.52 68.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 61.24 111.103 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.28 -32.02 55.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 75.51 111.112 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.9 tp -51.43 -38.76 55.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 75.1 110.916 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -101.47 -36.69 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 74.34 111.154 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -67.02 -64.65 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 74.34 110.871 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.34 -60.8 2.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 74.13 110.907 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.0 mp -71.0 160.63 81.85 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.598 0.713 . . . . 74.33 110.921 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 144.63 54.77 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.701 2.267 . . . . 75.54 112.313 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.76 95.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 72.4 110.877 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 53.85 -172.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 73.1 110.862 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.4 m -114.81 -74.49 0.61 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 63.11 110.862 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.41 -27.74 66.18 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.726 . . . . 73.42 112.515 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -52.1 -34.92 46.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.852 0.358 . . . . 72.24 110.821 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.6 mttt -52.98 -51.92 59.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 71.35 110.894 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 9.7 ttm -64.3 -45.44 87.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 73.4 110.882 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.7 m -58.28 -36.96 74.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.446 . . . . 75.25 111.177 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.62 -32.6 60.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 73.02 110.939 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 6.8 m -65.26 -52.01 57.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 73.24 110.897 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.4 tt -60.26 -34.95 59.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 70.23 111.112 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -24.98 66.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 74.01 110.853 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.3 t -57.95 -35.59 52.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 74.4 111.137 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mp -52.98 -28.88 25.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 71.51 110.893 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.37 -38.99 78.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 71.34 110.925 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.45 -30.05 70.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 75.22 111.093 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.9 mt -64.7 -54.72 27.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 64.11 110.944 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.97 -38.17 87.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 72.25 111.112 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 76.4 t -71.44 -32.83 47.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 70.11 111.111 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -51.51 -30.67 21.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 73.33 110.909 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.9 tp -75.0 -40.06 60.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 75.51 110.915 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.9 mt -73.22 -34.8 66.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 72.01 110.916 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.11 -53.87 13.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.456 . . . . 73.32 110.906 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.6 tt -56.43 -26.17 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 74.34 111.104 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.5 m -80.15 -22.4 42.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 71.11 110.862 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -70.77 -10.5 59.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 74.33 110.873 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.4 pp -56.61 -23.72 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 72.24 111.133 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.4 t 64.11 75.49 0.38 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.598 0.713 . . . . 65.22 111.127 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 167.26 24.93 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.656 2.237 . . . . 63.25 112.348 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -48.8 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.713 2.275 . . . . 73.32 112.331 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.4 t -116.6 -19.93 9.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 74.44 111.148 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 p 63.46 23.27 13.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 64.54 110.873 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.72 31.21 2.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 75.22 110.915 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -94.63 47.16 1.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.457 . . . . 72.33 110.875 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.527 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -66.74 -57.72 11.22 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.586 0.708 . . . . 73.33 111.142 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.7 Cg_endo -69.77 -20.0 35.34 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.679 2.252 . . . . 74.35 112.322 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.15 -53.16 10.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.246 -0.434 . . . . 72.01 110.875 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.11 -38.01 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 72.12 111.085 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.1 -43.43 56.18 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.752 -0.737 . . . . 75.3 112.448 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -21.92 64.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.806 0.336 . . . . 74.11 110.911 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -78.13 -41.88 33.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 74.54 110.902 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.9 mt -55.69 -29.71 59.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 73.35 110.875 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -43.42 76.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 74.45 110.876 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.4 ' O ' HG22 ' A' ' 100' ' ' VAL . 50.9 t80 -75.27 -51.69 12.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 75.23 110.871 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 t -53.16 -29.88 33.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 74.34 111.113 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.8 mmt -66.63 -30.12 70.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 75.13 110.878 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.7 -30.08 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 75.43 111.153 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.0 -33.2 61.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 74.11 110.906 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.2 m -76.91 -38.12 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 74.43 111.155 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 74.1 m -72.47 -40.05 67.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.472 . . . . 74.33 111.135 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -64.49 -31.92 73.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 71.13 110.852 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.6 t -74.4 -34.51 63.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 61.2 110.859 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.5 mt -74.43 -50.72 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 72.41 111.135 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 34.5 m -54.05 -33.99 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 73.31 111.111 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.0 m -52.41 -32.53 39.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 63.23 111.164 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.1 m -50.45 -31.46 15.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 73.24 110.891 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.4 p -52.5 -32.73 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 72.15 111.115 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 35.5 m -66.94 -48.74 67.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 64.53 110.868 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 77.7 t -70.49 -35.37 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 74.43 111.124 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.0 mt -72.09 -40.31 68.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 74.32 110.911 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -52.12 -31.66 31.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 74.3 110.863 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.3 p -102.31 -24.18 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 73.21 111.139 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -54.02 -74.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 72.51 110.879 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -179.15 35.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 75.54 110.857 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -119.93 -173.62 2.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 74.41 110.846 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.58 160.58 47.34 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.652 0.739 . . . . 62.14 110.851 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -171.25 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.717 2.278 . . . . 75.33 112.3 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.0 -72.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.468 . . . . 73.25 111.129 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -143.54 -62.49 0.4 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.211 -0.45 . . . . 72.45 111.14 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -109.76 -176.2 2.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 74.24 110.867 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.5 m 64.27 73.64 0.45 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.615 0.721 . . . . 72.44 111.162 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -170.96 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.672 2.248 . . . . 72.41 112.351 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.5 ttm-85 63.22 161.7 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 74.03 110.853 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -164.27 64.26 0.24 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.751 . . . . 65.52 112.497 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -136.74 112.84 0.98 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.689 -0.767 . . . . 72.31 112.484 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 112.19 -147.62 18.21 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.781 -0.724 . . . . 71.25 112.462 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -165.7 -60.42 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.797 -0.716 . . . . 71.32 112.518 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -69.32 -26.35 64.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.969 0.414 . . . . 75.25 110.946 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.1 m -54.72 -27.1 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.054 -0.521 . . . . 75.31 111.113 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.83 -27.66 43.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 75.34 111.117 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 37.0 mmt -53.0 -31.01 38.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 71.42 110.876 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 62.4 t -56.94 -56.02 16.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.267 -0.424 . . . . 73.43 111.105 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.8 mp -73.94 -38.66 50.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 73.11 111.116 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -61.13 -30.46 70.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 73.35 110.899 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.76 -27.28 40.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.478 . . . . 71.15 110.88 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.01 -50.63 21.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 72.04 110.909 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -69.06 -53.59 19.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 74.4 110.887 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.08 -32.4 34.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 74.54 110.907 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -61.45 -51.48 68.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 74.54 110.884 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.1 mt -74.35 -32.0 29.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 75.12 111.156 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -56.0 -56.46 20.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 71.44 110.847 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 30.6 t -54.3 -35.56 30.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 73.31 111.138 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -69.96 -37.86 75.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 72.02 110.884 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 63.0 t -54.9 -34.06 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 72.41 111.145 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.78 -47.99 67.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 72.5 110.91 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.5 -36.69 42.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 73.2 111.126 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -54.89 -26.92 38.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 72.34 110.92 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.58 -59.05 4.26 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 73.35 112.423 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 4.4 t -54.59 -34.09 61.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.788 0.328 . . . . 70.23 111.162 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 47.6 mt -70.24 -25.21 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 74.14 111.091 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.83 -49.92 32.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.704 -0.76 . . . . 61.32 112.514 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.65 -32.01 57.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.345 . . . . 73.42 110.928 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -72.68 -20.84 61.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 74.01 110.879 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.3 mt -79.34 -27.11 42.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 73.12 110.917 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.523 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 11.5 tp60 -51.75 -58.17 12.02 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.584 0.706 . . . . 75.12 110.884 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 54.1 Cg_endo -69.74 -29.38 24.07 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.745 2.296 . . . . 72.22 112.334 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.97 -53.52 40.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 74.54 110.909 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 4.8 t80 64.46 14.45 8.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 72.24 110.858 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 60.19 47.48 9.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 74.22 110.928 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -162.7 -60.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 73.54 110.923 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 71.54 110.899 -179.927 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.783 0.325 . . . . 73.32 110.841 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -65.68 91.07 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 74.51 110.883 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.31 79.23 44.88 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.582 0.706 . . . . 71.13 110.889 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 -5.07 15.33 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.704 2.269 . . . . 71.12 112.313 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.0 pp -52.29 -30.95 30.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 75.41 110.923 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -80.26 -32.01 38.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 74.42 110.914 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -73.12 -46.16 52.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 75.04 110.926 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 t -59.67 -39.99 86.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 72.43 111.157 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.19 -29.1 21.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 74.44 111.132 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -55.58 -27.24 48.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 75.3 110.869 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.27 -19.08 23.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.201 -0.454 . . . . 75.44 110.93 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.8 mm -76.51 -35.03 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 74.22 111.138 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.535 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.68 -57.14 22.91 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.609 0.719 . . . . 74.52 111.127 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.9 Cg_endo -69.75 -21.58 33.32 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.683 2.255 . . . . 72.04 112.308 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.2 t -73.09 -46.91 48.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 73.24 110.871 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.5 p -81.53 -29.01 10.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 70.21 111.117 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.1 mt -50.89 -34.01 26.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 73.31 110.949 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.2 tp -58.76 -34.64 52.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 74.55 111.113 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.3 p -65.66 -34.53 78.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 64.42 111.141 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.06 -49.01 72.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 75.33 110.864 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.0 tp -73.17 -43.21 61.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 61.01 110.922 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.94 -39.99 75.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 73.41 111.13 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.07 -32.45 58.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 73.31 111.102 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.0 tp -51.57 -37.15 48.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 65.2 110.915 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.01 -35.78 4.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 71.31 111.09 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -67.08 -62.86 1.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 74.24 110.881 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.23 -40.33 70.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 75.43 110.922 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.43 159.18 85.73 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.602 0.715 . . . . 73.02 110.887 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -172.28 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.615 2.21 . . . . 74.41 112.389 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.9 t 63.28 87.75 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 71.33 110.865 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -89.86 50.4 1.88 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 73.03 110.875 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.7 p -63.21 -173.38 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 71.32 110.898 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.2 -30.02 30.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.754 -0.736 . . . . 71.53 112.492 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -60.89 -34.88 75.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.977 0.417 . . . . 73.1 110.932 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -46.07 82.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 71.44 110.873 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 23.9 ttm -71.64 -46.49 58.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 72.32 110.889 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 30.4 p -54.38 -27.18 34.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 72.43 111.109 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.24 -51.0 34.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 74.24 110.906 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 7.3 m -54.66 -46.53 74.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.429 . . . . 71.21 110.931 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 15.8 tt -71.22 -34.96 56.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 74.21 111.148 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 m -53.85 -28.07 33.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 70.41 110.898 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.0 t -58.08 -38.37 67.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.487 . . . . 72.22 111.169 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.91 -28.87 25.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 72.54 110.962 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.01 -39.04 79.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 75.31 110.927 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.48 -29.97 70.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 71.23 111.084 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.5 mt -66.04 -54.81 21.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 63.31 110.903 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -60.94 -38.37 85.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 71.14 111.148 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 81.9 t -71.5 -37.19 63.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 73.32 111.124 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -68.55 -31.87 71.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 73.31 110.853 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.8 tt -75.03 -43.62 52.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 75.24 110.904 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.8 mp -73.32 -44.06 59.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 74.45 110.893 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.3 tt -55.55 -55.16 35.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 72.44 110.936 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.4 tt -62.91 -25.08 37.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 75.31 111.074 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.4 m -80.14 -14.62 58.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 75.33 110.848 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -54.43 -26.42 30.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 72.13 110.891 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.423 ' O ' ' C ' ' A' ' 81' ' ' VAL . 1.0 OUTLIER -62.42 -16.78 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 75.34 111.084 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' A' ' 80' ' ' ILE . 2.4 p 35.53 80.95 0.25 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.601 0.715 . . . . 73.34 111.097 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 165.76 29.87 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.714 2.276 . . . . 73.12 112.376 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 -50.13 0.5 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.704 2.269 . . . . 75.42 112.388 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.5 t -136.98 -38.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 71.53 111.14 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 178.7 82.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 74.35 110.85 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.21 -17.82 20.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 64.54 110.914 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -152.56 23.88 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 74.24 110.879 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -66.86 -57.8 10.82 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.63 0.728 . . . . 73.33 111.113 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.4 Cg_endo -69.79 -21.55 33.21 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.67 2.247 . . . . 72.33 112.322 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.15 -53.1 10.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.44 . . . . 75.24 110.934 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.32 -44.89 24.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 74.23 111.164 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.04 -39.2 48.83 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.736 -0.745 . . . . 53.21 112.446 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -73.75 -23.56 59.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.798 0.333 . . . . 73.45 110.936 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -75.35 -37.82 60.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 75.42 110.931 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.9 mt -54.45 -29.85 50.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 73.51 110.89 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.36 -43.65 73.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 55.21 110.885 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -75.17 -51.12 14.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 73.03 110.884 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 t -53.15 -29.74 33.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 73.12 111.129 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.78 -30.18 70.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.44 . . . . 73.52 110.909 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.85 -29.95 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 72.31 111.154 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.06 -33.22 61.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 73.43 110.915 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.1 m -76.91 -38.06 28.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 73.32 111.164 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 74.5 m -72.51 -38.54 68.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 75.11 111.113 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -66.41 -31.84 72.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 73.3 110.87 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.01 -34.76 64.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 73.24 110.872 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.3 mt -73.83 -51.03 25.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 73.01 111.177 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.2 m -53.94 -34.21 25.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 65.32 111.133 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.3 m -52.39 -32.51 39.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 74.02 111.144 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.0 p -50.41 -31.45 14.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 75.43 110.862 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.5 p -52.56 -32.8 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 75.21 111.118 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 27.3 m -66.2 -48.14 71.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 74.12 110.905 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.6 t -71.44 -35.98 59.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 63.22 111.144 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.8 mt -72.03 -34.68 68.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 75.11 110.912 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -55.44 -32.73 62.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 74.02 110.886 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.6 p -102.34 -24.28 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 64.54 111.121 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -81.48 -70.08 0.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 75.4 110.812 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -123.2 77.64 1.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 75.23 110.871 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.0 -50.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 75.33 110.846 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.5 t -165.47 73.38 1.37 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.631 0.729 . . . . 72.41 110.851 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 107.02 1.77 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.663 2.242 . . . . 75.24 112.333 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 17.2 m -76.22 -25.96 55.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 73.42 111.119 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.38 102.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.445 . . . . 73.0 111.161 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -119.81 -71.95 0.71 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 74.43 110.903 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -160.18 67.93 2.79 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.592 0.71 . . . . 64.35 111.142 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -172.31 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.72 2.28 . . . . 72.42 112.373 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.66 -57.66 1.72 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 74.31 110.889 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -104.23 -41.77 2.02 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.724 -0.75 . . . . 71.34 112.452 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 129.63 92.42 0.66 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.758 -0.734 . . . . 73.33 112.47 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 169.29 -76.53 0.11 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.673 -0.775 . . . . 75.01 112.489 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.63 61.12 0.28 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.753 -0.737 . . . . 73.11 112.518 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -87.17 -30.78 20.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.893 0.378 . . . . 72.15 110.882 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 23.4 m -73.66 -28.26 24.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 71.13 111.16 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.95 -25.12 42.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 54.42 111.146 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -52.96 -30.88 37.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 63.24 110.89 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 64.9 t -56.97 -56.66 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 74.12 111.141 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 31.9 mm -74.09 -36.42 44.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 75.22 111.133 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -62.84 -29.88 71.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 71.32 110.864 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.18 -27.6 35.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 74.03 110.909 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.9 tt -70.47 -50.22 40.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 75.34 110.928 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -72.09 -28.95 63.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 74.54 110.925 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.8 tt -56.77 -40.74 76.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 71.01 110.918 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -72.44 -51.07 21.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 74.33 110.976 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 51.0 mm -57.96 -32.21 42.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 73.22 111.164 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -56.27 -57.14 13.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 73.44 110.878 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 21.7 t -66.73 -36.31 76.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.48 . . . . 74.44 111.108 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.34 -36.13 68.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 75.11 110.851 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 94.4 t -58.82 -53.22 50.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 75.24 111.117 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -56.23 -32.6 64.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 75.54 110.893 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 67.5 t -71.07 -34.2 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 74.33 111.097 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -71.88 -27.44 62.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 73.22 110.939 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.07 -48.58 5.99 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.705 -0.76 . . . . 71.33 112.482 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.4 t -51.81 -39.39 58.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.751 0.31 . . . . 73.1 111.14 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 41.1 mt -63.09 -43.18 98.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 71.43 111.135 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -52.88 -48.55 57.27 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.747 -0.74 . . . . 74.05 112.495 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -31.94 66.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.792 0.329 . . . . 74.42 110.887 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -71.32 -24.58 62.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.443 . . . . 72.41 110.902 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.7 mt -75.7 -26.46 57.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 72.31 110.939 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.473 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 1.3 mm-40 -51.91 -60.5 5.97 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.581 0.705 . . . . 72.24 110.865 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.9 Cg_endo -69.77 -15.68 37.14 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.668 2.246 . . . . 73.42 112.349 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 30.8 mt -92.1 44.94 1.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 64.15 110.904 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.88 -26.14 17.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 62.45 110.84 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 61.92 58.5 1.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 74.44 110.906 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -122.63 96.28 4.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 64.34 110.89 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 75.0 t80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 74.33 110.904 -179.903 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 77.1 mmt-85 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.799 0.333 . . . . 75.54 110.873 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -96.22 26.6 4.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 74.4 110.842 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -118.88 73.09 11.86 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.61 0.719 . . . . 74.54 110.922 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -12.19 32.37 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.659 2.239 . . . . 71.51 112.369 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 pp -51.99 -30.95 27.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 73.32 110.927 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -78.82 -33.49 46.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 75.1 110.879 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -72.46 -46.23 55.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 72.51 110.94 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -60.08 -40.02 88.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.511 . . . . 64.21 111.11 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.19 -29.11 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 74.2 111.101 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -55.8 -27.12 49.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 72.04 110.856 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.29 -19.19 23.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 71.31 110.942 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.6 mm -76.6 -34.94 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 65.03 111.134 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.53 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.3 mm -55.61 -57.21 22.35 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.659 0.742 . . . . 64.12 111.136 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.6 Cg_endo -69.82 -20.91 33.95 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.661 2.24 . . . . 64.11 112.336 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 48.6 t -75.98 -44.65 38.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 75.41 110.908 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.61 -28.86 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 71.41 111.128 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.3 mt -50.97 -33.97 26.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 73.24 110.919 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.76 -34.65 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 64.5 111.131 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 p -65.81 -39.73 91.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 64.41 111.188 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.99 -51.11 62.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 74.31 110.809 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.9 tp -69.48 -38.81 77.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 75.13 110.896 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.7 -39.64 77.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 54.01 111.106 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.33 -31.93 55.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 70.14 111.125 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.5 -38.7 55.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 74.21 110.927 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -101.45 -36.73 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 73.22 111.139 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -67.1 -64.62 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 74.34 110.894 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.22 -61.96 1.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 74.13 110.944 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.2 mp -67.62 160.65 71.58 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.617 0.723 . . . . 75.22 110.928 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 161.53 45.56 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.722 2.282 . . . . 64.41 112.336 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -174.88 -69.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 72.1 110.895 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -178.37 -171.73 0.27 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 71.11 110.887 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 50.2 t -94.83 -74.39 0.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 73.13 110.892 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.75 -47.1 59.2 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 70.41 112.506 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.56 -35.54 70.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.916 0.389 . . . . 65.22 110.862 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -66.02 -44.58 84.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 75.41 110.885 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.35 -45.76 71.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 72.43 110.863 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 77.3 p -62.45 -26.09 68.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 73.41 111.131 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.24 -37.34 61.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 73.22 110.913 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 82.5 m -74.0 -48.65 28.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 74.32 110.839 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.7 pt -54.85 -32.26 25.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 73.41 111.121 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.1 -28.45 67.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 70.01 110.9 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.13 -38.25 66.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 74.05 111.141 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tp -52.89 -28.92 25.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 72.34 110.876 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.23 -38.94 78.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 74.42 110.933 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.65 -30.01 70.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 74.3 111.093 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.2 mt -65.31 -54.81 23.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 72.21 110.87 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.47 -38.63 87.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 71.24 111.151 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.2 t -71.52 -32.96 47.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 65.24 111.13 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -52.03 -34.09 41.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 74.42 110.889 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.1 tp -60.96 -51.11 70.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 74.41 110.939 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.5 mt -73.14 -32.13 64.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.47 . . . . 74.21 110.87 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.7 tt -66.69 -52.33 45.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 71.24 110.895 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.5 tt -69.17 -30.55 46.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 74.13 111.117 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.0 m -80.19 -21.3 43.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 72.2 110.862 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -60.38 -19.95 57.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.107 -0.497 . . . . 74.33 110.947 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -59.17 -20.71 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 72.13 111.132 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.8 t 51.56 76.62 0.52 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.609 0.719 . . . . 71.41 111.118 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 112.08 2.99 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.711 2.274 . . . . 72.52 112.35 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 -48.61 0.67 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.716 2.277 . . . . 72.31 112.309 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.5 t -117.05 -21.86 8.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 73.12 111.13 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.18 -48.74 61.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 73.43 110.86 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.3 tp 51.0 56.14 8.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.108 -0.496 . . . . 74.13 110.918 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -95.36 24.03 5.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 75.31 110.875 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.523 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.2 -57.82 10.16 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.609 0.719 . . . . 60.42 111.132 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.9 Cg_endo -69.76 -20.8 34.35 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.706 2.27 . . . . 74.34 112.324 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.07 -53.13 10.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 75.43 110.939 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.6 t -65.37 -36.43 77.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 61.21 111.135 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.94 -41.46 52.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.761 -0.733 . . . . 52.12 112.464 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.6 mmpm? -75.21 -22.07 58.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.748 0.308 . . . . 74.24 110.867 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -75.68 -33.4 60.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.259 -0.428 . . . . 75.14 110.954 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.2 mt -53.39 -29.83 36.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 72.3 110.937 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.26 -43.65 73.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 65.4 110.923 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -75.23 -51.16 14.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 74.42 110.901 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 t -53.17 -29.93 34.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 72.14 111.126 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.0 mmt -66.53 -30.15 70.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 75.24 110.892 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.85 -30.07 13.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 74.43 111.135 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.88 -33.2 62.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 74.2 110.94 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.1 m -76.92 -38.08 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 74.12 111.129 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 78.8 m -72.48 -38.55 68.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 75.33 111.107 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -66.86 -32.03 73.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 74.14 110.888 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.0 t -71.56 -35.55 70.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 75.23 110.831 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.4 mt -71.7 -51.92 29.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 74.44 111.112 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 p -54.05 -36.36 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 72.25 111.139 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.1 m -52.34 -32.41 37.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 75.33 111.182 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.0 m -50.46 -31.32 14.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 72.51 110.836 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.3 p -52.49 -32.83 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 75.13 111.089 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 23.6 m -65.51 -44.35 87.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 73.32 110.926 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 82.1 t -75.96 -35.83 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 75.34 111.067 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.0 mt -71.95 -31.79 66.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 75.22 110.95 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -60.03 -31.71 70.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 74.51 110.919 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.3 p -102.32 -24.77 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 75.41 111.151 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -90.47 -74.14 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 71.51 110.869 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -179.14 105.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 74.02 110.896 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -97.12 104.75 16.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 65.53 110.883 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -178.45 160.59 1.15 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.664 0.745 . . . . 74.15 110.845 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 126.2 13.03 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.749 2.299 . . . . 65.23 112.343 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -169.78 94.36 0.26 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 71.13 111.135 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.5 t -116.64 -25.01 7.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 75.1 111.169 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -100.36 -26.8 13.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 75.14 110.835 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.5 m -116.88 69.15 4.59 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.542 0.687 . . . . 74.42 111.136 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 157.19 61.25 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.645 2.23 . . . . 71.12 112.364 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -145.56 -74.25 0.23 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 75.11 110.87 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.31 168.74 7.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.804 -0.713 . . . . 74.23 112.47 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 151.65 63.46 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.711 -0.756 . . . . 65.1 112.444 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 111.79 -149.47 18.11 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.725 -0.75 . . . . 74.32 112.491 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.79 19.52 19.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.744 -0.741 . . . . 73.15 112.516 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -87.9 -26.48 22.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.924 0.392 . . . . 73.54 110.911 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.5 m -55.59 -30.79 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 65.12 111.122 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.02 -26.08 63.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 51.0 111.101 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 31.8 mmt -52.95 -30.99 37.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 74.55 110.904 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 52.4 t -57.01 -58.43 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 73.2 111.109 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 44.5 mm -73.98 -37.77 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 71.14 111.135 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -61.17 -30.4 70.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 71.14 110.9 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.78 -28.19 33.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 74.32 110.903 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.0 tp -65.4 -50.81 64.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 75.24 110.916 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -73.78 -42.89 60.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 74.33 110.876 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 tt -52.01 -32.78 35.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 73.31 110.892 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -66.63 -43.01 85.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 74.03 110.931 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.9 mt -76.43 -32.15 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 75.34 111.099 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -55.96 -56.41 21.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 74.34 110.884 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.2 m -60.72 -35.22 62.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 63.23 111.072 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -64.68 -41.52 95.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 74.03 110.855 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 88.9 t -58.39 -34.23 49.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 75.55 111.106 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 89.8 m -57.79 -51.98 67.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 43.11 110.842 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 57.0 t -75.99 -35.23 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 72.13 111.089 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -63.42 -37.73 88.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 74.3 110.919 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.25 -46.14 9.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.792 -0.718 . . . . 71.34 112.445 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 95.4 m -59.96 -51.99 67.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.785 0.326 . . . . 73.41 111.16 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 20.4 tt -55.9 -26.63 21.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 73.52 111.129 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -52.0 -49.99 46.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.764 -0.732 . . . . 63.22 112.447 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.2 mmt -71.65 -31.81 67.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 73.23 110.919 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -68.83 -21.45 64.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 75.04 110.904 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.3 mt -74.68 -29.13 61.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 75.43 110.932 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.468 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -51.93 -60.56 5.83 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.602 0.715 . . . . 65.41 110.884 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 54.1 Cg_endo -69.74 -16.95 37.9 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.68 2.253 . . . . 75.12 112.341 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.1 tp -94.16 40.66 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 74.02 110.924 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -55.22 -26.85 42.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 74.13 110.878 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 62.75 99.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 73.31 110.891 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 71.03 -70.18 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 55.41 110.917 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 72.31 110.901 -179.907 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.813 0.34 . . . . 75.12 110.865 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -95.74 -56.15 2.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 74.31 110.852 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.77 68.25 69.61 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.541 0.686 . . . . 75.31 110.907 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 78.52 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.717 2.278 . . . . 74.01 112.354 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.07 -30.96 65.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 72.31 110.86 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -78.26 -31.82 49.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 74.21 110.917 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -73.63 -44.87 55.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 75.54 110.876 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -60.55 -39.86 89.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 62.21 111.156 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -29.07 21.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 75.44 111.135 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.03 -27.08 51.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 72.23 110.898 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.31 -19.19 23.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 71.14 110.904 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.4 mm -76.87 -34.62 22.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 75.13 111.112 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.525 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.78 -57.08 23.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.614 0.721 . . . . 70.01 111.13 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.4 Cg_endo -69.77 -19.34 36.21 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.709 2.273 . . . . 64.22 112.348 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 37.4 t -70.12 -46.29 65.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 74.42 110.872 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 p -81.53 -28.91 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 75.53 111.16 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.5 mt -51.04 -33.91 27.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 70.24 110.902 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.2 tp -58.73 -34.64 52.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 75.34 111.146 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 p -65.73 -36.56 83.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 72.42 111.096 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.37 -44.77 72.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 74.54 110.881 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.01 -42.3 39.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 62.22 110.91 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.11 -34.63 66.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 73.3 111.126 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.1 mp -64.54 -32.39 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 75.04 111.121 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.4 tp -51.55 -37.43 49.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 74.2 110.932 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -101.98 -36.13 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 65.35 111.144 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -68.31 -64.96 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 75.42 110.885 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -56.36 -39.15 72.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.148 -0.478 . . . . 74.33 110.916 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.7 tp -57.61 139.0 81.79 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.613 0.72 . . . . 74.41 110.871 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 178.81 4.21 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.663 2.242 . . . . 50.24 112.349 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.23 161.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 64.23 110.859 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -160.88 175.9 12.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.102 -0.499 . . . . 74.55 110.87 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.5 p -176.19 -174.36 0.62 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 63.55 110.892 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.52 -31.45 63.32 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.737 -0.744 . . . . 62.41 112.486 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -75.09 -54.74 6.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.882 0.372 . . . . 74.51 110.904 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -53.2 -45.33 68.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 74.44 110.919 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -57.68 -51.74 68.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 73.45 110.844 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 60.4 p -65.37 -28.43 69.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.264 -0.425 . . . . 75.35 111.136 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.51 -34.57 67.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 74.45 110.934 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 80.2 m -72.78 -51.99 16.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 74.21 110.913 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.5 tt -54.39 -33.06 25.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 74.14 111.112 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.69 -25.24 6.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 74.05 110.858 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.9 p -57.13 -32.62 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.485 . . . . 75.31 111.127 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.93 -35.36 61.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 72.41 110.917 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -68.96 -46.7 67.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 63.2 110.891 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.8 -29.53 19.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 75.12 111.089 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 40.9 mt -57.83 -54.51 46.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 75.45 110.918 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.2 t -63.45 -27.28 69.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 74.2 111.156 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.6 t -71.35 -34.11 52.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 74.44 111.169 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -52.07 -30.11 24.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 75.1 110.865 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.93 -39.49 61.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 72.45 110.923 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.0 mp -73.24 -40.13 64.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 73.52 110.902 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.6 -55.05 22.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 73.24 110.937 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 tt -56.22 -24.69 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 73.21 111.17 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.1 p -68.1 -15.0 63.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 74.32 110.876 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -19.83 55.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 74.24 110.94 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pt -53.57 -27.17 14.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 64.34 111.134 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 50.2 t 61.41 75.23 0.45 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.661 0.743 . . . . 71.43 111.101 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 167.46 24.35 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.663 2.242 . . . . 75.04 112.395 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -48.64 0.67 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.671 2.247 . . . . 71.42 112.35 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.6 t -117.26 -19.63 9.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 71.01 111.15 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.3 t 63.72 38.37 9.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.451 . . . . 72.43 110.822 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 tp -99.72 35.33 2.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.144 -0.48 . . . . 71.0 110.94 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -95.58 24.37 5.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 64.45 110.887 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.514 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.31 -57.73 10.13 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.623 0.725 . . . . 62.3 111.195 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.6 Cg_endo -69.82 -20.32 34.71 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.664 2.242 . . . . 71.04 112.329 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.14 -53.09 10.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 72.25 110.949 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.7 t -80.31 -20.53 11.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 75.2 111.116 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.28 -31.49 27.45 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.775 -0.726 . . . . 75.23 112.494 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -35.39 59.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.8 0.333 . . . . 75.53 110.883 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -65.69 -44.84 84.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 75.13 110.872 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.5 mt -51.94 -29.81 21.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 73.55 110.953 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -43.38 76.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 72.21 110.892 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.401 ' O ' HG23 ' A' ' 100' ' ' VAL . 33.7 t80 -75.22 -51.83 12.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 74.42 110.9 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -53.07 -29.97 33.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 74.25 111.185 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.2 mmt -66.61 -30.04 70.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 75.54 110.923 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.83 -30.04 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 73.23 111.111 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.92 -33.31 61.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 74.44 110.947 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.8 -38.07 29.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 74.33 111.115 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 71.4 m -72.49 -39.81 67.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 74.14 111.149 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -64.69 -31.96 73.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 74.13 110.898 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.4 t -71.54 -35.75 70.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 64.14 110.859 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.7 mt -71.58 -51.83 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 73.5 111.116 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 p -53.97 -35.1 27.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 74.01 111.13 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.6 m -52.34 -32.43 38.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 75.25 111.146 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.4 m -50.42 -31.52 15.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 60.21 110.871 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.5 p -52.49 -32.79 17.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.102 -0.499 . . . . 71.43 111.153 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 42.1 m -66.59 -45.66 78.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 75.42 110.868 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 88.4 t -73.91 -34.7 40.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 75.42 111.128 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.07 -42.02 66.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 75.11 110.906 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -52.02 -30.71 26.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 75.32 110.901 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.4 p -102.31 -23.07 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 71.34 111.13 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -52.49 -66.22 0.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 74.42 110.896 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -162.15 28.48 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 74.31 110.876 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.2 mtt85 -117.72 -178.91 3.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 73.0 110.86 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.1 p -55.27 160.6 3.32 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.694 0.759 . . . . 75.33 110.839 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 168.46 21.52 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.707 2.272 . . . . 73.41 112.335 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.59 -172.76 2.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 73.04 111.105 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.0 m -75.86 69.14 2.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 73.53 111.138 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 61.29 89.54 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 64.42 110.853 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.83 159.64 32.81 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.585 0.707 . . . . 75.45 111.096 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -12.52 33.06 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.697 2.265 . . . . 71.3 112.326 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 ttm-85 -52.29 123.81 11.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 74.44 110.885 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -177.12 106.6 0.22 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.771 -0.728 . . . . 70.24 112.526 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -177.39 -136.04 2.36 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.703 -0.76 . . . . 53.54 112.457 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -112.61 -19.3 7.05 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.773 -0.727 . . . . 72.23 112.515 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 153.35 -51.2 0.49 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.729 -0.748 . . . . 74.24 112.467 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -63.29 -26.12 68.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.961 0.41 . . . . 75.32 110.953 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.8 m -56.9 -33.68 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.116 -0.493 . . . . 75.52 111.15 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.2 -25.22 67.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 74.2 111.091 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 16.7 mmt -53.0 -30.92 38.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 74.22 110.833 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 49.2 t -56.96 -63.86 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 75.4 111.11 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.0 mp -70.46 -38.35 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 73.44 111.134 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -60.56 -30.02 69.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 73.41 110.879 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.5 mtt-85 -56.18 -26.03 49.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 75.41 110.881 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.01 -50.99 35.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 74.14 110.941 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -73.97 -28.44 61.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 64.43 110.862 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.02 -36.4 83.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 71.42 110.913 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -58.99 -48.74 80.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 73.11 110.883 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 58.5 mt -77.04 -32.29 19.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 75.01 111.159 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.0 -56.88 15.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 75.03 110.89 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.42 -35.06 60.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 74.35 111.155 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.06 -32.97 74.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 71.54 110.892 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.9 t -53.98 -34.11 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 75.42 111.139 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 4.8 t -52.03 -42.98 63.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 73.14 110.878 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 25.5 t -75.99 -33.03 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 73.53 111.124 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -52.44 -49.9 63.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 73.23 110.93 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.2 -19.78 73.87 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.71 -0.757 . . . . 74.41 112.53 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.4 m -63.46 -52.85 59.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.783 0.325 . . . . 52.41 111.167 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 89.2 mt -76.49 -25.89 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 73.02 111.149 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -52.19 -29.39 29.15 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 74.51 112.502 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.92 -31.9 51.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.737 0.303 . . . . 64.03 110.883 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.33 -15.75 61.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 74.1 110.843 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.54 -38.04 74.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 65.21 110.942 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.464 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 1.6 mm-40 -51.61 -60.74 5.29 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.62 0.724 . . . . 73.44 110.915 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 54.1 Cg_endo -69.69 -33.74 16.25 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.738 2.292 . . . . 73.44 112.363 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.7 mt -53.68 -45.5 70.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 73.33 110.968 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 5.9 t80 64.31 14.5 8.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 74.11 110.902 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -68.41 -26.97 65.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 75.25 110.912 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -72.95 78.79 1.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 73.34 110.908 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 77.1 t80 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 74.42 110.917 -179.906 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.832 0.348 . . . . 73.45 110.876 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -65.46 91.26 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 75.3 110.901 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.34 79.0 53.52 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.554 0.692 . . . . 75.22 110.88 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -5.03 15.24 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.71 2.273 . . . . 73.54 112.319 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 pp -52.08 -30.99 28.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 73.21 110.933 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -80.08 -32.52 39.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 72.24 110.838 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -72.66 -46.25 54.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.206 -0.452 . . . . 71.42 110.892 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -59.81 -39.95 86.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.492 . . . . 65.23 111.148 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.13 -29.06 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 73.15 111.135 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.65 -27.59 50.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 74.43 110.886 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.78 -18.14 25.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 73.44 110.896 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.9 mm -76.33 -35.31 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 71.01 111.083 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.533 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.77 -57.13 23.23 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.605 0.717 . . . . 75.23 111.098 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.9 Cg_endo -69.8 -21.83 32.74 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.689 2.259 . . . . 75.44 112.374 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.6 t -73.86 -44.43 55.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 73.54 110.826 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.57 -28.91 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 74.32 111.138 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mt -50.97 -33.93 26.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 74.32 110.948 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.2 tp -58.73 -34.68 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 74.54 111.122 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.2 p -65.69 -42.84 90.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 72.33 111.093 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.99 -41.74 64.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.425 . . . . 74.35 110.829 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.4 tp -77.03 -38.43 52.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 73.14 110.946 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.8 -52.14 67.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 73.33 111.056 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.4 mp -49.72 -31.44 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 72.41 111.079 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.2 tp -50.79 -42.3 57.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 74.21 110.926 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -101.46 -37.5 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 63.1 111.12 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -63.68 -64.46 0.89 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 75.4 110.85 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.89 -60.73 2.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 75.32 110.897 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -78.39 159.22 75.35 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.549 0.69 . . . . 75.42 110.943 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 138.68 38.31 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.657 2.238 . . . . 73.45 112.321 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.3 112.67 0.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 65.12 110.854 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 56.32 -176.06 0.05 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.145 -0.479 . . . . 74.22 110.859 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 50.0 t -113.7 -74.51 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 74.25 110.859 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.71 -23.01 62.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.742 . . . . 60.15 112.493 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -52.11 -34.96 46.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.914 0.387 . . . . 73.52 110.932 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -51.96 60.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 73.53 110.911 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -48.56 68.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 71.22 110.852 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 29.3 p -53.07 -31.88 44.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 74.43 111.134 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -50.84 43.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 63.42 110.93 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 68.1 m -52.97 -47.75 67.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 74.55 110.861 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.3 tt -72.31 -35.04 51.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 72.45 111.141 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.67 -25.61 60.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 64.33 110.879 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.09 -41.39 92.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.101 -0.5 . . . . 74.21 111.119 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 tt -52.88 -28.87 25.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 63.12 110.991 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.26 -39.1 78.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 72.33 110.872 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.41 -30.03 70.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 75.21 111.099 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.8 mt -64.78 -54.7 27.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 74.05 110.957 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.94 -38.26 87.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 64.33 111.147 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.0 t -71.44 -32.82 47.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 65.2 111.134 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -61.85 -29.85 70.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 72.45 110.89 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 tt -71.99 -44.93 62.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 75.11 110.941 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.7 mp -73.22 -39.31 65.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 75.03 110.931 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.28 -51.67 67.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.51 110.907 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.8 tt -68.17 -30.2 47.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 75.2 111.092 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.1 t -80.53 -14.93 57.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 75.15 110.821 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.29 -9.9 58.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.151 -0.477 . . . . 75.22 110.903 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.413 ' O ' ' C ' ' A' ' 81' ' ' VAL . 1.1 pp -63.84 -15.37 16.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.422 . . . . 73.34 111.147 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 80' ' ' ILE . 2.4 p 35.79 81.21 0.25 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.609 0.718 . . . . 71.02 111.137 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 167.3 24.78 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.704 2.269 . . . . 74.02 112.364 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 -48.61 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.657 2.238 . . . . 73.51 112.313 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.0 t -117.26 -19.48 9.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 74.32 111.125 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.54 46.99 3.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 74.24 110.866 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.1 -11.1 60.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 75.21 110.901 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -95.36 23.96 5.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 75.22 110.892 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.515 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.58 -57.8 9.56 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.626 0.727 . . . . 71.12 111.161 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.5 Cg_endo -69.77 -20.02 35.31 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.679 2.253 . . . . 64.2 112.358 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.22 -53.1 10.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 75.15 110.863 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.3 t -68.6 -43.42 83.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 73.12 111.146 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.07 -38.86 48.43 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.76 . . . . 72.21 112.497 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.66 -24.39 59.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.783 0.325 . . . . 74.44 110.902 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -74.5 -37.92 62.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 73.12 110.897 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.5 mt -54.79 -29.57 54.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 75.14 110.927 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.0 mmt -71.28 -41.56 69.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 72.44 110.884 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -75.28 -51.06 14.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 74.4 110.888 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -53.09 -29.87 32.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.474 . . . . 74.11 111.18 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.68 -30.09 70.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 63.33 110.85 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.8 -30.05 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.443 . . . . 72.32 111.113 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.93 -32.99 61.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 75.11 110.924 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.4 m -76.6 -37.46 29.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 72.44 111.091 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 55.3 m -72.98 -46.6 51.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 75.24 111.154 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -51.96 -31.7 30.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 74.35 110.916 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.8 p -74.59 -48.73 24.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 72.23 110.813 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.8 mt -56.15 -34.52 39.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 75.55 111.148 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.1 t -53.85 -45.55 62.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 71.35 111.083 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.9 m -52.3 -32.38 37.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 70.11 111.153 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.5 t -50.28 -31.49 14.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 74.34 110.857 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.5 p -52.51 -32.83 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 74.34 111.159 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 34.7 m -65.89 -44.52 85.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 73.22 110.874 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 83.8 t -75.52 -35.78 33.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 74.44 111.154 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.8 mt -72.21 -33.62 67.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 73.15 110.916 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -62.6 -28.95 70.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 64.54 110.93 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.2 p -102.39 -20.94 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 72.22 111.084 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -76.08 73.69 2.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 73.24 110.833 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 52.15 63.33 2.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 73.23 110.836 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -150.14 169.31 21.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 74.51 110.89 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.5 m -100.48 160.55 26.64 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.707 0.765 . . . . 72.43 110.818 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 111.46 2.81 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.674 2.249 . . . . 75.51 112.327 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -71.14 0.5 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 71.41 111.147 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.19 128.29 1.9 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 72.3 111.146 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 54.3 t60 63.29 161.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 64.44 110.868 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 23.6 m 61.25 68.2 1.26 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.574 0.702 . . . . 72.24 111.137 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 83.72 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.695 2.264 . . . . 74.33 112.357 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.03 172.66 8.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 72.31 110.907 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -173.8 147.04 9.14 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.715 -0.755 . . . . 64.33 112.48 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 145.43 -134.08 5.34 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 63.44 112.504 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -112.03 -64.84 0.49 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.738 -0.744 . . . . 72.52 112.517 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -174.05 -68.95 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.778 -0.725 . . . . 42.23 112.543 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -62.14 -26.39 68.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.968 0.413 . . . . 74.24 110.945 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.4 m -54.14 -27.2 16.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 74.11 111.147 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.62 -26.25 55.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 75.02 111.136 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 11.3 ptm -53.04 -30.79 37.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 64.32 110.846 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 58.6 t -56.9 -61.55 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 73.14 111.159 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.5 mp -74.06 -25.96 20.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 74.11 111.136 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -58.5 -29.96 66.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.462 . . . . 72.43 110.884 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -30.1 23.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 74.02 110.863 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 7.0 tp -63.22 -50.73 69.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 65.41 110.916 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -74.03 -41.22 62.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 71.3 110.882 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.93 -31.98 31.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 73.22 110.915 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.18 -46.25 84.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.192 -0.458 . . . . 73.31 110.913 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 3.9 mt -76.98 -31.96 19.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 75.43 111.155 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -56.01 -55.89 27.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 72.51 110.873 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 31.8 t -54.01 -36.68 32.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 73.44 111.153 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -70.05 -41.38 74.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 73.21 110.867 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 96.7 t -54.07 -34.45 26.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 74.21 111.087 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 95.6 m -51.9 -52.08 52.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 74.13 110.873 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 31.5 t -76.06 -33.26 24.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 74.14 111.14 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.72 -27.05 37.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 75.14 110.846 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.97 -57.67 3.42 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.733 -0.746 . . . . 71.01 112.485 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 92.5 m -61.35 -45.01 96.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.779 0.323 . . . . 72.14 111.185 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 20.3 tt -55.9 -25.86 19.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 73.51 111.128 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -51.93 -50.07 45.99 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.746 -0.74 . . . . 74.1 112.454 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.66 -31.84 63.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.773 0.32 . . . . 72.13 110.85 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -68.61 -21.24 64.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 75.54 110.9 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.3 mt -74.72 -29.19 61.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 75.32 110.895 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.476 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.9 OUTLIER -51.9 -60.6 5.74 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.636 0.731 . . . . 74.52 110.917 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.8 Cg_endo -69.77 -26.84 27.1 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.667 2.245 . . . . 73.33 112.326 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.6 -54.17 36.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 74.2 110.906 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 5.1 t80 64.55 14.42 8.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 72.34 110.878 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 72.18 -68.83 0.21 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 75.3 110.957 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 53.71 77.77 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 63.5 110.933 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 71.31 110.917 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.782 0.325 . . . . 75.52 110.855 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.88 26.55 6.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 74.13 110.863 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.66 78.99 48.12 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.574 0.702 . . . . 72.14 110.88 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -5.04 15.25 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.66 2.24 . . . . 71.35 112.354 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 pp -53.57 -30.93 44.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 75.41 110.917 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -80.58 -28.56 37.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 73.22 110.898 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -76.74 -44.79 31.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 74.42 110.913 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.4 t -62.87 -39.54 94.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 74.23 111.182 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.79 -29.03 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 74.3 111.12 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -68.87 -25.31 64.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 74.45 110.922 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -92.0 -27.81 17.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 74.2 110.884 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.2 mm -79.51 -28.38 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 74.35 111.145 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.533 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.96 -57.15 23.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.575 0.702 . . . . 72.3 111.086 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.79 -24.82 29.1 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.676 2.251 . . . . 72.41 112.356 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.1 t -74.57 -45.4 45.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 65.21 110.892 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.9 p -81.45 -28.91 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 72.25 111.161 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mt -51.02 -33.96 27.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 75.21 110.898 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -58.68 -34.6 52.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 72.11 111.138 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.69 -34.98 79.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 74.53 111.094 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 m -57.33 -52.6 64.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 75.14 110.836 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.8 tp -70.16 -34.45 73.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 73.23 110.922 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.24 -44.89 90.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.452 . . . . 62.4 111.11 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.26 -31.98 55.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 72.55 111.137 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mp -51.39 -38.88 55.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 73.45 110.916 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -101.45 -36.7 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 63.03 111.107 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -67.05 -64.65 0.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 74.51 110.861 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.4 -60.08 2.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 62.45 110.936 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.1 mp -78.2 160.67 72.82 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.609 0.719 . . . . 64.02 110.92 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 157.25 61.14 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.711 2.274 . . . . 75.23 112.329 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.32 -170.19 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 71.43 110.845 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.33 171.21 1.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 71.21 110.859 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 5.6 t -81.51 -68.11 0.72 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 73.21 110.922 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.53 -23.64 43.66 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.782 -0.723 . . . . 75.11 112.495 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -52.36 -42.89 64.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.933 0.397 . . . . 72.43 110.908 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -53.53 -43.45 68.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 73.0 110.868 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.93 -50.77 26.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 71.15 110.867 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.2 p -53.39 -44.64 68.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 64.54 111.136 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.93 -28.93 64.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 71.3 110.93 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 1.3 m -71.43 -44.96 63.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 63.25 110.889 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.8 tt -72.41 -35.09 50.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 75.43 111.118 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -55.96 -26.25 47.27 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.174 -0.466 . . . . 72.33 110.809 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.2 t -58.68 -38.63 72.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 74.22 111.113 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.89 -28.93 25.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 73.14 110.918 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.16 -39.14 78.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 75.13 110.893 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.4 -30.12 70.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 55.11 111.079 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.7 mt -64.93 -54.66 27.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.448 . . . . 72.24 110.93 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.92 -38.25 87.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 70.01 111.139 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.3 t -71.44 -32.85 47.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 72.25 111.165 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -51.87 -38.39 55.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 74.41 110.864 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.3 tp -75.12 -30.87 60.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.487 . . . . 72.31 110.905 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 65.5 mt -73.26 -54.03 9.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 74.13 110.888 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.61 -54.16 47.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 75.31 110.928 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.4 tt -55.49 -27.59 21.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 71.54 111.135 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.5 m -80.03 -24.8 40.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 64.42 110.895 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.7 mttp -64.74 -15.27 61.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 74.44 110.853 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.2 pp -56.16 -24.38 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 64.4 111.136 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 22.1 t 63.81 75.11 0.4 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.595 0.712 . . . . 73.43 111.118 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 166.69 26.77 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.71 2.273 . . . . 74.53 112.302 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -49.1 0.6 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.679 2.253 . . . . 72.12 112.347 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.9 t -118.88 -25.61 6.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 70.33 111.136 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 64.26 47.99 3.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 73.14 110.831 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.18 37.15 1.59 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 72.14 110.902 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.44 22.76 14.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 72.11 110.856 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.527 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -68.05 -57.89 8.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.578 0.704 . . . . 64.44 111.106 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.7 Cg_endo -69.74 -19.93 35.6 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.653 2.236 . . . . 75.24 112.341 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.09 -51.54 15.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 74.54 110.964 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.1 t -80.17 -24.38 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 75.03 111.089 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.7 -50.0 44.86 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.729 -0.748 . . . . 74.14 112.496 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -35.46 80.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.78 0.324 . . . . 75.22 110.879 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -60.51 -40.1 90.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.218 -0.446 . . . . 71.43 110.906 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.5 mt -51.79 -29.87 20.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 72.15 110.918 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.21 -43.62 73.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 73.14 110.859 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -75.19 -51.34 13.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 75.0 110.863 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 t -53.07 -29.91 32.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 74.22 111.169 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.9 mmt -66.69 -30.11 70.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 74.54 110.834 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.73 -30.12 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 75.32 111.123 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.89 -33.26 62.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 75.52 110.944 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.9 m -76.95 -38.04 27.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 71.22 111.141 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 69.8 m -72.51 -40.67 66.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 73.21 111.158 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -63.41 -31.98 73.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 72.13 110.87 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.29 -32.98 69.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 71.3 110.841 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.3 mt -73.96 -51.69 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 74.44 111.131 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -54.21 -34.29 27.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 71.23 111.164 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.5 m -53.0 -34.97 58.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 71.25 111.119 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.0 t -52.24 -48.34 65.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 73.24 110.845 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.7 t -52.91 -33.83 19.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.493 . . . . 72.42 111.155 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 31.2 m -65.09 -39.9 93.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 55.14 110.875 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 65.6 t -79.98 -36.14 16.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 74.41 111.175 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 87.6 mt -72.86 -51.7 17.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 74.43 110.886 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -51.73 -29.5 18.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 72.3 110.901 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.9 p -99.43 -16.81 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 63.45 111.157 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -54.26 -52.53 61.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 73.45 110.924 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -163.04 32.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 74.14 110.86 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -131.92 -178.38 4.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 74.24 110.845 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.51 160.58 41.8 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.641 0.734 . . . . 72.34 110.885 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 161.06 47.4 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.667 2.245 . . . . 74.11 112.315 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.23 -176.96 3.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 62.14 111.161 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 15.0 t -118.41 28.55 8.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.251 -0.432 . . . . 61.4 111.147 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -148.18 95.14 2.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 75.43 110.893 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 8.6 m 53.37 68.34 3.0 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.587 0.708 . . . . 75.31 111.175 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 179.72 3.49 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.701 2.268 . . . . 73.31 112.382 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -142.53 -42.78 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 74.31 110.902 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.4 141.27 0.12 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.712 -0.756 . . . . 75.01 112.524 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 111.39 -166.49 12.26 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.756 -0.735 . . . . 72.31 112.473 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.75 -138.65 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.719 -0.753 . . . . 70.02 112.475 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -99.8 -20.3 17.16 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.743 -0.742 . . . . 61.24 112.503 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -76.37 -27.0 56.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.938 0.399 . . . . 73.45 110.911 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.8 m -58.62 -37.39 64.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 74.52 111.158 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -72.8 -29.3 63.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 73.25 111.074 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 14.6 mmt -56.66 -31.02 63.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 73.34 110.806 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 65.9 t -56.99 -65.9 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 74.12 111.146 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 38.9 mm -69.17 -33.07 56.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 74.33 111.12 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -64.27 -29.97 71.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 74.23 110.859 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.09 -29.1 39.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 73.1 110.873 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.96 -44.54 61.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 64.1 110.926 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -74.0 -53.96 8.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 63.54 110.895 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.23 -36.98 53.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 73.13 110.96 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 32.9 t-105 -52.98 -51.48 61.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 74.24 110.905 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 74.3 mt -76.99 -38.81 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 75.15 111.127 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -56.14 -57.15 13.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 64.54 110.839 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 46.2 t -56.74 -34.96 44.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 73.03 111.128 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -66.58 -32.95 74.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.864 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 94.5 t -53.99 -33.96 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 73.34 111.128 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.97 -36.77 50.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 73.23 110.845 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 83.1 t -75.95 -35.93 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 71.51 111.102 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -71.9 -27.01 62.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 75.44 110.863 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -52.2 -58.9 9.67 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.753 -0.737 . . . . 71.31 112.462 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.5 t -54.06 -35.08 61.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.78 0.324 . . . . 75.43 111.192 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 51.0 mm -66.67 -57.98 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 74.32 111.158 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -54.13 -26.07 34.15 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.764 -0.731 . . . . 63.21 112.488 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -32.0 73.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 73.25 110.903 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -80.5 -26.15 38.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 73.35 110.89 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 95.9 mt -79.75 -25.87 40.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 71.3 110.941 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.509 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 1.4 tp-100 -52.07 -58.05 12.83 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.608 0.718 . . . . 72.14 110.922 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 54.2 Cg_endo -69.76 -16.33 37.52 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.684 2.256 . . . . 73.11 112.334 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.8 tp -93.96 40.73 1.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 73.45 110.903 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.89 -59.65 2.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 72.01 110.876 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 72.22 -68.96 0.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 74.32 110.872 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 38.9 t30 52.15 42.3 30.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 72.13 110.856 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 74.35 110.931 -179.948 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.828 0.346 . . . . 73.44 110.845 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.27 -32.76 74.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 72.53 110.87 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.09 78.91 51.67 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.639 0.733 . . . . 75.43 110.919 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -4.96 15.1 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.707 2.271 . . . . 63.25 112.312 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 pp -52.9 -31.5 40.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 74.13 110.927 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -80.35 -29.88 37.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 73.23 110.896 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -76.81 -42.35 40.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.13 -0.486 . . . . 74.11 110.935 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.1 t -62.21 -38.52 89.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 73.04 111.179 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -29.12 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 75.51 111.124 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -57.53 -27.73 62.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 74.23 110.887 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.55 -20.13 22.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 64.23 110.924 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.4 mm -76.96 -34.22 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 72.32 111.131 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.528 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.3 mm -54.95 -57.32 20.08 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.634 0.731 . . . . 74.12 111.143 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.5 Cg_endo -69.72 -11.8 31.65 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.657 2.238 . . . . 72.41 112.363 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.1 t -62.07 -43.41 98.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 73.12 110.895 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.3 p -79.47 -27.28 12.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 71.13 111.073 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -50.39 -34.31 23.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 74.21 110.909 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -58.7 -34.94 53.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 74.32 111.115 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.3 p -64.95 -36.59 84.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 72.2 111.105 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.1 t -54.17 -46.35 72.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 71.23 110.847 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tp -77.13 -38.08 52.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 75.21 110.936 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.65 -52.12 67.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 65.35 111.07 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.4 mp -49.82 -31.51 6.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 74.3 111.11 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 tt -50.78 -41.91 57.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 74.32 110.92 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.61 -36.77 4.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 75.14 111.117 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -64.47 -64.56 0.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 73.53 110.888 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.71 -62.01 1.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 74.24 110.965 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.4 mp -67.04 160.75 68.51 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.61 0.719 . . . . 74.11 110.896 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 143.12 49.55 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.692 2.262 . . . . 74.34 112.316 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.42 -170.1 3.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 73.51 110.816 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.14 172.67 11.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 73.51 110.851 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 22.5 m -68.29 -62.07 1.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 71.32 110.869 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.25 -22.94 38.82 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.709 -0.757 . . . . 71.03 112.526 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -35.01 41.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.919 0.39 . . . . 71.02 110.915 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -56.24 -46.48 79.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 75.54 110.93 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -52.01 51.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 75.55 110.923 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 55.3 p -55.28 -25.95 37.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 75.31 111.129 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 tp -72.99 -37.27 67.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 74.14 110.896 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 39.4 t -73.85 -48.52 30.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 65.11 110.893 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.6 pt -58.09 -32.59 44.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 73.35 111.096 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.13 -57.15 4.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 75.3 110.848 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.2 p -60.64 -33.61 55.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 63.34 111.128 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 tt -52.67 -31.08 35.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 75.14 110.906 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -68.36 -37.78 80.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 75.22 110.944 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.0 -29.96 69.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 75.24 111.07 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.4 mt -66.78 -54.86 18.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.236 -0.438 . . . . 75.21 110.928 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 t -59.95 -38.81 83.54 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.17 -0.468 . . . . 75.25 111.167 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.6 t -71.42 -33.0 48.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 75.13 111.124 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -65.46 -38.44 89.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 71.33 110.916 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.6 mp -74.99 -35.41 62.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.117 -0.492 . . . . 75.43 110.932 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.1 mp -73.42 -47.84 38.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 75.42 110.902 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.98 -48.33 80.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 74.53 110.924 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 tt -65.96 -28.83 44.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 73.14 111.122 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 t -80.85 -23.87 38.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 73.25 110.833 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -58.81 -22.04 57.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.484 . . . . 74.21 110.914 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 26.0 pt -51.25 -30.87 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 74.24 111.097 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 58.4 t 55.71 80.13 0.31 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.655 0.74 . . . . 74.32 111.158 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 112.11 3.0 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.652 2.235 . . . . 75.02 112.359 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -48.56 0.7 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.713 2.275 . . . . 74.32 112.363 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.0 t -116.84 -22.07 8.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 74.42 111.131 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.71 -47.5 63.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 62.44 110.841 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.6 tp 51.73 49.8 20.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 74.11 110.951 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -95.99 29.19 2.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 75.12 110.893 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -66.98 -57.77 10.65 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.612 0.72 . . . . 72.53 111.136 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.5 Cg_endo -69.78 -20.87 34.19 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.663 2.242 . . . . 73.21 112.337 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.25 -43.87 55.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 75.44 110.959 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.7 t -80.7 -38.84 17.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 73.12 111.106 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.89 -51.21 40.97 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.689 -0.767 . . . . 71.02 112.509 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -34.71 78.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.81 0.338 . . . . 73.42 110.891 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -61.26 -36.03 78.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 72.14 110.913 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.4 mt -51.82 -33.0 33.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 75.11 110.894 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.85 -28.05 33.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 73.35 110.891 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -72.98 -54.68 7.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 72.12 110.89 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.4 -28.54 30.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.494 . . . . 73.33 111.142 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 27.4 mmt -68.59 -30.04 68.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 75.14 110.875 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.91 -29.74 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 73.03 111.107 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.74 -32.73 62.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 73.31 110.876 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.7 m -77.08 -38.18 27.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 70.5 111.178 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 84.4 m -72.66 -37.7 67.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 72.23 111.126 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -68.54 -32.19 71.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 75.5 110.851 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.0 t -70.42 -33.62 71.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 74.21 110.833 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 30.8 mt -72.6 -51.39 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 74.32 111.127 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.3 p -56.18 -35.35 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 75.34 111.121 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 98.3 m -52.48 -32.32 39.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.156 -0.475 . . . . 71.2 111.104 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.41 -31.54 15.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 74.41 110.875 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.3 p -52.57 -32.87 17.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 73.13 111.129 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 43.0 m -66.11 -47.67 73.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 62.21 110.877 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.7 t -71.99 -36.04 56.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 71.35 111.141 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.5 mt -72.02 -33.48 68.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 63.12 110.961 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -59.64 -30.73 68.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 73.41 110.907 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.5 p -102.34 -24.21 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 75.5 111.127 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -90.72 -73.23 0.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 72.45 110.857 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.57 99.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 72.44 110.833 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 47.0 tpt85 -86.22 -73.94 0.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 74.41 110.885 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.3 160.56 4.89 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.665 0.745 . . . . 63.52 110.875 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 131.57 21.52 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.726 2.284 . . . . 64.33 112.371 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.7 p -150.42 80.45 1.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 52.32 111.106 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.9 m 63.63 106.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 72.33 111.127 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -52.18 103.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 74.45 110.859 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.1 p -141.1 73.92 25.82 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.629 0.728 . . . . 75.33 111.157 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 155.25 66.45 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.695 2.263 . . . . 74.41 112.356 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.7 mtm180 63.05 103.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 74.14 110.885 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.01 130.57 5.52 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.74 -0.743 . . . . 72.11 112.479 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 162.82 -165.85 36.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.788 -0.72 . . . . 53.5 112.488 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -143.99 119.13 1.26 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.686 -0.769 . . . . 64.34 112.431 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 179.18 38.04 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.704 -0.76 . . . . 72.22 112.455 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -87.87 -24.93 23.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.912 0.387 . . . . 73.33 110.901 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 23.8 m -53.98 -30.51 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 72.12 111.066 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.25 -25.05 58.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 73.44 111.082 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.8 ptm -52.94 -30.94 37.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 73.34 110.892 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 59.1 t -56.92 -53.64 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.284 -0.416 . . . . 73.42 111.128 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 64.9 mt -73.93 -38.56 50.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 71.21 111.156 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.97 -30.03 70.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 74.12 110.909 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -30.14 23.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 74.2 110.863 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.4 tt -63.47 -50.91 67.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 74.4 110.868 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -73.99 -36.97 64.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 71.54 110.901 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.0 -34.33 42.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 72.15 110.957 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 21.4 t90 -64.17 -50.68 67.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 74.31 110.915 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 51.2 mm -68.35 -32.12 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 72.31 111.148 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -56.02 -56.72 17.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 75.44 110.859 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 21.7 t -65.95 -35.91 76.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 65.03 111.147 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.51 -33.2 65.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 74.24 110.842 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 58.0 t -54.07 -34.11 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 61.32 111.126 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 71.8 m -51.95 -43.55 63.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.167 -0.47 . . . . 71.51 110.849 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 64.3 t -75.22 -35.06 32.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 54.42 111.112 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -54.74 -28.71 50.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 75.43 110.873 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -70.8 -22.43 78.19 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.734 -0.745 . . . . 63.03 112.493 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.1 m -79.46 -52.8 7.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.76 0.314 . . . . 75.3 111.15 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 47.6 mm -76.5 -24.15 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 73.22 111.147 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -52.13 -50.04 47.37 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.728 -0.748 . . . . 44.21 112.463 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -31.98 67.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 74.04 110.899 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.76 -23.57 62.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 73.21 110.899 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.5 mt -75.25 -27.41 59.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 75.34 110.905 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.471 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.8 OUTLIER -51.94 -60.55 5.88 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.607 0.717 . . . . 71.11 110.947 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.7 Cg_endo -69.74 -16.47 37.64 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.647 2.231 . . . . 75.31 112.347 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.1 tp -93.96 40.73 1.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.441 . . . . 75.43 110.951 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.85 -59.06 2.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 71.05 110.873 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -179.15 -74.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 74.55 110.959 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 26.2 t30 59.68 97.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 74.2 110.86 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 2.2 t80 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 73.33 110.959 -179.967 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.859 0.275 . . . . 70.310000000000002 112.367 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.426 HD13 ' HE1' ' A' ' 156' ' ' PHE . 4.4 pp -52.0 -30.96 27.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 64.209999999999994 110.905 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.409 ' N ' HD12 ' A' ' 29' ' ' LEU . 52.2 t80 -78.54 -33.58 47.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 73.010000000000005 110.865 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -72.5 -45.96 56.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 62.219999999999999 110.905 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -60.23 -40.03 88.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 74.200000000000003 111.129 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.441 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.18 -29.11 21.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 75.310000000000002 111.138 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -55.87 -27.06 49.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 64.230000000000004 110.869 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.587 ' CB ' HD12 ' A' ' 77' ' ' ILE . 4.1 mm? -91.35 -19.18 23.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 55.119999999999997 110.922 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.468 HG21 HG23 ' A' ' 152' ' ' THR . 45.6 mm -76.73 -34.84 23.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.453 . . . . 62.130000000000003 111.137 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.544 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.2 mt -55.7 -57.13 23.0 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.621 0.724 . . . . 73.030000000000001 111.139 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.3 Cg_endo -69.81 -20.47 34.56 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.696 2.264 . . . . 73.329999999999998 112.32 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.624 ' O ' HG22 ' A' ' 42' ' ' ILE . 48.7 t -75.88 -44.59 39.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 62.520000000000003 110.867 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.53 -28.96 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 74.519999999999996 111.163 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 mt -51.0 -33.97 27.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 74.430000000000007 110.922 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.1 tp -58.73 -34.65 52.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 73.25 111.153 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.73 -40.9 92.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 72.120000000000005 111.167 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.25 -43.45 67.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 62.109999999999999 110.816 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 tp -76.46 -39.32 53.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.453 . . . . 74.319999999999993 110.908 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.88 -36.29 72.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 61.43 111.102 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.438 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.2 mp -64.97 -32.32 57.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 71.530000000000001 111.112 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.29 -33.78 63.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 73.109999999999999 110.901 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.997 HG11 HD13 ' A' ' 62' ' ' LEU . 29.0 m -101.66 -36.82 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 75.25 111.086 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -71.6 -64.81 0.85 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 65.299999999999997 110.927 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.509 ' CE2' HD22 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -69.63 -61.77 1.65 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 73.230000000000004 110.948 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.77 160.63 60.22 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.656 0.741 . . . . 74.019999999999996 110.907 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 136.37 32.85 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.709 2.272 . . . . 71.209999999999994 112.355 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.65 44.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 70.230000000000004 110.862 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -53.06 109.58 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 64.439999999999998 110.877 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -179.16 159.06 0.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 55.109999999999999 110.886 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.48 -26.71 31.52 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.748 . . . . 75.340000000000003 112.487 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -72.58 -35.0 67.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 75.0 110.85 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.0 -49.25 66.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 75.409999999999997 110.896 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -70.51 -48.08 57.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 54.539999999999999 110.913 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.2 m -54.27 -27.02 32.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 72.319999999999993 111.18 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.997 HD13 HG11 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -72.86 -38.92 66.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.446 . . . . 73.140000000000001 110.913 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 26.3 m -66.87 -45.59 77.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 71.530000000000001 110.861 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.9 tt -71.26 -35.0 56.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 64.439999999999998 111.101 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.6 m -58.43 -26.36 63.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 65.010000000000005 110.861 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 62' ' ' LEU . 22.3 t -61.73 -40.06 85.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.477 . . . . 74.239999999999995 111.063 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.89 -28.88 25.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 71.239999999999995 110.902 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.485 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.13 -39.17 79.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 72.140000000000001 110.914 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.39 -29.99 70.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 53.43 111.116 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.721 HD13 HG11 ' A' ' 102' ' ' VAL . 9.8 mt -65.11 -54.7 25.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 75.400000000000006 110.915 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.81 -38.26 87.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 71.5 111.172 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 68' ' ' LEU . 78.6 t -71.5 -32.98 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 75.409999999999997 111.12 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.553 ' O ' HG22 ' A' ' 77' ' ' ILE . 69.4 t80 -54.58 -30.01 53.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.481 . . . . 72.209999999999994 110.866 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.846 HD11 HD13 ' A' ' 95' ' ' LEU . 0.3 OUTLIER -65.78 -50.54 64.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 50.420000000000002 110.954 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.4 mt -73.23 -33.09 65.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 75.019999999999996 110.949 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -55.08 22.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 61.509999999999998 110.909 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.587 HD12 ' CB ' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -64.93 -30.48 50.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 63.210000000000001 111.152 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.8 t -80.47 -19.12 46.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 72.329999999999998 110.839 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.715 ' O ' HG23 ' A' ' 81' ' ' VAL . 8.2 mttt -78.16 -10.26 59.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 74.540000000000006 110.931 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 77' ' ' ILE . 2.1 pp -55.62 -25.19 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 75.230000000000004 111.12 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 79' ' ' LYS . 30.1 t 62.89 76.21 0.38 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.654 0.74 . . . . 55.149999999999999 111.155 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 167.5 24.29 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.685 2.257 . . . . 64.5 112.317 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -48.85 0.64 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.623 2.215 . . . . 65.319999999999993 112.37 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.3 t -133.65 14.43 4.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 74.140000000000001 111.122 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.3 p 51.65 37.96 21.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 74.140000000000001 110.856 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.15 -11.81 61.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 74.140000000000001 110.922 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.646 ' HA ' HD23 ' A' ' 90' ' ' LEU . 2.1 m-20 -95.28 23.36 5.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 55.409999999999997 110.835 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.539 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.8 -57.91 9.01 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.603 0.716 . . . . 75.109999999999999 111.128 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 54.7 Cg_endo -69.68 -19.99 35.78 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.698 2.265 . . . . 74.239999999999995 112.391 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.646 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.15 -50.36 19.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 62.399999999999999 110.897 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 87' ' ' ASP . 21.7 t -78.54 -47.35 23.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 74.219999999999999 111.138 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.87 -40.77 50.42 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.695 -0.764 . . . . 53.049999999999997 112.504 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.5 tttp -74.25 -23.5 59.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.797 0.332 . . . . 73.209999999999994 110.879 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -74.68 -34.34 62.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 73.319999999999993 110.971 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.846 HD13 HD11 ' A' ' 74' ' ' LEU . 14.9 mt -53.0 -29.67 30.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.079 -0.509 . . . . 75.319999999999993 110.939 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.56 -43.65 72.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 74.129999999999995 110.831 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.494 ' O ' HG22 ' A' ' 100' ' ' VAL . 47.0 t80 -75.18 -51.14 14.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 71.230000000000004 110.877 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.8 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.08 -29.95 33.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 64.230000000000004 111.132 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 8.9 mmt -66.54 -30.09 70.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 65.329999999999998 110.928 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.83 -30.12 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 74.430000000000007 111.088 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.8 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.88 -33.29 62.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 74.200000000000003 110.916 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.721 HG11 HD13 ' A' ' 70' ' ' LEU . 31.2 m -76.86 -38.06 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 74.540000000000006 111.128 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 76.5 m -72.51 -38.41 68.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 63.520000000000003 111.153 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -66.81 -32.0 72.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 74.019999999999996 110.911 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.5 t -71.5 -36.44 71.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 63.299999999999997 110.877 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 38.4 mt -70.78 -52.0 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 71.319999999999993 111.077 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.551 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.7 p -54.0 -35.96 29.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 72.120000000000005 111.114 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.3 m -52.42 -32.42 39.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 72.310000000000002 111.188 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 t -50.45 -31.36 14.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 63.539999999999999 110.874 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.4 p -52.42 -32.85 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 74.109999999999999 111.13 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 14.9 m -64.49 -46.59 82.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 72.409999999999997 110.912 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 130' ' ' GLY . 95.0 t -73.97 -38.93 50.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 74.510000000000005 111.111 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.5 mt -69.11 -30.92 69.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 72.219999999999999 110.931 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -58.18 -33.51 69.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 74.109999999999999 110.872 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.624 ' CG1' ' HB2' ' A' ' 133' ' ' ALA . 7.9 p -102.27 -24.79 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 72.549999999999997 111.156 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -58.84 -69.89 0.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 75.439999999999998 110.837 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 72.340000000000003 110.847 179.984 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.699 ' O ' HG13 ' A' ' 112' ' ' VAL . . . . . . . . 0 N--CA 1.452 -0.265 0 N-CA-C 112.455 -0.258 . . . . 64.409999999999997 112.455 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -77.62 -26.14 50.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.963 0.411 . . . . 63.340000000000003 110.955 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.501 ' CG2' HG21 ' A' ' 115' ' ' VAL . 22.1 m -60.58 -37.48 75.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 71.040000000000006 111.087 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.624 ' HB2' ' CG1' ' A' ' 115' ' ' VAL . . . -63.7 -25.02 68.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 60.009999999999998 111.078 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 13.2 mmt -52.97 -30.98 38.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 72.0 110.909 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.9 t -56.97 -57.03 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 75.540000000000006 111.154 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 64.1 mt -74.02 -38.37 49.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 71.349999999999994 111.1 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -61.23 -29.96 70.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 74.349999999999994 110.896 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.02 -30.17 24.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 73.25 110.871 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.66 -50.83 70.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 52.399999999999999 110.935 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -74.04 -44.23 55.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 73.329999999999998 110.885 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.509 HD22 ' CE2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -52.06 -33.86 40.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 52.329999999999998 110.88 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -53.76 -46.51 70.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 65.409999999999997 110.905 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.518 ' O ' HG23 ' A' ' 147' ' ' VAL . 43.3 mm -76.9 -31.96 19.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 74.329999999999998 111.117 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -56.09 -56.82 16.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 71.109999999999999 110.865 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.9 m -54.9 -35.0 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 75.409999999999997 111.171 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -63.38 -32.95 74.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 73.439999999999998 110.9 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 143' ' ' ILE . 31.7 t -66.56 -37.74 80.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 74.230000000000004 111.129 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 91.8 m -58.93 -51.94 67.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 72.239999999999995 110.882 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.48 -32.99 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 64.239999999999995 111.125 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -52.71 -52.0 57.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 71.230000000000004 110.887 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.85 -19.38 75.51 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.757 . . . . 40.509999999999998 112.484 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.468 HG23 HG21 ' A' ' 36' ' ' ILE . 33.6 m -74.72 -52.83 10.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.81 0.338 . . . . 63.530000000000001 111.18 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.7 mt -76.52 -29.77 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 64.310000000000002 111.105 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -55.43 -49.95 62.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.725 -0.75 . . . . 55.399999999999999 112.491 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.4 mmt -71.13 -32.03 68.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.877 0.37 . . . . 70.129999999999995 110.923 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.426 ' HE1' HD13 ' A' ' 29' ' ' LEU . 15.1 t80 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 73.209999999999994 110.905 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.232 0.193 0 CA-C-O 120.827 0.261 . . . . 72.209999999999994 112.352 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 pp -52.08 -30.93 28.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 71.450000000000003 110.932 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -78.43 -33.34 48.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 65.329999999999998 110.828 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.514 ' HE1' HG22 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -72.61 -45.81 57.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 73.129999999999995 110.936 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -60.28 -39.95 88.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 63.020000000000003 111.109 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.437 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.18 -29.03 21.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 72.239999999999995 111.146 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -26.72 52.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 72.120000000000005 110.857 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.57 -19.46 22.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 71.430000000000007 110.955 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.4 mm -76.68 -34.78 24.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 73.200000000000003 111.159 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.55 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.2 mt -55.74 -57.18 22.83 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.681 0.753 . . . . 74.120000000000005 111.14 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 54.1 Cg_endo -69.73 -20.97 34.29 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.673 2.249 . . . . 74.129999999999995 112.354 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.638 ' O ' HG22 ' A' ' 42' ' ' ILE . 48.5 t -75.89 -44.92 38.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.251 -0.431 . . . . 62.020000000000003 110.873 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.2 p -81.59 -28.89 10.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 74.400000000000006 111.166 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.2 mt -50.95 -33.94 26.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 74.239999999999995 110.89 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.77 -34.65 52.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 75.540000000000006 111.164 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 p -65.73 -34.74 78.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 51.219999999999999 111.164 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.14 -46.8 79.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 52.299999999999997 110.883 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.64 -41.6 60.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 75.120000000000005 110.896 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.52 -51.42 69.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 73.299999999999997 111.095 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.03 -32.09 56.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 65.019999999999996 111.166 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.558 ' O ' HD22 ' A' ' 52' ' ' LEU . 5.4 tp -51.62 -37.93 52.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 73.0 110.905 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.0 p -101.64 -35.79 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 75.219999999999999 111.153 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -66.28 -62.06 1.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 75.530000000000001 110.877 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.515 ' CE2' HD13 ' A' ' 141' ' ' LEU . 0.3 OUTLIER -55.52 -53.73 52.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 73.200000000000003 110.935 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.558 HD22 ' O ' ' A' ' 48' ' ' LEU . 10.9 mp -51.96 160.53 1.13 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.585 0.707 . . . . 65.400000000000006 110.968 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -170.97 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.688 2.259 . . . . 73.329999999999998 112.343 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 55.1 91.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 73.109999999999999 110.848 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -152.24 147.31 26.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 70.420000000000002 110.845 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -173.97 -74.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 75.439999999999998 110.877 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -85.95 -50.81 3.79 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.756 -0.735 . . . . 61.210000000000001 112.491 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -61.57 -44.34 97.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.899 0.38 . . . . 73.420000000000002 110.908 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.08 -48.9 67.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 73.409999999999997 110.931 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -66.02 -37.53 86.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 74.349999999999994 110.923 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.5 m -66.91 -29.14 68.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 64.310000000000002 111.17 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.701 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.9 OUTLIER -71.66 -50.69 28.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 74.510000000000005 110.937 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -51.21 62.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 74.010000000000005 110.86 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.5 tt -66.85 -35.02 73.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 74.120000000000005 111.154 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 m -65.79 -25.12 67.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 64.129999999999995 110.858 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 62' ' ' LEU . 64.0 t -58.02 -36.64 57.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 64.340000000000003 111.13 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.92 -28.95 25.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 75.230000000000004 110.898 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.495 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.29 -38.94 78.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 71.310000000000002 110.917 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.51 -30.0 70.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 70.299999999999997 111.133 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.641 HD22 HG11 ' A' ' 102' ' ' VAL . 9.5 mt -64.99 -54.78 25.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 110.904 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.68 -38.46 87.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 71.25 111.196 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 68' ' ' LEU . 79.3 t -71.43 -32.89 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.219999999999999 111.12 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -51.82 -30.14 22.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 75.109999999999999 110.895 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.561 HD11 HD11 ' A' ' 95' ' ' LEU . 0.3 OUTLIER -73.9 -41.62 61.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 62.399999999999999 110.928 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.0 mt -73.27 -34.6 65.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 73.040000000000006 110.873 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.402 HD13 ' HD2' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -69.6 -55.07 11.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 73.439999999999998 110.916 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.556 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -56.22 -24.59 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 61.109999999999999 111.083 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.5 -16.43 60.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 74.340000000000003 110.813 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.747 ' O ' HG23 ' A' ' 81' ' ' VAL . 2.0 ptmm? -64.05 -15.54 59.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 73.25 110.896 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 77' ' ' ILE . 1.0 OUTLIER -51.73 -28.68 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 70.109999999999999 111.106 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 79' ' ' LYS . 58.6 t 61.01 76.72 0.4 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.664 0.745 . . . . 70.140000000000001 111.12 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 167.41 24.46 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.702 2.268 . . . . 74.340000000000003 112.377 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -49.05 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.661 2.241 . . . . 75.299999999999997 112.365 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.9 t -134.48 18.37 3.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 70.430000000000007 111.125 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.2 p 50.09 46.51 24.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 74.150000000000006 110.856 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mt -94.68 22.12 6.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 62.329999999999998 110.94 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.628 ' HA ' HD23 ' A' ' 90' ' ' LEU . 4.1 m-20 -99.07 24.53 7.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 75.109999999999999 110.854 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.537 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.14 -57.78 10.34 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.634 0.731 . . . . 73.099999999999994 111.142 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.4 Cg_endo -69.77 -20.53 34.68 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.721 2.281 . . . . 62.109999999999999 112.341 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.628 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.16 -53.12 10.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 75.230000000000004 110.926 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.05 -40.39 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 72.140000000000001 111.116 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -53.17 -33.69 45.81 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.774 -0.727 . . . . 51.43 112.481 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.0 -23.25 44.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.831 0.348 . . . . 72.310000000000002 110.911 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -76.57 -35.19 58.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 74.400000000000006 110.942 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.561 HD11 HD11 ' A' ' 74' ' ' LEU . 13.3 mt -52.28 -29.9 25.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 61.420000000000002 110.916 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -43.15 79.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 73.439999999999998 110.92 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.504 ' O ' HG22 ' A' ' 100' ' ' VAL . 62.8 t80 -75.37 -52.09 11.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 73.530000000000001 110.852 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.785 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.14 -29.76 33.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 55.210000000000001 111.169 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.9 mmt -66.83 -30.06 70.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 73.540000000000006 110.916 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.77 -30.07 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 72.140000000000001 111.122 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.785 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.89 -33.19 62.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 64.030000000000001 110.927 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.641 HG11 HD22 ' A' ' 70' ' ' LEU . 31.6 m -76.87 -38.1 28.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 71.109999999999999 111.131 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.41 ' O ' HG13 ' A' ' 107' ' ' VAL . 73.6 m -72.45 -40.39 67.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 62.310000000000002 111.151 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -64.11 -31.95 73.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 63.210000000000001 110.902 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.7 m -73.89 -33.77 64.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 64.0 110.892 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 30.4 mt -75.1 -50.94 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 71.530000000000001 111.142 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.557 ' O ' HG12 ' A' ' 110' ' ' VAL . 34.5 m -53.9 -33.98 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 55.340000000000003 111.124 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.4 m -52.48 -32.46 40.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 54.229999999999997 111.09 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 t -50.48 -31.49 15.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 73.420000000000002 110.851 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.5 p -52.5 -32.77 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 73.219999999999999 111.158 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 42.6 m -66.86 -49.04 66.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 53.240000000000002 110.884 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 67.8 t -70.16 -35.67 64.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 62.140000000000001 111.159 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.8 mt -72.08 -38.97 69.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 74.25 110.887 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -53.9 -31.33 49.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 70.109999999999999 110.885 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.78 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.7 p -102.31 -23.68 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 74.209999999999994 111.167 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -52.87 -51.07 62.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 55.439999999999998 110.873 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 62.43 110.868 179.998 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.535 -0.226 . . . . 74.129999999999995 112.535 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -83.43 -26.59 30.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.892 0.377 . . . . 64.030000000000001 110.917 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.1 m -64.47 -30.04 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 74.400000000000006 111.131 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.78 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -58.14 -25.09 61.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.530000000000001 111.071 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 38.8 mmt -53.02 -30.86 37.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 73.340000000000003 110.902 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 71.6 t -56.98 -58.59 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 71.299999999999997 111.127 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.8 mt -74.03 -37.79 47.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 73.329999999999998 111.099 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.98 -30.88 70.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 75.129999999999995 110.883 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.26 -28.74 29.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 71.409999999999997 110.888 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.52 -43.36 63.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 73.129999999999995 110.94 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -73.96 -52.48 12.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 74.319999999999993 110.888 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.515 HD13 ' CE2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -52.01 -32.09 32.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 54.130000000000003 110.903 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -67.3 -42.53 83.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 72.209999999999994 110.876 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.743 ' O ' HG23 ' A' ' 147' ' ' VAL . 69.6 mt -76.85 -32.22 19.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.416 . . . . 74.420000000000002 111.103 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -56.0 -56.99 14.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 61.310000000000002 110.871 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.5 m -54.94 -35.05 32.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 71.319999999999993 111.123 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -68.32 -33.03 73.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 54.350000000000001 110.888 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 143' ' ' ILE . 46.0 t -69.17 -34.0 61.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 73.129999999999995 111.146 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.48 -52.04 60.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 73.340000000000003 110.922 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.0 m -73.1 -35.41 47.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 74.129999999999995 111.149 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -52.46 -40.16 61.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 75.109999999999999 110.878 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -76.6 -20.3 76.81 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.71 -0.757 . . . . 65.209999999999994 112.499 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 35.0 m -72.08 -52.86 14.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.755 0.312 . . . . 73.209999999999994 111.172 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 19.7 mt -76.58 -24.82 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 72.030000000000001 111.098 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.35 -49.63 76.45 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.734 -0.745 . . . . 21.010000000000002 112.503 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -32.05 55.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.843 0.354 . . . . 74.430000000000007 110.893 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 14.7 t80 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 63.340000000000003 110.859 -179.927 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.84 0.267 . . . . 52.43 112.377 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 pp -53.37 -31.0 42.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 75.140000000000001 110.921 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -77.39 -30.2 53.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 71.099999999999994 110.902 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.458 ' HE1' HG22 ' A' ' 80' ' ' ILE . 0.6 OUTLIER -77.02 -44.46 30.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.15 -0.477 . . . . 74.409999999999997 110.932 -179.873 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -60.34 -40.06 89.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 64.510000000000005 111.129 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.431 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -71.83 -28.86 31.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 65.420000000000002 111.146 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.37 -26.58 68.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 70.439999999999998 110.921 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.617 HD13 HD22 ' A' ' 76' ' ' LEU . 1.0 OUTLIER -90.27 -24.44 20.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 60.32 110.899 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.8 mm -79.4 -29.41 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 70.140000000000001 111.121 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.65 -57.15 22.76 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.634 0.731 . . . . 72.349999999999994 111.123 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.3 Cg_endo -69.74 -19.69 35.88 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.696 2.264 . . . . 55.310000000000002 112.328 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.63 ' O ' HG22 ' A' ' 42' ' ' ILE . 47.5 t -76.04 -44.65 38.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 65.140000000000001 110.864 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 p -81.64 -28.89 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 52.310000000000002 111.128 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 mt -50.99 -33.94 26.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 75.230000000000004 110.943 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.63 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.72 -34.62 52.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 70.150000000000006 111.153 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 p -65.88 -41.53 91.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 74.329999999999998 111.105 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.8 t -52.92 -42.91 65.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 72.25 110.864 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.0 tp -76.71 -39.69 51.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 74.120000000000005 110.89 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.85 -51.35 70.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 64.420000000000002 111.082 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.436 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.4 mp -49.7 -31.46 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 71.239999999999995 111.09 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.74 -42.3 57.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 65.109999999999999 110.912 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.736 HG21 ' HA ' ' A' ' 59' ' ' LYS . 7.2 p -101.47 -37.52 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 74.400000000000006 111.093 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -63.61 -64.48 0.89 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 72.109999999999999 110.853 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.47 ' CG ' HD23 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -72.68 -56.06 5.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 73.239999999999995 110.978 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.5 mp -95.71 160.55 30.04 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.602 0.715 . . . . 72.430000000000007 110.898 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 141.24 44.44 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.617 2.211 . . . . 71.120000000000005 112.351 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.5 m -161.98 105.85 1.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 62.409999999999997 110.849 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.02 -170.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 74.540000000000006 110.838 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 78.8 m -110.9 -73.71 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 72.319999999999993 110.894 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.35 -26.81 72.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.744 -0.741 . . . . 60.240000000000002 112.514 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.08 -35.05 46.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.946 0.403 . . . . 74.319999999999993 110.877 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.736 ' HA ' HG21 ' A' ' 49' ' ' VAL . 2.2 ttpt -54.22 -51.42 64.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 73.430000000000007 110.938 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.459 ' O ' HG22 ' A' ' 64' ' ' ILE . 4.5 tpt -60.43 -51.31 70.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 73.239999999999995 110.917 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 30.0 p -54.8 -31.33 58.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 73.319999999999993 111.14 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -74.96 -41.34 59.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 74.219999999999999 110.926 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 81.5 m -66.84 -50.94 60.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 64.230000000000004 110.93 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 60' ' ' MET . 15.9 tt -62.27 -35.0 66.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 71.409999999999997 111.14 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.2 t -63.58 -27.08 69.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 75.239999999999995 110.874 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 62' ' ' LEU . 63.6 t -59.38 -39.37 78.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 65.150000000000006 111.124 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 tp -53.11 -29.03 28.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 75.25 110.879 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.501 ' O ' HD22 ' A' ' 68' ' ' LEU . 2.0 tm? -74.16 -46.81 39.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 60.049999999999997 110.888 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.76 -29.59 19.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 74.030000000000001 111.112 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.776 HD22 HG11 ' A' ' 102' ' ' VAL . 30.0 mt -58.04 -54.58 45.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 74.319999999999993 110.909 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 68' ' ' LEU . 1.1 t -63.12 -27.26 69.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 71.540000000000006 111.134 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.2 t -71.23 -32.94 49.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 72.310000000000002 111.107 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -52.08 -50.02 62.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 74.400000000000006 110.869 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.0 tp -61.54 -32.5 72.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 73.319999999999993 110.91 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 71' ' ' THR . 9.7 mp -73.04 -44.24 60.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.452 . . . . 71.129999999999995 110.941 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.617 HD22 HD13 ' A' ' 35' ' ' LEU . 1.2 tt -67.73 -50.22 58.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 63.32 110.912 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.473 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -57.43 -25.51 24.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 64.150000000000006 111.106 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.04 -18.58 49.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 65.109999999999999 110.904 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.744 ' O ' HG23 ' A' ' 81' ' ' VAL . 4.9 mmmt -69.07 -11.71 61.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 51.200000000000003 110.876 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.473 HG23 ' O ' ' A' ' 77' ' ' ILE . 1.4 pp -54.17 -26.33 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 71.230000000000004 111.097 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 79' ' ' LYS . 44.6 t 62.12 75.72 0.42 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.629 0.728 . . . . 74.430000000000007 111.149 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 167.61 23.91 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.646 2.231 . . . . 64.510000000000005 112.381 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -48.91 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.676 2.25 . . . . 40.299999999999997 112.361 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.42 HG23 ' HB2' ' A' ' 86' ' ' LEU . 11.8 t -133.1 13.29 4.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 70.439999999999998 111.175 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.1 m 51.55 65.23 1.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 74.340000000000003 110.882 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.42 ' HB2' HG23 ' A' ' 84' ' ' THR . 10.3 tp -117.19 25.93 10.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 54.0 110.899 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.639 ' HA ' HD23 ' A' ' 90' ' ' LEU . 1.5 m-20 -104.5 22.47 14.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 75.209999999999994 110.907 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.536 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -68.2 -57.94 8.31 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.649 0.738 . . . . 75.439999999999998 111.131 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.6 Cg_endo -69.72 -19.61 36.08 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.664 2.243 . . . . 73.400000000000006 112.385 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.639 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.15 -53.01 10.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 64.120000000000005 110.874 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.543 HG12 HD21 ' A' ' 95' ' ' LEU . 21.8 t -80.24 -23.79 11.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 73.540000000000006 111.146 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.68 -50.67 42.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.76 -0.733 . . . . 73.439999999999998 112.445 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.42 -35.06 78.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.757 0.313 . . . . 74.219999999999999 110.883 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -61.27 -42.46 98.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 75.299999999999997 110.943 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.543 HD21 HG12 ' A' ' 91' ' ' VAL . 7.7 mt -51.94 -29.83 22.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 65.030000000000001 110.938 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.0 mmt -67.77 -42.87 81.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 63.329999999999998 110.868 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.501 ' O ' HG22 ' A' ' 100' ' ' VAL . 62.2 t80 -75.24 -52.41 10.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 73.109999999999999 110.919 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.79 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.17 -29.77 33.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 70.239999999999995 111.185 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.2 mmt -66.86 -29.92 69.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.479 . . . . 70.049999999999997 110.883 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.84 -30.05 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 73.019999999999996 111.128 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.79 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -74.87 -33.38 62.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 62.310000000000002 110.918 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.776 HG11 HD22 ' A' ' 70' ' ' LEU . 30.4 m -76.89 -38.0 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 71.310000000000002 111.106 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.483 ' O ' HG13 ' A' ' 107' ' ' VAL . 63.2 m -72.44 -42.23 65.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 45.420000000000002 111.15 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -60.65 -31.96 71.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 63.439999999999998 110.929 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.1 t -75.08 -36.05 61.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 71.310000000000002 110.881 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 39.4 mt -74.87 -49.31 29.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.489 . . . . 74.049999999999997 111.16 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.547 ' O ' HG12 ' A' ' 110' ' ' VAL . 34.0 m -53.89 -33.91 24.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 75.420000000000002 111.158 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.8 m -52.34 -32.5 38.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 74.230000000000004 111.194 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.9 m -50.52 -31.48 15.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 73.299999999999997 110.856 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.5 p -52.41 -32.77 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 71.430000000000007 111.111 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 20.5 m -64.3 -42.81 96.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 64.5 110.943 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 75.7 t -78.07 -35.37 20.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 71.510000000000005 111.134 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.436 HD22 ' O ' ' A' ' 117' ' ' HIS . 85.4 mt -71.83 -30.99 66.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 72.439999999999998 110.901 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -60.15 -32.28 70.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 73.120000000000005 110.907 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.769 HG11 ' HB2' ' A' ' 133' ' ' ALA . 7.9 p -102.31 -24.67 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 70.409999999999997 111.136 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -89.1 -71.79 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 74.120000000000005 110.842 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.436 ' O ' HD22 ' A' ' 113' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 72.510000000000005 110.879 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.495 -0.242 . . . . 64.329999999999998 112.495 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -87.49 -26.86 22.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 75.5 110.88 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.6 m -64.96 -34.94 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 70.439999999999998 111.08 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.769 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -71.72 -25.01 61.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 73.120000000000005 111.077 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.42 ' HE1' ' CE1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -52.96 -31.1 38.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 72.340000000000003 110.872 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.6 t -56.94 -58.73 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 70.310000000000002 111.121 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.5 mp -73.99 -37.52 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 72.310000000000002 111.157 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -61.42 -29.97 70.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 71.219999999999999 110.819 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.0 -30.51 25.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.269 -0.423 . . . . 72.040000000000006 110.871 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.3 mt -71.76 -40.85 69.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 73.129999999999995 110.958 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -73.61 -53.06 11.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 72.099999999999994 110.92 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.47 HD23 ' CG ' ' A' ' 51' ' ' TYR . 4.8 mp -52.42 -32.02 37.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 75.340000000000003 110.851 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -61.37 -43.61 98.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.234 -0.439 . . . . 73.219999999999999 110.906 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.583 ' O ' HG23 ' A' ' 147' ' ' VAL . 68.2 mt -76.97 -33.49 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 74.140000000000001 111.152 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -56.36 -56.67 18.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 70.230000000000004 110.893 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 141' ' ' LEU . 28.2 t -55.2 -35.12 34.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 64.219999999999999 111.126 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.18 -32.99 74.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 73.140000000000001 110.852 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 143' ' ' ILE . 46.0 t -61.2 -51.78 69.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 61.5 111.09 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.1 m -52.05 -32.06 32.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 71.329999999999998 110.86 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.5 t -57.72 -50.89 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.229 -0.441 . . . . 75.409999999999997 111.101 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -72.06 -26.86 62.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 62.32 110.912 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -52.21 -58.98 9.48 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.715 -0.755 . . . . 64.510000000000005 112.468 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.5 t -60.82 -31.95 71.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.766 0.317 . . . . 75.310000000000002 111.119 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 43.9 mm -72.65 -24.94 21.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 72.140000000000001 111.151 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -65.65 -49.9 57.28 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.722 -0.751 . . . . 51.299999999999997 112.504 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.24 -32.01 43.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.781 0.324 . . . . 75.040000000000006 110.885 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 32.6 t80 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 74.519999999999996 110.83 -179.883 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.167 0 CA-C-O 120.853 0.272 . . . . 64.140000000000001 112.313 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.05 -30.96 65.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 64.209999999999994 110.961 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -78.34 -32.15 48.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 64.109999999999999 110.879 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.08 -45.01 59.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 75.239999999999995 110.927 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -60.53 -39.95 89.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 75.420000000000002 111.132 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.447 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.24 -29.12 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 63.5 111.117 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.95 -26.84 49.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 72.200000000000003 110.913 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.54 -19.22 23.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 73.409999999999997 110.917 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.426 ' O ' HG12 ' A' ' 40' ' ' VAL . 45.6 mm -76.6 -35.01 24.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 72.209999999999994 111.108 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.552 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.76 -57.15 23.07 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.574 0.702 . . . . 72.530000000000001 111.131 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.77 -22.12 32.49 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.645 2.23 . . . . 61.109999999999999 112.376 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.628 ' O ' HG22 ' A' ' 42' ' ' ILE . 45.9 t -76.04 -45.67 33.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 72.150000000000006 110.871 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 36' ' ' ILE . 9.1 p -81.53 -28.83 10.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 72.299999999999997 111.165 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mt -50.92 -34.01 26.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 73.209999999999994 110.89 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.628 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.72 -34.65 52.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 64.049999999999997 111.103 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.7 p -65.89 -35.29 80.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 71.310000000000002 111.121 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.73 -51.22 66.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 72.540000000000006 110.858 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 tp -70.64 -42.23 71.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 74.299999999999997 110.915 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.06 -48.76 75.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 64.209999999999994 111.094 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.449 HD11 ' CD2' ' A' ' 141' ' ' LEU . 0.9 OUTLIER -65.09 -32.25 57.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 61.43 111.093 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.561 ' O ' HD13 ' A' ' 52' ' ' LEU . 14.6 tp -51.62 -37.73 51.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 74.239999999999995 110.89 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -101.52 -35.95 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 74.310000000000002 111.144 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -66.44 -62.45 1.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 64.0 110.909 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.51 -43.44 75.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 74.120000000000005 110.919 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.561 HD13 ' O ' ' A' ' 48' ' ' LEU . 4.3 mp -54.45 160.63 2.49 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.617 0.722 . . . . 42.420000000000002 110.911 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 179.91 3.37 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.669 2.246 . . . . 73.5 112.334 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 62.99 162.04 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 52.200000000000003 110.864 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -179.18 84.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 75.329999999999998 110.85 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.7 m -80.64 -170.63 2.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 75.420000000000002 110.911 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.82 -27.17 27.91 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.709 -0.758 . . . . 32.32 112.463 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -57.1 -34.96 68.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.924 0.392 . . . . 75.409999999999997 110.894 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.24 -51.36 64.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 73.319999999999993 110.882 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.7 ttm -53.05 -51.96 60.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 71.409999999999997 110.896 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.2 p -60.93 -35.53 76.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 61.229999999999997 111.15 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.472 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.5 OUTLIER -65.87 -47.19 75.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.425 . . . . 65.120000000000005 110.939 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.426 ' HB3' HG23 ' A' ' 106' ' ' ILE . 75.6 m -57.73 -51.98 67.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 72.209999999999994 110.888 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.452 HG13 HD12 ' A' ' 67' ' ' LEU . 17.8 tt -66.54 -34.96 73.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 73.030000000000001 111.1 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.5 m -59.76 -25.08 64.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 73.310000000000002 110.832 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 62' ' ' LEU . 48.3 t -57.92 -38.02 64.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 71.129999999999995 111.12 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.452 HD12 HG13 ' A' ' 64' ' ' ILE . 5.8 mt -52.89 -28.9 25.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 63.399999999999999 110.894 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.485 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.63 -38.74 77.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 54.340000000000003 110.886 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.57 -30.07 70.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 73.230000000000004 111.137 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.793 HD22 HG11 ' A' ' 102' ' ' VAL . 9.4 mt -64.95 -54.72 26.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 70.030000000000001 110.954 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.72 -38.43 87.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.469 . . . . 55.43 111.139 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 68' ' ' LEU . 78.9 t -71.48 -32.82 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 72.420000000000002 111.135 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -51.59 -30.56 21.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 75.25 110.877 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.6 tp -75.02 -38.84 61.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 64.239999999999995 110.937 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.0 mp -73.26 -40.32 64.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 74.219999999999999 110.923 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.2 tt -65.05 -54.07 35.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 74.519999999999996 110.893 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.06 -23.59 18.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 73.129999999999995 111.143 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.5 m -80.26 -21.95 42.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 71.209999999999994 110.845 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.755 ' O ' HG23 ' A' ' 81' ' ' VAL . 25.3 mttt -59.81 -20.44 56.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.481 . . . . 74.150000000000006 110.849 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.7 pt -51.92 -29.06 10.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 73.329999999999998 111.156 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 79' ' ' LYS . 59.1 t 61.17 76.81 0.39 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.654 0.74 . . . . 70.150000000000006 111.162 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 167.47 24.29 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.666 2.244 . . . . 72.230000000000004 112.35 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -48.78 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.683 2.255 . . . . 64.310000000000002 112.324 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.0 t -117.23 -20.16 9.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 72.510000000000005 111.134 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.74 45.51 4.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 64.400000000000006 110.882 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 tp -95.73 25.8 4.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 73.109999999999999 110.897 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -102.94 23.72 11.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 73.140000000000001 110.886 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.532 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -66.74 -57.72 11.23 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.594 0.711 . . . . 65.510000000000005 111.128 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 54.0 Cg_endo -69.72 -37.32 9.43 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.741 2.294 . . . . 64.239999999999995 112.342 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.7 mp -53.95 -52.96 58.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 71.120000000000005 110.899 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.532 HG12 HD21 ' A' ' 95' ' ' LEU . 21.7 t -80.24 -26.37 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 70.140000000000001 111.089 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.72 -51.32 39.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 75.310000000000002 112.532 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.54 -35.39 80.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.813 0.339 . . . . 63.130000000000003 110.9 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -60.52 -38.2 83.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 74.319999999999993 110.946 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.532 HD21 HG12 ' A' ' 91' ' ' VAL . 9.2 mt -51.79 -29.75 20.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 54.420000000000002 110.923 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.04 -42.99 79.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 73.5 110.876 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.5 ' O ' HG22 ' A' ' 100' ' ' VAL . 57.8 t80 -75.25 -52.2 11.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 75.430000000000007 110.887 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.795 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.15 -29.88 33.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 63.130000000000003 111.131 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.6 mmt -66.66 -30.1 70.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 72.25 110.846 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.76 -30.05 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 64.109999999999999 111.135 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.795 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -74.97 -33.19 61.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 74.329999999999998 110.918 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.793 HG11 HD22 ' A' ' 70' ' ' LEU . 30.8 m -76.85 -37.94 28.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.510000000000005 111.158 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.444 ' O ' HG13 ' A' ' 107' ' ' VAL . 60.9 m -72.51 -41.9 65.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 65.129999999999995 111.135 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -60.91 -31.89 71.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 71.519999999999996 110.895 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.7 t -74.8 -35.52 62.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 43.039999999999999 110.868 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.426 HG23 ' HB3' ' A' ' 63' ' ' CYS . 40.7 mt -74.97 -49.65 27.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 74.430000000000007 111.124 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.555 ' O ' HG12 ' A' ' 110' ' ' VAL . 34.2 m -53.99 -33.86 24.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 63.350000000000001 111.143 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.5 m -52.44 -32.43 39.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 72.120000000000005 111.173 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.7 m -50.45 -31.59 15.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 74.439999999999998 110.87 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.7 p -52.6 -32.68 17.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 55.509999999999998 111.144 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 49.4 m -66.7 -47.05 73.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 71.040000000000006 110.848 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 88.4 t -72.35 -35.37 51.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 63.409999999999997 111.143 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 89.5 mt -72.08 -39.69 68.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 62.350000000000001 110.964 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -54.1 -30.67 49.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 61.43 110.879 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.8 HG11 ' HB2' ' A' ' 133' ' ' ALA . 9.4 p -102.32 -23.23 4.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 64.030000000000001 111.126 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -53.82 -61.61 2.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 75.150000000000006 110.839 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 74.329999999999998 110.844 -179.979 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.491 -0.244 . . . . 73.409999999999997 112.491 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -71.52 -26.8 62.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.94 0.4 . . . . 74.409999999999997 110.909 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.8 m -64.58 -27.01 41.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 74.109999999999999 111.142 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.8 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -56.23 -24.95 45.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 70.230000000000004 111.135 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.0 -30.9 38.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 75.109999999999999 110.871 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 58.9 t -56.99 -59.0 3.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 71.510000000000005 111.13 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.7 mt -74.05 -37.72 47.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 73.209999999999994 111.121 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -61.28 -29.96 70.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 72.5 110.827 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.37 -29.69 25.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 72.140000000000001 110.912 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.93 -50.41 23.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 73.349999999999994 110.929 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -66.37 -53.99 29.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 64.230000000000004 110.876 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.449 ' CD2' HD11 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -52.0 -32.23 32.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 53.43 110.937 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -71.74 -38.1 70.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 75.230000000000004 110.913 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.558 ' O ' HG23 ' A' ' 147' ' ' VAL . 55.9 mt -76.87 -32.03 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 61.329999999999998 111.132 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -56.11 -56.31 22.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 55.140000000000001 110.875 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.26 -34.99 45.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 74.400000000000006 111.153 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -59.64 -47.53 85.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 71.239999999999995 110.914 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 143' ' ' ILE . 91.8 t -69.38 -34.1 60.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 70.5 111.129 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.95 -51.47 56.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 53.409999999999997 110.916 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 40.8 t -75.87 -33.11 24.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 74.209999999999994 111.121 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.36 -42.99 83.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 72.239999999999995 110.896 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.02 -19.32 67.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 73.099999999999994 112.436 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 94.9 m -63.02 -51.94 64.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.756 0.312 . . . . 70.109999999999999 111.145 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 20.5 tt -55.94 -25.64 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 73.019999999999996 111.162 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -51.87 -49.54 47.75 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.707 -0.759 . . . . 62.420000000000002 112.524 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 1.3 mmt -61.82 -31.79 72.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.834 0.349 . . . . 53.509999999999998 110.916 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 73.219999999999999 110.886 -179.929 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.232 0.198 0 CA-C-O 120.785 0.244 . . . . 70.25 112.334 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 pp -53.31 -30.98 41.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 63.520000000000003 110.95 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -79.94 -29.34 39.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 71.25 110.865 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -77.07 -45.4 27.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.468 . . . . 74.150000000000006 110.938 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.2 t -59.45 -40.33 86.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 64.430000000000007 111.093 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.425 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -71.68 -28.84 32.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 73.219999999999999 111.123 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.37 -25.89 68.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 63.340000000000003 110.896 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.622 HD12 HD12 ' A' ' 77' ' ' ILE . 1.1 mm? -91.24 -23.08 20.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 75.340000000000003 110.872 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.6 mm -78.55 -31.2 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.447 . . . . 72.040000000000006 111.107 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.544 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.7 -57.16 22.82 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.615 0.721 . . . . 62.119999999999997 111.123 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 54.2 Cg_endo -69.76 -20.79 34.36 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.676 2.251 . . . . 61.119999999999997 112.378 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.64 ' O ' HG22 ' A' ' 42' ' ' ILE . 7.6 t -76.01 -43.27 45.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 63.32 110.876 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.61 -28.89 10.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 73.450000000000003 111.126 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 mt -50.97 -33.95 26.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 64.040000000000006 110.912 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.64 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.1 tp -58.8 -34.62 52.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 72.129999999999995 111.123 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.81 -38.62 89.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 71.420000000000002 111.177 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.6 m -53.04 -45.04 67.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 64.239999999999995 110.86 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.2 tp -76.93 -40.1 48.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 60.039999999999999 110.899 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.63 -38.34 74.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 73.310000000000002 111.091 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.446 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.3 mp -64.22 -31.98 55.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 63.119999999999997 111.142 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 tp -51.45 -38.74 55.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 63.509999999999998 110.896 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.8 p -101.47 -36.66 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 53.039999999999999 111.187 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -67.1 -64.65 0.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 74.420000000000002 110.876 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.546 ' CZ ' HD13 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -71.24 -25.94 62.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 74.099999999999994 110.9 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.1 mp -124.84 72.0 61.82 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.616 0.722 . . . . 73.540000000000006 110.961 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -173.0 0.64 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.651 2.234 . . . . 72.519999999999996 112.34 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.2 p -158.71 27.48 0.23 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 74.219999999999999 110.878 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 57.2 93.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 63.119999999999997 110.822 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.03 141.77 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 64.510000000000005 110.874 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.19 -22.97 45.55 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 52.530000000000001 112.469 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -52.06 -34.99 45.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 71.239999999999995 110.908 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.07 -37.47 61.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 74.120000000000005 110.914 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.19 -50.86 35.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 63.539999999999999 110.848 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.1 p -60.24 -29.3 68.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 73.230000000000004 111.121 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.55 -37.31 60.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.439 . . . . 74.430000000000007 110.893 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.506 ' O ' HG12 ' A' ' 66' ' ' VAL . 62.4 m -66.27 -44.86 82.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 54.439999999999998 110.929 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.6 tt -75.59 -33.14 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 51.329999999999998 111.149 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 t -51.74 -25.81 8.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 74.019999999999996 110.827 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.506 HG12 ' O ' ' A' ' 63' ' ' CYS . 8.9 p -57.08 -32.55 40.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 73.120000000000005 111.111 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.9 -28.93 25.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 70.209999999999994 110.925 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.497 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.25 -38.88 78.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 70.319999999999993 110.92 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.64 -30.03 70.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 65.209999999999994 111.054 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.819 HD22 HG11 ' A' ' 102' ' ' VAL . 9.2 mt -65.38 -54.63 26.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 65.340000000000003 110.94 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.59 -38.57 88.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 63.509999999999998 111.151 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 68' ' ' LEU . 83.4 t -71.56 -32.89 47.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 75.219999999999999 111.152 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.499 ' O ' HG22 ' A' ' 77' ' ' ILE . 18.4 t80 -52.0 -30.14 23.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 74.439999999999998 110.867 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.547 HD11 HD11 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -69.73 -45.93 67.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 74.5 110.937 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.7 mt -73.1 -34.14 65.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 72.319999999999993 110.906 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.43 -54.99 15.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 74.519999999999996 110.925 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.622 HD12 HD12 ' A' ' 35' ' ' LEU . 1.4 tt -61.45 -30.02 47.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 70.340000000000003 111.135 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.6 m -80.07 -23.71 41.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 62.340000000000003 110.862 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.706 ' O ' HG23 ' A' ' 81' ' ' VAL . 6.8 mtmt -66.8 -15.64 63.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 75.219999999999999 110.924 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.2 pp -56.08 -24.84 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 75.129999999999995 111.121 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 79' ' ' LYS . 23.3 t 63.52 75.42 0.4 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.57 0.7 . . . . 62.200000000000003 111.112 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 167.65 23.83 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.708 2.272 . . . . 64.329999999999998 112.363 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -22.13 32.52 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.649 2.233 . . . . 63.520000000000003 112.366 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.584 HG23 ' H ' ' A' ' 86' ' ' LEU . 7.9 t -95.24 -31.41 13.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 64.329999999999998 111.139 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 55.47 26.12 8.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 74.519999999999996 110.849 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.584 ' H ' HG23 ' A' ' 84' ' ' THR . 1.2 tp -141.84 51.89 1.51 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 71.140000000000001 110.918 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.633 ' HA ' HD23 ' A' ' 90' ' ' LEU . 1.9 m-20 -97.91 27.34 4.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 40.229999999999997 110.87 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.524 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.12 -57.75 10.42 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.607 0.717 . . . . 60.240000000000002 111.132 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.53 ' HG2' HD22 ' A' ' 90' ' ' LEU . 53.8 Cg_endo -69.83 -20.67 34.2 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.683 2.255 . . . . 73.150000000000006 112.289 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.633 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.19 -52.3 12.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 62.210000000000001 110.933 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.458 HG12 HD21 ' A' ' 95' ' ' LEU . 22.0 t -80.2 -22.81 11.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 72.5 111.096 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.65 -47.55 52.06 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.755 -0.736 . . . . 44.109999999999999 112.474 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -34.94 76.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.755 0.312 . . . . 75.430000000000007 110.859 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -60.62 -34.57 74.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.268 -0.423 . . . . 61.310000000000002 110.904 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.547 HD11 HD11 ' A' ' 74' ' ' LEU . 10.7 mt -51.7 -29.79 19.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 64.450000000000003 110.924 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -43.22 78.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 74.019999999999996 110.873 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.506 ' O ' HG22 ' A' ' 100' ' ' VAL . 30.3 t80 -75.27 -52.0 11.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 65.140000000000001 110.84 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.805 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.05 -29.94 32.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 71.0 111.137 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.5 mmt -66.41 -30.42 70.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 75.140000000000001 110.898 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.59 -29.94 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 70.420000000000002 111.139 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.805 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -75.26 -33.43 61.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 74.200000000000003 110.859 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.819 HG11 HD22 ' A' ' 70' ' ' LEU . 29.5 m -77.54 -39.51 27.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 64.450000000000003 111.14 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.666 ' HA ' HD12 ' A' ' 106' ' ' ILE . 2.5 t -72.58 -32.14 65.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 74.340000000000003 111.161 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -57.74 -33.89 68.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 74.219999999999999 110.88 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.4 t -74.95 -33.98 62.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 53.130000000000003 110.848 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.666 HD12 ' HA ' ' A' ' 103' ' ' THR . 7.4 mt -75.11 -50.56 24.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 62.229999999999997 111.138 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.544 ' O ' HG12 ' A' ' 110' ' ' VAL . 32.5 m -53.91 -35.73 28.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 70.450000000000003 111.149 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.6 m -52.61 -32.29 40.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 64.109999999999999 111.132 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 51.8 p -50.33 -31.56 14.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.43 . . . . 54.32 110.854 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.4 p -52.5 -32.75 17.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 73.129999999999995 111.123 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 44.1 m -67.08 -49.02 66.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 73.129999999999995 110.846 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 65.4 t -70.08 -35.49 64.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 72.530000000000001 111.109 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.1 mt -72.11 -41.09 67.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 71.209999999999994 110.928 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -51.94 -31.34 28.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 74.510000000000005 110.924 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.78 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.6 p -102.27 -23.97 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 70.310000000000002 111.135 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -53.18 -74.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 74.400000000000006 110.864 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 70.420000000000002 110.869 179.987 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.544 -0.222 . . . . 53.509999999999998 112.544 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -76.55 -37.47 56.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.947 0.403 . . . . 63.240000000000002 110.916 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.2 m -65.18 -34.7 72.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 72.200000000000003 111.097 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.78 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -68.33 -25.13 64.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 73.310000000000002 111.108 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 23.4 mmt -53.01 -30.96 38.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 74.340000000000003 110.894 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.0 -57.66 8.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 73.319999999999993 111.161 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.8 mm -74.01 -37.37 47.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.486 . . . . 62.25 111.157 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.82 -29.96 70.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 72.209999999999994 110.871 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -52.09 -30.2 25.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 75.349999999999994 110.87 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.2 tt -72.1 -50.38 28.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 71.099999999999994 110.931 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -63.03 -52.07 64.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 73.109999999999999 110.861 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.546 HD13 ' CZ ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -51.94 -35.16 45.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 74.510000000000005 110.917 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -60.81 -40.27 92.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 73.299999999999997 110.918 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.644 ' O ' HG23 ' A' ' 147' ' ' VAL . 45.6 mm -76.85 -31.98 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 70.400000000000006 111.166 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -56.02 -56.76 16.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.486 . . . . 64.409999999999997 110.906 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.6 m -56.67 -35.32 45.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 75.129999999999995 111.153 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.4 -34.1 77.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 74.519999999999996 110.879 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 143' ' ' ILE . 67.4 t -54.06 -35.93 30.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 64.329999999999998 111.146 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -52.82 -49.78 65.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 73.129999999999995 110.852 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.36 -33.04 57.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 71.209999999999994 111.125 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.19 -54.99 23.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 64.230000000000004 110.877 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.58 -19.48 71.0 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 64.549999999999997 112.484 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 32.7 m -55.95 -52.83 62.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.77 0.319 . . . . 63.439999999999998 111.123 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 29.8 mt -76.52 -27.99 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 73.329999999999998 111.126 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -53.71 -50.03 55.6 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.788 -0.72 . . . . 70.049999999999997 112.494 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -71.37 -31.99 67.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 75.519999999999996 110.844 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 27.6 t80 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 70.209999999999994 110.929 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.825 0.261 . . . . 73.230000000000004 112.344 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.0 pp -52.26 -31.02 30.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 65.349999999999994 110.926 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -80.86 -31.69 35.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 75.430000000000007 110.853 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.478 ' HB3' HD11 ' A' ' 86' ' ' LEU . 1.4 t80 -72.98 -46.27 53.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.127 -0.488 . . . . 74.219999999999999 110.956 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 t -59.57 -39.89 85.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.483 . . . . 73.209999999999994 111.133 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.16 -29.08 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 70.349999999999994 111.156 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.73 -27.5 50.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.152 -0.477 . . . . 65.430000000000007 110.863 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.89 -18.75 24.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 51.43 110.903 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.6 mm -76.76 -34.82 23.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 71.450000000000003 111.106 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.547 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.68 -57.17 22.76 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.575 0.702 . . . . 74.540000000000006 111.057 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.8 Cg_endo -69.78 -19.3 36.2 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.686 2.258 . . . . 71.040000000000006 112.347 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.63 ' O ' HG22 ' A' ' 42' ' ' ILE . 48.7 t -73.02 -43.91 61.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 71.129999999999995 110.881 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.53 -28.93 10.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 74.109999999999999 111.115 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.1 mt -50.96 -33.94 26.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 72.239999999999995 110.874 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.63 HG22 ' O ' ' A' ' 39' ' ' CYS . 0.7 OUTLIER -58.78 -34.71 52.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 53.350000000000001 111.095 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.82 -41.19 92.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 73.109999999999999 111.138 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.09 -43.16 66.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 71.120000000000005 110.867 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 tp -76.29 -39.74 53.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 72.219999999999999 110.904 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.66 -51.46 69.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 73.420000000000002 111.125 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.432 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.4 mp -49.8 -31.36 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 75.349999999999994 111.134 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.1 tp -50.83 -42.17 58.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 62.229999999999997 110.912 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.776 HG21 ' HA ' ' A' ' 59' ' ' LYS . 7.2 p -101.53 -37.38 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 74.420000000000002 111.151 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -63.77 -64.45 0.89 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 72.140000000000001 110.856 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.625 ' CE1' HD13 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -72.67 -62.05 1.59 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.457 . . . . 60.340000000000003 110.947 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 mp -67.83 160.64 72.52 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.633 0.73 . . . . 62.420000000000002 110.921 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 154.0 68.62 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.713 2.276 . . . . 74.140000000000001 112.329 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.554 ' HB3' HG23 ' A' ' 49' ' ' VAL . 1.5 t -175.79 65.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 71.439999999999998 110.835 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -62.23 95.03 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 74.140000000000001 110.819 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.2 145.82 0.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 74.140000000000001 110.871 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.19 -28.26 25.99 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.672 -0.775 . . . . 71.5 112.47 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -53.42 -34.95 59.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.951 0.405 . . . . 75.230000000000004 110.894 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.776 ' HA ' HG21 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -52.94 -51.97 59.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 63.399999999999999 110.863 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.67 -48.95 78.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 62.210000000000001 110.88 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.6 p -60.73 -34.16 74.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 74.319999999999993 111.154 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.4 mt -67.0 -51.07 59.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 75.510000000000005 110.903 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 79.6 m -53.79 -51.06 64.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 71.310000000000002 110.89 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.0 tt -68.86 -34.96 67.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 71.420000000000002 111.151 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.1 -29.91 23.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 63.520000000000003 110.84 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.22 -40.54 88.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 72.319999999999993 111.126 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.697 HD22 HD12 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -52.93 -28.96 25.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 75.329999999999998 110.921 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.484 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.08 -39.0 79.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 71.120000000000005 110.928 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.46 -30.03 70.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 71.140000000000001 111.087 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.697 HD12 HD22 ' A' ' 67' ' ' LEU . 8.6 mt -65.8 -54.78 22.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.263 -0.426 . . . . 74.420000000000002 110.893 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.14 -38.41 86.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 72.150000000000006 111.121 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 68' ' ' LEU . 80.5 t -71.38 -32.92 48.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 41.409999999999997 111.153 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -60.06 -29.79 68.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 73.430000000000007 110.896 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.642 ' HG ' HD13 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -63.21 -55.03 28.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 55.420000000000002 110.927 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.15 -31.93 64.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 63.240000000000002 110.905 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tt -60.96 -54.44 44.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 74.140000000000001 110.88 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 tt -66.15 -27.02 39.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 73.319999999999993 111.112 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.7 t -83.23 -14.75 52.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 73.409999999999997 110.812 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.745 ' O ' HG23 ' A' ' 81' ' ' VAL . 15.8 mttt -93.7 -9.76 36.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 73.519999999999996 110.878 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.487 HD11 HD22 ' A' ' 86' ' ' LEU . 10.5 pt -54.26 -28.22 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 71.25 111.158 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 79' ' ' LYS . 40.5 t 63.07 74.75 0.44 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.624 0.726 . . . . 73.439999999999998 111.127 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 166.34 27.94 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.682 2.255 . . . . 74.219999999999999 112.359 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -49.15 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.664 2.243 . . . . 75.209999999999994 112.354 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.1 t -115.93 -41.7 3.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 65.140000000000001 111.115 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.476 ' HB3' HG23 ' A' ' 88' ' ' VAL . 0.5 OUTLIER -179.61 -42.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 64.400000000000006 110.824 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.487 HD22 HD11 ' A' ' 80' ' ' ILE . 0.5 OUTLIER 63.56 70.48 0.52 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.139 -0.482 . . . . 73.310000000000002 110.922 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 91' ' ' VAL . 4.3 m-20 51.05 64.14 1.96 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 74.150000000000006 110.838 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.536 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -69.17 -58.09 6.61 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.645 0.736 . . . . 64.109999999999999 111.177 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.602 ' HG2' HD22 ' A' ' 90' ' ' LEU . 53.2 Cg_endo -69.83 -24.21 29.63 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.692 2.261 . . . . 64.040000000000006 112.301 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.602 HD22 ' HG2' ' A' ' 89' ' ' PRO . 3.3 mm? -74.21 -53.09 10.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 62.140000000000001 110.913 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 87' ' ' ASP . 97.6 t -65.07 -48.93 81.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 72.329999999999998 111.111 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.83 -46.58 54.67 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.773 -0.727 . . . . 63.450000000000003 112.446 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -72.08 -24.93 61.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.819 0.342 . . . . 73.219999999999999 110.909 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -71.21 -30.93 66.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 70.140000000000001 110.939 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.642 HD13 ' HG ' ' A' ' 74' ' ' LEU . 13.1 mt -54.83 -29.66 55.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 52.25 110.917 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.51 -42.41 71.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 70.439999999999998 110.849 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.502 ' O ' HG22 ' A' ' 100' ' ' VAL . 77.0 t80 -75.13 -51.16 14.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 75.120000000000005 110.866 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.798 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.04 -29.96 32.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 73.200000000000003 111.125 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.8 mmt -66.58 -30.11 70.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 60.32 110.867 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.82 -30.11 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.427 . . . . 71.400000000000006 111.118 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.798 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.97 -33.12 61.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 50.109999999999999 110.913 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.47 -37.64 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 70.239999999999995 111.143 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.731 ' O ' HG23 ' A' ' 107' ' ' VAL . 55.1 m -72.86 -46.47 52.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 73.340000000000003 111.134 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -52.59 -31.64 37.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 73.439999999999998 110.898 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 53.2 p -74.68 -49.0 22.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 72.409999999999997 110.85 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.639 HD12 ' HA ' ' A' ' 103' ' ' THR . 9.8 mt -55.77 -34.56 36.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 74.040000000000006 111.131 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 103' ' ' THR . 22.0 t -53.7 -45.78 61.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 74.430000000000007 111.159 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.1 m -52.38 -32.49 38.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.099 -0.501 . . . . 74.040000000000006 111.147 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.7 m -50.35 -31.39 14.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 74.450000000000003 110.855 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.7 p -52.44 -32.76 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 70.310000000000002 111.112 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 34.4 m -66.72 -47.04 73.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 55.130000000000003 110.88 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 82.8 t -72.4 -35.05 50.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 63.409999999999997 111.126 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 87.8 mt -72.04 -42.8 65.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 54.130000000000003 110.88 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -52.11 -30.3 25.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 71.030000000000001 110.917 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.813 HG11 ' HB2' ' A' ' 133' ' ' ALA . 9.9 p -102.22 -22.25 4.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.142 -0.481 . . . . 75.409999999999997 111.114 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -58.65 -71.72 0.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 70.430000000000007 110.84 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.439 . . . . 72.120000000000005 110.842 -179.937 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.443 -0.263 . . . . 62.210000000000001 112.443 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.51 ' CZ ' HG13 ' A' ' 132' ' ' VAL . 27.3 p90 -88.03 -30.34 20.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.926 0.393 . . . . 71.400000000000006 110.939 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.51 HG13 ' CZ ' ' A' ' 131' ' ' TYR . 19.8 m -73.94 -30.33 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 63.100000000000001 111.096 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.813 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -56.33 -24.94 47.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 53.409999999999997 111.111 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.96 -30.97 37.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 74.099999999999994 110.872 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 64.5 t -56.83 -62.33 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 70.510000000000005 111.158 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 41.8 mm -71.64 -38.15 65.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 74.430000000000007 111.104 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.437 ' OD2' HD11 ' A' ' 141' ' ' LEU . 25.8 t0 -60.65 -30.46 69.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 64.140000000000001 110.859 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.18 -25.74 48.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 63.439999999999998 110.824 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 7.6 tt -68.87 -50.93 45.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 62.409999999999997 110.925 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -73.97 -36.08 64.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 64.549999999999997 110.849 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.625 HD13 ' CE1' ' A' ' 51' ' ' TYR . 9.9 mt -52.21 -33.76 42.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 64.549999999999997 110.948 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -61.21 -48.38 81.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.451 . . . . 73.329999999999998 110.895 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.757 ' O ' HG23 ' A' ' 147' ' ' VAL . 39.0 mt -75.6 -31.98 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 54.539999999999999 111.128 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -56.0 -56.72 17.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 75.030000000000001 110.888 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 141' ' ' LEU . 22.8 t -57.65 -35.7 51.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 75.030000000000001 111.089 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -66.79 -32.98 74.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 75.549999999999997 110.892 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 143' ' ' ILE . 90.5 t -61.99 -34.0 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 72.209999999999994 111.151 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 49.7 m -63.24 -52.02 63.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 54.409999999999997 110.861 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.493 ' HB ' HD12 ' A' ' 153' ' ' ILE . 27.3 m -71.48 -35.56 57.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 72.430000000000007 111.119 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -67.45 -41.15 85.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 74.319999999999993 110.889 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.44 -33.25 39.76 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.754 -0.736 . . . . 71.530000000000001 112.485 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.7 m -76.48 -52.86 8.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.738 0.304 . . . . 71.140000000000001 111.141 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.493 HD12 ' HB ' ' A' ' 149' ' ' VAL . 7.9 mt -76.48 -24.5 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 72.129999999999995 111.185 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.01 -49.39 78.99 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.698 -0.763 . . . . 73.049999999999997 112.434 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -31.96 55.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.813 0.34 . . . . 55.340000000000003 110.853 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 20.4 t80 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 61.100000000000001 110.871 -179.958 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.188 0 CA-C-O 120.845 0.269 . . . . 62.119999999999997 112.335 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 pp -51.97 -30.88 26.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 54.450000000000003 110.873 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -79.28 -33.35 43.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 71.519999999999996 110.885 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -72.33 -46.44 55.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 75.140000000000001 110.913 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -59.78 -40.12 87.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 63.409999999999997 111.186 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.448 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.21 -29.06 21.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 75.049999999999997 111.149 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -55.66 -27.14 48.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 35.439999999999998 110.884 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.455 HD21 HG21 ' A' ' 80' ' ' ILE . 4.1 mm? -91.31 -18.74 23.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 73.310000000000002 110.913 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.41 ' O ' HG12 ' A' ' 40' ' ' VAL . 45.8 mm -76.43 -35.25 26.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 70.129999999999995 111.125 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.55 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.76 -57.14 23.16 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.626 0.727 . . . . 75.109999999999999 111.153 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.6 Cg_endo -69.75 -21.94 32.82 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.705 2.27 . . . . 75.430000000000007 112.306 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.618 ' O ' HG22 ' A' ' 42' ' ' ILE . 42.7 t -76.01 -45.59 33.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 61.200000000000003 110.9 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 36' ' ' ILE . 9.3 p -81.52 -28.91 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 73.019999999999996 111.149 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mt -51.02 -33.92 27.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 74.5 110.923 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.71 -34.68 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 64.230000000000004 111.103 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 p -65.69 -40.68 92.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 72.310000000000002 111.141 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.01 -44.38 67.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 75.409999999999997 110.9 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.9 tp -75.3 -40.41 58.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 73.340000000000003 110.949 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.97 -36.53 70.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 73.230000000000004 111.1 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.414 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.2 mp -64.93 -32.31 57.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 72.209999999999994 111.112 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 tp -55.28 -33.82 63.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 70.299999999999997 110.893 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.1 m -101.64 -36.66 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 72.019999999999996 111.138 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -71.7 -64.93 0.83 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 72.310000000000002 110.87 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.678 ' CZ ' HD13 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -69.46 -58.74 3.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.486 . . . . 75.430000000000007 110.903 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 mp -77.03 160.69 75.65 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.629 0.728 . . . . 74.439999999999998 110.873 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 146.69 61.07 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.722 2.281 . . . . 64.109999999999999 112.329 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -178.22 74.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 65.140000000000001 110.841 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 53.91 -172.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.154 -0.475 . . . . 64.209999999999994 110.861 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 95.5 m -120.45 -54.8 2.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 72.549999999999997 110.904 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.32 -57.43 13.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.743 . . . . 73.439999999999998 112.502 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -52.08 -34.97 46.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.361 . . . . 65.329999999999998 110.846 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.97 -48.21 67.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 74.340000000000003 110.92 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 29.4 ttm -62.34 -52.06 65.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 74.25 110.866 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.7 p -58.02 -27.06 63.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 63.340000000000003 111.107 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.648 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -75.87 -34.19 60.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.29 -0.413 . . . . 73.209999999999994 110.886 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 90.2 m -70.96 -51.89 23.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 54.119999999999997 110.845 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 15.8 tt -63.24 -35.29 71.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 65.329999999999998 111.134 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.5 t -63.54 -25.46 68.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 74.329999999999998 110.847 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 62' ' ' LEU . 83.6 t -57.95 -36.15 54.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 62.140000000000001 111.08 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.87 -28.83 24.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 73.310000000000002 110.926 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.493 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.24 -38.98 78.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 73.340000000000003 110.924 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.56 -29.95 70.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 54.340000000000003 111.136 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.607 HD13 HG11 ' A' ' 102' ' ' VAL . 9.4 mt -65.16 -54.71 25.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 73.319999999999993 110.945 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.7 -38.56 88.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 74.120000000000005 111.149 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 68' ' ' LEU . 82.2 t -71.5 -32.91 47.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 74.120000000000005 111.105 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.446 ' O ' HG22 ' A' ' 77' ' ' ILE . 28.0 t80 -51.86 -30.55 24.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 70.209999999999994 110.859 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.624 HD11 HD11 ' A' ' 95' ' ' LEU . 0.3 OUTLIER -75.02 -39.24 61.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 74.329999999999998 110.892 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.07 -39.38 65.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 72.340000000000003 110.901 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.4 tt -66.46 -55.06 17.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 72.129999999999995 110.918 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 73' ' ' PHE . 1.1 tt -57.04 -30.6 34.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 73.430000000000007 111.13 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.5 t -80.22 -23.36 40.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 74.030000000000001 110.83 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.685 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.4 OUTLIER -69.63 -12.9 62.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 72.319999999999993 110.895 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.455 HG21 HD21 ' A' ' 35' ' ' LEU . 2.2 pp -56.41 -24.53 18.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 75.209999999999994 111.088 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 79' ' ' LYS . 21.8 t 63.68 75.21 0.4 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.649 0.737 . . . . 60.520000000000003 111.173 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 167.55 24.2 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.638 2.226 . . . . 60.520000000000003 112.352 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -48.63 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.694 2.263 . . . . 61.530000000000001 112.356 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.4 t -117.22 -19.88 9.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 70.019999999999996 111.07 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.76 47.02 3.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 72.540000000000006 110.858 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 tp -99.27 26.05 6.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 71.219999999999999 110.91 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.631 ' HA ' HD23 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -99.91 23.68 9.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 74.519999999999996 110.845 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.542 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.74 -57.79 9.32 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.66 0.743 . . . . 71.049999999999997 111.152 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.7 Cg_endo -69.81 -20.0 35.18 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.664 2.243 . . . . 72.519999999999996 112.35 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.631 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.19 -53.09 10.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 63.43 110.911 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.519 HG12 HD21 ' A' ' 95' ' ' LEU . 24.9 t -80.68 -33.69 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 70.219999999999999 111.125 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.82 -52.21 35.63 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.734 -0.746 . . . . 75.030000000000001 112.466 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -35.35 80.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 73.409999999999997 110.882 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -60.32 -36.98 79.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.438 . . . . 75.099999999999994 110.923 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.624 HD11 HD11 ' A' ' 74' ' ' LEU . 9.5 mt -51.91 -29.75 21.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 75.030000000000001 110.915 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 4.1 mmt -67.67 -42.86 81.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 73.430000000000007 110.921 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.501 ' O ' HG22 ' A' ' 100' ' ' VAL . 4.4 t80 -75.29 -52.47 10.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 61.200000000000003 110.849 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.785 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.1 -29.87 33.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 75.109999999999999 111.135 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.71 -30.08 70.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 73.340000000000003 110.913 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.73 -30.05 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 73.450000000000003 111.103 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.785 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -74.96 -33.25 61.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 54.25 110.893 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.607 HG11 HD13 ' A' ' 70' ' ' LEU . 31.1 m -76.93 -37.96 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 72.239999999999995 111.095 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.603 ' HA ' HD12 ' A' ' 106' ' ' ILE . 61.3 m -72.45 -41.37 66.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 72.400000000000006 111.116 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -61.67 -32.02 72.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 72.329999999999998 110.873 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -32.58 69.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 63.329999999999998 110.843 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' A' ' 103' ' ' THR . 12.3 mt -74.41 -51.77 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 74.310000000000002 111.165 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.558 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.3 p -53.95 -33.93 24.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 73.310000000000002 111.158 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 91.8 m -52.36 -32.4 38.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 63.439999999999998 111.131 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.34 -31.74 15.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 74.120000000000005 110.874 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.5 p -52.72 -32.83 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.492 . . . . 62.439999999999998 111.114 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 47.5 m -65.23 -43.53 91.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 64.230000000000004 110.881 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.5 t -76.82 -35.77 24.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 71.439999999999998 111.161 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.3 mt -72.14 -31.13 65.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 75.109999999999999 110.882 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -64.73 -29.46 70.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 64.230000000000004 110.87 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.76 HG11 ' HB2' ' A' ' 133' ' ' ALA . 10.8 p -102.24 -20.91 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 73.120000000000005 111.102 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -79.18 -74.55 0.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 72.140000000000001 110.853 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 74.409999999999997 110.876 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.391 0 N-CA-C 112.523 -0.231 . . . . 74.340000000000003 112.523 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -71.43 -26.93 62.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.897 0.379 . . . . 71.409999999999997 110.915 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.62 ' O ' HG22 ' A' ' 135' ' ' VAL . 34.8 m -55.8 -26.96 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 52.539999999999999 111.139 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.76 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -55.99 -24.84 41.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 61.200000000000003 111.069 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.1 mtt -52.66 -31.0 34.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 63.32 110.889 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 132' ' ' VAL . 17.7 m -59.55 -30.55 44.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 74.219999999999999 111.156 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 28.2 mt -74.15 -47.38 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 73.319999999999993 111.163 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -69.66 -29.95 67.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 65.310000000000002 110.839 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.1 mtm-85 -55.87 -25.64 43.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 71.530000000000001 110.838 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.6 mt -71.02 -50.99 28.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 60.329999999999998 110.887 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -73.82 -27.13 60.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 55.32 110.853 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.678 HD13 ' CZ ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -51.93 -36.8 50.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.17 -0.468 . . . . 65.010000000000005 110.884 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -53.03 -52.01 59.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 63.329999999999998 110.905 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.735 ' O ' HG23 ' A' ' 147' ' ' VAL . 3.4 mt -77.02 -37.74 26.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 72.109999999999999 111.17 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -56.01 -56.96 14.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 73.109999999999999 110.915 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 141' ' ' LEU . 42.7 t -56.67 -34.97 43.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 73.439999999999998 111.165 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -68.48 -34.95 76.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 75.439999999999998 110.882 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 143' ' ' ILE . 93.5 t -55.58 -41.62 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 73.310000000000002 111.133 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 98.6 m -52.02 -48.23 64.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 74.340000000000003 110.9 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.461 ' O ' HG22 ' A' ' 153' ' ' ILE . 43.6 t -75.69 -36.9 34.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 54.130000000000003 111.122 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.31 -26.85 61.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 75.200000000000003 110.903 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.15 -59.07 2.48 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.696 -0.764 . . . . 50.109999999999999 112.455 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 4.6 t -55.3 -41.78 72.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.741 0.305 . . . . 22.440000000000001 111.092 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.461 HG22 ' O ' ' A' ' 149' ' ' VAL . 18.7 tt -63.06 -26.29 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 74.420000000000002 111.141 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -51.98 -49.82 47.36 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.767 -0.73 . . . . 63.409999999999997 112.47 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 22.7 mmt -71.57 -31.9 67.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.828 0.347 . . . . 74.409999999999997 110.878 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 72.340000000000003 110.903 -179.959 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo . . . . . 0 C--O 1.232 0.188 0 CA-C-O 120.883 0.285 . . . . 64.340000000000003 112.376 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.92 -30.94 65.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 74.310000000000002 110.873 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -78.18 -31.84 49.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 74.200000000000003 110.84 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.668 ' CE1' HG22 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -73.66 -44.91 55.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 74.510000000000005 110.926 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.6 t -60.56 -39.78 89.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 53.130000000000003 111.14 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.12 -29.12 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 74.010000000000005 111.118 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.13 -27.05 52.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 55.210000000000001 110.909 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.522 ' CD1' HD22 ' A' ' 76' ' ' LEU . 4.1 mm? -91.25 -19.28 23.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 70.239999999999995 110.925 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.3 mm -76.84 -34.58 22.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 63.119999999999997 111.118 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.551 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.75 -57.18 22.9 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.629 0.728 . . . . 74.120000000000005 111.112 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.8 Cg_endo -69.74 -20.47 34.9 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.663 2.242 . . . . 60.130000000000003 112.356 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.631 ' O ' HG22 ' A' ' 42' ' ' ILE . 49.3 t -75.94 -44.42 40.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 61.329999999999998 110.87 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.2 p -81.57 -28.93 10.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 73.010000000000005 111.104 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.5 mt -50.99 -33.94 26.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 75.230000000000004 110.917 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.631 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.74 -34.69 52.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 64.329999999999998 111.1 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.82 -36.79 84.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 71.209999999999994 111.121 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.07 -52.65 60.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 71.510000000000005 110.862 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.1 tp -68.91 -40.51 79.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 73.239999999999995 110.922 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.93 -51.38 69.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 70.239999999999995 111.101 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.13 -31.85 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 74.25 111.141 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.558 ' O ' HD13 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -51.68 -38.1 53.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 73.239999999999995 110.926 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.7 p -101.6 -37.17 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 74.340000000000003 111.175 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -67.43 -63.28 1.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 71.209999999999994 110.86 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.39 -26.01 38.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 75.420000000000002 110.946 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 48' ' ' LEU . 4.2 mp -76.78 160.65 76.29 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.596 0.712 . . . . 54.530000000000001 110.907 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 78.84 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.704 2.27 . . . . 73.019999999999996 112.339 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.7 t -165.8 151.69 9.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 54.520000000000003 110.848 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -161.16 26.14 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 74.310000000000002 110.85 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 30.3 p -65.97 -170.24 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 54.210000000000001 110.86 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.99 -43.73 72.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.723 -0.751 . . . . 64.200000000000003 112.488 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -53.04 -41.27 64.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.93 0.395 . . . . 72.040000000000006 110.929 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -59.28 -45.21 91.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 73.510000000000005 110.894 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 33.4 ttm -63.92 -51.68 63.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 53.229999999999997 110.902 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 80.8 p -54.08 -34.82 61.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 71.519999999999996 111.135 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.533 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -65.64 -50.33 65.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 74.310000000000002 110.921 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 59.4 m -53.87 -51.96 62.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 62.030000000000001 110.886 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.6 tt -67.37 -35.06 72.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 73.329999999999998 111.095 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 m -60.26 -26.01 66.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 75.019999999999996 110.911 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 62' ' ' LEU . 41.6 t -57.97 -38.52 67.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 51.340000000000003 111.139 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.88 -28.9 25.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 71.200000000000003 110.913 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.493 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.03 -39.34 79.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 74.040000000000006 110.945 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.27 -29.98 70.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 74.5 111.081 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.529 HD22 HG11 ' A' ' 102' ' ' VAL . 10.1 mt -64.82 -54.74 26.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 62.039999999999999 110.908 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.97 -38.08 87.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 63.409999999999997 111.127 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 68' ' ' LEU . 75.0 t -71.45 -32.91 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 54.420000000000002 111.094 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -60.13 -29.88 68.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 75.409999999999997 110.901 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.568 HD11 HD13 ' A' ' 95' ' ' LEU . 1.7 tt -73.25 -44.17 59.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.124 -0.489 . . . . 74.450000000000003 110.89 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.4 mt -73.35 -33.04 64.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 72.120000000000005 110.918 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.545 HD23 ' HD2' ' A' ' 79' ' ' LYS . 1.6 tt -68.87 -55.14 12.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 73.319999999999993 110.882 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.442 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.6 OUTLIER -56.93 -23.38 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 74.25 111.16 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.5 t -70.03 -14.69 62.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 71.420000000000002 110.882 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.745 ' O ' HG23 ' A' ' 81' ' ' VAL . 12.6 ptmt -62.17 -17.04 56.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 53.530000000000001 110.893 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.668 HG22 ' CE1' ' A' ' 31' ' ' TYR . 24.7 pt -50.37 -31.4 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 75.349999999999994 111.099 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 79' ' ' LYS . 66.7 t 56.73 80.33 0.29 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.635 0.731 . . . . 63.420000000000002 111.137 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 166.8 26.3 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.735 2.29 . . . . 75.310000000000002 112.358 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -49.14 0.59 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.658 2.239 . . . . 74.049999999999997 112.374 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.1 t -135.67 22.2 3.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 63.340000000000003 111.153 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.7 t 52.17 48.57 22.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 64.200000000000003 110.856 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tp -95.55 24.65 5.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 61.219999999999999 110.915 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.635 ' HA ' HD23 ' A' ' 90' ' ' LEU . 3.3 m-20 -110.92 25.85 11.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 73.230000000000004 110.894 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.533 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.03 -57.82 10.45 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.664 0.745 . . . . 72.129999999999995 111.092 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.539 ' HG2' HD22 ' A' ' 90' ' ' LEU . 53.9 Cg_endo -69.72 -20.59 34.84 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.661 2.241 . . . . 63.539999999999999 112.392 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.635 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.19 -53.07 10.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 74.099999999999994 110.978 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.07 -36.54 16.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 74.540000000000006 111.096 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.21 -40.43 52.35 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.768 -0.729 . . . . 61.149999999999999 112.475 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -67.66 -24.6 65.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 65.209999999999994 110.865 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -78.04 -44.3 26.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 75.340000000000003 110.971 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.568 HD13 HD11 ' A' ' 74' ' ' LEU . 10.0 mt -55.45 -29.72 59.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 73.140000000000001 110.923 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.38 -43.26 77.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 74.239999999999995 110.847 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.503 ' O ' HG22 ' A' ' 100' ' ' VAL . 39.1 t80 -75.29 -51.85 12.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 75.319999999999993 110.941 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.776 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.12 -29.87 33.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 72.200000000000003 111.165 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.1 mmt -66.69 -30.11 70.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 73.109999999999999 110.875 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.76 -30.09 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 75.049999999999997 111.116 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.776 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.89 -33.27 62.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 75.430000000000007 110.884 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.529 HG11 HD22 ' A' ' 70' ' ' LEU . 31.1 m -76.87 -38.1 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 63.350000000000001 111.159 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 73.9 m -72.46 -39.77 67.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 53.240000000000002 111.143 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -64.87 -31.99 73.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 73.510000000000005 110.843 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.9 t -72.57 -35.25 67.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 60.210000000000001 110.857 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 36.8 mt -72.55 -51.36 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 72.420000000000002 111.099 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.549 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.5 p -53.97 -36.41 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 74.540000000000006 111.097 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 94.7 m -52.42 -32.4 39.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 74.310000000000002 111.099 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.9 p -50.44 -31.4 14.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 55.539999999999999 110.826 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.4 p -52.45 -32.82 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 63.219999999999999 111.106 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 31.0 m -65.81 -43.17 89.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 73.409999999999997 110.895 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.8 t -77.02 -35.45 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 74.439999999999998 111.145 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 87.5 mt -71.99 -32.98 67.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 74.109999999999999 110.906 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -59.71 -31.24 69.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 65.400000000000006 110.881 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.769 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.7 p -102.29 -23.96 4.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 74.510000000000005 111.135 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -77.04 -26.17 53.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 71.439999999999998 110.833 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 75.310000000000002 110.827 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.524 -0.23 . . . . 32.420000000000002 112.524 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -86.37 -26.79 24.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 70.019999999999996 110.882 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.6 m -54.4 -26.91 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 71.409999999999997 111.124 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.769 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -55.22 -26.04 36.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 54.229999999999997 111.066 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 6.4 ptm -52.99 -30.94 38.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 74.439999999999998 110.89 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 62.8 t -56.96 -58.95 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 72.230000000000004 111.092 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.8 mt -73.96 -37.78 48.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 71.319999999999993 111.14 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -61.25 -30.01 70.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 62.210000000000001 110.851 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.01 -29.02 26.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 61.420000000000002 110.9 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.52 -48.3 70.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 72.319999999999993 110.925 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -73.69 -41.77 62.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 42.450000000000003 110.824 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.615 ' O ' HG23 ' A' ' 145' ' ' VAL . 0.4 OUTLIER -52.07 -32.7 35.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 54.450000000000003 110.933 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 23.7 m0 -61.85 -51.98 65.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 54.43 110.906 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.681 ' O ' HG23 ' A' ' 147' ' ' VAL . 66.6 mt -71.21 -32.05 46.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 55.43 111.175 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -56.33 -40.76 74.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 65.340000000000003 110.858 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 141' ' ' LEU . 21.8 t -73.63 -44.97 52.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 72.019999999999996 111.101 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.4 -40.73 62.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 72.219999999999999 110.851 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 143' ' ' ILE . 65.5 t -54.34 -33.96 27.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 60.409999999999997 111.119 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 72.0 m -52.06 -51.96 54.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.191 -0.459 . . . . 54.25 110.871 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.91 -33.7 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 72.010000000000005 111.143 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -52.38 -40.57 62.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 74.109999999999999 110.902 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.76 -44.24 8.52 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.771 -0.728 . . . . 72.349999999999994 112.506 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 35.1 m -51.85 -52.85 46.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 51.32 111.163 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 47.5 mm -76.52 -24.92 16.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 52.43 111.16 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -53.92 -49.9 56.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 74.439999999999998 112.513 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -31.95 73.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.825 0.345 . . . . 64.340000000000003 110.894 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 23.1 t80 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 65.040000000000006 110.881 -179.971 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.839 0.266 . . . . 72.329999999999998 112.343 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 pp -52.06 -30.91 27.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 71.5 110.92 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -79.08 -33.17 44.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 61.020000000000003 110.9 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.45 -46.0 56.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 74.409999999999997 110.938 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -60.03 -39.97 87.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 71.140000000000001 111.182 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.442 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.24 -29.05 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 53.020000000000003 111.132 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.87 -27.19 50.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 72.129999999999995 110.89 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.23 -19.14 23.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 64.219999999999999 110.894 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.52 HD12 HG23 ' A' ' 152' ' ' THR . 45.7 mm -76.77 -34.73 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 62.119999999999997 111.138 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.545 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.7 -57.15 22.91 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.62 0.724 . . . . 73.409999999999997 111.09 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.9 Cg_endo -69.73 -22.83 31.68 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.655 2.237 . . . . 50.210000000000001 112.377 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.627 ' O ' HG22 ' A' ' 42' ' ' ILE . 49.6 t -76.08 -46.49 28.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 72.349999999999994 110.825 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 36' ' ' ILE . 8.7 p -81.6 -28.78 10.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 72.25 111.117 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.6 mt -50.93 -33.99 26.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 72.230000000000004 110.932 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.627 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.68 -34.71 52.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 71.140000000000001 111.119 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.7 p -66.04 -38.55 88.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 74.530000000000001 111.147 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.8 m -52.92 -53.77 44.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.229 -0.442 . . . . 75.439999999999998 110.897 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tp -67.55 -39.47 84.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 52.420000000000002 110.954 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.99 74.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 43.329999999999998 111.142 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.422 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.3 mp -64.93 -32.47 58.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 72.230000000000004 111.104 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.6 tp -53.76 -34.61 59.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 75.140000000000001 110.887 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.585 HG23 ' HB2' ' A' ' 55' ' ' ASP . 7.1 p -102.26 -36.59 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 74.439999999999998 111.145 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.48 -64.92 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 74.540000000000006 110.891 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.629 ' CD2' HD22 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -69.27 -62.3 1.44 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.099 -0.5 . . . . 74.019999999999996 110.956 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.6 mp -63.47 160.09 45.54 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.587 0.708 . . . . 61.240000000000002 110.932 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -168.54 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.687 2.258 . . . . 73.519999999999996 112.349 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.88 154.53 0.07 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 72.510000000000005 110.856 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.585 ' HB2' HG23 ' A' ' 49' ' ' VAL . 43.8 m-20 53.01 88.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 73.129999999999995 110.813 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 94.5 m -88.71 -69.61 0.7 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 62.240000000000002 110.831 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.95 -32.0 59.0 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.708 -0.758 . . . . 41.32 112.493 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -51.97 -34.97 44.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.9 0.381 . . . . 75.409999999999997 110.924 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -52.98 -48.79 67.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 73.030000000000001 110.906 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.4 ttm -57.83 -51.78 68.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 75.099999999999994 110.892 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.4 p -61.95 -28.34 69.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 64.010000000000005 111.111 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.747 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -75.81 -50.78 14.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 74.239999999999995 110.931 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 71.4 m -52.96 -42.19 65.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 73.329999999999998 110.895 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.7 tt -73.37 -34.95 44.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 51.200000000000003 111.127 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.9 t -69.14 -25.85 64.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 71.319999999999993 110.841 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 62' ' ' LEU . 99.5 t -57.95 -34.6 49.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 72.420000000000002 111.12 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -52.89 -28.91 25.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 71.420000000000002 110.891 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.493 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.37 -38.92 78.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 72.200000000000003 110.95 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.6 -29.94 70.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 72.5 111.105 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.766 HD22 HG11 ' A' ' 102' ' ' VAL . 9.5 mt -65.08 -54.79 24.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 72.109999999999999 110.86 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.71 -38.38 87.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 74.25 111.173 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 68' ' ' LEU . 79.3 t -71.48 -32.83 47.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 55.109999999999999 111.109 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -51.94 -30.0 22.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 74.420000000000002 110.855 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.08 -41.71 61.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 74.450000000000003 110.88 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.9 mt -73.2 -34.78 66.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 70.530000000000001 110.91 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.443 HD13 ' HD2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -69.31 -55.09 11.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 74.319999999999993 110.885 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.6 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -56.19 -25.0 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 52.109999999999999 111.117 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.6 -14.9 63.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 63.119999999999997 110.851 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.757 ' O ' HG23 ' A' ' 81' ' ' VAL . 2.2 ptmm? -59.23 -20.76 56.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 72.25 110.884 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 77' ' ' ILE . 36.8 pt -51.55 -29.38 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 74.319999999999993 111.108 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 79' ' ' LYS . 60.2 t 60.87 77.54 0.36 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.589 0.709 . . . . 55.200000000000003 111.112 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 167.57 24.06 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.714 2.276 . . . . 75.310000000000002 112.356 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -48.76 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.657 2.238 . . . . 71.540000000000006 112.33 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.5 t -131.73 9.89 4.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 73.420000000000002 111.179 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.73 52.74 13.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 61.409999999999997 110.82 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.89 25.65 4.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 73.25 110.91 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.636 ' HA ' HD23 ' A' ' 90' ' ' LEU . 1.5 m-20 -104.3 23.71 12.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 75.439999999999998 110.87 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.542 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.37 -57.84 9.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.63 0.728 . . . . 63.030000000000001 111.133 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.3 Cg_endo -69.75 -20.35 35.01 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.716 2.277 . . . . 73.239999999999995 112.337 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.636 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.17 -53.02 10.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 72.219999999999999 110.937 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.573 HG12 HD21 ' A' ' 95' ' ' LEU . 24.6 t -80.75 -32.87 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 70.140000000000001 111.114 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.72 -52.1 35.69 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.707 -0.759 . . . . 55.549999999999997 112.476 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -35.01 79.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.778 0.323 . . . . 75.129999999999995 110.883 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -61.22 -36.61 80.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 75.129999999999995 110.906 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.573 HD21 HG12 ' A' ' 91' ' ' VAL . 9.2 mt -51.82 -29.87 21.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 71.25 110.924 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -69.25 -43.63 73.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 75.040000000000006 110.864 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.506 ' O ' HG22 ' A' ' 100' ' ' VAL . 72.4 t80 -75.26 -51.26 13.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 75.140000000000001 110.867 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.808 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.05 -29.86 32.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 74.420000000000002 111.157 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.8 mmt -66.6 -30.24 70.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 71.439999999999998 110.859 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.67 -29.97 13.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 61.229999999999997 111.097 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.808 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -75.23 -33.49 61.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 72.109999999999999 110.903 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.766 HG11 HD22 ' A' ' 70' ' ' LEU . 29.3 m -77.53 -39.65 27.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 74.519999999999996 111.104 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.719 ' HA ' HD12 ' A' ' 106' ' ' ILE . 2.9 t -72.55 -32.3 65.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 70.329999999999998 111.082 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -56.83 -35.14 68.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 62.219999999999999 110.861 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.4 t -75.02 -32.59 61.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 73.120000000000005 110.882 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.719 HD12 ' HA ' ' A' ' 103' ' ' THR . 9.3 mt -75.16 -51.3 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 71.319999999999993 111.092 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.542 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.5 p -53.99 -35.87 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 75.430000000000007 111.101 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.7 m -52.42 -32.36 38.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 74.319999999999993 111.135 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.2 t -50.33 -31.58 14.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 74.450000000000003 110.822 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.2 p -52.5 -32.77 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 71.409999999999997 111.124 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 35.5 m -66.2 -47.55 73.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 52.200000000000003 110.915 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.2 t -72.1 -36.09 55.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.475 . . . . 75.230000000000004 111.137 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.5 mt -72.04 -33.31 67.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 75.329999999999998 110.927 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -59.82 -30.72 69.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 74.400000000000006 110.906 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.777 HG11 ' HB2' ' A' ' 133' ' ' ALA . 9.4 p -102.26 -23.83 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 73.329999999999998 111.15 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 -85.44 -70.37 0.59 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 64.349999999999994 110.858 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.1 t60 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 73.230000000000004 110.869 179.965 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.478 -0.249 . . . . 75.5 112.478 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -87.89 -26.07 22.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.964 0.412 . . . . 73.420000000000002 110.947 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.3 m -54.35 -26.93 16.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.077 -0.511 . . . . 75.329999999999998 111.083 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.777 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -55.96 -25.05 41.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 73.319999999999993 111.091 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.94 -30.84 36.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 70.129999999999995 110.912 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 91.5 t -57.09 -59.31 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 75.450000000000003 111.08 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 65.1 mt -73.97 -35.26 41.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 73.140000000000001 111.137 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -62.98 -30.16 71.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 54.140000000000001 110.843 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -53.78 -28.23 33.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 61.240000000000002 110.881 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.8 mp -67.36 -48.91 66.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 73.120000000000005 110.888 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -73.67 -47.47 39.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 73.319999999999993 110.892 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.629 HD22 ' CD2' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -51.92 -49.74 62.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.483 . . . . 61.329999999999998 110.944 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -53.22 -32.3 47.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 75.420000000000002 110.94 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.697 ' O ' HG23 ' A' ' 147' ' ' VAL . 63.8 mt -76.99 -42.33 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 74.439999999999998 111.118 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -56.17 -57.01 13.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 75.099999999999994 110.938 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 31.1 t -54.15 -37.08 34.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 74.319999999999993 111.118 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -70.01 -44.04 70.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 73.219999999999999 110.854 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 143' ' ' ILE . 91.1 t -63.52 -34.09 65.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 73.150000000000006 111.158 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 17.2 m -51.85 -44.23 63.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 72.409999999999997 110.907 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.459 HG12 HD12 ' A' ' 153' ' ' ILE . 26.5 t -75.84 -33.19 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 70.409999999999997 111.097 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -58.8 -54.63 44.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 73.439999999999998 110.882 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -68.42 -19.4 72.58 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 50.229999999999997 112.512 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.52 HG23 HD12 ' A' ' 36' ' ' ILE . 33.1 m -75.64 -52.83 9.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.754 0.311 . . . . 62.409999999999997 111.172 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.459 HD12 HG12 ' A' ' 149' ' ' VAL . 49.3 mt -76.5 -27.5 17.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 65.109999999999999 111.132 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -53.65 -49.55 57.27 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.725 -0.75 . . . . 62.100000000000001 112.533 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -31.89 67.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 75.129999999999995 110.906 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 71.6 t80 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 73.329999999999998 110.877 -179.96 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.232 0.19 0 CA-C-O 120.828 0.262 . . . . 72.129999999999995 112.358 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 pp -52.16 -31.0 29.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 70.230000000000004 110.93 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -81.0 -31.95 34.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 75.140000000000001 110.865 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -72.51 -46.1 56.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 71.409999999999997 110.896 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 t -59.83 -40.17 87.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 73.409999999999997 111.146 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.26 -29.11 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 71.239999999999995 111.105 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -55.59 -27.0 46.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 73.409999999999997 110.899 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.672 ' HG ' HD12 ' A' ' 77' ' ' ILE . 4.1 mm? -91.51 -18.95 23.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 53.039999999999999 110.947 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.8 mm -76.53 -35.17 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 72.430000000000007 111.103 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.53 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.3 mm -55.68 -57.15 22.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.609 0.718 . . . . 71.430000000000007 111.125 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.78 -21.4 33.45 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.67 2.247 . . . . 73.030000000000001 112.323 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.641 ' O ' HG22 ' A' ' 42' ' ' ILE . 43.0 t -71.33 -45.36 63.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 65.400000000000006 110.912 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 p -81.62 -28.94 10.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 74.25 111.091 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 mt -50.95 -33.91 26.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 74.439999999999998 110.915 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.641 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.77 -34.68 52.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 74.409999999999997 111.145 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.72 -39.81 91.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 54.229999999999997 111.145 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.95 -51.23 62.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 62.340000000000003 110.885 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.7 tp -70.68 -35.96 73.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 64.409999999999997 110.908 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.73 -38.84 82.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 42.140000000000001 111.075 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.3 mp -64.25 -32.03 55.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 53.039999999999999 111.15 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 tp -51.42 -38.74 55.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 74.030000000000001 110.944 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.747 HG21 ' HA ' ' A' ' 59' ' ' LYS . 7.8 p -101.48 -36.79 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 61.210000000000001 111.145 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -66.97 -64.59 0.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 73.409999999999997 110.926 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.732 ' CZ ' HD13 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -71.22 -25.98 62.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 74.439999999999998 110.924 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.6 mp -125.08 71.65 63.22 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.622 0.725 . . . . 74.420000000000002 110.9 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 173.27 11.19 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.748 2.299 . . . . 64.219999999999999 112.3 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.0 p -167.8 -170.27 1.34 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 70.209999999999994 110.876 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.0 95.71 10.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 72.140000000000001 110.839 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -179.1 138.78 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 71.109999999999999 110.841 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.33 -22.96 77.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.741 -0.743 . . . . 64.319999999999993 112.452 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -52.06 -34.94 45.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.932 0.396 . . . . 71.409999999999997 110.87 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.747 ' HA ' HG21 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -52.98 -51.57 61.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 72.420000000000002 110.905 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.8 ttm -65.41 -28.02 68.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 62.329999999999998 110.835 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.4 m -75.49 -31.65 60.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 44.140000000000001 111.148 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.606 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -68.45 -51.07 47.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 70.310000000000002 110.912 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -53.88 -48.01 70.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 62.229999999999997 110.887 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.6 tt -70.68 -34.95 58.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 71.420000000000002 111.119 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -61.52 -27.96 68.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 64.409999999999997 110.885 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 62' ' ' LEU . 60.2 t -57.93 -39.48 71.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 62.140000000000001 111.099 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -29.13 27.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 62.130000000000003 110.915 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.487 ' O ' HD22 ' A' ' 68' ' ' LEU . 2.1 tm? -74.56 -45.77 43.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 73.540000000000006 110.94 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.91 -29.59 20.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 70.219999999999999 111.086 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.517 HD22 HG11 ' A' ' 102' ' ' VAL . 37.3 mt -58.69 -54.46 46.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 62.229999999999997 110.91 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 68' ' ' LEU . 1.0 OUTLIER -62.31 -27.21 68.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 71.010000000000005 111.126 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 97.8 t -70.69 -33.05 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 75.400000000000006 111.154 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -64.7 -31.97 73.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 71.310000000000002 110.886 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.61 HD11 ' CD1' ' A' ' 95' ' ' LEU . 1.3 tp -75.1 -50.73 15.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 72.430000000000007 110.897 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.2 mp -65.84 -37.58 86.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 74.439999999999998 110.908 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.4 tt -62.63 -55.07 30.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 74.310000000000002 110.93 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.672 HD12 ' HG ' ' A' ' 35' ' ' LEU . 1.6 tt -66.31 -29.51 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 71.510000000000005 111.097 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.3 t -81.55 -14.78 56.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 110.822 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.461 ' O ' HG23 ' A' ' 81' ' ' VAL . 1.3 mmmt -93.67 -9.72 36.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 64.439999999999998 110.89 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.52 -16.88 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 71.319999999999993 111.122 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 79' ' ' LYS . 21.2 t 64.28 78.01 0.29 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.561 0.696 . . . . 54.420000000000002 111.118 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.402 ' HB3' ' HB2' ' A' ' 86' ' ' LEU . 53.3 Cg_endo -69.84 164.11 35.84 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.659 2.24 . . . . 62.109999999999999 112.355 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -49.3 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.745 2.296 . . . . 74.030000000000001 112.36 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 t -124.9 -35.32 2.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 73.129999999999995 111.153 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.24 -39.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 60.340000000000003 110.865 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 82' ' ' PRO . 8.2 tp 64.53 70.6 0.49 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 74.129999999999995 110.917 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.519 ' O ' HG23 ' A' ' 91' ' ' VAL . 4.0 m-20 50.15 60.17 4.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 55.409999999999997 110.894 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.533 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -68.62 -58.21 7.26 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.625 0.726 . . . . 60.329999999999998 111.114 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.587 ' HG2' HD22 ' A' ' 90' ' ' LEU . 53.4 Cg_endo -69.77 -26.02 27.98 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.673 2.248 . . . . 50.43 112.342 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.587 HD22 ' HG2' ' A' ' 89' ' ' PRO . 3.3 mm? -71.83 -39.81 69.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 60.409999999999997 110.916 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 87' ' ' ASP . 84.3 t -80.53 -41.85 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 72.200000000000003 111.164 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.0 -46.39 55.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.769 -0.729 . . . . 53.509999999999998 112.464 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -32.95 69.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.816 0.341 . . . . 73.209999999999994 110.896 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -62.25 -31.97 72.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 72.400000000000006 110.879 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.61 ' CD1' HD11 ' A' ' 74' ' ' LEU . 11.3 mt -53.17 -29.8 33.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 55.119999999999997 110.903 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -42.48 86.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 72.430000000000007 110.859 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.49 ' O ' HG22 ' A' ' 100' ' ' VAL . 24.5 t80 -75.26 -53.19 9.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 74.340000000000003 110.892 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.789 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.03 -29.93 32.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 75.400000000000006 111.165 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.1 mmt -66.61 -30.13 70.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 72.430000000000007 110.901 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.76 -30.1 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 64.409999999999997 111.116 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.789 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.92 -33.12 61.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 74.140000000000001 110.953 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.517 HG11 HD22 ' A' ' 70' ' ' LEU . 31.6 m -76.96 -37.99 27.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 73.299999999999997 111.118 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.437 ' O ' HG13 ' A' ' 107' ' ' VAL . 70.5 m -72.53 -39.68 67.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 74.400000000000006 111.153 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -64.73 -31.93 73.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 53.520000000000003 110.847 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.6 t -74.3 -33.92 63.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.461 . . . . 42.039999999999999 110.852 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.3 mt -74.93 -50.65 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 72.5 111.151 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 110' ' ' VAL . 34.7 m -54.15 -34.12 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 64.040000000000006 111.111 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.0 m -52.41 -32.45 39.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 74.010000000000005 111.188 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.4 m -50.42 -31.54 15.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 73.430000000000007 110.857 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.4 p -52.47 -32.8 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.496 . . . . 71.340000000000003 111.143 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 31.5 m -65.46 -43.17 91.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.143 -0.481 . . . . 63.039999999999999 110.846 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.3 t -77.12 -34.81 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 74.239999999999995 111.106 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.546 HD22 ' O ' ' A' ' 117' ' ' HIS . 85.1 mt -72.05 -33.11 67.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 73.099999999999994 110.917 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -59.68 -31.03 69.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 73.310000000000002 110.888 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.776 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.8 p -102.32 -24.24 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 74.340000000000003 111.139 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -94.24 -74.68 0.53 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.472 . . . . 75.129999999999995 110.897 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.546 ' O ' HD22 ' A' ' 113' ' ' LEU . 4.2 t-80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 44.310000000000002 110.897 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.47 -0.252 . . . . 71.329999999999998 112.47 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -87.87 -26.11 22.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.914 0.388 . . . . 71.409999999999997 110.932 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.8 -36.92 77.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 63.130000000000003 111.08 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.776 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -67.04 -25.8 66.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 74.010000000000005 111.123 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 30.4 mmt -52.96 -30.95 37.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 63.039999999999999 110.91 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 74.8 t -56.97 -59.02 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 42.43 111.134 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 136' ' ' ILE . 3.6 mp -74.01 -37.74 47.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 71.420000000000002 111.136 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -61.26 -29.94 70.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 73.420000000000002 110.896 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.08 -30.14 24.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 73.430000000000007 110.872 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.42 -42.24 68.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 74.319999999999993 110.933 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -74.0 -51.43 15.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 72.040000000000006 110.881 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.732 HD13 ' CZ ' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -52.03 -33.31 38.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 61.229999999999997 110.893 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 45.6 t-105 -61.8 -45.42 93.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.236 -0.438 . . . . 64.140000000000001 110.924 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.751 ' O ' HG23 ' A' ' 147' ' ' VAL . 50.8 mm -76.96 -32.87 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 72.129999999999995 111.135 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -56.07 -56.96 14.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 72.129999999999995 110.867 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.7 m -55.6 -35.0 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 72.239999999999995 111.146 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -69.72 -33.11 72.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 73.310000000000002 110.883 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 143' ' ' ILE . 82.0 t -67.62 -33.99 65.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 52.299999999999997 111.144 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 67.9 m -66.32 -46.41 77.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 61.219999999999999 110.874 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.532 ' O ' HG22 ' A' ' 152' ' ' THR . 43.4 t -76.03 -36.82 32.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 72.120000000000005 111.104 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.573 ' O ' HG22 ' A' ' 153' ' ' ILE . 68.5 t80 -71.87 -28.6 63.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 74.310000000000002 110.861 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -52.24 -27.75 24.81 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.754 -0.736 . . . . 54.140000000000001 112.468 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 149' ' ' VAL . 14.8 t -53.81 -32.01 51.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 63.109999999999999 111.155 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 150' ' ' PHE . 20.0 tt -55.89 -25.7 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 75.0 111.163 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -51.9 -49.93 46.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.723 -0.751 . . . . 61.020000000000003 112.507 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -73.92 -31.8 63.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.785 0.326 . . . . 72.450000000000003 110.825 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 77.4 t80 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.429 . . . . 75.109999999999999 110.906 -179.937 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.232 0.224 0 CA-C-O 120.794 0.248 . . . . 72.430000000000007 112.292 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.409 HD11 ' CE1' ' A' ' 30' ' ' PHE . 2.4 pp -52.0 -30.96 27.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 74.420000000000002 110.904 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.409 ' CE1' HD11 ' A' ' 29' ' ' LEU . 42.8 m-85 -78.98 -33.31 45.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 63.340000000000003 110.901 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -72.5 -46.19 55.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 74.510000000000005 110.922 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -59.98 -40.03 87.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.511 . . . . 75.239999999999995 111.125 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.11 -29.1 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 64.409999999999997 111.141 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.1 -26.87 51.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 60.210000000000001 110.866 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.616 ' HG ' HD12 ' A' ' 77' ' ' ILE . 4.1 mm? -91.51 -19.2 23.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 73.129999999999995 110.9 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mm -76.76 -34.86 23.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 63.329999999999998 111.087 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.539 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.1 mt -55.72 -57.12 23.15 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.6 0.714 . . . . 73.150000000000006 111.109 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.4 Cg_endo -69.8 -20.34 34.77 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.683 2.255 . . . . 72.019999999999996 112.337 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.635 ' O ' HG22 ' A' ' 42' ' ' ILE . 48.4 t -75.51 -44.26 44.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 62.109999999999999 110.869 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 p -81.54 -28.95 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 74.310000000000002 111.144 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.3 mt -50.97 -33.97 26.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 75.120000000000005 110.872 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.635 HG22 ' O ' ' A' ' 39' ' ' CYS . 0.7 OUTLIER -58.76 -34.66 52.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 64.510000000000005 111.121 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.83 -38.43 88.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.19 -0.459 . . . . 71.510000000000005 111.132 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.07 -49.08 67.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 65.409999999999997 110.849 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.0 tp -74.31 -36.02 63.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 73.439999999999998 110.938 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.48 -37.99 76.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 61.130000000000003 111.106 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.421 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.2 mp -64.9 -32.49 58.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 73.239999999999995 111.108 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 tp -55.07 -33.77 63.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 74.420000000000002 110.882 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.589 HG11 ' HG ' ' A' ' 62' ' ' LEU . 27.5 m -101.76 -36.73 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 73.319999999999993 111.126 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -71.43 -64.91 0.83 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 71.099999999999994 110.903 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.739 ' CZ ' HD13 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -68.98 -23.27 64.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 62.439999999999998 110.875 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.7 mp -128.05 73.6 79.3 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.634 0.73 . . . . 73.510000000000005 110.889 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 133.18 24.89 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.721 2.28 . . . . 75.329999999999998 112.351 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.2 m -87.08 -67.73 0.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 53.210000000000001 110.824 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.53 -75.14 0.59 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 73.030000000000001 110.841 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.45 -62.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 72.219999999999999 110.859 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.16 -62.93 5.26 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.751 -0.737 . . . . 71.200000000000003 112.477 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -51.94 -36.93 50.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 64.349999999999994 110.881 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -62.93 -44.06 97.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 75.109999999999999 110.882 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.0 tpt -72.06 -48.47 44.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 74.219999999999999 110.842 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 82.0 p -54.99 -26.15 34.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.424 . . . . 71.400000000000006 111.101 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.589 ' HG ' HG11 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -75.65 -37.4 59.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 63.329999999999998 110.874 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 35.0 m -74.01 -48.19 31.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 74.540000000000006 110.914 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.6 pt -54.92 -32.21 26.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 73.510000000000005 111.115 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.0 t -70.84 -25.14 62.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 71.239999999999995 110.838 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.1 t -57.94 -37.13 59.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 75.510000000000005 111.137 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mt -55.37 -29.7 58.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 50.140000000000001 110.907 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.485 ' O ' HD22 ' A' ' 68' ' ' LEU . 2.1 tm? -69.85 -45.44 67.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 73.329999999999998 110.872 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.07 -29.7 22.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 30.300000000000001 111.082 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.774 HD22 HG11 ' A' ' 102' ' ' VAL . 23.9 mt -59.81 -54.53 45.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 63.43 110.932 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 68' ' ' LEU . 0.8 OUTLIER -60.76 -27.16 67.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 62.5 111.148 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.1 t -70.32 -32.94 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 72.299999999999997 111.127 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.535 ' O ' HG22 ' A' ' 77' ' ' ILE . 1.8 t80 -61.66 -29.84 70.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 74.510000000000005 110.911 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.888 HD11 HD13 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -66.73 -50.3 63.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 73.25 110.903 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.4 -38.25 65.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 73.329999999999998 110.866 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.5 tt -58.03 -55.05 40.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 74.310000000000002 110.969 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.616 HD12 ' HG ' ' A' ' 35' ' ' LEU . 1.3 tt -66.62 -23.95 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 74.519999999999996 111.162 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.6 t -80.32 -17.96 50.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 64.019999999999996 110.817 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.752 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -68.55 -12.18 60.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 73.409999999999997 110.925 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.492 HG23 ' O ' ' A' ' 77' ' ' ILE . 47.7 pt -52.77 -28.04 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 73.239999999999995 111.151 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.752 HG23 ' O ' ' A' ' 79' ' ' LYS . 57.5 t 61.48 77.14 0.37 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.664 0.745 . . . . 72.510000000000005 111.117 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 167.28 24.89 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.681 2.254 . . . . 74.519999999999996 112.318 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -48.99 0.6 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.656 2.237 . . . . 63.420000000000002 112.369 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 t -134.82 18.49 3.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 73.140000000000001 111.106 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.2 m 51.73 64.55 1.8 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 52.420000000000002 110.845 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.15 24.96 11.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 74.430000000000007 110.877 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -115.05 25.48 10.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 71.209999999999994 110.861 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.537 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -65.15 -57.61 14.92 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.643 0.735 . . . . 74.519999999999996 111.121 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.6 Cg_endo -69.76 -21.4 33.53 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.676 2.25 . . . . 55.450000000000003 112.326 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.0 mp -73.41 -52.97 11.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 64.450000000000003 110.935 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.1 t -80.03 -42.86 22.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.458 . . . . 63.030000000000001 111.14 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.41 -38.05 49.83 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.784 -0.722 . . . . 50.030000000000001 112.46 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.35 -23.7 60.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.789 0.328 . . . . 52.329999999999998 110.9 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -76.15 -39.34 55.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 72.340000000000003 110.951 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.888 HD13 HD11 ' A' ' 74' ' ' LEU . 12.0 mt -55.68 -29.74 59.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.108 -0.496 . . . . 72.239999999999995 110.924 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.9 mmt -70.23 -42.57 72.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 72.219999999999999 110.896 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.506 ' O ' HG22 ' A' ' 100' ' ' VAL . 4.7 t80 -75.26 -51.09 14.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 74.209999999999994 110.863 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.804 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.23 -29.84 34.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 74.129999999999995 111.127 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.6 mmt -66.77 -30.01 70.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 72.120000000000005 110.877 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.81 -30.01 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 62.210000000000001 111.137 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.804 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -74.91 -33.12 61.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 52.520000000000003 110.916 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.774 HG11 HD22 ' A' ' 70' ' ' LEU . 30.2 m -76.55 -37.73 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 64.109999999999999 111.118 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.728 ' O ' HG23 ' A' ' 107' ' ' VAL . 53.7 m -72.7 -46.6 52.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 72.120000000000005 111.097 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.444 ' CE2' HG21 ' A' ' 147' ' ' VAL . 69.9 t80 -51.86 -31.26 27.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 71.319999999999993 110.894 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 m -73.86 -51.09 17.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 70.409999999999997 110.842 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 103' ' ' THR . 7.6 mt -54.76 -34.68 30.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 61.509999999999998 111.117 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 103' ' ' THR . 25.6 t -54.02 -45.73 64.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 63.039999999999999 111.103 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.6 m -52.3 -32.45 37.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 71.400000000000006 111.152 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.1 p -50.41 -31.36 14.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 65.319999999999993 110.855 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.6 p -52.45 -32.86 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 70.299999999999997 111.154 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 28.9 m -65.86 -47.35 75.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.468 . . . . 71.25 110.897 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.42 HG23 ' OD1' ' A' ' 137' ' ' ASP . 84.6 t -72.46 -36.28 54.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 73.340000000000003 111.121 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.1 mt -72.05 -32.72 67.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 65.129999999999995 110.93 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -60.98 -30.59 70.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 73.530000000000001 110.852 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.778 HG11 ' HB2' ' A' ' 133' ' ' ALA . 9.8 p -102.3 -23.2 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 72.120000000000005 111.126 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -109.37 117.7 34.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 73.510000000000005 110.886 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 16.7 t60 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.456 . . . . 73.120000000000005 110.855 -179.979 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.501 -0.24 . . . . 63.32 112.501 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -66.29 -39.96 89.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.944 0.402 . . . . 74.219999999999999 110.952 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 135' ' ' VAL . 34.7 m -54.72 -27.04 17.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 43.049999999999997 111.079 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.778 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -56.31 -25.33 48.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 61.32 111.094 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 37.1 mmt -53.01 -30.98 38.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 70.230000000000004 110.849 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 132' ' ' VAL . 52.6 t -56.94 -58.26 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 64.109999999999999 111.114 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 45.5 mm -74.06 -37.94 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 73.019999999999996 111.101 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.42 ' OD1' HG23 ' A' ' 112' ' ' VAL . 0.8 OUTLIER -58.73 -32.86 69.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 61.409999999999997 110.869 179.839 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.07 -26.02 59.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 73.349999999999994 110.895 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 16.1 tp -68.51 -50.88 48.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 74.150000000000006 110.939 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -73.23 -37.01 66.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 73.439999999999998 110.895 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.739 HD13 ' CZ ' ' A' ' 51' ' ' TYR . 3.5 mt -52.02 -33.31 37.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 73.400000000000006 110.885 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -74.31 -34.53 63.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.213 -0.449 . . . . 75.439999999999998 110.905 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.556 ' O ' HG23 ' A' ' 147' ' ' VAL . 36.0 mt -76.94 -32.01 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 72.150000000000006 111.101 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -56.05 -56.96 14.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 74.129999999999995 110.861 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.3 m -54.19 -34.99 28.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 41.240000000000002 111.132 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -67.34 -41.18 85.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 74.409999999999997 110.895 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 143' ' ' ILE . 87.9 t -62.18 -34.04 61.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 44.32 111.121 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 98.9 m -53.8 -39.07 65.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.14 -0.482 . . . . 74.450000000000003 110.89 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.9 t -75.46 -33.0 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 74.510000000000005 111.122 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.98 -54.7 26.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 63.140000000000001 110.92 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.42 -19.35 79.87 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.794 -0.717 . . . . 73.040000000000006 112.461 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 34.6 m -73.61 -52.83 12.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.806 0.336 . . . . 70.519999999999996 111.176 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 45.4 mm -76.51 -24.26 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 71.040000000000006 111.128 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -53.95 -48.51 62.26 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.767 -0.73 . . . . 71.120000000000005 112.472 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.21 -33.14 50.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.762 0.315 . . . . 72.439999999999998 110.881 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 72.099999999999994 110.867 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.797 0.249 . . . . 74.109999999999999 112.388 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.99 -30.94 65.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 62.140000000000001 110.886 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -77.7 -32.24 52.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 62.25 110.873 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -73.45 -44.98 56.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 72.349999999999994 110.91 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 t -60.71 -39.71 89.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.102 -0.499 . . . . 62.219999999999999 111.183 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.446 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.18 -29.07 21.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 51.200000000000003 111.097 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -56.0 -27.58 53.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 75.019999999999996 110.892 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.756 ' HG ' HD12 ' A' ' 77' ' ' ILE . 4.1 mm? -90.69 -18.42 25.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 52.210000000000001 110.908 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mm -76.79 -34.79 23.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 73.25 111.165 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.55 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.73 -57.16 22.94 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.61 0.719 . . . . 75.540000000000006 111.092 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.8 Cg_endo -69.75 -20.85 34.35 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.718 2.279 . . . . 52.539999999999999 112.335 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.626 ' O ' HG22 ' A' ' 42' ' ' ILE . 48.6 t -76.0 -44.69 38.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 71.349999999999994 110.859 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.5 -28.88 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 75.450000000000003 111.183 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mt -51.01 -34.01 27.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 73.430000000000007 110.909 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.626 HG22 ' O ' ' A' ' 39' ' ' CYS . 0.7 OUTLIER -58.64 -34.73 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 41.140000000000001 111.143 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.75 -41.15 92.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 74.519999999999996 111.13 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.01 -43.01 66.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 72.010000000000005 110.865 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 tp -76.59 -40.03 50.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 74.299999999999997 110.938 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.72 -51.46 69.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 61.439999999999998 111.075 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.442 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.4 mp -49.73 -31.44 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 73.540000000000006 111.136 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.0 tp -50.76 -42.22 57.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 74.219999999999999 110.943 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.7 HG23 ' CB ' ' A' ' 54' ' ' SER . 7.2 p -101.49 -37.48 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 75.230000000000004 111.145 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.493 ' HB3' HD21 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -63.68 -64.53 0.87 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 65.219999999999999 110.871 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.581 ' CD2' HD22 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -72.85 -62.0 1.61 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.484 . . . . 75.329999999999998 110.907 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.2 mp -67.89 160.67 72.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.599 0.714 . . . . 72.140000000000001 110.874 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 143.68 51.77 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.73 2.287 . . . . 51.310000000000002 112.329 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.7 ' CB ' HG23 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -155.17 -176.83 6.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 50.43 110.846 -179.864 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -173.41 -169.99 0.57 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.5 . . . . 71.25 110.872 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 63.35 172.5 0.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 64.129999999999995 110.893 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.4 -22.93 39.91 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.712 -0.756 . . . . 64.409999999999997 112.48 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.654 ' O ' HD12 ' A' ' 62' ' ' LEU . 5.4 tt0 -51.97 -35.01 44.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.917 0.389 . . . . 73.409999999999997 110.887 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.527 ' HA ' HG21 ' A' ' 49' ' ' VAL . 6.3 ttpp -52.96 -52.0 59.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 64.420000000000002 110.897 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 6.8 tpt -72.01 -42.09 66.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 74.120000000000005 110.87 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.6 m -53.08 -28.4 24.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 62.420000000000002 111.13 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 58' ' ' GLU . 0.2 OUTLIER -71.53 -40.21 70.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 54.119999999999997 110.899 179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 28.7 m -66.04 -45.65 80.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 63.32 110.908 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 12.4 tt -72.37 -35.05 50.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 70.530000000000001 111.145 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.14 -43.25 70.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 72.430000000000007 110.898 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.5 ' HA ' HD11 ' A' ' 42' ' ' ILE . 99.7 t -58.01 -34.83 49.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 65.450000000000003 111.134 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.87 -28.98 25.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 71.439999999999998 110.895 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.487 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -68.99 -39.25 79.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 74.310000000000002 110.896 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.39 -30.05 70.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 64.5 111.086 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.761 HD13 HG11 ' A' ' 102' ' ' VAL . 9.9 mt -64.85 -54.67 27.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 70.239999999999995 110.947 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.97 -38.22 87.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 70.230000000000004 111.172 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 68' ' ' LEU . 77.5 t -71.37 -32.9 48.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 74.510000000000005 111.151 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.525 ' O ' HG22 ' A' ' 77' ' ' ILE . 64.2 t80 -66.68 -29.88 69.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 75.25 110.853 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.489 HD11 HD13 ' A' ' 95' ' ' LEU . 4.3 tt -72.06 -47.61 50.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 44.399999999999999 110.896 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.5 mt -73.04 -39.63 65.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 65.140000000000001 110.915 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.9 tt -58.22 -51.3 70.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 62.119999999999997 110.932 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.756 HD12 ' HG ' ' A' ' 35' ' ' LEU . 1.6 tt -71.68 -26.2 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 62.539999999999999 111.145 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 25.5 t -80.53 -13.8 58.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 62.140000000000001 110.868 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.616 ' O ' HG23 ' A' ' 81' ' ' VAL . 5.5 mmmt -50.71 -29.21 10.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 74.329999999999998 110.878 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.9 pt -50.53 -37.43 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 55.409999999999997 111.111 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 79' ' ' LYS . 53.0 t 51.37 81.68 0.26 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.59 0.709 . . . . 74.349999999999994 111.178 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 167.47 24.43 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.657 2.238 . . . . 60.439999999999998 112.335 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -49.96 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.701 2.267 . . . . 73.040000000000006 112.342 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.2 t -136.75 -38.92 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 74.430000000000007 111.179 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.64 83.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 70.030000000000001 110.886 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.8 -18.04 16.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 54.119999999999997 110.893 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.582 ' HA ' HD23 ' A' ' 90' ' ' LEU . 5.5 m-20 -153.7 24.1 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 71.209999999999994 110.873 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.538 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -66.9 -57.9 10.56 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.649 0.738 . . . . 73.040000000000006 111.159 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.554 ' HG2' HD22 ' A' ' 90' ' ' LEU . 54.1 Cg_endo -69.75 -21.54 33.38 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.709 2.273 . . . . 74.430000000000007 112.372 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.582 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.4 mm? -74.12 -53.17 10.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 64.420000000000002 110.938 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.7 -46.65 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 43.520000000000003 111.134 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.87 -39.46 47.94 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.754 -0.736 . . . . 32.219999999999999 112.47 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -73.22 -24.37 60.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.331 . . . . 70.310000000000002 110.922 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -74.43 -37.95 63.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 64.219999999999999 110.916 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.489 HD13 HD11 ' A' ' 74' ' ' LEU . 11.6 mt -57.38 -29.71 64.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.076 -0.511 . . . . 74.409999999999997 110.938 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 5.2 mmt -69.51 -43.57 72.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 74.030000000000001 110.866 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.49 ' O ' HG22 ' A' ' 100' ' ' VAL . 64.5 t80 -75.16 -51.22 13.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 60.520000000000003 110.854 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.793 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.08 -29.9 33.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 65.329999999999998 111.097 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 9.0 mmt -66.65 -30.13 70.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 61.140000000000001 110.887 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.77 -30.18 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 62.200000000000003 111.114 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.793 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.79 -33.29 62.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 74.219999999999999 110.931 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.761 HG11 HD13 ' A' ' 70' ' ' LEU . 30.9 m -76.93 -38.06 28.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 73.200000000000003 111.097 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 76.7 m -72.4 -38.91 68.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 71.0 111.162 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -66.17 -31.93 73.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 61.149999999999999 110.874 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.0 t -73.41 -37.12 66.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 63.329999999999998 110.841 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.0 mt -70.29 -51.45 38.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 51.409999999999997 111.157 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.55 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.1 p -54.06 -35.53 29.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 42.219999999999999 111.15 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.3 m -52.41 -32.42 39.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 70.230000000000004 111.162 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.6 m -50.36 -31.54 14.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 74.040000000000006 110.847 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.55 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.3 p -52.51 -32.83 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 74.349999999999994 111.092 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 33.6 m -65.69 -43.56 88.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.199 -0.455 . . . . 61.119999999999997 110.863 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.9 t -76.74 -35.64 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 65.340000000000003 111.11 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 89.6 mt -72.1 -31.57 66.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 75.409999999999997 110.903 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -62.51 -30.26 71.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 64.209999999999994 110.896 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.803 HG11 ' HB2' ' A' ' 133' ' ' ALA . 9.9 p -102.31 -22.78 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 31.399999999999999 111.173 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -60.91 -74.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 73.030000000000001 110.903 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 73.150000000000006 110.86 179.97 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.481 -0.248 . . . . 63.32 112.481 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -87.9 -43.0 12.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.919 0.39 . . . . 70.230000000000004 110.951 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.2 m -54.97 -31.84 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 62.119999999999997 111.119 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.803 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -71.81 -24.99 61.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 65.519999999999996 111.069 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 18.2 mmt -52.93 -31.05 38.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 71.310000000000002 110.894 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 32.2 t -57.0 -49.44 79.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 63.549999999999997 111.105 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 30.8 mm -74.03 -40.65 52.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 72.420000000000002 111.121 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -61.97 -30.02 70.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 64.519999999999996 110.848 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.0 mtm-85 -54.32 -27.53 36.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 65.409999999999997 110.857 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 tp -67.66 -50.85 55.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 73.400000000000006 110.931 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -74.05 -31.44 62.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 74.5 110.847 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.581 HD22 ' CD2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -52.15 -32.04 33.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 54.310000000000002 110.906 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -35.16 61.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 72.049999999999997 110.923 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.511 ' O ' HG23 ' A' ' 147' ' ' VAL . 36.9 mm -76.91 -32.16 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 63.210000000000001 111.11 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -56.02 -56.74 17.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 74.439999999999998 110.923 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.27 -35.46 62.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 64.140000000000001 111.142 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.32 -33.07 67.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 75.310000000000002 110.851 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 143' ' ' ILE . 28.8 t -65.96 -37.04 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 74.140000000000001 111.118 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.1 t -57.09 -51.69 68.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 73.409999999999997 110.854 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.9 t -69.17 -33.47 58.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 71.019999999999996 111.094 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -52.32 -53.5 43.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 74.549999999999997 110.895 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.04 -19.63 77.06 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.702 -0.761 . . . . 60.409999999999997 112.486 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 35.1 m -65.82 -52.83 47.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.74 0.305 . . . . 53.119999999999997 111.174 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 20.6 mt -76.58 -25.26 16.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 70.239999999999995 111.142 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -58.5 -49.92 72.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 32.030000000000001 112.462 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 9.6 mmt -70.13 -31.99 69.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.782 0.325 . . . . 75.019999999999996 110.854 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 75.3 t80 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 71.299999999999997 110.882 -179.972 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.232 0.197 0 CA-C-O 120.748 0.228 . . . . 51.32 112.3 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 pp -52.36 -30.98 31.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 74.109999999999999 110.905 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -80.99 -31.69 34.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.468 . . . . 75.219999999999999 110.902 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -72.88 -46.29 53.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 72.230000000000004 110.951 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 t -59.49 -40.09 85.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 65.230000000000004 111.145 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.442 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.16 -29.05 21.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 74.150000000000006 111.149 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.0 -26.87 50.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 71.209999999999994 110.91 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.411 HD21 HG21 ' A' ' 80' ' ' ILE . 4.1 mm? -91.5 -19.24 23.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 72.439999999999998 110.891 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mm -76.66 -34.95 24.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 65.329999999999998 111.131 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.54 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.65 -57.16 22.74 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.62 0.724 . . . . 74.099999999999994 111.12 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.4 Cg_endo -69.73 -20.45 34.95 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.743 2.295 . . . . 64.040000000000006 112.318 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.629 ' O ' HG22 ' A' ' 42' ' ' ILE . 48.0 t -75.98 -44.54 39.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 73.540000000000006 110.885 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.2 p -81.57 -28.93 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 74.120000000000005 111.131 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 mt -50.98 -33.94 26.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.459 . . . . 71.340000000000003 110.93 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.629 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.1 tp -58.76 -34.64 52.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 55.32 111.122 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 p -65.79 -38.8 90.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 72.340000000000003 111.111 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 t -53.0 -46.46 68.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 75.329999999999998 110.866 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.63 -41.41 60.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 50.350000000000001 110.938 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.4 -35.74 68.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 71.109999999999999 111.089 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.423 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.2 mp -64.81 -32.54 58.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 71.430000000000007 111.122 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.8 tp -55.04 -33.64 62.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 72.219999999999999 110.916 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.7 m -102.04 -35.57 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 71.099999999999994 111.102 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -72.58 -64.87 0.87 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 70.349999999999994 110.87 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.528 ' CE2' HD22 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -64.76 -41.14 96.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 74.209999999999994 110.911 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.49 74.78 2.29 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.639 0.733 . . . . 71.319999999999993 110.942 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 125.89 12.67 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.723 2.282 . . . . 74.400000000000006 112.312 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.8 t -116.31 -26.78 7.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 61.43 110.826 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -161.96 125.87 3.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.107 -0.497 . . . . 72.319999999999993 110.853 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.7 p -57.72 -26.0 61.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 73.209999999999994 110.871 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.607 ' O ' HG23 ' A' ' 61' ' ' THR . . . -52.95 -62.97 5.43 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.76 -0.733 . . . . 44.200000000000003 112.462 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.535 ' O ' HD23 ' A' ' 62' ' ' LEU . 1.5 tt0 -74.89 -35.46 62.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.889 0.376 . . . . 72.409999999999997 110.876 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -55.76 -50.49 70.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 73.420000000000002 110.869 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.5 ttm -64.96 -51.7 60.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 71.230000000000004 110.877 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 57' ' ' GLY . 70.9 p -56.22 -28.63 59.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 73.049999999999997 111.175 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.684 ' O ' HG23 ' A' ' 66' ' ' VAL . 1.6 mm? -72.78 -51.0 20.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 71.109999999999999 110.908 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.01 -49.67 65.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 65.0 110.887 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.6 tt -68.29 -35.01 69.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 72.340000000000003 111.125 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 m -65.71 -25.07 67.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 63.520000000000003 110.837 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 62' ' ' LEU . 61.0 t -57.96 -37.57 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.494 . . . . 43.310000000000002 111.107 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -28.95 26.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 73.150000000000006 110.884 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.49 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.36 -38.86 78.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 73.25 110.917 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.53 -30.02 70.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 51.100000000000001 111.128 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.589 HD13 HG11 ' A' ' 102' ' ' VAL . 9.6 mt -65.08 -54.7 26.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 63.100000000000001 110.897 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.69 -38.49 88.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 71.140000000000001 111.152 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 68' ' ' LEU . 80.0 t -71.43 -32.93 48.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 53.039999999999999 111.127 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.406 ' O ' HG22 ' A' ' 77' ' ' ILE . 90.3 t80 -51.84 -30.18 22.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 72.5 110.917 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.588 HD11 HD11 ' A' ' 95' ' ' LEU . 0.3 OUTLIER -73.22 -42.36 62.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.491 . . . . 75.040000000000006 110.936 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.6 mt -73.21 -33.91 65.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 74.109999999999999 110.897 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 tt -70.22 -55.07 10.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 73.209999999999994 110.973 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 80' ' ' ILE . 1.2 tt -57.08 -30.43 34.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 74.319999999999993 111.104 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.1 m -80.17 -23.42 41.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 72.25 110.858 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.69 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.4 OUTLIER -69.79 -12.75 61.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.477 . . . . 74.129999999999995 110.895 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.43 HG23 ' O ' ' A' ' 77' ' ' ILE . 2.2 pp -56.31 -24.57 18.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 73.120000000000005 111.123 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 79' ' ' LYS . 22.0 t 63.7 75.27 0.4 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.641 0.734 . . . . 72.129999999999995 111.151 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 167.53 24.22 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.658 2.238 . . . . 51.210000000000001 112.342 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 -48.66 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.69 2.26 . . . . 70.420000000000002 112.354 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.0 t -117.2 -19.79 9.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 73.010000000000005 111.143 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.69 45.08 4.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 72.510000000000005 110.872 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.6 tp -95.7 25.9 4.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 75.230000000000004 110.909 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.646 ' HA ' HD23 ' A' ' 90' ' ' LEU . 4.0 m-20 -104.57 24.39 11.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 72.200000000000003 110.862 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.19 -57.79 10.23 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.642 0.735 . . . . 61.25 111.145 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.537 ' HG2' HD22 ' A' ' 90' ' ' LEU . 54.3 Cg_endo -69.79 -20.48 34.62 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.696 2.264 . . . . 74.230000000000004 112.359 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.646 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.12 -45.6 47.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 75.400000000000006 110.955 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.493 HG12 HD21 ' A' ' 95' ' ' LEU . 38.4 t -80.67 -37.85 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 51.43 111.121 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.92 -52.1 36.66 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.724 -0.751 . . . . 73.400000000000006 112.542 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -35.19 79.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.828 0.347 . . . . 70.540000000000006 110.895 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -60.77 -36.75 79.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 60.109999999999999 110.952 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.588 HD11 HD11 ' A' ' 74' ' ' LEU . 9.7 mt -51.89 -29.8 21.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 54.399999999999999 110.934 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 13.4 mmt -67.85 -43.12 80.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 74.510000000000005 110.916 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.5 ' O ' HG22 ' A' ' 100' ' ' VAL . 67.2 t80 -75.28 -52.25 11.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 74.219999999999999 110.888 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.781 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.02 -29.91 32.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 74.510000000000005 111.165 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.72 -30.05 70.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 72.140000000000001 110.858 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.8 -30.04 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 65.129999999999995 111.134 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.781 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -74.91 -33.21 61.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 75.409999999999997 110.929 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.589 HG11 HD13 ' A' ' 70' ' ' LEU . 31.3 m -76.91 -38.09 28.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 72.319999999999993 111.156 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.484 ' HA ' HD12 ' A' ' 106' ' ' ILE . 73.0 m -72.46 -40.73 66.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 70.200000000000003 111.203 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -63.51 -32.17 73.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 63.229999999999997 110.88 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.0 t -71.38 -32.04 68.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 74.299999999999997 110.828 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.484 HD12 ' HA ' ' A' ' 103' ' ' THR . 22.3 mt -75.01 -52.1 19.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 64.129999999999995 111.163 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.547 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.1 p -54.16 -36.65 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 55.509999999999998 111.139 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.7 m -52.38 -32.4 38.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 62.310000000000002 111.173 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.7 m -50.46 -31.29 14.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.463 . . . . 71.099999999999994 110.835 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.2 p -52.51 -32.73 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 75.530000000000001 111.109 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 17.9 m -64.15 -43.87 93.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 45.039999999999999 110.878 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 84.1 t -76.89 -34.74 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 62.329999999999998 111.087 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.432 HD22 ' O ' ' A' ' 117' ' ' HIS . 83.4 mt -71.99 -32.25 67.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 71.409999999999997 110.895 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -59.18 -31.97 69.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 72.319999999999993 110.858 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.788 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.0 p -102.32 -24.84 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 42.409999999999997 111.166 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 -90.25 -73.73 0.51 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.123 -0.49 . . . . 74.430000000000007 110.828 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.432 ' O ' HD22 ' A' ' 113' ' ' LEU . 9.5 t-80 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 75.319999999999993 110.816 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.464 -0.254 . . . . 44.039999999999999 112.464 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -87.97 -29.81 20.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.987 0.422 . . . . 74.150000000000006 110.922 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.9 m -66.44 -35.93 76.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 61.420000000000002 111.105 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.788 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -64.46 -25.02 67.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 75.040000000000006 111.094 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 39.1 mmt -53.0 -31.02 38.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 73.019999999999996 110.872 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 64.5 t -56.99 -58.17 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.281 -0.418 . . . . 74.519999999999996 111.082 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.9 mt -73.95 -36.93 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 73.219999999999999 111.12 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -62.09 -29.94 70.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 63.5 110.884 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.18 -29.86 24.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 73.319999999999993 110.886 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.31 -39.48 74.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 74.200000000000003 110.879 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -73.86 -53.38 10.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 64.030000000000001 110.897 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.538 ' O ' HG23 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -52.39 -33.6 44.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 63.219999999999999 110.913 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 20.7 t90 -55.51 -50.6 69.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 75.200000000000003 110.937 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.715 ' O ' HG23 ' A' ' 147' ' ' VAL . 57.8 mt -76.01 -33.49 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 50.210000000000001 111.121 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -56.16 -56.02 25.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 63.109999999999999 110.867 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 141' ' ' LEU . 23.2 t -59.95 -35.01 58.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 62.109999999999999 111.089 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -66.06 -33.27 75.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 70.209999999999994 110.895 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 143' ' ' ILE . 78.7 t -54.25 -50.64 54.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 74.510000000000005 111.155 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.39 -47.7 66.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 74.439999999999998 110.921 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.7 t -63.67 -33.03 59.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 74.329999999999998 111.132 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -52.07 -54.94 24.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 73.439999999999998 110.893 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.32 -19.55 74.05 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 44.439999999999998 112.486 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.2 m -60.11 -52.82 63.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.733 0.301 . . . . 65.519999999999996 111.136 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 47.3 mm -76.48 -33.65 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 73.209999999999994 111.132 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -55.2 -49.98 61.31 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.741 -0.742 . . . . 55.32 112.51 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 3.3 mmt -72.43 -31.99 65.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.822 0.344 . . . . 75.319999999999993 110.91 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 17.5 t80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 74.430000000000007 110.856 -179.949 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.209 0 CA-C-O 120.843 0.268 . . . . 74.430000000000007 112.375 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.0 pp -52.08 -30.99 28.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 71.310000000000002 110.913 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -78.04 -33.59 50.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 72.420000000000002 110.882 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -72.64 -45.89 56.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 74.129999999999995 110.904 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -60.31 -39.96 88.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 63.43 111.14 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.455 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.17 -29.08 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 64.519999999999996 111.145 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.88 -27.26 51.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.420000000000002 110.861 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.558 HD21 HG21 ' A' ' 80' ' ' ILE . 4.1 mm? -91.1 -18.8 23.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 70.420000000000002 110.957 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.7 mm -76.54 -34.97 25.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 64.420000000000002 111.173 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.545 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.72 -57.15 22.97 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.583 0.706 . . . . 72.540000000000006 111.107 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.5 Cg_endo -69.77 -21.35 33.54 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.683 2.255 . . . . 72.530000000000001 112.285 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.622 ' O ' HG22 ' A' ' 42' ' ' ILE . 47.3 t -75.87 -44.52 40.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 72.510000000000005 110.882 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.508 HG23 ' SG ' ' A' ' 148' ' ' CYS . 9.7 p -81.57 -28.93 10.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 63.210000000000001 111.139 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 mt -50.97 -34.01 27.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 72.25 110.907 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.1 tp -58.68 -34.68 52.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 65.25 111.141 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 p -65.69 -40.48 92.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.458 . . . . 72.340000000000003 111.138 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.97 -43.08 66.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 71.420000000000002 110.876 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.9 tp -76.96 -40.79 45.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.12 -0.491 . . . . 61.340000000000003 110.914 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.1 -36.52 68.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 61.240000000000002 111.103 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.426 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.3 mp -64.28 -32.02 55.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 75.420000000000002 111.112 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.9 tp -51.43 -38.76 55.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 71.239999999999995 110.916 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.674 HG21 HD13 ' A' ' 62' ' ' LEU . 7.9 p -101.47 -36.69 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 70.239999999999995 111.154 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -67.02 -64.65 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 72.340000000000003 110.871 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.547 ' CE2' HD22 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -71.34 -60.8 2.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 74.129999999999995 110.907 -179.826 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.0 mp -71.0 160.63 81.85 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.598 0.713 . . . . 65.540000000000006 110.921 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 144.63 54.77 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.701 2.267 . . . . 55.100000000000001 112.313 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.76 95.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 72.400000000000006 110.877 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 53.85 -172.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 54.420000000000002 110.862 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.4 m -114.81 -74.49 0.61 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 62.310000000000002 110.862 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.41 -27.74 66.18 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.726 . . . . 44.100000000000001 112.515 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.489 ' HG2' HD12 ' A' ' 62' ' ' LEU . 11.6 tt0 -52.1 -34.92 46.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.852 0.358 . . . . 70.349999999999994 110.821 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.6 mttt -52.98 -51.92 59.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 71.349999999999994 110.894 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 9.7 ttm -64.3 -45.44 87.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 51.32 110.882 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.7 m -58.28 -36.96 74.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.446 . . . . 75.25 111.177 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.674 HD13 HG21 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -75.62 -32.6 60.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 71.430000000000007 110.939 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 6.8 m -65.26 -52.01 57.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 71.129999999999995 110.897 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.4 tt -60.26 -34.95 59.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 62.520000000000003 111.112 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -24.98 66.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 73.129999999999995 110.853 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.3 t -57.95 -35.59 52.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 74.400000000000006 111.137 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mp -52.98 -28.88 25.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 71.510000000000005 110.893 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.495 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.37 -38.99 78.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 65.409999999999997 110.925 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.45 -30.05 70.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 53.109999999999999 111.093 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.842 HD22 HG11 ' A' ' 102' ' ' VAL . 9.9 mt -64.7 -54.72 27.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 41.310000000000002 110.944 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.97 -38.17 87.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 53.32 111.112 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 68' ' ' LEU . 76.4 t -71.44 -32.83 47.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 53.130000000000003 111.111 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -51.51 -30.67 21.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 73.329999999999998 110.909 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.456 HD11 HD11 ' A' ' 95' ' ' LEU . 8.9 tp -75.0 -40.06 60.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 75.510000000000005 110.915 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.9 mt -73.22 -34.8 66.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 70.319999999999993 110.916 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.11 -53.87 13.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.456 . . . . 70.129999999999995 110.906 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 80' ' ' ILE . 1.6 tt -56.43 -26.17 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 70.010000000000005 111.104 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.5 m -80.15 -22.4 42.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 71.109999999999999 110.862 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.684 ' O ' HG23 ' A' ' 81' ' ' VAL . 7.1 mttp -70.77 -10.5 59.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 74.329999999999998 110.873 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.558 HG21 HD21 ' A' ' 35' ' ' LEU . 2.4 pp -56.61 -23.72 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 64.549999999999997 111.133 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 79' ' ' LYS . 21.4 t 64.11 75.49 0.38 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.598 0.713 . . . . 65.219999999999999 111.127 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 167.26 24.93 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.656 2.237 . . . . 63.25 112.348 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -48.8 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.713 2.275 . . . . 71.219999999999999 112.331 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.75 HG23 ' H ' ' A' ' 86' ' ' LEU . 8.4 t -116.6 -19.93 9.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 74.439999999999998 111.148 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 p 63.46 23.27 13.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 64.540000000000006 110.873 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.75 ' H ' HG23 ' A' ' 84' ' ' THR . 0.1 OUTLIER -95.72 31.21 2.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 63.310000000000002 110.915 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.66 ' HA ' HD23 ' A' ' 90' ' ' LEU . 75.7 m-20 -94.63 47.16 1.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.457 . . . . 72.329999999999998 110.875 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.536 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -66.74 -57.72 11.22 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.586 0.708 . . . . 73.329999999999998 111.142 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.7 Cg_endo -69.77 -20.0 35.34 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.679 2.252 . . . . 73.319999999999993 112.322 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.66 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.15 -53.16 10.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.246 -0.434 . . . . 71.340000000000003 110.875 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.11 -38.01 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 71.299999999999997 111.085 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.1 -43.43 56.18 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.752 -0.737 . . . . 75.299999999999997 112.448 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -21.92 64.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.806 0.336 . . . . 73.540000000000006 110.911 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -78.13 -41.88 33.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 61.310000000000002 110.902 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.469 ' HA ' HG22 ' A' ' 98' ' ' THR . 10.9 mt -55.69 -29.71 59.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 73.349999999999994 110.875 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -43.42 76.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 74.450000000000003 110.876 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.504 ' O ' HG22 ' A' ' 100' ' ' VAL . 50.9 t80 -75.27 -51.69 12.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 75.230000000000004 110.871 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.791 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.16 -29.88 33.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 74.340000000000003 111.113 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.8 mmt -66.63 -30.12 70.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 72.019999999999996 110.878 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.7 -30.08 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 51.049999999999997 111.153 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -75.0 -33.2 61.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 74.109999999999999 110.906 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.842 HG11 HD22 ' A' ' 70' ' ' LEU . 31.2 m -76.91 -38.12 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 73.040000000000006 111.155 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.45 ' O ' HG13 ' A' ' 107' ' ' VAL . 74.1 m -72.47 -40.05 67.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.472 . . . . 74.329999999999998 111.135 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -64.49 -31.92 73.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 63.329999999999998 110.852 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.6 t -74.4 -34.51 63.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 61.200000000000003 110.859 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.5 mt -74.43 -50.72 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 72.409999999999997 111.135 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.555 ' O ' HG12 ' A' ' 110' ' ' VAL . 34.5 m -54.05 -33.99 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 70.219999999999999 111.111 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.0 m -52.41 -32.53 39.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 63.229999999999997 111.164 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.1 m -50.45 -31.46 15.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 73.239999999999995 110.891 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.4 p -52.5 -32.73 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 72.150000000000006 111.115 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 35.5 m -66.94 -48.74 67.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 64.530000000000001 110.868 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 77.7 t -70.49 -35.37 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 64.219999999999999 111.124 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.0 mt -72.09 -40.31 68.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 64.5 110.911 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -52.12 -31.66 31.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 72.230000000000004 110.863 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.775 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.3 p -102.31 -24.18 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 65.519999999999996 111.139 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -54.02 -74.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 72.510000000000005 110.879 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 75.540000000000006 110.857 179.956 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.518 -0.233 . . . . 71.319999999999993 112.518 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -69.32 -26.35 64.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.969 0.414 . . . . 75.25 110.946 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.1 m -54.72 -27.1 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.054 -0.521 . . . . 75.310000000000002 111.113 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.775 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -54.83 -27.66 43.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 51.240000000000002 111.117 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 37.0 mmt -53.0 -31.01 38.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 71.420000000000002 110.876 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 62.4 t -56.94 -56.02 16.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.267 -0.424 . . . . 73.430000000000007 111.105 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.8 mp -73.94 -38.66 50.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 73.010000000000005 111.116 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -61.13 -30.46 70.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 73.349999999999994 110.899 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.76 -27.28 40.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.478 . . . . 71.150000000000006 110.88 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.01 -50.63 21.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 72.040000000000006 110.909 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -69.06 -53.59 19.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 72.140000000000001 110.887 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.621 ' O ' HG23 ' A' ' 145' ' ' VAL . 0.2 OUTLIER -52.08 -32.4 34.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 74.540000000000006 110.907 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -61.45 -51.48 68.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 74.540000000000006 110.884 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.748 ' O ' HG23 ' A' ' 147' ' ' VAL . 62.1 mt -74.35 -32.0 29.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 75.120000000000005 111.156 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -56.0 -56.46 20.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 70.129999999999995 110.847 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 141' ' ' LEU . 30.6 t -54.3 -35.56 30.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 62.210000000000001 111.138 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -69.96 -37.86 75.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 64.209999999999994 110.884 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 143' ' ' ILE . 63.0 t -54.9 -34.06 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 71.109999999999999 111.145 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.508 ' SG ' HG23 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -52.78 -47.99 67.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 71.530000000000001 110.91 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.788 HG12 HD11 ' A' ' 153' ' ' ILE . 22.0 t -74.5 -36.69 42.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 51.450000000000003 111.126 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -54.89 -26.92 38.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 63.140000000000001 110.92 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.58 -59.05 4.26 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 73.349999999999994 112.423 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 4.4 t -54.59 -34.09 61.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.788 0.328 . . . . 64.450000000000003 111.162 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.788 HD11 HG12 ' A' ' 149' ' ' VAL . 47.6 mt -70.24 -25.21 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 62.140000000000001 111.091 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.83 -49.92 32.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.704 -0.76 . . . . 54.030000000000001 112.514 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.65 -32.01 57.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.345 . . . . 55.340000000000003 110.928 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 20.3 t80 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 74.010000000000005 110.879 -179.964 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.83 0.263 . . . . 55.219999999999999 112.313 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.0 pp -52.29 -30.95 30.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 75.409999999999997 110.923 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -80.26 -32.01 38.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 72.409999999999997 110.914 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -73.12 -46.16 52.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 72.209999999999994 110.926 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 t -59.67 -39.99 86.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 72.430000000000007 111.157 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.447 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.19 -29.1 21.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 64.400000000000006 111.132 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -55.58 -27.24 48.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 63.310000000000002 110.869 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.56 ' HG ' HD12 ' A' ' 77' ' ' ILE . 4.1 mm? -91.27 -19.08 23.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.201 -0.454 . . . . 74.109999999999999 110.93 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.8 mm -76.51 -35.03 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 74.219999999999999 111.138 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.547 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.68 -57.14 22.91 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.609 0.719 . . . . 74.519999999999996 111.127 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.9 Cg_endo -69.75 -21.58 33.32 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.683 2.255 . . . . 63.539999999999999 112.308 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.621 ' O ' HG22 ' A' ' 42' ' ' ILE . 36.2 t -73.09 -46.91 48.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 63.229999999999997 110.871 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.5 p -81.53 -29.01 10.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 62.399999999999999 111.117 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.1 mt -50.89 -34.01 26.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 72.420000000000002 110.949 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.621 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.76 -34.64 52.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 74.549999999999997 111.113 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.3 p -65.66 -34.53 78.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 63.210000000000001 111.141 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.06 -49.01 72.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 72.019999999999996 110.864 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.0 tp -73.17 -43.21 61.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 61.009999999999998 110.922 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.94 -39.99 75.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 52.100000000000001 111.13 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.07 -32.45 58.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 73.310000000000002 111.102 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.523 ' O ' HD23 ' A' ' 52' ' ' LEU . 4.0 tp -51.57 -37.15 48.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 65.200000000000003 110.915 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.01 -35.78 4.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 51.299999999999997 111.09 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -67.08 -62.86 1.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 73.549999999999997 110.881 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.23 -40.33 70.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 75.430000000000007 110.922 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.523 HD23 ' O ' ' A' ' 48' ' ' LEU . 4.5 mm? -70.43 159.18 85.73 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.602 0.715 . . . . 73.019999999999996 110.887 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -172.28 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.615 2.21 . . . . 72.0 112.389 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.9 t 63.28 87.75 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 71.329999999999998 110.865 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -89.86 50.4 1.88 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 73.030000000000001 110.875 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.7 p -63.21 -173.38 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 71.319999999999993 110.898 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.738 ' O ' HG23 ' A' ' 61' ' ' THR . . . -52.2 -30.02 30.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.754 -0.736 . . . . 50.530000000000001 112.492 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -60.89 -34.88 75.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.977 0.417 . . . . 73.099999999999994 110.932 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -46.07 82.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 71.439999999999998 110.873 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 23.9 ttm -71.64 -46.49 58.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 62.130000000000003 110.889 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.738 HG23 ' O ' ' A' ' 57' ' ' GLY . 30.4 p -54.38 -27.18 34.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 72.430000000000007 111.109 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.24 -51.0 34.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 73.140000000000001 110.906 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 7.3 m -54.66 -46.53 74.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.429 . . . . 64.329999999999998 110.931 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 15.8 tt -71.22 -34.96 56.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 74.209999999999994 111.148 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 m -53.85 -28.07 33.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 63.210000000000001 110.898 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.0 t -58.08 -38.37 67.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.487 . . . . 61.340000000000003 111.169 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.91 -28.87 25.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 70.010000000000005 110.962 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.482 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.01 -39.04 79.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 75.310000000000002 110.927 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.48 -29.97 70.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 60.100000000000001 111.084 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.015 HD11 HG11 ' A' ' 102' ' ' VAL . 8.5 mt -66.04 -54.81 21.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 62.329999999999998 110.903 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -60.94 -38.37 85.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 71.140000000000001 111.148 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 68' ' ' LEU . 81.9 t -71.5 -37.19 63.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 73.319999999999993 111.124 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.514 ' CE2' HD12 ' A' ' 35' ' ' LEU . 49.7 t80 -68.55 -31.87 71.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 73.310000000000002 110.853 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.401 HD11 ' CD1' ' A' ' 95' ' ' LEU . 2.8 tt -75.03 -43.62 52.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 60.450000000000003 110.904 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.8 mp -73.32 -44.06 59.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 72.030000000000001 110.893 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.3 tt -55.55 -55.16 35.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 52.200000000000003 110.936 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.56 HD12 ' HG ' ' A' ' 35' ' ' LEU . 1.4 tt -62.91 -25.08 37.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 73.409999999999997 111.074 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.4 m -80.14 -14.62 58.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 75.329999999999998 110.848 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -54.43 -26.42 30.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 63.229999999999997 110.891 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.423 ' O ' ' C ' ' A' ' 81' ' ' VAL . 1.0 OUTLIER -62.42 -16.78 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 73.219999999999999 111.084 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 81' ' ' VAL . 2.4 p 35.53 80.95 0.25 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.601 0.715 . . . . 70.319999999999993 111.097 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 165.76 29.87 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.714 2.276 . . . . 73.120000000000005 112.376 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 -50.13 0.5 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.704 2.269 . . . . 54.350000000000001 112.388 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.5 t -136.98 -38.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 71.530000000000001 111.14 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 178.7 82.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 74.349999999999994 110.85 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -96.21 -17.82 20.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 64.099999999999994 110.914 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.593 ' HA ' HD23 ' A' ' 90' ' ' LEU . 4.3 m-20 -152.56 23.88 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 71.400000000000006 110.879 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.538 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -66.86 -57.8 10.82 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.63 0.728 . . . . 72.299999999999997 111.113 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.551 ' HG2' HD22 ' A' ' 90' ' ' LEU . 53.4 Cg_endo -69.79 -21.55 33.21 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.67 2.247 . . . . 72.219999999999999 112.322 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.593 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.4 mm? -74.15 -53.1 10.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.44 . . . . 71.5 110.934 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.32 -44.89 24.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 74.230000000000004 111.164 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.04 -39.2 48.83 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.736 -0.745 . . . . 53.210000000000001 112.446 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -73.75 -23.56 59.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.798 0.333 . . . . 73.450000000000003 110.936 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -75.35 -37.82 60.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 75.420000000000002 110.931 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.439 ' HA ' HG22 ' A' ' 98' ' ' THR . 12.9 mt -54.45 -29.85 50.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 73.510000000000005 110.89 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.36 -43.65 73.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 55.210000000000001 110.885 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.501 ' O ' HG22 ' A' ' 100' ' ' VAL . 39.0 t80 -75.17 -51.12 14.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 73.030000000000001 110.884 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.805 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.15 -29.74 33.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 73.030000000000001 111.129 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.78 -30.18 70.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.44 . . . . 73.319999999999993 110.909 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.85 -29.95 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 64.310000000000002 111.154 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.805 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -75.06 -33.22 61.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 63.149999999999999 110.915 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 1.015 HG11 HD11 ' A' ' 70' ' ' LEU . 30.1 m -76.91 -38.06 28.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 72.430000000000007 111.164 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.447 ' O ' HG13 ' A' ' 107' ' ' VAL . 74.5 m -72.51 -38.54 68.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 74.140000000000001 111.113 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -66.41 -31.84 72.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 73.299999999999997 110.87 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.01 -34.76 64.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 73.239999999999995 110.872 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.3 mt -73.83 -51.03 25.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 51.229999999999997 111.177 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.552 ' O ' HG12 ' A' ' 110' ' ' VAL . 35.2 m -53.94 -34.21 25.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 65.319999999999993 111.133 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.3 m -52.39 -32.51 39.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 32.020000000000003 111.144 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.0 p -50.41 -31.45 14.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 64.439999999999998 110.862 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.5 p -52.56 -32.8 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 75.209999999999994 111.118 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 27.3 m -66.2 -48.14 71.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 53.240000000000002 110.905 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.6 t -71.44 -35.98 59.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 63.219999999999999 111.144 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.8 mt -72.03 -34.68 68.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 75.109999999999999 110.912 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -55.44 -32.73 62.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 72.329999999999998 110.886 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.782 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.6 p -102.34 -24.28 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 64.540000000000006 111.121 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -81.48 -70.08 0.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 75.400000000000006 110.812 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 75.230000000000004 110.871 -179.965 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.518 -0.233 . . . . 73.109999999999999 112.518 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -87.17 -30.78 20.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.893 0.378 . . . . 54.240000000000002 110.882 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 23.4 m -73.66 -28.26 24.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 54.130000000000003 111.16 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.782 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -55.95 -25.12 42.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 54.420000000000002 111.146 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -52.96 -30.88 37.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 63.240000000000002 110.89 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 64.9 t -56.97 -56.66 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 51.439999999999998 111.141 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 31.9 mm -74.09 -36.42 44.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 75.219999999999999 111.133 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -62.84 -29.88 71.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 71.319999999999993 110.864 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.18 -27.6 35.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 60.439999999999998 110.909 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.9 tt -70.47 -50.22 40.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 73.409999999999997 110.928 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -72.09 -28.95 63.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 44.539999999999999 110.925 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.8 tt -56.77 -40.74 76.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 52.409999999999997 110.918 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -72.44 -51.07 21.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 73.140000000000001 110.976 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.746 ' O ' HG23 ' A' ' 147' ' ' VAL . 51.0 mm -57.96 -32.21 42.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 63.399999999999999 111.164 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -56.27 -57.14 13.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 73.439999999999998 110.878 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 21.7 t -66.73 -36.31 76.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.48 . . . . 74.439999999999998 111.108 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.34 -36.13 68.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 62.329999999999998 110.851 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 143' ' ' ILE . 94.4 t -58.82 -53.22 50.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 64.540000000000006 111.117 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -56.23 -32.6 64.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 73.430000000000007 110.893 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 67.5 t -71.07 -34.2 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 74.329999999999998 111.097 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -71.88 -27.44 62.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 73.219999999999999 110.939 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.07 -48.58 5.99 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.705 -0.76 . . . . 71.329999999999998 112.482 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.4 t -51.81 -39.39 58.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.751 0.31 . . . . 61.030000000000001 111.14 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 41.1 mt -63.09 -43.18 98.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 43.030000000000001 111.135 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -52.88 -48.55 57.27 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.747 -0.74 . . . . 74.049999999999997 112.495 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -31.94 66.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.792 0.329 . . . . 74.420000000000002 110.887 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 1.5 t80 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.443 . . . . 72.409999999999997 110.902 -179.944 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.821 0.259 . . . . 60.039999999999999 112.369 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 pp -51.99 -30.95 27.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 64.25 110.927 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -78.82 -33.49 46.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 75.099999999999994 110.879 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -72.46 -46.23 55.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 72.040000000000006 110.94 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -60.08 -40.02 88.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.511 . . . . 54.149999999999999 111.11 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.445 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.19 -29.11 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 74.200000000000003 111.101 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -55.8 -27.12 49.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 72.040000000000006 110.856 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.43 ' HB3' HD12 ' A' ' 77' ' ' ILE . 4.1 mm? -91.29 -19.19 23.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 71.310000000000002 110.942 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.6 mm -76.6 -34.94 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 65.030000000000001 111.134 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.543 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.3 mm -55.61 -57.21 22.35 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.659 0.742 . . . . 50.210000000000001 111.136 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.6 Cg_endo -69.82 -20.91 33.95 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.661 2.24 . . . . 64.109999999999999 112.336 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.633 ' O ' HG22 ' A' ' 42' ' ' ILE . 48.6 t -75.98 -44.65 38.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 75.409999999999997 110.908 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.61 -28.86 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 64.430000000000007 111.128 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.3 mt -50.97 -33.97 26.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 42.130000000000003 110.919 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 39' ' ' CYS . 0.7 OUTLIER -58.76 -34.65 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 44.210000000000001 111.131 179.844 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 p -65.81 -39.73 91.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 53.32 111.188 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.99 -51.11 62.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 74.310000000000002 110.809 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.9 tp -69.48 -38.81 77.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 74.310000000000002 110.896 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.7 -39.64 77.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 54.009999999999998 111.106 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.447 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.3 mp -64.33 -31.93 55.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 45.109999999999999 111.125 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.5 -38.7 55.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 74.209999999999994 110.927 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -101.45 -36.73 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 73.219999999999999 111.139 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -67.1 -64.62 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 71.129999999999995 110.894 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.447 ' HB2' HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -71.22 -61.96 1.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 74.129999999999995 110.944 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.2 mp -67.62 160.65 71.58 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.617 0.723 . . . . 75.219999999999999 110.928 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 161.53 45.56 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.722 2.282 . . . . 64.219999999999999 112.336 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -174.88 -69.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 72.099999999999994 110.895 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -178.37 -171.73 0.27 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 71.109999999999999 110.887 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 50.2 t -94.83 -74.39 0.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 64.310000000000002 110.892 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.75 -47.1 59.2 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 70.409999999999997 112.506 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.56 -35.54 70.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.916 0.389 . . . . 60.210000000000001 110.862 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -66.02 -44.58 84.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 75.409999999999997 110.885 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.605 ' O ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.35 -45.76 71.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 72.430000000000007 110.863 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 77.3 p -62.45 -26.09 68.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 73.409999999999997 111.131 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.24 -37.34 61.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 52.509999999999998 110.913 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 82.5 m -74.0 -48.65 28.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 74.319999999999993 110.839 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 60' ' ' MET . 24.7 pt -54.85 -32.26 25.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 73.409999999999997 111.121 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.1 -28.45 67.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 65.310000000000002 110.9 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.13 -38.25 66.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 74.049999999999997 111.141 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tp -52.89 -28.92 25.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 63.450000000000003 110.876 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.491 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.23 -38.94 78.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 74.319999999999993 110.933 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.65 -30.01 70.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 74.299999999999997 111.093 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.794 HD13 HG11 ' A' ' 102' ' ' VAL . 9.2 mt -65.31 -54.81 23.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 72.209999999999994 110.87 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.47 -38.63 87.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 65.510000000000005 111.151 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 68' ' ' LEU . 84.2 t -71.52 -32.96 47.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 61.210000000000001 111.13 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.582 ' O ' HG22 ' A' ' 77' ' ' ILE . 72.4 t80 -52.03 -34.09 41.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 73.140000000000001 110.889 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.1 tp -60.96 -51.11 70.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 74.409999999999997 110.939 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.5 mt -73.14 -32.13 64.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.47 . . . . 53.520000000000003 110.87 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.7 tt -66.69 -52.33 45.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 64.349999999999994 110.895 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 73' ' ' PHE . 1.5 tt -69.17 -30.55 46.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 74.129999999999995 111.117 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.0 m -80.19 -21.3 43.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 54.520000000000003 110.862 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.651 ' O ' HG23 ' A' ' 81' ' ' VAL . 4.8 mttt -60.38 -19.95 57.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.107 -0.497 . . . . 73.120000000000005 110.947 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -59.17 -20.71 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 72.129999999999995 111.132 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 79' ' ' LYS . 23.8 t 51.56 76.62 0.52 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.609 0.719 . . . . 65.099999999999994 111.118 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.429 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 54.0 Cg_endo -69.77 112.08 2.99 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.711 2.274 . . . . 63.130000000000003 112.35 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 82' ' ' PRO . 53.1 Cg_endo -69.82 -48.61 0.67 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.716 2.277 . . . . 72.120000000000005 112.309 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.5 t -117.05 -21.86 8.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 73.120000000000005 111.13 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.18 -48.74 61.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 73.430000000000007 110.86 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.3 tp 51.0 56.14 8.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.108 -0.496 . . . . 74.129999999999995 110.918 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.625 ' HA ' HD23 ' A' ' 90' ' ' LEU . 3.7 m-20 -95.36 24.03 5.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 75.310000000000002 110.875 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.536 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.2 -57.82 10.16 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.609 0.719 . . . . 60.420000000000002 111.132 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.9 Cg_endo -69.76 -20.8 34.35 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.706 2.27 . . . . 73.25 112.324 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.625 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.07 -53.13 10.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 74.329999999999998 110.939 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.526 HG12 HD21 ' A' ' 95' ' ' LEU . 60.6 t -65.37 -36.43 77.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 52.420000000000002 111.135 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.94 -41.46 52.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.761 -0.733 . . . . 52.119999999999997 112.464 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.6 mmpm? -75.21 -22.07 58.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.748 0.308 . . . . 74.239999999999995 110.867 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -75.68 -33.4 60.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.259 -0.428 . . . . 75.140000000000001 110.954 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.526 HD21 HG12 ' A' ' 91' ' ' VAL . 13.2 mt -53.39 -29.83 36.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 72.299999999999997 110.937 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.26 -43.65 73.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 64.450000000000003 110.923 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.489 ' O ' HG22 ' A' ' 100' ' ' VAL . 65.9 t80 -75.23 -51.16 14.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 74.420000000000002 110.901 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.786 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.17 -29.93 34.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 43.450000000000003 111.126 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.0 mmt -66.53 -30.15 70.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 74.310000000000002 110.892 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.85 -30.07 13.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 74.430000000000007 111.135 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.786 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.88 -33.2 62.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 63.409999999999997 110.94 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.794 HG11 HD13 ' A' ' 70' ' ' LEU . 31.1 m -76.92 -38.08 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 71.299999999999997 111.129 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 78.8 m -72.48 -38.55 68.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 75.329999999999998 111.107 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -66.86 -32.03 73.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 74.040000000000006 110.888 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.0 t -71.56 -35.55 70.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 75.230000000000004 110.831 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.4 mt -71.7 -51.92 29.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 71.040000000000006 111.112 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.548 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.7 p -54.05 -36.36 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 61.539999999999999 111.139 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.1 m -52.34 -32.41 37.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 62.32 111.182 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.0 m -50.46 -31.32 14.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 72.510000000000005 110.836 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.548 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.3 p -52.49 -32.83 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 61.200000000000003 111.089 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 23.6 m -65.51 -44.35 87.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 64.319999999999993 110.926 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 82.1 t -75.96 -35.83 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 75.340000000000003 111.067 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.449 HD22 ' O ' ' A' ' 117' ' ' HIS . 90.0 mt -71.95 -31.79 66.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 75.219999999999999 110.95 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -60.03 -31.71 70.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 74.510000000000005 110.919 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.765 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.3 p -102.32 -24.77 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 64.430000000000007 111.151 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -90.47 -74.14 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 62.420000000000002 110.869 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.449 ' O ' HD22 ' A' ' 113' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 73.219999999999999 110.896 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.516 -0.234 . . . . 73.150000000000006 112.516 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -87.9 -26.48 22.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.924 0.392 . . . . 72.129999999999995 110.911 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.5 m -55.59 -30.79 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 55.130000000000003 111.122 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.765 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -70.02 -26.08 63.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 51.0 111.101 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 31.8 mmt -52.95 -30.99 37.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 72.010000000000005 110.904 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 52.4 t -57.01 -58.43 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 73.200000000000003 111.109 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 44.5 mm -73.98 -37.77 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 71.140000000000001 111.135 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -61.17 -30.4 70.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 71.140000000000001 110.9 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.78 -28.19 33.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 74.319999999999993 110.903 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.0 tp -65.4 -50.81 64.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 75.239999999999995 110.916 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -73.78 -42.89 60.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 74.329999999999998 110.876 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 tt -52.01 -32.78 35.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 54.200000000000003 110.892 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -66.63 -43.01 85.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 74.030000000000001 110.931 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.751 ' O ' HG23 ' A' ' 147' ' ' VAL . 4.9 mt -76.43 -32.15 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 71.420000000000002 111.099 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -55.96 -56.41 21.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 65.040000000000006 110.884 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.2 m -60.72 -35.22 62.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 63.229999999999997 111.072 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -64.68 -41.52 95.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 63.049999999999997 110.855 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 143' ' ' ILE . 88.9 t -58.39 -34.23 49.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 61.009999999999998 111.106 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 89.8 m -57.79 -51.98 67.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 41.100000000000001 110.842 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.454 ' O ' HG22 ' A' ' 153' ' ' ILE . 57.0 t -75.99 -35.23 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 72.129999999999995 111.089 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -63.42 -37.73 88.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 65.439999999999998 110.919 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.25 -46.14 9.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.792 -0.718 . . . . 71.340000000000003 112.445 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 95.4 m -59.96 -51.99 67.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.785 0.326 . . . . 71.540000000000006 111.16 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 149' ' ' VAL . 20.4 tt -55.9 -26.63 21.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 73.329999999999998 111.129 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -52.0 -49.99 46.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.764 -0.732 . . . . 42.229999999999997 112.447 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.2 mmt -71.65 -31.81 67.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 64.400000000000006 110.919 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 50.0 t80 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 75.040000000000006 110.904 -179.952 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.231 0.147 0 CA-C-O 120.822 0.259 . . . . 74.010000000000005 112.354 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.07 -30.96 65.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 72.310000000000002 110.86 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -78.26 -31.82 49.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 74.209999999999994 110.917 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.627 ' CE1' HG22 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -73.63 -44.87 55.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 74.040000000000006 110.876 -179.83 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -60.55 -39.86 89.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 35.310000000000002 111.156 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.437 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.18 -29.07 21.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 52.350000000000001 111.135 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.03 -27.08 51.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 72.230000000000004 110.898 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.31 -19.19 23.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 71.140000000000001 110.904 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.4 mm -76.87 -34.62 22.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 55.200000000000003 111.112 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.537 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.78 -57.08 23.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.614 0.721 . . . . 70.010000000000005 111.13 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.4 Cg_endo -69.77 -19.34 36.21 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.709 2.273 . . . . 64.219999999999999 112.348 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.63 ' O ' HG22 ' A' ' 42' ' ' ILE . 37.4 t -70.12 -46.29 65.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 74.420000000000002 110.872 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 p -81.53 -28.91 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 74.049999999999997 111.16 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 38' ' ' PRO . 11.5 mt -51.04 -33.91 27.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 51.229999999999997 110.902 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.63 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.73 -34.64 52.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 63.409999999999997 111.146 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 p -65.73 -36.56 83.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 62.25 111.096 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.37 -44.77 72.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 71.430000000000007 110.881 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.01 -42.3 39.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 55.219999999999999 110.91 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.11 -34.63 66.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 73.299999999999997 111.126 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.409 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.1 mp -64.54 -32.39 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 75.040000000000006 111.121 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.4 tp -51.55 -37.43 49.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 74.200000000000003 110.932 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.69 HG23 ' HD3' ' A' ' 59' ' ' LYS . 7.9 p -101.98 -36.13 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 45.229999999999997 111.144 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -68.31 -64.96 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 75.420000000000002 110.885 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.458 ' CE2' HD22 ' A' ' 141' ' ' LEU . 0.3 OUTLIER -56.36 -39.15 72.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.148 -0.478 . . . . 74.329999999999998 110.916 -179.823 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.7 tp -57.61 139.0 81.79 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.613 0.72 . . . . 74.409999999999997 110.871 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 178.81 4.21 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.663 2.242 . . . . 50.240000000000002 112.349 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.23 161.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 64.219999999999999 110.859 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -160.88 175.9 12.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.102 -0.499 . . . . 74.549999999999997 110.87 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.5 p -176.19 -174.36 0.62 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 41.520000000000003 110.892 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 61' ' ' THR . . . -57.52 -31.45 63.32 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.737 -0.744 . . . . 62.409999999999997 112.486 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -75.09 -54.74 6.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.882 0.372 . . . . 74.510000000000005 110.904 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.69 ' HD3' HG23 ' A' ' 49' ' ' VAL . 3.3 mttm -53.2 -45.33 68.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 71.519999999999996 110.919 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -57.68 -51.74 68.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 73.450000000000003 110.844 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 57' ' ' GLY . 60.4 p -65.37 -28.43 69.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.264 -0.425 . . . . 75.349999999999994 111.136 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.51 -34.57 67.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 74.450000000000003 110.934 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.481 ' O ' HG12 ' A' ' 66' ' ' VAL . 80.2 m -72.78 -51.99 16.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 63.140000000000001 110.913 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.5 tt -54.39 -33.06 25.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 71.129999999999995 111.112 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.69 -25.24 6.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 74.049999999999997 110.858 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 63' ' ' CYS . 9.9 p -57.13 -32.62 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.485 . . . . 72.099999999999994 111.127 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.93 -35.36 61.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 72.409999999999997 110.917 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.503 ' O ' HD22 ' A' ' 68' ' ' LEU . 2.0 tm? -68.96 -46.7 67.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 63.200000000000003 110.891 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.8 -29.53 19.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 60.109999999999999 111.089 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.773 HD22 HG11 ' A' ' 102' ' ' VAL . 40.9 mt -57.83 -54.51 46.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 75.450000000000003 110.918 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 68' ' ' LEU . 1.2 t -63.45 -27.28 69.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 61.350000000000001 111.156 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.6 t -71.35 -34.11 52.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 70.230000000000004 111.169 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -52.07 -30.11 24.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 75.099999999999994 110.865 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.608 HD11 HD11 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -74.93 -39.49 61.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 72.450000000000003 110.923 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.0 mp -73.24 -40.13 64.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 73.120000000000005 110.902 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.6 -55.05 22.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 73.239999999999995 110.937 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 tt -56.22 -24.69 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 73.209999999999994 111.17 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.1 p -68.1 -15.0 63.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 74.319999999999993 110.876 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.729 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -60.11 -19.83 55.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 54.100000000000001 110.94 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.627 HG22 ' CE1' ' A' ' 31' ' ' TYR . 1.1 pt -53.57 -27.17 14.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 61.219999999999999 111.134 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 79' ' ' LYS . 50.2 t 61.41 75.23 0.45 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.661 0.743 . . . . 70.239999999999995 111.101 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 167.46 24.35 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.663 2.242 . . . . 64.540000000000006 112.395 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -48.64 0.67 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.671 2.247 . . . . 71.420000000000002 112.35 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 86' ' ' LEU . 9.6 t -117.26 -19.63 9.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 71.010000000000005 111.15 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.3 t 63.72 38.37 9.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.451 . . . . 72.349999999999994 110.822 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.456 ' H ' HG23 ' A' ' 84' ' ' THR . 1.2 tp -99.72 35.33 2.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.144 -0.48 . . . . 61.240000000000002 110.94 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.634 ' HA ' HD23 ' A' ' 90' ' ' LEU . 1.8 m-20 -95.58 24.37 5.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 64.450000000000003 110.887 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.521 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.31 -57.73 10.13 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.623 0.725 . . . . 40.229999999999997 111.195 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.535 ' HG2' HD22 ' A' ' 90' ' ' LEU . 53.6 Cg_endo -69.82 -20.32 34.71 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.664 2.242 . . . . 63.109999999999999 112.329 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.634 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.14 -53.09 10.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 71.519999999999996 110.949 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.48 HG12 HD21 ' A' ' 95' ' ' LEU . 39.7 t -80.31 -20.53 11.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 74.409999999999997 111.116 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.28 -31.49 27.45 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.775 -0.726 . . . . 71.340000000000003 112.494 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -35.39 59.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.8 0.333 . . . . 51.219999999999999 110.883 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -65.69 -44.84 84.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 75.129999999999995 110.872 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.608 HD11 HD11 ' A' ' 74' ' ' LEU . 7.5 mt -51.94 -29.81 21.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 71.140000000000001 110.953 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -43.38 76.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 72.209999999999994 110.892 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.498 ' O ' HG22 ' A' ' 100' ' ' VAL . 33.7 t80 -75.22 -51.83 12.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 74.420000000000002 110.9 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.792 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.07 -29.97 33.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 74.25 111.185 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.2 mmt -66.61 -30.04 70.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 65.200000000000003 110.923 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.83 -30.04 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 73.230000000000004 111.111 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.792 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -74.92 -33.31 61.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 73.109999999999999 110.947 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.773 HG11 HD22 ' A' ' 70' ' ' LEU . 31.3 m -76.8 -38.07 29.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 74.329999999999998 111.115 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.489 ' HA ' HD12 ' A' ' 106' ' ' ILE . 71.4 m -72.49 -39.81 67.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 71.430000000000007 111.149 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -64.69 -31.96 73.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 74.129999999999995 110.898 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.4 t -71.54 -35.75 70.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 51.409999999999997 110.859 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 103' ' ' THR . 11.7 mt -71.58 -51.83 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 73.5 111.116 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.556 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.5 p -53.97 -35.1 27.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 72.310000000000002 111.13 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.6 m -52.34 -32.43 38.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 75.25 111.146 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.4 m -50.42 -31.52 15.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 50.039999999999999 110.871 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.5 p -52.49 -32.79 17.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.102 -0.499 . . . . 71.430000000000007 111.153 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 42.1 m -66.59 -45.66 78.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 63.539999999999999 110.868 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 88.4 t -73.91 -34.7 40.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 75.420000000000002 111.128 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.07 -42.02 66.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 75.109999999999999 110.906 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -52.02 -30.71 26.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 75.319999999999993 110.901 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.77 HG11 ' HB2' ' A' ' 133' ' ' ALA . 9.4 p -102.31 -23.07 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 71.340000000000003 111.13 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -52.49 -66.22 0.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 73.120000000000005 110.896 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 74.310000000000002 110.876 179.994 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.467 -0.253 . . . . 72.200000000000003 112.467 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -63.29 -26.12 68.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.961 0.41 . . . . 71.25 110.953 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.8 m -56.9 -33.68 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.116 -0.493 . . . . 62.210000000000001 111.15 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.77 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -65.2 -25.22 67.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 41.420000000000002 111.091 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 16.7 mmt -53.0 -30.92 38.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 62.119999999999997 110.833 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 49.2 t -56.96 -63.86 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 62.039999999999999 111.11 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.0 mp -70.46 -38.35 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 65.129999999999995 111.134 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -60.56 -30.02 69.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 73.409999999999997 110.879 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.5 mtt-85 -56.18 -26.03 49.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 75.400000000000006 110.881 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.01 -50.99 35.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 74.140000000000001 110.941 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -73.97 -28.44 61.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 64.430000000000007 110.862 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.492 ' O ' HG23 ' A' ' 145' ' ' VAL . 0.2 OUTLIER -64.02 -36.4 83.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 71.420000000000002 110.913 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -58.99 -48.74 80.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 73.109999999999999 110.883 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.724 ' O ' HG23 ' A' ' 147' ' ' VAL . 58.5 mt -77.04 -32.29 19.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 63.229999999999997 111.159 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.0 -56.88 15.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 75.030000000000001 110.89 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 141' ' ' LEU . 21.6 t -60.42 -35.06 60.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 70.420000000000002 111.155 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.06 -32.97 74.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 51.450000000000003 110.892 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 143' ' ' ILE . 92.9 t -53.98 -34.11 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 62.25 111.139 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 4.8 t -52.03 -42.98 63.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 73.140000000000001 110.878 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 25.5 t -75.99 -33.03 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 73.530000000000001 111.124 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -52.44 -49.9 63.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 73.230000000000004 110.93 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.2 -19.78 73.87 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.71 -0.757 . . . . 74.409999999999997 112.53 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.4 m -63.46 -52.85 59.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.783 0.325 . . . . 43.229999999999997 111.167 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 89.2 mt -76.49 -25.89 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 71.140000000000001 111.149 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -52.19 -29.39 29.15 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 31.039999999999999 112.502 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.92 -31.9 51.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.737 0.303 . . . . 63.420000000000002 110.883 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 74.099999999999994 110.843 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.192 0 CA-C-O 120.835 0.265 . . . . 73.540000000000006 112.319 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 pp -52.08 -30.99 28.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 73.209999999999994 110.933 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -80.08 -32.52 39.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 64.519999999999996 110.838 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -72.66 -46.25 54.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.206 -0.452 . . . . 71.040000000000006 110.892 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -59.81 -39.95 86.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.492 . . . . 54.109999999999999 111.148 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.431 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.13 -29.06 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 53.25 111.135 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.65 -27.59 50.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 73.400000000000006 110.886 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.557 ' HG ' HD12 ' A' ' 77' ' ' ILE . 4.1 mm? -90.78 -18.14 25.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 60.240000000000002 110.896 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.9 mm -76.33 -35.31 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 71.010000000000005 111.083 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.549 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.77 -57.13 23.23 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.605 0.717 . . . . 75.230000000000004 111.098 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.9 Cg_endo -69.8 -21.83 32.74 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.689 2.259 . . . . 74.519999999999996 112.374 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.618 ' O ' HG22 ' A' ' 42' ' ' ILE . 43.6 t -73.86 -44.43 55.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 73.540000000000006 110.826 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.57 -28.91 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 74.319999999999993 111.138 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mt -50.97 -33.93 26.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 73.349999999999994 110.948 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.73 -34.68 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 74.540000000000006 111.122 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.2 p -65.69 -42.84 90.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 72.329999999999998 111.093 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.99 -41.74 64.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.425 . . . . 74.349999999999994 110.829 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.4 tp -77.03 -38.43 52.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 72.209999999999994 110.946 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.8 -52.14 67.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 54.229999999999997 111.056 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.43 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.4 mp -49.72 -31.44 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 71.150000000000006 111.079 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.2 tp -50.79 -42.3 57.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 65.400000000000006 110.926 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.421 HG11 HD23 ' A' ' 62' ' ' LEU . 7.1 p -101.46 -37.5 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 63.100000000000001 111.12 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -63.68 -64.46 0.89 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 75.400000000000006 110.85 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.647 ' CZ ' HD23 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -72.89 -60.73 2.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 73.430000000000007 110.897 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -78.39 159.22 75.35 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.549 0.69 . . . . 75.420000000000002 110.943 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 138.68 38.31 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.657 2.238 . . . . 73.450000000000003 112.321 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.3 112.67 0.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 43.409999999999997 110.854 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 56.32 -176.06 0.05 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.145 -0.479 . . . . 74.219999999999999 110.859 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 50.0 t -113.7 -74.51 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 54.229999999999997 110.859 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.428 ' O ' HG23 ' A' ' 61' ' ' THR . . . -61.71 -23.01 62.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.742 . . . . 42.439999999999998 112.493 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -52.11 -34.96 46.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.914 0.387 . . . . 70.319999999999993 110.932 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -51.96 60.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 70.400000000000006 110.911 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -48.56 68.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 65.420000000000002 110.852 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 57' ' ' GLY . 29.3 p -53.07 -31.88 44.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 74.319999999999993 111.134 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.516 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -69.2 -50.84 43.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 63.420000000000002 110.93 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 68.1 m -52.97 -47.75 67.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 71.409999999999997 110.861 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.3 tt -72.31 -35.04 51.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 72.450000000000003 111.141 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.67 -25.61 60.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 61.240000000000002 110.879 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 62' ' ' LEU . 21.7 t -63.09 -41.39 92.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.101 -0.5 . . . . 63.409999999999997 111.119 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 tt -52.88 -28.87 25.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 63.119999999999997 110.991 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.489 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.26 -39.1 78.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 55.329999999999998 110.872 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.41 -30.03 70.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 75.209999999999994 111.099 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.503 HD13 HG11 ' A' ' 102' ' ' VAL . 9.8 mt -64.78 -54.7 27.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 74.049999999999997 110.957 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.94 -38.26 87.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 55.229999999999997 111.147 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 68' ' ' LEU . 77.0 t -71.44 -32.82 47.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 65.200000000000003 111.134 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.499 ' O ' HG22 ' A' ' 77' ' ' ILE . 73.6 t80 -61.85 -29.85 70.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 64.209999999999994 110.89 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.739 HD11 HD13 ' A' ' 95' ' ' LEU . 3.1 tt -71.99 -44.93 62.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 74.420000000000002 110.941 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.7 mp -73.22 -39.31 65.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 71.430000000000007 110.931 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.28 -51.67 67.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.129999999999995 110.907 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.557 HD12 ' HG ' ' A' ' 35' ' ' LEU . 1.8 tt -68.17 -30.2 47.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 75.200000000000003 111.092 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.1 t -80.53 -14.93 57.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 75.150000000000006 110.821 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.29 -9.9 58.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.151 -0.477 . . . . 74.409999999999997 110.903 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 77' ' ' ILE . 1.1 pp -63.84 -15.37 16.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.422 . . . . 73.340000000000003 111.147 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 81' ' ' VAL . 2.4 p 35.79 81.21 0.25 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.609 0.718 . . . . 64.0 111.137 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 167.3 24.78 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.704 2.269 . . . . 74.019999999999996 112.364 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 -48.61 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.657 2.238 . . . . 73.510000000000005 112.313 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.0 t -117.26 -19.48 9.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 74.319999999999993 111.125 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.54 46.99 3.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 55.439999999999998 110.866 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.1 -11.1 60.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 62.240000000000002 110.901 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.634 ' HA ' HD23 ' A' ' 90' ' ' LEU . 3.7 m-20 -95.36 23.96 5.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 75.219999999999999 110.892 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.58 -57.8 9.56 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.626 0.727 . . . . 60.240000000000002 111.161 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.5 Cg_endo -69.77 -20.02 35.31 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.679 2.253 . . . . 64.200000000000003 112.358 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.634 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.22 -53.1 10.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 74.430000000000007 110.863 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 87' ' ' ASP . 40.3 t -68.6 -43.42 83.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 73.120000000000005 111.146 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.07 -38.86 48.43 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.76 . . . . 65.040000000000006 112.497 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.66 -24.39 59.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.783 0.325 . . . . 72.549999999999997 110.902 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -74.5 -37.92 62.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 72.310000000000002 110.897 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.739 HD13 HD11 ' A' ' 74' ' ' LEU . 12.5 mt -54.79 -29.57 54.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 75.140000000000001 110.927 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.0 mmt -71.28 -41.56 69.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 72.439999999999998 110.884 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.494 ' O ' HG22 ' A' ' 100' ' ' VAL . 23.3 t80 -75.28 -51.06 14.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 64.010000000000005 110.888 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.786 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.09 -29.87 32.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.474 . . . . 60.140000000000001 111.18 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.68 -30.09 70.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 63.329999999999998 110.85 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.8 -30.05 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.443 . . . . 72.219999999999999 111.113 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.786 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.93 -32.99 61.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 74.340000000000003 110.924 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.503 HG11 HD13 ' A' ' 70' ' ' LEU . 29.4 m -76.6 -37.46 29.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 72.439999999999998 111.091 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.716 ' O ' HG23 ' A' ' 107' ' ' VAL . 55.3 m -72.98 -46.6 51.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 72.049999999999997 111.154 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -51.96 -31.7 30.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 43.420000000000002 110.916 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.8 p -74.59 -48.73 24.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 72.230000000000004 110.813 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.643 HD12 ' HA ' ' A' ' 103' ' ' THR . 9.8 mt -56.15 -34.52 39.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 63.32 111.148 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 103' ' ' THR . 22.1 t -53.85 -45.55 62.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 62.32 111.083 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.9 m -52.3 -32.38 37.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 64.319999999999993 111.153 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.5 t -50.28 -31.49 14.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 74.340000000000003 110.857 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.5 p -52.51 -32.83 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 74.340000000000003 111.159 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 34.7 m -65.89 -44.52 85.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 73.219999999999999 110.874 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 83.8 t -75.52 -35.78 33.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 74.439999999999998 111.154 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.8 mt -72.21 -33.62 67.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 71.120000000000005 110.916 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -62.6 -28.95 70.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 64.540000000000006 110.93 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.8 HG11 ' HB2' ' A' ' 133' ' ' ALA . 11.2 p -102.39 -20.94 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 54.340000000000003 111.084 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -76.08 73.69 2.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 70.329999999999998 110.833 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 73.230000000000004 110.836 179.964 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.543 -0.223 . . . . 42.229999999999997 112.543 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -62.14 -26.39 68.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.968 0.413 . . . . 74.239999999999995 110.945 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.4 m -54.14 -27.2 16.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 42.229999999999997 111.147 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.8 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -56.62 -26.25 55.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 55.340000000000003 111.136 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 11.3 ptm -53.04 -30.79 37.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 62.43 110.846 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 58.6 t -56.9 -61.55 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 73.140000000000001 111.159 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.481 ' H ' HD12 ' A' ' 136' ' ' ILE . 4.5 mp -74.06 -25.96 20.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 74.109999999999999 111.136 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.442 ' OD2' HD13 ' A' ' 141' ' ' LEU . 25.5 t0 -58.5 -29.96 66.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.462 . . . . 72.430000000000007 110.884 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -30.1 23.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 73.439999999999998 110.863 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 7.0 tp -63.22 -50.73 69.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 61.439999999999998 110.916 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -74.03 -41.22 62.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 62.240000000000002 110.882 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.647 HD23 ' CZ ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -51.93 -31.98 31.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 73.209999999999994 110.915 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.18 -46.25 84.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.192 -0.458 . . . . 73.310000000000002 110.913 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.745 ' O ' HG23 ' A' ' 147' ' ' VAL . 3.9 mt -76.98 -31.96 19.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 70.120000000000005 111.155 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -56.01 -55.89 27.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 71.239999999999995 110.873 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 141' ' ' LEU . 31.8 t -54.01 -36.68 32.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 73.439999999999998 111.153 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -70.05 -41.38 74.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 73.209999999999994 110.867 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 143' ' ' ILE . 96.7 t -54.07 -34.45 26.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 45.219999999999999 111.087 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 95.6 m -51.9 -52.08 52.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 63.310000000000002 110.873 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.46 ' O ' HG22 ' A' ' 153' ' ' ILE . 31.5 t -76.06 -33.26 24.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 74.140000000000001 111.14 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.72 -27.05 37.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 75.140000000000001 110.846 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.97 -57.67 3.42 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.733 -0.746 . . . . 71.010000000000005 112.485 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 92.5 m -61.35 -45.01 96.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.779 0.323 . . . . 72.140000000000001 111.185 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.46 HG22 ' O ' ' A' ' 149' ' ' VAL . 20.3 tt -55.9 -25.86 19.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 73.400000000000006 111.128 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -51.93 -50.07 45.99 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.746 -0.74 . . . . 74.099999999999994 112.454 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.66 -31.84 63.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.773 0.32 . . . . 71.530000000000001 110.85 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 75.540000000000006 110.9 -179.92 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.822 0.259 . . . . 61.329999999999998 112.354 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 pp -53.57 -30.93 44.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 63.530000000000001 110.917 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -80.58 -28.56 37.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 60.5 110.898 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.475 ' CE1' HG21 ' A' ' 80' ' ' ILE . 7.5 t80 -76.74 -44.79 31.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 74.420000000000002 110.913 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.4 t -62.87 -39.54 94.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 73.140000000000001 111.182 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.442 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -73.79 -29.03 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 74.299999999999997 111.12 179.902 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -68.87 -25.31 64.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 72.230000000000004 110.922 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.51 ' CD1' HD12 ' A' ' 77' ' ' ILE . 3.6 mm? -92.0 -27.81 17.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 73.230000000000004 110.884 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.532 ' O ' HG12 ' A' ' 40' ' ' VAL . 26.2 mm -79.51 -28.38 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 74.349999999999994 111.145 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.549 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.96 -57.15 23.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.575 0.702 . . . . 72.299999999999997 111.086 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.79 -24.82 29.1 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.676 2.251 . . . . 72.409999999999997 112.356 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.636 ' O ' HG22 ' A' ' 42' ' ' ILE . 3.1 t -74.57 -45.4 45.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 60.109999999999999 110.892 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 36' ' ' ILE . 8.9 p -81.45 -28.91 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 53.329999999999998 111.161 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mt -51.02 -33.96 27.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 64.319999999999993 110.898 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 39' ' ' CYS . 0.8 OUTLIER -58.68 -34.6 52.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 72.109999999999999 111.138 179.85 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.69 -34.98 79.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 64.549999999999997 111.094 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 m -57.33 -52.6 64.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 75.140000000000001 110.836 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.8 tp -70.16 -34.45 73.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 54.210000000000001 110.922 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.24 -44.89 90.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.452 . . . . 10.23 111.11 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.432 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.3 mp -64.26 -31.98 55.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 63.229999999999997 111.137 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mp -51.39 -38.88 55.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 73.450000000000003 110.916 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.782 HG22 ' HD3' ' A' ' 59' ' ' LYS . 7.9 p -101.45 -36.7 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 63.030000000000001 111.107 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -67.05 -64.65 0.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 63.109999999999999 110.861 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.432 ' HB2' HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -71.4 -60.08 2.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 54.530000000000001 110.936 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.1 mp -78.2 160.67 72.82 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.609 0.719 . . . . 64.019999999999996 110.92 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 157.25 61.14 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.711 2.274 . . . . 73.239999999999995 112.329 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.486 ' HB3' HG23 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -179.32 -170.19 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 71.430000000000007 110.845 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.33 171.21 1.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 71.209999999999994 110.859 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 5.6 t -81.51 -68.11 0.72 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 71.150000000000006 110.922 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.53 -23.64 43.66 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.782 -0.723 . . . . 70.319999999999993 112.495 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -52.36 -42.89 64.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.933 0.397 . . . . 72.430000000000007 110.908 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.782 ' HD3' HG22 ' A' ' 49' ' ' VAL . 1.1 mmmt -53.53 -43.45 68.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 73.0 110.868 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.93 -50.77 26.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 51.130000000000003 110.867 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.2 p -53.39 -44.64 68.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 64.540000000000006 111.136 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.93 -28.93 64.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 71.299999999999997 110.93 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.468 ' HB3' HG23 ' A' ' 106' ' ' ILE . 1.3 m -71.43 -44.96 63.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 63.25 110.889 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.8 tt -72.41 -35.09 50.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 61.119999999999997 111.118 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -55.96 -26.25 47.27 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.174 -0.466 . . . . 70.5 110.809 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.2 t -58.68 -38.63 72.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 74.219999999999999 111.113 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.89 -28.93 25.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 55.109999999999999 110.918 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.492 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.16 -39.14 78.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 75.129999999999995 110.893 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.4 -30.12 70.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 50.539999999999999 111.079 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.685 HD22 HG11 ' A' ' 102' ' ' VAL . 9.7 mt -64.93 -54.66 27.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.448 . . . . 72.239999999999995 110.93 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.92 -38.25 87.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 62.030000000000001 111.139 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 68' ' ' LEU . 77.3 t -71.44 -32.85 47.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 63.399999999999999 111.165 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -51.87 -38.39 55.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 71.129999999999995 110.864 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.3 tp -75.12 -30.87 60.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.487 . . . . 70.420000000000002 110.905 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 65.5 mt -73.26 -54.03 9.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 64.200000000000003 110.888 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.61 -54.16 47.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 75.310000000000002 110.928 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.51 HD12 ' CD1' ' A' ' 35' ' ' LEU . 3.4 tt -55.49 -27.59 21.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 71.030000000000001 111.135 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.5 m -80.03 -24.8 40.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 62.509999999999998 110.895 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.686 ' O ' HG23 ' A' ' 81' ' ' VAL . 14.7 mttp -64.74 -15.27 61.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 74.439999999999998 110.853 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.475 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.2 pp -56.16 -24.38 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 64.400000000000006 111.136 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 79' ' ' LYS . 22.1 t 63.81 75.11 0.4 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.595 0.712 . . . . 64.209999999999994 111.118 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 166.69 26.77 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.71 2.273 . . . . 74.530000000000001 112.302 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -49.1 0.6 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.679 2.253 . . . . 62.539999999999999 112.347 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.9 t -118.88 -25.61 6.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 70.329999999999998 111.136 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 64.26 47.99 3.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 61.310000000000002 110.831 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.18 37.15 1.59 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 72.140000000000001 110.902 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.623 ' HA ' HD23 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -112.44 22.76 14.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 72.109999999999999 110.856 179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.54 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -68.05 -57.89 8.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.578 0.704 . . . . 52.140000000000001 111.106 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.7 Cg_endo -69.74 -19.93 35.6 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.653 2.236 . . . . 43.530000000000001 112.341 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.623 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.09 -51.54 15.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 72.519999999999996 110.964 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.569 HG12 HD21 ' A' ' 95' ' ' LEU . 39.1 t -80.17 -24.38 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 75.030000000000001 111.089 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.7 -50.0 44.86 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.729 -0.748 . . . . 74.140000000000001 112.496 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -35.46 80.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.78 0.324 . . . . 75.219999999999999 110.879 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -60.51 -40.1 90.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.218 -0.446 . . . . 64.420000000000002 110.906 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.569 HD21 HG12 ' A' ' 91' ' ' VAL . 8.5 mt -51.79 -29.87 20.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 71.109999999999999 110.918 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.21 -43.62 73.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 73.140000000000001 110.859 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.508 ' O ' HG22 ' A' ' 100' ' ' VAL . 51.7 t80 -75.19 -51.34 13.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 75.0 110.863 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.783 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.07 -29.91 32.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 64.409999999999997 111.169 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.9 mmt -66.69 -30.11 70.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 74.540000000000006 110.834 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.73 -30.12 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 72.129999999999995 111.123 179.955 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.783 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.89 -33.26 62.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 71.219999999999999 110.944 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.685 HG11 HD22 ' A' ' 70' ' ' LEU . 30.9 m -76.95 -38.04 27.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 70.319999999999993 111.141 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.503 ' HA ' HD12 ' A' ' 106' ' ' ILE . 69.8 m -72.51 -40.67 66.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 73.209999999999994 111.158 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -63.41 -31.98 73.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 72.129999999999995 110.87 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.29 -32.98 69.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 60.509999999999998 110.841 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 103' ' ' THR . 20.3 mt -73.96 -51.69 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 63.240000000000002 111.131 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -54.21 -34.29 27.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 71.230000000000004 111.164 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.5 m -53.0 -34.97 58.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 64.430000000000007 111.119 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.0 t -52.24 -48.34 65.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 72.400000000000006 110.845 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.7 t -52.91 -33.83 19.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.493 . . . . 61.350000000000001 111.155 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' CYS . . . . . 0.46 ' O ' HG12 ' A' ' 115' ' ' VAL . 31.2 m -65.09 -39.9 93.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 55.140000000000001 110.875 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 65.6 t -79.98 -36.14 16.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 74.409999999999997 111.175 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.611 HD21 ' HE2' ' A' ' 59' ' ' LYS . 87.6 mt -72.86 -51.7 17.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 74.430000000000007 110.886 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -51.73 -29.5 18.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 72.299999999999997 110.901 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.82 HG11 ' HB2' ' A' ' 133' ' ' ALA . 12.9 p -99.43 -16.81 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 63.450000000000003 111.157 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -54.26 -52.53 61.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 73.450000000000003 110.924 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 74.140000000000001 110.86 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.503 -0.239 . . . . 61.240000000000002 112.503 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -76.37 -27.0 56.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.938 0.399 . . . . 64.450000000000003 110.911 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.8 m -58.62 -37.39 64.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 71.329999999999998 111.158 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.82 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -72.8 -29.3 63.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 51.450000000000003 111.074 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 14.6 mmt -56.66 -31.02 63.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 73.340000000000003 110.806 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 65.9 t -56.99 -65.9 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 74.120000000000005 111.146 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 38.9 mm -69.17 -33.07 56.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 63.509999999999998 111.12 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -64.27 -29.97 71.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 64.140000000000001 110.859 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.09 -29.1 39.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 64.230000000000004 110.873 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.96 -44.54 61.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 64.099999999999994 110.926 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -74.0 -53.96 8.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 53.100000000000001 110.895 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.596 ' O ' HG23 ' A' ' 145' ' ' VAL . 0.8 OUTLIER -52.23 -36.98 53.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 73.129999999999995 110.96 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 32.9 t-105 -52.98 -51.48 61.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 73.340000000000003 110.905 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.621 ' O ' HG23 ' A' ' 147' ' ' VAL . 74.3 mt -76.99 -38.81 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 75.150000000000006 111.127 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -56.14 -57.15 13.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 53.340000000000003 110.839 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 141' ' ' LEU . 46.2 t -56.74 -34.96 44.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 73.030000000000001 111.128 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -66.58 -32.95 74.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 74.409999999999997 110.864 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 143' ' ' ILE . 94.5 t -53.99 -33.96 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 73.299999999999997 111.128 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.97 -36.77 50.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 72.430000000000007 110.845 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 83.1 t -75.95 -35.93 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 65.299999999999997 111.102 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -71.9 -27.01 62.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 73.230000000000004 110.863 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -52.2 -58.9 9.67 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.753 -0.737 . . . . 71.310000000000002 112.462 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.5 t -54.06 -35.08 61.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.78 0.324 . . . . 74.0 111.192 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 51.0 mm -66.67 -57.98 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 74.319999999999993 111.158 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -54.13 -26.07 34.15 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.764 -0.731 . . . . 63.210000000000001 112.488 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -32.0 73.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 41.049999999999997 110.903 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 18.3 t80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 73.349999999999994 110.89 -179.966 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.808 0.253 . . . . 63.25 112.312 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 pp -52.9 -31.5 40.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 72.329999999999998 110.927 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -80.35 -29.88 37.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 64.239999999999995 110.896 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -76.81 -42.35 40.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.13 -0.486 . . . . 74.109999999999999 110.935 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.1 t -62.21 -38.52 89.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 73.040000000000006 111.179 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.446 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -74.96 -29.12 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 65.540000000000006 111.124 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -57.53 -27.73 62.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 74.230000000000004 110.887 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.422 HD11 ' HG ' ' A' ' 76' ' ' LEU . 4.3 mm? -90.55 -20.13 22.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 63.030000000000001 110.924 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.4 mm -76.96 -34.22 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 50.219999999999999 111.131 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.543 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.3 mm -54.95 -57.32 20.08 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.634 0.731 . . . . 71.040000000000006 111.143 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.654 ' HA ' HD23 ' A' ' 41' ' ' LEU . 53.5 Cg_endo -69.72 -11.8 31.65 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.657 2.238 . . . . 43.299999999999997 112.363 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.622 ' O ' HG22 ' A' ' 42' ' ' ILE . 3.1 t -62.07 -43.41 98.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 73.120000000000005 110.895 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 37' ' ' ILE . 14.3 p -79.47 -27.28 12.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 71.129999999999995 111.073 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.654 HD23 ' HA ' ' A' ' 38' ' ' PRO . 2.9 mm? -50.39 -34.31 23.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 71.310000000000002 110.909 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 39' ' ' CYS . 0.8 OUTLIER -58.7 -34.94 53.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 74.319999999999993 111.115 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.3 p -64.95 -36.59 84.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 72.099999999999994 111.105 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.1 t -54.17 -46.35 72.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 41.229999999999997 110.847 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tp -77.13 -38.08 52.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 75.209999999999994 110.936 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.65 -52.12 67.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 50.200000000000003 111.07 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.426 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.4 mp -49.82 -31.51 6.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 74.299999999999997 111.11 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 tt -50.78 -41.91 57.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 73.319999999999993 110.92 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.762 HG13 HD22 ' A' ' 62' ' ' LEU . 7.2 p -101.61 -36.77 4.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 45.340000000000003 111.117 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -64.47 -64.56 0.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 73.530000000000001 110.888 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.426 ' HB2' HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -71.71 -62.01 1.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 74.239999999999995 110.965 -179.856 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.4 mp -67.04 160.75 68.51 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.61 0.719 . . . . 74.109999999999999 110.896 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 143.12 49.55 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.692 2.262 . . . . 64.540000000000006 112.316 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.686 ' CB ' HG23 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -153.42 -170.1 3.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 72.310000000000002 110.816 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.14 172.67 11.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 73.510000000000005 110.851 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 22.5 m -68.29 -62.07 1.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 71.319999999999993 110.869 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.25 -22.94 38.82 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.709 -0.757 . . . . 40.25 112.526 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -35.01 41.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.919 0.39 . . . . 64.120000000000005 110.915 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -56.24 -46.48 79.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 73.319999999999993 110.93 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -52.01 51.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 55.299999999999997 110.923 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 55.3 p -55.28 -25.95 37.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 75.310000000000002 111.129 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.762 HD22 HG13 ' A' ' 49' ' ' VAL . 22.4 tp -72.99 -37.27 67.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 74.140000000000001 110.896 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 39.4 t -73.85 -48.52 30.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 61.119999999999997 110.893 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.6 pt -58.09 -32.59 44.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 65.450000000000003 111.096 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.13 -57.15 4.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 74.420000000000002 110.848 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.558 HG23 ' CD1' ' A' ' 42' ' ' ILE . 13.2 p -60.64 -33.61 55.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 63.340000000000003 111.128 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 tt -52.67 -31.08 35.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 75.140000000000001 110.906 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.499 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -68.36 -37.78 80.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 71.519999999999996 110.944 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.0 -29.96 69.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 64.310000000000002 111.07 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.429 HD13 HG11 ' A' ' 102' ' ' VAL . 7.4 mt -66.78 -54.86 18.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.236 -0.438 . . . . 71.200000000000003 110.928 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.576 ' O ' HD13 ' A' ' 75' ' ' LEU . 4.7 t -59.95 -38.81 83.54 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.17 -0.468 . . . . 75.25 111.167 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 68' ' ' LEU . 84.6 t -71.42 -33.0 48.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 75.129999999999995 111.124 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -65.46 -38.44 89.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 71.329999999999998 110.916 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.782 HD23 HD13 ' A' ' 95' ' ' LEU . 7.6 mp -74.99 -35.41 62.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.117 -0.492 . . . . 73.209999999999994 110.932 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.576 HD13 ' O ' ' A' ' 71' ' ' THR . 8.1 mp -73.42 -47.84 38.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 60.350000000000001 110.902 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.437 ' O ' HD13 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -57.98 -48.33 80.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 62.020000000000003 110.924 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 tt -65.96 -28.83 44.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 73.140000000000001 111.122 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 t -80.85 -23.87 38.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 70.549999999999997 110.833 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.723 ' O ' HG23 ' A' ' 81' ' ' VAL . 7.6 mmtp -58.81 -22.04 57.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.484 . . . . 62.229999999999997 110.914 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 26.0 pt -51.25 -30.87 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 74.239999999999995 111.097 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 79' ' ' LYS . 58.4 t 55.71 80.13 0.31 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.655 0.74 . . . . 74.319999999999993 111.158 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 53.6 Cg_endo -69.79 112.11 3.0 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.652 2.235 . . . . 75.019999999999996 112.359 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 82' ' ' PRO . 53.6 Cg_endo -69.72 -48.56 0.7 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.713 2.275 . . . . 74.319999999999993 112.363 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.0 t -116.84 -22.07 8.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 74.420000000000002 111.131 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.71 -47.5 63.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 60.399999999999999 110.841 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.6 tp 51.73 49.8 20.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 74.109999999999999 110.951 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.639 ' HA ' HD23 ' A' ' 90' ' ' LEU . 9.7 m-20 -95.99 29.19 2.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 75.120000000000005 110.893 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.539 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -66.98 -57.77 10.65 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.612 0.72 . . . . 54.450000000000003 111.136 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.5 Cg_endo -69.78 -20.87 34.19 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.663 2.242 . . . . 73.209999999999994 112.337 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.639 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.25 -43.87 55.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 75.439999999999998 110.959 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.477 HG12 HD21 ' A' ' 95' ' ' LEU . 61.7 t -80.7 -38.84 17.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 42.539999999999999 111.106 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.89 -51.21 40.97 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.689 -0.767 . . . . 71.019999999999996 112.509 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -34.71 78.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.81 0.338 . . . . 73.400000000000006 110.891 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -61.26 -36.03 78.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 72.140000000000001 110.913 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.782 HD13 HD23 ' A' ' 74' ' ' LEU . 10.4 mt -51.82 -33.0 33.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 64.329999999999998 110.894 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.85 -28.05 33.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 64.010000000000005 110.891 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.491 ' O ' HG22 ' A' ' 100' ' ' VAL . 5.2 t80 -72.98 -54.68 7.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 63.109999999999999 110.89 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.803 ' HA ' HD23 ' A' ' 101' ' ' LEU . 0.6 OUTLIER -53.4 -28.54 30.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.494 . . . . 72.239999999999995 111.142 -179.933 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 27.4 mmt -68.59 -30.04 68.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 72.150000000000006 110.875 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.91 -29.74 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 73.030000000000001 111.107 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.803 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.74 -32.73 62.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 62.409999999999997 110.876 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.429 HG11 HD13 ' A' ' 70' ' ' LEU . 27.7 m -77.08 -38.18 27.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 44.119999999999997 111.178 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 84.4 m -72.66 -37.7 67.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 72.230000000000004 111.126 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -68.54 -32.19 71.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 75.5 110.851 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.0 t -70.42 -33.62 71.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 74.209999999999994 110.833 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 30.8 mt -72.6 -51.39 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 72.129999999999995 111.127 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.554 ' O ' HG12 ' A' ' 110' ' ' VAL . 6.3 p -56.18 -35.35 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 74.439999999999998 111.121 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 98.3 m -52.48 -32.32 39.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.156 -0.475 . . . . 51.140000000000001 111.104 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.41 -31.54 15.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 71.120000000000005 110.875 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.554 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.3 p -52.57 -32.87 17.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 73.129999999999995 111.129 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 43.0 m -66.11 -47.67 73.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 62.210000000000001 110.877 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.7 t -71.99 -36.04 56.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 71.349999999999994 111.141 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.5 mt -72.02 -33.48 68.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 63.119999999999997 110.961 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -59.64 -30.73 68.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 73.409999999999997 110.907 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.815 HG11 ' HB2' ' A' ' 133' ' ' ALA . 9.5 p -102.34 -24.21 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 65.219999999999999 111.127 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -90.72 -73.23 0.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 72.450000000000003 110.857 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 72.439999999999998 110.833 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.261 0 N-CA-C 112.455 -0.258 . . . . 72.219999999999999 112.455 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -87.87 -24.93 23.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.912 0.387 . . . . 73.329999999999998 110.901 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 23.8 m -53.98 -30.51 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 72.120000000000005 111.066 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.815 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -57.25 -25.05 58.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 73.439999999999998 111.082 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.8 ptm -52.94 -30.94 37.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 71.430000000000007 110.892 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 59.1 t -56.92 -53.64 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.284 -0.416 . . . . 73.420000000000002 111.128 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 64.9 mt -73.93 -38.56 50.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 64.230000000000004 111.156 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.97 -30.03 70.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 74.120000000000005 110.909 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -30.14 23.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 74.200000000000003 110.863 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.4 tt -63.47 -50.91 67.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 74.400000000000006 110.868 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -73.99 -36.97 64.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 71.540000000000006 110.901 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.0 -34.33 42.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 64.319999999999993 110.957 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 21.4 t90 -64.17 -50.68 67.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 74.310000000000002 110.915 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.633 ' O ' HG23 ' A' ' 147' ' ' VAL . 51.2 mm -68.35 -32.12 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 72.310000000000002 111.148 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -56.02 -56.72 17.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 70.409999999999997 110.859 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 21.7 t -65.95 -35.91 76.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 61.109999999999999 111.147 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.51 -33.2 65.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 71.129999999999995 110.842 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 143' ' ' ILE . 58.0 t -54.07 -34.11 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 54.409999999999997 111.126 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 71.8 m -51.95 -43.55 63.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.167 -0.47 . . . . 71.510000000000005 110.849 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 64.3 t -75.22 -35.06 32.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 54.420000000000002 111.112 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -54.74 -28.71 50.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 75.430000000000007 110.873 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -70.8 -22.43 78.19 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.734 -0.745 . . . . 62.149999999999999 112.493 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.1 m -79.46 -52.8 7.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.76 0.314 . . . . 54.310000000000002 111.15 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 47.6 mm -76.5 -24.15 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 73.219999999999999 111.147 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -52.13 -50.04 47.37 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.728 -0.748 . . . . 34.200000000000003 112.463 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -31.98 67.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 71.549999999999997 110.899 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 72.519999999999996 110.899 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.78 0.324 . . . . 75.239999999999995 110.853 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.13 -69.97 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 65.129999999999995 110.891 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.56 158.68 0.12 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.556 0.693 . . . . 74.219999999999999 110.947 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -12.68 33.36 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.729 2.286 . . . . 70.310000000000002 112.367 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.426 HD13 ' HE1' ' A' ' 156' ' ' PHE . 4.4 pp -52.0 -30.96 27.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 64.209999999999994 110.905 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.409 ' N ' HD12 ' A' ' 29' ' ' LEU . 52.2 t80 -78.54 -33.58 47.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 73.010000000000005 110.865 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -72.5 -45.96 56.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 62.219999999999999 110.905 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -60.23 -40.03 88.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 74.200000000000003 111.129 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.441 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.18 -29.11 21.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 75.310000000000002 111.138 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -55.87 -27.06 49.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 64.230000000000004 110.869 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.587 ' CB ' HD12 ' A' ' 77' ' ' ILE . 4.1 mm? -91.35 -19.18 23.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 55.119999999999997 110.922 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.468 HG21 HG23 ' A' ' 152' ' ' THR . 45.6 mm -76.73 -34.84 23.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.453 . . . . 62.130000000000003 111.137 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.544 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.2 mt -55.7 -57.13 23.0 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.621 0.724 . . . . 73.030000000000001 111.139 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.3 Cg_endo -69.81 -20.47 34.56 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.696 2.264 . . . . 73.329999999999998 112.32 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.624 ' O ' HG22 ' A' ' 42' ' ' ILE . 48.7 t -75.88 -44.59 39.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 62.520000000000003 110.867 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.53 -28.96 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 74.519999999999996 111.163 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 mt -51.0 -33.97 27.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 74.430000000000007 110.922 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.1 tp -58.73 -34.65 52.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 73.25 111.153 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.73 -40.9 92.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 72.120000000000005 111.167 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.25 -43.45 67.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 62.109999999999999 110.816 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 tp -76.46 -39.32 53.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.453 . . . . 74.319999999999993 110.908 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.88 -36.29 72.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 61.43 111.102 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.438 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.2 mp -64.97 -32.32 57.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 71.530000000000001 111.112 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.29 -33.78 63.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 73.109999999999999 110.901 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.997 HG11 HD13 ' A' ' 62' ' ' LEU . 29.0 m -101.66 -36.82 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 75.25 111.086 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -71.6 -64.81 0.85 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 65.299999999999997 110.927 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.509 ' CE2' HD22 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -69.63 -61.77 1.65 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 73.230000000000004 110.948 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.77 160.63 60.22 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.656 0.741 . . . . 74.019999999999996 110.907 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 136.37 32.85 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.709 2.272 . . . . 71.209999999999994 112.355 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.65 44.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 70.230000000000004 110.862 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -53.06 109.58 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 64.439999999999998 110.877 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -179.16 159.06 0.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 55.109999999999999 110.886 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.48 -26.71 31.52 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.748 . . . . 75.340000000000003 112.487 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -72.58 -35.0 67.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 75.0 110.85 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.0 -49.25 66.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 75.409999999999997 110.896 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -70.51 -48.08 57.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 54.539999999999999 110.913 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.2 m -54.27 -27.02 32.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 72.319999999999993 111.18 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.997 HD13 HG11 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -72.86 -38.92 66.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.446 . . . . 73.140000000000001 110.913 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 26.3 m -66.87 -45.59 77.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 71.530000000000001 110.861 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.9 tt -71.26 -35.0 56.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 64.439999999999998 111.101 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.6 m -58.43 -26.36 63.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 65.010000000000005 110.861 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 62' ' ' LEU . 22.3 t -61.73 -40.06 85.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.477 . . . . 74.239999999999995 111.063 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.89 -28.88 25.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 71.239999999999995 110.902 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.485 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.13 -39.17 79.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 72.140000000000001 110.914 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.39 -29.99 70.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 53.43 111.116 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.721 HD13 HG11 ' A' ' 102' ' ' VAL . 9.8 mt -65.11 -54.7 25.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 75.400000000000006 110.915 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.81 -38.26 87.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 71.5 111.172 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 68' ' ' LEU . 78.6 t -71.5 -32.98 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 75.409999999999997 111.12 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.553 ' O ' HG22 ' A' ' 77' ' ' ILE . 69.4 t80 -54.58 -30.01 53.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.481 . . . . 72.209999999999994 110.866 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.846 HD11 HD13 ' A' ' 95' ' ' LEU . 0.3 OUTLIER -65.78 -50.54 64.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 50.420000000000002 110.954 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.4 mt -73.23 -33.09 65.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 75.019999999999996 110.949 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -55.08 22.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 61.509999999999998 110.909 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.587 HD12 ' CB ' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -64.93 -30.48 50.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 63.210000000000001 111.152 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.8 t -80.47 -19.12 46.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 72.329999999999998 110.839 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.715 ' O ' HG23 ' A' ' 81' ' ' VAL . 8.2 mttt -78.16 -10.26 59.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 74.540000000000006 110.931 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 77' ' ' ILE . 2.1 pp -55.62 -25.19 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 75.230000000000004 111.12 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 79' ' ' LYS . 30.1 t 62.89 76.21 0.38 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.654 0.74 . . . . 55.149999999999999 111.155 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 167.5 24.29 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.685 2.257 . . . . 64.5 112.317 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -48.85 0.64 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.623 2.215 . . . . 65.319999999999993 112.37 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.3 t -133.65 14.43 4.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 74.140000000000001 111.122 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.3 p 51.65 37.96 21.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 74.140000000000001 110.856 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.15 -11.81 61.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 74.140000000000001 110.922 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.646 ' HA ' HD23 ' A' ' 90' ' ' LEU . 2.1 m-20 -95.28 23.36 5.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 55.409999999999997 110.835 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.539 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.8 -57.91 9.01 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.603 0.716 . . . . 75.109999999999999 111.128 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 54.7 Cg_endo -69.68 -19.99 35.78 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.698 2.265 . . . . 74.239999999999995 112.391 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.646 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.15 -50.36 19.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 62.399999999999999 110.897 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 87' ' ' ASP . 21.7 t -78.54 -47.35 23.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 74.219999999999999 111.138 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.87 -40.77 50.42 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.695 -0.764 . . . . 53.049999999999997 112.504 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.5 tttp -74.25 -23.5 59.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.797 0.332 . . . . 73.209999999999994 110.879 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -74.68 -34.34 62.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 73.319999999999993 110.971 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.846 HD13 HD11 ' A' ' 74' ' ' LEU . 14.9 mt -53.0 -29.67 30.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.079 -0.509 . . . . 75.319999999999993 110.939 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.56 -43.65 72.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 74.129999999999995 110.831 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.494 ' O ' HG22 ' A' ' 100' ' ' VAL . 47.0 t80 -75.18 -51.14 14.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 71.230000000000004 110.877 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.8 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.08 -29.95 33.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 64.230000000000004 111.132 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 8.9 mmt -66.54 -30.09 70.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 65.329999999999998 110.928 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.83 -30.12 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 74.430000000000007 111.088 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.8 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.88 -33.29 62.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 74.200000000000003 110.916 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.721 HG11 HD13 ' A' ' 70' ' ' LEU . 31.2 m -76.86 -38.06 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 74.540000000000006 111.128 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 76.5 m -72.51 -38.41 68.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 63.520000000000003 111.153 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -66.81 -32.0 72.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 74.019999999999996 110.911 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.5 t -71.5 -36.44 71.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 63.299999999999997 110.877 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 38.4 mt -70.78 -52.0 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 71.319999999999993 111.077 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.551 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.7 p -54.0 -35.96 29.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 72.120000000000005 111.114 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.3 m -52.42 -32.42 39.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 72.310000000000002 111.188 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 t -50.45 -31.36 14.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 63.539999999999999 110.874 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.4 p -52.42 -32.85 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 74.109999999999999 111.13 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 14.9 m -64.49 -46.59 82.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 72.409999999999997 110.912 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 130' ' ' GLY . 95.0 t -73.97 -38.93 50.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 74.510000000000005 111.111 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.5 mt -69.11 -30.92 69.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 72.219999999999999 110.931 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -58.18 -33.51 69.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 74.109999999999999 110.872 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.624 ' CG1' ' HB2' ' A' ' 133' ' ' ALA . 7.9 p -102.27 -24.79 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 72.549999999999997 111.156 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -58.84 -69.89 0.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 75.439999999999998 110.837 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -168.91 48.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 72.340000000000003 110.847 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.5 mtp85 -153.76 92.13 1.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 65.420000000000002 110.901 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.8 t 63.03 73.37 0.51 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.686 0.755 . . . . 74.319999999999993 110.899 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 124.28 10.95 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.673 2.249 . . . . 52.109999999999999 112.341 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.45 -24.69 14.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 64.030000000000001 111.141 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.42 98.87 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 74.329999999999998 111.108 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -131.42 -40.4 1.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.462 . . . . 73.209999999999994 110.839 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.98 159.66 40.05 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.615 0.721 . . . . 75.510000000000005 111.139 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 -172.55 0.6 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.689 2.259 . . . . 72.230000000000004 112.297 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.3 mtp85 60.95 173.43 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 71.299999999999997 110.869 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -169.94 -134.63 1.77 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.751 . . . . 73.109999999999999 112.451 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.8 -58.84 4.5 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.757 -0.735 . . . . 54.43 112.522 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -128.98 -149.92 7.01 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.724 -0.75 . . . . 74.150000000000006 112.479 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.699 ' O ' HG13 ' A' ' 112' ' ' VAL . . . -111.39 19.72 24.01 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.741 -0.742 . . . . 64.409999999999997 112.455 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -77.62 -26.14 50.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.963 0.411 . . . . 63.340000000000003 110.955 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.501 ' CG2' HG21 ' A' ' 115' ' ' VAL . 22.1 m -60.58 -37.48 75.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 71.040000000000006 111.087 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.624 ' HB2' ' CG1' ' A' ' 115' ' ' VAL . . . -63.7 -25.02 68.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 60.009999999999998 111.078 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 13.2 mmt -52.97 -30.98 38.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 72.0 110.909 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.9 t -56.97 -57.03 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 75.540000000000006 111.154 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 64.1 mt -74.02 -38.37 49.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 71.349999999999994 111.1 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -61.23 -29.96 70.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 74.349999999999994 110.896 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.02 -30.17 24.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 73.25 110.871 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.66 -50.83 70.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 52.399999999999999 110.935 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -74.04 -44.23 55.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 73.329999999999998 110.885 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.509 HD22 ' CE2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -52.06 -33.86 40.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 52.329999999999998 110.88 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -53.76 -46.51 70.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 65.409999999999997 110.905 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.518 ' O ' HG23 ' A' ' 147' ' ' VAL . 43.3 mm -76.9 -31.96 19.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 74.329999999999998 111.117 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -56.09 -56.82 16.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 71.109999999999999 110.865 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.9 m -54.9 -35.0 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 75.409999999999997 111.171 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -63.38 -32.95 74.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 73.439999999999998 110.9 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 143' ' ' ILE . 31.7 t -66.56 -37.74 80.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 74.230000000000004 111.129 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 91.8 m -58.93 -51.94 67.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 72.239999999999995 110.882 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.48 -32.99 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 64.239999999999995 111.125 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -52.71 -52.0 57.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 71.230000000000004 110.887 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.85 -19.38 75.51 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.757 . . . . 40.509999999999998 112.484 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.468 HG23 HG21 ' A' ' 36' ' ' ILE . 33.6 m -74.72 -52.83 10.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.81 0.338 . . . . 63.530000000000001 111.18 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.517 HG22 ' CD1' ' A' ' 157' ' ' LEU . 86.7 mt -76.52 -29.77 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 64.310000000000002 111.105 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -55.43 -49.95 62.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.725 -0.75 . . . . 55.399999999999999 112.491 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.4 mmt -71.13 -32.03 68.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.877 0.37 . . . . 70.129999999999995 110.923 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.426 ' HE1' HD13 ' A' ' 29' ' ' LEU . 15.1 t80 -71.82 -24.93 61.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 73.209999999999994 110.905 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.517 ' CD1' HG22 ' A' ' 153' ' ' ILE . 14.9 mt -75.48 -26.45 58.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 63.240000000000002 110.932 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.489 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.3 OUTLIER -51.9 -60.53 5.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.594 0.711 . . . . 63.340000000000003 110.917 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.5 Cg_endo -69.8 -16.34 37.34 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.669 2.246 . . . . 52.25 112.298 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.8 tp -93.93 40.85 1.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 73.420000000000002 110.92 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.97 -62.63 1.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 63.439999999999998 110.897 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -176.46 -74.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 74.340000000000003 110.928 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 60.53 99.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 72.140000000000001 110.885 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 16.1 t80 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 73.340000000000003 110.894 -179.914 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.82 0.343 . . . . 74.420000000000002 110.853 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.1 mtt-85 -65.17 91.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 72.209999999999994 110.911 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -114.03 73.01 2.32 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.548 0.69 . . . . 74.519999999999996 110.873 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -12.88 33.93 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.689 2.259 . . . . 72.209999999999994 112.352 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 pp -52.08 -30.93 28.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 71.450000000000003 110.932 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -78.43 -33.34 48.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 65.329999999999998 110.828 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.514 ' HE1' HG22 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -72.61 -45.81 57.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 73.129999999999995 110.936 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -60.28 -39.95 88.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 63.020000000000003 111.109 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.437 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.18 -29.03 21.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 72.239999999999995 111.146 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -26.72 52.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 72.120000000000005 110.857 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.57 -19.46 22.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 71.430000000000007 110.955 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.4 mm -76.68 -34.78 24.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 73.200000000000003 111.159 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.55 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.2 mt -55.74 -57.18 22.83 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.681 0.753 . . . . 74.120000000000005 111.14 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 54.1 Cg_endo -69.73 -20.97 34.29 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.673 2.249 . . . . 74.129999999999995 112.354 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.638 ' O ' HG22 ' A' ' 42' ' ' ILE . 48.5 t -75.89 -44.92 38.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.251 -0.431 . . . . 62.020000000000003 110.873 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.2 p -81.59 -28.89 10.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 74.400000000000006 111.166 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.2 mt -50.95 -33.94 26.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 74.239999999999995 110.89 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.77 -34.65 52.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 75.540000000000006 111.164 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 p -65.73 -34.74 78.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 51.219999999999999 111.164 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.14 -46.8 79.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 52.299999999999997 110.883 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.64 -41.6 60.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 75.120000000000005 110.896 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.52 -51.42 69.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 73.299999999999997 111.095 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.03 -32.09 56.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 65.019999999999996 111.166 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.558 ' O ' HD22 ' A' ' 52' ' ' LEU . 5.4 tp -51.62 -37.93 52.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 73.0 110.905 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.0 p -101.64 -35.79 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 75.219999999999999 111.153 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -66.28 -62.06 1.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 75.530000000000001 110.877 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.515 ' CE2' HD13 ' A' ' 141' ' ' LEU . 0.3 OUTLIER -55.52 -53.73 52.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 73.200000000000003 110.935 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.558 HD22 ' O ' ' A' ' 48' ' ' LEU . 10.9 mp -51.96 160.53 1.13 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.585 0.707 . . . . 65.400000000000006 110.968 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -170.97 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.688 2.259 . . . . 73.329999999999998 112.343 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 55.1 91.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 73.109999999999999 110.848 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -152.24 147.31 26.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 70.420000000000002 110.845 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -173.97 -74.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 75.439999999999998 110.877 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -85.95 -50.81 3.79 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.756 -0.735 . . . . 61.210000000000001 112.491 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -61.57 -44.34 97.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.899 0.38 . . . . 73.420000000000002 110.908 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.08 -48.9 67.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 73.409999999999997 110.931 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -66.02 -37.53 86.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 74.349999999999994 110.923 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.5 m -66.91 -29.14 68.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 64.310000000000002 111.17 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.701 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.9 OUTLIER -71.66 -50.69 28.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 74.510000000000005 110.937 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -51.21 62.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 74.010000000000005 110.86 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.5 tt -66.85 -35.02 73.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 74.120000000000005 111.154 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 m -65.79 -25.12 67.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 64.129999999999995 110.858 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 62' ' ' LEU . 64.0 t -58.02 -36.64 57.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 64.340000000000003 111.13 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.92 -28.95 25.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 75.230000000000004 110.898 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.495 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.29 -38.94 78.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 71.310000000000002 110.917 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.51 -30.0 70.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 70.299999999999997 111.133 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.641 HD22 HG11 ' A' ' 102' ' ' VAL . 9.5 mt -64.99 -54.78 25.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 110.904 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.68 -38.46 87.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 71.25 111.196 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 68' ' ' LEU . 79.3 t -71.43 -32.89 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.219999999999999 111.12 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -51.82 -30.14 22.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 75.109999999999999 110.895 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.561 HD11 HD11 ' A' ' 95' ' ' LEU . 0.3 OUTLIER -73.9 -41.62 61.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 62.399999999999999 110.928 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.0 mt -73.27 -34.6 65.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 73.040000000000006 110.873 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.402 HD13 ' HD2' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -69.6 -55.07 11.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 73.439999999999998 110.916 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.556 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -56.22 -24.59 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 61.109999999999999 111.083 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.5 -16.43 60.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 74.340000000000003 110.813 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.747 ' O ' HG23 ' A' ' 81' ' ' VAL . 2.0 ptmm? -64.05 -15.54 59.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 73.25 110.896 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 77' ' ' ILE . 1.0 OUTLIER -51.73 -28.68 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 70.109999999999999 111.106 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 79' ' ' LYS . 58.6 t 61.01 76.72 0.4 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.664 0.745 . . . . 70.140000000000001 111.12 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 167.41 24.46 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.702 2.268 . . . . 74.340000000000003 112.377 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -49.05 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.661 2.241 . . . . 75.299999999999997 112.365 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.9 t -134.48 18.37 3.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 70.430000000000007 111.125 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.2 p 50.09 46.51 24.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 74.150000000000006 110.856 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mt -94.68 22.12 6.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 62.329999999999998 110.94 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.628 ' HA ' HD23 ' A' ' 90' ' ' LEU . 4.1 m-20 -99.07 24.53 7.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 75.109999999999999 110.854 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.537 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.14 -57.78 10.34 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.634 0.731 . . . . 73.099999999999994 111.142 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.4 Cg_endo -69.77 -20.53 34.68 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.721 2.281 . . . . 62.109999999999999 112.341 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.628 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.16 -53.12 10.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 75.230000000000004 110.926 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.05 -40.39 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 72.140000000000001 111.116 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -53.17 -33.69 45.81 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.774 -0.727 . . . . 51.43 112.481 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.0 -23.25 44.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.831 0.348 . . . . 72.310000000000002 110.911 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -76.57 -35.19 58.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 74.400000000000006 110.942 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.561 HD11 HD11 ' A' ' 74' ' ' LEU . 13.3 mt -52.28 -29.9 25.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 61.420000000000002 110.916 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -43.15 79.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 73.439999999999998 110.92 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.504 ' O ' HG22 ' A' ' 100' ' ' VAL . 62.8 t80 -75.37 -52.09 11.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 73.530000000000001 110.852 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.785 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.14 -29.76 33.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 55.210000000000001 111.169 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.9 mmt -66.83 -30.06 70.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 73.540000000000006 110.916 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.77 -30.07 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 72.140000000000001 111.122 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.785 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.89 -33.19 62.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 64.030000000000001 110.927 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.641 HG11 HD22 ' A' ' 70' ' ' LEU . 31.6 m -76.87 -38.1 28.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 71.109999999999999 111.131 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.41 ' O ' HG13 ' A' ' 107' ' ' VAL . 73.6 m -72.45 -40.39 67.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 62.310000000000002 111.151 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -64.11 -31.95 73.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 63.210000000000001 110.902 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.7 m -73.89 -33.77 64.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 64.0 110.892 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 30.4 mt -75.1 -50.94 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 71.530000000000001 111.142 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.557 ' O ' HG12 ' A' ' 110' ' ' VAL . 34.5 m -53.9 -33.98 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 55.340000000000003 111.124 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.4 m -52.48 -32.46 40.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 54.229999999999997 111.09 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 t -50.48 -31.49 15.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 73.420000000000002 110.851 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.5 p -52.5 -32.77 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 73.219999999999999 111.158 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 42.6 m -66.86 -49.04 66.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 53.240000000000002 110.884 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 67.8 t -70.16 -35.67 64.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 62.140000000000001 111.159 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.8 mt -72.08 -38.97 69.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 74.25 110.887 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.576 ' ND2' HG23 ' A' ' 121' ' ' THR . 21.0 t-20 -53.9 -31.33 49.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 70.109999999999999 110.885 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.78 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.7 p -102.31 -23.68 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 74.209999999999994 111.167 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -52.87 -51.07 62.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 55.439999999999998 110.873 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -173.32 39.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 62.43 110.868 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.7 mtt85 -133.24 176.67 8.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 75.430000000000007 110.879 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.74 160.59 18.81 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.659 0.742 . . . . 74.219999999999999 110.879 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 146.4 59.83 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.671 2.247 . . . . 54.350000000000001 112.33 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.576 HG23 ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -84.65 -174.46 5.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 72.109999999999999 111.167 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.6 m -134.13 68.88 1.47 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 72.310000000000002 111.174 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.49 ' O ' HG23 ' A' ' 124' ' ' THR . 32.1 t-80 -177.1 -48.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 63.420000000000002 110.894 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 123' ' ' HIS . 0.9 OUTLIER -159.99 68.2 2.89 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.607 0.718 . . . . 75.239999999999995 111.174 -179.859 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -171.06 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.64 2.227 . . . . 75.400000000000006 112.339 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.458 ' HG2' HD11 ' A' ' 136' ' ' ILE . 0.0 OUTLIER -151.92 -71.06 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 72.540000000000006 110.915 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 177.8 -93.47 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.758 -0.734 . . . . 73.230000000000004 112.506 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -162.57 167.44 37.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.779 -0.724 . . . . 70.450000000000003 112.472 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 110.67 -76.76 0.22 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.765 -0.731 . . . . 54.109999999999999 112.512 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 137.21 -28.43 2.8 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.762 -0.733 . . . . 74.129999999999995 112.535 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -83.43 -26.59 30.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.892 0.377 . . . . 64.030000000000001 110.917 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.1 m -64.47 -30.04 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 74.400000000000006 111.131 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.78 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -58.14 -25.09 61.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.530000000000001 111.071 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 38.8 mmt -53.02 -30.86 37.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 73.340000000000003 110.902 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 71.6 t -56.98 -58.59 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 71.299999999999997 111.127 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.458 HD11 ' HG2' ' A' ' 126' ' ' ARG . 3.8 mt -74.03 -37.79 47.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 73.329999999999998 111.099 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.98 -30.88 70.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 75.129999999999995 110.883 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.26 -28.74 29.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 71.409999999999997 110.888 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.52 -43.36 63.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 73.129999999999995 110.94 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -73.96 -52.48 12.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 74.319999999999993 110.888 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.515 HD13 ' CE2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -52.01 -32.09 32.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 54.130000000000003 110.903 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -67.3 -42.53 83.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 72.209999999999994 110.876 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.743 ' O ' HG23 ' A' ' 147' ' ' VAL . 69.6 mt -76.85 -32.22 19.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.416 . . . . 74.420000000000002 111.103 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -56.0 -56.99 14.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 61.310000000000002 110.871 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.5 m -54.94 -35.05 32.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 71.319999999999993 111.123 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -68.32 -33.03 73.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 54.350000000000001 110.888 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 143' ' ' ILE . 46.0 t -69.17 -34.0 61.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 73.129999999999995 111.146 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.48 -52.04 60.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 73.340000000000003 110.922 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.0 m -73.1 -35.41 47.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 74.129999999999995 111.149 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -52.46 -40.16 61.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 75.109999999999999 110.878 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -76.6 -20.3 76.81 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.71 -0.757 . . . . 65.209999999999994 112.499 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 35.0 m -72.08 -52.86 14.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.755 0.312 . . . . 73.209999999999994 111.172 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 19.7 mt -76.58 -24.82 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 72.030000000000001 111.098 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.35 -49.63 76.45 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.734 -0.745 . . . . 21.010000000000002 112.503 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -32.05 55.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.843 0.354 . . . . 74.430000000000007 110.893 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.639 ' CE2' HD11 ' A' ' 160' ' ' LEU . 14.7 t80 -71.09 -24.04 62.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 63.340000000000003 110.859 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 13.2 mt -75.26 -27.17 59.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 55.310000000000002 110.916 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.479 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.8 OUTLIER -51.81 -60.59 5.71 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.62 0.724 . . . . 45.200000000000003 110.92 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 54.2 Cg_endo -69.74 -16.32 37.59 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.673 2.249 . . . . 61.509999999999998 112.364 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.639 HD11 ' CE2' ' A' ' 156' ' ' PHE . 52.3 mt -92.9 43.44 1.12 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 72.129999999999995 110.938 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.39 -68.94 0.68 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 73.420000000000002 110.898 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.43 -26.1 7.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 61.039999999999999 110.883 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -51.97 -62.19 1.79 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 54.229999999999997 110.949 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 71.439999999999998 110.925 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.795 0.331 . . . . 73.420000000000002 110.833 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -70.52 -26.2 63.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 74.439999999999998 110.858 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.72 73.04 0.8 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.566 0.698 . . . . 70.209999999999994 110.919 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 -12.17 32.47 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.742 2.294 . . . . 52.43 112.377 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 pp -53.37 -31.0 42.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 75.140000000000001 110.921 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -77.39 -30.2 53.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 71.099999999999994 110.902 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.458 ' HE1' HG22 ' A' ' 80' ' ' ILE . 0.6 OUTLIER -77.02 -44.46 30.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.15 -0.477 . . . . 74.409999999999997 110.932 -179.873 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -60.34 -40.06 89.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 64.510000000000005 111.129 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.431 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -71.83 -28.86 31.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 65.420000000000002 111.146 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.37 -26.58 68.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 70.439999999999998 110.921 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.617 HD13 HD22 ' A' ' 76' ' ' LEU . 1.0 OUTLIER -90.27 -24.44 20.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 60.32 110.899 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.8 mm -79.4 -29.41 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 70.140000000000001 111.121 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.65 -57.15 22.76 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.634 0.731 . . . . 72.349999999999994 111.123 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.3 Cg_endo -69.74 -19.69 35.88 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.696 2.264 . . . . 55.310000000000002 112.328 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.63 ' O ' HG22 ' A' ' 42' ' ' ILE . 47.5 t -76.04 -44.65 38.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 65.140000000000001 110.864 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 p -81.64 -28.89 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 52.310000000000002 111.128 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 mt -50.99 -33.94 26.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 75.230000000000004 110.943 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.63 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.72 -34.62 52.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 70.150000000000006 111.153 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 p -65.88 -41.53 91.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 74.329999999999998 111.105 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.8 t -52.92 -42.91 65.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 72.25 110.864 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.0 tp -76.71 -39.69 51.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 74.120000000000005 110.89 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.85 -51.35 70.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 64.420000000000002 111.082 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.436 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.4 mp -49.7 -31.46 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 71.239999999999995 111.09 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.74 -42.3 57.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 65.109999999999999 110.912 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.736 HG21 ' HA ' ' A' ' 59' ' ' LYS . 7.2 p -101.47 -37.52 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 74.400000000000006 111.093 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -63.61 -64.48 0.89 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 72.109999999999999 110.853 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.47 ' CG ' HD23 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -72.68 -56.06 5.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 73.239999999999995 110.978 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.5 mp -95.71 160.55 30.04 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.602 0.715 . . . . 72.430000000000007 110.898 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 141.24 44.44 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.617 2.211 . . . . 71.120000000000005 112.351 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.5 m -161.98 105.85 1.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 62.409999999999997 110.849 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.02 -170.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 74.540000000000006 110.838 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 78.8 m -110.9 -73.71 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 72.319999999999993 110.894 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.35 -26.81 72.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.744 -0.741 . . . . 60.240000000000002 112.514 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.08 -35.05 46.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.946 0.403 . . . . 74.319999999999993 110.877 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.736 ' HA ' HG21 ' A' ' 49' ' ' VAL . 2.2 ttpt -54.22 -51.42 64.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 73.430000000000007 110.938 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.459 ' O ' HG22 ' A' ' 64' ' ' ILE . 4.5 tpt -60.43 -51.31 70.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 73.239999999999995 110.917 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 30.0 p -54.8 -31.33 58.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 73.319999999999993 111.14 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -74.96 -41.34 59.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 74.219999999999999 110.926 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 81.5 m -66.84 -50.94 60.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 64.230000000000004 110.93 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 60' ' ' MET . 15.9 tt -62.27 -35.0 66.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 71.409999999999997 111.14 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.2 t -63.58 -27.08 69.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 75.239999999999995 110.874 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 62' ' ' LEU . 63.6 t -59.38 -39.37 78.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 65.150000000000006 111.124 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 tp -53.11 -29.03 28.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 75.25 110.879 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.501 ' O ' HD22 ' A' ' 68' ' ' LEU . 2.0 tm? -74.16 -46.81 39.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 60.049999999999997 110.888 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.76 -29.59 19.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 74.030000000000001 111.112 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.776 HD22 HG11 ' A' ' 102' ' ' VAL . 30.0 mt -58.04 -54.58 45.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 74.319999999999993 110.909 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 68' ' ' LEU . 1.1 t -63.12 -27.26 69.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 71.540000000000006 111.134 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.2 t -71.23 -32.94 49.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 72.310000000000002 111.107 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -52.08 -50.02 62.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 74.400000000000006 110.869 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.0 tp -61.54 -32.5 72.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 73.319999999999993 110.91 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 71' ' ' THR . 9.7 mp -73.04 -44.24 60.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.452 . . . . 71.129999999999995 110.941 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.617 HD22 HD13 ' A' ' 35' ' ' LEU . 1.2 tt -67.73 -50.22 58.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 63.32 110.912 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.473 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -57.43 -25.51 24.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 64.150000000000006 111.106 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.04 -18.58 49.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 65.109999999999999 110.904 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.744 ' O ' HG23 ' A' ' 81' ' ' VAL . 4.9 mmmt -69.07 -11.71 61.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 51.200000000000003 110.876 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.473 HG23 ' O ' ' A' ' 77' ' ' ILE . 1.4 pp -54.17 -26.33 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 71.230000000000004 111.097 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 79' ' ' LYS . 44.6 t 62.12 75.72 0.42 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.629 0.728 . . . . 74.430000000000007 111.149 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 167.61 23.91 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.646 2.231 . . . . 64.510000000000005 112.381 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -48.91 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.676 2.25 . . . . 40.299999999999997 112.361 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.42 HG23 ' HB2' ' A' ' 86' ' ' LEU . 11.8 t -133.1 13.29 4.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 70.439999999999998 111.175 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.1 m 51.55 65.23 1.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 74.340000000000003 110.882 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.42 ' HB2' HG23 ' A' ' 84' ' ' THR . 10.3 tp -117.19 25.93 10.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 54.0 110.899 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.639 ' HA ' HD23 ' A' ' 90' ' ' LEU . 1.5 m-20 -104.5 22.47 14.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 75.209999999999994 110.907 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.536 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -68.2 -57.94 8.31 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.649 0.738 . . . . 75.439999999999998 111.131 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.6 Cg_endo -69.72 -19.61 36.08 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.664 2.243 . . . . 73.400000000000006 112.385 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.639 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.15 -53.01 10.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 64.120000000000005 110.874 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.543 HG12 HD21 ' A' ' 95' ' ' LEU . 21.8 t -80.24 -23.79 11.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 73.540000000000006 111.146 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.68 -50.67 42.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.76 -0.733 . . . . 73.439999999999998 112.445 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.42 -35.06 78.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.757 0.313 . . . . 74.219999999999999 110.883 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -61.27 -42.46 98.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 75.299999999999997 110.943 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.543 HD21 HG12 ' A' ' 91' ' ' VAL . 7.7 mt -51.94 -29.83 22.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 65.030000000000001 110.938 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.0 mmt -67.77 -42.87 81.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 63.329999999999998 110.868 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.501 ' O ' HG22 ' A' ' 100' ' ' VAL . 62.2 t80 -75.24 -52.41 10.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 73.109999999999999 110.919 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.79 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.17 -29.77 33.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 70.239999999999995 111.185 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.2 mmt -66.86 -29.92 69.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.479 . . . . 70.049999999999997 110.883 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.84 -30.05 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 73.019999999999996 111.128 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.79 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -74.87 -33.38 62.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 62.310000000000002 110.918 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.776 HG11 HD22 ' A' ' 70' ' ' LEU . 30.4 m -76.89 -38.0 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 71.310000000000002 111.106 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.483 ' O ' HG13 ' A' ' 107' ' ' VAL . 63.2 m -72.44 -42.23 65.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 45.420000000000002 111.15 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -60.65 -31.96 71.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 63.439999999999998 110.929 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.1 t -75.08 -36.05 61.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 71.310000000000002 110.881 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 39.4 mt -74.87 -49.31 29.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.489 . . . . 74.049999999999997 111.16 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.547 ' O ' HG12 ' A' ' 110' ' ' VAL . 34.0 m -53.89 -33.91 24.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 75.420000000000002 111.158 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.8 m -52.34 -32.5 38.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 74.230000000000004 111.194 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.9 m -50.52 -31.48 15.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 73.299999999999997 110.856 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.5 p -52.41 -32.77 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 71.430000000000007 111.111 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 20.5 m -64.3 -42.81 96.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 64.5 110.943 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 75.7 t -78.07 -35.37 20.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 71.510000000000005 111.134 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.436 HD22 ' O ' ' A' ' 117' ' ' HIS . 85.4 mt -71.83 -30.99 66.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 72.439999999999998 110.901 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -60.15 -32.28 70.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 73.120000000000005 110.907 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.769 HG11 ' HB2' ' A' ' 133' ' ' ALA . 7.9 p -102.31 -24.67 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 70.409999999999997 111.136 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -89.1 -71.79 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 74.120000000000005 110.842 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.436 ' O ' HD22 ' A' ' 113' ' ' LEU . 0.4 OUTLIER -178.63 111.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 72.510000000000005 110.879 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 29.3 ttp85 -117.82 -34.34 4.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.453 . . . . 73.540000000000006 110.871 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.08 160.5 1.55 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.657 0.741 . . . . 74.109999999999999 110.854 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.529 ' O ' HG23 ' A' ' 121' ' ' THR . 53.9 Cg_endo -69.73 175.08 8.56 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.683 2.255 . . . . 73.109999999999999 112.353 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -170.88 -73.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 73.25 111.163 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.6 -172.83 4.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 75.329999999999998 111.088 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -77.62 60.09 2.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 72.209999999999994 110.854 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.92 159.67 68.84 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.567 0.699 . . . . 62.329999999999998 111.157 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -12.55 33.15 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.741 2.294 . . . . 75.400000000000006 112.324 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 52.06 88.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.457 . . . . 64.340000000000003 110.882 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -129.86 -176.75 14.55 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.785 -0.721 . . . . 61.149999999999999 112.502 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 159.8 -116.68 0.73 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 70.409999999999997 112.514 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -110.35 -114.61 3.58 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.781 -0.724 . . . . 50.119999999999997 112.473 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.54 39.61 2.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 64.329999999999998 112.495 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -87.49 -26.86 22.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 75.5 110.88 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.6 m -64.96 -34.94 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 70.439999999999998 111.08 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.769 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -71.72 -25.01 61.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 73.120000000000005 111.077 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.42 ' HE1' ' CE1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -52.96 -31.1 38.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 72.340000000000003 110.872 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.6 t -56.94 -58.73 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 70.310000000000002 111.121 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.5 mp -73.99 -37.52 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 72.310000000000002 111.157 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -61.42 -29.97 70.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 71.219999999999999 110.819 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.0 -30.51 25.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.269 -0.423 . . . . 72.040000000000006 110.871 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.3 mt -71.76 -40.85 69.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 73.129999999999995 110.958 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -73.61 -53.06 11.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 72.099999999999994 110.92 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.47 HD23 ' CG ' ' A' ' 51' ' ' TYR . 4.8 mp -52.42 -32.02 37.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 75.340000000000003 110.851 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -61.37 -43.61 98.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.234 -0.439 . . . . 73.219999999999999 110.906 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.583 ' O ' HG23 ' A' ' 147' ' ' VAL . 68.2 mt -76.97 -33.49 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 74.140000000000001 111.152 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -56.36 -56.67 18.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 70.230000000000004 110.893 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 141' ' ' LEU . 28.2 t -55.2 -35.12 34.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 64.219999999999999 111.126 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.18 -32.99 74.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 73.140000000000001 110.852 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 143' ' ' ILE . 46.0 t -61.2 -51.78 69.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 61.5 111.09 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.1 m -52.05 -32.06 32.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 71.329999999999998 110.86 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.5 t -57.72 -50.89 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.229 -0.441 . . . . 75.409999999999997 111.101 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -72.06 -26.86 62.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 62.32 110.912 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -52.21 -58.98 9.48 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.715 -0.755 . . . . 64.510000000000005 112.468 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.5 t -60.82 -31.95 71.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.766 0.317 . . . . 75.310000000000002 111.119 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.416 HG22 ' CD1' ' A' ' 157' ' ' LEU . 43.9 mm -72.65 -24.94 21.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 72.140000000000001 111.151 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -65.65 -49.9 57.28 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.722 -0.751 . . . . 51.299999999999997 112.504 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.24 -32.01 43.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.781 0.324 . . . . 75.040000000000006 110.885 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -71.09 -23.81 62.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 74.519999999999996 110.83 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.416 ' CD1' HG22 ' A' ' 153' ' ' ILE . 8.7 mt -75.11 -27.5 59.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 73.129999999999995 110.91 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.486 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.9 OUTLIER -51.79 -60.64 5.6 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.618 0.723 . . . . 74.450000000000003 110.921 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.9 Cg_endo -69.69 -16.27 37.76 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.681 2.254 . . . . 75.329999999999998 112.392 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.5 tp -93.97 40.73 1.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 72.329999999999998 110.931 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -90.22 -30.59 17.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 72.129999999999995 110.887 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.49 -52.63 2.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 73.299999999999997 110.946 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -72.62 79.01 1.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 65.230000000000004 110.921 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 71.019999999999996 110.934 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 62.1 mtt-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.773 0.32 . . . . 72.340000000000003 110.89 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -99.76 54.64 0.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 74.049999999999997 110.915 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.4 71.33 12.84 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.609 0.718 . . . . 72.340000000000003 110.893 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 78.59 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.667 2.245 . . . . 64.140000000000001 112.313 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.05 -30.96 65.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 64.209999999999994 110.961 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -78.34 -32.15 48.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 64.109999999999999 110.879 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.08 -45.01 59.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 75.239999999999995 110.927 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -60.53 -39.95 89.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 75.420000000000002 111.132 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.447 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.24 -29.12 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 63.5 111.117 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.95 -26.84 49.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 72.200000000000003 110.913 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.54 -19.22 23.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 73.409999999999997 110.917 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.426 ' O ' HG12 ' A' ' 40' ' ' VAL . 45.6 mm -76.6 -35.01 24.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 72.209999999999994 111.108 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.552 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.76 -57.15 23.07 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.574 0.702 . . . . 72.530000000000001 111.131 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.77 -22.12 32.49 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.645 2.23 . . . . 61.109999999999999 112.376 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.628 ' O ' HG22 ' A' ' 42' ' ' ILE . 45.9 t -76.04 -45.67 33.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 72.150000000000006 110.871 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 36' ' ' ILE . 9.1 p -81.53 -28.83 10.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 72.299999999999997 111.165 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mt -50.92 -34.01 26.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 73.209999999999994 110.89 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.628 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.72 -34.65 52.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 64.049999999999997 111.103 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.7 p -65.89 -35.29 80.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 71.310000000000002 111.121 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.73 -51.22 66.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 72.540000000000006 110.858 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 tp -70.64 -42.23 71.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 74.299999999999997 110.915 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.06 -48.76 75.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 64.209999999999994 111.094 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.449 HD11 ' CD2' ' A' ' 141' ' ' LEU . 0.9 OUTLIER -65.09 -32.25 57.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 61.43 111.093 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.561 ' O ' HD13 ' A' ' 52' ' ' LEU . 14.6 tp -51.62 -37.73 51.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 74.239999999999995 110.89 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -101.52 -35.95 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 74.310000000000002 111.144 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -66.44 -62.45 1.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 64.0 110.909 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.51 -43.44 75.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 74.120000000000005 110.919 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.561 HD13 ' O ' ' A' ' 48' ' ' LEU . 4.3 mp -54.45 160.63 2.49 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.617 0.722 . . . . 42.420000000000002 110.911 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 179.91 3.37 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.669 2.246 . . . . 73.5 112.334 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 62.99 162.04 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 52.200000000000003 110.864 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -179.18 84.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 75.329999999999998 110.85 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.7 m -80.64 -170.63 2.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 75.420000000000002 110.911 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.82 -27.17 27.91 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.709 -0.758 . . . . 32.32 112.463 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -57.1 -34.96 68.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.924 0.392 . . . . 75.409999999999997 110.894 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.24 -51.36 64.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 73.319999999999993 110.882 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.7 ttm -53.05 -51.96 60.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 71.409999999999997 110.896 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.2 p -60.93 -35.53 76.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 61.229999999999997 111.15 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.472 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.5 OUTLIER -65.87 -47.19 75.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.425 . . . . 65.120000000000005 110.939 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.426 ' HB3' HG23 ' A' ' 106' ' ' ILE . 75.6 m -57.73 -51.98 67.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 72.209999999999994 110.888 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.452 HG13 HD12 ' A' ' 67' ' ' LEU . 17.8 tt -66.54 -34.96 73.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 73.030000000000001 111.1 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.5 m -59.76 -25.08 64.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 73.310000000000002 110.832 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 62' ' ' LEU . 48.3 t -57.92 -38.02 64.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 71.129999999999995 111.12 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.452 HD12 HG13 ' A' ' 64' ' ' ILE . 5.8 mt -52.89 -28.9 25.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 63.399999999999999 110.894 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.485 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.63 -38.74 77.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 54.340000000000003 110.886 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.57 -30.07 70.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 73.230000000000004 111.137 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.793 HD22 HG11 ' A' ' 102' ' ' VAL . 9.4 mt -64.95 -54.72 26.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 70.030000000000001 110.954 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.72 -38.43 87.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.469 . . . . 55.43 111.139 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 68' ' ' LEU . 78.9 t -71.48 -32.82 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 72.420000000000002 111.135 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -51.59 -30.56 21.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 75.25 110.877 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.6 tp -75.02 -38.84 61.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 64.239999999999995 110.937 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.0 mp -73.26 -40.32 64.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 74.219999999999999 110.923 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.2 tt -65.05 -54.07 35.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 74.519999999999996 110.893 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.06 -23.59 18.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 73.129999999999995 111.143 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.5 m -80.26 -21.95 42.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 71.209999999999994 110.845 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.755 ' O ' HG23 ' A' ' 81' ' ' VAL . 25.3 mttt -59.81 -20.44 56.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.481 . . . . 74.150000000000006 110.849 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.7 pt -51.92 -29.06 10.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 73.329999999999998 111.156 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 79' ' ' LYS . 59.1 t 61.17 76.81 0.39 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.654 0.74 . . . . 70.150000000000006 111.162 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 167.47 24.29 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.666 2.244 . . . . 72.230000000000004 112.35 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -48.78 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.683 2.255 . . . . 64.310000000000002 112.324 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.0 t -117.23 -20.16 9.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 72.510000000000005 111.134 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.74 45.51 4.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 64.400000000000006 110.882 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 tp -95.73 25.8 4.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 73.109999999999999 110.897 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -102.94 23.72 11.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 73.140000000000001 110.886 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.532 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -66.74 -57.72 11.23 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.594 0.711 . . . . 65.510000000000005 111.128 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 54.0 Cg_endo -69.72 -37.32 9.43 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.741 2.294 . . . . 64.239999999999995 112.342 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.7 mp -53.95 -52.96 58.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 71.120000000000005 110.899 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.532 HG12 HD21 ' A' ' 95' ' ' LEU . 21.7 t -80.24 -26.37 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 70.140000000000001 111.089 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.72 -51.32 39.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 75.310000000000002 112.532 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.54 -35.39 80.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.813 0.339 . . . . 63.130000000000003 110.9 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -60.52 -38.2 83.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 74.319999999999993 110.946 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.532 HD21 HG12 ' A' ' 91' ' ' VAL . 9.2 mt -51.79 -29.75 20.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 54.420000000000002 110.923 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.04 -42.99 79.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 73.5 110.876 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.5 ' O ' HG22 ' A' ' 100' ' ' VAL . 57.8 t80 -75.25 -52.2 11.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 75.430000000000007 110.887 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.795 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.15 -29.88 33.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 63.130000000000003 111.131 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.6 mmt -66.66 -30.1 70.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 72.25 110.846 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.76 -30.05 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 64.109999999999999 111.135 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.795 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -74.97 -33.19 61.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 74.329999999999998 110.918 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.793 HG11 HD22 ' A' ' 70' ' ' LEU . 30.8 m -76.85 -37.94 28.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.510000000000005 111.158 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.444 ' O ' HG13 ' A' ' 107' ' ' VAL . 60.9 m -72.51 -41.9 65.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 65.129999999999995 111.135 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -60.91 -31.89 71.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 71.519999999999996 110.895 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.7 t -74.8 -35.52 62.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 43.039999999999999 110.868 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.426 HG23 ' HB3' ' A' ' 63' ' ' CYS . 40.7 mt -74.97 -49.65 27.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 74.430000000000007 111.124 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.555 ' O ' HG12 ' A' ' 110' ' ' VAL . 34.2 m -53.99 -33.86 24.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 63.350000000000001 111.143 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.5 m -52.44 -32.43 39.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 72.120000000000005 111.173 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.7 m -50.45 -31.59 15.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 74.439999999999998 110.87 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.7 p -52.6 -32.68 17.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 55.509999999999998 111.144 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 49.4 m -66.7 -47.05 73.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 71.040000000000006 110.848 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 88.4 t -72.35 -35.37 51.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 63.409999999999997 111.143 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 89.5 mt -72.08 -39.69 68.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 62.350000000000001 110.964 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -54.1 -30.67 49.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 61.43 110.879 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.8 HG11 ' HB2' ' A' ' 133' ' ' ALA . 9.4 p -102.32 -23.23 4.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 64.030000000000001 111.126 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -53.82 -61.61 2.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 75.150000000000006 110.839 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -156.1 28.32 0.36 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 74.329999999999998 110.844 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -123.22 -177.79 3.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 72.439999999999998 110.851 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.33 160.55 25.8 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.658 0.742 . . . . 64.329999999999998 110.845 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.76 149.19 66.54 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.671 2.248 . . . . 53.43 112.316 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.56 -73.55 0.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 71.340000000000003 111.11 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.9 26.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 63.109999999999999 111.137 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -137.65 -60.15 0.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 65.549999999999997 110.898 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 34.2 m -113.84 73.92 2.4 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.567 0.699 . . . . 63.530000000000001 111.151 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 175.85 7.54 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.69 2.26 . . . . 73.329999999999998 112.38 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.1 mtt180 63.21 104.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 74.519999999999996 110.873 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -52.25 147.05 13.9 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.703 -0.761 . . . . 51.520000000000003 112.495 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -151.22 -147.02 4.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.734 -0.746 . . . . 50.140000000000001 112.487 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -112.49 -75.5 0.74 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.736 -0.745 . . . . 40.140000000000001 112.51 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -175.84 -44.35 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.739 -0.743 . . . . 73.409999999999997 112.491 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -71.52 -26.8 62.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.94 0.4 . . . . 74.409999999999997 110.909 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.8 m -64.58 -27.01 41.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 74.109999999999999 111.142 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.8 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -56.23 -24.95 45.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 70.230000000000004 111.135 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.0 -30.9 38.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 75.109999999999999 110.871 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 58.9 t -56.99 -59.0 3.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 71.510000000000005 111.13 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.7 mt -74.05 -37.72 47.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 73.209999999999994 111.121 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -61.28 -29.96 70.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 72.5 110.827 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.37 -29.69 25.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 72.140000000000001 110.912 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.93 -50.41 23.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 73.349999999999994 110.929 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -66.37 -53.99 29.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 64.230000000000004 110.876 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.449 ' CD2' HD11 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -52.0 -32.23 32.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 53.43 110.937 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -71.74 -38.1 70.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 75.230000000000004 110.913 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.558 ' O ' HG23 ' A' ' 147' ' ' VAL . 55.9 mt -76.87 -32.03 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 61.329999999999998 111.132 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -56.11 -56.31 22.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 55.140000000000001 110.875 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.26 -34.99 45.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 74.400000000000006 111.153 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -59.64 -47.53 85.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 71.239999999999995 110.914 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 143' ' ' ILE . 91.8 t -69.38 -34.1 60.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 70.5 111.129 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.95 -51.47 56.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 53.409999999999997 110.916 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 40.8 t -75.87 -33.11 24.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 74.209999999999994 111.121 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.36 -42.99 83.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 72.239999999999995 110.896 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.02 -19.32 67.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 73.099999999999994 112.436 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 94.9 m -63.02 -51.94 64.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.756 0.312 . . . . 70.109999999999999 111.145 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 20.5 tt -55.94 -25.64 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 73.019999999999996 111.162 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -51.87 -49.54 47.75 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.707 -0.759 . . . . 62.420000000000002 112.524 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 1.3 mmt -61.82 -31.79 72.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.834 0.349 . . . . 53.509999999999998 110.916 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -73.83 -22.8 59.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 73.219999999999999 110.886 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.619 HD23 HD22 ' A' ' 160' ' ' LEU . 1.1 mt -79.75 -25.55 41.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 72.209999999999994 110.898 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.529 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 15.1 tp60 -51.95 -58.07 12.63 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.558 0.694 . . . . 75.019999999999996 110.933 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.6 Cg_endo -69.77 -19.07 36.54 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.647 2.231 . . . . 71.450000000000003 112.346 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.619 HD22 HD23 ' A' ' 157' ' ' LEU . 9.8 tp -52.21 -58.23 7.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 71.140000000000001 110.935 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 5.6 t80 64.42 14.38 8.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 73.010000000000005 110.876 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 -88.91 54.02 2.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 64.349999999999994 110.925 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -80.21 -26.31 39.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 72.25 110.887 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 74.340000000000003 110.894 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.845 0.355 . . . . 73.549999999999997 110.86 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.0 mtt180 -90.55 -25.96 19.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 74.519999999999996 110.889 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -125.15 79.08 66.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.608 0.718 . . . . 75.239999999999995 110.924 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -5.06 15.29 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.724 2.283 . . . . 70.25 112.334 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 pp -53.31 -30.98 41.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 63.520000000000003 110.95 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -79.94 -29.34 39.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 71.25 110.865 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -77.07 -45.4 27.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.468 . . . . 74.150000000000006 110.938 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.2 t -59.45 -40.33 86.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 64.430000000000007 111.093 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.425 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -71.68 -28.84 32.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 73.219999999999999 111.123 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.37 -25.89 68.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 63.340000000000003 110.896 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.622 HD12 HD12 ' A' ' 77' ' ' ILE . 1.1 mm? -91.24 -23.08 20.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 75.340000000000003 110.872 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.6 mm -78.55 -31.2 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.447 . . . . 72.040000000000006 111.107 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.544 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.7 -57.16 22.82 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.615 0.721 . . . . 62.119999999999997 111.123 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 54.2 Cg_endo -69.76 -20.79 34.36 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.676 2.251 . . . . 61.119999999999997 112.378 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.64 ' O ' HG22 ' A' ' 42' ' ' ILE . 7.6 t -76.01 -43.27 45.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 63.32 110.876 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.61 -28.89 10.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 73.450000000000003 111.126 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 mt -50.97 -33.95 26.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 64.040000000000006 110.912 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.64 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.1 tp -58.8 -34.62 52.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 72.129999999999995 111.123 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.81 -38.62 89.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 71.420000000000002 111.177 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.6 m -53.04 -45.04 67.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 64.239999999999995 110.86 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.2 tp -76.93 -40.1 48.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 60.039999999999999 110.899 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.63 -38.34 74.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 73.310000000000002 111.091 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.446 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.3 mp -64.22 -31.98 55.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 63.119999999999997 111.142 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 tp -51.45 -38.74 55.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 63.509999999999998 110.896 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.8 p -101.47 -36.66 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 53.039999999999999 111.187 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -67.1 -64.65 0.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 74.420000000000002 110.876 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.546 ' CZ ' HD13 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -71.24 -25.94 62.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 74.099999999999994 110.9 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.1 mp -124.84 72.0 61.82 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.616 0.722 . . . . 73.540000000000006 110.961 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -173.0 0.64 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.651 2.234 . . . . 72.519999999999996 112.34 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.2 p -158.71 27.48 0.23 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 74.219999999999999 110.878 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 57.2 93.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 63.119999999999997 110.822 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.03 141.77 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 64.510000000000005 110.874 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.19 -22.97 45.55 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 52.530000000000001 112.469 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -52.06 -34.99 45.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 71.239999999999995 110.908 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.07 -37.47 61.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 74.120000000000005 110.914 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.19 -50.86 35.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 63.539999999999999 110.848 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.1 p -60.24 -29.3 68.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 73.230000000000004 111.121 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.55 -37.31 60.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.439 . . . . 74.430000000000007 110.893 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.506 ' O ' HG12 ' A' ' 66' ' ' VAL . 62.4 m -66.27 -44.86 82.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 54.439999999999998 110.929 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.6 tt -75.59 -33.14 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 51.329999999999998 111.149 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 t -51.74 -25.81 8.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 74.019999999999996 110.827 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.506 HG12 ' O ' ' A' ' 63' ' ' CYS . 8.9 p -57.08 -32.55 40.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 73.120000000000005 111.111 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.9 -28.93 25.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 70.209999999999994 110.925 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.497 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.25 -38.88 78.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 70.319999999999993 110.92 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.64 -30.03 70.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 65.209999999999994 111.054 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.819 HD22 HG11 ' A' ' 102' ' ' VAL . 9.2 mt -65.38 -54.63 26.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 65.340000000000003 110.94 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.59 -38.57 88.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 63.509999999999998 111.151 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 68' ' ' LEU . 83.4 t -71.56 -32.89 47.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 75.219999999999999 111.152 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.499 ' O ' HG22 ' A' ' 77' ' ' ILE . 18.4 t80 -52.0 -30.14 23.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 74.439999999999998 110.867 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.547 HD11 HD11 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -69.73 -45.93 67.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 74.5 110.937 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.7 mt -73.1 -34.14 65.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 72.319999999999993 110.906 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.43 -54.99 15.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 74.519999999999996 110.925 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.622 HD12 HD12 ' A' ' 35' ' ' LEU . 1.4 tt -61.45 -30.02 47.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 70.340000000000003 111.135 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.6 m -80.07 -23.71 41.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 62.340000000000003 110.862 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.706 ' O ' HG23 ' A' ' 81' ' ' VAL . 6.8 mtmt -66.8 -15.64 63.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 75.219999999999999 110.924 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.2 pp -56.08 -24.84 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 75.129999999999995 111.121 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 79' ' ' LYS . 23.3 t 63.52 75.42 0.4 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.57 0.7 . . . . 62.200000000000003 111.112 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 167.65 23.83 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.708 2.272 . . . . 64.329999999999998 112.363 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -22.13 32.52 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.649 2.233 . . . . 63.520000000000003 112.366 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.584 HG23 ' H ' ' A' ' 86' ' ' LEU . 7.9 t -95.24 -31.41 13.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 64.329999999999998 111.139 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 55.47 26.12 8.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 74.519999999999996 110.849 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.584 ' H ' HG23 ' A' ' 84' ' ' THR . 1.2 tp -141.84 51.89 1.51 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 71.140000000000001 110.918 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.633 ' HA ' HD23 ' A' ' 90' ' ' LEU . 1.9 m-20 -97.91 27.34 4.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 40.229999999999997 110.87 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.524 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.12 -57.75 10.42 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.607 0.717 . . . . 60.240000000000002 111.132 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.53 ' HG2' HD22 ' A' ' 90' ' ' LEU . 53.8 Cg_endo -69.83 -20.67 34.2 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.683 2.255 . . . . 73.150000000000006 112.289 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.633 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.19 -52.3 12.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 62.210000000000001 110.933 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.458 HG12 HD21 ' A' ' 95' ' ' LEU . 22.0 t -80.2 -22.81 11.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 72.5 111.096 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.65 -47.55 52.06 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.755 -0.736 . . . . 44.109999999999999 112.474 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -34.94 76.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.755 0.312 . . . . 75.430000000000007 110.859 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -60.62 -34.57 74.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.268 -0.423 . . . . 61.310000000000002 110.904 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.547 HD11 HD11 ' A' ' 74' ' ' LEU . 10.7 mt -51.7 -29.79 19.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 64.450000000000003 110.924 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -43.22 78.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 74.019999999999996 110.873 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.506 ' O ' HG22 ' A' ' 100' ' ' VAL . 30.3 t80 -75.27 -52.0 11.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 65.140000000000001 110.84 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.805 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.05 -29.94 32.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 71.0 111.137 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.5 mmt -66.41 -30.42 70.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 75.140000000000001 110.898 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.59 -29.94 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 70.420000000000002 111.139 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.805 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -75.26 -33.43 61.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 74.200000000000003 110.859 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.819 HG11 HD22 ' A' ' 70' ' ' LEU . 29.5 m -77.54 -39.51 27.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 64.450000000000003 111.14 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.666 ' HA ' HD12 ' A' ' 106' ' ' ILE . 2.5 t -72.58 -32.14 65.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 74.340000000000003 111.161 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -57.74 -33.89 68.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 74.219999999999999 110.88 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.4 t -74.95 -33.98 62.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 53.130000000000003 110.848 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.666 HD12 ' HA ' ' A' ' 103' ' ' THR . 7.4 mt -75.11 -50.56 24.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 62.229999999999997 111.138 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.544 ' O ' HG12 ' A' ' 110' ' ' VAL . 32.5 m -53.91 -35.73 28.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 70.450000000000003 111.149 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.6 m -52.61 -32.29 40.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 64.109999999999999 111.132 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 51.8 p -50.33 -31.56 14.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.43 . . . . 54.32 110.854 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.4 p -52.5 -32.75 17.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 73.129999999999995 111.123 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 44.1 m -67.08 -49.02 66.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 73.129999999999995 110.846 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 65.4 t -70.08 -35.49 64.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 72.530000000000001 111.109 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.1 mt -72.11 -41.09 67.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 71.209999999999994 110.928 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -51.94 -31.34 28.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 74.510000000000005 110.924 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.78 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.6 p -102.27 -23.97 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 70.310000000000002 111.135 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -53.18 -74.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 74.400000000000006 110.864 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -153.35 -44.08 0.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 70.420000000000002 110.869 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -67.8 120.14 13.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 72.140000000000001 110.914 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 49.3 m 52.29 71.9 1.34 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.665 0.745 . . . . 64.400000000000006 110.829 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 163.61 37.62 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.693 2.262 . . . . 71.5 112.356 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.11 24.94 10.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 74.430000000000007 111.172 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.6 m 63.17 45.32 5.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 72.439999999999998 111.149 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.411 ' O ' HG23 ' A' ' 124' ' ' THR . 53.5 t-80 -167.98 114.45 0.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 63.219999999999999 110.848 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.411 HG23 ' O ' ' A' ' 123' ' ' HIS . 0.8 OUTLIER -156.89 68.38 4.39 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.538 0.685 . . . . 75.129999999999995 111.133 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 92.88 0.51 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.696 2.264 . . . . 52.210000000000001 112.301 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 61.4 -170.35 0.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 65.129999999999995 110.86 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 111.89 169.01 18.27 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.752 -0.737 . . . . 61.020000000000003 112.496 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -128.95 -50.31 0.13 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.783 -0.722 . . . . 65.409999999999997 112.492 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -129.32 19.64 5.37 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 44.119999999999997 112.496 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.11 45.54 0.87 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.769 -0.729 . . . . 53.509999999999998 112.544 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -76.55 -37.47 56.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.947 0.403 . . . . 63.240000000000002 110.916 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.2 m -65.18 -34.7 72.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 72.200000000000003 111.097 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.78 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -68.33 -25.13 64.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 73.310000000000002 111.108 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 23.4 mmt -53.01 -30.96 38.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 74.340000000000003 110.894 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.0 -57.66 8.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 73.319999999999993 111.161 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.8 mm -74.01 -37.37 47.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.486 . . . . 62.25 111.157 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.82 -29.96 70.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 72.209999999999994 110.871 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -52.09 -30.2 25.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 75.349999999999994 110.87 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.2 tt -72.1 -50.38 28.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 71.099999999999994 110.931 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -63.03 -52.07 64.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 73.109999999999999 110.861 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.546 HD13 ' CZ ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -51.94 -35.16 45.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 74.510000000000005 110.917 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -60.81 -40.27 92.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 73.299999999999997 110.918 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.644 ' O ' HG23 ' A' ' 147' ' ' VAL . 45.6 mm -76.85 -31.98 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 70.400000000000006 111.166 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -56.02 -56.76 16.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.486 . . . . 64.409999999999997 110.906 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.6 m -56.67 -35.32 45.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 75.129999999999995 111.153 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.4 -34.1 77.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 74.519999999999996 110.879 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 143' ' ' ILE . 67.4 t -54.06 -35.93 30.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 64.329999999999998 111.146 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -52.82 -49.78 65.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 73.129999999999995 110.852 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.36 -33.04 57.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 71.209999999999994 111.125 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.19 -54.99 23.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 64.230000000000004 110.877 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.58 -19.48 71.0 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 64.549999999999997 112.484 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 32.7 m -55.95 -52.83 62.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.77 0.319 . . . . 63.439999999999998 111.123 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.464 HG22 ' CD1' ' A' ' 157' ' ' LEU . 29.8 mt -76.52 -27.99 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 73.329999999999998 111.126 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -53.71 -50.03 55.6 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.788 -0.72 . . . . 70.049999999999997 112.494 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -71.37 -31.99 67.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 75.519999999999996 110.844 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -71.24 -24.03 62.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 70.209999999999994 110.929 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.464 ' CD1' HG22 ' A' ' 153' ' ' ILE . 8.8 mt -75.27 -27.13 59.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 65.239999999999995 110.939 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.482 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -51.95 -60.58 5.81 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.584 0.707 . . . . 74.409999999999997 110.907 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.4 Cg_endo -69.78 -15.39 37.0 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.656 2.238 . . . . 70.329999999999998 112.349 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.96 40.86 1.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 74.439999999999998 110.946 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.62 -26.28 32.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 74.329999999999998 110.853 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 63.26 105.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.484 . . . . 64.099999999999994 110.945 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -111.6 26.21 10.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 75.140000000000001 110.865 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 8.2 t80 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 75.200000000000003 110.928 -179.885 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.826 0.346 . . . . 74.129999999999995 110.895 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.34 91.73 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 74.230000000000004 110.859 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.9 79.09 50.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.587 0.708 . . . . 62.32 110.882 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -5.0 15.17 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.67 2.247 . . . . 73.230000000000004 112.344 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.0 pp -52.26 -31.02 30.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 65.349999999999994 110.926 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -80.86 -31.69 35.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 75.430000000000007 110.853 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.478 ' HB3' HD11 ' A' ' 86' ' ' LEU . 1.4 t80 -72.98 -46.27 53.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.127 -0.488 . . . . 74.219999999999999 110.956 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 t -59.57 -39.89 85.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.483 . . . . 73.209999999999994 111.133 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.16 -29.08 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 70.349999999999994 111.156 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.73 -27.5 50.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.152 -0.477 . . . . 65.430000000000007 110.863 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.89 -18.75 24.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 51.43 110.903 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.6 mm -76.76 -34.82 23.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 71.450000000000003 111.106 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.547 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.68 -57.17 22.76 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.575 0.702 . . . . 74.540000000000006 111.057 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.8 Cg_endo -69.78 -19.3 36.2 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.686 2.258 . . . . 71.040000000000006 112.347 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.63 ' O ' HG22 ' A' ' 42' ' ' ILE . 48.7 t -73.02 -43.91 61.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 71.129999999999995 110.881 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.53 -28.93 10.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 74.109999999999999 111.115 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.1 mt -50.96 -33.94 26.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 72.239999999999995 110.874 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.63 HG22 ' O ' ' A' ' 39' ' ' CYS . 0.7 OUTLIER -58.78 -34.71 52.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 53.350000000000001 111.095 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.82 -41.19 92.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 73.109999999999999 111.138 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.09 -43.16 66.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 71.120000000000005 110.867 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 tp -76.29 -39.74 53.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 72.219999999999999 110.904 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.66 -51.46 69.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 73.420000000000002 111.125 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.432 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.4 mp -49.8 -31.36 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 75.349999999999994 111.134 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.1 tp -50.83 -42.17 58.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 62.229999999999997 110.912 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.776 HG21 ' HA ' ' A' ' 59' ' ' LYS . 7.2 p -101.53 -37.38 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 74.420000000000002 111.151 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -63.77 -64.45 0.89 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 72.140000000000001 110.856 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.625 ' CE1' HD13 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -72.67 -62.05 1.59 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.457 . . . . 60.340000000000003 110.947 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 mp -67.83 160.64 72.52 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.633 0.73 . . . . 62.420000000000002 110.921 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 154.0 68.62 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.713 2.276 . . . . 74.140000000000001 112.329 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.554 ' HB3' HG23 ' A' ' 49' ' ' VAL . 1.5 t -175.79 65.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 71.439999999999998 110.835 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -62.23 95.03 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 74.140000000000001 110.819 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.2 145.82 0.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 74.140000000000001 110.871 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.19 -28.26 25.99 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.672 -0.775 . . . . 71.5 112.47 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -53.42 -34.95 59.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.951 0.405 . . . . 75.230000000000004 110.894 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.776 ' HA ' HG21 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -52.94 -51.97 59.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 63.399999999999999 110.863 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.67 -48.95 78.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 62.210000000000001 110.88 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.6 p -60.73 -34.16 74.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 74.319999999999993 111.154 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.4 mt -67.0 -51.07 59.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 75.510000000000005 110.903 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 79.6 m -53.79 -51.06 64.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 71.310000000000002 110.89 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.0 tt -68.86 -34.96 67.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 71.420000000000002 111.151 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.1 -29.91 23.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 63.520000000000003 110.84 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.22 -40.54 88.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 72.319999999999993 111.126 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.697 HD22 HD12 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -52.93 -28.96 25.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 75.329999999999998 110.921 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.484 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.08 -39.0 79.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 71.120000000000005 110.928 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.46 -30.03 70.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 71.140000000000001 111.087 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.697 HD12 HD22 ' A' ' 67' ' ' LEU . 8.6 mt -65.8 -54.78 22.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.263 -0.426 . . . . 74.420000000000002 110.893 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.14 -38.41 86.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 72.150000000000006 111.121 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 68' ' ' LEU . 80.5 t -71.38 -32.92 48.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 41.409999999999997 111.153 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -60.06 -29.79 68.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 73.430000000000007 110.896 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.642 ' HG ' HD13 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -63.21 -55.03 28.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 55.420000000000002 110.927 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.15 -31.93 64.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 63.240000000000002 110.905 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tt -60.96 -54.44 44.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 74.140000000000001 110.88 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 tt -66.15 -27.02 39.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 73.319999999999993 111.112 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.7 t -83.23 -14.75 52.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 73.409999999999997 110.812 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.745 ' O ' HG23 ' A' ' 81' ' ' VAL . 15.8 mttt -93.7 -9.76 36.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 73.519999999999996 110.878 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.487 HD11 HD22 ' A' ' 86' ' ' LEU . 10.5 pt -54.26 -28.22 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 71.25 111.158 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 79' ' ' LYS . 40.5 t 63.07 74.75 0.44 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.624 0.726 . . . . 73.439999999999998 111.127 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 166.34 27.94 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.682 2.255 . . . . 74.219999999999999 112.359 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -49.15 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.664 2.243 . . . . 75.209999999999994 112.354 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.1 t -115.93 -41.7 3.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 65.140000000000001 111.115 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.476 ' HB3' HG23 ' A' ' 88' ' ' VAL . 0.5 OUTLIER -179.61 -42.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 64.400000000000006 110.824 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.487 HD22 HD11 ' A' ' 80' ' ' ILE . 0.5 OUTLIER 63.56 70.48 0.52 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.139 -0.482 . . . . 73.310000000000002 110.922 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 91' ' ' VAL . 4.3 m-20 51.05 64.14 1.96 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 74.150000000000006 110.838 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.536 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -69.17 -58.09 6.61 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.645 0.736 . . . . 64.109999999999999 111.177 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.602 ' HG2' HD22 ' A' ' 90' ' ' LEU . 53.2 Cg_endo -69.83 -24.21 29.63 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.692 2.261 . . . . 64.040000000000006 112.301 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.602 HD22 ' HG2' ' A' ' 89' ' ' PRO . 3.3 mm? -74.21 -53.09 10.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 62.140000000000001 110.913 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 87' ' ' ASP . 97.6 t -65.07 -48.93 81.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 72.329999999999998 111.111 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.83 -46.58 54.67 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.773 -0.727 . . . . 63.450000000000003 112.446 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -72.08 -24.93 61.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.819 0.342 . . . . 73.219999999999999 110.909 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -71.21 -30.93 66.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 70.140000000000001 110.939 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.642 HD13 ' HG ' ' A' ' 74' ' ' LEU . 13.1 mt -54.83 -29.66 55.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 52.25 110.917 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.51 -42.41 71.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 70.439999999999998 110.849 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.502 ' O ' HG22 ' A' ' 100' ' ' VAL . 77.0 t80 -75.13 -51.16 14.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 75.120000000000005 110.866 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.798 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.04 -29.96 32.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 73.200000000000003 111.125 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.8 mmt -66.58 -30.11 70.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 60.32 110.867 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.82 -30.11 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.427 . . . . 71.400000000000006 111.118 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.798 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.97 -33.12 61.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 50.109999999999999 110.913 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.47 -37.64 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 70.239999999999995 111.143 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.731 ' O ' HG23 ' A' ' 107' ' ' VAL . 55.1 m -72.86 -46.47 52.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 73.340000000000003 111.134 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -52.59 -31.64 37.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 73.439999999999998 110.898 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 53.2 p -74.68 -49.0 22.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 72.409999999999997 110.85 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.639 HD12 ' HA ' ' A' ' 103' ' ' THR . 9.8 mt -55.77 -34.56 36.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 74.040000000000006 111.131 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 103' ' ' THR . 22.0 t -53.7 -45.78 61.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 74.430000000000007 111.159 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.1 m -52.38 -32.49 38.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.099 -0.501 . . . . 74.040000000000006 111.147 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.7 m -50.35 -31.39 14.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 74.450000000000003 110.855 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.7 p -52.44 -32.76 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 70.310000000000002 111.112 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 34.4 m -66.72 -47.04 73.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 55.130000000000003 110.88 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 82.8 t -72.4 -35.05 50.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 63.409999999999997 111.126 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 87.8 mt -72.04 -42.8 65.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 54.130000000000003 110.88 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -52.11 -30.3 25.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 71.030000000000001 110.917 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.813 HG11 ' HB2' ' A' ' 133' ' ' ALA . 9.9 p -102.22 -22.25 4.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.142 -0.481 . . . . 75.409999999999997 111.114 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -58.65 -71.72 0.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 70.430000000000007 110.84 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -177.99 36.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.439 . . . . 72.120000000000005 110.842 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -151.88 122.79 7.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 71.409999999999997 110.897 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 68.4 m 56.15 68.6 2.21 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.651 0.738 . . . . 73.439999999999998 110.851 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.52 ' O ' HG23 ' A' ' 121' ' ' THR . 53.8 Cg_endo -69.75 102.79 1.07 Allowed 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.723 2.282 . . . . 74.430000000000007 112.312 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -169.9 83.53 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 53.310000000000002 111.111 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.8 t -160.23 173.13 16.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.264 -0.426 . . . . 72.530000000000001 111.107 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -100.34 74.42 1.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 73.150000000000006 110.858 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.22 159.67 46.55 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.577 0.703 . . . . 73.409999999999997 111.172 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 85.58 0.61 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.688 2.259 . . . . 74.230000000000004 112.329 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.25 105.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 73.549999999999997 110.878 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -52.33 102.99 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.733 -0.746 . . . . 43.549999999999997 112.497 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -168.34 131.63 2.36 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.725 -0.75 . . . . 72.400000000000006 112.488 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 58.37 174.32 0.47 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.77 -0.729 . . . . 62.240000000000002 112.461 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -112.7 18.71 22.12 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.678 -0.772 . . . . 62.210000000000001 112.443 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.51 ' CZ ' HG13 ' A' ' 132' ' ' VAL . 27.3 p90 -88.03 -30.34 20.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.926 0.393 . . . . 71.400000000000006 110.939 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.51 HG13 ' CZ ' ' A' ' 131' ' ' TYR . 19.8 m -73.94 -30.33 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 63.100000000000001 111.096 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.813 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -56.33 -24.94 47.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 53.409999999999997 111.111 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.96 -30.97 37.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 74.099999999999994 110.872 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 64.5 t -56.83 -62.33 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 70.510000000000005 111.158 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 41.8 mm -71.64 -38.15 65.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 74.430000000000007 111.104 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.437 ' OD2' HD11 ' A' ' 141' ' ' LEU . 25.8 t0 -60.65 -30.46 69.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 64.140000000000001 110.859 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.18 -25.74 48.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 63.439999999999998 110.824 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 7.6 tt -68.87 -50.93 45.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 62.409999999999997 110.925 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -73.97 -36.08 64.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 64.549999999999997 110.849 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.625 HD13 ' CE1' ' A' ' 51' ' ' TYR . 9.9 mt -52.21 -33.76 42.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 64.549999999999997 110.948 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -61.21 -48.38 81.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.451 . . . . 73.329999999999998 110.895 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.757 ' O ' HG23 ' A' ' 147' ' ' VAL . 39.0 mt -75.6 -31.98 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 54.539999999999999 111.128 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -56.0 -56.72 17.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 75.030000000000001 110.888 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 141' ' ' LEU . 22.8 t -57.65 -35.7 51.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 75.030000000000001 111.089 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -66.79 -32.98 74.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 75.549999999999997 110.892 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 143' ' ' ILE . 90.5 t -61.99 -34.0 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 72.209999999999994 111.151 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 49.7 m -63.24 -52.02 63.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 54.409999999999997 110.861 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.493 ' HB ' HD12 ' A' ' 153' ' ' ILE . 27.3 m -71.48 -35.56 57.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 72.430000000000007 111.119 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -67.45 -41.15 85.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 74.319999999999993 110.889 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.44 -33.25 39.76 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.754 -0.736 . . . . 71.530000000000001 112.485 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.7 m -76.48 -52.86 8.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.738 0.304 . . . . 71.140000000000001 111.141 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.493 HD12 ' HB ' ' A' ' 149' ' ' VAL . 7.9 mt -76.48 -24.5 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 72.129999999999995 111.185 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.01 -49.39 78.99 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.698 -0.763 . . . . 73.049999999999997 112.434 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -31.96 55.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.813 0.34 . . . . 55.340000000000003 110.853 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -71.17 -24.07 62.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 61.100000000000001 110.871 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.539 HD23 HD22 ' A' ' 160' ' ' LEU . 13.4 mt -75.23 -27.22 59.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 71.450000000000003 110.935 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.487 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -51.77 -60.58 5.72 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.624 0.726 . . . . 61.43 110.938 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 54.2 Cg_endo -69.76 -27.36 26.56 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.695 2.263 . . . . 75.420000000000002 112.36 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.539 HD22 HD23 ' A' ' 157' ' ' LEU . 5.1 tp -52.06 -55.45 20.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 71.349999999999994 110.938 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 5.0 t80 64.48 14.38 8.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 71.519999999999996 110.857 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -171.51 112.39 0.34 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.495 . . . . 74.430000000000007 110.956 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -64.18 -62.49 1.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 73.140000000000001 110.841 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 9.5 t80 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 75.219999999999999 110.97 -179.883 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.862 0.363 . . . . 74.310000000000002 110.885 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -143.82 -167.89 2.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 73.340000000000003 110.861 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.459 ' HB2' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -49.68 108.17 0.93 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.569 0.7 . . . . 74.109999999999999 110.867 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -11.65 31.29 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.698 2.266 . . . . 62.119999999999997 112.335 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.459 HD23 ' HB2' ' A' ' 27' ' ' LYS . 2.0 pp -51.97 -30.88 26.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 54.450000000000003 110.873 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -79.28 -33.35 43.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 71.519999999999996 110.885 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -72.33 -46.44 55.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 75.140000000000001 110.913 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -59.78 -40.12 87.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 63.409999999999997 111.186 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.448 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.21 -29.06 21.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 75.049999999999997 111.149 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -55.66 -27.14 48.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 35.439999999999998 110.884 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.455 HD21 HG21 ' A' ' 80' ' ' ILE . 4.1 mm? -91.31 -18.74 23.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 73.310000000000002 110.913 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.41 ' O ' HG12 ' A' ' 40' ' ' VAL . 45.8 mm -76.43 -35.25 26.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 70.129999999999995 111.125 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.55 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.76 -57.14 23.16 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.626 0.727 . . . . 75.109999999999999 111.153 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.6 Cg_endo -69.75 -21.94 32.82 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.705 2.27 . . . . 75.430000000000007 112.306 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.618 ' O ' HG22 ' A' ' 42' ' ' ILE . 42.7 t -76.01 -45.59 33.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 61.200000000000003 110.9 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 36' ' ' ILE . 9.3 p -81.52 -28.91 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 73.019999999999996 111.149 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mt -51.02 -33.92 27.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 74.5 110.923 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.71 -34.68 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 64.230000000000004 111.103 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 p -65.69 -40.68 92.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 72.310000000000002 111.141 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.01 -44.38 67.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 75.409999999999997 110.9 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.9 tp -75.3 -40.41 58.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 73.340000000000003 110.949 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.97 -36.53 70.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 73.230000000000004 111.1 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.414 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.2 mp -64.93 -32.31 57.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 72.209999999999994 111.112 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 tp -55.28 -33.82 63.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 70.299999999999997 110.893 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.1 m -101.64 -36.66 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 72.019999999999996 111.138 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -71.7 -64.93 0.83 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 72.310000000000002 110.87 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.678 ' CZ ' HD13 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -69.46 -58.74 3.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.486 . . . . 75.430000000000007 110.903 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 mp -77.03 160.69 75.65 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.629 0.728 . . . . 74.439999999999998 110.873 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 146.69 61.07 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.722 2.281 . . . . 64.109999999999999 112.329 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -178.22 74.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 65.140000000000001 110.841 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 53.91 -172.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.154 -0.475 . . . . 64.209999999999994 110.861 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 95.5 m -120.45 -54.8 2.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 72.549999999999997 110.904 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.32 -57.43 13.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.743 . . . . 73.439999999999998 112.502 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -52.08 -34.97 46.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.361 . . . . 65.329999999999998 110.846 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.97 -48.21 67.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 74.340000000000003 110.92 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 29.4 ttm -62.34 -52.06 65.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 74.25 110.866 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.7 p -58.02 -27.06 63.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 63.340000000000003 111.107 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.648 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -75.87 -34.19 60.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.29 -0.413 . . . . 73.209999999999994 110.886 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 90.2 m -70.96 -51.89 23.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 54.119999999999997 110.845 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 15.8 tt -63.24 -35.29 71.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 65.329999999999998 111.134 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.5 t -63.54 -25.46 68.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 74.329999999999998 110.847 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 62' ' ' LEU . 83.6 t -57.95 -36.15 54.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 62.140000000000001 111.08 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.87 -28.83 24.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 73.310000000000002 110.926 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.493 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.24 -38.98 78.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 73.340000000000003 110.924 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.56 -29.95 70.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 54.340000000000003 111.136 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.607 HD13 HG11 ' A' ' 102' ' ' VAL . 9.4 mt -65.16 -54.71 25.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 73.319999999999993 110.945 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.7 -38.56 88.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 74.120000000000005 111.149 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 68' ' ' LEU . 82.2 t -71.5 -32.91 47.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 74.120000000000005 111.105 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.446 ' O ' HG22 ' A' ' 77' ' ' ILE . 28.0 t80 -51.86 -30.55 24.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 70.209999999999994 110.859 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.624 HD11 HD11 ' A' ' 95' ' ' LEU . 0.3 OUTLIER -75.02 -39.24 61.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 74.329999999999998 110.892 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.07 -39.38 65.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 72.340000000000003 110.901 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.4 tt -66.46 -55.06 17.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 72.129999999999995 110.918 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 73' ' ' PHE . 1.1 tt -57.04 -30.6 34.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 73.430000000000007 111.13 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.5 t -80.22 -23.36 40.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 74.030000000000001 110.83 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.685 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.4 OUTLIER -69.63 -12.9 62.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 72.319999999999993 110.895 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.455 HG21 HD21 ' A' ' 35' ' ' LEU . 2.2 pp -56.41 -24.53 18.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 75.209999999999994 111.088 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 79' ' ' LYS . 21.8 t 63.68 75.21 0.4 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.649 0.737 . . . . 60.520000000000003 111.173 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 167.55 24.2 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.638 2.226 . . . . 60.520000000000003 112.352 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -48.63 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.694 2.263 . . . . 61.530000000000001 112.356 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.4 t -117.22 -19.88 9.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 70.019999999999996 111.07 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.76 47.02 3.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 72.540000000000006 110.858 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 tp -99.27 26.05 6.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 71.219999999999999 110.91 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.631 ' HA ' HD23 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -99.91 23.68 9.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 74.519999999999996 110.845 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.542 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.74 -57.79 9.32 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.66 0.743 . . . . 71.049999999999997 111.152 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.7 Cg_endo -69.81 -20.0 35.18 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.664 2.243 . . . . 72.519999999999996 112.35 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.631 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.19 -53.09 10.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 63.43 110.911 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.519 HG12 HD21 ' A' ' 95' ' ' LEU . 24.9 t -80.68 -33.69 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 70.219999999999999 111.125 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.82 -52.21 35.63 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.734 -0.746 . . . . 75.030000000000001 112.466 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -35.35 80.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 73.409999999999997 110.882 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -60.32 -36.98 79.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.438 . . . . 75.099999999999994 110.923 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.624 HD11 HD11 ' A' ' 74' ' ' LEU . 9.5 mt -51.91 -29.75 21.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 75.030000000000001 110.915 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 4.1 mmt -67.67 -42.86 81.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 73.430000000000007 110.921 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.501 ' O ' HG22 ' A' ' 100' ' ' VAL . 4.4 t80 -75.29 -52.47 10.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 61.200000000000003 110.849 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.785 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.1 -29.87 33.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 75.109999999999999 111.135 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.71 -30.08 70.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 73.340000000000003 110.913 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.73 -30.05 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 73.450000000000003 111.103 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.785 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -74.96 -33.25 61.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 54.25 110.893 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.607 HG11 HD13 ' A' ' 70' ' ' LEU . 31.1 m -76.93 -37.96 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 72.239999999999995 111.095 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.603 ' HA ' HD12 ' A' ' 106' ' ' ILE . 61.3 m -72.45 -41.37 66.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 72.400000000000006 111.116 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -61.67 -32.02 72.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 72.329999999999998 110.873 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -32.58 69.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 63.329999999999998 110.843 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' A' ' 103' ' ' THR . 12.3 mt -74.41 -51.77 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 74.310000000000002 111.165 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.558 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.3 p -53.95 -33.93 24.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 73.310000000000002 111.158 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 91.8 m -52.36 -32.4 38.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 63.439999999999998 111.131 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.34 -31.74 15.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 74.120000000000005 110.874 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.5 p -52.72 -32.83 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.492 . . . . 62.439999999999998 111.114 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 47.5 m -65.23 -43.53 91.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 64.230000000000004 110.881 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.5 t -76.82 -35.77 24.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 71.439999999999998 111.161 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.425 HD13 ' HD2' ' A' ' 118' ' ' ARG . 90.3 mt -72.14 -31.13 65.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 75.109999999999999 110.882 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -64.73 -29.46 70.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 64.230000000000004 110.87 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.76 HG11 ' HB2' ' A' ' 133' ' ' ALA . 10.8 p -102.24 -20.91 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 73.120000000000005 111.102 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -79.18 -74.55 0.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 72.140000000000001 110.853 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -177.26 110.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 74.409999999999997 110.876 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.425 ' HD2' HD13 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -178.03 -178.55 0.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 70.019999999999996 110.876 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.1 160.63 1.15 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.699 0.761 . . . . 65.409999999999997 110.855 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 79.61 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.67 2.247 . . . . 71.310000000000002 112.342 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.78 -179.42 5.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 74.519999999999996 111.135 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.98 128.74 15.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 70.439999999999998 111.126 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.61 -58.52 0.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 73.040000000000006 110.884 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.88 159.64 39.98 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.554 0.692 . . . . 74.450000000000003 111.117 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -12.47 32.88 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.725 2.284 . . . . 55.439999999999998 112.318 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -63.54 151.5 41.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 72.510000000000005 110.897 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -176.6 -164.53 30.72 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.741 -0.742 . . . . 70.530000000000001 112.496 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 129.26 -136.7 9.12 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 70.019999999999996 112.457 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.58 -133.07 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.756 -0.735 . . . . 74.549999999999997 112.505 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -112.43 -51.62 0.54 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.732 -0.746 . . . . 74.340000000000003 112.523 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -71.43 -26.93 62.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.897 0.379 . . . . 71.409999999999997 110.915 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.62 ' O ' HG22 ' A' ' 135' ' ' VAL . 34.8 m -55.8 -26.96 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 52.539999999999999 111.139 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.76 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -55.99 -24.84 41.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 61.200000000000003 111.069 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.1 mtt -52.66 -31.0 34.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 63.32 110.889 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 132' ' ' VAL . 17.7 m -59.55 -30.55 44.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 74.219999999999999 111.156 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 28.2 mt -74.15 -47.38 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 73.319999999999993 111.163 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -69.66 -29.95 67.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 65.310000000000002 110.839 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.1 mtm-85 -55.87 -25.64 43.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 71.530000000000001 110.838 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.6 mt -71.02 -50.99 28.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 60.329999999999998 110.887 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -73.82 -27.13 60.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 55.32 110.853 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.678 HD13 ' CZ ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -51.93 -36.8 50.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.17 -0.468 . . . . 65.010000000000005 110.884 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -53.03 -52.01 59.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 63.329999999999998 110.905 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.735 ' O ' HG23 ' A' ' 147' ' ' VAL . 3.4 mt -77.02 -37.74 26.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 72.109999999999999 111.17 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -56.01 -56.96 14.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 73.109999999999999 110.915 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 141' ' ' LEU . 42.7 t -56.67 -34.97 43.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 73.439999999999998 111.165 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -68.48 -34.95 76.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 75.439999999999998 110.882 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 143' ' ' ILE . 93.5 t -55.58 -41.62 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 73.310000000000002 111.133 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 98.6 m -52.02 -48.23 64.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 74.340000000000003 110.9 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.461 ' O ' HG22 ' A' ' 153' ' ' ILE . 43.6 t -75.69 -36.9 34.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 54.130000000000003 111.122 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.31 -26.85 61.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 75.200000000000003 110.903 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.15 -59.07 2.48 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.696 -0.764 . . . . 50.109999999999999 112.455 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 4.6 t -55.3 -41.78 72.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.741 0.305 . . . . 22.440000000000001 111.092 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.461 HG22 ' O ' ' A' ' 149' ' ' VAL . 18.7 tt -63.06 -26.29 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 74.420000000000002 111.141 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -51.98 -49.82 47.36 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.767 -0.73 . . . . 63.409999999999997 112.47 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 22.7 mmt -71.57 -31.9 67.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.828 0.347 . . . . 74.409999999999997 110.878 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -67.97 -20.28 65.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 72.340000000000003 110.903 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.6 mt -74.43 -28.96 61.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 73.120000000000005 110.849 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.487 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 1.0 OUTLIER -53.27 -60.56 6.58 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.618 0.723 . . . . 72.329999999999998 110.952 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.4 Cg_endo -69.82 -21.56 33.04 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.674 2.249 . . . . 63.509999999999998 112.31 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.449 HD13 ' O ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -55.82 -25.65 42.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 72.299999999999997 110.903 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -51.99 -30.3 24.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 74.299999999999997 110.88 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.16 104.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 75.299999999999997 110.905 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -115.92 27.36 9.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 61.399999999999999 110.918 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 78.2 t80 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 72.450000000000003 110.888 -179.913 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.81 0.338 . . . . 64.120000000000005 110.852 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.2 mmt-85 -68.2 -60.75 2.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 50.219999999999999 110.876 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -120.64 68.3 15.09 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.63 0.729 . . . . 74.010000000000005 110.904 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.74 78.47 1.0 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.688 2.258 . . . . 64.340000000000003 112.376 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.92 -30.94 65.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 74.310000000000002 110.873 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -78.18 -31.84 49.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 74.200000000000003 110.84 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.668 ' CE1' HG22 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -73.66 -44.91 55.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 74.510000000000005 110.926 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.6 t -60.56 -39.78 89.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 53.130000000000003 111.14 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.12 -29.12 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 74.010000000000005 111.118 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.13 -27.05 52.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 55.210000000000001 110.909 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.522 ' CD1' HD22 ' A' ' 76' ' ' LEU . 4.1 mm? -91.25 -19.28 23.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 70.239999999999995 110.925 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.3 mm -76.84 -34.58 22.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 63.119999999999997 111.118 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.551 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.75 -57.18 22.9 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.629 0.728 . . . . 74.120000000000005 111.112 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.8 Cg_endo -69.74 -20.47 34.9 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.663 2.242 . . . . 60.130000000000003 112.356 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.631 ' O ' HG22 ' A' ' 42' ' ' ILE . 49.3 t -75.94 -44.42 40.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 61.329999999999998 110.87 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.2 p -81.57 -28.93 10.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 73.010000000000005 111.104 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.5 mt -50.99 -33.94 26.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 75.230000000000004 110.917 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.631 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.74 -34.69 52.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 64.329999999999998 111.1 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.82 -36.79 84.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 71.209999999999994 111.121 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.07 -52.65 60.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 71.510000000000005 110.862 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.1 tp -68.91 -40.51 79.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 73.239999999999995 110.922 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.93 -51.38 69.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 70.239999999999995 111.101 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.13 -31.85 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 74.25 111.141 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.558 ' O ' HD13 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -51.68 -38.1 53.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 73.239999999999995 110.926 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.7 p -101.6 -37.17 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 74.340000000000003 111.175 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -67.43 -63.28 1.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 71.209999999999994 110.86 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.39 -26.01 38.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 75.420000000000002 110.946 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 48' ' ' LEU . 4.2 mp -76.78 160.65 76.29 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.596 0.712 . . . . 54.530000000000001 110.907 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 78.84 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.704 2.27 . . . . 73.019999999999996 112.339 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.7 t -165.8 151.69 9.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 54.520000000000003 110.848 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -161.16 26.14 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 74.310000000000002 110.85 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 30.3 p -65.97 -170.24 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 54.210000000000001 110.86 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.99 -43.73 72.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.723 -0.751 . . . . 64.200000000000003 112.488 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -53.04 -41.27 64.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.93 0.395 . . . . 72.040000000000006 110.929 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -59.28 -45.21 91.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 73.510000000000005 110.894 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 33.4 ttm -63.92 -51.68 63.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 53.229999999999997 110.902 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 80.8 p -54.08 -34.82 61.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 71.519999999999996 111.135 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.533 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -65.64 -50.33 65.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 74.310000000000002 110.921 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 59.4 m -53.87 -51.96 62.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 62.030000000000001 110.886 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.6 tt -67.37 -35.06 72.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 73.329999999999998 111.095 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 m -60.26 -26.01 66.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 75.019999999999996 110.911 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 62' ' ' LEU . 41.6 t -57.97 -38.52 67.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 51.340000000000003 111.139 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.88 -28.9 25.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 71.200000000000003 110.913 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.493 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.03 -39.34 79.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 74.040000000000006 110.945 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.27 -29.98 70.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 74.5 111.081 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.529 HD22 HG11 ' A' ' 102' ' ' VAL . 10.1 mt -64.82 -54.74 26.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 62.039999999999999 110.908 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.97 -38.08 87.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 63.409999999999997 111.127 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 68' ' ' LEU . 75.0 t -71.45 -32.91 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 54.420000000000002 111.094 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -60.13 -29.88 68.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 75.409999999999997 110.901 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.568 HD11 HD13 ' A' ' 95' ' ' LEU . 1.7 tt -73.25 -44.17 59.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.124 -0.489 . . . . 74.450000000000003 110.89 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.4 mt -73.35 -33.04 64.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 72.120000000000005 110.918 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.545 HD23 ' HD2' ' A' ' 79' ' ' LYS . 1.6 tt -68.87 -55.14 12.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 73.319999999999993 110.882 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.442 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.6 OUTLIER -56.93 -23.38 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 74.25 111.16 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.5 t -70.03 -14.69 62.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 71.420000000000002 110.882 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.745 ' O ' HG23 ' A' ' 81' ' ' VAL . 12.6 ptmt -62.17 -17.04 56.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 53.530000000000001 110.893 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.668 HG22 ' CE1' ' A' ' 31' ' ' TYR . 24.7 pt -50.37 -31.4 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 75.349999999999994 111.099 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 79' ' ' LYS . 66.7 t 56.73 80.33 0.29 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.635 0.731 . . . . 63.420000000000002 111.137 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 166.8 26.3 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.735 2.29 . . . . 75.310000000000002 112.358 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -49.14 0.59 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.658 2.239 . . . . 74.049999999999997 112.374 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.1 t -135.67 22.2 3.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 63.340000000000003 111.153 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.7 t 52.17 48.57 22.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 64.200000000000003 110.856 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tp -95.55 24.65 5.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 61.219999999999999 110.915 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.635 ' HA ' HD23 ' A' ' 90' ' ' LEU . 3.3 m-20 -110.92 25.85 11.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 73.230000000000004 110.894 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.533 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.03 -57.82 10.45 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.664 0.745 . . . . 72.129999999999995 111.092 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.539 ' HG2' HD22 ' A' ' 90' ' ' LEU . 53.9 Cg_endo -69.72 -20.59 34.84 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.661 2.241 . . . . 63.539999999999999 112.392 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.635 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.19 -53.07 10.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 74.099999999999994 110.978 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.07 -36.54 16.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 74.540000000000006 111.096 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.21 -40.43 52.35 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.768 -0.729 . . . . 61.149999999999999 112.475 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -67.66 -24.6 65.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 65.209999999999994 110.865 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -78.04 -44.3 26.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 75.340000000000003 110.971 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.568 HD13 HD11 ' A' ' 74' ' ' LEU . 10.0 mt -55.45 -29.72 59.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 73.140000000000001 110.923 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.38 -43.26 77.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 74.239999999999995 110.847 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.503 ' O ' HG22 ' A' ' 100' ' ' VAL . 39.1 t80 -75.29 -51.85 12.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 75.319999999999993 110.941 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.776 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.12 -29.87 33.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 72.200000000000003 111.165 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.1 mmt -66.69 -30.11 70.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 73.109999999999999 110.875 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.76 -30.09 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 75.049999999999997 111.116 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.776 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.89 -33.27 62.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 75.430000000000007 110.884 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.529 HG11 HD22 ' A' ' 70' ' ' LEU . 31.1 m -76.87 -38.1 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 63.350000000000001 111.159 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 73.9 m -72.46 -39.77 67.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 53.240000000000002 111.143 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -64.87 -31.99 73.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 73.510000000000005 110.843 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.9 t -72.57 -35.25 67.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 60.210000000000001 110.857 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 36.8 mt -72.55 -51.36 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 72.420000000000002 111.099 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.549 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.5 p -53.97 -36.41 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 74.540000000000006 111.097 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 94.7 m -52.42 -32.4 39.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 74.310000000000002 111.099 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.9 p -50.44 -31.4 14.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 55.539999999999999 110.826 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.4 p -52.45 -32.82 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 63.219999999999999 111.106 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 31.0 m -65.81 -43.17 89.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 73.409999999999997 110.895 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.8 t -77.02 -35.45 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 74.439999999999998 111.145 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 87.5 mt -71.99 -32.98 67.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 74.109999999999999 110.906 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -59.71 -31.24 69.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 65.400000000000006 110.881 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.769 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.7 p -102.29 -23.96 4.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 74.510000000000005 111.135 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -77.04 -26.17 53.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 71.439999999999998 110.833 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -173.27 -169.94 0.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 75.310000000000002 110.827 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 56.71 -174.24 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 74.510000000000005 110.903 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.5 160.62 29.74 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.665 0.745 . . . . 64.120000000000005 110.844 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 125.3 11.97 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.68 2.253 . . . . 74.329999999999998 112.33 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.97 -73.22 0.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 52.009999999999998 111.127 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 48.8 m -93.54 -42.89 8.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 63.439999999999998 111.147 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -91.24 -169.93 2.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 73.430000000000007 110.841 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.36 147.55 43.47 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.577 0.704 . . . . 74.140000000000001 111.141 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -173.93 0.81 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.667 2.245 . . . . 74.219999999999999 112.372 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.04 120.15 1.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 75.409999999999997 110.866 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -53.98 102.52 0.12 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.746 -0.74 . . . . 24.210000000000001 112.479 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -176.21 -109.24 0.24 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.771 -0.728 . . . . 44.140000000000001 112.496 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -166.68 -37.24 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.701 -0.761 . . . . 63.340000000000003 112.449 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 167.63 -30.59 0.18 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.768 -0.73 . . . . 32.420000000000002 112.524 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -86.37 -26.79 24.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 70.019999999999996 110.882 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.6 m -54.4 -26.91 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 71.409999999999997 111.124 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.769 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -55.22 -26.04 36.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 54.229999999999997 111.066 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 6.4 ptm -52.99 -30.94 38.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 74.439999999999998 110.89 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 62.8 t -56.96 -58.95 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 72.230000000000004 111.092 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.8 mt -73.96 -37.78 48.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 71.319999999999993 111.14 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -61.25 -30.01 70.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 62.210000000000001 110.851 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.01 -29.02 26.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 61.420000000000002 110.9 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.52 -48.3 70.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 72.319999999999993 110.925 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -73.69 -41.77 62.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 42.450000000000003 110.824 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.615 ' O ' HG23 ' A' ' 145' ' ' VAL . 0.4 OUTLIER -52.07 -32.7 35.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 54.450000000000003 110.933 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 23.7 m0 -61.85 -51.98 65.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 54.43 110.906 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.681 ' O ' HG23 ' A' ' 147' ' ' VAL . 66.6 mt -71.21 -32.05 46.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 55.43 111.175 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -56.33 -40.76 74.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 65.340000000000003 110.858 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 141' ' ' LEU . 21.8 t -73.63 -44.97 52.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 72.019999999999996 111.101 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.4 -40.73 62.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 72.219999999999999 110.851 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 143' ' ' ILE . 65.5 t -54.34 -33.96 27.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 60.409999999999997 111.119 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 72.0 m -52.06 -51.96 54.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.191 -0.459 . . . . 54.25 110.871 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.91 -33.7 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 72.010000000000005 111.143 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -52.38 -40.57 62.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 74.109999999999999 110.902 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.76 -44.24 8.52 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.771 -0.728 . . . . 72.349999999999994 112.506 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 35.1 m -51.85 -52.85 46.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 51.32 111.163 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 47.5 mm -76.52 -24.92 16.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 52.43 111.16 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -53.92 -49.9 56.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 74.439999999999998 112.513 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -31.95 73.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.825 0.345 . . . . 64.340000000000003 110.894 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -76.97 -23.77 52.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 65.040000000000006 110.881 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.571 HD23 HD23 ' A' ' 160' ' ' LEU . 2.3 mt -78.51 -26.79 45.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 73.310000000000002 110.889 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.527 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 4.6 tt0 -51.98 -58.69 10.36 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.577 0.703 . . . . 73.25 110.854 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.9 Cg_endo -69.79 -17.17 37.59 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.697 2.265 . . . . 75.109999999999999 112.327 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.571 HD23 HD23 ' A' ' 157' ' ' LEU . 26.0 tp -83.76 -26.45 29.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 75.019999999999996 110.879 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -53.86 -71.63 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 72.140000000000001 110.904 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 63.06 104.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 73.400000000000006 110.911 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -75.9 79.74 2.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 73.099999999999994 110.887 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 13.2 p90 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 74.120000000000005 110.956 -179.898 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.83 0.348 . . . . 64.140000000000001 110.829 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.97 -167.89 2.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 74.209999999999994 110.894 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.9 mtpp 55.83 73.62 0.82 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.564 0.697 . . . . 61.409999999999997 110.894 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 -11.64 31.36 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.735 2.29 . . . . 72.329999999999998 112.343 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 pp -52.06 -30.91 27.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 71.5 110.92 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -79.08 -33.17 44.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 61.020000000000003 110.9 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.45 -46.0 56.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 74.409999999999997 110.938 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -60.03 -39.97 87.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 71.140000000000001 111.182 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.442 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.24 -29.05 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 53.020000000000003 111.132 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.87 -27.19 50.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 72.129999999999995 110.89 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.23 -19.14 23.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 64.219999999999999 110.894 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.52 HD12 HG23 ' A' ' 152' ' ' THR . 45.7 mm -76.77 -34.73 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 62.119999999999997 111.138 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.545 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.7 -57.15 22.91 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.62 0.724 . . . . 73.409999999999997 111.09 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.9 Cg_endo -69.73 -22.83 31.68 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.655 2.237 . . . . 50.210000000000001 112.377 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.627 ' O ' HG22 ' A' ' 42' ' ' ILE . 49.6 t -76.08 -46.49 28.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 72.349999999999994 110.825 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 36' ' ' ILE . 8.7 p -81.6 -28.78 10.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 72.25 111.117 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.6 mt -50.93 -33.99 26.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 72.230000000000004 110.932 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.627 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.68 -34.71 52.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 71.140000000000001 111.119 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.7 p -66.04 -38.55 88.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 74.530000000000001 111.147 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.8 m -52.92 -53.77 44.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.229 -0.442 . . . . 75.439999999999998 110.897 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tp -67.55 -39.47 84.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 52.420000000000002 110.954 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.99 74.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 43.329999999999998 111.142 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.422 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.3 mp -64.93 -32.47 58.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 72.230000000000004 111.104 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.6 tp -53.76 -34.61 59.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 75.140000000000001 110.887 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.585 HG23 ' HB2' ' A' ' 55' ' ' ASP . 7.1 p -102.26 -36.59 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 74.439999999999998 111.145 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.48 -64.92 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 74.540000000000006 110.891 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.629 ' CD2' HD22 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -69.27 -62.3 1.44 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.099 -0.5 . . . . 74.019999999999996 110.956 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.6 mp -63.47 160.09 45.54 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.587 0.708 . . . . 61.240000000000002 110.932 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -168.54 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.687 2.258 . . . . 73.519999999999996 112.349 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.88 154.53 0.07 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 72.510000000000005 110.856 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.585 ' HB2' HG23 ' A' ' 49' ' ' VAL . 43.8 m-20 53.01 88.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 73.129999999999995 110.813 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 94.5 m -88.71 -69.61 0.7 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 62.240000000000002 110.831 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.95 -32.0 59.0 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.708 -0.758 . . . . 41.32 112.493 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -51.97 -34.97 44.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.9 0.381 . . . . 75.409999999999997 110.924 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -52.98 -48.79 67.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 73.030000000000001 110.906 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.4 ttm -57.83 -51.78 68.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 75.099999999999994 110.892 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.4 p -61.95 -28.34 69.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 64.010000000000005 111.111 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.747 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -75.81 -50.78 14.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 74.239999999999995 110.931 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 71.4 m -52.96 -42.19 65.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 73.329999999999998 110.895 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.7 tt -73.37 -34.95 44.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 51.200000000000003 111.127 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.9 t -69.14 -25.85 64.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 71.319999999999993 110.841 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 62' ' ' LEU . 99.5 t -57.95 -34.6 49.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 72.420000000000002 111.12 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -52.89 -28.91 25.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 71.420000000000002 110.891 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.493 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.37 -38.92 78.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 72.200000000000003 110.95 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.6 -29.94 70.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 72.5 111.105 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.766 HD22 HG11 ' A' ' 102' ' ' VAL . 9.5 mt -65.08 -54.79 24.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 72.109999999999999 110.86 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.71 -38.38 87.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 74.25 111.173 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 68' ' ' LEU . 79.3 t -71.48 -32.83 47.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 55.109999999999999 111.109 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -51.94 -30.0 22.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 74.420000000000002 110.855 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.08 -41.71 61.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 74.450000000000003 110.88 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.9 mt -73.2 -34.78 66.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 70.530000000000001 110.91 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.443 HD13 ' HD2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -69.31 -55.09 11.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 74.319999999999993 110.885 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.6 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -56.19 -25.0 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 52.109999999999999 111.117 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.6 -14.9 63.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 63.119999999999997 110.851 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.757 ' O ' HG23 ' A' ' 81' ' ' VAL . 2.2 ptmm? -59.23 -20.76 56.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 72.25 110.884 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 77' ' ' ILE . 36.8 pt -51.55 -29.38 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 74.319999999999993 111.108 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 79' ' ' LYS . 60.2 t 60.87 77.54 0.36 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.589 0.709 . . . . 55.200000000000003 111.112 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 167.57 24.06 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.714 2.276 . . . . 75.310000000000002 112.356 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -48.76 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.657 2.238 . . . . 71.540000000000006 112.33 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.5 t -131.73 9.89 4.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 73.420000000000002 111.179 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.73 52.74 13.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 61.409999999999997 110.82 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.89 25.65 4.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 73.25 110.91 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.636 ' HA ' HD23 ' A' ' 90' ' ' LEU . 1.5 m-20 -104.3 23.71 12.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 75.439999999999998 110.87 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.542 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.37 -57.84 9.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.63 0.728 . . . . 63.030000000000001 111.133 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.3 Cg_endo -69.75 -20.35 35.01 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.716 2.277 . . . . 73.239999999999995 112.337 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.636 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.17 -53.02 10.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 72.219999999999999 110.937 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.573 HG12 HD21 ' A' ' 95' ' ' LEU . 24.6 t -80.75 -32.87 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 70.140000000000001 111.114 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.72 -52.1 35.69 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.707 -0.759 . . . . 55.549999999999997 112.476 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -35.01 79.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.778 0.323 . . . . 75.129999999999995 110.883 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -61.22 -36.61 80.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 75.129999999999995 110.906 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.573 HD21 HG12 ' A' ' 91' ' ' VAL . 9.2 mt -51.82 -29.87 21.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 71.25 110.924 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -69.25 -43.63 73.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 75.040000000000006 110.864 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.506 ' O ' HG22 ' A' ' 100' ' ' VAL . 72.4 t80 -75.26 -51.26 13.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 75.140000000000001 110.867 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.808 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.05 -29.86 32.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 74.420000000000002 111.157 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.8 mmt -66.6 -30.24 70.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 71.439999999999998 110.859 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.67 -29.97 13.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 61.229999999999997 111.097 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.808 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -75.23 -33.49 61.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 72.109999999999999 110.903 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.766 HG11 HD22 ' A' ' 70' ' ' LEU . 29.3 m -77.53 -39.65 27.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 74.519999999999996 111.104 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.719 ' HA ' HD12 ' A' ' 106' ' ' ILE . 2.9 t -72.55 -32.3 65.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 70.329999999999998 111.082 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -56.83 -35.14 68.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 62.219999999999999 110.861 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.4 t -75.02 -32.59 61.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 73.120000000000005 110.882 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.719 HD12 ' HA ' ' A' ' 103' ' ' THR . 9.3 mt -75.16 -51.3 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 71.319999999999993 111.092 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.542 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.5 p -53.99 -35.87 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 75.430000000000007 111.101 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.7 m -52.42 -32.36 38.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 74.319999999999993 111.135 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.2 t -50.33 -31.58 14.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 74.450000000000003 110.822 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.2 p -52.5 -32.77 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 71.409999999999997 111.124 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 35.5 m -66.2 -47.55 73.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 52.200000000000003 110.915 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.2 t -72.1 -36.09 55.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.475 . . . . 75.230000000000004 111.137 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.5 mt -72.04 -33.31 67.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 75.329999999999998 110.927 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -59.82 -30.72 69.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 74.400000000000006 110.906 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.777 HG11 ' HB2' ' A' ' 133' ' ' ALA . 9.4 p -102.26 -23.83 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 73.329999999999998 111.15 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 -85.44 -70.37 0.59 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 64.349999999999994 110.858 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -178.88 121.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 73.230000000000004 110.869 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.3 ttp85 -153.45 159.12 42.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 73.109999999999999 110.849 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.11 160.62 0.99 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.646 0.736 . . . . 74.540000000000006 110.862 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.527 ' O ' HG23 ' A' ' 121' ' ' THR . 53.4 Cg_endo -69.78 78.7 1.0 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.709 2.273 . . . . 63.299999999999997 112.315 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -171.11 177.55 3.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 61.219999999999999 111.172 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.55 69.29 1.4 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 70.519999999999996 111.102 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.495 ' O ' HG23 ' A' ' 124' ' ' THR . 11.5 t-160 -81.48 -74.44 0.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.456 . . . . 73.010000000000005 110.888 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 123' ' ' HIS . 0.1 OUTLIER -171.56 159.69 4.9 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.607 0.718 . . . . 72.129999999999995 111.131 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.448 ' HD2' HG22 ' A' ' 124' ' ' THR . 53.1 Cg_endo -69.81 -12.45 32.82 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.642 2.228 . . . . 71.109999999999999 112.34 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -52.35 127.48 22.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 64.040000000000006 110.89 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.36 133.25 1.57 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.771 -0.728 . . . . 50.340000000000003 112.529 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -135.8 151.68 20.74 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.733 . . . . 64.299999999999997 112.487 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 112.38 94.45 2.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.769 -0.729 . . . . 41.340000000000003 112.506 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 156.26 51.27 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.733 -0.746 . . . . 75.5 112.478 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -87.89 -26.07 22.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.964 0.412 . . . . 73.420000000000002 110.947 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.3 m -54.35 -26.93 16.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.077 -0.511 . . . . 75.329999999999998 111.083 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.777 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -55.96 -25.05 41.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 73.319999999999993 111.091 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.94 -30.84 36.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 70.129999999999995 110.912 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 91.5 t -57.09 -59.31 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 75.450000000000003 111.08 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 65.1 mt -73.97 -35.26 41.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 73.140000000000001 111.137 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -62.98 -30.16 71.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 54.140000000000001 110.843 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -53.78 -28.23 33.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 61.240000000000002 110.881 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.8 mp -67.36 -48.91 66.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 73.120000000000005 110.888 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -73.67 -47.47 39.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 73.319999999999993 110.892 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.629 HD22 ' CD2' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -51.92 -49.74 62.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.483 . . . . 61.329999999999998 110.944 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -53.22 -32.3 47.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 75.420000000000002 110.94 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.697 ' O ' HG23 ' A' ' 147' ' ' VAL . 63.8 mt -76.99 -42.33 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 74.439999999999998 111.118 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -56.17 -57.01 13.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 75.099999999999994 110.938 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 31.1 t -54.15 -37.08 34.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 74.319999999999993 111.118 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -70.01 -44.04 70.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 73.219999999999999 110.854 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 143' ' ' ILE . 91.1 t -63.52 -34.09 65.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 73.150000000000006 111.158 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 17.2 m -51.85 -44.23 63.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 72.409999999999997 110.907 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.459 HG12 HD12 ' A' ' 153' ' ' ILE . 26.5 t -75.84 -33.19 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 70.409999999999997 111.097 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -58.8 -54.63 44.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 73.439999999999998 110.882 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -68.42 -19.4 72.58 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 50.229999999999997 112.512 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.52 HG23 HD12 ' A' ' 36' ' ' ILE . 33.1 m -75.64 -52.83 9.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.754 0.311 . . . . 62.409999999999997 111.172 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.459 HD12 HG12 ' A' ' 149' ' ' VAL . 49.3 mt -76.5 -27.5 17.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 65.109999999999999 111.132 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -53.65 -49.55 57.27 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.725 -0.75 . . . . 62.100000000000001 112.533 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -31.89 67.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 75.129999999999995 110.906 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -72.75 -20.98 61.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 73.329999999999998 110.877 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.44 ' CD1' HG22 ' A' ' 153' ' ' ILE . 20.1 mt -79.37 -26.79 41.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 63.439999999999998 110.942 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.53 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 14.4 tp60 -52.0 -58.17 12.28 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.577 0.703 . . . . 62.200000000000003 110.88 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 54.1 Cg_endo -69.68 -15.73 37.53 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.695 2.263 . . . . 54.5 112.348 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.91 40.84 1.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 75.099999999999994 110.94 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -73.3 -26.17 60.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 74.420000000000002 110.874 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 63.27 105.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 65.450000000000003 110.905 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -91.05 -64.5 1.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 72.310000000000002 110.909 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 69.0 t80 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 71.310000000000002 110.942 -179.921 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.817 0.341 . . . . 71.150000000000006 110.921 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.6 mtm-85 -59.29 -28.41 66.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 74.219999999999999 110.865 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -123.06 79.01 51.47 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.532 0.682 . . . . 54.420000000000002 110.882 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 -5.07 15.28 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.688 2.258 . . . . 72.129999999999995 112.358 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 pp -52.16 -31.0 29.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 70.230000000000004 110.93 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -81.0 -31.95 34.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 75.140000000000001 110.865 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -72.51 -46.1 56.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 71.409999999999997 110.896 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 t -59.83 -40.17 87.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 73.409999999999997 111.146 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.26 -29.11 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 71.239999999999995 111.105 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -55.59 -27.0 46.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 73.409999999999997 110.899 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.672 ' HG ' HD12 ' A' ' 77' ' ' ILE . 4.1 mm? -91.51 -18.95 23.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 53.039999999999999 110.947 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.8 mm -76.53 -35.17 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 72.430000000000007 111.103 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.53 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.3 mm -55.68 -57.15 22.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.609 0.718 . . . . 71.430000000000007 111.125 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.78 -21.4 33.45 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.67 2.247 . . . . 73.030000000000001 112.323 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.641 ' O ' HG22 ' A' ' 42' ' ' ILE . 43.0 t -71.33 -45.36 63.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 65.400000000000006 110.912 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 p -81.62 -28.94 10.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 74.25 111.091 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 mt -50.95 -33.91 26.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 74.439999999999998 110.915 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.641 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.77 -34.68 52.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 74.409999999999997 111.145 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.72 -39.81 91.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 54.229999999999997 111.145 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.95 -51.23 62.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 62.340000000000003 110.885 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.7 tp -70.68 -35.96 73.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 64.409999999999997 110.908 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.73 -38.84 82.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 42.140000000000001 111.075 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.3 mp -64.25 -32.03 55.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 53.039999999999999 111.15 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 tp -51.42 -38.74 55.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 74.030000000000001 110.944 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.747 HG21 ' HA ' ' A' ' 59' ' ' LYS . 7.8 p -101.48 -36.79 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 61.210000000000001 111.145 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -66.97 -64.59 0.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 73.409999999999997 110.926 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.732 ' CZ ' HD13 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -71.22 -25.98 62.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 74.439999999999998 110.924 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.6 mp -125.08 71.65 63.22 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.622 0.725 . . . . 74.420000000000002 110.9 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 173.27 11.19 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.748 2.299 . . . . 64.219999999999999 112.3 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.0 p -167.8 -170.27 1.34 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 70.209999999999994 110.876 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.0 95.71 10.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 72.140000000000001 110.839 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -179.1 138.78 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 71.109999999999999 110.841 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.33 -22.96 77.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.741 -0.743 . . . . 64.319999999999993 112.452 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -52.06 -34.94 45.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.932 0.396 . . . . 71.409999999999997 110.87 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.747 ' HA ' HG21 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -52.98 -51.57 61.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 72.420000000000002 110.905 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.8 ttm -65.41 -28.02 68.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 62.329999999999998 110.835 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.4 m -75.49 -31.65 60.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 44.140000000000001 111.148 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.606 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -68.45 -51.07 47.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 70.310000000000002 110.912 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -53.88 -48.01 70.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 62.229999999999997 110.887 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.6 tt -70.68 -34.95 58.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 71.420000000000002 111.119 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -61.52 -27.96 68.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 64.409999999999997 110.885 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 62' ' ' LEU . 60.2 t -57.93 -39.48 71.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 62.140000000000001 111.099 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -29.13 27.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 62.130000000000003 110.915 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.487 ' O ' HD22 ' A' ' 68' ' ' LEU . 2.1 tm? -74.56 -45.77 43.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 73.540000000000006 110.94 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.91 -29.59 20.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 70.219999999999999 111.086 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.517 HD22 HG11 ' A' ' 102' ' ' VAL . 37.3 mt -58.69 -54.46 46.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 62.229999999999997 110.91 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 68' ' ' LEU . 1.0 OUTLIER -62.31 -27.21 68.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 71.010000000000005 111.126 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 97.8 t -70.69 -33.05 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 75.400000000000006 111.154 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -64.7 -31.97 73.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 71.310000000000002 110.886 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.61 HD11 ' CD1' ' A' ' 95' ' ' LEU . 1.3 tp -75.1 -50.73 15.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 72.430000000000007 110.897 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.2 mp -65.84 -37.58 86.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 74.439999999999998 110.908 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.4 tt -62.63 -55.07 30.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 74.310000000000002 110.93 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.672 HD12 ' HG ' ' A' ' 35' ' ' LEU . 1.6 tt -66.31 -29.51 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 71.510000000000005 111.097 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.3 t -81.55 -14.78 56.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 110.822 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.461 ' O ' HG23 ' A' ' 81' ' ' VAL . 1.3 mmmt -93.67 -9.72 36.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 64.439999999999998 110.89 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.52 -16.88 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 71.319999999999993 111.122 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 79' ' ' LYS . 21.2 t 64.28 78.01 0.29 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.561 0.696 . . . . 54.420000000000002 111.118 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.402 ' HB3' ' HB2' ' A' ' 86' ' ' LEU . 53.3 Cg_endo -69.84 164.11 35.84 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.659 2.24 . . . . 62.109999999999999 112.355 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -49.3 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.745 2.296 . . . . 74.030000000000001 112.36 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 t -124.9 -35.32 2.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 73.129999999999995 111.153 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.24 -39.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 60.340000000000003 110.865 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 82' ' ' PRO . 8.2 tp 64.53 70.6 0.49 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 74.129999999999995 110.917 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.519 ' O ' HG23 ' A' ' 91' ' ' VAL . 4.0 m-20 50.15 60.17 4.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 55.409999999999997 110.894 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.533 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -68.62 -58.21 7.26 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.625 0.726 . . . . 60.329999999999998 111.114 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.587 ' HG2' HD22 ' A' ' 90' ' ' LEU . 53.4 Cg_endo -69.77 -26.02 27.98 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.673 2.248 . . . . 50.43 112.342 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.587 HD22 ' HG2' ' A' ' 89' ' ' PRO . 3.3 mm? -71.83 -39.81 69.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 60.409999999999997 110.916 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 87' ' ' ASP . 84.3 t -80.53 -41.85 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 72.200000000000003 111.164 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.0 -46.39 55.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.769 -0.729 . . . . 53.509999999999998 112.464 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -32.95 69.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.816 0.341 . . . . 73.209999999999994 110.896 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -62.25 -31.97 72.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 72.400000000000006 110.879 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.61 ' CD1' HD11 ' A' ' 74' ' ' LEU . 11.3 mt -53.17 -29.8 33.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 55.119999999999997 110.903 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -42.48 86.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 72.430000000000007 110.859 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.49 ' O ' HG22 ' A' ' 100' ' ' VAL . 24.5 t80 -75.26 -53.19 9.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 74.340000000000003 110.892 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.789 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.03 -29.93 32.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 75.400000000000006 111.165 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.1 mmt -66.61 -30.13 70.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 72.430000000000007 110.901 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.76 -30.1 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 64.409999999999997 111.116 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.789 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.92 -33.12 61.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 74.140000000000001 110.953 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.517 HG11 HD22 ' A' ' 70' ' ' LEU . 31.6 m -76.96 -37.99 27.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 73.299999999999997 111.118 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.437 ' O ' HG13 ' A' ' 107' ' ' VAL . 70.5 m -72.53 -39.68 67.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 74.400000000000006 111.153 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -64.73 -31.93 73.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 53.520000000000003 110.847 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.6 t -74.3 -33.92 63.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.461 . . . . 42.039999999999999 110.852 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.3 mt -74.93 -50.65 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 72.5 111.151 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 110' ' ' VAL . 34.7 m -54.15 -34.12 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 64.040000000000006 111.111 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.0 m -52.41 -32.45 39.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 74.010000000000005 111.188 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.4 m -50.42 -31.54 15.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 73.430000000000007 110.857 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.4 p -52.47 -32.8 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.496 . . . . 71.340000000000003 111.143 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 31.5 m -65.46 -43.17 91.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.143 -0.481 . . . . 63.039999999999999 110.846 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.3 t -77.12 -34.81 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 74.239999999999995 111.106 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.546 HD22 ' O ' ' A' ' 117' ' ' HIS . 85.1 mt -72.05 -33.11 67.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 73.099999999999994 110.917 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -59.68 -31.03 69.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 73.310000000000002 110.888 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.776 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.8 p -102.32 -24.24 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 74.340000000000003 111.139 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -94.24 -74.68 0.53 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.472 . . . . 75.129999999999995 110.897 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.546 ' O ' HD22 ' A' ' 113' ' ' LEU . 4.2 t-80 -158.94 96.58 1.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 44.310000000000002 110.897 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.36 -26.0 13.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 74.099999999999994 110.877 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.13 160.59 1.17 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.711 0.767 . . . . 74.349999999999994 110.806 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.537 ' O ' HG23 ' A' ' 121' ' ' THR . 53.8 Cg_endo -69.75 134.94 29.23 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.687 2.258 . . . . 70.340000000000003 112.385 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -171.07 83.67 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 64.019999999999996 111.13 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.6 p -95.53 25.5 4.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.436 . . . . 73.150000000000006 111.142 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -135.3 -51.44 0.76 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 73.409999999999997 110.814 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 30.6 m -144.78 68.44 14.42 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.57 0.7 . . . . 75.530000000000001 111.156 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -12.45 32.85 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.638 2.225 . . . . 54.350000000000001 112.356 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.12 136.67 29.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 73.530000000000001 110.887 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.7 110.54 0.78 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 32.200000000000003 112.471 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 112.14 -159.16 13.87 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.78 -0.724 . . . . 65.129999999999995 112.525 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.91 -84.21 0.17 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.745 -0.741 . . . . 54.240000000000002 112.494 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.12 19.88 7.4 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 71.329999999999998 112.47 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -87.87 -26.11 22.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.914 0.388 . . . . 71.409999999999997 110.932 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.8 -36.92 77.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 63.130000000000003 111.08 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.776 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -67.04 -25.8 66.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 74.010000000000005 111.123 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 30.4 mmt -52.96 -30.95 37.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 63.039999999999999 110.91 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 74.8 t -56.97 -59.02 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 42.43 111.134 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 136' ' ' ILE . 3.6 mp -74.01 -37.74 47.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 71.420000000000002 111.136 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -61.26 -29.94 70.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 73.420000000000002 110.896 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.08 -30.14 24.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 73.430000000000007 110.872 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.42 -42.24 68.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 74.319999999999993 110.933 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -74.0 -51.43 15.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 72.040000000000006 110.881 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.732 HD13 ' CZ ' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -52.03 -33.31 38.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 61.229999999999997 110.893 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 45.6 t-105 -61.8 -45.42 93.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.236 -0.438 . . . . 64.140000000000001 110.924 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.751 ' O ' HG23 ' A' ' 147' ' ' VAL . 50.8 mm -76.96 -32.87 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 72.129999999999995 111.135 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -56.07 -56.96 14.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 72.129999999999995 110.867 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.7 m -55.6 -35.0 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 72.239999999999995 111.146 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -69.72 -33.11 72.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 73.310000000000002 110.883 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 143' ' ' ILE . 82.0 t -67.62 -33.99 65.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 52.299999999999997 111.144 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 67.9 m -66.32 -46.41 77.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 61.219999999999999 110.874 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.532 ' O ' HG22 ' A' ' 152' ' ' THR . 43.4 t -76.03 -36.82 32.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 72.120000000000005 111.104 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.573 ' O ' HG22 ' A' ' 153' ' ' ILE . 68.5 t80 -71.87 -28.6 63.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 74.310000000000002 110.861 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -52.24 -27.75 24.81 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.754 -0.736 . . . . 54.140000000000001 112.468 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 149' ' ' VAL . 14.8 t -53.81 -32.01 51.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 63.109999999999999 111.155 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 150' ' ' PHE . 20.0 tt -55.89 -25.7 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 75.0 111.163 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -51.9 -49.93 46.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.723 -0.751 . . . . 61.020000000000003 112.507 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -73.92 -31.8 63.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.785 0.326 . . . . 72.450000000000003 110.825 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -68.91 -21.49 64.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.429 . . . . 75.109999999999999 110.906 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.4 mt -74.74 -29.05 61.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 44.109999999999999 110.884 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.48 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.7 OUTLIER -51.95 -60.62 5.74 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.592 0.71 . . . . 72.519999999999996 110.877 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.9 Cg_endo -69.7 -16.53 37.84 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.753 2.302 . . . . 74.239999999999995 112.331 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -93.96 40.72 1.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 63.329999999999998 110.925 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -72.76 -26.32 61.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.442 . . . . 64.409999999999997 110.903 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 63.32 103.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.487 . . . . 73.299999999999997 110.867 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -78.88 -72.27 0.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 70.310000000000002 110.897 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 16.5 t80 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 73.439999999999998 110.88 -179.898 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 27.3 mmt-85 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.814 0.34 . . . . 74.129999999999995 110.845 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -96.16 26.16 4.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 64.430000000000007 110.848 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.97 73.73 2.46 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.536 0.684 . . . . 72.140000000000001 110.896 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -11.84 31.6 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.661 2.24 . . . . 72.430000000000007 112.292 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.409 HD11 ' CE1' ' A' ' 30' ' ' PHE . 2.4 pp -52.0 -30.96 27.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 74.420000000000002 110.904 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.409 ' CE1' HD11 ' A' ' 29' ' ' LEU . 42.8 m-85 -78.98 -33.31 45.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 63.340000000000003 110.901 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -72.5 -46.19 55.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 74.510000000000005 110.922 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -59.98 -40.03 87.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.511 . . . . 75.239999999999995 111.125 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.11 -29.1 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 64.409999999999997 111.141 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.1 -26.87 51.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 60.210000000000001 110.866 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.616 ' HG ' HD12 ' A' ' 77' ' ' ILE . 4.1 mm? -91.51 -19.2 23.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 73.129999999999995 110.9 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mm -76.76 -34.86 23.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 63.329999999999998 111.087 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.539 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.1 mt -55.72 -57.12 23.15 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.6 0.714 . . . . 73.150000000000006 111.109 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.4 Cg_endo -69.8 -20.34 34.77 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.683 2.255 . . . . 72.019999999999996 112.337 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.635 ' O ' HG22 ' A' ' 42' ' ' ILE . 48.4 t -75.51 -44.26 44.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 62.109999999999999 110.869 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 p -81.54 -28.95 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 74.310000000000002 111.144 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.3 mt -50.97 -33.97 26.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 75.120000000000005 110.872 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.635 HG22 ' O ' ' A' ' 39' ' ' CYS . 0.7 OUTLIER -58.76 -34.66 52.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 64.510000000000005 111.121 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.83 -38.43 88.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.19 -0.459 . . . . 71.510000000000005 111.132 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.07 -49.08 67.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 65.409999999999997 110.849 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.0 tp -74.31 -36.02 63.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 73.439999999999998 110.938 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.48 -37.99 76.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 61.130000000000003 111.106 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.421 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.2 mp -64.9 -32.49 58.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 73.239999999999995 111.108 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 tp -55.07 -33.77 63.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 74.420000000000002 110.882 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.589 HG11 ' HG ' ' A' ' 62' ' ' LEU . 27.5 m -101.76 -36.73 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 73.319999999999993 111.126 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -71.43 -64.91 0.83 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 71.099999999999994 110.903 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.739 ' CZ ' HD13 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -68.98 -23.27 64.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 62.439999999999998 110.875 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.7 mp -128.05 73.6 79.3 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.634 0.73 . . . . 73.510000000000005 110.889 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 133.18 24.89 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.721 2.28 . . . . 75.329999999999998 112.351 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.2 m -87.08 -67.73 0.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 53.210000000000001 110.824 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.53 -75.14 0.59 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 73.030000000000001 110.841 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.45 -62.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 72.219999999999999 110.859 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.16 -62.93 5.26 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.751 -0.737 . . . . 71.200000000000003 112.477 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -51.94 -36.93 50.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 64.349999999999994 110.881 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -62.93 -44.06 97.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 75.109999999999999 110.882 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.0 tpt -72.06 -48.47 44.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 74.219999999999999 110.842 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 82.0 p -54.99 -26.15 34.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.424 . . . . 71.400000000000006 111.101 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.589 ' HG ' HG11 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -75.65 -37.4 59.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 63.329999999999998 110.874 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 35.0 m -74.01 -48.19 31.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 74.540000000000006 110.914 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.6 pt -54.92 -32.21 26.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 73.510000000000005 111.115 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.0 t -70.84 -25.14 62.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 71.239999999999995 110.838 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.1 t -57.94 -37.13 59.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 75.510000000000005 111.137 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mt -55.37 -29.7 58.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 50.140000000000001 110.907 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.485 ' O ' HD22 ' A' ' 68' ' ' LEU . 2.1 tm? -69.85 -45.44 67.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 73.329999999999998 110.872 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.07 -29.7 22.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 30.300000000000001 111.082 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.774 HD22 HG11 ' A' ' 102' ' ' VAL . 23.9 mt -59.81 -54.53 45.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 63.43 110.932 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 68' ' ' LEU . 0.8 OUTLIER -60.76 -27.16 67.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 62.5 111.148 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.1 t -70.32 -32.94 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 72.299999999999997 111.127 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.535 ' O ' HG22 ' A' ' 77' ' ' ILE . 1.8 t80 -61.66 -29.84 70.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 74.510000000000005 110.911 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.888 HD11 HD13 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -66.73 -50.3 63.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 73.25 110.903 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.4 -38.25 65.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 73.329999999999998 110.866 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.5 tt -58.03 -55.05 40.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 74.310000000000002 110.969 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.616 HD12 ' HG ' ' A' ' 35' ' ' LEU . 1.3 tt -66.62 -23.95 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 74.519999999999996 111.162 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.6 t -80.32 -17.96 50.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 64.019999999999996 110.817 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.752 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -68.55 -12.18 60.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 73.409999999999997 110.925 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.492 HG23 ' O ' ' A' ' 77' ' ' ILE . 47.7 pt -52.77 -28.04 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 73.239999999999995 111.151 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.752 HG23 ' O ' ' A' ' 79' ' ' LYS . 57.5 t 61.48 77.14 0.37 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.664 0.745 . . . . 72.510000000000005 111.117 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 167.28 24.89 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.681 2.254 . . . . 74.519999999999996 112.318 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -48.99 0.6 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.656 2.237 . . . . 63.420000000000002 112.369 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 t -134.82 18.49 3.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 73.140000000000001 111.106 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.2 m 51.73 64.55 1.8 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 52.420000000000002 110.845 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.15 24.96 11.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 74.430000000000007 110.877 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -115.05 25.48 10.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 71.209999999999994 110.861 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.537 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -65.15 -57.61 14.92 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.643 0.735 . . . . 74.519999999999996 111.121 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.6 Cg_endo -69.76 -21.4 33.53 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.676 2.25 . . . . 55.450000000000003 112.326 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.0 mp -73.41 -52.97 11.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 64.450000000000003 110.935 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.1 t -80.03 -42.86 22.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.458 . . . . 63.030000000000001 111.14 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.41 -38.05 49.83 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.784 -0.722 . . . . 50.030000000000001 112.46 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.35 -23.7 60.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.789 0.328 . . . . 52.329999999999998 110.9 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -76.15 -39.34 55.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 72.340000000000003 110.951 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.888 HD13 HD11 ' A' ' 74' ' ' LEU . 12.0 mt -55.68 -29.74 59.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.108 -0.496 . . . . 72.239999999999995 110.924 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.9 mmt -70.23 -42.57 72.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 72.219999999999999 110.896 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.506 ' O ' HG22 ' A' ' 100' ' ' VAL . 4.7 t80 -75.26 -51.09 14.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 74.209999999999994 110.863 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.804 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.23 -29.84 34.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 74.129999999999995 111.127 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.6 mmt -66.77 -30.01 70.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 72.120000000000005 110.877 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.81 -30.01 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 62.210000000000001 111.137 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.804 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -74.91 -33.12 61.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 52.520000000000003 110.916 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.774 HG11 HD22 ' A' ' 70' ' ' LEU . 30.2 m -76.55 -37.73 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 64.109999999999999 111.118 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.728 ' O ' HG23 ' A' ' 107' ' ' VAL . 53.7 m -72.7 -46.6 52.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 72.120000000000005 111.097 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.444 ' CE2' HG21 ' A' ' 147' ' ' VAL . 69.9 t80 -51.86 -31.26 27.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 71.319999999999993 110.894 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 m -73.86 -51.09 17.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 70.409999999999997 110.842 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 103' ' ' THR . 7.6 mt -54.76 -34.68 30.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 61.509999999999998 111.117 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 103' ' ' THR . 25.6 t -54.02 -45.73 64.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 63.039999999999999 111.103 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.6 m -52.3 -32.45 37.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 71.400000000000006 111.152 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.1 p -50.41 -31.36 14.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 65.319999999999993 110.855 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.6 p -52.45 -32.86 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 70.299999999999997 111.154 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 28.9 m -65.86 -47.35 75.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.468 . . . . 71.25 110.897 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.42 HG23 ' OD1' ' A' ' 137' ' ' ASP . 84.6 t -72.46 -36.28 54.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 73.340000000000003 111.121 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.612 HD13 HH21 ' A' ' 118' ' ' ARG . 95.1 mt -72.05 -32.72 67.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 65.129999999999995 110.93 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -60.98 -30.59 70.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 73.530000000000001 110.852 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.778 HG11 ' HB2' ' A' ' 133' ' ' ALA . 9.8 p -102.3 -23.2 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 72.120000000000005 111.126 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -109.37 117.7 34.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 73.510000000000005 110.886 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -52.96 169.98 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.456 . . . . 73.120000000000005 110.855 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.612 HH21 HD13 ' A' ' 113' ' ' LEU . 2.0 ttm180 -173.1 -173.88 0.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 73.510000000000005 110.861 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.04 160.61 1.14 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.654 0.74 . . . . 74.010000000000005 110.833 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 78.95 0.98 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.662 2.241 . . . . 71.319999999999993 112.319 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.11 -172.68 3.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 72.319999999999993 111.159 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.8 t -116.81 -24.58 7.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 64.010000000000005 111.178 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -51.88 -74.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 74.310000000000002 110.864 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 64.4 m -160.62 73.8 2.82 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.588 0.708 . . . . 72.549999999999997 111.145 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 100.05 0.79 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.667 2.245 . . . . 75.120000000000005 112.37 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -146.2 156.09 43.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 50.030000000000001 110.855 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -136.1 -162.5 9.57 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.762 -0.733 . . . . 71.319999999999993 112.491 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 103.41 57.42 0.75 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.714 -0.755 . . . . 64.400000000000006 112.46 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 130.38 -164.9 22.8 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.752 -0.737 . . . . 33.240000000000002 112.471 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 176.14 -64.01 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 63.32 112.501 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -66.29 -39.96 89.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.944 0.402 . . . . 74.219999999999999 110.952 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 135' ' ' VAL . 34.7 m -54.72 -27.04 17.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 43.049999999999997 111.079 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.778 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -56.31 -25.33 48.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 61.32 111.094 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 37.1 mmt -53.01 -30.98 38.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 70.230000000000004 110.849 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 132' ' ' VAL . 52.6 t -56.94 -58.26 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 64.109999999999999 111.114 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 45.5 mm -74.06 -37.94 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 73.019999999999996 111.101 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.42 ' OD1' HG23 ' A' ' 112' ' ' VAL . 0.8 OUTLIER -58.73 -32.86 69.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 61.409999999999997 110.869 179.839 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.07 -26.02 59.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 73.349999999999994 110.895 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 16.1 tp -68.51 -50.88 48.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 74.150000000000006 110.939 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -73.23 -37.01 66.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 73.439999999999998 110.895 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.739 HD13 ' CZ ' ' A' ' 51' ' ' TYR . 3.5 mt -52.02 -33.31 37.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 73.400000000000006 110.885 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -74.31 -34.53 63.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.213 -0.449 . . . . 75.439999999999998 110.905 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.556 ' O ' HG23 ' A' ' 147' ' ' VAL . 36.0 mt -76.94 -32.01 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 72.150000000000006 111.101 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -56.05 -56.96 14.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 74.129999999999995 110.861 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.3 m -54.19 -34.99 28.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 41.240000000000002 111.132 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -67.34 -41.18 85.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 74.409999999999997 110.895 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 143' ' ' ILE . 87.9 t -62.18 -34.04 61.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 44.32 111.121 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 98.9 m -53.8 -39.07 65.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.14 -0.482 . . . . 74.450000000000003 110.89 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.9 t -75.46 -33.0 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 74.510000000000005 111.122 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.98 -54.7 26.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 63.140000000000001 110.92 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.42 -19.35 79.87 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.794 -0.717 . . . . 73.040000000000006 112.461 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 34.6 m -73.61 -52.83 12.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.806 0.336 . . . . 70.519999999999996 111.176 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 45.4 mm -76.51 -24.26 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 71.040000000000006 111.128 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -53.95 -48.51 62.26 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.767 -0.73 . . . . 71.120000000000005 112.472 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.21 -33.14 50.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.762 0.315 . . . . 72.439999999999998 110.881 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.69 -21.14 64.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 72.099999999999994 110.867 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.9 mt -74.85 -29.18 60.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 64.140000000000001 110.868 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.484 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -51.93 -60.55 5.86 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.645 0.735 . . . . 75.439999999999998 110.879 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.5 Cg_endo -69.76 -31.12 21.13 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.668 2.246 . . . . 61.109999999999999 112.345 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.532 HD12 ' HB2' ' A' ' 162' ' ' GLN . 0.1 OUTLIER -52.1 -53.5 41.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 71.329999999999998 110.933 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 5.1 t80 64.75 14.05 8.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 73.230000000000004 110.885 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.532 ' HB2' HD12 ' A' ' 160' ' ' LEU . 3.5 tt0 -56.13 -65.38 0.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 72.400000000000006 110.905 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 62.6 t30 53.07 30.98 10.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 75.209999999999994 110.876 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 3.3 t80 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 72.5 110.946 -179.887 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.801 0.334 . . . . 72.109999999999999 110.836 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.95 -67.98 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 74.239999999999995 110.891 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? -119.56 68.44 11.07 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.551 0.691 . . . . 73.540000000000006 110.909 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 78.7 0.99 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.716 2.278 . . . . 74.109999999999999 112.388 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.99 -30.94 65.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 62.140000000000001 110.886 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -77.7 -32.24 52.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 62.25 110.873 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -73.45 -44.98 56.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 72.349999999999994 110.91 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 t -60.71 -39.71 89.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.102 -0.499 . . . . 62.219999999999999 111.183 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.446 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.18 -29.07 21.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 51.200000000000003 111.097 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -56.0 -27.58 53.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 75.019999999999996 110.892 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.756 ' HG ' HD12 ' A' ' 77' ' ' ILE . 4.1 mm? -90.69 -18.42 25.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 52.210000000000001 110.908 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mm -76.79 -34.79 23.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 73.25 111.165 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.55 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.73 -57.16 22.94 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.61 0.719 . . . . 75.540000000000006 111.092 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.8 Cg_endo -69.75 -20.85 34.35 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.718 2.279 . . . . 52.539999999999999 112.335 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.626 ' O ' HG22 ' A' ' 42' ' ' ILE . 48.6 t -76.0 -44.69 38.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 71.349999999999994 110.859 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.5 -28.88 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 75.450000000000003 111.183 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mt -51.01 -34.01 27.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 73.430000000000007 110.909 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.626 HG22 ' O ' ' A' ' 39' ' ' CYS . 0.7 OUTLIER -58.64 -34.73 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 41.140000000000001 111.143 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.75 -41.15 92.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 74.519999999999996 111.13 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.01 -43.01 66.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 72.010000000000005 110.865 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 tp -76.59 -40.03 50.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 74.299999999999997 110.938 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.72 -51.46 69.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 61.439999999999998 111.075 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.442 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.4 mp -49.73 -31.44 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 73.540000000000006 111.136 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.0 tp -50.76 -42.22 57.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 74.219999999999999 110.943 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.7 HG23 ' CB ' ' A' ' 54' ' ' SER . 7.2 p -101.49 -37.48 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 75.230000000000004 111.145 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.493 ' HB3' HD21 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -63.68 -64.53 0.87 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 65.219999999999999 110.871 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.581 ' CD2' HD22 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -72.85 -62.0 1.61 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.484 . . . . 75.329999999999998 110.907 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.2 mp -67.89 160.67 72.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.599 0.714 . . . . 72.140000000000001 110.874 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 143.68 51.77 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.73 2.287 . . . . 51.310000000000002 112.329 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.7 ' CB ' HG23 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -155.17 -176.83 6.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 50.43 110.846 -179.864 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -173.41 -169.99 0.57 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.5 . . . . 71.25 110.872 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 63.35 172.5 0.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 64.129999999999995 110.893 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.4 -22.93 39.91 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.712 -0.756 . . . . 64.409999999999997 112.48 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.654 ' O ' HD12 ' A' ' 62' ' ' LEU . 5.4 tt0 -51.97 -35.01 44.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.917 0.389 . . . . 73.409999999999997 110.887 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.527 ' HA ' HG21 ' A' ' 49' ' ' VAL . 6.3 ttpp -52.96 -52.0 59.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 64.420000000000002 110.897 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 6.8 tpt -72.01 -42.09 66.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 74.120000000000005 110.87 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.6 m -53.08 -28.4 24.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 62.420000000000002 111.13 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 58' ' ' GLU . 0.2 OUTLIER -71.53 -40.21 70.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 54.119999999999997 110.899 179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 28.7 m -66.04 -45.65 80.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 63.32 110.908 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 12.4 tt -72.37 -35.05 50.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 70.530000000000001 111.145 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.14 -43.25 70.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 72.430000000000007 110.898 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.5 ' HA ' HD11 ' A' ' 42' ' ' ILE . 99.7 t -58.01 -34.83 49.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 65.450000000000003 111.134 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.87 -28.98 25.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 71.439999999999998 110.895 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.487 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -68.99 -39.25 79.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 74.310000000000002 110.896 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.39 -30.05 70.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 64.5 111.086 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.761 HD13 HG11 ' A' ' 102' ' ' VAL . 9.9 mt -64.85 -54.67 27.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 70.239999999999995 110.947 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.97 -38.22 87.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 70.230000000000004 111.172 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 68' ' ' LEU . 77.5 t -71.37 -32.9 48.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 74.510000000000005 111.151 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.525 ' O ' HG22 ' A' ' 77' ' ' ILE . 64.2 t80 -66.68 -29.88 69.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 75.25 110.853 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.489 HD11 HD13 ' A' ' 95' ' ' LEU . 4.3 tt -72.06 -47.61 50.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 44.399999999999999 110.896 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.5 mt -73.04 -39.63 65.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 65.140000000000001 110.915 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.9 tt -58.22 -51.3 70.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 62.119999999999997 110.932 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.756 HD12 ' HG ' ' A' ' 35' ' ' LEU . 1.6 tt -71.68 -26.2 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 62.539999999999999 111.145 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 25.5 t -80.53 -13.8 58.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 62.140000000000001 110.868 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.616 ' O ' HG23 ' A' ' 81' ' ' VAL . 5.5 mmmt -50.71 -29.21 10.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 74.329999999999998 110.878 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.9 pt -50.53 -37.43 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 55.409999999999997 111.111 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 79' ' ' LYS . 53.0 t 51.37 81.68 0.26 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.59 0.709 . . . . 74.349999999999994 111.178 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 167.47 24.43 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.657 2.238 . . . . 60.439999999999998 112.335 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -49.96 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.701 2.267 . . . . 73.040000000000006 112.342 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.2 t -136.75 -38.92 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 74.430000000000007 111.179 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.64 83.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 70.030000000000001 110.886 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.8 -18.04 16.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 54.119999999999997 110.893 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.582 ' HA ' HD23 ' A' ' 90' ' ' LEU . 5.5 m-20 -153.7 24.1 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 71.209999999999994 110.873 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.538 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -66.9 -57.9 10.56 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.649 0.738 . . . . 73.040000000000006 111.159 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.554 ' HG2' HD22 ' A' ' 90' ' ' LEU . 54.1 Cg_endo -69.75 -21.54 33.38 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.709 2.273 . . . . 74.430000000000007 112.372 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.582 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.4 mm? -74.12 -53.17 10.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 64.420000000000002 110.938 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.7 -46.65 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 43.520000000000003 111.134 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.87 -39.46 47.94 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.754 -0.736 . . . . 32.219999999999999 112.47 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -73.22 -24.37 60.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.331 . . . . 70.310000000000002 110.922 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -74.43 -37.95 63.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 64.219999999999999 110.916 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.489 HD13 HD11 ' A' ' 74' ' ' LEU . 11.6 mt -57.38 -29.71 64.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.076 -0.511 . . . . 74.409999999999997 110.938 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 5.2 mmt -69.51 -43.57 72.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 74.030000000000001 110.866 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.49 ' O ' HG22 ' A' ' 100' ' ' VAL . 64.5 t80 -75.16 -51.22 13.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 60.520000000000003 110.854 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.793 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.08 -29.9 33.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 65.329999999999998 111.097 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 9.0 mmt -66.65 -30.13 70.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 61.140000000000001 110.887 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.77 -30.18 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 62.200000000000003 111.114 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.793 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.79 -33.29 62.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 74.219999999999999 110.931 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.761 HG11 HD13 ' A' ' 70' ' ' LEU . 30.9 m -76.93 -38.06 28.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 73.200000000000003 111.097 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 76.7 m -72.4 -38.91 68.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 71.0 111.162 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -66.17 -31.93 73.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 61.149999999999999 110.874 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.0 t -73.41 -37.12 66.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 63.329999999999998 110.841 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.0 mt -70.29 -51.45 38.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 51.409999999999997 111.157 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.55 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.1 p -54.06 -35.53 29.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 42.219999999999999 111.15 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.3 m -52.41 -32.42 39.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 70.230000000000004 111.162 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.6 m -50.36 -31.54 14.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 74.040000000000006 110.847 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.55 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.3 p -52.51 -32.83 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 74.349999999999994 111.092 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 33.6 m -65.69 -43.56 88.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.199 -0.455 . . . . 61.119999999999997 110.863 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.9 t -76.74 -35.64 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 65.340000000000003 111.11 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 89.6 mt -72.1 -31.57 66.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 75.409999999999997 110.903 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -62.51 -30.26 71.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 64.209999999999994 110.896 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.803 HG11 ' HB2' ' A' ' 133' ' ' ALA . 9.9 p -102.31 -22.78 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 31.399999999999999 111.173 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -60.91 -74.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 73.030000000000001 110.903 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -174.97 76.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 73.150000000000006 110.86 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.12 -170.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 72.310000000000002 110.862 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 63.2 69.12 0.86 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.65 0.738 . . . . 41.109999999999999 110.814 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -170.97 0.43 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.703 2.269 . . . . 64.120000000000005 112.332 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.93 -73.53 0.58 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 62.240000000000002 111.163 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.68 150.2 49.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 73.040000000000006 111.146 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 56.46 -169.87 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 73.430000000000007 110.853 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.0 t -114.07 72.4 2.24 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.55 0.691 . . . . 74.010000000000005 111.129 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 139.55 40.55 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.667 2.245 . . . . 53.109999999999999 112.309 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.8 158.36 44.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 74.450000000000003 110.866 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 109.54 156.44 16.66 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.797 -0.716 . . . . 75.340000000000003 112.472 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 132.23 -158.06 22.77 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.729 -0.748 . . . . 62.43 112.471 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.84 -146.64 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.724 -0.75 . . . . 74.150000000000006 112.469 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.04 45.69 0.8 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.714 -0.755 . . . . 63.32 112.481 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -87.9 -43.0 12.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.919 0.39 . . . . 70.230000000000004 110.951 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.2 m -54.97 -31.84 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 62.119999999999997 111.119 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.803 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -71.81 -24.99 61.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 65.519999999999996 111.069 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 18.2 mmt -52.93 -31.05 38.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 71.310000000000002 110.894 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 32.2 t -57.0 -49.44 79.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 63.549999999999997 111.105 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 30.8 mm -74.03 -40.65 52.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 72.420000000000002 111.121 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -61.97 -30.02 70.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 64.519999999999996 110.848 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.0 mtm-85 -54.32 -27.53 36.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 65.409999999999997 110.857 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 tp -67.66 -50.85 55.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 73.400000000000006 110.931 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -74.05 -31.44 62.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 74.5 110.847 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.581 HD22 ' CD2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -52.15 -32.04 33.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 54.310000000000002 110.906 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -35.16 61.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 72.049999999999997 110.923 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.511 ' O ' HG23 ' A' ' 147' ' ' VAL . 36.9 mm -76.91 -32.16 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 63.210000000000001 111.11 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -56.02 -56.74 17.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 74.439999999999998 110.923 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.27 -35.46 62.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 64.140000000000001 111.142 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.32 -33.07 67.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 75.310000000000002 110.851 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 143' ' ' ILE . 28.8 t -65.96 -37.04 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 74.140000000000001 111.118 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.1 t -57.09 -51.69 68.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 73.409999999999997 110.854 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.9 t -69.17 -33.47 58.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 71.019999999999996 111.094 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -52.32 -53.5 43.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 74.549999999999997 110.895 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.04 -19.63 77.06 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.702 -0.761 . . . . 60.409999999999997 112.486 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 35.1 m -65.82 -52.83 47.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.74 0.305 . . . . 53.119999999999997 111.174 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.425 HG22 ' CD1' ' A' ' 157' ' ' LEU . 20.6 mt -76.58 -25.26 16.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 70.239999999999995 111.142 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -58.5 -49.92 72.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 32.030000000000001 112.462 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 9.6 mmt -70.13 -31.99 69.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.782 0.325 . . . . 75.019999999999996 110.854 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -71.64 -24.32 61.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 71.299999999999997 110.882 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.425 ' CD1' HG22 ' A' ' 153' ' ' ILE . 10.7 mt -75.35 -26.74 58.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 54.409999999999997 110.932 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.478 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.9 OUTLIER -52.13 -60.61 5.83 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.592 0.71 . . . . 75.439999999999998 110.894 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 54.0 Cg_endo -69.71 -36.26 11.26 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.705 2.27 . . . . 75.140000000000001 112.38 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.407 ' O ' ' CB ' ' A' ' 161' ' ' PHE . 4.5 tp 48.72 34.96 5.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 62.310000000000002 110.91 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.407 ' CB ' ' O ' ' A' ' 160' ' ' LEU . 8.9 t80 76.39 -52.22 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 70.019999999999996 110.868 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -170.4 -72.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 74.25 110.933 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -174.92 118.07 0.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 64.099999999999994 110.917 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 3.7 t80 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 74.299999999999997 110.917 -179.873 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.824 0.345 . . . . 63.43 110.859 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.471 ' O ' ' C ' ' A' ' 27' ' ' LYS . 8.6 mtt-85 -78.74 67.3 4.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 71.25 110.85 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER 31.85 77.0 0.36 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.622 0.725 . . . . 53.020000000000003 110.902 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -3.32 11.79 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.714 2.276 . . . . 51.32 112.3 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 pp -52.36 -30.98 31.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 74.109999999999999 110.905 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -80.99 -31.69 34.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.468 . . . . 75.219999999999999 110.902 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -72.88 -46.29 53.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 72.230000000000004 110.951 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 t -59.49 -40.09 85.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 65.230000000000004 111.145 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.442 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.16 -29.05 21.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 74.150000000000006 111.149 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.0 -26.87 50.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 71.209999999999994 110.91 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.411 HD21 HG21 ' A' ' 80' ' ' ILE . 4.1 mm? -91.5 -19.24 23.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 72.439999999999998 110.891 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mm -76.66 -34.95 24.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 65.329999999999998 111.131 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.54 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.65 -57.16 22.74 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.62 0.724 . . . . 74.099999999999994 111.12 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.4 Cg_endo -69.73 -20.45 34.95 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.743 2.295 . . . . 64.040000000000006 112.318 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.629 ' O ' HG22 ' A' ' 42' ' ' ILE . 48.0 t -75.98 -44.54 39.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 73.540000000000006 110.885 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.2 p -81.57 -28.93 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 74.120000000000005 111.131 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 mt -50.98 -33.94 26.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.459 . . . . 71.340000000000003 110.93 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.629 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.1 tp -58.76 -34.64 52.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 55.32 111.122 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 p -65.79 -38.8 90.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 72.340000000000003 111.111 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 t -53.0 -46.46 68.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 75.329999999999998 110.866 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.63 -41.41 60.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 50.350000000000001 110.938 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.4 -35.74 68.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 71.109999999999999 111.089 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.423 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.2 mp -64.81 -32.54 58.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 71.430000000000007 111.122 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.8 tp -55.04 -33.64 62.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 72.219999999999999 110.916 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.7 m -102.04 -35.57 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 71.099999999999994 111.102 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -72.58 -64.87 0.87 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 70.349999999999994 110.87 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.528 ' CE2' HD22 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -64.76 -41.14 96.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 74.209999999999994 110.911 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.49 74.78 2.29 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.639 0.733 . . . . 71.319999999999993 110.942 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 125.89 12.67 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.723 2.282 . . . . 74.400000000000006 112.312 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.8 t -116.31 -26.78 7.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 61.43 110.826 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -161.96 125.87 3.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.107 -0.497 . . . . 72.319999999999993 110.853 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.7 p -57.72 -26.0 61.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 73.209999999999994 110.871 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.607 ' O ' HG23 ' A' ' 61' ' ' THR . . . -52.95 -62.97 5.43 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.76 -0.733 . . . . 44.200000000000003 112.462 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.535 ' O ' HD23 ' A' ' 62' ' ' LEU . 1.5 tt0 -74.89 -35.46 62.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.889 0.376 . . . . 72.409999999999997 110.876 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -55.76 -50.49 70.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 73.420000000000002 110.869 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.5 ttm -64.96 -51.7 60.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 71.230000000000004 110.877 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 57' ' ' GLY . 70.9 p -56.22 -28.63 59.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 73.049999999999997 111.175 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.684 ' O ' HG23 ' A' ' 66' ' ' VAL . 1.6 mm? -72.78 -51.0 20.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 71.109999999999999 110.908 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.01 -49.67 65.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 65.0 110.887 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.6 tt -68.29 -35.01 69.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 72.340000000000003 111.125 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 m -65.71 -25.07 67.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 63.520000000000003 110.837 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 62' ' ' LEU . 61.0 t -57.96 -37.57 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.494 . . . . 43.310000000000002 111.107 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -28.95 26.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 73.150000000000006 110.884 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.49 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.36 -38.86 78.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 73.25 110.917 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.53 -30.02 70.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 51.100000000000001 111.128 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.589 HD13 HG11 ' A' ' 102' ' ' VAL . 9.6 mt -65.08 -54.7 26.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 63.100000000000001 110.897 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.69 -38.49 88.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 71.140000000000001 111.152 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 68' ' ' LEU . 80.0 t -71.43 -32.93 48.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 53.039999999999999 111.127 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.406 ' O ' HG22 ' A' ' 77' ' ' ILE . 90.3 t80 -51.84 -30.18 22.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 72.5 110.917 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.588 HD11 HD11 ' A' ' 95' ' ' LEU . 0.3 OUTLIER -73.22 -42.36 62.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.491 . . . . 75.040000000000006 110.936 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.6 mt -73.21 -33.91 65.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 74.109999999999999 110.897 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 tt -70.22 -55.07 10.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 73.209999999999994 110.973 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 80' ' ' ILE . 1.2 tt -57.08 -30.43 34.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 74.319999999999993 111.104 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.1 m -80.17 -23.42 41.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 72.25 110.858 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.69 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.4 OUTLIER -69.79 -12.75 61.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.477 . . . . 74.129999999999995 110.895 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.43 HG23 ' O ' ' A' ' 77' ' ' ILE . 2.2 pp -56.31 -24.57 18.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 73.120000000000005 111.123 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 79' ' ' LYS . 22.0 t 63.7 75.27 0.4 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.641 0.734 . . . . 72.129999999999995 111.151 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 167.53 24.22 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.658 2.238 . . . . 51.210000000000001 112.342 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 -48.66 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.69 2.26 . . . . 70.420000000000002 112.354 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.0 t -117.2 -19.79 9.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 73.010000000000005 111.143 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.69 45.08 4.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 72.510000000000005 110.872 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.6 tp -95.7 25.9 4.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 75.230000000000004 110.909 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.646 ' HA ' HD23 ' A' ' 90' ' ' LEU . 4.0 m-20 -104.57 24.39 11.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 72.200000000000003 110.862 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.19 -57.79 10.23 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.642 0.735 . . . . 61.25 111.145 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.537 ' HG2' HD22 ' A' ' 90' ' ' LEU . 54.3 Cg_endo -69.79 -20.48 34.62 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.696 2.264 . . . . 74.230000000000004 112.359 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.646 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.12 -45.6 47.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 75.400000000000006 110.955 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.493 HG12 HD21 ' A' ' 95' ' ' LEU . 38.4 t -80.67 -37.85 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 51.43 111.121 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.92 -52.1 36.66 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.724 -0.751 . . . . 73.400000000000006 112.542 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -35.19 79.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.828 0.347 . . . . 70.540000000000006 110.895 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -60.77 -36.75 79.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 60.109999999999999 110.952 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.588 HD11 HD11 ' A' ' 74' ' ' LEU . 9.7 mt -51.89 -29.8 21.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 54.399999999999999 110.934 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 13.4 mmt -67.85 -43.12 80.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 74.510000000000005 110.916 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.5 ' O ' HG22 ' A' ' 100' ' ' VAL . 67.2 t80 -75.28 -52.25 11.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 74.219999999999999 110.888 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.781 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.02 -29.91 32.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 74.510000000000005 111.165 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.72 -30.05 70.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 72.140000000000001 110.858 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.8 -30.04 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 65.129999999999995 111.134 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.781 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -74.91 -33.21 61.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 75.409999999999997 110.929 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.589 HG11 HD13 ' A' ' 70' ' ' LEU . 31.3 m -76.91 -38.09 28.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 72.319999999999993 111.156 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.484 ' HA ' HD12 ' A' ' 106' ' ' ILE . 73.0 m -72.46 -40.73 66.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 70.200000000000003 111.203 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -63.51 -32.17 73.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 63.229999999999997 110.88 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.0 t -71.38 -32.04 68.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 74.299999999999997 110.828 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.484 HD12 ' HA ' ' A' ' 103' ' ' THR . 22.3 mt -75.01 -52.1 19.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 64.129999999999995 111.163 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.547 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.1 p -54.16 -36.65 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 55.509999999999998 111.139 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.7 m -52.38 -32.4 38.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 62.310000000000002 111.173 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.7 m -50.46 -31.29 14.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.463 . . . . 71.099999999999994 110.835 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.2 p -52.51 -32.73 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 75.530000000000001 111.109 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 17.9 m -64.15 -43.87 93.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 45.039999999999999 110.878 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 84.1 t -76.89 -34.74 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 62.329999999999998 111.087 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.432 HD22 ' O ' ' A' ' 117' ' ' HIS . 83.4 mt -71.99 -32.25 67.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 71.409999999999997 110.895 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -59.18 -31.97 69.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 72.319999999999993 110.858 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.788 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.0 p -102.32 -24.84 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 42.409999999999997 111.166 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 -90.25 -73.73 0.51 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.123 -0.49 . . . . 74.430000000000007 110.828 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.432 ' O ' HD22 ' A' ' 113' ' ' LEU . 9.5 t-80 -172.72 99.14 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 75.319999999999993 110.816 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.432 HH11 ' N ' ' A' ' 119' ' ' SER . 52.3 tpt85 -98.76 118.1 34.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 70.239999999999995 110.909 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.432 ' N ' HH11 ' A' ' 118' ' ' ARG . 0.1 OUTLIER -179.12 160.59 0.99 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.689 0.757 . . . . 73.400000000000006 110.826 -179.812 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.519 ' O ' HG23 ' A' ' 121' ' ' THR . 54.0 Cg_endo -69.74 135.93 31.75 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.647 2.231 . . . . 72.019999999999996 112.384 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -170.4 145.85 2.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 54.409999999999997 111.18 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.5 m -160.47 69.02 0.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 51.219999999999999 111.132 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -156.28 26.21 0.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 55.219999999999999 110.879 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 27.2 m 60.62 73.95 0.58 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.574 0.702 . . . . 73.129999999999995 111.173 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -170.99 0.43 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.702 2.268 . . . . 71.109999999999999 112.349 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.0 mmt-85 -126.04 -74.29 0.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 74.129999999999995 110.862 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 52.4 -144.38 20.26 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.759 -0.734 . . . . 61.240000000000002 112.49 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 144.83 125.89 1.85 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.768 -0.73 . . . . 71.239999999999995 112.525 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 131.04 -154.53 20.84 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.747 -0.74 . . . . 71.319999999999993 112.495 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 90.31 28.75 16.26 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 44.039999999999999 112.464 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -87.97 -29.81 20.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.987 0.422 . . . . 74.150000000000006 110.922 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.9 m -66.44 -35.93 76.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 61.420000000000002 111.105 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.788 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -64.46 -25.02 67.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 75.040000000000006 111.094 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 39.1 mmt -53.0 -31.02 38.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 73.019999999999996 110.872 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 64.5 t -56.99 -58.17 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.281 -0.418 . . . . 74.519999999999996 111.082 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.9 mt -73.95 -36.93 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 73.219999999999999 111.12 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -62.09 -29.94 70.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 63.5 110.884 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.18 -29.86 24.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 73.319999999999993 110.886 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.31 -39.48 74.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 74.200000000000003 110.879 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -73.86 -53.38 10.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 64.030000000000001 110.897 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.538 ' O ' HG23 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -52.39 -33.6 44.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 63.219999999999999 110.913 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 20.7 t90 -55.51 -50.6 69.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 75.200000000000003 110.937 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.715 ' O ' HG23 ' A' ' 147' ' ' VAL . 57.8 mt -76.01 -33.49 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 50.210000000000001 111.121 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -56.16 -56.02 25.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 63.109999999999999 110.867 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 141' ' ' LEU . 23.2 t -59.95 -35.01 58.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 62.109999999999999 111.089 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -66.06 -33.27 75.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 70.209999999999994 110.895 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 143' ' ' ILE . 78.7 t -54.25 -50.64 54.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 74.510000000000005 111.155 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.39 -47.7 66.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 74.439999999999998 110.921 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.7 t -63.67 -33.03 59.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 74.329999999999998 111.132 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -52.07 -54.94 24.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 73.439999999999998 110.893 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.32 -19.55 74.05 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 44.439999999999998 112.486 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.2 m -60.11 -52.82 63.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.733 0.301 . . . . 65.519999999999996 111.136 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.587 HG22 ' CD1' ' A' ' 157' ' ' LEU . 47.3 mm -76.48 -33.65 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 73.209999999999994 111.132 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -55.2 -49.98 61.31 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.741 -0.742 . . . . 55.32 112.51 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 3.3 mmt -72.43 -31.99 65.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.822 0.344 . . . . 75.319999999999993 110.91 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -71.22 -24.18 62.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 74.430000000000007 110.856 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.587 ' CD1' HG22 ' A' ' 153' ' ' ILE . 5.8 mt -75.28 -26.97 59.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 65.030000000000001 110.963 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.475 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.8 OUTLIER -52.0 -60.55 5.91 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.629 0.728 . . . . 75.510000000000005 110.915 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.4 Cg_endo -69.81 -15.61 36.96 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.701 2.267 . . . . 65.230000000000004 112.339 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.96 40.87 1.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 73.099999999999994 110.949 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -67.93 -26.09 65.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 72.400000000000006 110.854 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 72.21 -69.01 0.2 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 62.329999999999998 110.968 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 22.8 t30 52.02 87.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 55.030000000000001 110.904 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 35.1 t80 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 73.120000000000005 110.927 -179.9 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.819 0.342 . . . . 70.230000000000004 110.865 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -146.96 -168.0 2.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 45.219999999999999 110.876 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 28' ' ' PRO . 8.9 ptpt -49.66 108.1 0.92 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.583 0.706 . . . . 75.510000000000005 110.933 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 27' ' ' LYS . 54.0 Cg_endo -69.71 -13.46 34.82 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.652 2.235 . . . . 74.430000000000007 112.375 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.0 pp -52.08 -30.99 28.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 71.310000000000002 110.913 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -78.04 -33.59 50.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 72.420000000000002 110.882 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -72.64 -45.89 56.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 74.129999999999995 110.904 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -60.31 -39.96 88.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 63.43 111.14 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.455 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.17 -29.08 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 64.519999999999996 111.145 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.88 -27.26 51.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.420000000000002 110.861 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.558 HD21 HG21 ' A' ' 80' ' ' ILE . 4.1 mm? -91.1 -18.8 23.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 70.420000000000002 110.957 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.7 mm -76.54 -34.97 25.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 64.420000000000002 111.173 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.545 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.72 -57.15 22.97 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.583 0.706 . . . . 72.540000000000006 111.107 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.5 Cg_endo -69.77 -21.35 33.54 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.683 2.255 . . . . 72.530000000000001 112.285 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.622 ' O ' HG22 ' A' ' 42' ' ' ILE . 47.3 t -75.87 -44.52 40.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 72.510000000000005 110.882 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.508 HG23 ' SG ' ' A' ' 148' ' ' CYS . 9.7 p -81.57 -28.93 10.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 63.210000000000001 111.139 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 mt -50.97 -34.01 27.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 72.25 110.907 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.1 tp -58.68 -34.68 52.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 65.25 111.141 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 p -65.69 -40.48 92.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.458 . . . . 72.340000000000003 111.138 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.97 -43.08 66.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 71.420000000000002 110.876 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.9 tp -76.96 -40.79 45.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.12 -0.491 . . . . 61.340000000000003 110.914 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.1 -36.52 68.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 61.240000000000002 111.103 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.426 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.3 mp -64.28 -32.02 55.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 75.420000000000002 111.112 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.9 tp -51.43 -38.76 55.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 71.239999999999995 110.916 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.674 HG21 HD13 ' A' ' 62' ' ' LEU . 7.9 p -101.47 -36.69 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 70.239999999999995 111.154 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -67.02 -64.65 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 72.340000000000003 110.871 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.547 ' CE2' HD22 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -71.34 -60.8 2.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 74.129999999999995 110.907 -179.826 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.0 mp -71.0 160.63 81.85 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.598 0.713 . . . . 65.540000000000006 110.921 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 144.63 54.77 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.701 2.267 . . . . 55.100000000000001 112.313 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.76 95.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 72.400000000000006 110.877 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 53.85 -172.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 54.420000000000002 110.862 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.4 m -114.81 -74.49 0.61 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 62.310000000000002 110.862 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.41 -27.74 66.18 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.726 . . . . 44.100000000000001 112.515 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.489 ' HG2' HD12 ' A' ' 62' ' ' LEU . 11.6 tt0 -52.1 -34.92 46.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.852 0.358 . . . . 70.349999999999994 110.821 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.6 mttt -52.98 -51.92 59.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 71.349999999999994 110.894 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 9.7 ttm -64.3 -45.44 87.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 51.32 110.882 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.7 m -58.28 -36.96 74.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.446 . . . . 75.25 111.177 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.674 HD13 HG21 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -75.62 -32.6 60.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 71.430000000000007 110.939 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 6.8 m -65.26 -52.01 57.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 71.129999999999995 110.897 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.4 tt -60.26 -34.95 59.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 62.520000000000003 111.112 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -24.98 66.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 73.129999999999995 110.853 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.3 t -57.95 -35.59 52.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 74.400000000000006 111.137 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mp -52.98 -28.88 25.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 71.510000000000005 110.893 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.495 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.37 -38.99 78.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 65.409999999999997 110.925 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.45 -30.05 70.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 53.109999999999999 111.093 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.842 HD22 HG11 ' A' ' 102' ' ' VAL . 9.9 mt -64.7 -54.72 27.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 41.310000000000002 110.944 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.97 -38.17 87.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 53.32 111.112 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 68' ' ' LEU . 76.4 t -71.44 -32.83 47.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 53.130000000000003 111.111 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -51.51 -30.67 21.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 73.329999999999998 110.909 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.456 HD11 HD11 ' A' ' 95' ' ' LEU . 8.9 tp -75.0 -40.06 60.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 75.510000000000005 110.915 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.9 mt -73.22 -34.8 66.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 70.319999999999993 110.916 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.11 -53.87 13.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.456 . . . . 70.129999999999995 110.906 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 80' ' ' ILE . 1.6 tt -56.43 -26.17 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 70.010000000000005 111.104 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.5 m -80.15 -22.4 42.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 71.109999999999999 110.862 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.684 ' O ' HG23 ' A' ' 81' ' ' VAL . 7.1 mttp -70.77 -10.5 59.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 74.329999999999998 110.873 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.558 HG21 HD21 ' A' ' 35' ' ' LEU . 2.4 pp -56.61 -23.72 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 64.549999999999997 111.133 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 79' ' ' LYS . 21.4 t 64.11 75.49 0.38 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.598 0.713 . . . . 65.219999999999999 111.127 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 167.26 24.93 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.656 2.237 . . . . 63.25 112.348 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -48.8 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.713 2.275 . . . . 71.219999999999999 112.331 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.75 HG23 ' H ' ' A' ' 86' ' ' LEU . 8.4 t -116.6 -19.93 9.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 74.439999999999998 111.148 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 p 63.46 23.27 13.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 64.540000000000006 110.873 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.75 ' H ' HG23 ' A' ' 84' ' ' THR . 0.1 OUTLIER -95.72 31.21 2.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 63.310000000000002 110.915 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.66 ' HA ' HD23 ' A' ' 90' ' ' LEU . 75.7 m-20 -94.63 47.16 1.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.457 . . . . 72.329999999999998 110.875 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.536 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -66.74 -57.72 11.22 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.586 0.708 . . . . 73.329999999999998 111.142 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.7 Cg_endo -69.77 -20.0 35.34 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.679 2.252 . . . . 73.319999999999993 112.322 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.66 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.15 -53.16 10.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.246 -0.434 . . . . 71.340000000000003 110.875 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.11 -38.01 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 71.299999999999997 111.085 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.1 -43.43 56.18 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.752 -0.737 . . . . 75.299999999999997 112.448 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -21.92 64.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.806 0.336 . . . . 73.540000000000006 110.911 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -78.13 -41.88 33.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 61.310000000000002 110.902 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.469 ' HA ' HG22 ' A' ' 98' ' ' THR . 10.9 mt -55.69 -29.71 59.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 73.349999999999994 110.875 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -43.42 76.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 74.450000000000003 110.876 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.504 ' O ' HG22 ' A' ' 100' ' ' VAL . 50.9 t80 -75.27 -51.69 12.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 75.230000000000004 110.871 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.791 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.16 -29.88 33.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 74.340000000000003 111.113 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.8 mmt -66.63 -30.12 70.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 72.019999999999996 110.878 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.7 -30.08 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 51.049999999999997 111.153 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -75.0 -33.2 61.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 74.109999999999999 110.906 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.842 HG11 HD22 ' A' ' 70' ' ' LEU . 31.2 m -76.91 -38.12 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 73.040000000000006 111.155 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.45 ' O ' HG13 ' A' ' 107' ' ' VAL . 74.1 m -72.47 -40.05 67.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.472 . . . . 74.329999999999998 111.135 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -64.49 -31.92 73.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 63.329999999999998 110.852 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.6 t -74.4 -34.51 63.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 61.200000000000003 110.859 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.5 mt -74.43 -50.72 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 72.409999999999997 111.135 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.555 ' O ' HG12 ' A' ' 110' ' ' VAL . 34.5 m -54.05 -33.99 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 70.219999999999999 111.111 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.0 m -52.41 -32.53 39.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 63.229999999999997 111.164 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.1 m -50.45 -31.46 15.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 73.239999999999995 110.891 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.4 p -52.5 -32.73 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 72.150000000000006 111.115 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 35.5 m -66.94 -48.74 67.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 64.530000000000001 110.868 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 77.7 t -70.49 -35.37 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 64.219999999999999 111.124 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.452 HD13 HH11 ' A' ' 118' ' ' ARG . 90.0 mt -72.09 -40.31 68.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 64.5 110.911 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -52.12 -31.66 31.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 72.230000000000004 110.863 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.775 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.3 p -102.31 -24.18 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 65.519999999999996 111.139 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -54.02 -74.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 72.510000000000005 110.879 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -179.15 35.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 75.540000000000006 110.857 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.452 HH11 HD13 ' A' ' 113' ' ' LEU . 3.2 ttp180 -119.93 -173.62 2.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 74.409999999999997 110.846 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.58 160.58 47.34 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.652 0.739 . . . . 54.109999999999999 110.851 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -171.25 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.717 2.278 . . . . 75.329999999999998 112.3 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.0 -72.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.468 . . . . 73.25 111.129 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -143.54 -62.49 0.4 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.211 -0.45 . . . . 72.450000000000003 111.14 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -109.76 -176.2 2.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 74.239999999999995 110.867 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.5 m 64.27 73.64 0.45 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.615 0.721 . . . . 71.239999999999995 111.162 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -170.96 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.672 2.248 . . . . 63.43 112.351 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.5 ttm-85 63.22 161.7 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 73.120000000000005 110.853 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -164.27 64.26 0.24 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.751 . . . . 64.549999999999997 112.497 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -136.74 112.84 0.98 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.689 -0.767 . . . . 72.310000000000002 112.484 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 112.19 -147.62 18.21 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.781 -0.724 . . . . 71.25 112.462 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -165.7 -60.42 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.797 -0.716 . . . . 71.319999999999993 112.518 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -69.32 -26.35 64.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.969 0.414 . . . . 75.25 110.946 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.1 m -54.72 -27.1 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.054 -0.521 . . . . 75.310000000000002 111.113 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.775 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -54.83 -27.66 43.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 51.240000000000002 111.117 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 37.0 mmt -53.0 -31.01 38.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 71.420000000000002 110.876 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 62.4 t -56.94 -56.02 16.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.267 -0.424 . . . . 73.430000000000007 111.105 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.8 mp -73.94 -38.66 50.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 73.010000000000005 111.116 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -61.13 -30.46 70.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 73.349999999999994 110.899 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.76 -27.28 40.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.478 . . . . 71.150000000000006 110.88 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.01 -50.63 21.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 72.040000000000006 110.909 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -69.06 -53.59 19.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 72.140000000000001 110.887 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.621 ' O ' HG23 ' A' ' 145' ' ' VAL . 0.2 OUTLIER -52.08 -32.4 34.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 74.540000000000006 110.907 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -61.45 -51.48 68.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 74.540000000000006 110.884 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.748 ' O ' HG23 ' A' ' 147' ' ' VAL . 62.1 mt -74.35 -32.0 29.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 75.120000000000005 111.156 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -56.0 -56.46 20.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 70.129999999999995 110.847 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 141' ' ' LEU . 30.6 t -54.3 -35.56 30.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 62.210000000000001 111.138 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -69.96 -37.86 75.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 64.209999999999994 110.884 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 143' ' ' ILE . 63.0 t -54.9 -34.06 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 71.109999999999999 111.145 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.508 ' SG ' HG23 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -52.78 -47.99 67.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 71.530000000000001 110.91 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.788 HG12 HD11 ' A' ' 153' ' ' ILE . 22.0 t -74.5 -36.69 42.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 51.450000000000003 111.126 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -54.89 -26.92 38.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 63.140000000000001 110.92 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.58 -59.05 4.26 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 73.349999999999994 112.423 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 4.4 t -54.59 -34.09 61.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.788 0.328 . . . . 64.450000000000003 111.162 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.788 HD11 HG12 ' A' ' 149' ' ' VAL . 47.6 mt -70.24 -25.21 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 62.140000000000001 111.091 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.83 -49.92 32.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.704 -0.76 . . . . 54.030000000000001 112.514 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.65 -32.01 57.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.345 . . . . 55.340000000000003 110.928 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -72.68 -20.84 61.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 74.010000000000005 110.879 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.412 ' CD1' HG22 ' A' ' 153' ' ' ILE . 7.3 mt -79.34 -27.11 42.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 73.120000000000005 110.917 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.537 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 11.5 tp60 -51.75 -58.17 12.02 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.584 0.706 . . . . 61.530000000000001 110.884 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 54.1 Cg_endo -69.74 -29.38 24.07 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.745 2.296 . . . . 72.219999999999999 112.334 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.97 -53.52 40.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 72.150000000000006 110.909 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 4.8 t80 64.46 14.45 8.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 72.239999999999995 110.858 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 60.19 47.48 9.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 60.32 110.928 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -162.7 -60.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 73.219999999999999 110.923 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 64.209999999999994 110.899 -179.927 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.783 0.325 . . . . 71.099999999999994 110.841 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -65.68 91.07 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 74.510000000000005 110.883 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.31 79.23 44.88 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.582 0.706 . . . . 54.240000000000002 110.889 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 -5.07 15.33 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.704 2.269 . . . . 55.219999999999999 112.313 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.0 pp -52.29 -30.95 30.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 75.409999999999997 110.923 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -80.26 -32.01 38.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 72.409999999999997 110.914 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -73.12 -46.16 52.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 72.209999999999994 110.926 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 t -59.67 -39.99 86.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 72.430000000000007 111.157 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.447 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.19 -29.1 21.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 64.400000000000006 111.132 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -55.58 -27.24 48.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 63.310000000000002 110.869 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.56 ' HG ' HD12 ' A' ' 77' ' ' ILE . 4.1 mm? -91.27 -19.08 23.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.201 -0.454 . . . . 74.109999999999999 110.93 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.8 mm -76.51 -35.03 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 74.219999999999999 111.138 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.547 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.68 -57.14 22.91 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.609 0.719 . . . . 74.519999999999996 111.127 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.9 Cg_endo -69.75 -21.58 33.32 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.683 2.255 . . . . 63.539999999999999 112.308 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.621 ' O ' HG22 ' A' ' 42' ' ' ILE . 36.2 t -73.09 -46.91 48.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 63.229999999999997 110.871 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.5 p -81.53 -29.01 10.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 62.399999999999999 111.117 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.1 mt -50.89 -34.01 26.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 72.420000000000002 110.949 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.621 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.76 -34.64 52.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 74.549999999999997 111.113 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.3 p -65.66 -34.53 78.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 63.210000000000001 111.141 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.06 -49.01 72.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 72.019999999999996 110.864 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.0 tp -73.17 -43.21 61.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 61.009999999999998 110.922 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.94 -39.99 75.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 52.100000000000001 111.13 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.07 -32.45 58.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 73.310000000000002 111.102 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.523 ' O ' HD23 ' A' ' 52' ' ' LEU . 4.0 tp -51.57 -37.15 48.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 65.200000000000003 110.915 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.01 -35.78 4.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 51.299999999999997 111.09 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -67.08 -62.86 1.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 73.549999999999997 110.881 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.23 -40.33 70.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 75.430000000000007 110.922 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.523 HD23 ' O ' ' A' ' 48' ' ' LEU . 4.5 mm? -70.43 159.18 85.73 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.602 0.715 . . . . 73.019999999999996 110.887 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -172.28 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.615 2.21 . . . . 72.0 112.389 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.9 t 63.28 87.75 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 71.329999999999998 110.865 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -89.86 50.4 1.88 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 73.030000000000001 110.875 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.7 p -63.21 -173.38 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 71.319999999999993 110.898 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.738 ' O ' HG23 ' A' ' 61' ' ' THR . . . -52.2 -30.02 30.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.754 -0.736 . . . . 50.530000000000001 112.492 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -60.89 -34.88 75.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.977 0.417 . . . . 73.099999999999994 110.932 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -46.07 82.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 71.439999999999998 110.873 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 23.9 ttm -71.64 -46.49 58.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 62.130000000000003 110.889 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.738 HG23 ' O ' ' A' ' 57' ' ' GLY . 30.4 p -54.38 -27.18 34.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 72.430000000000007 111.109 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.24 -51.0 34.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 73.140000000000001 110.906 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 7.3 m -54.66 -46.53 74.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.429 . . . . 64.329999999999998 110.931 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 15.8 tt -71.22 -34.96 56.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 74.209999999999994 111.148 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 m -53.85 -28.07 33.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 63.210000000000001 110.898 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.0 t -58.08 -38.37 67.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.487 . . . . 61.340000000000003 111.169 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.91 -28.87 25.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 70.010000000000005 110.962 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.482 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.01 -39.04 79.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 75.310000000000002 110.927 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.48 -29.97 70.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 60.100000000000001 111.084 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.015 HD11 HG11 ' A' ' 102' ' ' VAL . 8.5 mt -66.04 -54.81 21.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 62.329999999999998 110.903 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -60.94 -38.37 85.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 71.140000000000001 111.148 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 68' ' ' LEU . 81.9 t -71.5 -37.19 63.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 73.319999999999993 111.124 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.514 ' CE2' HD12 ' A' ' 35' ' ' LEU . 49.7 t80 -68.55 -31.87 71.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 73.310000000000002 110.853 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.401 HD11 ' CD1' ' A' ' 95' ' ' LEU . 2.8 tt -75.03 -43.62 52.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 60.450000000000003 110.904 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.8 mp -73.32 -44.06 59.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 72.030000000000001 110.893 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.3 tt -55.55 -55.16 35.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 52.200000000000003 110.936 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.56 HD12 ' HG ' ' A' ' 35' ' ' LEU . 1.4 tt -62.91 -25.08 37.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 73.409999999999997 111.074 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.4 m -80.14 -14.62 58.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 75.329999999999998 110.848 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -54.43 -26.42 30.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 63.229999999999997 110.891 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.423 ' O ' ' C ' ' A' ' 81' ' ' VAL . 1.0 OUTLIER -62.42 -16.78 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 73.219999999999999 111.084 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 81' ' ' VAL . 2.4 p 35.53 80.95 0.25 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.601 0.715 . . . . 70.319999999999993 111.097 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 165.76 29.87 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.714 2.276 . . . . 73.120000000000005 112.376 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 -50.13 0.5 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.704 2.269 . . . . 54.350000000000001 112.388 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.5 t -136.98 -38.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 71.530000000000001 111.14 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 178.7 82.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 74.349999999999994 110.85 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -96.21 -17.82 20.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 64.099999999999994 110.914 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.593 ' HA ' HD23 ' A' ' 90' ' ' LEU . 4.3 m-20 -152.56 23.88 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 71.400000000000006 110.879 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.538 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -66.86 -57.8 10.82 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.63 0.728 . . . . 72.299999999999997 111.113 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.551 ' HG2' HD22 ' A' ' 90' ' ' LEU . 53.4 Cg_endo -69.79 -21.55 33.21 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.67 2.247 . . . . 72.219999999999999 112.322 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.593 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.4 mm? -74.15 -53.1 10.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.44 . . . . 71.5 110.934 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.32 -44.89 24.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 74.230000000000004 111.164 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.04 -39.2 48.83 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.736 -0.745 . . . . 53.210000000000001 112.446 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -73.75 -23.56 59.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.798 0.333 . . . . 73.450000000000003 110.936 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -75.35 -37.82 60.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 75.420000000000002 110.931 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.439 ' HA ' HG22 ' A' ' 98' ' ' THR . 12.9 mt -54.45 -29.85 50.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 73.510000000000005 110.89 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.36 -43.65 73.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 55.210000000000001 110.885 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.501 ' O ' HG22 ' A' ' 100' ' ' VAL . 39.0 t80 -75.17 -51.12 14.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 73.030000000000001 110.884 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.805 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.15 -29.74 33.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 73.030000000000001 111.129 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.78 -30.18 70.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.44 . . . . 73.319999999999993 110.909 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.85 -29.95 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 64.310000000000002 111.154 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.805 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -75.06 -33.22 61.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 63.149999999999999 110.915 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 1.015 HG11 HD11 ' A' ' 70' ' ' LEU . 30.1 m -76.91 -38.06 28.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 72.430000000000007 111.164 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.447 ' O ' HG13 ' A' ' 107' ' ' VAL . 74.5 m -72.51 -38.54 68.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 74.140000000000001 111.113 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -66.41 -31.84 72.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 73.299999999999997 110.87 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.01 -34.76 64.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 73.239999999999995 110.872 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.3 mt -73.83 -51.03 25.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 51.229999999999997 111.177 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.552 ' O ' HG12 ' A' ' 110' ' ' VAL . 35.2 m -53.94 -34.21 25.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 65.319999999999993 111.133 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.3 m -52.39 -32.51 39.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 32.020000000000003 111.144 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.0 p -50.41 -31.45 14.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 64.439999999999998 110.862 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.5 p -52.56 -32.8 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 75.209999999999994 111.118 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 27.3 m -66.2 -48.14 71.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 53.240000000000002 110.905 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.6 t -71.44 -35.98 59.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 63.219999999999999 111.144 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.8 mt -72.03 -34.68 68.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 75.109999999999999 110.912 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -55.44 -32.73 62.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 72.329999999999998 110.886 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.782 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.6 p -102.34 -24.28 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 64.540000000000006 111.121 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -81.48 -70.08 0.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 75.400000000000006 110.812 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -123.2 77.64 1.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 75.230000000000004 110.871 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.0 -50.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 73.439999999999998 110.846 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.5 t -165.47 73.38 1.37 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.631 0.729 . . . . 61.119999999999997 110.851 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 107.02 1.77 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.663 2.242 . . . . 61.439999999999998 112.333 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 17.2 m -76.22 -25.96 55.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 73.420000000000002 111.119 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.38 102.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.445 . . . . 70.019999999999996 111.161 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.501 ' O ' HG23 ' A' ' 124' ' ' THR . 19.3 t-160 -119.81 -71.95 0.71 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 74.430000000000007 110.903 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 123' ' ' HIS . 0.9 OUTLIER -160.18 67.93 2.79 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.592 0.71 . . . . 51.520000000000003 111.142 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -172.31 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.72 2.28 . . . . 63.100000000000001 112.373 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.66 -57.66 1.72 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 73.230000000000004 110.889 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -104.23 -41.77 2.02 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.724 -0.75 . . . . 71.340000000000003 112.452 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 129.63 92.42 0.66 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.758 -0.734 . . . . 65.109999999999999 112.47 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 169.29 -76.53 0.11 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.673 -0.775 . . . . 35.340000000000003 112.489 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.63 61.12 0.28 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.753 -0.737 . . . . 73.109999999999999 112.518 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -87.17 -30.78 20.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.893 0.378 . . . . 54.240000000000002 110.882 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.479 HG11 ' HB3' ' A' ' 123' ' ' HIS . 23.4 m -73.66 -28.26 24.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 54.130000000000003 111.16 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.782 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -55.95 -25.12 42.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 54.420000000000002 111.146 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -52.96 -30.88 37.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 63.240000000000002 110.89 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 64.9 t -56.97 -56.66 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 51.439999999999998 111.141 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 31.9 mm -74.09 -36.42 44.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 75.219999999999999 111.133 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -62.84 -29.88 71.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 71.319999999999993 110.864 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.18 -27.6 35.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 60.439999999999998 110.909 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.9 tt -70.47 -50.22 40.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 73.409999999999997 110.928 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -72.09 -28.95 63.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 44.539999999999999 110.925 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.8 tt -56.77 -40.74 76.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 52.409999999999997 110.918 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -72.44 -51.07 21.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 73.140000000000001 110.976 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.746 ' O ' HG23 ' A' ' 147' ' ' VAL . 51.0 mm -57.96 -32.21 42.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 63.399999999999999 111.164 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -56.27 -57.14 13.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 73.439999999999998 110.878 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 21.7 t -66.73 -36.31 76.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.48 . . . . 74.439999999999998 111.108 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.34 -36.13 68.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 62.329999999999998 110.851 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 143' ' ' ILE . 94.4 t -58.82 -53.22 50.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 64.540000000000006 111.117 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -56.23 -32.6 64.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 73.430000000000007 110.893 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 67.5 t -71.07 -34.2 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 74.329999999999998 111.097 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -71.88 -27.44 62.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 73.219999999999999 110.939 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.07 -48.58 5.99 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.705 -0.76 . . . . 71.329999999999998 112.482 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.4 t -51.81 -39.39 58.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.751 0.31 . . . . 61.030000000000001 111.14 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.524 HG22 ' CD1' ' A' ' 157' ' ' LEU . 41.1 mt -63.09 -43.18 98.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 43.030000000000001 111.135 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -52.88 -48.55 57.27 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.747 -0.74 . . . . 74.049999999999997 112.495 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -31.94 66.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.792 0.329 . . . . 74.420000000000002 110.887 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -71.32 -24.58 62.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.443 . . . . 72.409999999999997 110.902 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.524 ' CD1' HG22 ' A' ' 153' ' ' ILE . 3.7 mt -75.7 -26.46 57.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 72.219999999999999 110.939 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.485 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 1.3 mm-40 -51.91 -60.5 5.97 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.581 0.705 . . . . 65.099999999999994 110.865 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.9 Cg_endo -69.77 -15.68 37.14 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.668 2.246 . . . . 73.420000000000002 112.349 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 30.8 mt -92.1 44.94 1.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 61.310000000000002 110.904 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.88 -26.14 17.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 61.210000000000001 110.84 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 61.92 58.5 1.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 74.439999999999998 110.906 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -122.63 96.28 4.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 64.340000000000003 110.89 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 75.0 t80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 74.329999999999998 110.904 -179.903 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 77.1 mmt-85 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.799 0.333 . . . . 65.400000000000006 110.873 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -96.22 26.6 4.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 72.230000000000004 110.842 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -118.88 73.09 11.86 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.61 0.719 . . . . 72.120000000000005 110.922 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -12.19 32.37 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.659 2.239 . . . . 60.039999999999999 112.369 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 pp -51.99 -30.95 27.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 64.25 110.927 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -78.82 -33.49 46.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 75.099999999999994 110.879 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -72.46 -46.23 55.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 72.040000000000006 110.94 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -60.08 -40.02 88.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.511 . . . . 54.149999999999999 111.11 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.445 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.19 -29.11 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 74.200000000000003 111.101 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -55.8 -27.12 49.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 72.040000000000006 110.856 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.43 ' HB3' HD12 ' A' ' 77' ' ' ILE . 4.1 mm? -91.29 -19.19 23.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 71.310000000000002 110.942 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.6 mm -76.6 -34.94 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 65.030000000000001 111.134 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.543 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.3 mm -55.61 -57.21 22.35 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.659 0.742 . . . . 50.210000000000001 111.136 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.6 Cg_endo -69.82 -20.91 33.95 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.661 2.24 . . . . 64.109999999999999 112.336 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.633 ' O ' HG22 ' A' ' 42' ' ' ILE . 48.6 t -75.98 -44.65 38.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 75.409999999999997 110.908 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.61 -28.86 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 64.430000000000007 111.128 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.3 mt -50.97 -33.97 26.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 42.130000000000003 110.919 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 39' ' ' CYS . 0.7 OUTLIER -58.76 -34.65 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 44.210000000000001 111.131 179.844 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 p -65.81 -39.73 91.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 53.32 111.188 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.99 -51.11 62.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 74.310000000000002 110.809 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.9 tp -69.48 -38.81 77.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 74.310000000000002 110.896 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.7 -39.64 77.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 54.009999999999998 111.106 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.447 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.3 mp -64.33 -31.93 55.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 45.109999999999999 111.125 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.5 -38.7 55.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 74.209999999999994 110.927 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -101.45 -36.73 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 73.219999999999999 111.139 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -67.1 -64.62 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 71.129999999999995 110.894 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.447 ' HB2' HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -71.22 -61.96 1.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 74.129999999999995 110.944 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.2 mp -67.62 160.65 71.58 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.617 0.723 . . . . 75.219999999999999 110.928 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 161.53 45.56 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.722 2.282 . . . . 64.219999999999999 112.336 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -174.88 -69.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 72.099999999999994 110.895 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -178.37 -171.73 0.27 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 71.109999999999999 110.887 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 50.2 t -94.83 -74.39 0.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 64.310000000000002 110.892 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.75 -47.1 59.2 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 70.409999999999997 112.506 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.56 -35.54 70.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.916 0.389 . . . . 60.210000000000001 110.862 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -66.02 -44.58 84.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 75.409999999999997 110.885 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.605 ' O ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.35 -45.76 71.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 72.430000000000007 110.863 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 77.3 p -62.45 -26.09 68.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 73.409999999999997 111.131 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.24 -37.34 61.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 52.509999999999998 110.913 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 82.5 m -74.0 -48.65 28.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 74.319999999999993 110.839 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 60' ' ' MET . 24.7 pt -54.85 -32.26 25.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 73.409999999999997 111.121 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.1 -28.45 67.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 65.310000000000002 110.9 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.13 -38.25 66.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 74.049999999999997 111.141 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tp -52.89 -28.92 25.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 63.450000000000003 110.876 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.491 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.23 -38.94 78.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 74.319999999999993 110.933 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.65 -30.01 70.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 74.299999999999997 111.093 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.794 HD13 HG11 ' A' ' 102' ' ' VAL . 9.2 mt -65.31 -54.81 23.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 72.209999999999994 110.87 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.47 -38.63 87.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 65.510000000000005 111.151 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 68' ' ' LEU . 84.2 t -71.52 -32.96 47.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 61.210000000000001 111.13 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.582 ' O ' HG22 ' A' ' 77' ' ' ILE . 72.4 t80 -52.03 -34.09 41.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 73.140000000000001 110.889 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.1 tp -60.96 -51.11 70.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 74.409999999999997 110.939 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.5 mt -73.14 -32.13 64.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.47 . . . . 53.520000000000003 110.87 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.7 tt -66.69 -52.33 45.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 64.349999999999994 110.895 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 73' ' ' PHE . 1.5 tt -69.17 -30.55 46.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 74.129999999999995 111.117 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.0 m -80.19 -21.3 43.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 54.520000000000003 110.862 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.651 ' O ' HG23 ' A' ' 81' ' ' VAL . 4.8 mttt -60.38 -19.95 57.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.107 -0.497 . . . . 73.120000000000005 110.947 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -59.17 -20.71 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 72.129999999999995 111.132 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 79' ' ' LYS . 23.8 t 51.56 76.62 0.52 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.609 0.719 . . . . 65.099999999999994 111.118 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.429 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 54.0 Cg_endo -69.77 112.08 2.99 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.711 2.274 . . . . 63.130000000000003 112.35 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 82' ' ' PRO . 53.1 Cg_endo -69.82 -48.61 0.67 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.716 2.277 . . . . 72.120000000000005 112.309 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.5 t -117.05 -21.86 8.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 73.120000000000005 111.13 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.18 -48.74 61.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 73.430000000000007 110.86 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.3 tp 51.0 56.14 8.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.108 -0.496 . . . . 74.129999999999995 110.918 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.625 ' HA ' HD23 ' A' ' 90' ' ' LEU . 3.7 m-20 -95.36 24.03 5.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 75.310000000000002 110.875 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.536 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.2 -57.82 10.16 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.609 0.719 . . . . 60.420000000000002 111.132 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.9 Cg_endo -69.76 -20.8 34.35 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.706 2.27 . . . . 73.25 112.324 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.625 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.07 -53.13 10.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 74.329999999999998 110.939 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.526 HG12 HD21 ' A' ' 95' ' ' LEU . 60.6 t -65.37 -36.43 77.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 52.420000000000002 111.135 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.94 -41.46 52.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.761 -0.733 . . . . 52.119999999999997 112.464 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.6 mmpm? -75.21 -22.07 58.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.748 0.308 . . . . 74.239999999999995 110.867 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -75.68 -33.4 60.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.259 -0.428 . . . . 75.140000000000001 110.954 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.526 HD21 HG12 ' A' ' 91' ' ' VAL . 13.2 mt -53.39 -29.83 36.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 72.299999999999997 110.937 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.26 -43.65 73.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 64.450000000000003 110.923 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.489 ' O ' HG22 ' A' ' 100' ' ' VAL . 65.9 t80 -75.23 -51.16 14.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 74.420000000000002 110.901 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.786 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.17 -29.93 34.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 43.450000000000003 111.126 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.0 mmt -66.53 -30.15 70.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 74.310000000000002 110.892 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.85 -30.07 13.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 74.430000000000007 111.135 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.786 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.88 -33.2 62.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 63.409999999999997 110.94 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.794 HG11 HD13 ' A' ' 70' ' ' LEU . 31.1 m -76.92 -38.08 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 71.299999999999997 111.129 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 78.8 m -72.48 -38.55 68.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 75.329999999999998 111.107 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -66.86 -32.03 73.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 74.040000000000006 110.888 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.0 t -71.56 -35.55 70.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 75.230000000000004 110.831 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.4 mt -71.7 -51.92 29.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 71.040000000000006 111.112 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.548 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.7 p -54.05 -36.36 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 61.539999999999999 111.139 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.1 m -52.34 -32.41 37.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 62.32 111.182 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.0 m -50.46 -31.32 14.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 72.510000000000005 110.836 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.548 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.3 p -52.49 -32.83 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 61.200000000000003 111.089 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 23.6 m -65.51 -44.35 87.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 64.319999999999993 110.926 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 82.1 t -75.96 -35.83 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 75.340000000000003 111.067 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.449 HD22 ' O ' ' A' ' 117' ' ' HIS . 90.0 mt -71.95 -31.79 66.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 75.219999999999999 110.95 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -60.03 -31.71 70.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 74.510000000000005 110.919 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.765 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.3 p -102.32 -24.77 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 64.430000000000007 111.151 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -90.47 -74.14 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 62.420000000000002 110.869 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.449 ' O ' HD22 ' A' ' 113' ' ' LEU . 0.5 OUTLIER -179.14 105.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 73.219999999999999 110.896 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -97.12 104.75 16.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 64.109999999999999 110.883 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -178.45 160.59 1.15 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.664 0.745 . . . . 74.150000000000006 110.845 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.507 ' O ' HG23 ' A' ' 121' ' ' THR . 53.4 Cg_endo -69.76 126.2 13.03 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.749 2.299 . . . . 62.409999999999997 112.343 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -169.78 94.36 0.26 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 71.129999999999995 111.135 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.5 t -116.64 -25.01 7.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 64.409999999999997 111.169 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -100.36 -26.8 13.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 75.140000000000001 110.835 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.5 m -116.88 69.15 4.59 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.542 0.687 . . . . 74.420000000000002 111.136 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 157.19 61.25 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.645 2.23 . . . . 71.120000000000005 112.364 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -145.56 -74.25 0.23 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 71.319999999999993 110.87 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.31 168.74 7.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.804 -0.713 . . . . 74.230000000000004 112.47 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 151.65 63.46 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.711 -0.756 . . . . 33.109999999999999 112.444 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 111.79 -149.47 18.11 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.725 -0.75 . . . . 61.240000000000002 112.491 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.79 19.52 19.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.744 -0.741 . . . . 73.150000000000006 112.516 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -87.9 -26.48 22.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.924 0.392 . . . . 72.129999999999995 110.911 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.5 m -55.59 -30.79 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 55.130000000000003 111.122 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.765 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -70.02 -26.08 63.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 51.0 111.101 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 31.8 mmt -52.95 -30.99 37.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 72.010000000000005 110.904 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 52.4 t -57.01 -58.43 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 73.200000000000003 111.109 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 44.5 mm -73.98 -37.77 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 71.140000000000001 111.135 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -61.17 -30.4 70.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 71.140000000000001 110.9 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.78 -28.19 33.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 74.319999999999993 110.903 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.0 tp -65.4 -50.81 64.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 75.239999999999995 110.916 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -73.78 -42.89 60.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 74.329999999999998 110.876 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 tt -52.01 -32.78 35.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 54.200000000000003 110.892 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -66.63 -43.01 85.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 74.030000000000001 110.931 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.751 ' O ' HG23 ' A' ' 147' ' ' VAL . 4.9 mt -76.43 -32.15 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 71.420000000000002 111.099 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -55.96 -56.41 21.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 65.040000000000006 110.884 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.2 m -60.72 -35.22 62.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 63.229999999999997 111.072 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -64.68 -41.52 95.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 63.049999999999997 110.855 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 143' ' ' ILE . 88.9 t -58.39 -34.23 49.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 61.009999999999998 111.106 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 89.8 m -57.79 -51.98 67.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 41.100000000000001 110.842 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.454 ' O ' HG22 ' A' ' 153' ' ' ILE . 57.0 t -75.99 -35.23 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 72.129999999999995 111.089 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -63.42 -37.73 88.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 65.439999999999998 110.919 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.25 -46.14 9.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.792 -0.718 . . . . 71.340000000000003 112.445 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 95.4 m -59.96 -51.99 67.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.785 0.326 . . . . 71.540000000000006 111.16 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 149' ' ' VAL . 20.4 tt -55.9 -26.63 21.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 73.329999999999998 111.129 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -52.0 -49.99 46.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.764 -0.732 . . . . 42.229999999999997 112.447 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.2 mmt -71.65 -31.81 67.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 64.400000000000006 110.919 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -68.83 -21.45 64.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 75.040000000000006 110.904 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.3 mt -74.68 -29.13 61.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 72.420000000000002 110.932 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.483 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -51.93 -60.56 5.83 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.602 0.715 . . . . 65.409999999999997 110.884 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 54.1 Cg_endo -69.74 -16.95 37.9 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.68 2.253 . . . . 51.409999999999997 112.341 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.1 tp -94.16 40.66 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 74.019999999999996 110.924 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -55.22 -26.85 42.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 74.129999999999995 110.878 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 62.75 99.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 73.310000000000002 110.891 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 71.03 -70.18 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 54.439999999999998 110.917 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 72.239999999999995 110.901 -179.907 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.813 0.34 . . . . 75.120000000000005 110.865 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -95.74 -56.15 2.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 74.310000000000002 110.852 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.77 68.25 69.61 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.541 0.686 . . . . 71.5 110.907 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 78.52 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.717 2.278 . . . . 74.010000000000005 112.354 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.07 -30.96 65.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 72.310000000000002 110.86 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -78.26 -31.82 49.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 74.209999999999994 110.917 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.627 ' CE1' HG22 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -73.63 -44.87 55.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 74.040000000000006 110.876 -179.83 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -60.55 -39.86 89.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 35.310000000000002 111.156 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.437 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.18 -29.07 21.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 52.350000000000001 111.135 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.03 -27.08 51.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 72.230000000000004 110.898 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.31 -19.19 23.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 71.140000000000001 110.904 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.4 mm -76.87 -34.62 22.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 55.200000000000003 111.112 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.537 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.78 -57.08 23.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.614 0.721 . . . . 70.010000000000005 111.13 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.4 Cg_endo -69.77 -19.34 36.21 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.709 2.273 . . . . 64.219999999999999 112.348 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.63 ' O ' HG22 ' A' ' 42' ' ' ILE . 37.4 t -70.12 -46.29 65.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 74.420000000000002 110.872 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 p -81.53 -28.91 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 74.049999999999997 111.16 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 38' ' ' PRO . 11.5 mt -51.04 -33.91 27.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 51.229999999999997 110.902 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.63 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.73 -34.64 52.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 63.409999999999997 111.146 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 p -65.73 -36.56 83.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 62.25 111.096 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.37 -44.77 72.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 71.430000000000007 110.881 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.01 -42.3 39.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 55.219999999999999 110.91 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.11 -34.63 66.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 73.299999999999997 111.126 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.409 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.1 mp -64.54 -32.39 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 75.040000000000006 111.121 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.4 tp -51.55 -37.43 49.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 74.200000000000003 110.932 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.69 HG23 ' HD3' ' A' ' 59' ' ' LYS . 7.9 p -101.98 -36.13 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 45.229999999999997 111.144 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -68.31 -64.96 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 75.420000000000002 110.885 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.458 ' CE2' HD22 ' A' ' 141' ' ' LEU . 0.3 OUTLIER -56.36 -39.15 72.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.148 -0.478 . . . . 74.329999999999998 110.916 -179.823 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.7 tp -57.61 139.0 81.79 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.613 0.72 . . . . 74.409999999999997 110.871 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 178.81 4.21 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.663 2.242 . . . . 50.240000000000002 112.349 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.23 161.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 64.219999999999999 110.859 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -160.88 175.9 12.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.102 -0.499 . . . . 74.549999999999997 110.87 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.5 p -176.19 -174.36 0.62 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 41.520000000000003 110.892 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 61' ' ' THR . . . -57.52 -31.45 63.32 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.737 -0.744 . . . . 62.409999999999997 112.486 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -75.09 -54.74 6.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.882 0.372 . . . . 74.510000000000005 110.904 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.69 ' HD3' HG23 ' A' ' 49' ' ' VAL . 3.3 mttm -53.2 -45.33 68.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 71.519999999999996 110.919 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -57.68 -51.74 68.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 73.450000000000003 110.844 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 57' ' ' GLY . 60.4 p -65.37 -28.43 69.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.264 -0.425 . . . . 75.349999999999994 111.136 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.51 -34.57 67.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 74.450000000000003 110.934 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.481 ' O ' HG12 ' A' ' 66' ' ' VAL . 80.2 m -72.78 -51.99 16.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 63.140000000000001 110.913 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.5 tt -54.39 -33.06 25.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 71.129999999999995 111.112 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.69 -25.24 6.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 74.049999999999997 110.858 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 63' ' ' CYS . 9.9 p -57.13 -32.62 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.485 . . . . 72.099999999999994 111.127 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.93 -35.36 61.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 72.409999999999997 110.917 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.503 ' O ' HD22 ' A' ' 68' ' ' LEU . 2.0 tm? -68.96 -46.7 67.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 63.200000000000003 110.891 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.8 -29.53 19.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 60.109999999999999 111.089 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.773 HD22 HG11 ' A' ' 102' ' ' VAL . 40.9 mt -57.83 -54.51 46.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 75.450000000000003 110.918 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 68' ' ' LEU . 1.2 t -63.45 -27.28 69.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 61.350000000000001 111.156 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.6 t -71.35 -34.11 52.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 70.230000000000004 111.169 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -52.07 -30.11 24.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 75.099999999999994 110.865 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.608 HD11 HD11 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -74.93 -39.49 61.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 72.450000000000003 110.923 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.0 mp -73.24 -40.13 64.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 73.120000000000005 110.902 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.6 -55.05 22.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 73.239999999999995 110.937 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 tt -56.22 -24.69 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 73.209999999999994 111.17 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.1 p -68.1 -15.0 63.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 74.319999999999993 110.876 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.729 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -60.11 -19.83 55.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 54.100000000000001 110.94 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.627 HG22 ' CE1' ' A' ' 31' ' ' TYR . 1.1 pt -53.57 -27.17 14.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 61.219999999999999 111.134 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 79' ' ' LYS . 50.2 t 61.41 75.23 0.45 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.661 0.743 . . . . 70.239999999999995 111.101 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 167.46 24.35 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.663 2.242 . . . . 64.540000000000006 112.395 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -48.64 0.67 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.671 2.247 . . . . 71.420000000000002 112.35 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 86' ' ' LEU . 9.6 t -117.26 -19.63 9.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 71.010000000000005 111.15 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.3 t 63.72 38.37 9.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.451 . . . . 72.349999999999994 110.822 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.456 ' H ' HG23 ' A' ' 84' ' ' THR . 1.2 tp -99.72 35.33 2.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.144 -0.48 . . . . 61.240000000000002 110.94 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.634 ' HA ' HD23 ' A' ' 90' ' ' LEU . 1.8 m-20 -95.58 24.37 5.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 64.450000000000003 110.887 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.521 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.31 -57.73 10.13 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.623 0.725 . . . . 40.229999999999997 111.195 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.535 ' HG2' HD22 ' A' ' 90' ' ' LEU . 53.6 Cg_endo -69.82 -20.32 34.71 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.664 2.242 . . . . 63.109999999999999 112.329 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.634 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.14 -53.09 10.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 71.519999999999996 110.949 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.48 HG12 HD21 ' A' ' 95' ' ' LEU . 39.7 t -80.31 -20.53 11.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 74.409999999999997 111.116 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.28 -31.49 27.45 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.775 -0.726 . . . . 71.340000000000003 112.494 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -35.39 59.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.8 0.333 . . . . 51.219999999999999 110.883 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -65.69 -44.84 84.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 75.129999999999995 110.872 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.608 HD11 HD11 ' A' ' 74' ' ' LEU . 7.5 mt -51.94 -29.81 21.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 71.140000000000001 110.953 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -43.38 76.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 72.209999999999994 110.892 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.498 ' O ' HG22 ' A' ' 100' ' ' VAL . 33.7 t80 -75.22 -51.83 12.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 74.420000000000002 110.9 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.792 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.07 -29.97 33.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 74.25 111.185 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.2 mmt -66.61 -30.04 70.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 65.200000000000003 110.923 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.83 -30.04 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 73.230000000000004 111.111 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.792 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -74.92 -33.31 61.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 73.109999999999999 110.947 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.773 HG11 HD22 ' A' ' 70' ' ' LEU . 31.3 m -76.8 -38.07 29.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 74.329999999999998 111.115 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.489 ' HA ' HD12 ' A' ' 106' ' ' ILE . 71.4 m -72.49 -39.81 67.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 71.430000000000007 111.149 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -64.69 -31.96 73.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 74.129999999999995 110.898 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.4 t -71.54 -35.75 70.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 51.409999999999997 110.859 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 103' ' ' THR . 11.7 mt -71.58 -51.83 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 73.5 111.116 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.556 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.5 p -53.97 -35.1 27.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 72.310000000000002 111.13 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.6 m -52.34 -32.43 38.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 75.25 111.146 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.4 m -50.42 -31.52 15.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 50.039999999999999 110.871 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.5 p -52.49 -32.79 17.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.102 -0.499 . . . . 71.430000000000007 111.153 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 42.1 m -66.59 -45.66 78.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 63.539999999999999 110.868 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 88.4 t -73.91 -34.7 40.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 75.420000000000002 111.128 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.07 -42.02 66.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 75.109999999999999 110.906 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -52.02 -30.71 26.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 75.319999999999993 110.901 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.77 HG11 ' HB2' ' A' ' 133' ' ' ALA . 9.4 p -102.31 -23.07 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 71.340000000000003 111.13 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -52.49 -66.22 0.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 73.120000000000005 110.896 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -162.15 28.48 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 74.310000000000002 110.876 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.2 mtt85 -117.72 -178.91 3.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 73.0 110.86 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.1 p -55.27 160.6 3.32 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.694 0.759 . . . . 63.450000000000003 110.839 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 168.46 21.52 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.707 2.272 . . . . 73.409999999999997 112.335 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.59 -172.76 2.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 71.540000000000006 111.105 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.0 m -75.86 69.14 2.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 73.530000000000001 111.138 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 61.29 89.54 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 64.420000000000002 110.853 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.83 159.64 32.81 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.585 0.707 . . . . 74.230000000000004 111.096 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -12.52 33.06 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.697 2.265 . . . . 51.329999999999998 112.326 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 ttm-85 -52.29 123.81 11.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 74.439999999999998 110.885 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -177.12 106.6 0.22 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.771 -0.728 . . . . 70.239999999999995 112.526 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.412 ' HA3' HG11 ' A' ' 132' ' ' VAL . . . -177.39 -136.04 2.36 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.703 -0.76 . . . . 51.009999999999998 112.457 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -112.61 -19.3 7.05 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.773 -0.727 . . . . 71.530000000000001 112.515 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 153.35 -51.2 0.49 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.729 -0.748 . . . . 72.200000000000003 112.467 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -63.29 -26.12 68.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.961 0.41 . . . . 71.25 110.953 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.412 HG11 ' HA3' ' A' ' 128' ' ' GLY . 29.8 m -56.9 -33.68 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.116 -0.493 . . . . 62.210000000000001 111.15 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.77 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -65.2 -25.22 67.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 41.420000000000002 111.091 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 16.7 mmt -53.0 -30.92 38.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 62.119999999999997 110.833 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 49.2 t -56.96 -63.86 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 62.039999999999999 111.11 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.0 mp -70.46 -38.35 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 65.129999999999995 111.134 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -60.56 -30.02 69.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 73.409999999999997 110.879 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.5 mtt-85 -56.18 -26.03 49.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 75.400000000000006 110.881 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.01 -50.99 35.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 74.140000000000001 110.941 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -73.97 -28.44 61.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 64.430000000000007 110.862 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.492 ' O ' HG23 ' A' ' 145' ' ' VAL . 0.2 OUTLIER -64.02 -36.4 83.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 71.420000000000002 110.913 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -58.99 -48.74 80.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 73.109999999999999 110.883 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.724 ' O ' HG23 ' A' ' 147' ' ' VAL . 58.5 mt -77.04 -32.29 19.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 63.229999999999997 111.159 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.0 -56.88 15.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 75.030000000000001 110.89 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 141' ' ' LEU . 21.6 t -60.42 -35.06 60.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 70.420000000000002 111.155 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.06 -32.97 74.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 51.450000000000003 110.892 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 143' ' ' ILE . 92.9 t -53.98 -34.11 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 62.25 111.139 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 4.8 t -52.03 -42.98 63.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 73.140000000000001 110.878 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 25.5 t -75.99 -33.03 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 73.530000000000001 111.124 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -52.44 -49.9 63.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 73.230000000000004 110.93 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.2 -19.78 73.87 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.71 -0.757 . . . . 74.409999999999997 112.53 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.4 m -63.46 -52.85 59.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.783 0.325 . . . . 43.229999999999997 111.167 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 89.2 mt -76.49 -25.89 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 71.140000000000001 111.149 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -52.19 -29.39 29.15 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 31.039999999999999 112.502 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.92 -31.9 51.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.737 0.303 . . . . 63.420000000000002 110.883 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.33 -15.75 61.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 74.099999999999994 110.843 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.54 -38.04 74.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 65.209999999999994 110.942 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.477 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 1.6 mm-40 -51.61 -60.74 5.29 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.62 0.724 . . . . 63.200000000000003 110.915 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 54.1 Cg_endo -69.69 -33.74 16.25 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.738 2.292 . . . . 73.209999999999994 112.363 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.7 mt -53.68 -45.5 70.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 70.319999999999993 110.968 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 5.9 t80 64.31 14.5 8.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 74.109999999999999 110.902 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -68.41 -26.97 65.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 65.140000000000001 110.912 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -72.95 78.79 1.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 73.340000000000003 110.908 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 77.1 t80 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 73.420000000000002 110.917 -179.906 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.832 0.348 . . . . 54.43 110.876 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -65.46 91.26 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 73.510000000000005 110.901 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.34 79.0 53.52 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.554 0.692 . . . . 53.210000000000001 110.88 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -5.03 15.24 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.71 2.273 . . . . 73.540000000000006 112.319 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 pp -52.08 -30.99 28.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 73.209999999999994 110.933 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -80.08 -32.52 39.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 64.519999999999996 110.838 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -72.66 -46.25 54.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.206 -0.452 . . . . 71.040000000000006 110.892 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -59.81 -39.95 86.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.492 . . . . 54.109999999999999 111.148 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.431 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.13 -29.06 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 53.25 111.135 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.65 -27.59 50.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 73.400000000000006 110.886 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.557 ' HG ' HD12 ' A' ' 77' ' ' ILE . 4.1 mm? -90.78 -18.14 25.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 60.240000000000002 110.896 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.9 mm -76.33 -35.31 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 71.010000000000005 111.083 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.549 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.77 -57.13 23.23 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.605 0.717 . . . . 75.230000000000004 111.098 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.9 Cg_endo -69.8 -21.83 32.74 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.689 2.259 . . . . 74.519999999999996 112.374 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.618 ' O ' HG22 ' A' ' 42' ' ' ILE . 43.6 t -73.86 -44.43 55.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 73.540000000000006 110.826 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.57 -28.91 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 74.319999999999993 111.138 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mt -50.97 -33.93 26.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 73.349999999999994 110.948 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.73 -34.68 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 74.540000000000006 111.122 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.2 p -65.69 -42.84 90.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 72.329999999999998 111.093 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.99 -41.74 64.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.425 . . . . 74.349999999999994 110.829 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.4 tp -77.03 -38.43 52.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 72.209999999999994 110.946 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.8 -52.14 67.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 54.229999999999997 111.056 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.43 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.4 mp -49.72 -31.44 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 71.150000000000006 111.079 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.2 tp -50.79 -42.3 57.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 65.400000000000006 110.926 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.421 HG11 HD23 ' A' ' 62' ' ' LEU . 7.1 p -101.46 -37.5 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 63.100000000000001 111.12 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -63.68 -64.46 0.89 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 75.400000000000006 110.85 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.647 ' CZ ' HD23 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -72.89 -60.73 2.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 73.430000000000007 110.897 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -78.39 159.22 75.35 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.549 0.69 . . . . 75.420000000000002 110.943 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 138.68 38.31 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.657 2.238 . . . . 73.450000000000003 112.321 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.3 112.67 0.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 43.409999999999997 110.854 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 56.32 -176.06 0.05 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.145 -0.479 . . . . 74.219999999999999 110.859 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 50.0 t -113.7 -74.51 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 54.229999999999997 110.859 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.428 ' O ' HG23 ' A' ' 61' ' ' THR . . . -61.71 -23.01 62.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.742 . . . . 42.439999999999998 112.493 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -52.11 -34.96 46.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.914 0.387 . . . . 70.319999999999993 110.932 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -51.96 60.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 70.400000000000006 110.911 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -48.56 68.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 65.420000000000002 110.852 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 57' ' ' GLY . 29.3 p -53.07 -31.88 44.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 74.319999999999993 111.134 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.516 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -69.2 -50.84 43.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 63.420000000000002 110.93 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 68.1 m -52.97 -47.75 67.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 71.409999999999997 110.861 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.3 tt -72.31 -35.04 51.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 72.450000000000003 111.141 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.67 -25.61 60.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 61.240000000000002 110.879 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 62' ' ' LEU . 21.7 t -63.09 -41.39 92.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.101 -0.5 . . . . 63.409999999999997 111.119 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 tt -52.88 -28.87 25.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 63.119999999999997 110.991 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.489 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.26 -39.1 78.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 55.329999999999998 110.872 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.41 -30.03 70.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 75.209999999999994 111.099 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.503 HD13 HG11 ' A' ' 102' ' ' VAL . 9.8 mt -64.78 -54.7 27.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 74.049999999999997 110.957 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.94 -38.26 87.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 55.229999999999997 111.147 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 68' ' ' LEU . 77.0 t -71.44 -32.82 47.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 65.200000000000003 111.134 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.499 ' O ' HG22 ' A' ' 77' ' ' ILE . 73.6 t80 -61.85 -29.85 70.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 64.209999999999994 110.89 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.739 HD11 HD13 ' A' ' 95' ' ' LEU . 3.1 tt -71.99 -44.93 62.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 74.420000000000002 110.941 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.7 mp -73.22 -39.31 65.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 71.430000000000007 110.931 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.28 -51.67 67.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.129999999999995 110.907 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.557 HD12 ' HG ' ' A' ' 35' ' ' LEU . 1.8 tt -68.17 -30.2 47.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 75.200000000000003 111.092 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.1 t -80.53 -14.93 57.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 75.150000000000006 110.821 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.29 -9.9 58.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.151 -0.477 . . . . 74.409999999999997 110.903 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 77' ' ' ILE . 1.1 pp -63.84 -15.37 16.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.422 . . . . 73.340000000000003 111.147 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 81' ' ' VAL . 2.4 p 35.79 81.21 0.25 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.609 0.718 . . . . 64.0 111.137 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 167.3 24.78 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.704 2.269 . . . . 74.019999999999996 112.364 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 -48.61 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.657 2.238 . . . . 73.510000000000005 112.313 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.0 t -117.26 -19.48 9.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 74.319999999999993 111.125 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.54 46.99 3.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 55.439999999999998 110.866 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.1 -11.1 60.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 62.240000000000002 110.901 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.634 ' HA ' HD23 ' A' ' 90' ' ' LEU . 3.7 m-20 -95.36 23.96 5.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 75.219999999999999 110.892 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.58 -57.8 9.56 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.626 0.727 . . . . 60.240000000000002 111.161 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.5 Cg_endo -69.77 -20.02 35.31 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.679 2.253 . . . . 64.200000000000003 112.358 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.634 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.22 -53.1 10.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 74.430000000000007 110.863 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 87' ' ' ASP . 40.3 t -68.6 -43.42 83.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 73.120000000000005 111.146 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.07 -38.86 48.43 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.76 . . . . 65.040000000000006 112.497 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.66 -24.39 59.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.783 0.325 . . . . 72.549999999999997 110.902 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -74.5 -37.92 62.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 72.310000000000002 110.897 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.739 HD13 HD11 ' A' ' 74' ' ' LEU . 12.5 mt -54.79 -29.57 54.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 75.140000000000001 110.927 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.0 mmt -71.28 -41.56 69.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 72.439999999999998 110.884 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.494 ' O ' HG22 ' A' ' 100' ' ' VAL . 23.3 t80 -75.28 -51.06 14.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 64.010000000000005 110.888 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.786 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.09 -29.87 32.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.474 . . . . 60.140000000000001 111.18 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.68 -30.09 70.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 63.329999999999998 110.85 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.8 -30.05 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.443 . . . . 72.219999999999999 111.113 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.786 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.93 -32.99 61.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 74.340000000000003 110.924 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.503 HG11 HD13 ' A' ' 70' ' ' LEU . 29.4 m -76.6 -37.46 29.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 72.439999999999998 111.091 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.716 ' O ' HG23 ' A' ' 107' ' ' VAL . 55.3 m -72.98 -46.6 51.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 72.049999999999997 111.154 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -51.96 -31.7 30.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 43.420000000000002 110.916 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.8 p -74.59 -48.73 24.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 72.230000000000004 110.813 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.643 HD12 ' HA ' ' A' ' 103' ' ' THR . 9.8 mt -56.15 -34.52 39.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 63.32 111.148 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 103' ' ' THR . 22.1 t -53.85 -45.55 62.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 62.32 111.083 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.9 m -52.3 -32.38 37.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 64.319999999999993 111.153 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.5 t -50.28 -31.49 14.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 74.340000000000003 110.857 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.5 p -52.51 -32.83 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 74.340000000000003 111.159 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.47 ' SG ' HG21 ' A' ' 124' ' ' THR . 34.7 m -65.89 -44.52 85.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 73.219999999999999 110.874 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 83.8 t -75.52 -35.78 33.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 74.439999999999998 111.154 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.8 mt -72.21 -33.62 67.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 71.120000000000005 110.916 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -62.6 -28.95 70.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 64.540000000000006 110.93 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.8 HG11 ' HB2' ' A' ' 133' ' ' ALA . 11.2 p -102.39 -20.94 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 54.340000000000003 111.084 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -76.08 73.69 2.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 70.329999999999998 110.833 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 52.15 63.33 2.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 73.230000000000004 110.836 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -150.14 169.31 21.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 74.510000000000005 110.89 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.5 m -100.48 160.55 26.64 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.707 0.765 . . . . 72.430000000000007 110.818 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 111.46 2.81 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.674 2.249 . . . . 53.409999999999997 112.327 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -71.14 0.5 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 71.409999999999997 111.147 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.19 128.29 1.9 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 72.150000000000006 111.146 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 54.3 t60 63.29 161.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 64.439999999999998 110.868 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.47 HG21 ' SG ' ' A' ' 111' ' ' CYS . 23.6 m 61.25 68.2 1.26 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.574 0.702 . . . . 70.140000000000001 111.137 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 83.72 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.695 2.264 . . . . 74.329999999999998 112.357 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.03 172.66 8.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 71.430000000000007 110.907 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -173.8 147.04 9.14 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.715 -0.755 . . . . 64.329999999999998 112.48 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 145.43 -134.08 5.34 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 45.539999999999999 112.504 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -112.03 -64.84 0.49 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.738 -0.744 . . . . 64.329999999999998 112.517 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -174.05 -68.95 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.778 -0.725 . . . . 42.229999999999997 112.543 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -62.14 -26.39 68.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.968 0.413 . . . . 74.239999999999995 110.945 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.4 m -54.14 -27.2 16.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 42.229999999999997 111.147 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.8 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -56.62 -26.25 55.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 55.340000000000003 111.136 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 11.3 ptm -53.04 -30.79 37.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 62.43 110.846 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 58.6 t -56.9 -61.55 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 73.140000000000001 111.159 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.481 ' H ' HD12 ' A' ' 136' ' ' ILE . 4.5 mp -74.06 -25.96 20.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 74.109999999999999 111.136 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.442 ' OD2' HD13 ' A' ' 141' ' ' LEU . 25.5 t0 -58.5 -29.96 66.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.462 . . . . 72.430000000000007 110.884 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -30.1 23.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 73.439999999999998 110.863 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 7.0 tp -63.22 -50.73 69.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 61.439999999999998 110.916 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -74.03 -41.22 62.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 62.240000000000002 110.882 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.647 HD23 ' CZ ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -51.93 -31.98 31.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 73.209999999999994 110.915 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.18 -46.25 84.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.192 -0.458 . . . . 73.310000000000002 110.913 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.745 ' O ' HG23 ' A' ' 147' ' ' VAL . 3.9 mt -76.98 -31.96 19.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 70.120000000000005 111.155 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -56.01 -55.89 27.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 71.239999999999995 110.873 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 141' ' ' LEU . 31.8 t -54.01 -36.68 32.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 73.439999999999998 111.153 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -70.05 -41.38 74.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 73.209999999999994 110.867 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 143' ' ' ILE . 96.7 t -54.07 -34.45 26.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 45.219999999999999 111.087 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 95.6 m -51.9 -52.08 52.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 63.310000000000002 110.873 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.46 ' O ' HG22 ' A' ' 153' ' ' ILE . 31.5 t -76.06 -33.26 24.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 74.140000000000001 111.14 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.72 -27.05 37.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 75.140000000000001 110.846 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.97 -57.67 3.42 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.733 -0.746 . . . . 71.010000000000005 112.485 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 92.5 m -61.35 -45.01 96.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.779 0.323 . . . . 72.140000000000001 111.185 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.46 HG22 ' O ' ' A' ' 149' ' ' VAL . 20.3 tt -55.9 -25.86 19.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 73.400000000000006 111.128 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -51.93 -50.07 45.99 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.746 -0.74 . . . . 74.099999999999994 112.454 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.66 -31.84 63.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.773 0.32 . . . . 71.530000000000001 110.85 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -68.61 -21.24 64.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 75.540000000000006 110.9 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.3 mt -74.72 -29.19 61.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 75.319999999999993 110.895 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.488 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.9 OUTLIER -51.9 -60.6 5.74 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.636 0.731 . . . . 72.310000000000002 110.917 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.8 Cg_endo -69.77 -26.84 27.1 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.667 2.245 . . . . 73.329999999999998 112.326 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.6 -54.17 36.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 71.150000000000006 110.906 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 5.1 t80 64.55 14.42 8.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 65.230000000000004 110.878 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 72.18 -68.83 0.21 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 75.299999999999997 110.957 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 53.71 77.77 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 63.5 110.933 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 71.310000000000002 110.917 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.782 0.325 . . . . 75.519999999999996 110.855 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.88 26.55 6.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 74.129999999999995 110.863 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.66 78.99 48.12 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.574 0.702 . . . . 55.299999999999997 110.88 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -5.04 15.25 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.66 2.24 . . . . 61.329999999999998 112.354 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 pp -53.57 -30.93 44.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 63.530000000000001 110.917 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -80.58 -28.56 37.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 60.5 110.898 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.475 ' CE1' HG21 ' A' ' 80' ' ' ILE . 7.5 t80 -76.74 -44.79 31.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 74.420000000000002 110.913 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.4 t -62.87 -39.54 94.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 73.140000000000001 111.182 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.442 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -73.79 -29.03 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 74.299999999999997 111.12 179.902 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -68.87 -25.31 64.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 72.230000000000004 110.922 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.51 ' CD1' HD12 ' A' ' 77' ' ' ILE . 3.6 mm? -92.0 -27.81 17.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 73.230000000000004 110.884 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.532 ' O ' HG12 ' A' ' 40' ' ' VAL . 26.2 mm -79.51 -28.38 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 74.349999999999994 111.145 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.549 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.96 -57.15 23.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.575 0.702 . . . . 72.299999999999997 111.086 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.79 -24.82 29.1 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.676 2.251 . . . . 72.409999999999997 112.356 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.636 ' O ' HG22 ' A' ' 42' ' ' ILE . 3.1 t -74.57 -45.4 45.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 60.109999999999999 110.892 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 36' ' ' ILE . 8.9 p -81.45 -28.91 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 53.329999999999998 111.161 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mt -51.02 -33.96 27.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 64.319999999999993 110.898 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 39' ' ' CYS . 0.8 OUTLIER -58.68 -34.6 52.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 72.109999999999999 111.138 179.85 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.69 -34.98 79.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 64.549999999999997 111.094 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 m -57.33 -52.6 64.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 75.140000000000001 110.836 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.8 tp -70.16 -34.45 73.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 54.210000000000001 110.922 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.24 -44.89 90.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.452 . . . . 10.23 111.11 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.432 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.3 mp -64.26 -31.98 55.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 63.229999999999997 111.137 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mp -51.39 -38.88 55.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 73.450000000000003 110.916 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.782 HG22 ' HD3' ' A' ' 59' ' ' LYS . 7.9 p -101.45 -36.7 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 63.030000000000001 111.107 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -67.05 -64.65 0.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 63.109999999999999 110.861 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.432 ' HB2' HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -71.4 -60.08 2.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 54.530000000000001 110.936 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.1 mp -78.2 160.67 72.82 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.609 0.719 . . . . 64.019999999999996 110.92 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 157.25 61.14 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.711 2.274 . . . . 73.239999999999995 112.329 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.486 ' HB3' HG23 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -179.32 -170.19 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 71.430000000000007 110.845 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.33 171.21 1.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 71.209999999999994 110.859 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 5.6 t -81.51 -68.11 0.72 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 71.150000000000006 110.922 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.53 -23.64 43.66 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.782 -0.723 . . . . 70.319999999999993 112.495 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -52.36 -42.89 64.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.933 0.397 . . . . 72.430000000000007 110.908 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.782 ' HD3' HG22 ' A' ' 49' ' ' VAL . 1.1 mmmt -53.53 -43.45 68.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 73.0 110.868 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.93 -50.77 26.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 51.130000000000003 110.867 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.2 p -53.39 -44.64 68.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 64.540000000000006 111.136 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.93 -28.93 64.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 71.299999999999997 110.93 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.468 ' HB3' HG23 ' A' ' 106' ' ' ILE . 1.3 m -71.43 -44.96 63.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 63.25 110.889 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.8 tt -72.41 -35.09 50.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 61.119999999999997 111.118 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -55.96 -26.25 47.27 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.174 -0.466 . . . . 70.5 110.809 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.2 t -58.68 -38.63 72.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 74.219999999999999 111.113 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.89 -28.93 25.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 55.109999999999999 110.918 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.492 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.16 -39.14 78.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 75.129999999999995 110.893 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.4 -30.12 70.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 50.539999999999999 111.079 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.685 HD22 HG11 ' A' ' 102' ' ' VAL . 9.7 mt -64.93 -54.66 27.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.448 . . . . 72.239999999999995 110.93 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.92 -38.25 87.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 62.030000000000001 111.139 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 68' ' ' LEU . 77.3 t -71.44 -32.85 47.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 63.399999999999999 111.165 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -51.87 -38.39 55.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 71.129999999999995 110.864 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.3 tp -75.12 -30.87 60.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.487 . . . . 70.420000000000002 110.905 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 65.5 mt -73.26 -54.03 9.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 64.200000000000003 110.888 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.61 -54.16 47.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 75.310000000000002 110.928 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.51 HD12 ' CD1' ' A' ' 35' ' ' LEU . 3.4 tt -55.49 -27.59 21.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 71.030000000000001 111.135 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.5 m -80.03 -24.8 40.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 62.509999999999998 110.895 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.686 ' O ' HG23 ' A' ' 81' ' ' VAL . 14.7 mttp -64.74 -15.27 61.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 74.439999999999998 110.853 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.475 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.2 pp -56.16 -24.38 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 64.400000000000006 111.136 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 79' ' ' LYS . 22.1 t 63.81 75.11 0.4 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.595 0.712 . . . . 64.209999999999994 111.118 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 166.69 26.77 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.71 2.273 . . . . 74.530000000000001 112.302 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -49.1 0.6 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.679 2.253 . . . . 62.539999999999999 112.347 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.9 t -118.88 -25.61 6.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 70.329999999999998 111.136 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 64.26 47.99 3.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 61.310000000000002 110.831 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.18 37.15 1.59 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 72.140000000000001 110.902 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.623 ' HA ' HD23 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -112.44 22.76 14.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 72.109999999999999 110.856 179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.54 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -68.05 -57.89 8.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.578 0.704 . . . . 52.140000000000001 111.106 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.7 Cg_endo -69.74 -19.93 35.6 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.653 2.236 . . . . 43.530000000000001 112.341 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.623 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.09 -51.54 15.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 72.519999999999996 110.964 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.569 HG12 HD21 ' A' ' 95' ' ' LEU . 39.1 t -80.17 -24.38 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 75.030000000000001 111.089 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.7 -50.0 44.86 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.729 -0.748 . . . . 74.140000000000001 112.496 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -35.46 80.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.78 0.324 . . . . 75.219999999999999 110.879 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -60.51 -40.1 90.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.218 -0.446 . . . . 64.420000000000002 110.906 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.569 HD21 HG12 ' A' ' 91' ' ' VAL . 8.5 mt -51.79 -29.87 20.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 71.109999999999999 110.918 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.21 -43.62 73.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 73.140000000000001 110.859 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.508 ' O ' HG22 ' A' ' 100' ' ' VAL . 51.7 t80 -75.19 -51.34 13.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 75.0 110.863 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.783 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.07 -29.91 32.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 64.409999999999997 111.169 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.9 mmt -66.69 -30.11 70.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 74.540000000000006 110.834 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.73 -30.12 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 72.129999999999995 111.123 179.955 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.783 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.89 -33.26 62.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 71.219999999999999 110.944 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.685 HG11 HD22 ' A' ' 70' ' ' LEU . 30.9 m -76.95 -38.04 27.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 70.319999999999993 111.141 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.503 ' HA ' HD12 ' A' ' 106' ' ' ILE . 69.8 m -72.51 -40.67 66.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 73.209999999999994 111.158 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -63.41 -31.98 73.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 72.129999999999995 110.87 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.29 -32.98 69.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 60.509999999999998 110.841 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 103' ' ' THR . 20.3 mt -73.96 -51.69 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 63.240000000000002 111.131 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -54.21 -34.29 27.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 71.230000000000004 111.164 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.5 m -53.0 -34.97 58.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 64.430000000000007 111.119 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.0 t -52.24 -48.34 65.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 72.400000000000006 110.845 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.7 t -52.91 -33.83 19.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.493 . . . . 61.350000000000001 111.155 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.46 ' O ' HG12 ' A' ' 115' ' ' VAL . 31.2 m -65.09 -39.9 93.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 55.140000000000001 110.875 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 65.6 t -79.98 -36.14 16.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 74.409999999999997 111.175 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.611 HD21 ' HE2' ' A' ' 59' ' ' LYS . 87.6 mt -72.86 -51.7 17.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 74.430000000000007 110.886 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -51.73 -29.5 18.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 72.299999999999997 110.901 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.82 HG11 ' HB2' ' A' ' 133' ' ' ALA . 12.9 p -99.43 -16.81 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 63.450000000000003 111.157 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -54.26 -52.53 61.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 73.450000000000003 110.924 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -163.04 32.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 74.140000000000001 110.86 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -131.92 -178.38 4.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 74.239999999999995 110.845 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.51 160.58 41.8 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.641 0.734 . . . . 72.340000000000003 110.885 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 161.06 47.4 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.667 2.245 . . . . 61.130000000000003 112.315 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.23 -176.96 3.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 53.109999999999999 111.161 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 15.0 t -118.41 28.55 8.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.251 -0.432 . . . . 61.399999999999999 111.147 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -148.18 95.14 2.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 75.430000000000007 110.893 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 8.6 m 53.37 68.34 3.0 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.587 0.708 . . . . 75.310000000000002 111.175 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 179.72 3.49 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.701 2.268 . . . . 65.140000000000001 112.382 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -142.53 -42.78 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 74.209999999999994 110.902 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.4 141.27 0.12 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.712 -0.756 . . . . 75.010000000000005 112.524 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.672 ' HA3' HG11 ' A' ' 132' ' ' VAL . . . 111.39 -166.49 12.26 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.756 -0.735 . . . . 72.310000000000002 112.473 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.75 -138.65 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.719 -0.753 . . . . 31.109999999999999 112.475 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -99.8 -20.3 17.16 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.743 -0.742 . . . . 61.240000000000002 112.503 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -76.37 -27.0 56.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.938 0.399 . . . . 64.450000000000003 110.911 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.672 HG11 ' HA3' ' A' ' 128' ' ' GLY . 21.8 m -58.62 -37.39 64.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 71.329999999999998 111.158 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.82 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -72.8 -29.3 63.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 51.450000000000003 111.074 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 14.6 mmt -56.66 -31.02 63.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 73.340000000000003 110.806 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 65.9 t -56.99 -65.9 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 74.120000000000005 111.146 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 38.9 mm -69.17 -33.07 56.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 63.509999999999998 111.12 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -64.27 -29.97 71.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 64.140000000000001 110.859 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.09 -29.1 39.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 64.230000000000004 110.873 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.96 -44.54 61.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 64.099999999999994 110.926 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -74.0 -53.96 8.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 53.100000000000001 110.895 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.596 ' O ' HG23 ' A' ' 145' ' ' VAL . 0.8 OUTLIER -52.23 -36.98 53.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 73.129999999999995 110.96 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 32.9 t-105 -52.98 -51.48 61.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 73.340000000000003 110.905 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.621 ' O ' HG23 ' A' ' 147' ' ' VAL . 74.3 mt -76.99 -38.81 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 75.150000000000006 111.127 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -56.14 -57.15 13.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 53.340000000000003 110.839 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 141' ' ' LEU . 46.2 t -56.74 -34.96 44.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 73.030000000000001 111.128 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -66.58 -32.95 74.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 74.409999999999997 110.864 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 143' ' ' ILE . 94.5 t -53.99 -33.96 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 73.299999999999997 111.128 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.97 -36.77 50.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 72.430000000000007 110.845 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 83.1 t -75.95 -35.93 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 65.299999999999997 111.102 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -71.9 -27.01 62.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 73.230000000000004 110.863 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -52.2 -58.9 9.67 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.753 -0.737 . . . . 71.310000000000002 112.462 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.5 t -54.06 -35.08 61.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.78 0.324 . . . . 74.0 111.192 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 51.0 mm -66.67 -57.98 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 74.319999999999993 111.158 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -54.13 -26.07 34.15 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.764 -0.731 . . . . 63.210000000000001 112.488 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -32.0 73.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 41.049999999999997 110.903 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -80.5 -26.15 38.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 73.349999999999994 110.89 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 95.9 mt -79.75 -25.87 40.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 71.299999999999997 110.941 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.523 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 1.4 tp-100 -52.07 -58.05 12.83 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.608 0.718 . . . . 72.120000000000005 110.922 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 54.2 Cg_endo -69.76 -16.33 37.52 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.684 2.256 . . . . 73.109999999999999 112.334 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.8 tp -93.96 40.73 1.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 73.450000000000003 110.903 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.89 -59.65 2.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 72.010000000000005 110.876 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 72.22 -68.96 0.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 74.319999999999993 110.872 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 38.9 t30 52.15 42.3 30.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 72.129999999999995 110.856 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 74.349999999999994 110.931 -179.948 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.828 0.346 . . . . 61.130000000000003 110.845 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.27 -32.76 74.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 71.010000000000005 110.87 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.09 78.91 51.67 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.639 0.733 . . . . 61.0 110.919 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -4.96 15.1 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.707 2.271 . . . . 63.25 112.312 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 pp -52.9 -31.5 40.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 72.329999999999998 110.927 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -80.35 -29.88 37.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 64.239999999999995 110.896 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -76.81 -42.35 40.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.13 -0.486 . . . . 74.109999999999999 110.935 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.1 t -62.21 -38.52 89.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 73.040000000000006 111.179 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.446 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -74.96 -29.12 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 65.540000000000006 111.124 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -57.53 -27.73 62.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 74.230000000000004 110.887 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.422 HD11 ' HG ' ' A' ' 76' ' ' LEU . 4.3 mm? -90.55 -20.13 22.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 63.030000000000001 110.924 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.4 mm -76.96 -34.22 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 50.219999999999999 111.131 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.543 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.3 mm -54.95 -57.32 20.08 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.634 0.731 . . . . 71.040000000000006 111.143 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.654 ' HA ' HD23 ' A' ' 41' ' ' LEU . 53.5 Cg_endo -69.72 -11.8 31.65 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.657 2.238 . . . . 43.299999999999997 112.363 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.622 ' O ' HG22 ' A' ' 42' ' ' ILE . 3.1 t -62.07 -43.41 98.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 73.120000000000005 110.895 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 37' ' ' ILE . 14.3 p -79.47 -27.28 12.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 71.129999999999995 111.073 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.654 HD23 ' HA ' ' A' ' 38' ' ' PRO . 2.9 mm? -50.39 -34.31 23.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 71.310000000000002 110.909 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 39' ' ' CYS . 0.8 OUTLIER -58.7 -34.94 53.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 74.319999999999993 111.115 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.3 p -64.95 -36.59 84.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 72.099999999999994 111.105 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.1 t -54.17 -46.35 72.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 41.229999999999997 110.847 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tp -77.13 -38.08 52.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 75.209999999999994 110.936 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.65 -52.12 67.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 50.200000000000003 111.07 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.426 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.4 mp -49.82 -31.51 6.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 74.299999999999997 111.11 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 tt -50.78 -41.91 57.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 73.319999999999993 110.92 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.762 HG13 HD22 ' A' ' 62' ' ' LEU . 7.2 p -101.61 -36.77 4.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 45.340000000000003 111.117 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -64.47 -64.56 0.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 73.530000000000001 110.888 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.426 ' HB2' HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -71.71 -62.01 1.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 74.239999999999995 110.965 -179.856 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.4 mp -67.04 160.75 68.51 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.61 0.719 . . . . 74.109999999999999 110.896 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 143.12 49.55 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.692 2.262 . . . . 64.540000000000006 112.316 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.686 ' CB ' HG23 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -153.42 -170.1 3.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 72.310000000000002 110.816 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.14 172.67 11.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 73.510000000000005 110.851 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 22.5 m -68.29 -62.07 1.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 71.319999999999993 110.869 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.25 -22.94 38.82 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.709 -0.757 . . . . 40.25 112.526 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -35.01 41.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.919 0.39 . . . . 64.120000000000005 110.915 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -56.24 -46.48 79.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 73.319999999999993 110.93 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -52.01 51.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 55.299999999999997 110.923 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 55.3 p -55.28 -25.95 37.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 75.310000000000002 111.129 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.762 HD22 HG13 ' A' ' 49' ' ' VAL . 22.4 tp -72.99 -37.27 67.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 74.140000000000001 110.896 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 39.4 t -73.85 -48.52 30.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 61.119999999999997 110.893 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.6 pt -58.09 -32.59 44.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 65.450000000000003 111.096 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.13 -57.15 4.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 74.420000000000002 110.848 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.558 HG23 ' CD1' ' A' ' 42' ' ' ILE . 13.2 p -60.64 -33.61 55.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 63.340000000000003 111.128 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 tt -52.67 -31.08 35.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 75.140000000000001 110.906 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.499 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -68.36 -37.78 80.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 71.519999999999996 110.944 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.0 -29.96 69.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 64.310000000000002 111.07 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.429 HD13 HG11 ' A' ' 102' ' ' VAL . 7.4 mt -66.78 -54.86 18.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.236 -0.438 . . . . 71.200000000000003 110.928 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.576 ' O ' HD13 ' A' ' 75' ' ' LEU . 4.7 t -59.95 -38.81 83.54 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.17 -0.468 . . . . 75.25 111.167 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 68' ' ' LEU . 84.6 t -71.42 -33.0 48.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 75.129999999999995 111.124 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -65.46 -38.44 89.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 71.329999999999998 110.916 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.782 HD23 HD13 ' A' ' 95' ' ' LEU . 7.6 mp -74.99 -35.41 62.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.117 -0.492 . . . . 73.209999999999994 110.932 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.576 HD13 ' O ' ' A' ' 71' ' ' THR . 8.1 mp -73.42 -47.84 38.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 60.350000000000001 110.902 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.437 ' O ' HD13 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -57.98 -48.33 80.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 62.020000000000003 110.924 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 tt -65.96 -28.83 44.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 73.140000000000001 111.122 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 t -80.85 -23.87 38.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 70.549999999999997 110.833 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.723 ' O ' HG23 ' A' ' 81' ' ' VAL . 7.6 mmtp -58.81 -22.04 57.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.484 . . . . 62.229999999999997 110.914 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 26.0 pt -51.25 -30.87 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 74.239999999999995 111.097 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 79' ' ' LYS . 58.4 t 55.71 80.13 0.31 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.655 0.74 . . . . 74.319999999999993 111.158 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 53.6 Cg_endo -69.79 112.11 3.0 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.652 2.235 . . . . 75.019999999999996 112.359 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 82' ' ' PRO . 53.6 Cg_endo -69.72 -48.56 0.7 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.713 2.275 . . . . 74.319999999999993 112.363 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.0 t -116.84 -22.07 8.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 74.420000000000002 111.131 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.71 -47.5 63.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 60.399999999999999 110.841 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.6 tp 51.73 49.8 20.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 74.109999999999999 110.951 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.639 ' HA ' HD23 ' A' ' 90' ' ' LEU . 9.7 m-20 -95.99 29.19 2.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 75.120000000000005 110.893 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.539 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -66.98 -57.77 10.65 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.612 0.72 . . . . 54.450000000000003 111.136 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.5 Cg_endo -69.78 -20.87 34.19 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.663 2.242 . . . . 73.209999999999994 112.337 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.639 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.25 -43.87 55.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 75.439999999999998 110.959 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.477 HG12 HD21 ' A' ' 95' ' ' LEU . 61.7 t -80.7 -38.84 17.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 42.539999999999999 111.106 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.89 -51.21 40.97 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.689 -0.767 . . . . 71.019999999999996 112.509 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -34.71 78.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.81 0.338 . . . . 73.400000000000006 110.891 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -61.26 -36.03 78.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 72.140000000000001 110.913 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.782 HD13 HD23 ' A' ' 74' ' ' LEU . 10.4 mt -51.82 -33.0 33.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 64.329999999999998 110.894 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.85 -28.05 33.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 64.010000000000005 110.891 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.491 ' O ' HG22 ' A' ' 100' ' ' VAL . 5.2 t80 -72.98 -54.68 7.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 63.109999999999999 110.89 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.803 ' HA ' HD23 ' A' ' 101' ' ' LEU . 0.6 OUTLIER -53.4 -28.54 30.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.494 . . . . 72.239999999999995 111.142 -179.933 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 27.4 mmt -68.59 -30.04 68.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 72.150000000000006 110.875 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.91 -29.74 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 73.030000000000001 111.107 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.803 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.74 -32.73 62.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 62.409999999999997 110.876 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.429 HG11 HD13 ' A' ' 70' ' ' LEU . 27.7 m -77.08 -38.18 27.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 44.119999999999997 111.178 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 84.4 m -72.66 -37.7 67.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 72.230000000000004 111.126 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -68.54 -32.19 71.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 75.5 110.851 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.0 t -70.42 -33.62 71.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 74.209999999999994 110.833 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 30.8 mt -72.6 -51.39 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 72.129999999999995 111.127 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.554 ' O ' HG12 ' A' ' 110' ' ' VAL . 6.3 p -56.18 -35.35 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 74.439999999999998 111.121 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 98.3 m -52.48 -32.32 39.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.156 -0.475 . . . . 51.140000000000001 111.104 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.41 -31.54 15.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 71.120000000000005 110.875 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.554 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.3 p -52.57 -32.87 17.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 73.129999999999995 111.129 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 43.0 m -66.11 -47.67 73.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 62.210000000000001 110.877 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.7 t -71.99 -36.04 56.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 71.349999999999994 111.141 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.5 mt -72.02 -33.48 68.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 63.119999999999997 110.961 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -59.64 -30.73 68.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 73.409999999999997 110.907 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.815 HG11 ' HB2' ' A' ' 133' ' ' ALA . 9.5 p -102.34 -24.21 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 65.219999999999999 111.127 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -90.72 -73.23 0.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 72.450000000000003 110.857 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.57 99.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 72.439999999999998 110.833 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 47.0 tpt85 -86.22 -73.94 0.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 74.409999999999997 110.885 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.3 160.56 4.89 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.665 0.745 . . . . 63.520000000000003 110.875 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 131.57 21.52 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.726 2.284 . . . . 64.329999999999998 112.371 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.7 p -150.42 80.45 1.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 41.219999999999999 111.106 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.9 m 63.63 106.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 53.210000000000001 111.127 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -52.18 103.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 63.32 110.859 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.1 p -141.1 73.92 25.82 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.629 0.728 . . . . 73.219999999999999 111.157 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 155.25 66.45 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.695 2.263 . . . . 74.140000000000001 112.356 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.7 mtm180 63.05 103.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 73.439999999999998 110.885 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.01 130.57 5.52 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.74 -0.743 . . . . 50.130000000000003 112.479 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 162.82 -165.85 36.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.788 -0.72 . . . . 53.5 112.488 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -143.99 119.13 1.26 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.686 -0.769 . . . . 64.340000000000003 112.431 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 179.18 38.04 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.704 -0.76 . . . . 72.219999999999999 112.455 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -87.87 -24.93 23.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.912 0.387 . . . . 73.329999999999998 110.901 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 23.8 m -53.98 -30.51 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 72.120000000000005 111.066 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.815 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -57.25 -25.05 58.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 73.439999999999998 111.082 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.8 ptm -52.94 -30.94 37.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 71.430000000000007 110.892 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 59.1 t -56.92 -53.64 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.284 -0.416 . . . . 73.420000000000002 111.128 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 64.9 mt -73.93 -38.56 50.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 64.230000000000004 111.156 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.97 -30.03 70.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 74.120000000000005 110.909 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -30.14 23.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 74.200000000000003 110.863 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.4 tt -63.47 -50.91 67.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 74.400000000000006 110.868 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -73.99 -36.97 64.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 71.540000000000006 110.901 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.0 -34.33 42.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 64.319999999999993 110.957 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 21.4 t90 -64.17 -50.68 67.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 74.310000000000002 110.915 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.633 ' O ' HG23 ' A' ' 147' ' ' VAL . 51.2 mm -68.35 -32.12 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 72.310000000000002 111.148 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -56.02 -56.72 17.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 70.409999999999997 110.859 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 21.7 t -65.95 -35.91 76.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 61.109999999999999 111.147 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.51 -33.2 65.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 71.129999999999995 110.842 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 143' ' ' ILE . 58.0 t -54.07 -34.11 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 54.409999999999997 111.126 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 71.8 m -51.95 -43.55 63.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.167 -0.47 . . . . 71.510000000000005 110.849 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 64.3 t -75.22 -35.06 32.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 54.420000000000002 111.112 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -54.74 -28.71 50.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 75.430000000000007 110.873 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -70.8 -22.43 78.19 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.734 -0.745 . . . . 62.149999999999999 112.493 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.1 m -79.46 -52.8 7.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.76 0.314 . . . . 54.310000000000002 111.15 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 47.6 mm -76.5 -24.15 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 73.219999999999999 111.147 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -52.13 -50.04 47.37 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.728 -0.748 . . . . 34.200000000000003 112.463 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -31.98 67.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 71.549999999999997 110.899 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.76 -23.57 62.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 72.519999999999996 110.899 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.5 mt -75.25 -27.41 59.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 72.230000000000004 110.905 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.483 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.8 OUTLIER -51.94 -60.55 5.88 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.607 0.717 . . . . 71.109999999999999 110.947 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.7 Cg_endo -69.74 -16.47 37.64 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.647 2.231 . . . . 75.310000000000002 112.347 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.1 tp -93.96 40.73 1.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.441 . . . . 75.430000000000007 110.951 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.85 -59.06 2.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 71.049999999999997 110.873 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -179.15 -74.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 71.319999999999993 110.959 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 26.2 t30 59.68 97.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 64.0 110.86 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 2.2 t80 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 73.329999999999998 110.959 -179.967 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.859 0.275 . . . . 70.310000000000002 112.367 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.426 HD13 ' HE1' ' A' ' 156' ' ' PHE . 4.4 pp -52.0 -30.96 27.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 64.209999999999994 110.905 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.409 ' N ' HD12 ' A' ' 29' ' ' LEU . 52.2 t80 -78.54 -33.58 47.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 73.010000000000005 110.865 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -72.5 -45.96 56.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 62.219999999999999 110.905 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -60.23 -40.03 88.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 74.200000000000003 111.129 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.441 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.18 -29.11 21.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 75.310000000000002 111.138 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.87 -27.06 49.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 64.230000000000004 110.869 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.587 ' CB ' HD12 ' A' ' 77' ' ' ILE . 4.1 mm? -91.35 -19.18 23.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 55.119999999999997 110.922 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.468 HG21 HG23 ' A' ' 152' ' ' THR . 45.6 mm -76.73 -34.84 23.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.453 . . . . 62.130000000000003 111.137 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.544 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.2 mt -55.7 -57.13 23.0 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.621 0.724 . . . . 73.030000000000001 111.139 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.3 Cg_endo -69.81 -20.47 34.56 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.696 2.264 . . . . 73.329999999999998 112.32 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.624 ' O ' HG22 ' A' ' 42' ' ' ILE . 48.7 t -75.88 -44.59 39.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 62.520000000000003 110.867 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.53 -28.96 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 74.519999999999996 111.163 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 mt -51.0 -33.97 27.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 74.430000000000007 110.922 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.1 tp -58.73 -34.65 52.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 73.25 111.153 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.73 -40.9 92.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 72.120000000000005 111.167 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.25 -43.45 67.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 62.109999999999999 110.816 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 tp -76.46 -39.32 53.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.453 . . . . 74.319999999999993 110.908 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.88 -36.29 72.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 61.43 111.102 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.438 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.2 mp -64.97 -32.32 57.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 71.530000000000001 111.112 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.29 -33.78 63.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 73.109999999999999 110.901 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.997 HG11 HD13 ' A' ' 62' ' ' LEU . 29.0 m -101.66 -36.82 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 75.25 111.086 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -71.6 -64.81 0.85 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 65.299999999999997 110.927 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.509 ' CE2' HD22 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -69.63 -61.77 1.65 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 73.230000000000004 110.948 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.77 160.63 60.22 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.656 0.741 . . . . 74.019999999999996 110.907 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 136.37 32.85 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.709 2.272 . . . . 71.209999999999994 112.355 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.65 44.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 70.230000000000004 110.862 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -53.06 109.58 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 64.439999999999998 110.877 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -179.16 159.06 0.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 55.109999999999999 110.886 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.48 -26.71 31.52 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.748 . . . . 75.340000000000003 112.487 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -72.58 -35.0 67.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 75.0 110.85 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.0 -49.25 66.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 75.409999999999997 110.896 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -70.51 -48.08 57.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 54.539999999999999 110.913 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.2 m -54.27 -27.02 32.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 72.319999999999993 111.18 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.997 HD13 HG11 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -72.86 -38.92 66.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.446 . . . . 73.140000000000001 110.913 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 26.3 m -66.87 -45.59 77.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 71.530000000000001 110.861 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.9 tt -71.26 -35.0 56.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 64.439999999999998 111.101 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.6 m -58.43 -26.36 63.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 65.010000000000005 110.861 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 62' ' ' LEU . 22.3 t -61.73 -40.06 85.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.477 . . . . 74.239999999999995 111.063 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.89 -28.88 25.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 71.239999999999995 110.902 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.485 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.13 -39.17 79.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 72.140000000000001 110.914 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.39 -29.99 70.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 53.43 111.116 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.721 HD13 HG11 ' A' ' 102' ' ' VAL . 9.8 mt -65.11 -54.7 25.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 75.400000000000006 110.915 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.81 -38.26 87.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 71.5 111.172 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 68' ' ' LEU . 78.6 t -71.5 -32.98 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 75.409999999999997 111.12 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.553 ' O ' HG22 ' A' ' 77' ' ' ILE . 69.4 t80 -54.58 -30.01 53.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.481 . . . . 72.209999999999994 110.866 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.846 HD11 HD13 ' A' ' 95' ' ' LEU . 0.3 OUTLIER -65.78 -50.54 64.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 50.420000000000002 110.954 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.4 mt -73.23 -33.09 65.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 75.019999999999996 110.949 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -55.08 22.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 61.509999999999998 110.909 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.587 HD12 ' CB ' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -64.93 -30.48 50.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 63.210000000000001 111.152 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.8 t -80.47 -19.12 46.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 72.329999999999998 110.839 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.715 ' O ' HG23 ' A' ' 81' ' ' VAL . 8.2 mttt -78.16 -10.26 59.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 74.540000000000006 110.931 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 77' ' ' ILE . 2.1 pp -55.62 -25.19 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 75.230000000000004 111.12 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 79' ' ' LYS . 30.1 t 62.89 76.21 0.38 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.654 0.74 . . . . 55.149999999999999 111.155 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 167.5 24.29 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.685 2.257 . . . . 64.5 112.317 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -48.85 0.64 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.623 2.215 . . . . 65.319999999999993 112.37 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.3 t -133.65 14.43 4.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 74.140000000000001 111.122 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.3 p 51.65 37.96 21.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 74.140000000000001 110.856 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.15 -11.81 61.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 74.140000000000001 110.922 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.646 ' HA ' HD23 ' A' ' 90' ' ' LEU . 2.1 m-20 -95.28 23.36 5.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 55.409999999999997 110.835 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.539 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.8 -57.91 9.01 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.603 0.716 . . . . 75.109999999999999 111.128 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 54.7 Cg_endo -69.68 -19.99 35.78 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.698 2.265 . . . . 74.239999999999995 112.391 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.646 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.15 -50.36 19.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 62.399999999999999 110.897 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 87' ' ' ASP . 21.7 t -78.54 -47.35 23.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 74.219999999999999 111.138 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.87 -40.77 50.42 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.695 -0.764 . . . . 53.049999999999997 112.504 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.5 tttp -74.25 -23.5 59.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.797 0.332 . . . . 73.209999999999994 110.879 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -74.68 -34.34 62.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 73.319999999999993 110.971 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.846 HD13 HD11 ' A' ' 74' ' ' LEU . 14.9 mt -53.0 -29.67 30.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.079 -0.509 . . . . 75.319999999999993 110.939 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.56 -43.65 72.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 74.129999999999995 110.831 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.494 ' O ' HG22 ' A' ' 100' ' ' VAL . 47.0 t80 -75.18 -51.14 14.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 71.230000000000004 110.877 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.8 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.08 -29.95 33.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 64.230000000000004 111.132 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 8.9 mmt -66.54 -30.09 70.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 65.329999999999998 110.928 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.83 -30.12 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 74.430000000000007 111.088 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.8 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.88 -33.29 62.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 74.200000000000003 110.916 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.721 HG11 HD13 ' A' ' 70' ' ' LEU . 31.2 m -76.86 -38.06 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 74.540000000000006 111.128 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 76.5 m -72.51 -38.41 68.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 63.520000000000003 111.153 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -66.81 -32.0 72.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 74.019999999999996 110.911 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.5 t -71.5 -36.44 71.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 63.299999999999997 110.877 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 38.4 mt -70.78 -52.0 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 71.319999999999993 111.077 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.551 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.7 p -54.0 -35.96 29.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 72.120000000000005 111.114 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.3 m -52.42 -32.42 39.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 72.310000000000002 111.188 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 t -50.45 -31.36 14.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 63.539999999999999 110.874 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.4 p -52.42 -32.85 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 74.109999999999999 111.13 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 14.9 m -64.49 -46.59 82.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 72.409999999999997 110.912 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 130' ' ' GLY . 95.0 t -73.97 -38.93 50.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 74.510000000000005 111.111 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.5 mt -69.11 -30.92 69.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 72.219999999999999 110.931 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -58.18 -33.51 69.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 74.109999999999999 110.872 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.624 ' CG1' ' HB2' ' A' ' 133' ' ' ALA . 7.9 p -102.27 -24.79 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 72.549999999999997 111.156 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -58.84 -69.89 0.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 75.439999999999998 110.837 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 72.340000000000003 110.847 179.984 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.699 ' O ' HG13 ' A' ' 112' ' ' VAL . . . . . . . . 0 N--CA 1.452 -0.265 0 N-CA-C 112.455 -0.258 . . . . 64.409999999999997 112.455 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -77.62 -26.14 50.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.963 0.411 . . . . 63.340000000000003 110.955 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.501 ' CG2' HG21 ' A' ' 115' ' ' VAL . 22.1 m -60.58 -37.48 75.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 71.040000000000006 111.087 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.624 ' HB2' ' CG1' ' A' ' 115' ' ' VAL . . . -63.7 -25.02 68.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 60.009999999999998 111.078 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 13.2 mmt -52.97 -30.98 38.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 72.0 110.909 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.9 t -56.97 -57.03 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 75.540000000000006 111.154 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 64.1 mt -74.02 -38.37 49.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 71.349999999999994 111.1 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -61.23 -29.96 70.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 74.349999999999994 110.896 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.02 -30.17 24.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 73.25 110.871 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.66 -50.83 70.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 52.399999999999999 110.935 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -74.04 -44.23 55.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 73.329999999999998 110.885 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.509 HD22 ' CE2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -52.06 -33.86 40.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 52.329999999999998 110.88 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -53.76 -46.51 70.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 65.409999999999997 110.905 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.518 ' O ' HG23 ' A' ' 147' ' ' VAL . 43.3 mm -76.9 -31.96 19.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 74.329999999999998 111.117 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -56.09 -56.82 16.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 71.109999999999999 110.865 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.9 m -54.9 -35.0 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 75.409999999999997 111.171 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -63.38 -32.95 74.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 73.439999999999998 110.9 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 143' ' ' ILE . 31.7 t -66.56 -37.74 80.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 74.230000000000004 111.129 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 91.8 m -58.93 -51.94 67.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 72.239999999999995 110.882 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.48 -32.99 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 64.239999999999995 111.125 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -52.71 -52.0 57.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 71.230000000000004 110.887 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.85 -19.38 75.51 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.757 . . . . 40.509999999999998 112.484 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.468 HG23 HG21 ' A' ' 36' ' ' ILE . 33.6 m -74.72 -52.83 10.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.81 0.338 . . . . 63.530000000000001 111.18 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.7 mt -76.52 -29.77 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 64.310000000000002 111.105 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -55.43 -49.95 62.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.725 -0.75 . . . . 55.399999999999999 112.491 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.4 mmt -71.13 -32.03 68.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.877 0.37 . . . . 70.129999999999995 110.923 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.426 ' HE1' HD13 ' A' ' 29' ' ' LEU . 15.1 t80 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 73.209999999999994 110.905 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.232 0.193 0 CA-C-O 120.827 0.261 . . . . 72.209999999999994 112.352 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 pp -52.08 -30.93 28.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 71.450000000000003 110.932 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -78.43 -33.34 48.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 65.329999999999998 110.828 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.514 ' HE1' HG22 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -72.61 -45.81 57.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 73.129999999999995 110.936 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -60.28 -39.95 88.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 63.020000000000003 111.109 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.437 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.18 -29.03 21.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 72.239999999999995 111.146 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -26.72 52.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 72.120000000000005 110.857 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.57 -19.46 22.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 71.430000000000007 110.955 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.4 mm -76.68 -34.78 24.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 73.200000000000003 111.159 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.55 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.2 mt -55.74 -57.18 22.83 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.681 0.753 . . . . 74.120000000000005 111.14 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 54.1 Cg_endo -69.73 -20.97 34.29 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.673 2.249 . . . . 74.129999999999995 112.354 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.638 ' O ' HG22 ' A' ' 42' ' ' ILE . 48.5 t -75.89 -44.92 38.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.251 -0.431 . . . . 62.020000000000003 110.873 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.2 p -81.59 -28.89 10.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 74.400000000000006 111.166 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.2 mt -50.95 -33.94 26.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 74.239999999999995 110.89 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.77 -34.65 52.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 75.540000000000006 111.164 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 p -65.73 -34.74 78.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 51.219999999999999 111.164 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.14 -46.8 79.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 52.299999999999997 110.883 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.64 -41.6 60.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 75.120000000000005 110.896 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.52 -51.42 69.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 73.299999999999997 111.095 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.03 -32.09 56.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 65.019999999999996 111.166 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.558 ' O ' HD22 ' A' ' 52' ' ' LEU . 5.4 tp -51.62 -37.93 52.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 73.0 110.905 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.0 p -101.64 -35.79 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 75.219999999999999 111.153 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -66.28 -62.06 1.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 75.530000000000001 110.877 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.515 ' CE2' HD13 ' A' ' 141' ' ' LEU . 0.3 OUTLIER -55.52 -53.73 52.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 73.200000000000003 110.935 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.558 HD22 ' O ' ' A' ' 48' ' ' LEU . 10.9 mp -51.96 160.53 1.13 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.585 0.707 . . . . 65.400000000000006 110.968 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -170.97 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.688 2.259 . . . . 73.329999999999998 112.343 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 55.1 91.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 73.109999999999999 110.848 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -152.24 147.31 26.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 70.420000000000002 110.845 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -173.97 -74.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 75.439999999999998 110.877 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -85.95 -50.81 3.79 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.756 -0.735 . . . . 61.210000000000001 112.491 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -61.57 -44.34 97.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.899 0.38 . . . . 73.420000000000002 110.908 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.08 -48.9 67.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 73.409999999999997 110.931 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -66.02 -37.53 86.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 74.349999999999994 110.923 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.5 m -66.91 -29.14 68.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 64.310000000000002 111.17 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.701 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.9 OUTLIER -71.66 -50.69 28.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 74.510000000000005 110.937 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -51.21 62.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 74.010000000000005 110.86 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.5 tt -66.85 -35.02 73.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 74.120000000000005 111.154 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 m -65.79 -25.12 67.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 64.129999999999995 110.858 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 62' ' ' LEU . 64.0 t -58.02 -36.64 57.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 64.340000000000003 111.13 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.92 -28.95 25.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 75.230000000000004 110.898 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.495 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.29 -38.94 78.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 71.310000000000002 110.917 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.51 -30.0 70.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 70.299999999999997 111.133 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.641 HD22 HG11 ' A' ' 102' ' ' VAL . 9.5 mt -64.99 -54.78 25.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 110.904 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.68 -38.46 87.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 71.25 111.196 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 68' ' ' LEU . 79.3 t -71.43 -32.89 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.219999999999999 111.12 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -51.82 -30.14 22.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 75.109999999999999 110.895 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.561 HD11 HD11 ' A' ' 95' ' ' LEU . 0.3 OUTLIER -73.9 -41.62 61.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 62.399999999999999 110.928 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.0 mt -73.27 -34.6 65.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 73.040000000000006 110.873 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.402 HD13 ' HD2' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -69.6 -55.07 11.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 73.439999999999998 110.916 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.556 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -56.22 -24.59 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 61.109999999999999 111.083 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.5 -16.43 60.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 74.340000000000003 110.813 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.747 ' O ' HG23 ' A' ' 81' ' ' VAL . 2.0 ptmm? -64.05 -15.54 59.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 73.25 110.896 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 77' ' ' ILE . 1.0 OUTLIER -51.73 -28.68 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 70.109999999999999 111.106 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 79' ' ' LYS . 58.6 t 61.01 76.72 0.4 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.664 0.745 . . . . 70.140000000000001 111.12 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 167.41 24.46 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.702 2.268 . . . . 74.340000000000003 112.377 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -49.05 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.661 2.241 . . . . 75.299999999999997 112.365 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.9 t -134.48 18.37 3.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 70.430000000000007 111.125 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.2 p 50.09 46.51 24.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 74.150000000000006 110.856 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mt -94.68 22.12 6.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 62.329999999999998 110.94 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.628 ' HA ' HD23 ' A' ' 90' ' ' LEU . 4.1 m-20 -99.07 24.53 7.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 75.109999999999999 110.854 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.537 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.14 -57.78 10.34 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.634 0.731 . . . . 73.099999999999994 111.142 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.4 Cg_endo -69.77 -20.53 34.68 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.721 2.281 . . . . 62.109999999999999 112.341 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.628 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.16 -53.12 10.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 75.230000000000004 110.926 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.05 -40.39 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 72.140000000000001 111.116 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -53.17 -33.69 45.81 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.774 -0.727 . . . . 51.43 112.481 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.0 -23.25 44.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.831 0.348 . . . . 72.310000000000002 110.911 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -76.57 -35.19 58.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 74.400000000000006 110.942 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.561 HD11 HD11 ' A' ' 74' ' ' LEU . 13.3 mt -52.28 -29.9 25.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 61.420000000000002 110.916 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -43.15 79.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 73.439999999999998 110.92 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.504 ' O ' HG22 ' A' ' 100' ' ' VAL . 62.8 t80 -75.37 -52.09 11.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 73.530000000000001 110.852 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.785 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.14 -29.76 33.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 55.210000000000001 111.169 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.9 mmt -66.83 -30.06 70.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 73.540000000000006 110.916 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.77 -30.07 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 72.140000000000001 111.122 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.785 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.89 -33.19 62.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 64.030000000000001 110.927 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.641 HG11 HD22 ' A' ' 70' ' ' LEU . 31.6 m -76.87 -38.1 28.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 71.109999999999999 111.131 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.41 ' O ' HG13 ' A' ' 107' ' ' VAL . 73.6 m -72.45 -40.39 67.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 62.310000000000002 111.151 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -64.11 -31.95 73.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 63.210000000000001 110.902 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.7 m -73.89 -33.77 64.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 64.0 110.892 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 30.4 mt -75.1 -50.94 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 71.530000000000001 111.142 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.557 ' O ' HG12 ' A' ' 110' ' ' VAL . 34.5 m -53.9 -33.98 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 55.340000000000003 111.124 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.4 m -52.48 -32.46 40.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 54.229999999999997 111.09 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 t -50.48 -31.49 15.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 73.420000000000002 110.851 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.5 p -52.5 -32.77 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 73.219999999999999 111.158 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 42.6 m -66.86 -49.04 66.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 53.240000000000002 110.884 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 67.8 t -70.16 -35.67 64.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 62.140000000000001 111.159 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.8 mt -72.08 -38.97 69.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 74.25 110.887 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -53.9 -31.33 49.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 70.109999999999999 110.885 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.78 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.7 p -102.31 -23.68 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 74.209999999999994 111.167 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -52.87 -51.07 62.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 55.439999999999998 110.873 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 62.43 110.868 179.998 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.535 -0.226 . . . . 74.129999999999995 112.535 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -83.43 -26.59 30.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.892 0.377 . . . . 64.030000000000001 110.917 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.1 m -64.47 -30.04 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 74.400000000000006 111.131 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.78 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -58.14 -25.09 61.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.530000000000001 111.071 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 38.8 mmt -53.02 -30.86 37.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 73.340000000000003 110.902 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 71.6 t -56.98 -58.59 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 71.299999999999997 111.127 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.8 mt -74.03 -37.79 47.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 73.329999999999998 111.099 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.98 -30.88 70.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 75.129999999999995 110.883 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.26 -28.74 29.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 71.409999999999997 110.888 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.52 -43.36 63.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 73.129999999999995 110.94 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -73.96 -52.48 12.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 74.319999999999993 110.888 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.515 HD13 ' CE2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -52.01 -32.09 32.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 54.130000000000003 110.903 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -67.3 -42.53 83.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 72.209999999999994 110.876 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.743 ' O ' HG23 ' A' ' 147' ' ' VAL . 69.6 mt -76.85 -32.22 19.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.416 . . . . 74.420000000000002 111.103 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -56.0 -56.99 14.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 61.310000000000002 110.871 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.5 m -54.94 -35.05 32.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 71.319999999999993 111.123 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -68.32 -33.03 73.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 54.350000000000001 110.888 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 143' ' ' ILE . 46.0 t -69.17 -34.0 61.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 73.129999999999995 111.146 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.48 -52.04 60.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 73.340000000000003 110.922 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.0 m -73.1 -35.41 47.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 74.129999999999995 111.149 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -52.46 -40.16 61.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 75.109999999999999 110.878 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -76.6 -20.3 76.81 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.71 -0.757 . . . . 65.209999999999994 112.499 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 35.0 m -72.08 -52.86 14.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.755 0.312 . . . . 73.209999999999994 111.172 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 19.7 mt -76.58 -24.82 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 72.030000000000001 111.098 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.35 -49.63 76.45 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.734 -0.745 . . . . 21.010000000000002 112.503 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -32.05 55.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.843 0.354 . . . . 74.430000000000007 110.893 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 14.7 t80 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 63.340000000000003 110.859 -179.927 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.84 0.267 . . . . 52.43 112.377 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 pp -53.37 -31.0 42.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 75.140000000000001 110.921 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -77.39 -30.2 53.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 71.099999999999994 110.902 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.458 ' HE1' HG22 ' A' ' 80' ' ' ILE . 0.6 OUTLIER -77.02 -44.46 30.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.15 -0.477 . . . . 74.409999999999997 110.932 -179.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -60.34 -40.06 89.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 64.510000000000005 111.129 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.431 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -71.83 -28.86 31.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 65.420000000000002 111.146 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.37 -26.58 68.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 70.439999999999998 110.921 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.617 HD13 HD22 ' A' ' 76' ' ' LEU . 1.0 OUTLIER -90.27 -24.44 20.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 60.32 110.899 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.8 mm -79.4 -29.41 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 70.140000000000001 111.121 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.65 -57.15 22.76 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.634 0.731 . . . . 72.349999999999994 111.123 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.3 Cg_endo -69.74 -19.69 35.88 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.696 2.264 . . . . 55.310000000000002 112.328 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.63 ' O ' HG22 ' A' ' 42' ' ' ILE . 47.5 t -76.04 -44.65 38.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 65.140000000000001 110.864 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 p -81.64 -28.89 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 52.310000000000002 111.128 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 mt -50.99 -33.94 26.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 75.230000000000004 110.943 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.63 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.72 -34.62 52.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 70.150000000000006 111.153 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 p -65.88 -41.53 91.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 74.329999999999998 111.105 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.8 t -52.92 -42.91 65.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 72.25 110.864 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.0 tp -76.71 -39.69 51.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 74.120000000000005 110.89 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.85 -51.35 70.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 64.420000000000002 111.082 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.436 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.4 mp -49.7 -31.46 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 71.239999999999995 111.09 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.74 -42.3 57.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 65.109999999999999 110.912 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.736 HG21 ' HA ' ' A' ' 59' ' ' LYS . 7.2 p -101.47 -37.52 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 74.400000000000006 111.093 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -63.61 -64.48 0.89 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 72.109999999999999 110.853 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.47 ' CG ' HD23 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -72.68 -56.06 5.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 73.239999999999995 110.978 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.5 mp -95.71 160.55 30.04 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.602 0.715 . . . . 72.430000000000007 110.898 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 141.24 44.44 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.617 2.211 . . . . 71.120000000000005 112.351 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.5 m -161.98 105.85 1.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 62.409999999999997 110.849 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.02 -170.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 74.540000000000006 110.838 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 78.8 m -110.9 -73.71 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 72.319999999999993 110.894 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.35 -26.81 72.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.744 -0.741 . . . . 60.240000000000002 112.514 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.08 -35.05 46.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.946 0.403 . . . . 74.319999999999993 110.877 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.736 ' HA ' HG21 ' A' ' 49' ' ' VAL . 2.2 ttpt -54.22 -51.42 64.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 73.430000000000007 110.938 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.459 ' O ' HG22 ' A' ' 64' ' ' ILE . 4.5 tpt -60.43 -51.31 70.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 73.239999999999995 110.917 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 30.0 p -54.8 -31.33 58.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 73.319999999999993 111.14 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -74.96 -41.34 59.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 74.219999999999999 110.926 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 81.5 m -66.84 -50.94 60.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 64.230000000000004 110.93 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 60' ' ' MET . 15.9 tt -62.27 -35.0 66.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 71.409999999999997 111.14 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.2 t -63.58 -27.08 69.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 75.239999999999995 110.874 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 62' ' ' LEU . 63.6 t -59.38 -39.37 78.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 65.150000000000006 111.124 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 tp -53.11 -29.03 28.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 75.25 110.879 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.501 ' O ' HD22 ' A' ' 68' ' ' LEU . 2.0 tm? -74.16 -46.81 39.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 60.049999999999997 110.888 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.76 -29.59 19.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 74.030000000000001 111.112 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.776 HD22 HG11 ' A' ' 102' ' ' VAL . 30.0 mt -58.04 -54.58 45.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 74.319999999999993 110.909 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 68' ' ' LEU . 1.1 t -63.12 -27.26 69.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 71.540000000000006 111.134 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.2 t -71.23 -32.94 49.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 72.310000000000002 111.107 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -52.08 -50.02 62.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 74.400000000000006 110.869 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.0 tp -61.54 -32.5 72.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 73.319999999999993 110.91 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 71' ' ' THR . 9.7 mp -73.04 -44.24 60.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.452 . . . . 71.129999999999995 110.941 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.617 HD22 HD13 ' A' ' 35' ' ' LEU . 1.2 tt -67.73 -50.22 58.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 63.32 110.912 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.473 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -57.43 -25.51 24.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 64.150000000000006 111.106 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.04 -18.58 49.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 65.109999999999999 110.904 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.744 ' O ' HG23 ' A' ' 81' ' ' VAL . 4.9 mmmt -69.07 -11.71 61.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 51.200000000000003 110.876 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.473 HG23 ' O ' ' A' ' 77' ' ' ILE . 1.4 pp -54.17 -26.33 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 71.230000000000004 111.097 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 79' ' ' LYS . 44.6 t 62.12 75.72 0.42 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.629 0.728 . . . . 74.430000000000007 111.149 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 167.61 23.91 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.646 2.231 . . . . 64.510000000000005 112.381 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -48.91 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.676 2.25 . . . . 40.299999999999997 112.361 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.42 HG23 ' HB2' ' A' ' 86' ' ' LEU . 11.8 t -133.1 13.29 4.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 70.439999999999998 111.175 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.1 m 51.55 65.23 1.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 74.340000000000003 110.882 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.42 ' HB2' HG23 ' A' ' 84' ' ' THR . 10.3 tp -117.19 25.93 10.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 54.0 110.899 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.639 ' HA ' HD23 ' A' ' 90' ' ' LEU . 1.5 m-20 -104.5 22.47 14.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 75.209999999999994 110.907 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.536 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -68.2 -57.94 8.31 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.649 0.738 . . . . 75.439999999999998 111.131 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.6 Cg_endo -69.72 -19.61 36.08 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.664 2.243 . . . . 73.400000000000006 112.385 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.639 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.15 -53.01 10.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 64.120000000000005 110.874 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.543 HG12 HD21 ' A' ' 95' ' ' LEU . 21.8 t -80.24 -23.79 11.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 73.540000000000006 111.146 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.68 -50.67 42.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.76 -0.733 . . . . 73.439999999999998 112.445 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.42 -35.06 78.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.757 0.313 . . . . 74.219999999999999 110.883 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -61.27 -42.46 98.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 75.299999999999997 110.943 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.543 HD21 HG12 ' A' ' 91' ' ' VAL . 7.7 mt -51.94 -29.83 22.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 65.030000000000001 110.938 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.0 mmt -67.77 -42.87 81.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 63.329999999999998 110.868 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.501 ' O ' HG22 ' A' ' 100' ' ' VAL . 62.2 t80 -75.24 -52.41 10.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 73.109999999999999 110.919 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.79 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.17 -29.77 33.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 70.239999999999995 111.185 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.2 mmt -66.86 -29.92 69.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.479 . . . . 70.049999999999997 110.883 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.84 -30.05 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 73.019999999999996 111.128 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.79 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -74.87 -33.38 62.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 62.310000000000002 110.918 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.776 HG11 HD22 ' A' ' 70' ' ' LEU . 30.4 m -76.89 -38.0 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 71.310000000000002 111.106 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.483 ' O ' HG13 ' A' ' 107' ' ' VAL . 63.2 m -72.44 -42.23 65.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 45.420000000000002 111.15 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -60.65 -31.96 71.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 63.439999999999998 110.929 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.1 t -75.08 -36.05 61.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 71.310000000000002 110.881 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 39.4 mt -74.87 -49.31 29.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.489 . . . . 74.049999999999997 111.16 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.547 ' O ' HG12 ' A' ' 110' ' ' VAL . 34.0 m -53.89 -33.91 24.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 75.420000000000002 111.158 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.8 m -52.34 -32.5 38.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 74.230000000000004 111.194 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.9 m -50.52 -31.48 15.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 73.299999999999997 110.856 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.5 p -52.41 -32.77 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 71.430000000000007 111.111 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 20.5 m -64.3 -42.81 96.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 64.5 110.943 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 75.7 t -78.07 -35.37 20.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 71.510000000000005 111.134 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.436 HD22 ' O ' ' A' ' 117' ' ' HIS . 85.4 mt -71.83 -30.99 66.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 72.439999999999998 110.901 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -60.15 -32.28 70.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 73.120000000000005 110.907 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.769 HG11 ' HB2' ' A' ' 133' ' ' ALA . 7.9 p -102.31 -24.67 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 70.409999999999997 111.136 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -89.1 -71.79 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 74.120000000000005 110.842 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.436 ' O ' HD22 ' A' ' 113' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 72.510000000000005 110.879 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.495 -0.242 . . . . 64.329999999999998 112.495 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -87.49 -26.86 22.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 75.5 110.88 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.6 m -64.96 -34.94 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 70.439999999999998 111.08 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.769 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -71.72 -25.01 61.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 73.120000000000005 111.077 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.42 ' HE1' ' CE1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -52.96 -31.1 38.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 72.340000000000003 110.872 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.6 t -56.94 -58.73 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 70.310000000000002 111.121 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.5 mp -73.99 -37.52 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 72.310000000000002 111.157 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -61.42 -29.97 70.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 71.219999999999999 110.819 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.0 -30.51 25.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.269 -0.423 . . . . 72.040000000000006 110.871 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.3 mt -71.76 -40.85 69.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 73.129999999999995 110.958 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -73.61 -53.06 11.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 72.099999999999994 110.92 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.47 HD23 ' CG ' ' A' ' 51' ' ' TYR . 4.8 mp -52.42 -32.02 37.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 75.340000000000003 110.851 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -61.37 -43.61 98.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.234 -0.439 . . . . 73.219999999999999 110.906 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.583 ' O ' HG23 ' A' ' 147' ' ' VAL . 68.2 mt -76.97 -33.49 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 74.140000000000001 111.152 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -56.36 -56.67 18.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 70.230000000000004 110.893 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 141' ' ' LEU . 28.2 t -55.2 -35.12 34.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 64.219999999999999 111.126 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.18 -32.99 74.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 73.140000000000001 110.852 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 143' ' ' ILE . 46.0 t -61.2 -51.78 69.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 61.5 111.09 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.1 m -52.05 -32.06 32.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 71.329999999999998 110.86 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.5 t -57.72 -50.89 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.229 -0.441 . . . . 75.409999999999997 111.101 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -72.06 -26.86 62.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 62.32 110.912 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -52.21 -58.98 9.48 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.715 -0.755 . . . . 64.510000000000005 112.468 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.5 t -60.82 -31.95 71.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.766 0.317 . . . . 75.310000000000002 111.119 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 43.9 mm -72.65 -24.94 21.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 72.140000000000001 111.151 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -65.65 -49.9 57.28 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.722 -0.751 . . . . 51.299999999999997 112.504 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.24 -32.01 43.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.781 0.324 . . . . 75.040000000000006 110.885 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 32.6 t80 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 74.519999999999996 110.83 -179.883 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.167 0 CA-C-O 120.853 0.272 . . . . 64.140000000000001 112.313 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.05 -30.96 65.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 64.209999999999994 110.961 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -78.34 -32.15 48.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 64.109999999999999 110.879 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.08 -45.01 59.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 75.239999999999995 110.927 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -60.53 -39.95 89.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 75.420000000000002 111.132 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.447 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.24 -29.12 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 63.5 111.117 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.95 -26.84 49.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 72.200000000000003 110.913 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.54 -19.22 23.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 73.409999999999997 110.917 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.426 ' O ' HG12 ' A' ' 40' ' ' VAL . 45.6 mm -76.6 -35.01 24.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 72.209999999999994 111.108 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.552 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.76 -57.15 23.07 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.574 0.702 . . . . 72.530000000000001 111.131 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.77 -22.12 32.49 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.645 2.23 . . . . 61.109999999999999 112.376 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.628 ' O ' HG22 ' A' ' 42' ' ' ILE . 45.9 t -76.04 -45.67 33.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 72.150000000000006 110.871 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 36' ' ' ILE . 9.1 p -81.53 -28.83 10.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 72.299999999999997 111.165 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mt -50.92 -34.01 26.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 73.209999999999994 110.89 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.628 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.72 -34.65 52.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 64.049999999999997 111.103 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.7 p -65.89 -35.29 80.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 71.310000000000002 111.121 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.73 -51.22 66.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 72.540000000000006 110.858 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 tp -70.64 -42.23 71.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 74.299999999999997 110.915 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.06 -48.76 75.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 64.209999999999994 111.094 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.449 HD11 ' CD2' ' A' ' 141' ' ' LEU . 0.9 OUTLIER -65.09 -32.25 57.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 61.43 111.093 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.561 ' O ' HD13 ' A' ' 52' ' ' LEU . 14.6 tp -51.62 -37.73 51.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 74.239999999999995 110.89 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -101.52 -35.95 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 74.310000000000002 111.144 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -66.44 -62.45 1.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 64.0 110.909 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.51 -43.44 75.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 74.120000000000005 110.919 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.561 HD13 ' O ' ' A' ' 48' ' ' LEU . 4.3 mp -54.45 160.63 2.49 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.617 0.722 . . . . 42.420000000000002 110.911 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 179.91 3.37 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.669 2.246 . . . . 73.5 112.334 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 62.99 162.04 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 52.200000000000003 110.864 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -179.18 84.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 75.329999999999998 110.85 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.7 m -80.64 -170.63 2.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 75.420000000000002 110.911 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.82 -27.17 27.91 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.709 -0.758 . . . . 32.32 112.463 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -57.1 -34.96 68.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.924 0.392 . . . . 75.409999999999997 110.894 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.24 -51.36 64.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 73.319999999999993 110.882 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.7 ttm -53.05 -51.96 60.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 71.409999999999997 110.896 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.2 p -60.93 -35.53 76.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 61.229999999999997 111.15 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.472 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.5 OUTLIER -65.87 -47.19 75.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.425 . . . . 65.120000000000005 110.939 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.426 ' HB3' HG23 ' A' ' 106' ' ' ILE . 75.6 m -57.73 -51.98 67.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 72.209999999999994 110.888 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.452 HG13 HD12 ' A' ' 67' ' ' LEU . 17.8 tt -66.54 -34.96 73.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 73.030000000000001 111.1 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.5 m -59.76 -25.08 64.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 73.310000000000002 110.832 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 62' ' ' LEU . 48.3 t -57.92 -38.02 64.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 71.129999999999995 111.12 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.452 HD12 HG13 ' A' ' 64' ' ' ILE . 5.8 mt -52.89 -28.9 25.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 63.399999999999999 110.894 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.485 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.63 -38.74 77.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 54.340000000000003 110.886 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.57 -30.07 70.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 73.230000000000004 111.137 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.793 HD22 HG11 ' A' ' 102' ' ' VAL . 9.4 mt -64.95 -54.72 26.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 70.030000000000001 110.954 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.72 -38.43 87.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.469 . . . . 55.43 111.139 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 68' ' ' LEU . 78.9 t -71.48 -32.82 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 72.420000000000002 111.135 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -51.59 -30.56 21.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 75.25 110.877 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.6 tp -75.02 -38.84 61.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 64.239999999999995 110.937 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.0 mp -73.26 -40.32 64.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 74.219999999999999 110.923 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.2 tt -65.05 -54.07 35.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 74.519999999999996 110.893 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.06 -23.59 18.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 73.129999999999995 111.143 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.5 m -80.26 -21.95 42.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 71.209999999999994 110.845 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.755 ' O ' HG23 ' A' ' 81' ' ' VAL . 25.3 mttt -59.81 -20.44 56.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.481 . . . . 74.150000000000006 110.849 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.7 pt -51.92 -29.06 10.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 73.329999999999998 111.156 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 79' ' ' LYS . 59.1 t 61.17 76.81 0.39 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.654 0.74 . . . . 70.150000000000006 111.162 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 167.47 24.29 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.666 2.244 . . . . 72.230000000000004 112.35 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -48.78 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.683 2.255 . . . . 64.310000000000002 112.324 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.0 t -117.23 -20.16 9.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 72.510000000000005 111.134 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.74 45.51 4.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 64.400000000000006 110.882 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 tp -95.73 25.8 4.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 73.109999999999999 110.897 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -102.94 23.72 11.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 73.140000000000001 110.886 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.532 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -66.74 -57.72 11.23 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.594 0.711 . . . . 65.510000000000005 111.128 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 54.0 Cg_endo -69.72 -37.32 9.43 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.741 2.294 . . . . 64.239999999999995 112.342 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.7 mp -53.95 -52.96 58.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 71.120000000000005 110.899 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.532 HG12 HD21 ' A' ' 95' ' ' LEU . 21.7 t -80.24 -26.37 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 70.140000000000001 111.089 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.72 -51.32 39.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 75.310000000000002 112.532 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.54 -35.39 80.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.813 0.339 . . . . 63.130000000000003 110.9 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -60.52 -38.2 83.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 74.319999999999993 110.946 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.532 HD21 HG12 ' A' ' 91' ' ' VAL . 9.2 mt -51.79 -29.75 20.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 54.420000000000002 110.923 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.04 -42.99 79.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 73.5 110.876 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.5 ' O ' HG22 ' A' ' 100' ' ' VAL . 57.8 t80 -75.25 -52.2 11.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 75.430000000000007 110.887 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.795 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.15 -29.88 33.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 63.130000000000003 111.131 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.6 mmt -66.66 -30.1 70.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 72.25 110.846 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.76 -30.05 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 64.109999999999999 111.135 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.795 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -74.97 -33.19 61.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 74.329999999999998 110.918 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.793 HG11 HD22 ' A' ' 70' ' ' LEU . 30.8 m -76.85 -37.94 28.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.510000000000005 111.158 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.444 ' O ' HG13 ' A' ' 107' ' ' VAL . 60.9 m -72.51 -41.9 65.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 65.129999999999995 111.135 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -60.91 -31.89 71.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 71.519999999999996 110.895 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.7 t -74.8 -35.52 62.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 43.039999999999999 110.868 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.426 HG23 ' HB3' ' A' ' 63' ' ' CYS . 40.7 mt -74.97 -49.65 27.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 74.430000000000007 111.124 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.555 ' O ' HG12 ' A' ' 110' ' ' VAL . 34.2 m -53.99 -33.86 24.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 63.350000000000001 111.143 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.5 m -52.44 -32.43 39.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 72.120000000000005 111.173 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.7 m -50.45 -31.59 15.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 74.439999999999998 110.87 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.7 p -52.6 -32.68 17.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 55.509999999999998 111.144 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 49.4 m -66.7 -47.05 73.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 71.040000000000006 110.848 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 88.4 t -72.35 -35.37 51.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 63.409999999999997 111.143 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 89.5 mt -72.08 -39.69 68.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 62.350000000000001 110.964 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -54.1 -30.67 49.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 61.43 110.879 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.8 HG11 ' HB2' ' A' ' 133' ' ' ALA . 9.4 p -102.32 -23.23 4.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 64.030000000000001 111.126 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -53.82 -61.61 2.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 75.150000000000006 110.839 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 74.329999999999998 110.844 -179.979 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.491 -0.244 . . . . 73.409999999999997 112.491 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -71.52 -26.8 62.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.94 0.4 . . . . 74.409999999999997 110.909 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.8 m -64.58 -27.01 41.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 74.109999999999999 111.142 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.8 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -56.23 -24.95 45.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 70.230000000000004 111.135 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.0 -30.9 38.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 75.109999999999999 110.871 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 58.9 t -56.99 -59.0 3.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 71.510000000000005 111.13 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.7 mt -74.05 -37.72 47.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 73.209999999999994 111.121 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -61.28 -29.96 70.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 72.5 110.827 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.37 -29.69 25.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 72.140000000000001 110.912 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.93 -50.41 23.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 73.349999999999994 110.929 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -66.37 -53.99 29.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 64.230000000000004 110.876 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.449 ' CD2' HD11 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -52.0 -32.23 32.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 53.43 110.937 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -71.74 -38.1 70.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 75.230000000000004 110.913 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.558 ' O ' HG23 ' A' ' 147' ' ' VAL . 55.9 mt -76.87 -32.03 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 61.329999999999998 111.132 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -56.11 -56.31 22.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 55.140000000000001 110.875 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.26 -34.99 45.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 74.400000000000006 111.153 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -59.64 -47.53 85.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 71.239999999999995 110.914 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 143' ' ' ILE . 91.8 t -69.38 -34.1 60.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 70.5 111.129 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.95 -51.47 56.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 53.409999999999997 110.916 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 40.8 t -75.87 -33.11 24.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 74.209999999999994 111.121 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.36 -42.99 83.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 72.239999999999995 110.896 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.02 -19.32 67.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 73.099999999999994 112.436 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 94.9 m -63.02 -51.94 64.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.756 0.312 . . . . 70.109999999999999 111.145 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 20.5 tt -55.94 -25.64 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 73.019999999999996 111.162 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -51.87 -49.54 47.75 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.707 -0.759 . . . . 62.420000000000002 112.524 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 1.3 mmt -61.82 -31.79 72.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.834 0.349 . . . . 53.509999999999998 110.916 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 73.219999999999999 110.886 -179.929 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.232 0.198 0 CA-C-O 120.785 0.244 . . . . 70.25 112.334 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 pp -53.31 -30.98 41.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 63.520000000000003 110.95 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -79.94 -29.34 39.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 71.25 110.865 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -77.07 -45.4 27.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.468 . . . . 74.150000000000006 110.938 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.2 t -59.45 -40.33 86.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 64.430000000000007 111.093 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.425 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -71.68 -28.84 32.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 73.219999999999999 111.123 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.37 -25.89 68.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 63.340000000000003 110.896 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.622 HD12 HD12 ' A' ' 77' ' ' ILE . 1.1 mm? -91.24 -23.08 20.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 75.340000000000003 110.872 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.6 mm -78.55 -31.2 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.447 . . . . 72.040000000000006 111.107 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.544 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.7 -57.16 22.82 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.615 0.721 . . . . 62.119999999999997 111.123 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 54.2 Cg_endo -69.76 -20.79 34.36 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.676 2.251 . . . . 61.119999999999997 112.378 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.64 ' O ' HG22 ' A' ' 42' ' ' ILE . 7.6 t -76.01 -43.27 45.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 63.32 110.876 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.61 -28.89 10.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 73.450000000000003 111.126 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 mt -50.97 -33.95 26.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 64.040000000000006 110.912 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.64 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.1 tp -58.8 -34.62 52.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 72.129999999999995 111.123 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.81 -38.62 89.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 71.420000000000002 111.177 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.6 m -53.04 -45.04 67.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 64.239999999999995 110.86 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.2 tp -76.93 -40.1 48.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 60.039999999999999 110.899 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.63 -38.34 74.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 73.310000000000002 111.091 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.446 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.3 mp -64.22 -31.98 55.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 63.119999999999997 111.142 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 tp -51.45 -38.74 55.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 63.509999999999998 110.896 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.8 p -101.47 -36.66 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 53.039999999999999 111.187 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -67.1 -64.65 0.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 74.420000000000002 110.876 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.546 ' CZ ' HD13 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -71.24 -25.94 62.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 74.099999999999994 110.9 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.1 mp -124.84 72.0 61.82 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.616 0.722 . . . . 73.540000000000006 110.961 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -173.0 0.64 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.651 2.234 . . . . 72.519999999999996 112.34 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.2 p -158.71 27.48 0.23 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 74.219999999999999 110.878 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 57.2 93.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 63.119999999999997 110.822 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.03 141.77 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 64.510000000000005 110.874 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.19 -22.97 45.55 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 52.530000000000001 112.469 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -52.06 -34.99 45.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 71.239999999999995 110.908 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.07 -37.47 61.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 74.120000000000005 110.914 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.19 -50.86 35.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 63.539999999999999 110.848 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.1 p -60.24 -29.3 68.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 73.230000000000004 111.121 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.55 -37.31 60.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.439 . . . . 74.430000000000007 110.893 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.506 ' O ' HG12 ' A' ' 66' ' ' VAL . 62.4 m -66.27 -44.86 82.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 54.439999999999998 110.929 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.6 tt -75.59 -33.14 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 51.329999999999998 111.149 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 t -51.74 -25.81 8.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 74.019999999999996 110.827 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.506 HG12 ' O ' ' A' ' 63' ' ' CYS . 8.9 p -57.08 -32.55 40.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 73.120000000000005 111.111 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.9 -28.93 25.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 70.209999999999994 110.925 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.497 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.25 -38.88 78.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 70.319999999999993 110.92 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.64 -30.03 70.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 65.209999999999994 111.054 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.819 HD22 HG11 ' A' ' 102' ' ' VAL . 9.2 mt -65.38 -54.63 26.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 65.340000000000003 110.94 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.59 -38.57 88.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 63.509999999999998 111.151 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 68' ' ' LEU . 83.4 t -71.56 -32.89 47.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 75.219999999999999 111.152 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.499 ' O ' HG22 ' A' ' 77' ' ' ILE . 18.4 t80 -52.0 -30.14 23.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 74.439999999999998 110.867 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.547 HD11 HD11 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -69.73 -45.93 67.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 74.5 110.937 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.7 mt -73.1 -34.14 65.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 72.319999999999993 110.906 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.43 -54.99 15.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 74.519999999999996 110.925 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.622 HD12 HD12 ' A' ' 35' ' ' LEU . 1.4 tt -61.45 -30.02 47.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 70.340000000000003 111.135 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.6 m -80.07 -23.71 41.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 62.340000000000003 110.862 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.706 ' O ' HG23 ' A' ' 81' ' ' VAL . 6.8 mtmt -66.8 -15.64 63.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 75.219999999999999 110.924 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.2 pp -56.08 -24.84 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 75.129999999999995 111.121 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 79' ' ' LYS . 23.3 t 63.52 75.42 0.4 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.57 0.7 . . . . 62.200000000000003 111.112 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 167.65 23.83 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.708 2.272 . . . . 64.329999999999998 112.363 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -22.13 32.52 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.649 2.233 . . . . 63.520000000000003 112.366 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.584 HG23 ' H ' ' A' ' 86' ' ' LEU . 7.9 t -95.24 -31.41 13.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 64.329999999999998 111.139 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 55.47 26.12 8.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 74.519999999999996 110.849 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.584 ' H ' HG23 ' A' ' 84' ' ' THR . 1.2 tp -141.84 51.89 1.51 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 71.140000000000001 110.918 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.633 ' HA ' HD23 ' A' ' 90' ' ' LEU . 1.9 m-20 -97.91 27.34 4.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 40.229999999999997 110.87 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.524 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.12 -57.75 10.42 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.607 0.717 . . . . 60.240000000000002 111.132 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.53 ' HG2' HD22 ' A' ' 90' ' ' LEU . 53.8 Cg_endo -69.83 -20.67 34.2 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.683 2.255 . . . . 73.150000000000006 112.289 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.633 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.19 -52.3 12.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 62.210000000000001 110.933 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.458 HG12 HD21 ' A' ' 95' ' ' LEU . 22.0 t -80.2 -22.81 11.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 72.5 111.096 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.65 -47.55 52.06 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.755 -0.736 . . . . 44.109999999999999 112.474 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -34.94 76.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.755 0.312 . . . . 75.430000000000007 110.859 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -60.62 -34.57 74.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.268 -0.423 . . . . 61.310000000000002 110.904 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.547 HD11 HD11 ' A' ' 74' ' ' LEU . 10.7 mt -51.7 -29.79 19.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 64.450000000000003 110.924 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -43.22 78.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 74.019999999999996 110.873 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.506 ' O ' HG22 ' A' ' 100' ' ' VAL . 30.3 t80 -75.27 -52.0 11.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 65.140000000000001 110.84 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.805 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.05 -29.94 32.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 71.0 111.137 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.5 mmt -66.41 -30.42 70.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 75.140000000000001 110.898 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.59 -29.94 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 70.420000000000002 111.139 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.805 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -75.26 -33.43 61.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 74.200000000000003 110.859 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.819 HG11 HD22 ' A' ' 70' ' ' LEU . 29.5 m -77.54 -39.51 27.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 64.450000000000003 111.14 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.666 ' HA ' HD12 ' A' ' 106' ' ' ILE . 2.5 t -72.58 -32.14 65.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 74.340000000000003 111.161 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -57.74 -33.89 68.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 74.219999999999999 110.88 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.4 t -74.95 -33.98 62.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 53.130000000000003 110.848 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.666 HD12 ' HA ' ' A' ' 103' ' ' THR . 7.4 mt -75.11 -50.56 24.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 62.229999999999997 111.138 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.544 ' O ' HG12 ' A' ' 110' ' ' VAL . 32.5 m -53.91 -35.73 28.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 70.450000000000003 111.149 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.6 m -52.61 -32.29 40.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 64.109999999999999 111.132 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 51.8 p -50.33 -31.56 14.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.43 . . . . 54.32 110.854 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.4 p -52.5 -32.75 17.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 73.129999999999995 111.123 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 44.1 m -67.08 -49.02 66.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 73.129999999999995 110.846 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 65.4 t -70.08 -35.49 64.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 72.530000000000001 111.109 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.1 mt -72.11 -41.09 67.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 71.209999999999994 110.928 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -51.94 -31.34 28.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 74.510000000000005 110.924 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.78 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.6 p -102.27 -23.97 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 70.310000000000002 111.135 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -53.18 -74.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 74.400000000000006 110.864 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 70.420000000000002 110.869 179.987 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.544 -0.222 . . . . 53.509999999999998 112.544 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -76.55 -37.47 56.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.947 0.403 . . . . 63.240000000000002 110.916 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.2 m -65.18 -34.7 72.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 72.200000000000003 111.097 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.78 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -68.33 -25.13 64.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 73.310000000000002 111.108 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 23.4 mmt -53.01 -30.96 38.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 74.340000000000003 110.894 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.0 -57.66 8.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 73.319999999999993 111.161 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.8 mm -74.01 -37.37 47.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.486 . . . . 62.25 111.157 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.82 -29.96 70.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 72.209999999999994 110.871 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -52.09 -30.2 25.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 75.349999999999994 110.87 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.2 tt -72.1 -50.38 28.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 71.099999999999994 110.931 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -63.03 -52.07 64.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 73.109999999999999 110.861 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.546 HD13 ' CZ ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -51.94 -35.16 45.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 74.510000000000005 110.917 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -60.81 -40.27 92.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 73.299999999999997 110.918 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.644 ' O ' HG23 ' A' ' 147' ' ' VAL . 45.6 mm -76.85 -31.98 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 70.400000000000006 111.166 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -56.02 -56.76 16.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.486 . . . . 64.409999999999997 110.906 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.6 m -56.67 -35.32 45.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 75.129999999999995 111.153 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.4 -34.1 77.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 74.519999999999996 110.879 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 143' ' ' ILE . 67.4 t -54.06 -35.93 30.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 64.329999999999998 111.146 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -52.82 -49.78 65.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 73.129999999999995 110.852 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.36 -33.04 57.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 71.209999999999994 111.125 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.19 -54.99 23.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 64.230000000000004 110.877 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.58 -19.48 71.0 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 64.549999999999997 112.484 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 32.7 m -55.95 -52.83 62.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.77 0.319 . . . . 63.439999999999998 111.123 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 29.8 mt -76.52 -27.99 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 73.329999999999998 111.126 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -53.71 -50.03 55.6 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.788 -0.72 . . . . 70.049999999999997 112.494 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -71.37 -31.99 67.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 75.519999999999996 110.844 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 27.6 t80 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 70.209999999999994 110.929 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.825 0.261 . . . . 73.230000000000004 112.344 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.0 pp -52.26 -31.02 30.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 65.349999999999994 110.926 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -80.86 -31.69 35.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 75.430000000000007 110.853 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.478 ' HB3' HD11 ' A' ' 86' ' ' LEU . 1.4 t80 -72.98 -46.27 53.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.127 -0.488 . . . . 74.219999999999999 110.956 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 t -59.57 -39.89 85.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.483 . . . . 73.209999999999994 111.133 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.16 -29.08 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 70.349999999999994 111.156 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.73 -27.5 50.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.152 -0.477 . . . . 65.430000000000007 110.863 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.89 -18.75 24.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 51.43 110.903 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.6 mm -76.76 -34.82 23.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 71.450000000000003 111.106 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.547 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.68 -57.17 22.76 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.575 0.702 . . . . 74.540000000000006 111.057 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.8 Cg_endo -69.78 -19.3 36.2 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.686 2.258 . . . . 71.040000000000006 112.347 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.63 ' O ' HG22 ' A' ' 42' ' ' ILE . 48.7 t -73.02 -43.91 61.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 71.129999999999995 110.881 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.53 -28.93 10.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 74.109999999999999 111.115 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.1 mt -50.96 -33.94 26.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 72.239999999999995 110.874 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.63 HG22 ' O ' ' A' ' 39' ' ' CYS . 0.7 OUTLIER -58.78 -34.71 52.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 53.350000000000001 111.095 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.82 -41.19 92.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 73.109999999999999 111.138 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.09 -43.16 66.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 71.120000000000005 110.867 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 tp -76.29 -39.74 53.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 72.219999999999999 110.904 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.66 -51.46 69.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 73.420000000000002 111.125 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.432 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.4 mp -49.8 -31.36 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 75.349999999999994 111.134 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.1 tp -50.83 -42.17 58.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 62.229999999999997 110.912 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.776 HG21 ' HA ' ' A' ' 59' ' ' LYS . 7.2 p -101.53 -37.38 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 74.420000000000002 111.151 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -63.77 -64.45 0.89 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 72.140000000000001 110.856 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.625 ' CE1' HD13 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -72.67 -62.05 1.59 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.457 . . . . 60.340000000000003 110.947 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 mp -67.83 160.64 72.52 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.633 0.73 . . . . 62.420000000000002 110.921 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 154.0 68.62 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.713 2.276 . . . . 74.140000000000001 112.329 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.554 ' HB3' HG23 ' A' ' 49' ' ' VAL . 1.5 t -175.79 65.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 71.439999999999998 110.835 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -62.23 95.03 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 74.140000000000001 110.819 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.2 145.82 0.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 74.140000000000001 110.871 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.19 -28.26 25.99 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.672 -0.775 . . . . 71.5 112.47 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -53.42 -34.95 59.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.951 0.405 . . . . 75.230000000000004 110.894 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.776 ' HA ' HG21 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -52.94 -51.97 59.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 63.399999999999999 110.863 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.67 -48.95 78.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 62.210000000000001 110.88 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.6 p -60.73 -34.16 74.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 74.319999999999993 111.154 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.4 mt -67.0 -51.07 59.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 75.510000000000005 110.903 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 79.6 m -53.79 -51.06 64.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 71.310000000000002 110.89 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.0 tt -68.86 -34.96 67.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 71.420000000000002 111.151 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.1 -29.91 23.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 63.520000000000003 110.84 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.22 -40.54 88.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 72.319999999999993 111.126 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.697 HD22 HD12 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -52.93 -28.96 25.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 75.329999999999998 110.921 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.484 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.08 -39.0 79.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 71.120000000000005 110.928 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.46 -30.03 70.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 71.140000000000001 111.087 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.697 HD12 HD22 ' A' ' 67' ' ' LEU . 8.6 mt -65.8 -54.78 22.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.263 -0.426 . . . . 74.420000000000002 110.893 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.14 -38.41 86.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 72.150000000000006 111.121 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 68' ' ' LEU . 80.5 t -71.38 -32.92 48.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 41.409999999999997 111.153 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -60.06 -29.79 68.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 73.430000000000007 110.896 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.642 ' HG ' HD13 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -63.21 -55.03 28.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 55.420000000000002 110.927 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.15 -31.93 64.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 63.240000000000002 110.905 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tt -60.96 -54.44 44.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 74.140000000000001 110.88 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 tt -66.15 -27.02 39.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 73.319999999999993 111.112 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.7 t -83.23 -14.75 52.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 73.409999999999997 110.812 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.745 ' O ' HG23 ' A' ' 81' ' ' VAL . 15.8 mttt -93.7 -9.76 36.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 73.519999999999996 110.878 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.487 HD11 HD22 ' A' ' 86' ' ' LEU . 10.5 pt -54.26 -28.22 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 71.25 111.158 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 79' ' ' LYS . 40.5 t 63.07 74.75 0.44 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.624 0.726 . . . . 73.439999999999998 111.127 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 166.34 27.94 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.682 2.255 . . . . 74.219999999999999 112.359 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -49.15 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.664 2.243 . . . . 75.209999999999994 112.354 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.1 t -115.93 -41.7 3.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 65.140000000000001 111.115 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.476 ' HB3' HG23 ' A' ' 88' ' ' VAL . 0.5 OUTLIER -179.61 -42.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 64.400000000000006 110.824 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.487 HD22 HD11 ' A' ' 80' ' ' ILE . 0.5 OUTLIER 63.56 70.48 0.52 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.139 -0.482 . . . . 73.310000000000002 110.922 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 91' ' ' VAL . 4.3 m-20 51.05 64.14 1.96 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 74.150000000000006 110.838 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.536 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -69.17 -58.09 6.61 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.645 0.736 . . . . 64.109999999999999 111.177 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.602 ' HG2' HD22 ' A' ' 90' ' ' LEU . 53.2 Cg_endo -69.83 -24.21 29.63 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.692 2.261 . . . . 64.040000000000006 112.301 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.602 HD22 ' HG2' ' A' ' 89' ' ' PRO . 3.3 mm? -74.21 -53.09 10.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 62.140000000000001 110.913 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 87' ' ' ASP . 97.6 t -65.07 -48.93 81.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 72.329999999999998 111.111 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.83 -46.58 54.67 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.773 -0.727 . . . . 63.450000000000003 112.446 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -72.08 -24.93 61.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.819 0.342 . . . . 73.219999999999999 110.909 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -71.21 -30.93 66.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 70.140000000000001 110.939 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.642 HD13 ' HG ' ' A' ' 74' ' ' LEU . 13.1 mt -54.83 -29.66 55.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 52.25 110.917 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.51 -42.41 71.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 70.439999999999998 110.849 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.502 ' O ' HG22 ' A' ' 100' ' ' VAL . 77.0 t80 -75.13 -51.16 14.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 75.120000000000005 110.866 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.798 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.04 -29.96 32.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 73.200000000000003 111.125 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.8 mmt -66.58 -30.11 70.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 60.32 110.867 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.82 -30.11 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.427 . . . . 71.400000000000006 111.118 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.798 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.97 -33.12 61.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 50.109999999999999 110.913 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.47 -37.64 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 70.239999999999995 111.143 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.731 ' O ' HG23 ' A' ' 107' ' ' VAL . 55.1 m -72.86 -46.47 52.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 73.340000000000003 111.134 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -52.59 -31.64 37.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 73.439999999999998 110.898 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 53.2 p -74.68 -49.0 22.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 72.409999999999997 110.85 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.639 HD12 ' HA ' ' A' ' 103' ' ' THR . 9.8 mt -55.77 -34.56 36.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 74.040000000000006 111.131 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 103' ' ' THR . 22.0 t -53.7 -45.78 61.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 74.430000000000007 111.159 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.1 m -52.38 -32.49 38.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.099 -0.501 . . . . 74.040000000000006 111.147 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.7 m -50.35 -31.39 14.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 74.450000000000003 110.855 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.7 p -52.44 -32.76 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 70.310000000000002 111.112 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 34.4 m -66.72 -47.04 73.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 55.130000000000003 110.88 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 82.8 t -72.4 -35.05 50.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 63.409999999999997 111.126 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 87.8 mt -72.04 -42.8 65.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 54.130000000000003 110.88 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -52.11 -30.3 25.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 71.030000000000001 110.917 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.813 HG11 ' HB2' ' A' ' 133' ' ' ALA . 9.9 p -102.22 -22.25 4.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.142 -0.481 . . . . 75.409999999999997 111.114 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -58.65 -71.72 0.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 70.430000000000007 110.84 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.439 . . . . 72.120000000000005 110.842 -179.937 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.443 -0.263 . . . . 62.210000000000001 112.443 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.51 ' CZ ' HG13 ' A' ' 132' ' ' VAL . 27.3 p90 -88.03 -30.34 20.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.926 0.393 . . . . 71.400000000000006 110.939 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.51 HG13 ' CZ ' ' A' ' 131' ' ' TYR . 19.8 m -73.94 -30.33 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 63.100000000000001 111.096 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.813 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -56.33 -24.94 47.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 53.409999999999997 111.111 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.96 -30.97 37.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 74.099999999999994 110.872 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 64.5 t -56.83 -62.33 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 70.510000000000005 111.158 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 41.8 mm -71.64 -38.15 65.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 74.430000000000007 111.104 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.437 ' OD2' HD11 ' A' ' 141' ' ' LEU . 25.8 t0 -60.65 -30.46 69.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 64.140000000000001 110.859 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.18 -25.74 48.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 63.439999999999998 110.824 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 7.6 tt -68.87 -50.93 45.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 62.409999999999997 110.925 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -73.97 -36.08 64.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 64.549999999999997 110.849 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.625 HD13 ' CE1' ' A' ' 51' ' ' TYR . 9.9 mt -52.21 -33.76 42.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 64.549999999999997 110.948 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -61.21 -48.38 81.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.451 . . . . 73.329999999999998 110.895 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.757 ' O ' HG23 ' A' ' 147' ' ' VAL . 39.0 mt -75.6 -31.98 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 54.539999999999999 111.128 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -56.0 -56.72 17.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 75.030000000000001 110.888 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 141' ' ' LEU . 22.8 t -57.65 -35.7 51.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 75.030000000000001 111.089 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -66.79 -32.98 74.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 75.549999999999997 110.892 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 143' ' ' ILE . 90.5 t -61.99 -34.0 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 72.209999999999994 111.151 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 49.7 m -63.24 -52.02 63.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 54.409999999999997 110.861 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.493 ' HB ' HD12 ' A' ' 153' ' ' ILE . 27.3 m -71.48 -35.56 57.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 72.430000000000007 111.119 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -67.45 -41.15 85.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 74.319999999999993 110.889 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.44 -33.25 39.76 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.754 -0.736 . . . . 71.530000000000001 112.485 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.7 m -76.48 -52.86 8.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.738 0.304 . . . . 71.140000000000001 111.141 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.493 HD12 ' HB ' ' A' ' 149' ' ' VAL . 7.9 mt -76.48 -24.5 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 72.129999999999995 111.185 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.01 -49.39 78.99 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.698 -0.763 . . . . 73.049999999999997 112.434 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -31.96 55.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.813 0.34 . . . . 55.340000000000003 110.853 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 20.4 t80 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 61.100000000000001 110.871 -179.958 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.188 0 CA-C-O 120.845 0.269 . . . . 62.119999999999997 112.335 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 pp -51.97 -30.88 26.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 54.450000000000003 110.873 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -79.28 -33.35 43.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 71.519999999999996 110.885 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -72.33 -46.44 55.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 75.140000000000001 110.913 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -59.78 -40.12 87.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 63.409999999999997 111.186 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.448 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.21 -29.06 21.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 75.049999999999997 111.149 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -55.66 -27.14 48.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 35.439999999999998 110.884 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.455 HD21 HG21 ' A' ' 80' ' ' ILE . 4.1 mm? -91.31 -18.74 23.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 73.310000000000002 110.913 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.41 ' O ' HG12 ' A' ' 40' ' ' VAL . 45.8 mm -76.43 -35.25 26.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 70.129999999999995 111.125 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.55 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.76 -57.14 23.16 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.626 0.727 . . . . 75.109999999999999 111.153 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.6 Cg_endo -69.75 -21.94 32.82 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.705 2.27 . . . . 75.430000000000007 112.306 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.618 ' O ' HG22 ' A' ' 42' ' ' ILE . 42.7 t -76.01 -45.59 33.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 61.200000000000003 110.9 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 36' ' ' ILE . 9.3 p -81.52 -28.91 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 73.019999999999996 111.149 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mt -51.02 -33.92 27.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 74.5 110.923 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.71 -34.68 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 64.230000000000004 111.103 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 p -65.69 -40.68 92.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 72.310000000000002 111.141 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.01 -44.38 67.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 75.409999999999997 110.9 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.9 tp -75.3 -40.41 58.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 73.340000000000003 110.949 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.97 -36.53 70.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 73.230000000000004 111.1 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.414 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.2 mp -64.93 -32.31 57.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 72.209999999999994 111.112 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 tp -55.28 -33.82 63.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 70.299999999999997 110.893 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.1 m -101.64 -36.66 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 72.019999999999996 111.138 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -71.7 -64.93 0.83 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 72.310000000000002 110.87 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.678 ' CZ ' HD13 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -69.46 -58.74 3.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.486 . . . . 75.430000000000007 110.903 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 mp -77.03 160.69 75.65 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.629 0.728 . . . . 74.439999999999998 110.873 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 146.69 61.07 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.722 2.281 . . . . 64.109999999999999 112.329 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -178.22 74.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 65.140000000000001 110.841 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 53.91 -172.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.154 -0.475 . . . . 64.209999999999994 110.861 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 95.5 m -120.45 -54.8 2.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 72.549999999999997 110.904 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.32 -57.43 13.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.743 . . . . 73.439999999999998 112.502 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -52.08 -34.97 46.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.361 . . . . 65.329999999999998 110.846 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.97 -48.21 67.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 74.340000000000003 110.92 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 29.4 ttm -62.34 -52.06 65.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 74.25 110.866 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.7 p -58.02 -27.06 63.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 63.340000000000003 111.107 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.648 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -75.87 -34.19 60.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.29 -0.413 . . . . 73.209999999999994 110.886 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 90.2 m -70.96 -51.89 23.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 54.119999999999997 110.845 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 15.8 tt -63.24 -35.29 71.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 65.329999999999998 111.134 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.5 t -63.54 -25.46 68.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 74.329999999999998 110.847 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 62' ' ' LEU . 83.6 t -57.95 -36.15 54.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 62.140000000000001 111.08 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.87 -28.83 24.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 73.310000000000002 110.926 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.493 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.24 -38.98 78.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 73.340000000000003 110.924 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.56 -29.95 70.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 54.340000000000003 111.136 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.607 HD13 HG11 ' A' ' 102' ' ' VAL . 9.4 mt -65.16 -54.71 25.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 73.319999999999993 110.945 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.7 -38.56 88.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 74.120000000000005 111.149 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 68' ' ' LEU . 82.2 t -71.5 -32.91 47.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 74.120000000000005 111.105 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.446 ' O ' HG22 ' A' ' 77' ' ' ILE . 28.0 t80 -51.86 -30.55 24.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 70.209999999999994 110.859 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.624 HD11 HD11 ' A' ' 95' ' ' LEU . 0.3 OUTLIER -75.02 -39.24 61.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 74.329999999999998 110.892 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.07 -39.38 65.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 72.340000000000003 110.901 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.4 tt -66.46 -55.06 17.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 72.129999999999995 110.918 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 73' ' ' PHE . 1.1 tt -57.04 -30.6 34.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 73.430000000000007 111.13 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.5 t -80.22 -23.36 40.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 74.030000000000001 110.83 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.685 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.4 OUTLIER -69.63 -12.9 62.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 72.319999999999993 110.895 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.455 HG21 HD21 ' A' ' 35' ' ' LEU . 2.2 pp -56.41 -24.53 18.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 75.209999999999994 111.088 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 79' ' ' LYS . 21.8 t 63.68 75.21 0.4 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.649 0.737 . . . . 60.520000000000003 111.173 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 167.55 24.2 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.638 2.226 . . . . 60.520000000000003 112.352 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -48.63 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.694 2.263 . . . . 61.530000000000001 112.356 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.4 t -117.22 -19.88 9.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 70.019999999999996 111.07 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.76 47.02 3.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 72.540000000000006 110.858 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 tp -99.27 26.05 6.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 71.219999999999999 110.91 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.631 ' HA ' HD23 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -99.91 23.68 9.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 74.519999999999996 110.845 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.542 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.74 -57.79 9.32 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.66 0.743 . . . . 71.049999999999997 111.152 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.7 Cg_endo -69.81 -20.0 35.18 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.664 2.243 . . . . 72.519999999999996 112.35 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.631 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.19 -53.09 10.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 63.43 110.911 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.519 HG12 HD21 ' A' ' 95' ' ' LEU . 24.9 t -80.68 -33.69 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 70.219999999999999 111.125 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.82 -52.21 35.63 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.734 -0.746 . . . . 75.030000000000001 112.466 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -35.35 80.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 73.409999999999997 110.882 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -60.32 -36.98 79.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.438 . . . . 75.099999999999994 110.923 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.624 HD11 HD11 ' A' ' 74' ' ' LEU . 9.5 mt -51.91 -29.75 21.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 75.030000000000001 110.915 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 4.1 mmt -67.67 -42.86 81.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 73.430000000000007 110.921 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.501 ' O ' HG22 ' A' ' 100' ' ' VAL . 4.4 t80 -75.29 -52.47 10.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 61.200000000000003 110.849 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.785 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.1 -29.87 33.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 75.109999999999999 111.135 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.71 -30.08 70.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 73.340000000000003 110.913 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.73 -30.05 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 73.450000000000003 111.103 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.785 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -74.96 -33.25 61.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 54.25 110.893 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.607 HG11 HD13 ' A' ' 70' ' ' LEU . 31.1 m -76.93 -37.96 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 72.239999999999995 111.095 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.603 ' HA ' HD12 ' A' ' 106' ' ' ILE . 61.3 m -72.45 -41.37 66.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 72.400000000000006 111.116 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -61.67 -32.02 72.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 72.329999999999998 110.873 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -32.58 69.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 63.329999999999998 110.843 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' A' ' 103' ' ' THR . 12.3 mt -74.41 -51.77 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 74.310000000000002 111.165 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.558 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.3 p -53.95 -33.93 24.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 73.310000000000002 111.158 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 91.8 m -52.36 -32.4 38.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 63.439999999999998 111.131 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.34 -31.74 15.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 74.120000000000005 110.874 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.5 p -52.72 -32.83 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.492 . . . . 62.439999999999998 111.114 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 47.5 m -65.23 -43.53 91.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 64.230000000000004 110.881 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.5 t -76.82 -35.77 24.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 71.439999999999998 111.161 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.3 mt -72.14 -31.13 65.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 75.109999999999999 110.882 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -64.73 -29.46 70.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 64.230000000000004 110.87 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.76 HG11 ' HB2' ' A' ' 133' ' ' ALA . 10.8 p -102.24 -20.91 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 73.120000000000005 111.102 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -79.18 -74.55 0.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 72.140000000000001 110.853 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 74.409999999999997 110.876 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.391 0 N-CA-C 112.523 -0.231 . . . . 74.340000000000003 112.523 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -71.43 -26.93 62.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.897 0.379 . . . . 71.409999999999997 110.915 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.62 ' O ' HG22 ' A' ' 135' ' ' VAL . 34.8 m -55.8 -26.96 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 52.539999999999999 111.139 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.76 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -55.99 -24.84 41.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 61.200000000000003 111.069 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.1 mtt -52.66 -31.0 34.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 63.32 110.889 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 132' ' ' VAL . 17.7 m -59.55 -30.55 44.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 74.219999999999999 111.156 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 28.2 mt -74.15 -47.38 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 73.319999999999993 111.163 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -69.66 -29.95 67.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 65.310000000000002 110.839 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.1 mtm-85 -55.87 -25.64 43.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 71.530000000000001 110.838 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.6 mt -71.02 -50.99 28.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 60.329999999999998 110.887 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -73.82 -27.13 60.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 55.32 110.853 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.678 HD13 ' CZ ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -51.93 -36.8 50.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.17 -0.468 . . . . 65.010000000000005 110.884 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -53.03 -52.01 59.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 63.329999999999998 110.905 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.735 ' O ' HG23 ' A' ' 147' ' ' VAL . 3.4 mt -77.02 -37.74 26.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 72.109999999999999 111.17 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -56.01 -56.96 14.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 73.109999999999999 110.915 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 141' ' ' LEU . 42.7 t -56.67 -34.97 43.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 73.439999999999998 111.165 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -68.48 -34.95 76.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 75.439999999999998 110.882 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 143' ' ' ILE . 93.5 t -55.58 -41.62 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 73.310000000000002 111.133 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 98.6 m -52.02 -48.23 64.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 74.340000000000003 110.9 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.461 ' O ' HG22 ' A' ' 153' ' ' ILE . 43.6 t -75.69 -36.9 34.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 54.130000000000003 111.122 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.31 -26.85 61.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 75.200000000000003 110.903 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.15 -59.07 2.48 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.696 -0.764 . . . . 50.109999999999999 112.455 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 4.6 t -55.3 -41.78 72.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.741 0.305 . . . . 22.440000000000001 111.092 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.461 HG22 ' O ' ' A' ' 149' ' ' VAL . 18.7 tt -63.06 -26.29 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 74.420000000000002 111.141 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -51.98 -49.82 47.36 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.767 -0.73 . . . . 63.409999999999997 112.47 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 22.7 mmt -71.57 -31.9 67.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.828 0.347 . . . . 74.409999999999997 110.878 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 72.340000000000003 110.903 -179.959 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo . . . . . 0 C--O 1.232 0.188 0 CA-C-O 120.883 0.285 . . . . 64.340000000000003 112.376 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.92 -30.94 65.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 74.310000000000002 110.873 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -78.18 -31.84 49.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 74.200000000000003 110.84 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.668 ' CE1' HG22 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -73.66 -44.91 55.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 74.510000000000005 110.926 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.6 t -60.56 -39.78 89.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 53.130000000000003 111.14 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.12 -29.12 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 74.010000000000005 111.118 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.13 -27.05 52.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 55.210000000000001 110.909 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.522 ' CD1' HD22 ' A' ' 76' ' ' LEU . 4.1 mm? -91.25 -19.28 23.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 70.239999999999995 110.925 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.3 mm -76.84 -34.58 22.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 63.119999999999997 111.118 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.551 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.75 -57.18 22.9 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.629 0.728 . . . . 74.120000000000005 111.112 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.8 Cg_endo -69.74 -20.47 34.9 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.663 2.242 . . . . 60.130000000000003 112.356 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.631 ' O ' HG22 ' A' ' 42' ' ' ILE . 49.3 t -75.94 -44.42 40.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 61.329999999999998 110.87 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.2 p -81.57 -28.93 10.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 73.010000000000005 111.104 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.5 mt -50.99 -33.94 26.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 75.230000000000004 110.917 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.631 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.74 -34.69 52.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 64.329999999999998 111.1 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.82 -36.79 84.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 71.209999999999994 111.121 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.07 -52.65 60.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 71.510000000000005 110.862 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.1 tp -68.91 -40.51 79.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 73.239999999999995 110.922 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.93 -51.38 69.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 70.239999999999995 111.101 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.13 -31.85 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 74.25 111.141 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.558 ' O ' HD13 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -51.68 -38.1 53.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 73.239999999999995 110.926 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.7 p -101.6 -37.17 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 74.340000000000003 111.175 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -67.43 -63.28 1.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 71.209999999999994 110.86 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.39 -26.01 38.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 75.420000000000002 110.946 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 48' ' ' LEU . 4.2 mp -76.78 160.65 76.29 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.596 0.712 . . . . 54.530000000000001 110.907 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 78.84 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.704 2.27 . . . . 73.019999999999996 112.339 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.7 t -165.8 151.69 9.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 54.520000000000003 110.848 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -161.16 26.14 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 74.310000000000002 110.85 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 30.3 p -65.97 -170.24 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 54.210000000000001 110.86 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.99 -43.73 72.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.723 -0.751 . . . . 64.200000000000003 112.488 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -53.04 -41.27 64.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.93 0.395 . . . . 72.040000000000006 110.929 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -59.28 -45.21 91.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 73.510000000000005 110.894 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 33.4 ttm -63.92 -51.68 63.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 53.229999999999997 110.902 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 80.8 p -54.08 -34.82 61.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 71.519999999999996 111.135 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.533 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -65.64 -50.33 65.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 74.310000000000002 110.921 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 59.4 m -53.87 -51.96 62.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 62.030000000000001 110.886 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.6 tt -67.37 -35.06 72.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 73.329999999999998 111.095 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 m -60.26 -26.01 66.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 75.019999999999996 110.911 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 62' ' ' LEU . 41.6 t -57.97 -38.52 67.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 51.340000000000003 111.139 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.88 -28.9 25.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 71.200000000000003 110.913 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.493 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.03 -39.34 79.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 74.040000000000006 110.945 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.27 -29.98 70.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 74.5 111.081 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.529 HD22 HG11 ' A' ' 102' ' ' VAL . 10.1 mt -64.82 -54.74 26.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 62.039999999999999 110.908 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.97 -38.08 87.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 63.409999999999997 111.127 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 68' ' ' LEU . 75.0 t -71.45 -32.91 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 54.420000000000002 111.094 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -60.13 -29.88 68.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 75.409999999999997 110.901 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.568 HD11 HD13 ' A' ' 95' ' ' LEU . 1.7 tt -73.25 -44.17 59.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.124 -0.489 . . . . 74.450000000000003 110.89 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.4 mt -73.35 -33.04 64.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 72.120000000000005 110.918 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.545 HD23 ' HD2' ' A' ' 79' ' ' LYS . 1.6 tt -68.87 -55.14 12.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 73.319999999999993 110.882 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.442 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.6 OUTLIER -56.93 -23.38 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 74.25 111.16 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.5 t -70.03 -14.69 62.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 71.420000000000002 110.882 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.745 ' O ' HG23 ' A' ' 81' ' ' VAL . 12.6 ptmt -62.17 -17.04 56.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 53.530000000000001 110.893 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.668 HG22 ' CE1' ' A' ' 31' ' ' TYR . 24.7 pt -50.37 -31.4 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 75.349999999999994 111.099 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 79' ' ' LYS . 66.7 t 56.73 80.33 0.29 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.635 0.731 . . . . 63.420000000000002 111.137 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 166.8 26.3 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.735 2.29 . . . . 75.310000000000002 112.358 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -49.14 0.59 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.658 2.239 . . . . 74.049999999999997 112.374 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.1 t -135.67 22.2 3.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 63.340000000000003 111.153 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.7 t 52.17 48.57 22.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 64.200000000000003 110.856 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tp -95.55 24.65 5.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 61.219999999999999 110.915 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.635 ' HA ' HD23 ' A' ' 90' ' ' LEU . 3.3 m-20 -110.92 25.85 11.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 73.230000000000004 110.894 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.533 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.03 -57.82 10.45 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.664 0.745 . . . . 72.129999999999995 111.092 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.539 ' HG2' HD22 ' A' ' 90' ' ' LEU . 53.9 Cg_endo -69.72 -20.59 34.84 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.661 2.241 . . . . 63.539999999999999 112.392 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.635 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.19 -53.07 10.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 74.099999999999994 110.978 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.07 -36.54 16.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 74.540000000000006 111.096 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.21 -40.43 52.35 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.768 -0.729 . . . . 61.149999999999999 112.475 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -67.66 -24.6 65.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 65.209999999999994 110.865 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -78.04 -44.3 26.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 75.340000000000003 110.971 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.568 HD13 HD11 ' A' ' 74' ' ' LEU . 10.0 mt -55.45 -29.72 59.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 73.140000000000001 110.923 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.38 -43.26 77.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 74.239999999999995 110.847 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.503 ' O ' HG22 ' A' ' 100' ' ' VAL . 39.1 t80 -75.29 -51.85 12.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 75.319999999999993 110.941 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.776 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.12 -29.87 33.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 72.200000000000003 111.165 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.1 mmt -66.69 -30.11 70.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 73.109999999999999 110.875 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.76 -30.09 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 75.049999999999997 111.116 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.776 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.89 -33.27 62.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 75.430000000000007 110.884 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.529 HG11 HD22 ' A' ' 70' ' ' LEU . 31.1 m -76.87 -38.1 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 63.350000000000001 111.159 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 73.9 m -72.46 -39.77 67.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 53.240000000000002 111.143 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -64.87 -31.99 73.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 73.510000000000005 110.843 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.9 t -72.57 -35.25 67.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 60.210000000000001 110.857 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 36.8 mt -72.55 -51.36 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 72.420000000000002 111.099 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.549 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.5 p -53.97 -36.41 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 74.540000000000006 111.097 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 94.7 m -52.42 -32.4 39.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 74.310000000000002 111.099 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.9 p -50.44 -31.4 14.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 55.539999999999999 110.826 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.4 p -52.45 -32.82 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 63.219999999999999 111.106 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 31.0 m -65.81 -43.17 89.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 73.409999999999997 110.895 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.8 t -77.02 -35.45 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 74.439999999999998 111.145 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 87.5 mt -71.99 -32.98 67.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 74.109999999999999 110.906 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -59.71 -31.24 69.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 65.400000000000006 110.881 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.769 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.7 p -102.29 -23.96 4.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 74.510000000000005 111.135 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -77.04 -26.17 53.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 71.439999999999998 110.833 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 75.310000000000002 110.827 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.524 -0.23 . . . . 32.420000000000002 112.524 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -86.37 -26.79 24.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 70.019999999999996 110.882 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.6 m -54.4 -26.91 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 71.409999999999997 111.124 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.769 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -55.22 -26.04 36.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 54.229999999999997 111.066 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 6.4 ptm -52.99 -30.94 38.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 74.439999999999998 110.89 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 62.8 t -56.96 -58.95 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 72.230000000000004 111.092 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.8 mt -73.96 -37.78 48.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 71.319999999999993 111.14 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -61.25 -30.01 70.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 62.210000000000001 110.851 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.01 -29.02 26.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 61.420000000000002 110.9 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.52 -48.3 70.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 72.319999999999993 110.925 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -73.69 -41.77 62.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 42.450000000000003 110.824 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.615 ' O ' HG23 ' A' ' 145' ' ' VAL . 0.4 OUTLIER -52.07 -32.7 35.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 54.450000000000003 110.933 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 23.7 m0 -61.85 -51.98 65.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 54.43 110.906 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.681 ' O ' HG23 ' A' ' 147' ' ' VAL . 66.6 mt -71.21 -32.05 46.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 55.43 111.175 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -56.33 -40.76 74.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 65.340000000000003 110.858 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 141' ' ' LEU . 21.8 t -73.63 -44.97 52.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 72.019999999999996 111.101 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.4 -40.73 62.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 72.219999999999999 110.851 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 143' ' ' ILE . 65.5 t -54.34 -33.96 27.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 60.409999999999997 111.119 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 72.0 m -52.06 -51.96 54.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.191 -0.459 . . . . 54.25 110.871 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.91 -33.7 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 72.010000000000005 111.143 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -52.38 -40.57 62.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 74.109999999999999 110.902 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.76 -44.24 8.52 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.771 -0.728 . . . . 72.349999999999994 112.506 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 35.1 m -51.85 -52.85 46.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 51.32 111.163 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 47.5 mm -76.52 -24.92 16.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 52.43 111.16 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -53.92 -49.9 56.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 74.439999999999998 112.513 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -31.95 73.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.825 0.345 . . . . 64.340000000000003 110.894 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 23.1 t80 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 65.040000000000006 110.881 -179.971 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.839 0.266 . . . . 72.329999999999998 112.343 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 pp -52.06 -30.91 27.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 71.5 110.92 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -79.08 -33.17 44.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 61.020000000000003 110.9 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.45 -46.0 56.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 74.409999999999997 110.938 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -60.03 -39.97 87.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 71.140000000000001 111.182 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.442 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.24 -29.05 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 53.020000000000003 111.132 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.87 -27.19 50.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 72.129999999999995 110.89 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.23 -19.14 23.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 64.219999999999999 110.894 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.52 HD12 HG23 ' A' ' 152' ' ' THR . 45.7 mm -76.77 -34.73 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 62.119999999999997 111.138 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.545 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.7 -57.15 22.91 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.62 0.724 . . . . 73.409999999999997 111.09 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.9 Cg_endo -69.73 -22.83 31.68 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.655 2.237 . . . . 50.210000000000001 112.377 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.627 ' O ' HG22 ' A' ' 42' ' ' ILE . 49.6 t -76.08 -46.49 28.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 72.349999999999994 110.825 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 36' ' ' ILE . 8.7 p -81.6 -28.78 10.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 72.25 111.117 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.6 mt -50.93 -33.99 26.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 72.230000000000004 110.932 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.627 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.68 -34.71 52.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 71.140000000000001 111.119 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.7 p -66.04 -38.55 88.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 74.530000000000001 111.147 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.8 m -52.92 -53.77 44.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.229 -0.442 . . . . 75.439999999999998 110.897 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tp -67.55 -39.47 84.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 52.420000000000002 110.954 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.99 74.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 43.329999999999998 111.142 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.422 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.3 mp -64.93 -32.47 58.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 72.230000000000004 111.104 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.6 tp -53.76 -34.61 59.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 75.140000000000001 110.887 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.585 HG23 ' HB2' ' A' ' 55' ' ' ASP . 7.1 p -102.26 -36.59 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 74.439999999999998 111.145 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.48 -64.92 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 74.540000000000006 110.891 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.629 ' CD2' HD22 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -69.27 -62.3 1.44 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.099 -0.5 . . . . 74.019999999999996 110.956 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.6 mp -63.47 160.09 45.54 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.587 0.708 . . . . 61.240000000000002 110.932 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -168.54 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.687 2.258 . . . . 73.519999999999996 112.349 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.88 154.53 0.07 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 72.510000000000005 110.856 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.585 ' HB2' HG23 ' A' ' 49' ' ' VAL . 43.8 m-20 53.01 88.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 73.129999999999995 110.813 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 94.5 m -88.71 -69.61 0.7 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 62.240000000000002 110.831 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.95 -32.0 59.0 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.708 -0.758 . . . . 41.32 112.493 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -51.97 -34.97 44.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.9 0.381 . . . . 75.409999999999997 110.924 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -52.98 -48.79 67.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 73.030000000000001 110.906 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.4 ttm -57.83 -51.78 68.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 75.099999999999994 110.892 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.4 p -61.95 -28.34 69.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 64.010000000000005 111.111 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.747 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -75.81 -50.78 14.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 74.239999999999995 110.931 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 71.4 m -52.96 -42.19 65.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 73.329999999999998 110.895 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.7 tt -73.37 -34.95 44.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 51.200000000000003 111.127 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.9 t -69.14 -25.85 64.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 71.319999999999993 110.841 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 62' ' ' LEU . 99.5 t -57.95 -34.6 49.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 72.420000000000002 111.12 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -52.89 -28.91 25.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 71.420000000000002 110.891 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.493 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.37 -38.92 78.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 72.200000000000003 110.95 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.6 -29.94 70.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 72.5 111.105 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.766 HD22 HG11 ' A' ' 102' ' ' VAL . 9.5 mt -65.08 -54.79 24.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 72.109999999999999 110.86 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.71 -38.38 87.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 74.25 111.173 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 68' ' ' LEU . 79.3 t -71.48 -32.83 47.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 55.109999999999999 111.109 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -51.94 -30.0 22.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 74.420000000000002 110.855 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.08 -41.71 61.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 74.450000000000003 110.88 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.9 mt -73.2 -34.78 66.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 70.530000000000001 110.91 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.443 HD13 ' HD2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -69.31 -55.09 11.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 74.319999999999993 110.885 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.6 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -56.19 -25.0 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 52.109999999999999 111.117 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.6 -14.9 63.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 63.119999999999997 110.851 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.757 ' O ' HG23 ' A' ' 81' ' ' VAL . 2.2 ptmm? -59.23 -20.76 56.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 72.25 110.884 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 77' ' ' ILE . 36.8 pt -51.55 -29.38 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 74.319999999999993 111.108 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 79' ' ' LYS . 60.2 t 60.87 77.54 0.36 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.589 0.709 . . . . 55.200000000000003 111.112 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 167.57 24.06 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.714 2.276 . . . . 75.310000000000002 112.356 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -48.76 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.657 2.238 . . . . 71.540000000000006 112.33 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.5 t -131.73 9.89 4.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 73.420000000000002 111.179 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.73 52.74 13.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 61.409999999999997 110.82 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.89 25.65 4.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 73.25 110.91 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.636 ' HA ' HD23 ' A' ' 90' ' ' LEU . 1.5 m-20 -104.3 23.71 12.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 75.439999999999998 110.87 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.542 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.37 -57.84 9.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.63 0.728 . . . . 63.030000000000001 111.133 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.3 Cg_endo -69.75 -20.35 35.01 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.716 2.277 . . . . 73.239999999999995 112.337 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.636 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.17 -53.02 10.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 72.219999999999999 110.937 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.573 HG12 HD21 ' A' ' 95' ' ' LEU . 24.6 t -80.75 -32.87 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 70.140000000000001 111.114 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.72 -52.1 35.69 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.707 -0.759 . . . . 55.549999999999997 112.476 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -35.01 79.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.778 0.323 . . . . 75.129999999999995 110.883 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -61.22 -36.61 80.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 75.129999999999995 110.906 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.573 HD21 HG12 ' A' ' 91' ' ' VAL . 9.2 mt -51.82 -29.87 21.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 71.25 110.924 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -69.25 -43.63 73.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 75.040000000000006 110.864 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.506 ' O ' HG22 ' A' ' 100' ' ' VAL . 72.4 t80 -75.26 -51.26 13.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 75.140000000000001 110.867 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.808 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.05 -29.86 32.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 74.420000000000002 111.157 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.8 mmt -66.6 -30.24 70.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 71.439999999999998 110.859 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.67 -29.97 13.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 61.229999999999997 111.097 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.808 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -75.23 -33.49 61.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 72.109999999999999 110.903 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.766 HG11 HD22 ' A' ' 70' ' ' LEU . 29.3 m -77.53 -39.65 27.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 74.519999999999996 111.104 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.719 ' HA ' HD12 ' A' ' 106' ' ' ILE . 2.9 t -72.55 -32.3 65.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 70.329999999999998 111.082 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -56.83 -35.14 68.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 62.219999999999999 110.861 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.4 t -75.02 -32.59 61.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 73.120000000000005 110.882 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.719 HD12 ' HA ' ' A' ' 103' ' ' THR . 9.3 mt -75.16 -51.3 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 71.319999999999993 111.092 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.542 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.5 p -53.99 -35.87 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 75.430000000000007 111.101 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.7 m -52.42 -32.36 38.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 74.319999999999993 111.135 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.2 t -50.33 -31.58 14.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 74.450000000000003 110.822 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.2 p -52.5 -32.77 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 71.409999999999997 111.124 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 35.5 m -66.2 -47.55 73.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 52.200000000000003 110.915 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.2 t -72.1 -36.09 55.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.475 . . . . 75.230000000000004 111.137 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.5 mt -72.04 -33.31 67.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 75.329999999999998 110.927 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -59.82 -30.72 69.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 74.400000000000006 110.906 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.777 HG11 ' HB2' ' A' ' 133' ' ' ALA . 9.4 p -102.26 -23.83 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 73.329999999999998 111.15 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 -85.44 -70.37 0.59 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 64.349999999999994 110.858 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.1 t60 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 73.230000000000004 110.869 179.965 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.478 -0.249 . . . . 75.5 112.478 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -87.89 -26.07 22.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.964 0.412 . . . . 73.420000000000002 110.947 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.3 m -54.35 -26.93 16.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.077 -0.511 . . . . 75.329999999999998 111.083 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.777 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -55.96 -25.05 41.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 73.319999999999993 111.091 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.94 -30.84 36.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 70.129999999999995 110.912 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 91.5 t -57.09 -59.31 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 75.450000000000003 111.08 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 65.1 mt -73.97 -35.26 41.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 73.140000000000001 111.137 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -62.98 -30.16 71.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 54.140000000000001 110.843 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -53.78 -28.23 33.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 61.240000000000002 110.881 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.8 mp -67.36 -48.91 66.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 73.120000000000005 110.888 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -73.67 -47.47 39.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 73.319999999999993 110.892 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.629 HD22 ' CD2' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -51.92 -49.74 62.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.483 . . . . 61.329999999999998 110.944 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -53.22 -32.3 47.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 75.420000000000002 110.94 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.697 ' O ' HG23 ' A' ' 147' ' ' VAL . 63.8 mt -76.99 -42.33 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 74.439999999999998 111.118 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -56.17 -57.01 13.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 75.099999999999994 110.938 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 31.1 t -54.15 -37.08 34.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 74.319999999999993 111.118 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -70.01 -44.04 70.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 73.219999999999999 110.854 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 143' ' ' ILE . 91.1 t -63.52 -34.09 65.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 73.150000000000006 111.158 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 17.2 m -51.85 -44.23 63.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 72.409999999999997 110.907 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.459 HG12 HD12 ' A' ' 153' ' ' ILE . 26.5 t -75.84 -33.19 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 70.409999999999997 111.097 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -58.8 -54.63 44.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 73.439999999999998 110.882 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -68.42 -19.4 72.58 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 50.229999999999997 112.512 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.52 HG23 HD12 ' A' ' 36' ' ' ILE . 33.1 m -75.64 -52.83 9.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.754 0.311 . . . . 62.409999999999997 111.172 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.459 HD12 HG12 ' A' ' 149' ' ' VAL . 49.3 mt -76.5 -27.5 17.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 65.109999999999999 111.132 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -53.65 -49.55 57.27 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.725 -0.75 . . . . 62.100000000000001 112.533 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -31.89 67.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 75.129999999999995 110.906 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 71.6 t80 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 73.329999999999998 110.877 -179.96 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.232 0.19 0 CA-C-O 120.828 0.262 . . . . 72.129999999999995 112.358 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 pp -52.16 -31.0 29.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 70.230000000000004 110.93 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -81.0 -31.95 34.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 75.140000000000001 110.865 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -72.51 -46.1 56.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 71.409999999999997 110.896 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 t -59.83 -40.17 87.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 73.409999999999997 111.146 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.26 -29.11 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 71.239999999999995 111.105 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -55.59 -27.0 46.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 73.409999999999997 110.899 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.672 ' HG ' HD12 ' A' ' 77' ' ' ILE . 4.1 mm? -91.51 -18.95 23.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 53.039999999999999 110.947 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.8 mm -76.53 -35.17 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 72.430000000000007 111.103 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.53 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.3 mm -55.68 -57.15 22.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.609 0.718 . . . . 71.430000000000007 111.125 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.78 -21.4 33.45 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.67 2.247 . . . . 73.030000000000001 112.323 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.641 ' O ' HG22 ' A' ' 42' ' ' ILE . 43.0 t -71.33 -45.36 63.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 65.400000000000006 110.912 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 p -81.62 -28.94 10.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 74.25 111.091 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 mt -50.95 -33.91 26.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 74.439999999999998 110.915 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.641 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.77 -34.68 52.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 74.409999999999997 111.145 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.72 -39.81 91.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 54.229999999999997 111.145 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.95 -51.23 62.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 62.340000000000003 110.885 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.7 tp -70.68 -35.96 73.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 64.409999999999997 110.908 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.73 -38.84 82.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 42.140000000000001 111.075 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.3 mp -64.25 -32.03 55.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 53.039999999999999 111.15 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 tp -51.42 -38.74 55.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 74.030000000000001 110.944 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.747 HG21 ' HA ' ' A' ' 59' ' ' LYS . 7.8 p -101.48 -36.79 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 61.210000000000001 111.145 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -66.97 -64.59 0.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 73.409999999999997 110.926 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.732 ' CZ ' HD13 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -71.22 -25.98 62.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 74.439999999999998 110.924 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.6 mp -125.08 71.65 63.22 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.622 0.725 . . . . 74.420000000000002 110.9 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 173.27 11.19 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.748 2.299 . . . . 64.219999999999999 112.3 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.0 p -167.8 -170.27 1.34 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 70.209999999999994 110.876 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.0 95.71 10.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 72.140000000000001 110.839 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -179.1 138.78 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 71.109999999999999 110.841 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.33 -22.96 77.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.741 -0.743 . . . . 64.319999999999993 112.452 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -52.06 -34.94 45.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.932 0.396 . . . . 71.409999999999997 110.87 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.747 ' HA ' HG21 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -52.98 -51.57 61.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 72.420000000000002 110.905 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.8 ttm -65.41 -28.02 68.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 62.329999999999998 110.835 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.4 m -75.49 -31.65 60.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 44.140000000000001 111.148 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.606 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -68.45 -51.07 47.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 70.310000000000002 110.912 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -53.88 -48.01 70.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 62.229999999999997 110.887 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.6 tt -70.68 -34.95 58.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 71.420000000000002 111.119 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -61.52 -27.96 68.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 64.409999999999997 110.885 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 62' ' ' LEU . 60.2 t -57.93 -39.48 71.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 62.140000000000001 111.099 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -29.13 27.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 62.130000000000003 110.915 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.487 ' O ' HD22 ' A' ' 68' ' ' LEU . 2.1 tm? -74.56 -45.77 43.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 73.540000000000006 110.94 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.91 -29.59 20.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 70.219999999999999 111.086 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.517 HD22 HG11 ' A' ' 102' ' ' VAL . 37.3 mt -58.69 -54.46 46.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 62.229999999999997 110.91 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 68' ' ' LEU . 1.0 OUTLIER -62.31 -27.21 68.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 71.010000000000005 111.126 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 97.8 t -70.69 -33.05 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 75.400000000000006 111.154 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -64.7 -31.97 73.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 71.310000000000002 110.886 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.61 HD11 ' CD1' ' A' ' 95' ' ' LEU . 1.3 tp -75.1 -50.73 15.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 72.430000000000007 110.897 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.2 mp -65.84 -37.58 86.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 74.439999999999998 110.908 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.4 tt -62.63 -55.07 30.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 74.310000000000002 110.93 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.672 HD12 ' HG ' ' A' ' 35' ' ' LEU . 1.6 tt -66.31 -29.51 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 71.510000000000005 111.097 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.3 t -81.55 -14.78 56.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 110.822 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.461 ' O ' HG23 ' A' ' 81' ' ' VAL . 1.3 mmmt -93.67 -9.72 36.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 64.439999999999998 110.89 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.52 -16.88 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 71.319999999999993 111.122 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 79' ' ' LYS . 21.2 t 64.28 78.01 0.29 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.561 0.696 . . . . 54.420000000000002 111.118 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.402 ' HB3' ' HB2' ' A' ' 86' ' ' LEU . 53.3 Cg_endo -69.84 164.11 35.84 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.659 2.24 . . . . 62.109999999999999 112.355 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -49.3 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.745 2.296 . . . . 74.030000000000001 112.36 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 t -124.9 -35.32 2.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 73.129999999999995 111.153 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.24 -39.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 60.340000000000003 110.865 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 82' ' ' PRO . 8.2 tp 64.53 70.6 0.49 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 74.129999999999995 110.917 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.519 ' O ' HG23 ' A' ' 91' ' ' VAL . 4.0 m-20 50.15 60.17 4.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 55.409999999999997 110.894 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.533 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -68.62 -58.21 7.26 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.625 0.726 . . . . 60.329999999999998 111.114 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.587 ' HG2' HD22 ' A' ' 90' ' ' LEU . 53.4 Cg_endo -69.77 -26.02 27.98 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.673 2.248 . . . . 50.43 112.342 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.587 HD22 ' HG2' ' A' ' 89' ' ' PRO . 3.3 mm? -71.83 -39.81 69.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 60.409999999999997 110.916 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 87' ' ' ASP . 84.3 t -80.53 -41.85 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 72.200000000000003 111.164 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.0 -46.39 55.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.769 -0.729 . . . . 53.509999999999998 112.464 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -32.95 69.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.816 0.341 . . . . 73.209999999999994 110.896 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -62.25 -31.97 72.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 72.400000000000006 110.879 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.61 ' CD1' HD11 ' A' ' 74' ' ' LEU . 11.3 mt -53.17 -29.8 33.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 55.119999999999997 110.903 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -42.48 86.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 72.430000000000007 110.859 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.49 ' O ' HG22 ' A' ' 100' ' ' VAL . 24.5 t80 -75.26 -53.19 9.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 74.340000000000003 110.892 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.789 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.03 -29.93 32.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 75.400000000000006 111.165 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.1 mmt -66.61 -30.13 70.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 72.430000000000007 110.901 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.76 -30.1 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 64.409999999999997 111.116 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.789 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.92 -33.12 61.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 74.140000000000001 110.953 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.517 HG11 HD22 ' A' ' 70' ' ' LEU . 31.6 m -76.96 -37.99 27.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 73.299999999999997 111.118 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.437 ' O ' HG13 ' A' ' 107' ' ' VAL . 70.5 m -72.53 -39.68 67.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 74.400000000000006 111.153 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -64.73 -31.93 73.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 53.520000000000003 110.847 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.6 t -74.3 -33.92 63.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.461 . . . . 42.039999999999999 110.852 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.3 mt -74.93 -50.65 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 72.5 111.151 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 110' ' ' VAL . 34.7 m -54.15 -34.12 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 64.040000000000006 111.111 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.0 m -52.41 -32.45 39.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 74.010000000000005 111.188 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.4 m -50.42 -31.54 15.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 73.430000000000007 110.857 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.4 p -52.47 -32.8 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.496 . . . . 71.340000000000003 111.143 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 31.5 m -65.46 -43.17 91.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.143 -0.481 . . . . 63.039999999999999 110.846 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.3 t -77.12 -34.81 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 74.239999999999995 111.106 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.546 HD22 ' O ' ' A' ' 117' ' ' HIS . 85.1 mt -72.05 -33.11 67.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 73.099999999999994 110.917 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -59.68 -31.03 69.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 73.310000000000002 110.888 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.776 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.8 p -102.32 -24.24 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 74.340000000000003 111.139 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -94.24 -74.68 0.53 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.472 . . . . 75.129999999999995 110.897 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.546 ' O ' HD22 ' A' ' 113' ' ' LEU . 4.2 t-80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 44.310000000000002 110.897 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.47 -0.252 . . . . 71.329999999999998 112.47 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -87.87 -26.11 22.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.914 0.388 . . . . 71.409999999999997 110.932 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.8 -36.92 77.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 63.130000000000003 111.08 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.776 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -67.04 -25.8 66.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 74.010000000000005 111.123 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 30.4 mmt -52.96 -30.95 37.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 63.039999999999999 110.91 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 74.8 t -56.97 -59.02 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 42.43 111.134 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 136' ' ' ILE . 3.6 mp -74.01 -37.74 47.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 71.420000000000002 111.136 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -61.26 -29.94 70.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 73.420000000000002 110.896 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.08 -30.14 24.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 73.430000000000007 110.872 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.42 -42.24 68.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 74.319999999999993 110.933 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -74.0 -51.43 15.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 72.040000000000006 110.881 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.732 HD13 ' CZ ' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -52.03 -33.31 38.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 61.229999999999997 110.893 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 45.6 t-105 -61.8 -45.42 93.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.236 -0.438 . . . . 64.140000000000001 110.924 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.751 ' O ' HG23 ' A' ' 147' ' ' VAL . 50.8 mm -76.96 -32.87 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 72.129999999999995 111.135 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -56.07 -56.96 14.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 72.129999999999995 110.867 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.7 m -55.6 -35.0 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 72.239999999999995 111.146 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -69.72 -33.11 72.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 73.310000000000002 110.883 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 143' ' ' ILE . 82.0 t -67.62 -33.99 65.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 52.299999999999997 111.144 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 67.9 m -66.32 -46.41 77.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 61.219999999999999 110.874 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.532 ' O ' HG22 ' A' ' 152' ' ' THR . 43.4 t -76.03 -36.82 32.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 72.120000000000005 111.104 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.573 ' O ' HG22 ' A' ' 153' ' ' ILE . 68.5 t80 -71.87 -28.6 63.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 74.310000000000002 110.861 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -52.24 -27.75 24.81 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.754 -0.736 . . . . 54.140000000000001 112.468 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 149' ' ' VAL . 14.8 t -53.81 -32.01 51.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 63.109999999999999 111.155 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 150' ' ' PHE . 20.0 tt -55.89 -25.7 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 75.0 111.163 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -51.9 -49.93 46.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.723 -0.751 . . . . 61.020000000000003 112.507 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -73.92 -31.8 63.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.785 0.326 . . . . 72.450000000000003 110.825 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 77.4 t80 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.429 . . . . 75.109999999999999 110.906 -179.937 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.232 0.224 0 CA-C-O 120.794 0.248 . . . . 72.430000000000007 112.292 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.409 HD11 ' CE1' ' A' ' 30' ' ' PHE . 2.4 pp -52.0 -30.96 27.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 74.420000000000002 110.904 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.409 ' CE1' HD11 ' A' ' 29' ' ' LEU . 42.8 m-85 -78.98 -33.31 45.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 63.340000000000003 110.901 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -72.5 -46.19 55.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 74.510000000000005 110.922 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -59.98 -40.03 87.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.511 . . . . 75.239999999999995 111.125 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.11 -29.1 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 64.409999999999997 111.141 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.1 -26.87 51.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 60.210000000000001 110.866 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.616 ' HG ' HD12 ' A' ' 77' ' ' ILE . 4.1 mm? -91.51 -19.2 23.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 73.129999999999995 110.9 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mm -76.76 -34.86 23.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 63.329999999999998 111.087 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.539 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.1 mt -55.72 -57.12 23.15 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.6 0.714 . . . . 73.150000000000006 111.109 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.4 Cg_endo -69.8 -20.34 34.77 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.683 2.255 . . . . 72.019999999999996 112.337 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.635 ' O ' HG22 ' A' ' 42' ' ' ILE . 48.4 t -75.51 -44.26 44.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 62.109999999999999 110.869 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 p -81.54 -28.95 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 74.310000000000002 111.144 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.3 mt -50.97 -33.97 26.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 75.120000000000005 110.872 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.635 HG22 ' O ' ' A' ' 39' ' ' CYS . 0.7 OUTLIER -58.76 -34.66 52.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 64.510000000000005 111.121 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.83 -38.43 88.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.19 -0.459 . . . . 71.510000000000005 111.132 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.07 -49.08 67.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 65.409999999999997 110.849 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.0 tp -74.31 -36.02 63.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 73.439999999999998 110.938 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.48 -37.99 76.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 61.130000000000003 111.106 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.421 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.2 mp -64.9 -32.49 58.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 73.239999999999995 111.108 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 tp -55.07 -33.77 63.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 74.420000000000002 110.882 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.589 HG11 ' HG ' ' A' ' 62' ' ' LEU . 27.5 m -101.76 -36.73 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 73.319999999999993 111.126 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -71.43 -64.91 0.83 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 71.099999999999994 110.903 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.739 ' CZ ' HD13 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -68.98 -23.27 64.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 62.439999999999998 110.875 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.7 mp -128.05 73.6 79.3 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.634 0.73 . . . . 73.510000000000005 110.889 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 133.18 24.89 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.721 2.28 . . . . 75.329999999999998 112.351 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.2 m -87.08 -67.73 0.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 53.210000000000001 110.824 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.53 -75.14 0.59 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 73.030000000000001 110.841 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.45 -62.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 72.219999999999999 110.859 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.16 -62.93 5.26 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.751 -0.737 . . . . 71.200000000000003 112.477 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -51.94 -36.93 50.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 64.349999999999994 110.881 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -62.93 -44.06 97.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 75.109999999999999 110.882 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.0 tpt -72.06 -48.47 44.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 74.219999999999999 110.842 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 82.0 p -54.99 -26.15 34.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.424 . . . . 71.400000000000006 111.101 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.589 ' HG ' HG11 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -75.65 -37.4 59.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 63.329999999999998 110.874 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 35.0 m -74.01 -48.19 31.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 74.540000000000006 110.914 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.6 pt -54.92 -32.21 26.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 73.510000000000005 111.115 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.0 t -70.84 -25.14 62.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 71.239999999999995 110.838 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.1 t -57.94 -37.13 59.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 75.510000000000005 111.137 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mt -55.37 -29.7 58.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 50.140000000000001 110.907 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.485 ' O ' HD22 ' A' ' 68' ' ' LEU . 2.1 tm? -69.85 -45.44 67.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 73.329999999999998 110.872 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.07 -29.7 22.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 30.300000000000001 111.082 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.774 HD22 HG11 ' A' ' 102' ' ' VAL . 23.9 mt -59.81 -54.53 45.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 63.43 110.932 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 68' ' ' LEU . 0.8 OUTLIER -60.76 -27.16 67.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 62.5 111.148 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.1 t -70.32 -32.94 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 72.299999999999997 111.127 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.535 ' O ' HG22 ' A' ' 77' ' ' ILE . 1.8 t80 -61.66 -29.84 70.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 74.510000000000005 110.911 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.888 HD11 HD13 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -66.73 -50.3 63.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 73.25 110.903 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.4 -38.25 65.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 73.329999999999998 110.866 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.5 tt -58.03 -55.05 40.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 74.310000000000002 110.969 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.616 HD12 ' HG ' ' A' ' 35' ' ' LEU . 1.3 tt -66.62 -23.95 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 74.519999999999996 111.162 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.6 t -80.32 -17.96 50.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 64.019999999999996 110.817 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.752 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -68.55 -12.18 60.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 73.409999999999997 110.925 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.492 HG23 ' O ' ' A' ' 77' ' ' ILE . 47.7 pt -52.77 -28.04 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 73.239999999999995 111.151 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.752 HG23 ' O ' ' A' ' 79' ' ' LYS . 57.5 t 61.48 77.14 0.37 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.664 0.745 . . . . 72.510000000000005 111.117 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 167.28 24.89 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.681 2.254 . . . . 74.519999999999996 112.318 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -48.99 0.6 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.656 2.237 . . . . 63.420000000000002 112.369 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 t -134.82 18.49 3.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 73.140000000000001 111.106 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.2 m 51.73 64.55 1.8 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 52.420000000000002 110.845 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.15 24.96 11.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 74.430000000000007 110.877 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -115.05 25.48 10.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 71.209999999999994 110.861 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.537 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -65.15 -57.61 14.92 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.643 0.735 . . . . 74.519999999999996 111.121 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.6 Cg_endo -69.76 -21.4 33.53 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.676 2.25 . . . . 55.450000000000003 112.326 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.0 mp -73.41 -52.97 11.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 64.450000000000003 110.935 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.1 t -80.03 -42.86 22.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.458 . . . . 63.030000000000001 111.14 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.41 -38.05 49.83 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.784 -0.722 . . . . 50.030000000000001 112.46 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.35 -23.7 60.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.789 0.328 . . . . 52.329999999999998 110.9 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -76.15 -39.34 55.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 72.340000000000003 110.951 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.888 HD13 HD11 ' A' ' 74' ' ' LEU . 12.0 mt -55.68 -29.74 59.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.108 -0.496 . . . . 72.239999999999995 110.924 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.9 mmt -70.23 -42.57 72.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 72.219999999999999 110.896 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.506 ' O ' HG22 ' A' ' 100' ' ' VAL . 4.7 t80 -75.26 -51.09 14.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 74.209999999999994 110.863 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.804 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.23 -29.84 34.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 74.129999999999995 111.127 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.6 mmt -66.77 -30.01 70.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 72.120000000000005 110.877 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.81 -30.01 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 62.210000000000001 111.137 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.804 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -74.91 -33.12 61.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 52.520000000000003 110.916 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.774 HG11 HD22 ' A' ' 70' ' ' LEU . 30.2 m -76.55 -37.73 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 64.109999999999999 111.118 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.728 ' O ' HG23 ' A' ' 107' ' ' VAL . 53.7 m -72.7 -46.6 52.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 72.120000000000005 111.097 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.444 ' CE2' HG21 ' A' ' 147' ' ' VAL . 69.9 t80 -51.86 -31.26 27.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 71.319999999999993 110.894 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 m -73.86 -51.09 17.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 70.409999999999997 110.842 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 103' ' ' THR . 7.6 mt -54.76 -34.68 30.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 61.509999999999998 111.117 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 103' ' ' THR . 25.6 t -54.02 -45.73 64.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 63.039999999999999 111.103 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.6 m -52.3 -32.45 37.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 71.400000000000006 111.152 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.1 p -50.41 -31.36 14.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 65.319999999999993 110.855 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.6 p -52.45 -32.86 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 70.299999999999997 111.154 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 28.9 m -65.86 -47.35 75.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.468 . . . . 71.25 110.897 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.42 HG23 ' OD1' ' A' ' 137' ' ' ASP . 84.6 t -72.46 -36.28 54.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 73.340000000000003 111.121 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.1 mt -72.05 -32.72 67.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 65.129999999999995 110.93 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -60.98 -30.59 70.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 73.530000000000001 110.852 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.778 HG11 ' HB2' ' A' ' 133' ' ' ALA . 9.8 p -102.3 -23.2 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 72.120000000000005 111.126 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -109.37 117.7 34.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 73.510000000000005 110.886 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 16.7 t60 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.456 . . . . 73.120000000000005 110.855 -179.979 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.501 -0.24 . . . . 63.32 112.501 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -66.29 -39.96 89.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.944 0.402 . . . . 74.219999999999999 110.952 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 135' ' ' VAL . 34.7 m -54.72 -27.04 17.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 43.049999999999997 111.079 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.778 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -56.31 -25.33 48.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 61.32 111.094 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 37.1 mmt -53.01 -30.98 38.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 70.230000000000004 110.849 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 132' ' ' VAL . 52.6 t -56.94 -58.26 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 64.109999999999999 111.114 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 45.5 mm -74.06 -37.94 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 73.019999999999996 111.101 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.42 ' OD1' HG23 ' A' ' 112' ' ' VAL . 0.8 OUTLIER -58.73 -32.86 69.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 61.409999999999997 110.869 179.839 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.07 -26.02 59.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 73.349999999999994 110.895 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 16.1 tp -68.51 -50.88 48.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 74.150000000000006 110.939 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -73.23 -37.01 66.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 73.439999999999998 110.895 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.739 HD13 ' CZ ' ' A' ' 51' ' ' TYR . 3.5 mt -52.02 -33.31 37.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 73.400000000000006 110.885 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -74.31 -34.53 63.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.213 -0.449 . . . . 75.439999999999998 110.905 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.556 ' O ' HG23 ' A' ' 147' ' ' VAL . 36.0 mt -76.94 -32.01 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 72.150000000000006 111.101 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -56.05 -56.96 14.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 74.129999999999995 110.861 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.3 m -54.19 -34.99 28.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 41.240000000000002 111.132 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -67.34 -41.18 85.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 74.409999999999997 110.895 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 143' ' ' ILE . 87.9 t -62.18 -34.04 61.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 44.32 111.121 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 98.9 m -53.8 -39.07 65.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.14 -0.482 . . . . 74.450000000000003 110.89 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.9 t -75.46 -33.0 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 74.510000000000005 111.122 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.98 -54.7 26.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 63.140000000000001 110.92 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.42 -19.35 79.87 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.794 -0.717 . . . . 73.040000000000006 112.461 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 34.6 m -73.61 -52.83 12.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.806 0.336 . . . . 70.519999999999996 111.176 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 45.4 mm -76.51 -24.26 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 71.040000000000006 111.128 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -53.95 -48.51 62.26 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.767 -0.73 . . . . 71.120000000000005 112.472 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.21 -33.14 50.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.762 0.315 . . . . 72.439999999999998 110.881 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 72.099999999999994 110.867 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.797 0.249 . . . . 74.109999999999999 112.388 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.99 -30.94 65.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 62.140000000000001 110.886 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -77.7 -32.24 52.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 62.25 110.873 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -73.45 -44.98 56.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 72.349999999999994 110.91 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 t -60.71 -39.71 89.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.102 -0.499 . . . . 62.219999999999999 111.183 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.446 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.18 -29.07 21.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 51.200000000000003 111.097 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -56.0 -27.58 53.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 75.019999999999996 110.892 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.756 ' HG ' HD12 ' A' ' 77' ' ' ILE . 4.1 mm? -90.69 -18.42 25.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 52.210000000000001 110.908 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mm -76.79 -34.79 23.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 73.25 111.165 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.55 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.73 -57.16 22.94 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.61 0.719 . . . . 75.540000000000006 111.092 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.8 Cg_endo -69.75 -20.85 34.35 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.718 2.279 . . . . 52.539999999999999 112.335 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.626 ' O ' HG22 ' A' ' 42' ' ' ILE . 48.6 t -76.0 -44.69 38.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 71.349999999999994 110.859 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.5 -28.88 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 75.450000000000003 111.183 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mt -51.01 -34.01 27.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 73.430000000000007 110.909 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.626 HG22 ' O ' ' A' ' 39' ' ' CYS . 0.7 OUTLIER -58.64 -34.73 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 41.140000000000001 111.143 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.75 -41.15 92.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 74.519999999999996 111.13 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.01 -43.01 66.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 72.010000000000005 110.865 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 tp -76.59 -40.03 50.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 74.299999999999997 110.938 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.72 -51.46 69.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 61.439999999999998 111.075 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.442 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.4 mp -49.73 -31.44 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 73.540000000000006 111.136 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.0 tp -50.76 -42.22 57.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 74.219999999999999 110.943 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.7 HG23 ' CB ' ' A' ' 54' ' ' SER . 7.2 p -101.49 -37.48 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 75.230000000000004 111.145 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.493 ' HB3' HD21 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -63.68 -64.53 0.87 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 65.219999999999999 110.871 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.581 ' CD2' HD22 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -72.85 -62.0 1.61 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.484 . . . . 75.329999999999998 110.907 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.2 mp -67.89 160.67 72.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.599 0.714 . . . . 72.140000000000001 110.874 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 143.68 51.77 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.73 2.287 . . . . 51.310000000000002 112.329 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.7 ' CB ' HG23 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -155.17 -176.83 6.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 50.43 110.846 -179.864 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -173.41 -169.99 0.57 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.5 . . . . 71.25 110.872 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 63.35 172.5 0.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 64.129999999999995 110.893 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.4 -22.93 39.91 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.712 -0.756 . . . . 64.409999999999997 112.48 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.654 ' O ' HD12 ' A' ' 62' ' ' LEU . 5.4 tt0 -51.97 -35.01 44.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.917 0.389 . . . . 73.409999999999997 110.887 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.527 ' HA ' HG21 ' A' ' 49' ' ' VAL . 6.3 ttpp -52.96 -52.0 59.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 64.420000000000002 110.897 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 6.8 tpt -72.01 -42.09 66.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 74.120000000000005 110.87 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.6 m -53.08 -28.4 24.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 62.420000000000002 111.13 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 58' ' ' GLU . 0.2 OUTLIER -71.53 -40.21 70.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 54.119999999999997 110.899 179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 28.7 m -66.04 -45.65 80.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 63.32 110.908 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 12.4 tt -72.37 -35.05 50.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 70.530000000000001 111.145 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.14 -43.25 70.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 72.430000000000007 110.898 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.5 ' HA ' HD11 ' A' ' 42' ' ' ILE . 99.7 t -58.01 -34.83 49.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 65.450000000000003 111.134 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.87 -28.98 25.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 71.439999999999998 110.895 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.487 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -68.99 -39.25 79.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 74.310000000000002 110.896 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.39 -30.05 70.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 64.5 111.086 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.761 HD13 HG11 ' A' ' 102' ' ' VAL . 9.9 mt -64.85 -54.67 27.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 70.239999999999995 110.947 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.97 -38.22 87.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 70.230000000000004 111.172 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 68' ' ' LEU . 77.5 t -71.37 -32.9 48.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 74.510000000000005 111.151 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.525 ' O ' HG22 ' A' ' 77' ' ' ILE . 64.2 t80 -66.68 -29.88 69.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 75.25 110.853 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.489 HD11 HD13 ' A' ' 95' ' ' LEU . 4.3 tt -72.06 -47.61 50.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 44.399999999999999 110.896 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.5 mt -73.04 -39.63 65.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 65.140000000000001 110.915 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.9 tt -58.22 -51.3 70.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 62.119999999999997 110.932 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.756 HD12 ' HG ' ' A' ' 35' ' ' LEU . 1.6 tt -71.68 -26.2 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 62.539999999999999 111.145 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 25.5 t -80.53 -13.8 58.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 62.140000000000001 110.868 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.616 ' O ' HG23 ' A' ' 81' ' ' VAL . 5.5 mmmt -50.71 -29.21 10.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 74.329999999999998 110.878 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.9 pt -50.53 -37.43 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 55.409999999999997 111.111 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 79' ' ' LYS . 53.0 t 51.37 81.68 0.26 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.59 0.709 . . . . 74.349999999999994 111.178 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 167.47 24.43 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.657 2.238 . . . . 60.439999999999998 112.335 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -49.96 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.701 2.267 . . . . 73.040000000000006 112.342 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.2 t -136.75 -38.92 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 74.430000000000007 111.179 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.64 83.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 70.030000000000001 110.886 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.8 -18.04 16.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 54.119999999999997 110.893 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.582 ' HA ' HD23 ' A' ' 90' ' ' LEU . 5.5 m-20 -153.7 24.1 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 71.209999999999994 110.873 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.538 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -66.9 -57.9 10.56 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.649 0.738 . . . . 73.040000000000006 111.159 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.554 ' HG2' HD22 ' A' ' 90' ' ' LEU . 54.1 Cg_endo -69.75 -21.54 33.38 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.709 2.273 . . . . 74.430000000000007 112.372 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.582 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.4 mm? -74.12 -53.17 10.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 64.420000000000002 110.938 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.7 -46.65 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 43.520000000000003 111.134 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.87 -39.46 47.94 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.754 -0.736 . . . . 32.219999999999999 112.47 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -73.22 -24.37 60.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.331 . . . . 70.310000000000002 110.922 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -74.43 -37.95 63.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 64.219999999999999 110.916 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.489 HD13 HD11 ' A' ' 74' ' ' LEU . 11.6 mt -57.38 -29.71 64.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.076 -0.511 . . . . 74.409999999999997 110.938 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 5.2 mmt -69.51 -43.57 72.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 74.030000000000001 110.866 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.49 ' O ' HG22 ' A' ' 100' ' ' VAL . 64.5 t80 -75.16 -51.22 13.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 60.520000000000003 110.854 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.793 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.08 -29.9 33.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 65.329999999999998 111.097 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 9.0 mmt -66.65 -30.13 70.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 61.140000000000001 110.887 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.77 -30.18 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 62.200000000000003 111.114 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.793 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.79 -33.29 62.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 74.219999999999999 110.931 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.761 HG11 HD13 ' A' ' 70' ' ' LEU . 30.9 m -76.93 -38.06 28.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 73.200000000000003 111.097 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 76.7 m -72.4 -38.91 68.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 71.0 111.162 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -66.17 -31.93 73.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 61.149999999999999 110.874 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.0 t -73.41 -37.12 66.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 63.329999999999998 110.841 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.0 mt -70.29 -51.45 38.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 51.409999999999997 111.157 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.55 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.1 p -54.06 -35.53 29.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 42.219999999999999 111.15 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.3 m -52.41 -32.42 39.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 70.230000000000004 111.162 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.6 m -50.36 -31.54 14.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 74.040000000000006 110.847 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.55 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.3 p -52.51 -32.83 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 74.349999999999994 111.092 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 33.6 m -65.69 -43.56 88.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.199 -0.455 . . . . 61.119999999999997 110.863 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.9 t -76.74 -35.64 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 65.340000000000003 111.11 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 89.6 mt -72.1 -31.57 66.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 75.409999999999997 110.903 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -62.51 -30.26 71.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 64.209999999999994 110.896 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.803 HG11 ' HB2' ' A' ' 133' ' ' ALA . 9.9 p -102.31 -22.78 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 31.399999999999999 111.173 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -60.91 -74.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 73.030000000000001 110.903 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 73.150000000000006 110.86 179.97 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.481 -0.248 . . . . 63.32 112.481 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -87.9 -43.0 12.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.919 0.39 . . . . 70.230000000000004 110.951 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.2 m -54.97 -31.84 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 62.119999999999997 111.119 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.803 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -71.81 -24.99 61.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 65.519999999999996 111.069 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 18.2 mmt -52.93 -31.05 38.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 71.310000000000002 110.894 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 32.2 t -57.0 -49.44 79.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 63.549999999999997 111.105 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 30.8 mm -74.03 -40.65 52.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 72.420000000000002 111.121 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -61.97 -30.02 70.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 64.519999999999996 110.848 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.0 mtm-85 -54.32 -27.53 36.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 65.409999999999997 110.857 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 tp -67.66 -50.85 55.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 73.400000000000006 110.931 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -74.05 -31.44 62.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 74.5 110.847 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.581 HD22 ' CD2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -52.15 -32.04 33.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 54.310000000000002 110.906 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -35.16 61.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 72.049999999999997 110.923 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.511 ' O ' HG23 ' A' ' 147' ' ' VAL . 36.9 mm -76.91 -32.16 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 63.210000000000001 111.11 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -56.02 -56.74 17.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 74.439999999999998 110.923 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.27 -35.46 62.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 64.140000000000001 111.142 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.32 -33.07 67.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 75.310000000000002 110.851 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 143' ' ' ILE . 28.8 t -65.96 -37.04 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 74.140000000000001 111.118 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.1 t -57.09 -51.69 68.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 73.409999999999997 110.854 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.9 t -69.17 -33.47 58.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 71.019999999999996 111.094 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -52.32 -53.5 43.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 74.549999999999997 110.895 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.04 -19.63 77.06 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.702 -0.761 . . . . 60.409999999999997 112.486 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 35.1 m -65.82 -52.83 47.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.74 0.305 . . . . 53.119999999999997 111.174 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 20.6 mt -76.58 -25.26 16.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 70.239999999999995 111.142 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -58.5 -49.92 72.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 32.030000000000001 112.462 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 9.6 mmt -70.13 -31.99 69.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.782 0.325 . . . . 75.019999999999996 110.854 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 75.3 t80 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 71.299999999999997 110.882 -179.972 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.232 0.197 0 CA-C-O 120.748 0.228 . . . . 51.32 112.3 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 pp -52.36 -30.98 31.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 74.109999999999999 110.905 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -80.99 -31.69 34.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.468 . . . . 75.219999999999999 110.902 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -72.88 -46.29 53.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 72.230000000000004 110.951 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 t -59.49 -40.09 85.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 65.230000000000004 111.145 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.442 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.16 -29.05 21.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 74.150000000000006 111.149 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.0 -26.87 50.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 71.209999999999994 110.91 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.411 HD21 HG21 ' A' ' 80' ' ' ILE . 4.1 mm? -91.5 -19.24 23.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 72.439999999999998 110.891 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mm -76.66 -34.95 24.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 65.329999999999998 111.131 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.54 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.65 -57.16 22.74 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.62 0.724 . . . . 74.099999999999994 111.12 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.4 Cg_endo -69.73 -20.45 34.95 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.743 2.295 . . . . 64.040000000000006 112.318 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.629 ' O ' HG22 ' A' ' 42' ' ' ILE . 48.0 t -75.98 -44.54 39.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 73.540000000000006 110.885 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.2 p -81.57 -28.93 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 74.120000000000005 111.131 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 mt -50.98 -33.94 26.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.459 . . . . 71.340000000000003 110.93 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.629 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.1 tp -58.76 -34.64 52.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 55.32 111.122 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 p -65.79 -38.8 90.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 72.340000000000003 111.111 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 t -53.0 -46.46 68.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 75.329999999999998 110.866 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.63 -41.41 60.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 50.350000000000001 110.938 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.4 -35.74 68.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 71.109999999999999 111.089 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.423 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.2 mp -64.81 -32.54 58.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 71.430000000000007 111.122 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.8 tp -55.04 -33.64 62.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 72.219999999999999 110.916 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.7 m -102.04 -35.57 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 71.099999999999994 111.102 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -72.58 -64.87 0.87 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 70.349999999999994 110.87 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.528 ' CE2' HD22 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -64.76 -41.14 96.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 74.209999999999994 110.911 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.49 74.78 2.29 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.639 0.733 . . . . 71.319999999999993 110.942 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 125.89 12.67 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.723 2.282 . . . . 74.400000000000006 112.312 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.8 t -116.31 -26.78 7.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 61.43 110.826 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -161.96 125.87 3.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.107 -0.497 . . . . 72.319999999999993 110.853 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.7 p -57.72 -26.0 61.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 73.209999999999994 110.871 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.607 ' O ' HG23 ' A' ' 61' ' ' THR . . . -52.95 -62.97 5.43 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.76 -0.733 . . . . 44.200000000000003 112.462 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.535 ' O ' HD23 ' A' ' 62' ' ' LEU . 1.5 tt0 -74.89 -35.46 62.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.889 0.376 . . . . 72.409999999999997 110.876 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -55.76 -50.49 70.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 73.420000000000002 110.869 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.5 ttm -64.96 -51.7 60.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 71.230000000000004 110.877 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 57' ' ' GLY . 70.9 p -56.22 -28.63 59.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 73.049999999999997 111.175 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.684 ' O ' HG23 ' A' ' 66' ' ' VAL . 1.6 mm? -72.78 -51.0 20.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 71.109999999999999 110.908 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.01 -49.67 65.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 65.0 110.887 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.6 tt -68.29 -35.01 69.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 72.340000000000003 111.125 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 m -65.71 -25.07 67.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 63.520000000000003 110.837 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 62' ' ' LEU . 61.0 t -57.96 -37.57 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.494 . . . . 43.310000000000002 111.107 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -28.95 26.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 73.150000000000006 110.884 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.49 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.36 -38.86 78.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 73.25 110.917 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.53 -30.02 70.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 51.100000000000001 111.128 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.589 HD13 HG11 ' A' ' 102' ' ' VAL . 9.6 mt -65.08 -54.7 26.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 63.100000000000001 110.897 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.69 -38.49 88.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 71.140000000000001 111.152 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 68' ' ' LEU . 80.0 t -71.43 -32.93 48.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 53.039999999999999 111.127 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.406 ' O ' HG22 ' A' ' 77' ' ' ILE . 90.3 t80 -51.84 -30.18 22.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 72.5 110.917 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.588 HD11 HD11 ' A' ' 95' ' ' LEU . 0.3 OUTLIER -73.22 -42.36 62.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.491 . . . . 75.040000000000006 110.936 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.6 mt -73.21 -33.91 65.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 74.109999999999999 110.897 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 tt -70.22 -55.07 10.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 73.209999999999994 110.973 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 80' ' ' ILE . 1.2 tt -57.08 -30.43 34.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 74.319999999999993 111.104 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.1 m -80.17 -23.42 41.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 72.25 110.858 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.69 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.4 OUTLIER -69.79 -12.75 61.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.477 . . . . 74.129999999999995 110.895 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.43 HG23 ' O ' ' A' ' 77' ' ' ILE . 2.2 pp -56.31 -24.57 18.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 73.120000000000005 111.123 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 79' ' ' LYS . 22.0 t 63.7 75.27 0.4 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.641 0.734 . . . . 72.129999999999995 111.151 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 167.53 24.22 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.658 2.238 . . . . 51.210000000000001 112.342 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 -48.66 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.69 2.26 . . . . 70.420000000000002 112.354 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.0 t -117.2 -19.79 9.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 73.010000000000005 111.143 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.69 45.08 4.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 72.510000000000005 110.872 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.6 tp -95.7 25.9 4.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 75.230000000000004 110.909 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.646 ' HA ' HD23 ' A' ' 90' ' ' LEU . 4.0 m-20 -104.57 24.39 11.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 72.200000000000003 110.862 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.19 -57.79 10.23 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.642 0.735 . . . . 61.25 111.145 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.537 ' HG2' HD22 ' A' ' 90' ' ' LEU . 54.3 Cg_endo -69.79 -20.48 34.62 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.696 2.264 . . . . 74.230000000000004 112.359 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.646 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.12 -45.6 47.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 75.400000000000006 110.955 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.493 HG12 HD21 ' A' ' 95' ' ' LEU . 38.4 t -80.67 -37.85 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 51.43 111.121 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.92 -52.1 36.66 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.724 -0.751 . . . . 73.400000000000006 112.542 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -35.19 79.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.828 0.347 . . . . 70.540000000000006 110.895 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -60.77 -36.75 79.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 60.109999999999999 110.952 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.588 HD11 HD11 ' A' ' 74' ' ' LEU . 9.7 mt -51.89 -29.8 21.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 54.399999999999999 110.934 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 13.4 mmt -67.85 -43.12 80.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 74.510000000000005 110.916 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.5 ' O ' HG22 ' A' ' 100' ' ' VAL . 67.2 t80 -75.28 -52.25 11.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 74.219999999999999 110.888 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.781 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.02 -29.91 32.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 74.510000000000005 111.165 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.72 -30.05 70.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 72.140000000000001 110.858 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.8 -30.04 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 65.129999999999995 111.134 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.781 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -74.91 -33.21 61.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 75.409999999999997 110.929 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.589 HG11 HD13 ' A' ' 70' ' ' LEU . 31.3 m -76.91 -38.09 28.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 72.319999999999993 111.156 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.484 ' HA ' HD12 ' A' ' 106' ' ' ILE . 73.0 m -72.46 -40.73 66.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 70.200000000000003 111.203 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -63.51 -32.17 73.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 63.229999999999997 110.88 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.0 t -71.38 -32.04 68.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 74.299999999999997 110.828 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.484 HD12 ' HA ' ' A' ' 103' ' ' THR . 22.3 mt -75.01 -52.1 19.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 64.129999999999995 111.163 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.547 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.1 p -54.16 -36.65 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 55.509999999999998 111.139 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.7 m -52.38 -32.4 38.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 62.310000000000002 111.173 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.7 m -50.46 -31.29 14.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.463 . . . . 71.099999999999994 110.835 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.2 p -52.51 -32.73 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 75.530000000000001 111.109 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 17.9 m -64.15 -43.87 93.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 45.039999999999999 110.878 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 84.1 t -76.89 -34.74 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 62.329999999999998 111.087 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.432 HD22 ' O ' ' A' ' 117' ' ' HIS . 83.4 mt -71.99 -32.25 67.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 71.409999999999997 110.895 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -59.18 -31.97 69.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 72.319999999999993 110.858 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.788 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.0 p -102.32 -24.84 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 42.409999999999997 111.166 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 -90.25 -73.73 0.51 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.123 -0.49 . . . . 74.430000000000007 110.828 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.432 ' O ' HD22 ' A' ' 113' ' ' LEU . 9.5 t-80 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 75.319999999999993 110.816 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.464 -0.254 . . . . 44.039999999999999 112.464 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -87.97 -29.81 20.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.987 0.422 . . . . 74.150000000000006 110.922 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.9 m -66.44 -35.93 76.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 61.420000000000002 111.105 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.788 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -64.46 -25.02 67.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 75.040000000000006 111.094 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 39.1 mmt -53.0 -31.02 38.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 73.019999999999996 110.872 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 64.5 t -56.99 -58.17 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.281 -0.418 . . . . 74.519999999999996 111.082 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.9 mt -73.95 -36.93 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 73.219999999999999 111.12 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -62.09 -29.94 70.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 63.5 110.884 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.18 -29.86 24.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 73.319999999999993 110.886 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.31 -39.48 74.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 74.200000000000003 110.879 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -73.86 -53.38 10.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 64.030000000000001 110.897 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.538 ' O ' HG23 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -52.39 -33.6 44.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 63.219999999999999 110.913 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 20.7 t90 -55.51 -50.6 69.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 75.200000000000003 110.937 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.715 ' O ' HG23 ' A' ' 147' ' ' VAL . 57.8 mt -76.01 -33.49 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 50.210000000000001 111.121 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -56.16 -56.02 25.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 63.109999999999999 110.867 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 141' ' ' LEU . 23.2 t -59.95 -35.01 58.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 62.109999999999999 111.089 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -66.06 -33.27 75.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 70.209999999999994 110.895 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 143' ' ' ILE . 78.7 t -54.25 -50.64 54.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 74.510000000000005 111.155 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.39 -47.7 66.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 74.439999999999998 110.921 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.7 t -63.67 -33.03 59.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 74.329999999999998 111.132 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -52.07 -54.94 24.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 73.439999999999998 110.893 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.32 -19.55 74.05 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 44.439999999999998 112.486 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.2 m -60.11 -52.82 63.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.733 0.301 . . . . 65.519999999999996 111.136 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 47.3 mm -76.48 -33.65 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 73.209999999999994 111.132 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -55.2 -49.98 61.31 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.741 -0.742 . . . . 55.32 112.51 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 3.3 mmt -72.43 -31.99 65.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.822 0.344 . . . . 75.319999999999993 110.91 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 17.5 t80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 74.430000000000007 110.856 -179.949 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.209 0 CA-C-O 120.843 0.268 . . . . 74.430000000000007 112.375 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.0 pp -52.08 -30.99 28.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 71.310000000000002 110.913 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -78.04 -33.59 50.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 72.420000000000002 110.882 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -72.64 -45.89 56.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 74.129999999999995 110.904 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -60.31 -39.96 88.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 63.43 111.14 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.455 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.17 -29.08 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 64.519999999999996 111.145 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.88 -27.26 51.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.420000000000002 110.861 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.558 HD21 HG21 ' A' ' 80' ' ' ILE . 4.1 mm? -91.1 -18.8 23.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 70.420000000000002 110.957 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.7 mm -76.54 -34.97 25.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 64.420000000000002 111.173 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.545 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.72 -57.15 22.97 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.583 0.706 . . . . 72.540000000000006 111.107 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.5 Cg_endo -69.77 -21.35 33.54 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.683 2.255 . . . . 72.530000000000001 112.285 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.622 ' O ' HG22 ' A' ' 42' ' ' ILE . 47.3 t -75.87 -44.52 40.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 72.510000000000005 110.882 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.508 HG23 ' SG ' ' A' ' 148' ' ' CYS . 9.7 p -81.57 -28.93 10.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 63.210000000000001 111.139 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 mt -50.97 -34.01 27.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 72.25 110.907 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.1 tp -58.68 -34.68 52.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 65.25 111.141 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 p -65.69 -40.48 92.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.458 . . . . 72.340000000000003 111.138 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.97 -43.08 66.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 71.420000000000002 110.876 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.9 tp -76.96 -40.79 45.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.12 -0.491 . . . . 61.340000000000003 110.914 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.1 -36.52 68.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 61.240000000000002 111.103 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.426 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.3 mp -64.28 -32.02 55.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 75.420000000000002 111.112 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.9 tp -51.43 -38.76 55.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 71.239999999999995 110.916 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.674 HG21 HD13 ' A' ' 62' ' ' LEU . 7.9 p -101.47 -36.69 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 70.239999999999995 111.154 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -67.02 -64.65 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 72.340000000000003 110.871 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.547 ' CE2' HD22 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -71.34 -60.8 2.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 74.129999999999995 110.907 -179.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.0 mp -71.0 160.63 81.85 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.598 0.713 . . . . 65.540000000000006 110.921 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 144.63 54.77 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.701 2.267 . . . . 55.100000000000001 112.313 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.76 95.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 72.400000000000006 110.877 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 53.85 -172.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 54.420000000000002 110.862 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.4 m -114.81 -74.49 0.61 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 62.310000000000002 110.862 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.41 -27.74 66.18 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.726 . . . . 44.100000000000001 112.515 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.489 ' HG2' HD12 ' A' ' 62' ' ' LEU . 11.6 tt0 -52.1 -34.92 46.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.852 0.358 . . . . 70.349999999999994 110.821 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.6 mttt -52.98 -51.92 59.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 71.349999999999994 110.894 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 9.7 ttm -64.3 -45.44 87.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 51.32 110.882 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.7 m -58.28 -36.96 74.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.446 . . . . 75.25 111.177 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.674 HD13 HG21 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -75.62 -32.6 60.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 71.430000000000007 110.939 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 6.8 m -65.26 -52.01 57.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 71.129999999999995 110.897 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.4 tt -60.26 -34.95 59.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 62.520000000000003 111.112 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -24.98 66.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 73.129999999999995 110.853 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.3 t -57.95 -35.59 52.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 74.400000000000006 111.137 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mp -52.98 -28.88 25.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 71.510000000000005 110.893 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.495 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.37 -38.99 78.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 65.409999999999997 110.925 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.45 -30.05 70.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 53.109999999999999 111.093 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.842 HD22 HG11 ' A' ' 102' ' ' VAL . 9.9 mt -64.7 -54.72 27.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 41.310000000000002 110.944 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.97 -38.17 87.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 53.32 111.112 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 68' ' ' LEU . 76.4 t -71.44 -32.83 47.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 53.130000000000003 111.111 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -51.51 -30.67 21.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 73.329999999999998 110.909 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.456 HD11 HD11 ' A' ' 95' ' ' LEU . 8.9 tp -75.0 -40.06 60.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 75.510000000000005 110.915 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.9 mt -73.22 -34.8 66.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 70.319999999999993 110.916 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.11 -53.87 13.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.456 . . . . 70.129999999999995 110.906 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 80' ' ' ILE . 1.6 tt -56.43 -26.17 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 70.010000000000005 111.104 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.5 m -80.15 -22.4 42.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 71.109999999999999 110.862 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.684 ' O ' HG23 ' A' ' 81' ' ' VAL . 7.1 mttp -70.77 -10.5 59.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 74.329999999999998 110.873 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.558 HG21 HD21 ' A' ' 35' ' ' LEU . 2.4 pp -56.61 -23.72 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 64.549999999999997 111.133 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 79' ' ' LYS . 21.4 t 64.11 75.49 0.38 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.598 0.713 . . . . 65.219999999999999 111.127 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 167.26 24.93 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.656 2.237 . . . . 63.25 112.348 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -48.8 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.713 2.275 . . . . 71.219999999999999 112.331 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.75 HG23 ' H ' ' A' ' 86' ' ' LEU . 8.4 t -116.6 -19.93 9.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 74.439999999999998 111.148 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 p 63.46 23.27 13.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 64.540000000000006 110.873 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.75 ' H ' HG23 ' A' ' 84' ' ' THR . 0.1 OUTLIER -95.72 31.21 2.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 63.310000000000002 110.915 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.66 ' HA ' HD23 ' A' ' 90' ' ' LEU . 75.7 m-20 -94.63 47.16 1.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.457 . . . . 72.329999999999998 110.875 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.536 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -66.74 -57.72 11.22 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.586 0.708 . . . . 73.329999999999998 111.142 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.7 Cg_endo -69.77 -20.0 35.34 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.679 2.252 . . . . 73.319999999999993 112.322 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.66 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.15 -53.16 10.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.246 -0.434 . . . . 71.340000000000003 110.875 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.11 -38.01 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 71.299999999999997 111.085 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.1 -43.43 56.18 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.752 -0.737 . . . . 75.299999999999997 112.448 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -21.92 64.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.806 0.336 . . . . 73.540000000000006 110.911 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -78.13 -41.88 33.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 61.310000000000002 110.902 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.469 ' HA ' HG22 ' A' ' 98' ' ' THR . 10.9 mt -55.69 -29.71 59.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 73.349999999999994 110.875 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -43.42 76.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 74.450000000000003 110.876 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.504 ' O ' HG22 ' A' ' 100' ' ' VAL . 50.9 t80 -75.27 -51.69 12.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 75.230000000000004 110.871 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.791 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.16 -29.88 33.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 74.340000000000003 111.113 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.8 mmt -66.63 -30.12 70.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 72.019999999999996 110.878 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.7 -30.08 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 51.049999999999997 111.153 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -75.0 -33.2 61.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 74.109999999999999 110.906 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.842 HG11 HD22 ' A' ' 70' ' ' LEU . 31.2 m -76.91 -38.12 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 73.040000000000006 111.155 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.45 ' O ' HG13 ' A' ' 107' ' ' VAL . 74.1 m -72.47 -40.05 67.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.472 . . . . 74.329999999999998 111.135 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -64.49 -31.92 73.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 63.329999999999998 110.852 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.6 t -74.4 -34.51 63.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 61.200000000000003 110.859 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.5 mt -74.43 -50.72 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 72.409999999999997 111.135 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.555 ' O ' HG12 ' A' ' 110' ' ' VAL . 34.5 m -54.05 -33.99 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 70.219999999999999 111.111 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.0 m -52.41 -32.53 39.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 63.229999999999997 111.164 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.1 m -50.45 -31.46 15.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 73.239999999999995 110.891 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.4 p -52.5 -32.73 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 72.150000000000006 111.115 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 35.5 m -66.94 -48.74 67.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 64.530000000000001 110.868 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 77.7 t -70.49 -35.37 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 64.219999999999999 111.124 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.0 mt -72.09 -40.31 68.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 64.5 110.911 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -52.12 -31.66 31.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 72.230000000000004 110.863 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.775 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.3 p -102.31 -24.18 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 65.519999999999996 111.139 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -54.02 -74.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 72.510000000000005 110.879 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 75.540000000000006 110.857 179.956 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.518 -0.233 . . . . 71.319999999999993 112.518 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -69.32 -26.35 64.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.969 0.414 . . . . 75.25 110.946 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.1 m -54.72 -27.1 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.054 -0.521 . . . . 75.310000000000002 111.113 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.775 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -54.83 -27.66 43.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 51.240000000000002 111.117 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 37.0 mmt -53.0 -31.01 38.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 71.420000000000002 110.876 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 62.4 t -56.94 -56.02 16.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.267 -0.424 . . . . 73.430000000000007 111.105 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.8 mp -73.94 -38.66 50.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 73.010000000000005 111.116 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -61.13 -30.46 70.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 73.349999999999994 110.899 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.76 -27.28 40.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.478 . . . . 71.150000000000006 110.88 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.01 -50.63 21.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 72.040000000000006 110.909 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -69.06 -53.59 19.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 72.140000000000001 110.887 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.621 ' O ' HG23 ' A' ' 145' ' ' VAL . 0.2 OUTLIER -52.08 -32.4 34.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 74.540000000000006 110.907 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -61.45 -51.48 68.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 74.540000000000006 110.884 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.748 ' O ' HG23 ' A' ' 147' ' ' VAL . 62.1 mt -74.35 -32.0 29.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 75.120000000000005 111.156 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -56.0 -56.46 20.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 70.129999999999995 110.847 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 141' ' ' LEU . 30.6 t -54.3 -35.56 30.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 62.210000000000001 111.138 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -69.96 -37.86 75.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 64.209999999999994 110.884 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 143' ' ' ILE . 63.0 t -54.9 -34.06 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 71.109999999999999 111.145 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.508 ' SG ' HG23 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -52.78 -47.99 67.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 71.530000000000001 110.91 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.788 HG12 HD11 ' A' ' 153' ' ' ILE . 22.0 t -74.5 -36.69 42.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 51.450000000000003 111.126 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -54.89 -26.92 38.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 63.140000000000001 110.92 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.58 -59.05 4.26 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 73.349999999999994 112.423 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 4.4 t -54.59 -34.09 61.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.788 0.328 . . . . 64.450000000000003 111.162 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.788 HD11 HG12 ' A' ' 149' ' ' VAL . 47.6 mt -70.24 -25.21 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 62.140000000000001 111.091 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.83 -49.92 32.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.704 -0.76 . . . . 54.030000000000001 112.514 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.65 -32.01 57.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.345 . . . . 55.340000000000003 110.928 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 20.3 t80 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 74.010000000000005 110.879 -179.964 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.83 0.263 . . . . 55.219999999999999 112.313 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.0 pp -52.29 -30.95 30.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 75.409999999999997 110.923 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -80.26 -32.01 38.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 72.409999999999997 110.914 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -73.12 -46.16 52.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 72.209999999999994 110.926 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 t -59.67 -39.99 86.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 72.430000000000007 111.157 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.447 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.19 -29.1 21.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 64.400000000000006 111.132 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -55.58 -27.24 48.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 63.310000000000002 110.869 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.56 ' HG ' HD12 ' A' ' 77' ' ' ILE . 4.1 mm? -91.27 -19.08 23.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.201 -0.454 . . . . 74.109999999999999 110.93 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.8 mm -76.51 -35.03 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 74.219999999999999 111.138 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.547 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.68 -57.14 22.91 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.609 0.719 . . . . 74.519999999999996 111.127 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.9 Cg_endo -69.75 -21.58 33.32 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.683 2.255 . . . . 63.539999999999999 112.308 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.621 ' O ' HG22 ' A' ' 42' ' ' ILE . 36.2 t -73.09 -46.91 48.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 63.229999999999997 110.871 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.5 p -81.53 -29.01 10.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 62.399999999999999 111.117 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.1 mt -50.89 -34.01 26.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 72.420000000000002 110.949 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.621 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.76 -34.64 52.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 74.549999999999997 111.113 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.3 p -65.66 -34.53 78.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 63.210000000000001 111.141 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.06 -49.01 72.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 72.019999999999996 110.864 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.0 tp -73.17 -43.21 61.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 61.009999999999998 110.922 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.94 -39.99 75.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 52.100000000000001 111.13 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.07 -32.45 58.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 73.310000000000002 111.102 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.523 ' O ' HD23 ' A' ' 52' ' ' LEU . 4.0 tp -51.57 -37.15 48.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 65.200000000000003 110.915 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.01 -35.78 4.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 51.299999999999997 111.09 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -67.08 -62.86 1.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 73.549999999999997 110.881 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.23 -40.33 70.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 75.430000000000007 110.922 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.523 HD23 ' O ' ' A' ' 48' ' ' LEU . 4.5 mm? -70.43 159.18 85.73 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.602 0.715 . . . . 73.019999999999996 110.887 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -172.28 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.615 2.21 . . . . 72.0 112.389 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.9 t 63.28 87.75 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 71.329999999999998 110.865 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -89.86 50.4 1.88 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 73.030000000000001 110.875 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.7 p -63.21 -173.38 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 71.319999999999993 110.898 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.738 ' O ' HG23 ' A' ' 61' ' ' THR . . . -52.2 -30.02 30.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.754 -0.736 . . . . 50.530000000000001 112.492 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -60.89 -34.88 75.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.977 0.417 . . . . 73.099999999999994 110.932 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -46.07 82.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 71.439999999999998 110.873 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 23.9 ttm -71.64 -46.49 58.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 62.130000000000003 110.889 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.738 HG23 ' O ' ' A' ' 57' ' ' GLY . 30.4 p -54.38 -27.18 34.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 72.430000000000007 111.109 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.24 -51.0 34.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 73.140000000000001 110.906 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 7.3 m -54.66 -46.53 74.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.429 . . . . 64.329999999999998 110.931 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 15.8 tt -71.22 -34.96 56.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 74.209999999999994 111.148 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 m -53.85 -28.07 33.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 63.210000000000001 110.898 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.0 t -58.08 -38.37 67.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.487 . . . . 61.340000000000003 111.169 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.91 -28.87 25.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 70.010000000000005 110.962 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.482 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.01 -39.04 79.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 75.310000000000002 110.927 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.48 -29.97 70.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 60.100000000000001 111.084 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.015 HD11 HG11 ' A' ' 102' ' ' VAL . 8.5 mt -66.04 -54.81 21.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 62.329999999999998 110.903 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -60.94 -38.37 85.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 71.140000000000001 111.148 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 68' ' ' LEU . 81.9 t -71.5 -37.19 63.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 73.319999999999993 111.124 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.514 ' CE2' HD12 ' A' ' 35' ' ' LEU . 49.7 t80 -68.55 -31.87 71.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 73.310000000000002 110.853 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.401 HD11 ' CD1' ' A' ' 95' ' ' LEU . 2.8 tt -75.03 -43.62 52.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 60.450000000000003 110.904 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.8 mp -73.32 -44.06 59.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 72.030000000000001 110.893 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.3 tt -55.55 -55.16 35.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 52.200000000000003 110.936 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.56 HD12 ' HG ' ' A' ' 35' ' ' LEU . 1.4 tt -62.91 -25.08 37.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 73.409999999999997 111.074 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.4 m -80.14 -14.62 58.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 75.329999999999998 110.848 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -54.43 -26.42 30.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 63.229999999999997 110.891 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.423 ' O ' ' C ' ' A' ' 81' ' ' VAL . 1.0 OUTLIER -62.42 -16.78 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 73.219999999999999 111.084 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 81' ' ' VAL . 2.4 p 35.53 80.95 0.25 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.601 0.715 . . . . 70.319999999999993 111.097 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 165.76 29.87 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.714 2.276 . . . . 73.120000000000005 112.376 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 -50.13 0.5 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.704 2.269 . . . . 54.350000000000001 112.388 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.5 t -136.98 -38.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 71.530000000000001 111.14 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 178.7 82.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 74.349999999999994 110.85 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -96.21 -17.82 20.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 64.099999999999994 110.914 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.593 ' HA ' HD23 ' A' ' 90' ' ' LEU . 4.3 m-20 -152.56 23.88 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 71.400000000000006 110.879 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.538 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -66.86 -57.8 10.82 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.63 0.728 . . . . 72.299999999999997 111.113 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.551 ' HG2' HD22 ' A' ' 90' ' ' LEU . 53.4 Cg_endo -69.79 -21.55 33.21 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.67 2.247 . . . . 72.219999999999999 112.322 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.593 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.4 mm? -74.15 -53.1 10.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.44 . . . . 71.5 110.934 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.32 -44.89 24.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 74.230000000000004 111.164 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.04 -39.2 48.83 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.736 -0.745 . . . . 53.210000000000001 112.446 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -73.75 -23.56 59.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.798 0.333 . . . . 73.450000000000003 110.936 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -75.35 -37.82 60.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 75.420000000000002 110.931 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.439 ' HA ' HG22 ' A' ' 98' ' ' THR . 12.9 mt -54.45 -29.85 50.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 73.510000000000005 110.89 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.36 -43.65 73.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 55.210000000000001 110.885 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.501 ' O ' HG22 ' A' ' 100' ' ' VAL . 39.0 t80 -75.17 -51.12 14.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 73.030000000000001 110.884 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.805 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.15 -29.74 33.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 73.030000000000001 111.129 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.78 -30.18 70.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.44 . . . . 73.319999999999993 110.909 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.85 -29.95 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 64.310000000000002 111.154 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.805 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -75.06 -33.22 61.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 63.149999999999999 110.915 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 1.015 HG11 HD11 ' A' ' 70' ' ' LEU . 30.1 m -76.91 -38.06 28.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 72.430000000000007 111.164 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.447 ' O ' HG13 ' A' ' 107' ' ' VAL . 74.5 m -72.51 -38.54 68.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 74.140000000000001 111.113 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -66.41 -31.84 72.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 73.299999999999997 110.87 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.01 -34.76 64.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 73.239999999999995 110.872 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.3 mt -73.83 -51.03 25.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 51.229999999999997 111.177 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.552 ' O ' HG12 ' A' ' 110' ' ' VAL . 35.2 m -53.94 -34.21 25.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 65.319999999999993 111.133 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.3 m -52.39 -32.51 39.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 32.020000000000003 111.144 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.0 p -50.41 -31.45 14.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 64.439999999999998 110.862 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.5 p -52.56 -32.8 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 75.209999999999994 111.118 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 27.3 m -66.2 -48.14 71.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 53.240000000000002 110.905 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.6 t -71.44 -35.98 59.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 63.219999999999999 111.144 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.8 mt -72.03 -34.68 68.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 75.109999999999999 110.912 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -55.44 -32.73 62.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 72.329999999999998 110.886 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.782 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.6 p -102.34 -24.28 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 64.540000000000006 111.121 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -81.48 -70.08 0.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 75.400000000000006 110.812 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 75.230000000000004 110.871 -179.965 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.518 -0.233 . . . . 73.109999999999999 112.518 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -87.17 -30.78 20.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.893 0.378 . . . . 54.240000000000002 110.882 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 23.4 m -73.66 -28.26 24.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 54.130000000000003 111.16 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.782 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -55.95 -25.12 42.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 54.420000000000002 111.146 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -52.96 -30.88 37.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 63.240000000000002 110.89 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 64.9 t -56.97 -56.66 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 51.439999999999998 111.141 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 31.9 mm -74.09 -36.42 44.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 75.219999999999999 111.133 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -62.84 -29.88 71.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 71.319999999999993 110.864 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.18 -27.6 35.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 60.439999999999998 110.909 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.9 tt -70.47 -50.22 40.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 73.409999999999997 110.928 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -72.09 -28.95 63.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 44.539999999999999 110.925 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.8 tt -56.77 -40.74 76.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 52.409999999999997 110.918 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -72.44 -51.07 21.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 73.140000000000001 110.976 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.746 ' O ' HG23 ' A' ' 147' ' ' VAL . 51.0 mm -57.96 -32.21 42.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 63.399999999999999 111.164 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -56.27 -57.14 13.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 73.439999999999998 110.878 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 21.7 t -66.73 -36.31 76.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.48 . . . . 74.439999999999998 111.108 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.34 -36.13 68.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 62.329999999999998 110.851 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 143' ' ' ILE . 94.4 t -58.82 -53.22 50.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 64.540000000000006 111.117 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -56.23 -32.6 64.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 73.430000000000007 110.893 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 67.5 t -71.07 -34.2 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 74.329999999999998 111.097 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -71.88 -27.44 62.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 73.219999999999999 110.939 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.07 -48.58 5.99 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.705 -0.76 . . . . 71.329999999999998 112.482 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.4 t -51.81 -39.39 58.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.751 0.31 . . . . 61.030000000000001 111.14 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 41.1 mt -63.09 -43.18 98.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 43.030000000000001 111.135 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -52.88 -48.55 57.27 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.747 -0.74 . . . . 74.049999999999997 112.495 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -31.94 66.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.792 0.329 . . . . 74.420000000000002 110.887 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 1.5 t80 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.443 . . . . 72.409999999999997 110.902 -179.944 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.821 0.259 . . . . 60.039999999999999 112.369 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 pp -51.99 -30.95 27.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 64.25 110.927 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -78.82 -33.49 46.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 75.099999999999994 110.879 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -72.46 -46.23 55.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 72.040000000000006 110.94 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -60.08 -40.02 88.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.511 . . . . 54.149999999999999 111.11 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.445 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.19 -29.11 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 74.200000000000003 111.101 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -55.8 -27.12 49.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 72.040000000000006 110.856 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.43 ' HB3' HD12 ' A' ' 77' ' ' ILE . 4.1 mm? -91.29 -19.19 23.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 71.310000000000002 110.942 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.6 mm -76.6 -34.94 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 65.030000000000001 111.134 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.543 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.3 mm -55.61 -57.21 22.35 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.659 0.742 . . . . 50.210000000000001 111.136 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.6 Cg_endo -69.82 -20.91 33.95 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.661 2.24 . . . . 64.109999999999999 112.336 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.633 ' O ' HG22 ' A' ' 42' ' ' ILE . 48.6 t -75.98 -44.65 38.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 75.409999999999997 110.908 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.61 -28.86 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 64.430000000000007 111.128 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.3 mt -50.97 -33.97 26.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 42.130000000000003 110.919 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 39' ' ' CYS . 0.7 OUTLIER -58.76 -34.65 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 44.210000000000001 111.131 179.844 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 p -65.81 -39.73 91.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 53.32 111.188 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.99 -51.11 62.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 74.310000000000002 110.809 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.9 tp -69.48 -38.81 77.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 74.310000000000002 110.896 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.7 -39.64 77.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 54.009999999999998 111.106 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.447 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.3 mp -64.33 -31.93 55.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 45.109999999999999 111.125 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.5 -38.7 55.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 74.209999999999994 110.927 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -101.45 -36.73 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 73.219999999999999 111.139 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -67.1 -64.62 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 71.129999999999995 110.894 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.447 ' HB2' HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -71.22 -61.96 1.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 74.129999999999995 110.944 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.2 mp -67.62 160.65 71.58 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.617 0.723 . . . . 75.219999999999999 110.928 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 161.53 45.56 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.722 2.282 . . . . 64.219999999999999 112.336 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -174.88 -69.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 72.099999999999994 110.895 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -178.37 -171.73 0.27 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 71.109999999999999 110.887 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 50.2 t -94.83 -74.39 0.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 64.310000000000002 110.892 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.75 -47.1 59.2 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 70.409999999999997 112.506 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.56 -35.54 70.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.916 0.389 . . . . 60.210000000000001 110.862 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -66.02 -44.58 84.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 75.409999999999997 110.885 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.605 ' O ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.35 -45.76 71.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 72.430000000000007 110.863 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 77.3 p -62.45 -26.09 68.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 73.409999999999997 111.131 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.24 -37.34 61.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 52.509999999999998 110.913 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 82.5 m -74.0 -48.65 28.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 74.319999999999993 110.839 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 60' ' ' MET . 24.7 pt -54.85 -32.26 25.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 73.409999999999997 111.121 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.1 -28.45 67.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 65.310000000000002 110.9 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.13 -38.25 66.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 74.049999999999997 111.141 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tp -52.89 -28.92 25.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 63.450000000000003 110.876 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.491 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.23 -38.94 78.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 74.319999999999993 110.933 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.65 -30.01 70.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 74.299999999999997 111.093 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.794 HD13 HG11 ' A' ' 102' ' ' VAL . 9.2 mt -65.31 -54.81 23.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 72.209999999999994 110.87 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.47 -38.63 87.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 65.510000000000005 111.151 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 68' ' ' LEU . 84.2 t -71.52 -32.96 47.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 61.210000000000001 111.13 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.582 ' O ' HG22 ' A' ' 77' ' ' ILE . 72.4 t80 -52.03 -34.09 41.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 73.140000000000001 110.889 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.1 tp -60.96 -51.11 70.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 74.409999999999997 110.939 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.5 mt -73.14 -32.13 64.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.47 . . . . 53.520000000000003 110.87 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.7 tt -66.69 -52.33 45.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 64.349999999999994 110.895 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 73' ' ' PHE . 1.5 tt -69.17 -30.55 46.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 74.129999999999995 111.117 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.0 m -80.19 -21.3 43.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 54.520000000000003 110.862 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.651 ' O ' HG23 ' A' ' 81' ' ' VAL . 4.8 mttt -60.38 -19.95 57.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.107 -0.497 . . . . 73.120000000000005 110.947 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -59.17 -20.71 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 72.129999999999995 111.132 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 79' ' ' LYS . 23.8 t 51.56 76.62 0.52 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.609 0.719 . . . . 65.099999999999994 111.118 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.429 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 54.0 Cg_endo -69.77 112.08 2.99 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.711 2.274 . . . . 63.130000000000003 112.35 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 82' ' ' PRO . 53.1 Cg_endo -69.82 -48.61 0.67 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.716 2.277 . . . . 72.120000000000005 112.309 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.5 t -117.05 -21.86 8.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 73.120000000000005 111.13 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.18 -48.74 61.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 73.430000000000007 110.86 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.3 tp 51.0 56.14 8.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.108 -0.496 . . . . 74.129999999999995 110.918 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.625 ' HA ' HD23 ' A' ' 90' ' ' LEU . 3.7 m-20 -95.36 24.03 5.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 75.310000000000002 110.875 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.536 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.2 -57.82 10.16 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.609 0.719 . . . . 60.420000000000002 111.132 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.9 Cg_endo -69.76 -20.8 34.35 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.706 2.27 . . . . 73.25 112.324 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.625 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.07 -53.13 10.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 74.329999999999998 110.939 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.526 HG12 HD21 ' A' ' 95' ' ' LEU . 60.6 t -65.37 -36.43 77.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 52.420000000000002 111.135 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.94 -41.46 52.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.761 -0.733 . . . . 52.119999999999997 112.464 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.6 mmpm? -75.21 -22.07 58.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.748 0.308 . . . . 74.239999999999995 110.867 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -75.68 -33.4 60.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.259 -0.428 . . . . 75.140000000000001 110.954 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.526 HD21 HG12 ' A' ' 91' ' ' VAL . 13.2 mt -53.39 -29.83 36.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 72.299999999999997 110.937 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.26 -43.65 73.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 64.450000000000003 110.923 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.489 ' O ' HG22 ' A' ' 100' ' ' VAL . 65.9 t80 -75.23 -51.16 14.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 74.420000000000002 110.901 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.786 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.17 -29.93 34.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 43.450000000000003 111.126 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.0 mmt -66.53 -30.15 70.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 74.310000000000002 110.892 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.85 -30.07 13.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 74.430000000000007 111.135 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.786 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.88 -33.2 62.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 63.409999999999997 110.94 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.794 HG11 HD13 ' A' ' 70' ' ' LEU . 31.1 m -76.92 -38.08 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 71.299999999999997 111.129 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 78.8 m -72.48 -38.55 68.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 75.329999999999998 111.107 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -66.86 -32.03 73.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 74.040000000000006 110.888 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.0 t -71.56 -35.55 70.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 75.230000000000004 110.831 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.4 mt -71.7 -51.92 29.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 71.040000000000006 111.112 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.548 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.7 p -54.05 -36.36 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 61.539999999999999 111.139 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.1 m -52.34 -32.41 37.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 62.32 111.182 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.0 m -50.46 -31.32 14.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 72.510000000000005 110.836 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.548 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.3 p -52.49 -32.83 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 61.200000000000003 111.089 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 23.6 m -65.51 -44.35 87.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 64.319999999999993 110.926 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 82.1 t -75.96 -35.83 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 75.340000000000003 111.067 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.449 HD22 ' O ' ' A' ' 117' ' ' HIS . 90.0 mt -71.95 -31.79 66.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 75.219999999999999 110.95 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -60.03 -31.71 70.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 74.510000000000005 110.919 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.765 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.3 p -102.32 -24.77 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 64.430000000000007 111.151 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -90.47 -74.14 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 62.420000000000002 110.869 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.449 ' O ' HD22 ' A' ' 113' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 73.219999999999999 110.896 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.516 -0.234 . . . . 73.150000000000006 112.516 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -87.9 -26.48 22.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.924 0.392 . . . . 72.129999999999995 110.911 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.5 m -55.59 -30.79 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 55.130000000000003 111.122 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.765 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -70.02 -26.08 63.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 51.0 111.101 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 31.8 mmt -52.95 -30.99 37.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 72.010000000000005 110.904 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 52.4 t -57.01 -58.43 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 73.200000000000003 111.109 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 44.5 mm -73.98 -37.77 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 71.140000000000001 111.135 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -61.17 -30.4 70.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 71.140000000000001 110.9 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.78 -28.19 33.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 74.319999999999993 110.903 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.0 tp -65.4 -50.81 64.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 75.239999999999995 110.916 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -73.78 -42.89 60.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 74.329999999999998 110.876 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 tt -52.01 -32.78 35.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 54.200000000000003 110.892 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -66.63 -43.01 85.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 74.030000000000001 110.931 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.751 ' O ' HG23 ' A' ' 147' ' ' VAL . 4.9 mt -76.43 -32.15 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 71.420000000000002 111.099 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -55.96 -56.41 21.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 65.040000000000006 110.884 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.2 m -60.72 -35.22 62.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 63.229999999999997 111.072 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -64.68 -41.52 95.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 63.049999999999997 110.855 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 143' ' ' ILE . 88.9 t -58.39 -34.23 49.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 61.009999999999998 111.106 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 89.8 m -57.79 -51.98 67.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 41.100000000000001 110.842 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.454 ' O ' HG22 ' A' ' 153' ' ' ILE . 57.0 t -75.99 -35.23 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 72.129999999999995 111.089 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -63.42 -37.73 88.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 65.439999999999998 110.919 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.25 -46.14 9.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.792 -0.718 . . . . 71.340000000000003 112.445 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 95.4 m -59.96 -51.99 67.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.785 0.326 . . . . 71.540000000000006 111.16 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 149' ' ' VAL . 20.4 tt -55.9 -26.63 21.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 73.329999999999998 111.129 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -52.0 -49.99 46.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.764 -0.732 . . . . 42.229999999999997 112.447 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.2 mmt -71.65 -31.81 67.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 64.400000000000006 110.919 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 50.0 t80 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 75.040000000000006 110.904 -179.952 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.231 0.147 0 CA-C-O 120.822 0.259 . . . . 74.010000000000005 112.354 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.07 -30.96 65.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 72.310000000000002 110.86 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -78.26 -31.82 49.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 74.209999999999994 110.917 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.627 ' CE1' HG22 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -73.63 -44.87 55.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 74.040000000000006 110.876 -179.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -60.55 -39.86 89.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 35.310000000000002 111.156 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.437 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.18 -29.07 21.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 52.350000000000001 111.135 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.03 -27.08 51.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 72.230000000000004 110.898 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.31 -19.19 23.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 71.140000000000001 110.904 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.4 mm -76.87 -34.62 22.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 55.200000000000003 111.112 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.537 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.78 -57.08 23.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.614 0.721 . . . . 70.010000000000005 111.13 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.4 Cg_endo -69.77 -19.34 36.21 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.709 2.273 . . . . 64.219999999999999 112.348 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.63 ' O ' HG22 ' A' ' 42' ' ' ILE . 37.4 t -70.12 -46.29 65.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 74.420000000000002 110.872 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 p -81.53 -28.91 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 74.049999999999997 111.16 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 38' ' ' PRO . 11.5 mt -51.04 -33.91 27.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 51.229999999999997 110.902 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.63 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.73 -34.64 52.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 63.409999999999997 111.146 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 p -65.73 -36.56 83.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 62.25 111.096 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.37 -44.77 72.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 71.430000000000007 110.881 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.01 -42.3 39.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 55.219999999999999 110.91 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.11 -34.63 66.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 73.299999999999997 111.126 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.409 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.1 mp -64.54 -32.39 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 75.040000000000006 111.121 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.4 tp -51.55 -37.43 49.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 74.200000000000003 110.932 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.69 HG23 ' HD3' ' A' ' 59' ' ' LYS . 7.9 p -101.98 -36.13 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 45.229999999999997 111.144 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -68.31 -64.96 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 75.420000000000002 110.885 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.458 ' CE2' HD22 ' A' ' 141' ' ' LEU . 0.3 OUTLIER -56.36 -39.15 72.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.148 -0.478 . . . . 74.329999999999998 110.916 -179.823 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.7 tp -57.61 139.0 81.79 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.613 0.72 . . . . 74.409999999999997 110.871 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 178.81 4.21 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.663 2.242 . . . . 50.240000000000002 112.349 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.23 161.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 64.219999999999999 110.859 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -160.88 175.9 12.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.102 -0.499 . . . . 74.549999999999997 110.87 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.5 p -176.19 -174.36 0.62 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 41.520000000000003 110.892 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 61' ' ' THR . . . -57.52 -31.45 63.32 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.737 -0.744 . . . . 62.409999999999997 112.486 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -75.09 -54.74 6.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.882 0.372 . . . . 74.510000000000005 110.904 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.69 ' HD3' HG23 ' A' ' 49' ' ' VAL . 3.3 mttm -53.2 -45.33 68.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 71.519999999999996 110.919 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -57.68 -51.74 68.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 73.450000000000003 110.844 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 57' ' ' GLY . 60.4 p -65.37 -28.43 69.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.264 -0.425 . . . . 75.349999999999994 111.136 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.51 -34.57 67.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 74.450000000000003 110.934 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.481 ' O ' HG12 ' A' ' 66' ' ' VAL . 80.2 m -72.78 -51.99 16.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 63.140000000000001 110.913 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.5 tt -54.39 -33.06 25.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 71.129999999999995 111.112 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.69 -25.24 6.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 74.049999999999997 110.858 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 63' ' ' CYS . 9.9 p -57.13 -32.62 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.485 . . . . 72.099999999999994 111.127 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.93 -35.36 61.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 72.409999999999997 110.917 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.503 ' O ' HD22 ' A' ' 68' ' ' LEU . 2.0 tm? -68.96 -46.7 67.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 63.200000000000003 110.891 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.8 -29.53 19.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 60.109999999999999 111.089 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.773 HD22 HG11 ' A' ' 102' ' ' VAL . 40.9 mt -57.83 -54.51 46.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 75.450000000000003 110.918 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 68' ' ' LEU . 1.2 t -63.45 -27.28 69.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 61.350000000000001 111.156 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.6 t -71.35 -34.11 52.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 70.230000000000004 111.169 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -52.07 -30.11 24.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 75.099999999999994 110.865 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.608 HD11 HD11 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -74.93 -39.49 61.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 72.450000000000003 110.923 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.0 mp -73.24 -40.13 64.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 73.120000000000005 110.902 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.6 -55.05 22.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 73.239999999999995 110.937 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 tt -56.22 -24.69 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 73.209999999999994 111.17 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.1 p -68.1 -15.0 63.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 74.319999999999993 110.876 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.729 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -60.11 -19.83 55.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 54.100000000000001 110.94 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.627 HG22 ' CE1' ' A' ' 31' ' ' TYR . 1.1 pt -53.57 -27.17 14.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 61.219999999999999 111.134 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 79' ' ' LYS . 50.2 t 61.41 75.23 0.45 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.661 0.743 . . . . 70.239999999999995 111.101 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 167.46 24.35 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.663 2.242 . . . . 64.540000000000006 112.395 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -48.64 0.67 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.671 2.247 . . . . 71.420000000000002 112.35 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 86' ' ' LEU . 9.6 t -117.26 -19.63 9.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 71.010000000000005 111.15 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.3 t 63.72 38.37 9.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.451 . . . . 72.349999999999994 110.822 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.456 ' H ' HG23 ' A' ' 84' ' ' THR . 1.2 tp -99.72 35.33 2.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.144 -0.48 . . . . 61.240000000000002 110.94 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.634 ' HA ' HD23 ' A' ' 90' ' ' LEU . 1.8 m-20 -95.58 24.37 5.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 64.450000000000003 110.887 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.521 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.31 -57.73 10.13 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.623 0.725 . . . . 40.229999999999997 111.195 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.535 ' HG2' HD22 ' A' ' 90' ' ' LEU . 53.6 Cg_endo -69.82 -20.32 34.71 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.664 2.242 . . . . 63.109999999999999 112.329 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.634 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.14 -53.09 10.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 71.519999999999996 110.949 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.48 HG12 HD21 ' A' ' 95' ' ' LEU . 39.7 t -80.31 -20.53 11.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 74.409999999999997 111.116 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.28 -31.49 27.45 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.775 -0.726 . . . . 71.340000000000003 112.494 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -35.39 59.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.8 0.333 . . . . 51.219999999999999 110.883 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -65.69 -44.84 84.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 75.129999999999995 110.872 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.608 HD11 HD11 ' A' ' 74' ' ' LEU . 7.5 mt -51.94 -29.81 21.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 71.140000000000001 110.953 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -43.38 76.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 72.209999999999994 110.892 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.498 ' O ' HG22 ' A' ' 100' ' ' VAL . 33.7 t80 -75.22 -51.83 12.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 74.420000000000002 110.9 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.792 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.07 -29.97 33.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 74.25 111.185 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.2 mmt -66.61 -30.04 70.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 65.200000000000003 110.923 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.83 -30.04 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 73.230000000000004 111.111 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.792 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -74.92 -33.31 61.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 73.109999999999999 110.947 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.773 HG11 HD22 ' A' ' 70' ' ' LEU . 31.3 m -76.8 -38.07 29.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 74.329999999999998 111.115 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.489 ' HA ' HD12 ' A' ' 106' ' ' ILE . 71.4 m -72.49 -39.81 67.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 71.430000000000007 111.149 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -64.69 -31.96 73.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 74.129999999999995 110.898 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.4 t -71.54 -35.75 70.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 51.409999999999997 110.859 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 103' ' ' THR . 11.7 mt -71.58 -51.83 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 73.5 111.116 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.556 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.5 p -53.97 -35.1 27.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 72.310000000000002 111.13 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.6 m -52.34 -32.43 38.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 75.25 111.146 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.4 m -50.42 -31.52 15.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 50.039999999999999 110.871 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.5 p -52.49 -32.79 17.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.102 -0.499 . . . . 71.430000000000007 111.153 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 42.1 m -66.59 -45.66 78.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 63.539999999999999 110.868 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 88.4 t -73.91 -34.7 40.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 75.420000000000002 111.128 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.07 -42.02 66.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 75.109999999999999 110.906 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -52.02 -30.71 26.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 75.319999999999993 110.901 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.77 HG11 ' HB2' ' A' ' 133' ' ' ALA . 9.4 p -102.31 -23.07 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 71.340000000000003 111.13 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -52.49 -66.22 0.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 73.120000000000005 110.896 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 74.310000000000002 110.876 179.994 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.467 -0.253 . . . . 72.200000000000003 112.467 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -63.29 -26.12 68.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.961 0.41 . . . . 71.25 110.953 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.8 m -56.9 -33.68 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.116 -0.493 . . . . 62.210000000000001 111.15 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.77 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -65.2 -25.22 67.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 41.420000000000002 111.091 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 16.7 mmt -53.0 -30.92 38.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 62.119999999999997 110.833 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 49.2 t -56.96 -63.86 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 62.039999999999999 111.11 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.0 mp -70.46 -38.35 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 65.129999999999995 111.134 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -60.56 -30.02 69.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 73.409999999999997 110.879 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.5 mtt-85 -56.18 -26.03 49.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 75.400000000000006 110.881 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.01 -50.99 35.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 74.140000000000001 110.941 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -73.97 -28.44 61.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 64.430000000000007 110.862 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.492 ' O ' HG23 ' A' ' 145' ' ' VAL . 0.2 OUTLIER -64.02 -36.4 83.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 71.420000000000002 110.913 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -58.99 -48.74 80.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 73.109999999999999 110.883 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.724 ' O ' HG23 ' A' ' 147' ' ' VAL . 58.5 mt -77.04 -32.29 19.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 63.229999999999997 111.159 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.0 -56.88 15.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 75.030000000000001 110.89 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 141' ' ' LEU . 21.6 t -60.42 -35.06 60.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 70.420000000000002 111.155 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.06 -32.97 74.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 51.450000000000003 110.892 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 143' ' ' ILE . 92.9 t -53.98 -34.11 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 62.25 111.139 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 4.8 t -52.03 -42.98 63.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 73.140000000000001 110.878 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 25.5 t -75.99 -33.03 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 73.530000000000001 111.124 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -52.44 -49.9 63.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 73.230000000000004 110.93 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.2 -19.78 73.87 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.71 -0.757 . . . . 74.409999999999997 112.53 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.4 m -63.46 -52.85 59.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.783 0.325 . . . . 43.229999999999997 111.167 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 89.2 mt -76.49 -25.89 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 71.140000000000001 111.149 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -52.19 -29.39 29.15 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 31.039999999999999 112.502 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.92 -31.9 51.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.737 0.303 . . . . 63.420000000000002 110.883 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 74.099999999999994 110.843 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.192 0 CA-C-O 120.835 0.265 . . . . 73.540000000000006 112.319 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 pp -52.08 -30.99 28.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 73.209999999999994 110.933 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -80.08 -32.52 39.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 64.519999999999996 110.838 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -72.66 -46.25 54.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.206 -0.452 . . . . 71.040000000000006 110.892 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -59.81 -39.95 86.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.492 . . . . 54.109999999999999 111.148 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.431 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.13 -29.06 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 53.25 111.135 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.65 -27.59 50.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 73.400000000000006 110.886 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.557 ' HG ' HD12 ' A' ' 77' ' ' ILE . 4.1 mm? -90.78 -18.14 25.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 60.240000000000002 110.896 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.9 mm -76.33 -35.31 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 71.010000000000005 111.083 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.549 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.77 -57.13 23.23 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.605 0.717 . . . . 75.230000000000004 111.098 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.9 Cg_endo -69.8 -21.83 32.74 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.689 2.259 . . . . 74.519999999999996 112.374 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.618 ' O ' HG22 ' A' ' 42' ' ' ILE . 43.6 t -73.86 -44.43 55.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 73.540000000000006 110.826 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.57 -28.91 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 74.319999999999993 111.138 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mt -50.97 -33.93 26.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 73.349999999999994 110.948 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.73 -34.68 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 74.540000000000006 111.122 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.2 p -65.69 -42.84 90.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 72.329999999999998 111.093 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.99 -41.74 64.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.425 . . . . 74.349999999999994 110.829 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.4 tp -77.03 -38.43 52.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 72.209999999999994 110.946 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.8 -52.14 67.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 54.229999999999997 111.056 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.43 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.4 mp -49.72 -31.44 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 71.150000000000006 111.079 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.2 tp -50.79 -42.3 57.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 65.400000000000006 110.926 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.421 HG11 HD23 ' A' ' 62' ' ' LEU . 7.1 p -101.46 -37.5 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 63.100000000000001 111.12 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -63.68 -64.46 0.89 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 75.400000000000006 110.85 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.647 ' CZ ' HD23 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -72.89 -60.73 2.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 73.430000000000007 110.897 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -78.39 159.22 75.35 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.549 0.69 . . . . 75.420000000000002 110.943 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 138.68 38.31 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.657 2.238 . . . . 73.450000000000003 112.321 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.3 112.67 0.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 43.409999999999997 110.854 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 56.32 -176.06 0.05 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.145 -0.479 . . . . 74.219999999999999 110.859 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 50.0 t -113.7 -74.51 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 54.229999999999997 110.859 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.428 ' O ' HG23 ' A' ' 61' ' ' THR . . . -61.71 -23.01 62.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.742 . . . . 42.439999999999998 112.493 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -52.11 -34.96 46.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.914 0.387 . . . . 70.319999999999993 110.932 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -51.96 60.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 70.400000000000006 110.911 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -48.56 68.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 65.420000000000002 110.852 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 57' ' ' GLY . 29.3 p -53.07 -31.88 44.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 74.319999999999993 111.134 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.516 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -69.2 -50.84 43.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 63.420000000000002 110.93 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 68.1 m -52.97 -47.75 67.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 71.409999999999997 110.861 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.3 tt -72.31 -35.04 51.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 72.450000000000003 111.141 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.67 -25.61 60.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 61.240000000000002 110.879 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 62' ' ' LEU . 21.7 t -63.09 -41.39 92.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.101 -0.5 . . . . 63.409999999999997 111.119 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 tt -52.88 -28.87 25.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 63.119999999999997 110.991 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.489 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.26 -39.1 78.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 55.329999999999998 110.872 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.41 -30.03 70.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 75.209999999999994 111.099 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.503 HD13 HG11 ' A' ' 102' ' ' VAL . 9.8 mt -64.78 -54.7 27.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 74.049999999999997 110.957 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.94 -38.26 87.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 55.229999999999997 111.147 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 68' ' ' LEU . 77.0 t -71.44 -32.82 47.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 65.200000000000003 111.134 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.499 ' O ' HG22 ' A' ' 77' ' ' ILE . 73.6 t80 -61.85 -29.85 70.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 64.209999999999994 110.89 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.739 HD11 HD13 ' A' ' 95' ' ' LEU . 3.1 tt -71.99 -44.93 62.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 74.420000000000002 110.941 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.7 mp -73.22 -39.31 65.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 71.430000000000007 110.931 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.28 -51.67 67.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.129999999999995 110.907 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.557 HD12 ' HG ' ' A' ' 35' ' ' LEU . 1.8 tt -68.17 -30.2 47.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 75.200000000000003 111.092 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.1 t -80.53 -14.93 57.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 75.150000000000006 110.821 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.29 -9.9 58.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.151 -0.477 . . . . 74.409999999999997 110.903 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 77' ' ' ILE . 1.1 pp -63.84 -15.37 16.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.422 . . . . 73.340000000000003 111.147 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 81' ' ' VAL . 2.4 p 35.79 81.21 0.25 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.609 0.718 . . . . 64.0 111.137 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 167.3 24.78 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.704 2.269 . . . . 74.019999999999996 112.364 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 -48.61 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.657 2.238 . . . . 73.510000000000005 112.313 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.0 t -117.26 -19.48 9.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 74.319999999999993 111.125 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.54 46.99 3.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 55.439999999999998 110.866 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.1 -11.1 60.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 62.240000000000002 110.901 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.634 ' HA ' HD23 ' A' ' 90' ' ' LEU . 3.7 m-20 -95.36 23.96 5.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 75.219999999999999 110.892 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.58 -57.8 9.56 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.626 0.727 . . . . 60.240000000000002 111.161 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.5 Cg_endo -69.77 -20.02 35.31 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.679 2.253 . . . . 64.200000000000003 112.358 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.634 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.22 -53.1 10.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 74.430000000000007 110.863 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 87' ' ' ASP . 40.3 t -68.6 -43.42 83.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 73.120000000000005 111.146 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.07 -38.86 48.43 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.76 . . . . 65.040000000000006 112.497 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.66 -24.39 59.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.783 0.325 . . . . 72.549999999999997 110.902 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -74.5 -37.92 62.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 72.310000000000002 110.897 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.739 HD13 HD11 ' A' ' 74' ' ' LEU . 12.5 mt -54.79 -29.57 54.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 75.140000000000001 110.927 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.0 mmt -71.28 -41.56 69.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 72.439999999999998 110.884 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.494 ' O ' HG22 ' A' ' 100' ' ' VAL . 23.3 t80 -75.28 -51.06 14.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 64.010000000000005 110.888 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.786 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.09 -29.87 32.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.474 . . . . 60.140000000000001 111.18 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.68 -30.09 70.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 63.329999999999998 110.85 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.8 -30.05 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.443 . . . . 72.219999999999999 111.113 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.786 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.93 -32.99 61.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 74.340000000000003 110.924 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.503 HG11 HD13 ' A' ' 70' ' ' LEU . 29.4 m -76.6 -37.46 29.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 72.439999999999998 111.091 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.716 ' O ' HG23 ' A' ' 107' ' ' VAL . 55.3 m -72.98 -46.6 51.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 72.049999999999997 111.154 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -51.96 -31.7 30.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 43.420000000000002 110.916 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.8 p -74.59 -48.73 24.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 72.230000000000004 110.813 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.643 HD12 ' HA ' ' A' ' 103' ' ' THR . 9.8 mt -56.15 -34.52 39.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 63.32 111.148 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 103' ' ' THR . 22.1 t -53.85 -45.55 62.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 62.32 111.083 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.9 m -52.3 -32.38 37.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 64.319999999999993 111.153 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.5 t -50.28 -31.49 14.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 74.340000000000003 110.857 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.5 p -52.51 -32.83 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 74.340000000000003 111.159 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 34.7 m -65.89 -44.52 85.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 73.219999999999999 110.874 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 83.8 t -75.52 -35.78 33.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 74.439999999999998 111.154 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.8 mt -72.21 -33.62 67.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 71.120000000000005 110.916 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -62.6 -28.95 70.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 64.540000000000006 110.93 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.8 HG11 ' HB2' ' A' ' 133' ' ' ALA . 11.2 p -102.39 -20.94 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 54.340000000000003 111.084 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -76.08 73.69 2.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 70.329999999999998 110.833 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 73.230000000000004 110.836 179.964 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.543 -0.223 . . . . 42.229999999999997 112.543 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -62.14 -26.39 68.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.968 0.413 . . . . 74.239999999999995 110.945 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.4 m -54.14 -27.2 16.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 42.229999999999997 111.147 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.8 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -56.62 -26.25 55.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 55.340000000000003 111.136 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 11.3 ptm -53.04 -30.79 37.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 62.43 110.846 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 58.6 t -56.9 -61.55 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 73.140000000000001 111.159 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.481 ' H ' HD12 ' A' ' 136' ' ' ILE . 4.5 mp -74.06 -25.96 20.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 74.109999999999999 111.136 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.442 ' OD2' HD13 ' A' ' 141' ' ' LEU . 25.5 t0 -58.5 -29.96 66.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.462 . . . . 72.430000000000007 110.884 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -30.1 23.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 73.439999999999998 110.863 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 7.0 tp -63.22 -50.73 69.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 61.439999999999998 110.916 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -74.03 -41.22 62.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 62.240000000000002 110.882 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.647 HD23 ' CZ ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -51.93 -31.98 31.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 73.209999999999994 110.915 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.18 -46.25 84.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.192 -0.458 . . . . 73.310000000000002 110.913 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.745 ' O ' HG23 ' A' ' 147' ' ' VAL . 3.9 mt -76.98 -31.96 19.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 70.120000000000005 111.155 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -56.01 -55.89 27.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 71.239999999999995 110.873 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 141' ' ' LEU . 31.8 t -54.01 -36.68 32.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 73.439999999999998 111.153 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -70.05 -41.38 74.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 73.209999999999994 110.867 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 143' ' ' ILE . 96.7 t -54.07 -34.45 26.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 45.219999999999999 111.087 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 95.6 m -51.9 -52.08 52.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 63.310000000000002 110.873 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.46 ' O ' HG22 ' A' ' 153' ' ' ILE . 31.5 t -76.06 -33.26 24.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 74.140000000000001 111.14 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.72 -27.05 37.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 75.140000000000001 110.846 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.97 -57.67 3.42 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.733 -0.746 . . . . 71.010000000000005 112.485 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 92.5 m -61.35 -45.01 96.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.779 0.323 . . . . 72.140000000000001 111.185 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.46 HG22 ' O ' ' A' ' 149' ' ' VAL . 20.3 tt -55.9 -25.86 19.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 73.400000000000006 111.128 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -51.93 -50.07 45.99 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.746 -0.74 . . . . 74.099999999999994 112.454 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.66 -31.84 63.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.773 0.32 . . . . 71.530000000000001 110.85 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 75.540000000000006 110.9 -179.92 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.822 0.259 . . . . 61.329999999999998 112.354 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 pp -53.57 -30.93 44.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 63.530000000000001 110.917 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -80.58 -28.56 37.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 60.5 110.898 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.475 ' CE1' HG21 ' A' ' 80' ' ' ILE . 7.5 t80 -76.74 -44.79 31.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 74.420000000000002 110.913 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.4 t -62.87 -39.54 94.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 73.140000000000001 111.182 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.442 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -73.79 -29.03 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 74.299999999999997 111.12 179.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -68.87 -25.31 64.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 72.230000000000004 110.922 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.51 ' CD1' HD12 ' A' ' 77' ' ' ILE . 3.6 mm? -92.0 -27.81 17.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 73.230000000000004 110.884 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.532 ' O ' HG12 ' A' ' 40' ' ' VAL . 26.2 mm -79.51 -28.38 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 74.349999999999994 111.145 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.549 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.96 -57.15 23.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.575 0.702 . . . . 72.299999999999997 111.086 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.79 -24.82 29.1 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.676 2.251 . . . . 72.409999999999997 112.356 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.636 ' O ' HG22 ' A' ' 42' ' ' ILE . 3.1 t -74.57 -45.4 45.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 60.109999999999999 110.892 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 36' ' ' ILE . 8.9 p -81.45 -28.91 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 53.329999999999998 111.161 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mt -51.02 -33.96 27.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 64.319999999999993 110.898 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 39' ' ' CYS . 0.8 OUTLIER -58.68 -34.6 52.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 72.109999999999999 111.138 179.85 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.69 -34.98 79.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 64.549999999999997 111.094 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 m -57.33 -52.6 64.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 75.140000000000001 110.836 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.8 tp -70.16 -34.45 73.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 54.210000000000001 110.922 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.24 -44.89 90.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.452 . . . . 10.23 111.11 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.432 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.3 mp -64.26 -31.98 55.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 63.229999999999997 111.137 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mp -51.39 -38.88 55.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 73.450000000000003 110.916 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.782 HG22 ' HD3' ' A' ' 59' ' ' LYS . 7.9 p -101.45 -36.7 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 63.030000000000001 111.107 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -67.05 -64.65 0.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 63.109999999999999 110.861 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.432 ' HB2' HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -71.4 -60.08 2.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 54.530000000000001 110.936 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.1 mp -78.2 160.67 72.82 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.609 0.719 . . . . 64.019999999999996 110.92 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 157.25 61.14 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.711 2.274 . . . . 73.239999999999995 112.329 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.486 ' HB3' HG23 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -179.32 -170.19 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 71.430000000000007 110.845 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.33 171.21 1.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 71.209999999999994 110.859 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 5.6 t -81.51 -68.11 0.72 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 71.150000000000006 110.922 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.53 -23.64 43.66 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.782 -0.723 . . . . 70.319999999999993 112.495 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -52.36 -42.89 64.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.933 0.397 . . . . 72.430000000000007 110.908 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.782 ' HD3' HG22 ' A' ' 49' ' ' VAL . 1.1 mmmt -53.53 -43.45 68.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 73.0 110.868 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.93 -50.77 26.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 51.130000000000003 110.867 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.2 p -53.39 -44.64 68.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 64.540000000000006 111.136 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.93 -28.93 64.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 71.299999999999997 110.93 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.468 ' HB3' HG23 ' A' ' 106' ' ' ILE . 1.3 m -71.43 -44.96 63.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 63.25 110.889 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.8 tt -72.41 -35.09 50.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 61.119999999999997 111.118 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -55.96 -26.25 47.27 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.174 -0.466 . . . . 70.5 110.809 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.2 t -58.68 -38.63 72.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 74.219999999999999 111.113 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.89 -28.93 25.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 55.109999999999999 110.918 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.492 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.16 -39.14 78.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 75.129999999999995 110.893 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.4 -30.12 70.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 50.539999999999999 111.079 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.685 HD22 HG11 ' A' ' 102' ' ' VAL . 9.7 mt -64.93 -54.66 27.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.448 . . . . 72.239999999999995 110.93 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.92 -38.25 87.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 62.030000000000001 111.139 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 68' ' ' LEU . 77.3 t -71.44 -32.85 47.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 63.399999999999999 111.165 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -51.87 -38.39 55.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 71.129999999999995 110.864 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.3 tp -75.12 -30.87 60.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.487 . . . . 70.420000000000002 110.905 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 65.5 mt -73.26 -54.03 9.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 64.200000000000003 110.888 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.61 -54.16 47.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 75.310000000000002 110.928 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.51 HD12 ' CD1' ' A' ' 35' ' ' LEU . 3.4 tt -55.49 -27.59 21.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 71.030000000000001 111.135 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.5 m -80.03 -24.8 40.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 62.509999999999998 110.895 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.686 ' O ' HG23 ' A' ' 81' ' ' VAL . 14.7 mttp -64.74 -15.27 61.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 74.439999999999998 110.853 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.475 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.2 pp -56.16 -24.38 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 64.400000000000006 111.136 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 79' ' ' LYS . 22.1 t 63.81 75.11 0.4 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.595 0.712 . . . . 64.209999999999994 111.118 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 166.69 26.77 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.71 2.273 . . . . 74.530000000000001 112.302 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -49.1 0.6 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.679 2.253 . . . . 62.539999999999999 112.347 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.9 t -118.88 -25.61 6.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 70.329999999999998 111.136 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 64.26 47.99 3.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 61.310000000000002 110.831 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.18 37.15 1.59 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 72.140000000000001 110.902 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.623 ' HA ' HD23 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -112.44 22.76 14.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 72.109999999999999 110.856 179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.54 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -68.05 -57.89 8.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.578 0.704 . . . . 52.140000000000001 111.106 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.7 Cg_endo -69.74 -19.93 35.6 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.653 2.236 . . . . 43.530000000000001 112.341 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.623 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.09 -51.54 15.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 72.519999999999996 110.964 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.569 HG12 HD21 ' A' ' 95' ' ' LEU . 39.1 t -80.17 -24.38 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 75.030000000000001 111.089 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.7 -50.0 44.86 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.729 -0.748 . . . . 74.140000000000001 112.496 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -35.46 80.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.78 0.324 . . . . 75.219999999999999 110.879 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -60.51 -40.1 90.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.218 -0.446 . . . . 64.420000000000002 110.906 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.569 HD21 HG12 ' A' ' 91' ' ' VAL . 8.5 mt -51.79 -29.87 20.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 71.109999999999999 110.918 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.21 -43.62 73.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 73.140000000000001 110.859 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.508 ' O ' HG22 ' A' ' 100' ' ' VAL . 51.7 t80 -75.19 -51.34 13.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 75.0 110.863 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.783 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.07 -29.91 32.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 64.409999999999997 111.169 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.9 mmt -66.69 -30.11 70.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 74.540000000000006 110.834 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.73 -30.12 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 72.129999999999995 111.123 179.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.783 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.89 -33.26 62.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 71.219999999999999 110.944 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.685 HG11 HD22 ' A' ' 70' ' ' LEU . 30.9 m -76.95 -38.04 27.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 70.319999999999993 111.141 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.503 ' HA ' HD12 ' A' ' 106' ' ' ILE . 69.8 m -72.51 -40.67 66.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 73.209999999999994 111.158 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -63.41 -31.98 73.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 72.129999999999995 110.87 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.29 -32.98 69.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 60.509999999999998 110.841 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 103' ' ' THR . 20.3 mt -73.96 -51.69 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 63.240000000000002 111.131 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -54.21 -34.29 27.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 71.230000000000004 111.164 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.5 m -53.0 -34.97 58.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 64.430000000000007 111.119 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.0 t -52.24 -48.34 65.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 72.400000000000006 110.845 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.7 t -52.91 -33.83 19.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.493 . . . . 61.350000000000001 111.155 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . 0.46 ' O ' HG12 ' A' ' 115' ' ' VAL . 31.2 m -65.09 -39.9 93.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 55.140000000000001 110.875 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 65.6 t -79.98 -36.14 16.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 74.409999999999997 111.175 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.611 HD21 ' HE2' ' A' ' 59' ' ' LYS . 87.6 mt -72.86 -51.7 17.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 74.430000000000007 110.886 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -51.73 -29.5 18.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 72.299999999999997 110.901 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.82 HG11 ' HB2' ' A' ' 133' ' ' ALA . 12.9 p -99.43 -16.81 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 63.450000000000003 111.157 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -54.26 -52.53 61.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 73.450000000000003 110.924 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 74.140000000000001 110.86 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.503 -0.239 . . . . 61.240000000000002 112.503 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -76.37 -27.0 56.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.938 0.399 . . . . 64.450000000000003 110.911 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.8 m -58.62 -37.39 64.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 71.329999999999998 111.158 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.82 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -72.8 -29.3 63.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 51.450000000000003 111.074 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 14.6 mmt -56.66 -31.02 63.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 73.340000000000003 110.806 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 65.9 t -56.99 -65.9 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 74.120000000000005 111.146 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 38.9 mm -69.17 -33.07 56.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 63.509999999999998 111.12 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -64.27 -29.97 71.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 64.140000000000001 110.859 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.09 -29.1 39.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 64.230000000000004 110.873 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.96 -44.54 61.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 64.099999999999994 110.926 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -74.0 -53.96 8.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 53.100000000000001 110.895 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.596 ' O ' HG23 ' A' ' 145' ' ' VAL . 0.8 OUTLIER -52.23 -36.98 53.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 73.129999999999995 110.96 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 32.9 t-105 -52.98 -51.48 61.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 73.340000000000003 110.905 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.621 ' O ' HG23 ' A' ' 147' ' ' VAL . 74.3 mt -76.99 -38.81 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 75.150000000000006 111.127 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -56.14 -57.15 13.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 53.340000000000003 110.839 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 141' ' ' LEU . 46.2 t -56.74 -34.96 44.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 73.030000000000001 111.128 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -66.58 -32.95 74.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 74.409999999999997 110.864 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 143' ' ' ILE . 94.5 t -53.99 -33.96 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 73.299999999999997 111.128 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.97 -36.77 50.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 72.430000000000007 110.845 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 83.1 t -75.95 -35.93 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 65.299999999999997 111.102 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -71.9 -27.01 62.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 73.230000000000004 110.863 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -52.2 -58.9 9.67 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.753 -0.737 . . . . 71.310000000000002 112.462 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.5 t -54.06 -35.08 61.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.78 0.324 . . . . 74.0 111.192 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 51.0 mm -66.67 -57.98 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 74.319999999999993 111.158 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -54.13 -26.07 34.15 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.764 -0.731 . . . . 63.210000000000001 112.488 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -32.0 73.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 41.049999999999997 110.903 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 18.3 t80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 73.349999999999994 110.89 -179.966 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.808 0.253 . . . . 63.25 112.312 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 pp -52.9 -31.5 40.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 72.329999999999998 110.927 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -80.35 -29.88 37.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 64.239999999999995 110.896 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -76.81 -42.35 40.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.13 -0.486 . . . . 74.109999999999999 110.935 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.1 t -62.21 -38.52 89.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 73.040000000000006 111.179 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.446 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -74.96 -29.12 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 65.540000000000006 111.124 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -57.53 -27.73 62.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 74.230000000000004 110.887 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.422 HD11 ' HG ' ' A' ' 76' ' ' LEU . 4.3 mm? -90.55 -20.13 22.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 63.030000000000001 110.924 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.4 mm -76.96 -34.22 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 50.219999999999999 111.131 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.543 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.3 mm -54.95 -57.32 20.08 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.634 0.731 . . . . 71.040000000000006 111.143 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.654 ' HA ' HD23 ' A' ' 41' ' ' LEU . 53.5 Cg_endo -69.72 -11.8 31.65 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.657 2.238 . . . . 43.299999999999997 112.363 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.622 ' O ' HG22 ' A' ' 42' ' ' ILE . 3.1 t -62.07 -43.41 98.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 73.120000000000005 110.895 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 37' ' ' ILE . 14.3 p -79.47 -27.28 12.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 71.129999999999995 111.073 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.654 HD23 ' HA ' ' A' ' 38' ' ' PRO . 2.9 mm? -50.39 -34.31 23.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 71.310000000000002 110.909 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 39' ' ' CYS . 0.8 OUTLIER -58.7 -34.94 53.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 74.319999999999993 111.115 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.3 p -64.95 -36.59 84.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 72.099999999999994 111.105 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.1 t -54.17 -46.35 72.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 41.229999999999997 110.847 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tp -77.13 -38.08 52.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 75.209999999999994 110.936 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.65 -52.12 67.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 50.200000000000003 111.07 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.426 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.4 mp -49.82 -31.51 6.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 74.299999999999997 111.11 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 tt -50.78 -41.91 57.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 73.319999999999993 110.92 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.762 HG13 HD22 ' A' ' 62' ' ' LEU . 7.2 p -101.61 -36.77 4.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 45.340000000000003 111.117 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -64.47 -64.56 0.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 73.530000000000001 110.888 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.426 ' HB2' HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -71.71 -62.01 1.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 74.239999999999995 110.965 -179.856 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.4 mp -67.04 160.75 68.51 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.61 0.719 . . . . 74.109999999999999 110.896 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 143.12 49.55 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.692 2.262 . . . . 64.540000000000006 112.316 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.686 ' CB ' HG23 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -153.42 -170.1 3.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 72.310000000000002 110.816 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.14 172.67 11.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 73.510000000000005 110.851 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 22.5 m -68.29 -62.07 1.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 71.319999999999993 110.869 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.25 -22.94 38.82 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.709 -0.757 . . . . 40.25 112.526 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -35.01 41.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.919 0.39 . . . . 64.120000000000005 110.915 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -56.24 -46.48 79.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 73.319999999999993 110.93 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -52.01 51.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 55.299999999999997 110.923 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 55.3 p -55.28 -25.95 37.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 75.310000000000002 111.129 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.762 HD22 HG13 ' A' ' 49' ' ' VAL . 22.4 tp -72.99 -37.27 67.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 74.140000000000001 110.896 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 39.4 t -73.85 -48.52 30.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 61.119999999999997 110.893 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.6 pt -58.09 -32.59 44.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 65.450000000000003 111.096 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.13 -57.15 4.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 74.420000000000002 110.848 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.558 HG23 ' CD1' ' A' ' 42' ' ' ILE . 13.2 p -60.64 -33.61 55.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 63.340000000000003 111.128 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 tt -52.67 -31.08 35.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 75.140000000000001 110.906 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.499 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -68.36 -37.78 80.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 71.519999999999996 110.944 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.0 -29.96 69.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 64.310000000000002 111.07 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.429 HD13 HG11 ' A' ' 102' ' ' VAL . 7.4 mt -66.78 -54.86 18.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.236 -0.438 . . . . 71.200000000000003 110.928 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.576 ' O ' HD13 ' A' ' 75' ' ' LEU . 4.7 t -59.95 -38.81 83.54 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.17 -0.468 . . . . 75.25 111.167 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 68' ' ' LEU . 84.6 t -71.42 -33.0 48.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 75.129999999999995 111.124 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -65.46 -38.44 89.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 71.329999999999998 110.916 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.782 HD23 HD13 ' A' ' 95' ' ' LEU . 7.6 mp -74.99 -35.41 62.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.117 -0.492 . . . . 73.209999999999994 110.932 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.576 HD13 ' O ' ' A' ' 71' ' ' THR . 8.1 mp -73.42 -47.84 38.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 60.350000000000001 110.902 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.437 ' O ' HD13 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -57.98 -48.33 80.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 62.020000000000003 110.924 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 tt -65.96 -28.83 44.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 73.140000000000001 111.122 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 t -80.85 -23.87 38.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 70.549999999999997 110.833 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.723 ' O ' HG23 ' A' ' 81' ' ' VAL . 7.6 mmtp -58.81 -22.04 57.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.484 . . . . 62.229999999999997 110.914 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 26.0 pt -51.25 -30.87 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 74.239999999999995 111.097 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 79' ' ' LYS . 58.4 t 55.71 80.13 0.31 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.655 0.74 . . . . 74.319999999999993 111.158 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 53.6 Cg_endo -69.79 112.11 3.0 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.652 2.235 . . . . 75.019999999999996 112.359 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 82' ' ' PRO . 53.6 Cg_endo -69.72 -48.56 0.7 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.713 2.275 . . . . 74.319999999999993 112.363 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.0 t -116.84 -22.07 8.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 74.420000000000002 111.131 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.71 -47.5 63.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 60.399999999999999 110.841 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.6 tp 51.73 49.8 20.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 74.109999999999999 110.951 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.639 ' HA ' HD23 ' A' ' 90' ' ' LEU . 9.7 m-20 -95.99 29.19 2.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 75.120000000000005 110.893 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.539 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -66.98 -57.77 10.65 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.612 0.72 . . . . 54.450000000000003 111.136 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.5 Cg_endo -69.78 -20.87 34.19 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.663 2.242 . . . . 73.209999999999994 112.337 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.639 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.25 -43.87 55.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 75.439999999999998 110.959 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.477 HG12 HD21 ' A' ' 95' ' ' LEU . 61.7 t -80.7 -38.84 17.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 42.539999999999999 111.106 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.89 -51.21 40.97 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.689 -0.767 . . . . 71.019999999999996 112.509 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -34.71 78.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.81 0.338 . . . . 73.400000000000006 110.891 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -61.26 -36.03 78.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 72.140000000000001 110.913 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.782 HD13 HD23 ' A' ' 74' ' ' LEU . 10.4 mt -51.82 -33.0 33.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 64.329999999999998 110.894 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.85 -28.05 33.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 64.010000000000005 110.891 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.491 ' O ' HG22 ' A' ' 100' ' ' VAL . 5.2 t80 -72.98 -54.68 7.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 63.109999999999999 110.89 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.803 ' HA ' HD23 ' A' ' 101' ' ' LEU . 0.6 OUTLIER -53.4 -28.54 30.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.494 . . . . 72.239999999999995 111.142 -179.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 27.4 mmt -68.59 -30.04 68.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 72.150000000000006 110.875 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.91 -29.74 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 73.030000000000001 111.107 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.803 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.74 -32.73 62.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 62.409999999999997 110.876 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.429 HG11 HD13 ' A' ' 70' ' ' LEU . 27.7 m -77.08 -38.18 27.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 44.119999999999997 111.178 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 84.4 m -72.66 -37.7 67.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 72.230000000000004 111.126 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -68.54 -32.19 71.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 75.5 110.851 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.0 t -70.42 -33.62 71.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 74.209999999999994 110.833 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 30.8 mt -72.6 -51.39 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 72.129999999999995 111.127 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.554 ' O ' HG12 ' A' ' 110' ' ' VAL . 6.3 p -56.18 -35.35 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 74.439999999999998 111.121 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 98.3 m -52.48 -32.32 39.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.156 -0.475 . . . . 51.140000000000001 111.104 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.41 -31.54 15.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 71.120000000000005 110.875 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.554 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.3 p -52.57 -32.87 17.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 73.129999999999995 111.129 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 43.0 m -66.11 -47.67 73.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 62.210000000000001 110.877 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.7 t -71.99 -36.04 56.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 71.349999999999994 111.141 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.5 mt -72.02 -33.48 68.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 63.119999999999997 110.961 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -59.64 -30.73 68.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 73.409999999999997 110.907 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.815 HG11 ' HB2' ' A' ' 133' ' ' ALA . 9.5 p -102.34 -24.21 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 65.219999999999999 111.127 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -90.72 -73.23 0.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 72.450000000000003 110.857 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 72.439999999999998 110.833 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.261 0 N-CA-C 112.455 -0.258 . . . . 72.219999999999999 112.455 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -87.87 -24.93 23.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.912 0.387 . . . . 73.329999999999998 110.901 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 23.8 m -53.98 -30.51 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 72.120000000000005 111.066 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.815 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -57.25 -25.05 58.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 73.439999999999998 111.082 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.8 ptm -52.94 -30.94 37.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 71.430000000000007 110.892 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 59.1 t -56.92 -53.64 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.284 -0.416 . . . . 73.420000000000002 111.128 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 64.9 mt -73.93 -38.56 50.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 64.230000000000004 111.156 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.97 -30.03 70.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 74.120000000000005 110.909 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -30.14 23.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 74.200000000000003 110.863 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.4 tt -63.47 -50.91 67.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 74.400000000000006 110.868 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -73.99 -36.97 64.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 71.540000000000006 110.901 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.0 -34.33 42.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 64.319999999999993 110.957 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 21.4 t90 -64.17 -50.68 67.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 74.310000000000002 110.915 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.633 ' O ' HG23 ' A' ' 147' ' ' VAL . 51.2 mm -68.35 -32.12 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 72.310000000000002 111.148 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -56.02 -56.72 17.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 70.409999999999997 110.859 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 21.7 t -65.95 -35.91 76.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 61.109999999999999 111.147 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.51 -33.2 65.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 71.129999999999995 110.842 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 143' ' ' ILE . 58.0 t -54.07 -34.11 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 54.409999999999997 111.126 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 71.8 m -51.95 -43.55 63.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.167 -0.47 . . . . 71.510000000000005 110.849 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 64.3 t -75.22 -35.06 32.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 54.420000000000002 111.112 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -54.74 -28.71 50.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 75.430000000000007 110.873 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -70.8 -22.43 78.19 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.734 -0.745 . . . . 62.149999999999999 112.493 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.1 m -79.46 -52.8 7.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.76 0.314 . . . . 54.310000000000002 111.15 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 47.6 mm -76.5 -24.15 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 73.219999999999999 111.147 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -52.13 -50.04 47.37 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.728 -0.748 . . . . 34.200000000000003 112.463 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -31.98 67.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 71.549999999999997 110.899 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 72.519999999999996 110.899 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.78 0.324 . . . . 75.239999999999995 110.853 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.13 -69.97 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 65.129999999999995 110.891 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.56 158.68 0.12 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.556 0.693 . . . . 74.219999999999999 110.947 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -12.68 33.36 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.729 2.286 . . . . 70.310000000000002 112.367 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.426 HD13 ' HE1' ' A' ' 156' ' ' PHE . 4.4 pp -52.0 -30.96 27.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 64.209999999999994 110.905 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.409 ' N ' HD12 ' A' ' 29' ' ' LEU . 52.2 t80 -78.54 -33.58 47.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 73.010000000000005 110.865 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -72.5 -45.96 56.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 62.219999999999999 110.905 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -60.23 -40.03 88.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 74.200000000000003 111.129 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.441 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.18 -29.11 21.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 75.310000000000002 111.138 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.87 -27.06 49.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 64.230000000000004 110.869 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.587 ' CB ' HD12 ' A' ' 77' ' ' ILE . 4.1 mm? -91.35 -19.18 23.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 55.119999999999997 110.922 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.468 HG21 HG23 ' A' ' 152' ' ' THR . 45.6 mm -76.73 -34.84 23.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.453 . . . . 62.130000000000003 111.137 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.544 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.2 mt -55.7 -57.13 23.0 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.621 0.724 . . . . 73.030000000000001 111.139 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.3 Cg_endo -69.81 -20.47 34.56 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.696 2.264 . . . . 73.329999999999998 112.32 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.624 ' O ' HG22 ' A' ' 42' ' ' ILE . 48.7 t -75.88 -44.59 39.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 62.520000000000003 110.867 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.53 -28.96 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 74.519999999999996 111.163 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 mt -51.0 -33.97 27.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 74.430000000000007 110.922 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.1 tp -58.73 -34.65 52.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 73.25 111.153 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.73 -40.9 92.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 72.120000000000005 111.167 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.25 -43.45 67.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 62.109999999999999 110.816 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 tp -76.46 -39.32 53.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.453 . . . . 74.319999999999993 110.908 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.88 -36.29 72.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 61.43 111.102 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.438 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.2 mp -64.97 -32.32 57.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 71.530000000000001 111.112 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.29 -33.78 63.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 73.109999999999999 110.901 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.997 HG11 HD13 ' A' ' 62' ' ' LEU . 29.0 m -101.66 -36.82 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 75.25 111.086 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -71.6 -64.81 0.85 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 65.299999999999997 110.927 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.509 ' CE2' HD22 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -69.63 -61.77 1.65 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 73.230000000000004 110.948 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.77 160.63 60.22 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.656 0.741 . . . . 74.019999999999996 110.907 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 136.37 32.85 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.709 2.272 . . . . 71.209999999999994 112.355 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.65 44.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 70.230000000000004 110.862 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -53.06 109.58 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 64.439999999999998 110.877 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -179.16 159.06 0.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 55.109999999999999 110.886 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.48 -26.71 31.52 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.748 . . . . 75.340000000000003 112.487 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -72.58 -35.0 67.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 75.0 110.85 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.0 -49.25 66.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 75.409999999999997 110.896 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -70.51 -48.08 57.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 54.539999999999999 110.913 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.2 m -54.27 -27.02 32.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 72.319999999999993 111.18 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.997 HD13 HG11 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -72.86 -38.92 66.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.446 . . . . 73.140000000000001 110.913 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 26.3 m -66.87 -45.59 77.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 71.530000000000001 110.861 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.9 tt -71.26 -35.0 56.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 64.439999999999998 111.101 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.6 m -58.43 -26.36 63.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 65.010000000000005 110.861 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 62' ' ' LEU . 22.3 t -61.73 -40.06 85.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.477 . . . . 74.239999999999995 111.063 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.89 -28.88 25.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 71.239999999999995 110.902 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.485 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.13 -39.17 79.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 72.140000000000001 110.914 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.39 -29.99 70.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 53.43 111.116 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.721 HD13 HG11 ' A' ' 102' ' ' VAL . 9.8 mt -65.11 -54.7 25.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 75.400000000000006 110.915 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.81 -38.26 87.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 71.5 111.172 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 68' ' ' LEU . 78.6 t -71.5 -32.98 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 75.409999999999997 111.12 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.553 ' O ' HG22 ' A' ' 77' ' ' ILE . 69.4 t80 -54.58 -30.01 53.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.481 . . . . 72.209999999999994 110.866 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.846 HD11 HD13 ' A' ' 95' ' ' LEU . 0.3 OUTLIER -65.78 -50.54 64.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 50.420000000000002 110.954 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.4 mt -73.23 -33.09 65.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 75.019999999999996 110.949 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -55.08 22.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 61.509999999999998 110.909 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.587 HD12 ' CB ' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -64.93 -30.48 50.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 63.210000000000001 111.152 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.8 t -80.47 -19.12 46.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 72.329999999999998 110.839 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.715 ' O ' HG23 ' A' ' 81' ' ' VAL . 8.2 mttt -78.16 -10.26 59.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 74.540000000000006 110.931 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 77' ' ' ILE . 2.1 pp -55.62 -25.19 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 75.230000000000004 111.12 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 79' ' ' LYS . 30.1 t 62.89 76.21 0.38 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.654 0.74 . . . . 55.149999999999999 111.155 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 167.5 24.29 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.685 2.257 . . . . 64.5 112.317 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -48.85 0.64 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.623 2.215 . . . . 65.319999999999993 112.37 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.3 t -133.65 14.43 4.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 74.140000000000001 111.122 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.3 p 51.65 37.96 21.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 74.140000000000001 110.856 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.15 -11.81 61.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 74.140000000000001 110.922 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.646 ' HA ' HD23 ' A' ' 90' ' ' LEU . 2.1 m-20 -95.28 23.36 5.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 55.409999999999997 110.835 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.539 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.8 -57.91 9.01 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.603 0.716 . . . . 75.109999999999999 111.128 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 54.7 Cg_endo -69.68 -19.99 35.78 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.698 2.265 . . . . 74.239999999999995 112.391 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.646 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.15 -50.36 19.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 62.399999999999999 110.897 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 87' ' ' ASP . 21.7 t -78.54 -47.35 23.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 74.219999999999999 111.138 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.87 -40.77 50.42 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.695 -0.764 . . . . 53.049999999999997 112.504 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.5 tttp -74.25 -23.5 59.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.797 0.332 . . . . 73.209999999999994 110.879 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -74.68 -34.34 62.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 73.319999999999993 110.971 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.846 HD13 HD11 ' A' ' 74' ' ' LEU . 14.9 mt -53.0 -29.67 30.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.079 -0.509 . . . . 75.319999999999993 110.939 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.56 -43.65 72.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 74.129999999999995 110.831 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.494 ' O ' HG22 ' A' ' 100' ' ' VAL . 47.0 t80 -75.18 -51.14 14.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 71.230000000000004 110.877 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.8 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.08 -29.95 33.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 64.230000000000004 111.132 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 8.9 mmt -66.54 -30.09 70.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 65.329999999999998 110.928 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.83 -30.12 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 74.430000000000007 111.088 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.8 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.88 -33.29 62.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 74.200000000000003 110.916 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.721 HG11 HD13 ' A' ' 70' ' ' LEU . 31.2 m -76.86 -38.06 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 74.540000000000006 111.128 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 76.5 m -72.51 -38.41 68.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 63.520000000000003 111.153 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -66.81 -32.0 72.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 74.019999999999996 110.911 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.5 t -71.5 -36.44 71.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 63.299999999999997 110.877 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 38.4 mt -70.78 -52.0 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 71.319999999999993 111.077 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.551 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.7 p -54.0 -35.96 29.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 72.120000000000005 111.114 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.3 m -52.42 -32.42 39.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 72.310000000000002 111.188 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 t -50.45 -31.36 14.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 63.539999999999999 110.874 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.4 p -52.42 -32.85 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 74.109999999999999 111.13 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 14.9 m -64.49 -46.59 82.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 72.409999999999997 110.912 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 130' ' ' GLY . 95.0 t -73.97 -38.93 50.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 74.510000000000005 111.111 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.5 mt -69.11 -30.92 69.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 72.219999999999999 110.931 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -58.18 -33.51 69.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 74.109999999999999 110.872 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.624 ' CG1' ' HB2' ' A' ' 133' ' ' ALA . 7.9 p -102.27 -24.79 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 72.549999999999997 111.156 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -58.84 -69.89 0.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 75.439999999999998 110.837 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -168.91 48.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 72.340000000000003 110.847 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.5 mtp85 -153.76 92.13 1.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 65.420000000000002 110.901 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.8 t 63.03 73.37 0.51 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.686 0.755 . . . . 74.319999999999993 110.899 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 124.28 10.95 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.673 2.249 . . . . 52.109999999999999 112.341 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.45 -24.69 14.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 64.030000000000001 111.141 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.42 98.87 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 74.329999999999998 111.108 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -131.42 -40.4 1.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.462 . . . . 73.209999999999994 110.839 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.98 159.66 40.05 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.615 0.721 . . . . 75.510000000000005 111.139 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 -172.55 0.6 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.689 2.259 . . . . 72.230000000000004 112.297 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.3 mtp85 60.95 173.43 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 71.299999999999997 110.869 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -169.94 -134.63 1.77 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.751 . . . . 73.109999999999999 112.451 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.8 -58.84 4.5 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.757 -0.735 . . . . 54.43 112.522 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -128.98 -149.92 7.01 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.724 -0.75 . . . . 74.150000000000006 112.479 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.699 ' O ' HG13 ' A' ' 112' ' ' VAL . . . -111.39 19.72 24.01 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.741 -0.742 . . . . 64.409999999999997 112.455 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -77.62 -26.14 50.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.963 0.411 . . . . 63.340000000000003 110.955 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.501 ' CG2' HG21 ' A' ' 115' ' ' VAL . 22.1 m -60.58 -37.48 75.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 71.040000000000006 111.087 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.624 ' HB2' ' CG1' ' A' ' 115' ' ' VAL . . . -63.7 -25.02 68.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 60.009999999999998 111.078 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 13.2 mmt -52.97 -30.98 38.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 72.0 110.909 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.9 t -56.97 -57.03 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 75.540000000000006 111.154 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 64.1 mt -74.02 -38.37 49.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 71.349999999999994 111.1 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -61.23 -29.96 70.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 74.349999999999994 110.896 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.02 -30.17 24.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 73.25 110.871 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.66 -50.83 70.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 52.399999999999999 110.935 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -74.04 -44.23 55.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 73.329999999999998 110.885 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.509 HD22 ' CE2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -52.06 -33.86 40.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 52.329999999999998 110.88 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -53.76 -46.51 70.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 65.409999999999997 110.905 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.518 ' O ' HG23 ' A' ' 147' ' ' VAL . 43.3 mm -76.9 -31.96 19.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 74.329999999999998 111.117 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -56.09 -56.82 16.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 71.109999999999999 110.865 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.9 m -54.9 -35.0 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 75.409999999999997 111.171 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -63.38 -32.95 74.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 73.439999999999998 110.9 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 143' ' ' ILE . 31.7 t -66.56 -37.74 80.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 74.230000000000004 111.129 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 91.8 m -58.93 -51.94 67.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 72.239999999999995 110.882 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.48 -32.99 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 64.239999999999995 111.125 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -52.71 -52.0 57.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 71.230000000000004 110.887 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.85 -19.38 75.51 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.757 . . . . 40.509999999999998 112.484 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.468 HG23 HG21 ' A' ' 36' ' ' ILE . 33.6 m -74.72 -52.83 10.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.81 0.338 . . . . 63.530000000000001 111.18 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.517 HG22 ' CD1' ' A' ' 157' ' ' LEU . 86.7 mt -76.52 -29.77 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 64.310000000000002 111.105 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -55.43 -49.95 62.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.725 -0.75 . . . . 55.399999999999999 112.491 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.4 mmt -71.13 -32.03 68.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.877 0.37 . . . . 70.129999999999995 110.923 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.426 ' HE1' HD13 ' A' ' 29' ' ' LEU . 15.1 t80 -71.82 -24.93 61.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 73.209999999999994 110.905 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.517 ' CD1' HG22 ' A' ' 153' ' ' ILE . 14.9 mt -75.48 -26.45 58.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 63.240000000000002 110.932 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.489 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.3 OUTLIER -51.9 -60.53 5.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.594 0.711 . . . . 63.340000000000003 110.917 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.5 Cg_endo -69.8 -16.34 37.34 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.669 2.246 . . . . 52.25 112.298 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.8 tp -93.93 40.85 1.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 73.420000000000002 110.92 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.97 -62.63 1.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 63.439999999999998 110.897 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -176.46 -74.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 74.340000000000003 110.928 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 60.53 99.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 72.140000000000001 110.885 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 16.1 t80 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 73.340000000000003 110.894 -179.914 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.82 0.343 . . . . 74.420000000000002 110.853 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.1 mtt-85 -65.17 91.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 72.209999999999994 110.911 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -114.03 73.01 2.32 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.548 0.69 . . . . 74.519999999999996 110.873 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -12.88 33.93 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.689 2.259 . . . . 72.209999999999994 112.352 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 pp -52.08 -30.93 28.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 71.450000000000003 110.932 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -78.43 -33.34 48.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 65.329999999999998 110.828 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.514 ' HE1' HG22 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -72.61 -45.81 57.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 73.129999999999995 110.936 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -60.28 -39.95 88.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 63.020000000000003 111.109 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.437 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.18 -29.03 21.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 72.239999999999995 111.146 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -26.72 52.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 72.120000000000005 110.857 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.57 -19.46 22.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 71.430000000000007 110.955 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.4 mm -76.68 -34.78 24.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 73.200000000000003 111.159 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.55 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.2 mt -55.74 -57.18 22.83 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.681 0.753 . . . . 74.120000000000005 111.14 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 54.1 Cg_endo -69.73 -20.97 34.29 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.673 2.249 . . . . 74.129999999999995 112.354 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.638 ' O ' HG22 ' A' ' 42' ' ' ILE . 48.5 t -75.89 -44.92 38.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.251 -0.431 . . . . 62.020000000000003 110.873 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.2 p -81.59 -28.89 10.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 74.400000000000006 111.166 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.2 mt -50.95 -33.94 26.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 74.239999999999995 110.89 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.77 -34.65 52.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 75.540000000000006 111.164 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 p -65.73 -34.74 78.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 51.219999999999999 111.164 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.14 -46.8 79.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 52.299999999999997 110.883 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.64 -41.6 60.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 75.120000000000005 110.896 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.52 -51.42 69.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 73.299999999999997 111.095 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.03 -32.09 56.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 65.019999999999996 111.166 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.558 ' O ' HD22 ' A' ' 52' ' ' LEU . 5.4 tp -51.62 -37.93 52.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 73.0 110.905 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.0 p -101.64 -35.79 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 75.219999999999999 111.153 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -66.28 -62.06 1.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 75.530000000000001 110.877 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.515 ' CE2' HD13 ' A' ' 141' ' ' LEU . 0.3 OUTLIER -55.52 -53.73 52.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 73.200000000000003 110.935 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.558 HD22 ' O ' ' A' ' 48' ' ' LEU . 10.9 mp -51.96 160.53 1.13 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.585 0.707 . . . . 65.400000000000006 110.968 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -170.97 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.688 2.259 . . . . 73.329999999999998 112.343 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 55.1 91.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 73.109999999999999 110.848 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -152.24 147.31 26.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 70.420000000000002 110.845 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -173.97 -74.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 75.439999999999998 110.877 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -85.95 -50.81 3.79 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.756 -0.735 . . . . 61.210000000000001 112.491 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -61.57 -44.34 97.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.899 0.38 . . . . 73.420000000000002 110.908 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.08 -48.9 67.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 73.409999999999997 110.931 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -66.02 -37.53 86.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 74.349999999999994 110.923 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.5 m -66.91 -29.14 68.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 64.310000000000002 111.17 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.701 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.9 OUTLIER -71.66 -50.69 28.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 74.510000000000005 110.937 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -51.21 62.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 74.010000000000005 110.86 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.5 tt -66.85 -35.02 73.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 74.120000000000005 111.154 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 m -65.79 -25.12 67.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 64.129999999999995 110.858 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 62' ' ' LEU . 64.0 t -58.02 -36.64 57.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 64.340000000000003 111.13 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.92 -28.95 25.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 75.230000000000004 110.898 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.495 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.29 -38.94 78.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 71.310000000000002 110.917 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.51 -30.0 70.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 70.299999999999997 111.133 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.641 HD22 HG11 ' A' ' 102' ' ' VAL . 9.5 mt -64.99 -54.78 25.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 110.904 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.68 -38.46 87.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 71.25 111.196 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 68' ' ' LEU . 79.3 t -71.43 -32.89 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.219999999999999 111.12 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -51.82 -30.14 22.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 75.109999999999999 110.895 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.561 HD11 HD11 ' A' ' 95' ' ' LEU . 0.3 OUTLIER -73.9 -41.62 61.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 62.399999999999999 110.928 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.0 mt -73.27 -34.6 65.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 73.040000000000006 110.873 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.402 HD13 ' HD2' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -69.6 -55.07 11.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 73.439999999999998 110.916 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.556 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -56.22 -24.59 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 61.109999999999999 111.083 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.5 -16.43 60.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 74.340000000000003 110.813 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.747 ' O ' HG23 ' A' ' 81' ' ' VAL . 2.0 ptmm? -64.05 -15.54 59.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 73.25 110.896 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 77' ' ' ILE . 1.0 OUTLIER -51.73 -28.68 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 70.109999999999999 111.106 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 79' ' ' LYS . 58.6 t 61.01 76.72 0.4 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.664 0.745 . . . . 70.140000000000001 111.12 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 167.41 24.46 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.702 2.268 . . . . 74.340000000000003 112.377 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -49.05 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.661 2.241 . . . . 75.299999999999997 112.365 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.9 t -134.48 18.37 3.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 70.430000000000007 111.125 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.2 p 50.09 46.51 24.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 74.150000000000006 110.856 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mt -94.68 22.12 6.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 62.329999999999998 110.94 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.628 ' HA ' HD23 ' A' ' 90' ' ' LEU . 4.1 m-20 -99.07 24.53 7.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 75.109999999999999 110.854 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.537 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.14 -57.78 10.34 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.634 0.731 . . . . 73.099999999999994 111.142 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.4 Cg_endo -69.77 -20.53 34.68 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.721 2.281 . . . . 62.109999999999999 112.341 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.628 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.16 -53.12 10.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 75.230000000000004 110.926 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.05 -40.39 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 72.140000000000001 111.116 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -53.17 -33.69 45.81 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.774 -0.727 . . . . 51.43 112.481 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.0 -23.25 44.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.831 0.348 . . . . 72.310000000000002 110.911 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -76.57 -35.19 58.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 74.400000000000006 110.942 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.561 HD11 HD11 ' A' ' 74' ' ' LEU . 13.3 mt -52.28 -29.9 25.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 61.420000000000002 110.916 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -43.15 79.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 73.439999999999998 110.92 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.504 ' O ' HG22 ' A' ' 100' ' ' VAL . 62.8 t80 -75.37 -52.09 11.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 73.530000000000001 110.852 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.785 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.14 -29.76 33.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 55.210000000000001 111.169 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.9 mmt -66.83 -30.06 70.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 73.540000000000006 110.916 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.77 -30.07 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 72.140000000000001 111.122 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.785 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.89 -33.19 62.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 64.030000000000001 110.927 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.641 HG11 HD22 ' A' ' 70' ' ' LEU . 31.6 m -76.87 -38.1 28.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 71.109999999999999 111.131 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.41 ' O ' HG13 ' A' ' 107' ' ' VAL . 73.6 m -72.45 -40.39 67.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 62.310000000000002 111.151 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -64.11 -31.95 73.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 63.210000000000001 110.902 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.7 m -73.89 -33.77 64.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 64.0 110.892 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 30.4 mt -75.1 -50.94 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 71.530000000000001 111.142 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.557 ' O ' HG12 ' A' ' 110' ' ' VAL . 34.5 m -53.9 -33.98 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 55.340000000000003 111.124 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.4 m -52.48 -32.46 40.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 54.229999999999997 111.09 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 t -50.48 -31.49 15.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 73.420000000000002 110.851 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.5 p -52.5 -32.77 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 73.219999999999999 111.158 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 42.6 m -66.86 -49.04 66.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 53.240000000000002 110.884 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 67.8 t -70.16 -35.67 64.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 62.140000000000001 111.159 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.8 mt -72.08 -38.97 69.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 74.25 110.887 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.576 ' ND2' HG23 ' A' ' 121' ' ' THR . 21.0 t-20 -53.9 -31.33 49.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 70.109999999999999 110.885 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.78 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.7 p -102.31 -23.68 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 74.209999999999994 111.167 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -52.87 -51.07 62.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 55.439999999999998 110.873 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -173.32 39.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 62.43 110.868 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.7 mtt85 -133.24 176.67 8.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 75.430000000000007 110.879 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.74 160.59 18.81 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.659 0.742 . . . . 74.219999999999999 110.879 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 146.4 59.83 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.671 2.247 . . . . 54.350000000000001 112.33 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.576 HG23 ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -84.65 -174.46 5.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 72.109999999999999 111.167 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.6 m -134.13 68.88 1.47 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 72.310000000000002 111.174 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.49 ' O ' HG23 ' A' ' 124' ' ' THR . 79.0 t60 -177.1 -48.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 63.420000000000002 110.894 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 123' ' ' HIS . 0.9 OUTLIER -159.99 68.2 2.89 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.607 0.718 . . . . 75.239999999999995 111.174 -179.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -171.06 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.64 2.227 . . . . 75.400000000000006 112.339 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.458 ' HG2' HD11 ' A' ' 136' ' ' ILE . 0.0 OUTLIER -151.92 -71.06 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 72.540000000000006 110.915 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 177.8 -93.47 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.758 -0.734 . . . . 73.230000000000004 112.506 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -162.57 167.44 37.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.779 -0.724 . . . . 70.450000000000003 112.472 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 110.67 -76.76 0.22 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.765 -0.731 . . . . 54.109999999999999 112.512 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 137.21 -28.43 2.8 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.762 -0.733 . . . . 74.129999999999995 112.535 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -83.43 -26.59 30.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.892 0.377 . . . . 64.030000000000001 110.917 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.1 m -64.47 -30.04 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 74.400000000000006 111.131 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.78 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -58.14 -25.09 61.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.530000000000001 111.071 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 38.8 mmt -53.02 -30.86 37.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 73.340000000000003 110.902 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 71.6 t -56.98 -58.59 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 71.299999999999997 111.127 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.458 HD11 ' HG2' ' A' ' 126' ' ' ARG . 3.8 mt -74.03 -37.79 47.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 73.329999999999998 111.099 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.98 -30.88 70.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 75.129999999999995 110.883 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.26 -28.74 29.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 71.409999999999997 110.888 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.52 -43.36 63.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 73.129999999999995 110.94 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -73.96 -52.48 12.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 74.319999999999993 110.888 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.515 HD13 ' CE2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -52.01 -32.09 32.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 54.130000000000003 110.903 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -67.3 -42.53 83.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 72.209999999999994 110.876 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.743 ' O ' HG23 ' A' ' 147' ' ' VAL . 69.6 mt -76.85 -32.22 19.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.416 . . . . 74.420000000000002 111.103 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -56.0 -56.99 14.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 61.310000000000002 110.871 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.5 m -54.94 -35.05 32.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 71.319999999999993 111.123 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -68.32 -33.03 73.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 54.350000000000001 110.888 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 143' ' ' ILE . 46.0 t -69.17 -34.0 61.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 73.129999999999995 111.146 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.48 -52.04 60.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 73.340000000000003 110.922 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.0 m -73.1 -35.41 47.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 74.129999999999995 111.149 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -52.46 -40.16 61.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 75.109999999999999 110.878 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -76.6 -20.3 76.81 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.71 -0.757 . . . . 65.209999999999994 112.499 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 35.0 m -72.08 -52.86 14.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.755 0.312 . . . . 73.209999999999994 111.172 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 19.7 mt -76.58 -24.82 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 72.030000000000001 111.098 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.35 -49.63 76.45 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.734 -0.745 . . . . 21.010000000000002 112.503 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -32.05 55.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.843 0.354 . . . . 74.430000000000007 110.893 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.639 ' CE2' HD11 ' A' ' 160' ' ' LEU . 14.7 t80 -71.09 -24.04 62.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 63.340000000000003 110.859 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 13.2 mt -75.26 -27.17 59.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 55.310000000000002 110.916 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.479 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.8 OUTLIER -51.81 -60.59 5.71 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.62 0.724 . . . . 45.200000000000003 110.92 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 54.2 Cg_endo -69.74 -16.32 37.59 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.673 2.249 . . . . 61.509999999999998 112.364 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.639 HD11 ' CE2' ' A' ' 156' ' ' PHE . 52.3 mt -92.9 43.44 1.12 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 72.129999999999995 110.938 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.39 -68.94 0.68 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 73.420000000000002 110.898 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.43 -26.1 7.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 61.039999999999999 110.883 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -51.97 -62.19 1.79 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 54.229999999999997 110.949 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 71.439999999999998 110.925 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.795 0.331 . . . . 73.420000000000002 110.833 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -70.52 -26.2 63.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 74.439999999999998 110.858 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.72 73.04 0.8 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.566 0.698 . . . . 70.209999999999994 110.919 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 -12.17 32.47 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.742 2.294 . . . . 52.43 112.377 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 pp -53.37 -31.0 42.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 75.140000000000001 110.921 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -77.39 -30.2 53.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 71.099999999999994 110.902 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.458 ' HE1' HG22 ' A' ' 80' ' ' ILE . 0.6 OUTLIER -77.02 -44.46 30.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.15 -0.477 . . . . 74.409999999999997 110.932 -179.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -60.34 -40.06 89.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 64.510000000000005 111.129 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.431 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -71.83 -28.86 31.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 65.420000000000002 111.146 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.37 -26.58 68.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 70.439999999999998 110.921 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.617 HD13 HD22 ' A' ' 76' ' ' LEU . 1.0 OUTLIER -90.27 -24.44 20.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 60.32 110.899 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.8 mm -79.4 -29.41 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 70.140000000000001 111.121 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.65 -57.15 22.76 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.634 0.731 . . . . 72.349999999999994 111.123 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.3 Cg_endo -69.74 -19.69 35.88 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.696 2.264 . . . . 55.310000000000002 112.328 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.63 ' O ' HG22 ' A' ' 42' ' ' ILE . 47.5 t -76.04 -44.65 38.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 65.140000000000001 110.864 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 p -81.64 -28.89 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 52.310000000000002 111.128 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 mt -50.99 -33.94 26.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 75.230000000000004 110.943 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.63 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.72 -34.62 52.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 70.150000000000006 111.153 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 p -65.88 -41.53 91.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 74.329999999999998 111.105 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.8 t -52.92 -42.91 65.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 72.25 110.864 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.0 tp -76.71 -39.69 51.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 74.120000000000005 110.89 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.85 -51.35 70.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 64.420000000000002 111.082 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.436 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.4 mp -49.7 -31.46 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 71.239999999999995 111.09 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.74 -42.3 57.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 65.109999999999999 110.912 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.736 HG21 ' HA ' ' A' ' 59' ' ' LYS . 7.2 p -101.47 -37.52 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 74.400000000000006 111.093 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -63.61 -64.48 0.89 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 72.109999999999999 110.853 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.47 ' CG ' HD23 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -72.68 -56.06 5.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 73.239999999999995 110.978 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.5 mp -95.71 160.55 30.04 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.602 0.715 . . . . 72.430000000000007 110.898 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 141.24 44.44 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.617 2.211 . . . . 71.120000000000005 112.351 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.5 m -161.98 105.85 1.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 62.409999999999997 110.849 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.02 -170.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 74.540000000000006 110.838 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 78.8 m -110.9 -73.71 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 72.319999999999993 110.894 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.35 -26.81 72.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.744 -0.741 . . . . 60.240000000000002 112.514 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.08 -35.05 46.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.946 0.403 . . . . 74.319999999999993 110.877 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.736 ' HA ' HG21 ' A' ' 49' ' ' VAL . 2.2 ttpt -54.22 -51.42 64.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 73.430000000000007 110.938 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.459 ' O ' HG22 ' A' ' 64' ' ' ILE . 4.5 tpt -60.43 -51.31 70.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 73.239999999999995 110.917 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 30.0 p -54.8 -31.33 58.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 73.319999999999993 111.14 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -74.96 -41.34 59.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 74.219999999999999 110.926 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 81.5 m -66.84 -50.94 60.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 64.230000000000004 110.93 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 60' ' ' MET . 15.9 tt -62.27 -35.0 66.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 71.409999999999997 111.14 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.2 t -63.58 -27.08 69.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 75.239999999999995 110.874 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 62' ' ' LEU . 63.6 t -59.38 -39.37 78.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 65.150000000000006 111.124 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 tp -53.11 -29.03 28.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 75.25 110.879 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.501 ' O ' HD22 ' A' ' 68' ' ' LEU . 2.0 tm? -74.16 -46.81 39.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 60.049999999999997 110.888 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.76 -29.59 19.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 74.030000000000001 111.112 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.776 HD22 HG11 ' A' ' 102' ' ' VAL . 30.0 mt -58.04 -54.58 45.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 74.319999999999993 110.909 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 68' ' ' LEU . 1.1 t -63.12 -27.26 69.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 71.540000000000006 111.134 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.2 t -71.23 -32.94 49.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 72.310000000000002 111.107 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -52.08 -50.02 62.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 74.400000000000006 110.869 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.0 tp -61.54 -32.5 72.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 73.319999999999993 110.91 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 71' ' ' THR . 9.7 mp -73.04 -44.24 60.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.452 . . . . 71.129999999999995 110.941 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.617 HD22 HD13 ' A' ' 35' ' ' LEU . 1.2 tt -67.73 -50.22 58.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 63.32 110.912 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.473 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -57.43 -25.51 24.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 64.150000000000006 111.106 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.04 -18.58 49.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 65.109999999999999 110.904 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.744 ' O ' HG23 ' A' ' 81' ' ' VAL . 4.9 mmmt -69.07 -11.71 61.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 51.200000000000003 110.876 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.473 HG23 ' O ' ' A' ' 77' ' ' ILE . 1.4 pp -54.17 -26.33 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 71.230000000000004 111.097 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 79' ' ' LYS . 44.6 t 62.12 75.72 0.42 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.629 0.728 . . . . 74.430000000000007 111.149 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 167.61 23.91 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.646 2.231 . . . . 64.510000000000005 112.381 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -48.91 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.676 2.25 . . . . 40.299999999999997 112.361 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.42 HG23 ' HB2' ' A' ' 86' ' ' LEU . 11.8 t -133.1 13.29 4.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 70.439999999999998 111.175 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.1 m 51.55 65.23 1.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 74.340000000000003 110.882 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.42 ' HB2' HG23 ' A' ' 84' ' ' THR . 10.3 tp -117.19 25.93 10.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 54.0 110.899 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.639 ' HA ' HD23 ' A' ' 90' ' ' LEU . 1.5 m-20 -104.5 22.47 14.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 75.209999999999994 110.907 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.536 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -68.2 -57.94 8.31 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.649 0.738 . . . . 75.439999999999998 111.131 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.6 Cg_endo -69.72 -19.61 36.08 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.664 2.243 . . . . 73.400000000000006 112.385 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.639 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.15 -53.01 10.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 64.120000000000005 110.874 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.543 HG12 HD21 ' A' ' 95' ' ' LEU . 21.8 t -80.24 -23.79 11.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 73.540000000000006 111.146 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.68 -50.67 42.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.76 -0.733 . . . . 73.439999999999998 112.445 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.42 -35.06 78.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.757 0.313 . . . . 74.219999999999999 110.883 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -61.27 -42.46 98.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 75.299999999999997 110.943 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.543 HD21 HG12 ' A' ' 91' ' ' VAL . 7.7 mt -51.94 -29.83 22.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 65.030000000000001 110.938 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.0 mmt -67.77 -42.87 81.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 63.329999999999998 110.868 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.501 ' O ' HG22 ' A' ' 100' ' ' VAL . 62.2 t80 -75.24 -52.41 10.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 73.109999999999999 110.919 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.79 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.17 -29.77 33.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 70.239999999999995 111.185 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.2 mmt -66.86 -29.92 69.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.479 . . . . 70.049999999999997 110.883 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.84 -30.05 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 73.019999999999996 111.128 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.79 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -74.87 -33.38 62.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 62.310000000000002 110.918 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.776 HG11 HD22 ' A' ' 70' ' ' LEU . 30.4 m -76.89 -38.0 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 71.310000000000002 111.106 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.483 ' O ' HG13 ' A' ' 107' ' ' VAL . 63.2 m -72.44 -42.23 65.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 45.420000000000002 111.15 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -60.65 -31.96 71.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 63.439999999999998 110.929 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.1 t -75.08 -36.05 61.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 71.310000000000002 110.881 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 39.4 mt -74.87 -49.31 29.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.489 . . . . 74.049999999999997 111.16 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.547 ' O ' HG12 ' A' ' 110' ' ' VAL . 34.0 m -53.89 -33.91 24.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 75.420000000000002 111.158 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.8 m -52.34 -32.5 38.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 74.230000000000004 111.194 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.9 m -50.52 -31.48 15.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 73.299999999999997 110.856 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.5 p -52.41 -32.77 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 71.430000000000007 111.111 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 20.5 m -64.3 -42.81 96.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 64.5 110.943 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 75.7 t -78.07 -35.37 20.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 71.510000000000005 111.134 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.436 HD22 ' O ' ' A' ' 117' ' ' HIS . 85.4 mt -71.83 -30.99 66.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 72.439999999999998 110.901 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -60.15 -32.28 70.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 73.120000000000005 110.907 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.769 HG11 ' HB2' ' A' ' 133' ' ' ALA . 7.9 p -102.31 -24.67 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 70.409999999999997 111.136 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -89.1 -71.79 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 74.120000000000005 110.842 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.436 ' O ' HD22 ' A' ' 113' ' ' LEU . 0.4 OUTLIER -178.63 111.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 72.510000000000005 110.879 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 29.3 ttp85 -117.82 -34.34 4.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.453 . . . . 73.540000000000006 110.871 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.08 160.5 1.55 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.657 0.741 . . . . 74.109999999999999 110.854 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.529 ' O ' HG23 ' A' ' 121' ' ' THR . 53.9 Cg_endo -69.73 175.08 8.56 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.683 2.255 . . . . 73.109999999999999 112.353 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -170.88 -73.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 73.25 111.163 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.6 -172.83 4.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 75.329999999999998 111.088 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -77.62 60.09 2.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 72.209999999999994 110.854 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.92 159.67 68.84 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.567 0.699 . . . . 62.329999999999998 111.157 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -12.55 33.15 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.741 2.294 . . . . 75.400000000000006 112.324 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 52.06 88.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.457 . . . . 64.340000000000003 110.882 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -129.86 -176.75 14.55 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.785 -0.721 . . . . 61.149999999999999 112.502 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 159.8 -116.68 0.73 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 70.409999999999997 112.514 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -110.35 -114.61 3.58 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.781 -0.724 . . . . 50.119999999999997 112.473 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.54 39.61 2.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 64.329999999999998 112.495 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -87.49 -26.86 22.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 75.5 110.88 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.6 m -64.96 -34.94 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 70.439999999999998 111.08 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.769 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -71.72 -25.01 61.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 73.120000000000005 111.077 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.42 ' HE1' ' CE1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -52.96 -31.1 38.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 72.340000000000003 110.872 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.6 t -56.94 -58.73 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 70.310000000000002 111.121 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.5 mp -73.99 -37.52 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 72.310000000000002 111.157 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -61.42 -29.97 70.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 71.219999999999999 110.819 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.0 -30.51 25.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.269 -0.423 . . . . 72.040000000000006 110.871 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.3 mt -71.76 -40.85 69.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 73.129999999999995 110.958 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -73.61 -53.06 11.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 72.099999999999994 110.92 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.47 HD23 ' CG ' ' A' ' 51' ' ' TYR . 4.8 mp -52.42 -32.02 37.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 75.340000000000003 110.851 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -61.37 -43.61 98.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.234 -0.439 . . . . 73.219999999999999 110.906 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.583 ' O ' HG23 ' A' ' 147' ' ' VAL . 68.2 mt -76.97 -33.49 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 74.140000000000001 111.152 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -56.36 -56.67 18.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 70.230000000000004 110.893 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 141' ' ' LEU . 28.2 t -55.2 -35.12 34.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 64.219999999999999 111.126 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.18 -32.99 74.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 73.140000000000001 110.852 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 143' ' ' ILE . 46.0 t -61.2 -51.78 69.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 61.5 111.09 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.1 m -52.05 -32.06 32.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 71.329999999999998 110.86 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.5 t -57.72 -50.89 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.229 -0.441 . . . . 75.409999999999997 111.101 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -72.06 -26.86 62.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 62.32 110.912 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -52.21 -58.98 9.48 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.715 -0.755 . . . . 64.510000000000005 112.468 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.5 t -60.82 -31.95 71.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.766 0.317 . . . . 75.310000000000002 111.119 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.416 HG22 ' CD1' ' A' ' 157' ' ' LEU . 43.9 mm -72.65 -24.94 21.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 72.140000000000001 111.151 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -65.65 -49.9 57.28 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.722 -0.751 . . . . 51.299999999999997 112.504 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.24 -32.01 43.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.781 0.324 . . . . 75.040000000000006 110.885 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -71.09 -23.81 62.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 74.519999999999996 110.83 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.416 ' CD1' HG22 ' A' ' 153' ' ' ILE . 8.7 mt -75.11 -27.5 59.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 73.129999999999995 110.91 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.486 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.9 OUTLIER -51.79 -60.64 5.6 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.618 0.723 . . . . 74.450000000000003 110.921 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.9 Cg_endo -69.69 -16.27 37.76 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.681 2.254 . . . . 75.329999999999998 112.392 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.5 tp -93.97 40.73 1.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 72.329999999999998 110.931 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -90.22 -30.59 17.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 72.129999999999995 110.887 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.49 -52.63 2.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 73.299999999999997 110.946 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -72.62 79.01 1.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 65.230000000000004 110.921 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 71.019999999999996 110.934 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 62.1 mtt-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.773 0.32 . . . . 72.340000000000003 110.89 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -99.76 54.64 0.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 74.049999999999997 110.915 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.4 71.33 12.84 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.609 0.718 . . . . 72.340000000000003 110.893 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 78.59 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.667 2.245 . . . . 64.140000000000001 112.313 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.05 -30.96 65.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 64.209999999999994 110.961 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -78.34 -32.15 48.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 64.109999999999999 110.879 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.08 -45.01 59.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 75.239999999999995 110.927 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -60.53 -39.95 89.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 75.420000000000002 111.132 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.447 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.24 -29.12 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 63.5 111.117 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.95 -26.84 49.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 72.200000000000003 110.913 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.54 -19.22 23.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 73.409999999999997 110.917 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.426 ' O ' HG12 ' A' ' 40' ' ' VAL . 45.6 mm -76.6 -35.01 24.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 72.209999999999994 111.108 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.552 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.76 -57.15 23.07 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.574 0.702 . . . . 72.530000000000001 111.131 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.77 -22.12 32.49 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.645 2.23 . . . . 61.109999999999999 112.376 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.628 ' O ' HG22 ' A' ' 42' ' ' ILE . 45.9 t -76.04 -45.67 33.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 72.150000000000006 110.871 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 36' ' ' ILE . 9.1 p -81.53 -28.83 10.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 72.299999999999997 111.165 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mt -50.92 -34.01 26.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 73.209999999999994 110.89 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.628 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.72 -34.65 52.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 64.049999999999997 111.103 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.7 p -65.89 -35.29 80.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 71.310000000000002 111.121 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.73 -51.22 66.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 72.540000000000006 110.858 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 tp -70.64 -42.23 71.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 74.299999999999997 110.915 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.06 -48.76 75.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 64.209999999999994 111.094 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.449 HD11 ' CD2' ' A' ' 141' ' ' LEU . 0.9 OUTLIER -65.09 -32.25 57.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 61.43 111.093 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.561 ' O ' HD13 ' A' ' 52' ' ' LEU . 14.6 tp -51.62 -37.73 51.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 74.239999999999995 110.89 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -101.52 -35.95 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 74.310000000000002 111.144 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -66.44 -62.45 1.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 64.0 110.909 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.51 -43.44 75.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 74.120000000000005 110.919 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.561 HD13 ' O ' ' A' ' 48' ' ' LEU . 4.3 mp -54.45 160.63 2.49 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.617 0.722 . . . . 42.420000000000002 110.911 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 179.91 3.37 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.669 2.246 . . . . 73.5 112.334 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 62.99 162.04 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 52.200000000000003 110.864 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -179.18 84.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 75.329999999999998 110.85 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.7 m -80.64 -170.63 2.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 75.420000000000002 110.911 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.82 -27.17 27.91 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.709 -0.758 . . . . 32.32 112.463 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -57.1 -34.96 68.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.924 0.392 . . . . 75.409999999999997 110.894 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.24 -51.36 64.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 73.319999999999993 110.882 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.7 ttm -53.05 -51.96 60.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 71.409999999999997 110.896 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.2 p -60.93 -35.53 76.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 61.229999999999997 111.15 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.472 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.5 OUTLIER -65.87 -47.19 75.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.425 . . . . 65.120000000000005 110.939 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.426 ' HB3' HG23 ' A' ' 106' ' ' ILE . 75.6 m -57.73 -51.98 67.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 72.209999999999994 110.888 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.452 HG13 HD12 ' A' ' 67' ' ' LEU . 17.8 tt -66.54 -34.96 73.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 73.030000000000001 111.1 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.5 m -59.76 -25.08 64.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 73.310000000000002 110.832 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 62' ' ' LEU . 48.3 t -57.92 -38.02 64.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 71.129999999999995 111.12 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.452 HD12 HG13 ' A' ' 64' ' ' ILE . 5.8 mt -52.89 -28.9 25.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 63.399999999999999 110.894 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.485 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.63 -38.74 77.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 54.340000000000003 110.886 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.57 -30.07 70.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 73.230000000000004 111.137 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.793 HD22 HG11 ' A' ' 102' ' ' VAL . 9.4 mt -64.95 -54.72 26.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 70.030000000000001 110.954 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.72 -38.43 87.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.469 . . . . 55.43 111.139 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 68' ' ' LEU . 78.9 t -71.48 -32.82 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 72.420000000000002 111.135 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -51.59 -30.56 21.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 75.25 110.877 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.6 tp -75.02 -38.84 61.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 64.239999999999995 110.937 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.0 mp -73.26 -40.32 64.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 74.219999999999999 110.923 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.2 tt -65.05 -54.07 35.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 74.519999999999996 110.893 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.06 -23.59 18.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 73.129999999999995 111.143 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.5 m -80.26 -21.95 42.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 71.209999999999994 110.845 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.755 ' O ' HG23 ' A' ' 81' ' ' VAL . 25.3 mttt -59.81 -20.44 56.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.481 . . . . 74.150000000000006 110.849 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.7 pt -51.92 -29.06 10.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 73.329999999999998 111.156 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 79' ' ' LYS . 59.1 t 61.17 76.81 0.39 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.654 0.74 . . . . 70.150000000000006 111.162 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 167.47 24.29 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.666 2.244 . . . . 72.230000000000004 112.35 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -48.78 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.683 2.255 . . . . 64.310000000000002 112.324 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.0 t -117.23 -20.16 9.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 72.510000000000005 111.134 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.74 45.51 4.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 64.400000000000006 110.882 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 tp -95.73 25.8 4.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 73.109999999999999 110.897 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -102.94 23.72 11.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 73.140000000000001 110.886 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.532 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -66.74 -57.72 11.23 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.594 0.711 . . . . 65.510000000000005 111.128 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 54.0 Cg_endo -69.72 -37.32 9.43 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.741 2.294 . . . . 64.239999999999995 112.342 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.7 mp -53.95 -52.96 58.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 71.120000000000005 110.899 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.532 HG12 HD21 ' A' ' 95' ' ' LEU . 21.7 t -80.24 -26.37 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 70.140000000000001 111.089 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.72 -51.32 39.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 75.310000000000002 112.532 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.54 -35.39 80.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.813 0.339 . . . . 63.130000000000003 110.9 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -60.52 -38.2 83.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 74.319999999999993 110.946 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.532 HD21 HG12 ' A' ' 91' ' ' VAL . 9.2 mt -51.79 -29.75 20.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 54.420000000000002 110.923 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.04 -42.99 79.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 73.5 110.876 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.5 ' O ' HG22 ' A' ' 100' ' ' VAL . 57.8 t80 -75.25 -52.2 11.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 75.430000000000007 110.887 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.795 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.15 -29.88 33.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 63.130000000000003 111.131 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.6 mmt -66.66 -30.1 70.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 72.25 110.846 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.76 -30.05 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 64.109999999999999 111.135 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.795 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -74.97 -33.19 61.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 74.329999999999998 110.918 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.793 HG11 HD22 ' A' ' 70' ' ' LEU . 30.8 m -76.85 -37.94 28.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.510000000000005 111.158 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.444 ' O ' HG13 ' A' ' 107' ' ' VAL . 60.9 m -72.51 -41.9 65.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 65.129999999999995 111.135 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -60.91 -31.89 71.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 71.519999999999996 110.895 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.7 t -74.8 -35.52 62.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 43.039999999999999 110.868 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.426 HG23 ' HB3' ' A' ' 63' ' ' CYS . 40.7 mt -74.97 -49.65 27.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 74.430000000000007 111.124 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.555 ' O ' HG12 ' A' ' 110' ' ' VAL . 34.2 m -53.99 -33.86 24.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 63.350000000000001 111.143 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.5 m -52.44 -32.43 39.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 72.120000000000005 111.173 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.7 m -50.45 -31.59 15.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 74.439999999999998 110.87 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.7 p -52.6 -32.68 17.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 55.509999999999998 111.144 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 49.4 m -66.7 -47.05 73.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 71.040000000000006 110.848 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 88.4 t -72.35 -35.37 51.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 63.409999999999997 111.143 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 89.5 mt -72.08 -39.69 68.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 62.350000000000001 110.964 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -54.1 -30.67 49.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 61.43 110.879 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.8 HG11 ' HB2' ' A' ' 133' ' ' ALA . 9.4 p -102.32 -23.23 4.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 64.030000000000001 111.126 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -53.82 -61.61 2.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 75.150000000000006 110.839 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -156.1 28.32 0.36 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 74.329999999999998 110.844 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -123.22 -177.79 3.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 72.439999999999998 110.851 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.33 160.55 25.8 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.658 0.742 . . . . 64.329999999999998 110.845 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.76 149.19 66.54 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.671 2.248 . . . . 53.43 112.316 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.56 -73.55 0.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 71.340000000000003 111.11 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.9 26.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 63.109999999999999 111.137 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -137.65 -60.15 0.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 65.549999999999997 110.898 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 34.2 m -113.84 73.92 2.4 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.567 0.699 . . . . 63.530000000000001 111.151 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 175.85 7.54 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.69 2.26 . . . . 73.329999999999998 112.38 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.1 mtt180 63.21 104.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 74.519999999999996 110.873 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -52.25 147.05 13.9 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.703 -0.761 . . . . 51.520000000000003 112.495 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -151.22 -147.02 4.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.734 -0.746 . . . . 50.140000000000001 112.487 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -112.49 -75.5 0.74 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.736 -0.745 . . . . 40.140000000000001 112.51 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -175.84 -44.35 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.739 -0.743 . . . . 73.409999999999997 112.491 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -71.52 -26.8 62.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.94 0.4 . . . . 74.409999999999997 110.909 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.8 m -64.58 -27.01 41.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 74.109999999999999 111.142 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.8 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -56.23 -24.95 45.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 70.230000000000004 111.135 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.0 -30.9 38.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 75.109999999999999 110.871 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 58.9 t -56.99 -59.0 3.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 71.510000000000005 111.13 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.7 mt -74.05 -37.72 47.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 73.209999999999994 111.121 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -61.28 -29.96 70.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 72.5 110.827 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.37 -29.69 25.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 72.140000000000001 110.912 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.93 -50.41 23.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 73.349999999999994 110.929 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -66.37 -53.99 29.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 64.230000000000004 110.876 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.449 ' CD2' HD11 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -52.0 -32.23 32.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 53.43 110.937 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -71.74 -38.1 70.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 75.230000000000004 110.913 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.558 ' O ' HG23 ' A' ' 147' ' ' VAL . 55.9 mt -76.87 -32.03 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 61.329999999999998 111.132 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -56.11 -56.31 22.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 55.140000000000001 110.875 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.26 -34.99 45.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 74.400000000000006 111.153 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -59.64 -47.53 85.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 71.239999999999995 110.914 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 143' ' ' ILE . 91.8 t -69.38 -34.1 60.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 70.5 111.129 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.95 -51.47 56.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 53.409999999999997 110.916 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 40.8 t -75.87 -33.11 24.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 74.209999999999994 111.121 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.36 -42.99 83.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 72.239999999999995 110.896 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.02 -19.32 67.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 73.099999999999994 112.436 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 94.9 m -63.02 -51.94 64.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.756 0.312 . . . . 70.109999999999999 111.145 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 20.5 tt -55.94 -25.64 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 73.019999999999996 111.162 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -51.87 -49.54 47.75 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.707 -0.759 . . . . 62.420000000000002 112.524 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 1.3 mmt -61.82 -31.79 72.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.834 0.349 . . . . 53.509999999999998 110.916 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -73.83 -22.8 59.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 73.219999999999999 110.886 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.619 HD23 HD22 ' A' ' 160' ' ' LEU . 1.1 mt -79.75 -25.55 41.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 72.209999999999994 110.898 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.529 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 15.1 tp60 -51.95 -58.07 12.63 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.558 0.694 . . . . 75.019999999999996 110.933 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.6 Cg_endo -69.77 -19.07 36.54 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.647 2.231 . . . . 71.450000000000003 112.346 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.619 HD22 HD23 ' A' ' 157' ' ' LEU . 9.8 tp -52.21 -58.23 7.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 71.140000000000001 110.935 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 5.6 t80 64.42 14.38 8.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 73.010000000000005 110.876 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 -88.91 54.02 2.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 64.349999999999994 110.925 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -80.21 -26.31 39.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 72.25 110.887 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 74.340000000000003 110.894 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.845 0.355 . . . . 73.549999999999997 110.86 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.0 mtt180 -90.55 -25.96 19.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 74.519999999999996 110.889 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -125.15 79.08 66.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.608 0.718 . . . . 75.239999999999995 110.924 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -5.06 15.29 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.724 2.283 . . . . 70.25 112.334 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 pp -53.31 -30.98 41.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 63.520000000000003 110.95 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -79.94 -29.34 39.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 71.25 110.865 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -77.07 -45.4 27.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.468 . . . . 74.150000000000006 110.938 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.2 t -59.45 -40.33 86.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 64.430000000000007 111.093 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.425 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -71.68 -28.84 32.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 73.219999999999999 111.123 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.37 -25.89 68.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 63.340000000000003 110.896 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.622 HD12 HD12 ' A' ' 77' ' ' ILE . 1.1 mm? -91.24 -23.08 20.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 75.340000000000003 110.872 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.6 mm -78.55 -31.2 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.447 . . . . 72.040000000000006 111.107 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.544 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.7 -57.16 22.82 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.615 0.721 . . . . 62.119999999999997 111.123 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 54.2 Cg_endo -69.76 -20.79 34.36 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.676 2.251 . . . . 61.119999999999997 112.378 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.64 ' O ' HG22 ' A' ' 42' ' ' ILE . 7.6 t -76.01 -43.27 45.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 63.32 110.876 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.61 -28.89 10.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 73.450000000000003 111.126 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 mt -50.97 -33.95 26.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 64.040000000000006 110.912 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.64 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.1 tp -58.8 -34.62 52.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 72.129999999999995 111.123 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.81 -38.62 89.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 71.420000000000002 111.177 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.6 m -53.04 -45.04 67.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 64.239999999999995 110.86 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.2 tp -76.93 -40.1 48.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 60.039999999999999 110.899 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.63 -38.34 74.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 73.310000000000002 111.091 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.446 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.3 mp -64.22 -31.98 55.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 63.119999999999997 111.142 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 tp -51.45 -38.74 55.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 63.509999999999998 110.896 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.8 p -101.47 -36.66 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 53.039999999999999 111.187 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -67.1 -64.65 0.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 74.420000000000002 110.876 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.546 ' CZ ' HD13 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -71.24 -25.94 62.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 74.099999999999994 110.9 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.1 mp -124.84 72.0 61.82 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.616 0.722 . . . . 73.540000000000006 110.961 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -173.0 0.64 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.651 2.234 . . . . 72.519999999999996 112.34 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.2 p -158.71 27.48 0.23 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 74.219999999999999 110.878 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 57.2 93.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 63.119999999999997 110.822 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.03 141.77 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 64.510000000000005 110.874 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.19 -22.97 45.55 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 52.530000000000001 112.469 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -52.06 -34.99 45.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 71.239999999999995 110.908 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.07 -37.47 61.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 74.120000000000005 110.914 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.19 -50.86 35.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 63.539999999999999 110.848 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.1 p -60.24 -29.3 68.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 73.230000000000004 111.121 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.55 -37.31 60.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.439 . . . . 74.430000000000007 110.893 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.506 ' O ' HG12 ' A' ' 66' ' ' VAL . 62.4 m -66.27 -44.86 82.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 54.439999999999998 110.929 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.6 tt -75.59 -33.14 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 51.329999999999998 111.149 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 t -51.74 -25.81 8.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 74.019999999999996 110.827 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.506 HG12 ' O ' ' A' ' 63' ' ' CYS . 8.9 p -57.08 -32.55 40.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 73.120000000000005 111.111 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.9 -28.93 25.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 70.209999999999994 110.925 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.497 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.25 -38.88 78.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 70.319999999999993 110.92 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.64 -30.03 70.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 65.209999999999994 111.054 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.819 HD22 HG11 ' A' ' 102' ' ' VAL . 9.2 mt -65.38 -54.63 26.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 65.340000000000003 110.94 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.59 -38.57 88.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 63.509999999999998 111.151 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 68' ' ' LEU . 83.4 t -71.56 -32.89 47.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 75.219999999999999 111.152 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.499 ' O ' HG22 ' A' ' 77' ' ' ILE . 18.4 t80 -52.0 -30.14 23.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 74.439999999999998 110.867 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.547 HD11 HD11 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -69.73 -45.93 67.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 74.5 110.937 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.7 mt -73.1 -34.14 65.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 72.319999999999993 110.906 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.43 -54.99 15.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 74.519999999999996 110.925 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.622 HD12 HD12 ' A' ' 35' ' ' LEU . 1.4 tt -61.45 -30.02 47.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 70.340000000000003 111.135 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.6 m -80.07 -23.71 41.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 62.340000000000003 110.862 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.706 ' O ' HG23 ' A' ' 81' ' ' VAL . 6.8 mtmt -66.8 -15.64 63.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 75.219999999999999 110.924 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.2 pp -56.08 -24.84 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 75.129999999999995 111.121 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 79' ' ' LYS . 23.3 t 63.52 75.42 0.4 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.57 0.7 . . . . 62.200000000000003 111.112 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 167.65 23.83 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.708 2.272 . . . . 64.329999999999998 112.363 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -22.13 32.52 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.649 2.233 . . . . 63.520000000000003 112.366 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.584 HG23 ' H ' ' A' ' 86' ' ' LEU . 7.9 t -95.24 -31.41 13.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 64.329999999999998 111.139 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 55.47 26.12 8.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 74.519999999999996 110.849 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.584 ' H ' HG23 ' A' ' 84' ' ' THR . 1.2 tp -141.84 51.89 1.51 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 71.140000000000001 110.918 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.633 ' HA ' HD23 ' A' ' 90' ' ' LEU . 1.9 m-20 -97.91 27.34 4.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 40.229999999999997 110.87 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.524 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.12 -57.75 10.42 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.607 0.717 . . . . 60.240000000000002 111.132 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.53 ' HG2' HD22 ' A' ' 90' ' ' LEU . 53.8 Cg_endo -69.83 -20.67 34.2 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.683 2.255 . . . . 73.150000000000006 112.289 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.633 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.19 -52.3 12.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 62.210000000000001 110.933 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.458 HG12 HD21 ' A' ' 95' ' ' LEU . 22.0 t -80.2 -22.81 11.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 72.5 111.096 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.65 -47.55 52.06 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.755 -0.736 . . . . 44.109999999999999 112.474 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -34.94 76.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.755 0.312 . . . . 75.430000000000007 110.859 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -60.62 -34.57 74.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.268 -0.423 . . . . 61.310000000000002 110.904 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.547 HD11 HD11 ' A' ' 74' ' ' LEU . 10.7 mt -51.7 -29.79 19.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 64.450000000000003 110.924 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -43.22 78.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 74.019999999999996 110.873 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.506 ' O ' HG22 ' A' ' 100' ' ' VAL . 30.3 t80 -75.27 -52.0 11.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 65.140000000000001 110.84 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.805 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.05 -29.94 32.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 71.0 111.137 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.5 mmt -66.41 -30.42 70.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 75.140000000000001 110.898 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.59 -29.94 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 70.420000000000002 111.139 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.805 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -75.26 -33.43 61.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 74.200000000000003 110.859 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.819 HG11 HD22 ' A' ' 70' ' ' LEU . 29.5 m -77.54 -39.51 27.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 64.450000000000003 111.14 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.666 ' HA ' HD12 ' A' ' 106' ' ' ILE . 2.5 t -72.58 -32.14 65.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 74.340000000000003 111.161 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -57.74 -33.89 68.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 74.219999999999999 110.88 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.4 t -74.95 -33.98 62.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 53.130000000000003 110.848 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.666 HD12 ' HA ' ' A' ' 103' ' ' THR . 7.4 mt -75.11 -50.56 24.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 62.229999999999997 111.138 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.544 ' O ' HG12 ' A' ' 110' ' ' VAL . 32.5 m -53.91 -35.73 28.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 70.450000000000003 111.149 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.6 m -52.61 -32.29 40.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 64.109999999999999 111.132 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 51.8 p -50.33 -31.56 14.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.43 . . . . 54.32 110.854 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.4 p -52.5 -32.75 17.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 73.129999999999995 111.123 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 44.1 m -67.08 -49.02 66.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 73.129999999999995 110.846 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 65.4 t -70.08 -35.49 64.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 72.530000000000001 111.109 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.1 mt -72.11 -41.09 67.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 71.209999999999994 110.928 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -51.94 -31.34 28.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 74.510000000000005 110.924 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.78 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.6 p -102.27 -23.97 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 70.310000000000002 111.135 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -53.18 -74.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 74.400000000000006 110.864 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -153.35 -44.08 0.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 70.420000000000002 110.869 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -67.8 120.14 13.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 72.140000000000001 110.914 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 49.3 m 52.29 71.9 1.34 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.665 0.745 . . . . 64.400000000000006 110.829 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 163.61 37.62 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.693 2.262 . . . . 71.5 112.356 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.11 24.94 10.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 74.430000000000007 111.172 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.6 m 63.17 45.32 5.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 72.439999999999998 111.149 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.411 ' O ' HG23 ' A' ' 124' ' ' THR . 53.5 t-80 -167.98 114.45 0.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 63.219999999999999 110.848 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.411 HG23 ' O ' ' A' ' 123' ' ' HIS . 0.8 OUTLIER -156.89 68.38 4.39 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.538 0.685 . . . . 75.129999999999995 111.133 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 92.88 0.51 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.696 2.264 . . . . 52.210000000000001 112.301 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 61.4 -170.35 0.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 65.129999999999995 110.86 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 111.89 169.01 18.27 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.752 -0.737 . . . . 61.020000000000003 112.496 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -128.95 -50.31 0.13 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.783 -0.722 . . . . 65.409999999999997 112.492 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -129.32 19.64 5.37 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 44.119999999999997 112.496 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.11 45.54 0.87 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.769 -0.729 . . . . 53.509999999999998 112.544 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -76.55 -37.47 56.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.947 0.403 . . . . 63.240000000000002 110.916 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.2 m -65.18 -34.7 72.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 72.200000000000003 111.097 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.78 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -68.33 -25.13 64.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 73.310000000000002 111.108 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 23.4 mmt -53.01 -30.96 38.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 74.340000000000003 110.894 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.0 -57.66 8.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 73.319999999999993 111.161 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.8 mm -74.01 -37.37 47.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.486 . . . . 62.25 111.157 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.82 -29.96 70.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 72.209999999999994 110.871 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -52.09 -30.2 25.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 75.349999999999994 110.87 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.2 tt -72.1 -50.38 28.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 71.099999999999994 110.931 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -63.03 -52.07 64.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 73.109999999999999 110.861 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.546 HD13 ' CZ ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -51.94 -35.16 45.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 74.510000000000005 110.917 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -60.81 -40.27 92.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 73.299999999999997 110.918 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.644 ' O ' HG23 ' A' ' 147' ' ' VAL . 45.6 mm -76.85 -31.98 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 70.400000000000006 111.166 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -56.02 -56.76 16.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.486 . . . . 64.409999999999997 110.906 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.6 m -56.67 -35.32 45.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 75.129999999999995 111.153 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.4 -34.1 77.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 74.519999999999996 110.879 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 143' ' ' ILE . 67.4 t -54.06 -35.93 30.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 64.329999999999998 111.146 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -52.82 -49.78 65.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 73.129999999999995 110.852 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.36 -33.04 57.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 71.209999999999994 111.125 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.19 -54.99 23.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 64.230000000000004 110.877 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.58 -19.48 71.0 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 64.549999999999997 112.484 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 32.7 m -55.95 -52.83 62.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.77 0.319 . . . . 63.439999999999998 111.123 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.464 HG22 ' CD1' ' A' ' 157' ' ' LEU . 29.8 mt -76.52 -27.99 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 73.329999999999998 111.126 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -53.71 -50.03 55.6 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.788 -0.72 . . . . 70.049999999999997 112.494 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -71.37 -31.99 67.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 75.519999999999996 110.844 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -71.24 -24.03 62.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 70.209999999999994 110.929 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.464 ' CD1' HG22 ' A' ' 153' ' ' ILE . 8.8 mt -75.27 -27.13 59.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 65.239999999999995 110.939 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.482 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -51.95 -60.58 5.81 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.584 0.707 . . . . 74.409999999999997 110.907 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.4 Cg_endo -69.78 -15.39 37.0 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.656 2.238 . . . . 70.329999999999998 112.349 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.96 40.86 1.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 74.439999999999998 110.946 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.62 -26.28 32.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 74.329999999999998 110.853 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 63.26 105.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.484 . . . . 64.099999999999994 110.945 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -111.6 26.21 10.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 75.140000000000001 110.865 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 8.2 t80 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 75.200000000000003 110.928 -179.885 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.826 0.346 . . . . 74.129999999999995 110.895 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.34 91.73 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 74.230000000000004 110.859 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.9 79.09 50.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.587 0.708 . . . . 62.32 110.882 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -5.0 15.17 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.67 2.247 . . . . 73.230000000000004 112.344 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.0 pp -52.26 -31.02 30.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 65.349999999999994 110.926 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -80.86 -31.69 35.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 75.430000000000007 110.853 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.478 ' HB3' HD11 ' A' ' 86' ' ' LEU . 1.4 t80 -72.98 -46.27 53.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.127 -0.488 . . . . 74.219999999999999 110.956 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 t -59.57 -39.89 85.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.483 . . . . 73.209999999999994 111.133 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.16 -29.08 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 70.349999999999994 111.156 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.73 -27.5 50.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.152 -0.477 . . . . 65.430000000000007 110.863 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.89 -18.75 24.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 51.43 110.903 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.6 mm -76.76 -34.82 23.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 71.450000000000003 111.106 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.547 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.68 -57.17 22.76 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.575 0.702 . . . . 74.540000000000006 111.057 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.8 Cg_endo -69.78 -19.3 36.2 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.686 2.258 . . . . 71.040000000000006 112.347 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.63 ' O ' HG22 ' A' ' 42' ' ' ILE . 48.7 t -73.02 -43.91 61.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 71.129999999999995 110.881 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.53 -28.93 10.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 74.109999999999999 111.115 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.1 mt -50.96 -33.94 26.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 72.239999999999995 110.874 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.63 HG22 ' O ' ' A' ' 39' ' ' CYS . 0.7 OUTLIER -58.78 -34.71 52.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 53.350000000000001 111.095 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.82 -41.19 92.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 73.109999999999999 111.138 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.09 -43.16 66.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 71.120000000000005 110.867 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 tp -76.29 -39.74 53.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 72.219999999999999 110.904 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.66 -51.46 69.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 73.420000000000002 111.125 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.432 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.4 mp -49.8 -31.36 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 75.349999999999994 111.134 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.1 tp -50.83 -42.17 58.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 62.229999999999997 110.912 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.776 HG21 ' HA ' ' A' ' 59' ' ' LYS . 7.2 p -101.53 -37.38 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 74.420000000000002 111.151 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -63.77 -64.45 0.89 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 72.140000000000001 110.856 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.625 ' CE1' HD13 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -72.67 -62.05 1.59 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.457 . . . . 60.340000000000003 110.947 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 mp -67.83 160.64 72.52 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.633 0.73 . . . . 62.420000000000002 110.921 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 154.0 68.62 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.713 2.276 . . . . 74.140000000000001 112.329 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.554 ' HB3' HG23 ' A' ' 49' ' ' VAL . 1.5 t -175.79 65.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 71.439999999999998 110.835 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -62.23 95.03 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 74.140000000000001 110.819 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.2 145.82 0.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 74.140000000000001 110.871 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.19 -28.26 25.99 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.672 -0.775 . . . . 71.5 112.47 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -53.42 -34.95 59.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.951 0.405 . . . . 75.230000000000004 110.894 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.776 ' HA ' HG21 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -52.94 -51.97 59.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 63.399999999999999 110.863 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.67 -48.95 78.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 62.210000000000001 110.88 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.6 p -60.73 -34.16 74.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 74.319999999999993 111.154 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.4 mt -67.0 -51.07 59.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 75.510000000000005 110.903 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 79.6 m -53.79 -51.06 64.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 71.310000000000002 110.89 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.0 tt -68.86 -34.96 67.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 71.420000000000002 111.151 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.1 -29.91 23.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 63.520000000000003 110.84 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.22 -40.54 88.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 72.319999999999993 111.126 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.697 HD22 HD12 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -52.93 -28.96 25.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 75.329999999999998 110.921 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.484 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.08 -39.0 79.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 71.120000000000005 110.928 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.46 -30.03 70.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 71.140000000000001 111.087 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.697 HD12 HD22 ' A' ' 67' ' ' LEU . 8.6 mt -65.8 -54.78 22.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.263 -0.426 . . . . 74.420000000000002 110.893 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.14 -38.41 86.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 72.150000000000006 111.121 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 68' ' ' LEU . 80.5 t -71.38 -32.92 48.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 41.409999999999997 111.153 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -60.06 -29.79 68.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 73.430000000000007 110.896 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.642 ' HG ' HD13 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -63.21 -55.03 28.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 55.420000000000002 110.927 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.15 -31.93 64.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 63.240000000000002 110.905 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tt -60.96 -54.44 44.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 74.140000000000001 110.88 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 tt -66.15 -27.02 39.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 73.319999999999993 111.112 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.7 t -83.23 -14.75 52.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 73.409999999999997 110.812 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.745 ' O ' HG23 ' A' ' 81' ' ' VAL . 15.8 mttt -93.7 -9.76 36.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 73.519999999999996 110.878 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.487 HD11 HD22 ' A' ' 86' ' ' LEU . 10.5 pt -54.26 -28.22 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 71.25 111.158 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 79' ' ' LYS . 40.5 t 63.07 74.75 0.44 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.624 0.726 . . . . 73.439999999999998 111.127 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 166.34 27.94 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.682 2.255 . . . . 74.219999999999999 112.359 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -49.15 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.664 2.243 . . . . 75.209999999999994 112.354 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.1 t -115.93 -41.7 3.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 65.140000000000001 111.115 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.476 ' HB3' HG23 ' A' ' 88' ' ' VAL . 0.5 OUTLIER -179.61 -42.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 64.400000000000006 110.824 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.487 HD22 HD11 ' A' ' 80' ' ' ILE . 0.5 OUTLIER 63.56 70.48 0.52 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.139 -0.482 . . . . 73.310000000000002 110.922 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 91' ' ' VAL . 4.3 m-20 51.05 64.14 1.96 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 74.150000000000006 110.838 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.536 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -69.17 -58.09 6.61 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.645 0.736 . . . . 64.109999999999999 111.177 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.602 ' HG2' HD22 ' A' ' 90' ' ' LEU . 53.2 Cg_endo -69.83 -24.21 29.63 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.692 2.261 . . . . 64.040000000000006 112.301 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.602 HD22 ' HG2' ' A' ' 89' ' ' PRO . 3.3 mm? -74.21 -53.09 10.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 62.140000000000001 110.913 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 87' ' ' ASP . 97.6 t -65.07 -48.93 81.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 72.329999999999998 111.111 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.83 -46.58 54.67 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.773 -0.727 . . . . 63.450000000000003 112.446 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -72.08 -24.93 61.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.819 0.342 . . . . 73.219999999999999 110.909 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -71.21 -30.93 66.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 70.140000000000001 110.939 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.642 HD13 ' HG ' ' A' ' 74' ' ' LEU . 13.1 mt -54.83 -29.66 55.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 52.25 110.917 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.51 -42.41 71.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 70.439999999999998 110.849 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.502 ' O ' HG22 ' A' ' 100' ' ' VAL . 77.0 t80 -75.13 -51.16 14.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 75.120000000000005 110.866 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.798 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.04 -29.96 32.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 73.200000000000003 111.125 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.8 mmt -66.58 -30.11 70.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 60.32 110.867 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.82 -30.11 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.427 . . . . 71.400000000000006 111.118 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.798 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.97 -33.12 61.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 50.109999999999999 110.913 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.47 -37.64 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 70.239999999999995 111.143 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.731 ' O ' HG23 ' A' ' 107' ' ' VAL . 55.1 m -72.86 -46.47 52.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 73.340000000000003 111.134 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -52.59 -31.64 37.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 73.439999999999998 110.898 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 53.2 p -74.68 -49.0 22.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 72.409999999999997 110.85 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.639 HD12 ' HA ' ' A' ' 103' ' ' THR . 9.8 mt -55.77 -34.56 36.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 74.040000000000006 111.131 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 103' ' ' THR . 22.0 t -53.7 -45.78 61.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 74.430000000000007 111.159 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.1 m -52.38 -32.49 38.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.099 -0.501 . . . . 74.040000000000006 111.147 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.7 m -50.35 -31.39 14.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 74.450000000000003 110.855 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.7 p -52.44 -32.76 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 70.310000000000002 111.112 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 34.4 m -66.72 -47.04 73.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 55.130000000000003 110.88 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 82.8 t -72.4 -35.05 50.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 63.409999999999997 111.126 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 87.8 mt -72.04 -42.8 65.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 54.130000000000003 110.88 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -52.11 -30.3 25.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 71.030000000000001 110.917 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.813 HG11 ' HB2' ' A' ' 133' ' ' ALA . 9.9 p -102.22 -22.25 4.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.142 -0.481 . . . . 75.409999999999997 111.114 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -58.65 -71.72 0.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 70.430000000000007 110.84 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -177.99 36.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.439 . . . . 72.120000000000005 110.842 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -151.88 122.79 7.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 71.409999999999997 110.897 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 68.4 m 56.15 68.6 2.21 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.651 0.738 . . . . 73.439999999999998 110.851 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.52 ' O ' HG23 ' A' ' 121' ' ' THR . 53.8 Cg_endo -69.75 102.79 1.07 Allowed 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.723 2.282 . . . . 74.430000000000007 112.312 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -169.9 83.53 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 53.310000000000002 111.111 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.8 t -160.23 173.13 16.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.264 -0.426 . . . . 72.530000000000001 111.107 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -100.34 74.42 1.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 73.150000000000006 110.858 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.22 159.67 46.55 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.577 0.703 . . . . 73.409999999999997 111.172 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 85.58 0.61 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.688 2.259 . . . . 74.230000000000004 112.329 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.25 105.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 73.549999999999997 110.878 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -52.33 102.99 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.733 -0.746 . . . . 43.549999999999997 112.497 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -168.34 131.63 2.36 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.725 -0.75 . . . . 72.400000000000006 112.488 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 58.37 174.32 0.47 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.77 -0.729 . . . . 62.240000000000002 112.461 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -112.7 18.71 22.12 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.678 -0.772 . . . . 62.210000000000001 112.443 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.51 ' CZ ' HG13 ' A' ' 132' ' ' VAL . 27.3 p90 -88.03 -30.34 20.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.926 0.393 . . . . 71.400000000000006 110.939 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.51 HG13 ' CZ ' ' A' ' 131' ' ' TYR . 19.8 m -73.94 -30.33 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 63.100000000000001 111.096 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.813 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -56.33 -24.94 47.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 53.409999999999997 111.111 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.96 -30.97 37.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 74.099999999999994 110.872 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 64.5 t -56.83 -62.33 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 70.510000000000005 111.158 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 41.8 mm -71.64 -38.15 65.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 74.430000000000007 111.104 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.437 ' OD2' HD11 ' A' ' 141' ' ' LEU . 25.8 t0 -60.65 -30.46 69.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 64.140000000000001 110.859 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.18 -25.74 48.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 63.439999999999998 110.824 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 7.6 tt -68.87 -50.93 45.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 62.409999999999997 110.925 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -73.97 -36.08 64.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 64.549999999999997 110.849 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.625 HD13 ' CE1' ' A' ' 51' ' ' TYR . 9.9 mt -52.21 -33.76 42.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 64.549999999999997 110.948 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -61.21 -48.38 81.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.451 . . . . 73.329999999999998 110.895 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.757 ' O ' HG23 ' A' ' 147' ' ' VAL . 39.0 mt -75.6 -31.98 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 54.539999999999999 111.128 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -56.0 -56.72 17.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 75.030000000000001 110.888 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 141' ' ' LEU . 22.8 t -57.65 -35.7 51.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 75.030000000000001 111.089 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -66.79 -32.98 74.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 75.549999999999997 110.892 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 143' ' ' ILE . 90.5 t -61.99 -34.0 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 72.209999999999994 111.151 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 49.7 m -63.24 -52.02 63.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 54.409999999999997 110.861 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.493 ' HB ' HD12 ' A' ' 153' ' ' ILE . 27.3 m -71.48 -35.56 57.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 72.430000000000007 111.119 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -67.45 -41.15 85.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 74.319999999999993 110.889 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.44 -33.25 39.76 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.754 -0.736 . . . . 71.530000000000001 112.485 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.7 m -76.48 -52.86 8.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.738 0.304 . . . . 71.140000000000001 111.141 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.493 HD12 ' HB ' ' A' ' 149' ' ' VAL . 7.9 mt -76.48 -24.5 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 72.129999999999995 111.185 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.01 -49.39 78.99 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.698 -0.763 . . . . 73.049999999999997 112.434 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -31.96 55.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.813 0.34 . . . . 55.340000000000003 110.853 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -71.17 -24.07 62.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 61.100000000000001 110.871 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.539 HD23 HD22 ' A' ' 160' ' ' LEU . 13.4 mt -75.23 -27.22 59.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 71.450000000000003 110.935 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.487 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -51.77 -60.58 5.72 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.624 0.726 . . . . 61.43 110.938 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 54.2 Cg_endo -69.76 -27.36 26.56 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.695 2.263 . . . . 75.420000000000002 112.36 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.539 HD22 HD23 ' A' ' 157' ' ' LEU . 5.1 tp -52.06 -55.45 20.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 71.349999999999994 110.938 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 5.0 t80 64.48 14.38 8.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 71.519999999999996 110.857 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -171.51 112.39 0.34 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.495 . . . . 74.430000000000007 110.956 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -64.18 -62.49 1.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 73.140000000000001 110.841 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 9.5 t80 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 75.219999999999999 110.97 -179.883 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.862 0.363 . . . . 74.310000000000002 110.885 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -143.82 -167.89 2.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 73.340000000000003 110.861 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.459 ' HB2' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -49.68 108.17 0.93 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.569 0.7 . . . . 74.109999999999999 110.867 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -11.65 31.29 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.698 2.266 . . . . 62.119999999999997 112.335 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.459 HD23 ' HB2' ' A' ' 27' ' ' LYS . 2.0 pp -51.97 -30.88 26.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 54.450000000000003 110.873 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -79.28 -33.35 43.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 71.519999999999996 110.885 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -72.33 -46.44 55.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 75.140000000000001 110.913 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -59.78 -40.12 87.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 63.409999999999997 111.186 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.448 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.21 -29.06 21.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 75.049999999999997 111.149 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -55.66 -27.14 48.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 35.439999999999998 110.884 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.455 HD21 HG21 ' A' ' 80' ' ' ILE . 4.1 mm? -91.31 -18.74 23.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 73.310000000000002 110.913 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.41 ' O ' HG12 ' A' ' 40' ' ' VAL . 45.8 mm -76.43 -35.25 26.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 70.129999999999995 111.125 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.55 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.76 -57.14 23.16 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.626 0.727 . . . . 75.109999999999999 111.153 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.6 Cg_endo -69.75 -21.94 32.82 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.705 2.27 . . . . 75.430000000000007 112.306 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.618 ' O ' HG22 ' A' ' 42' ' ' ILE . 42.7 t -76.01 -45.59 33.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 61.200000000000003 110.9 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 36' ' ' ILE . 9.3 p -81.52 -28.91 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 73.019999999999996 111.149 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mt -51.02 -33.92 27.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 74.5 110.923 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.71 -34.68 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 64.230000000000004 111.103 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 p -65.69 -40.68 92.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 72.310000000000002 111.141 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.01 -44.38 67.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 75.409999999999997 110.9 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.9 tp -75.3 -40.41 58.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 73.340000000000003 110.949 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.97 -36.53 70.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 73.230000000000004 111.1 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.414 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.2 mp -64.93 -32.31 57.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 72.209999999999994 111.112 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 tp -55.28 -33.82 63.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 70.299999999999997 110.893 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.1 m -101.64 -36.66 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 72.019999999999996 111.138 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -71.7 -64.93 0.83 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 72.310000000000002 110.87 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.678 ' CZ ' HD13 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -69.46 -58.74 3.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.486 . . . . 75.430000000000007 110.903 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 mp -77.03 160.69 75.65 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.629 0.728 . . . . 74.439999999999998 110.873 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 146.69 61.07 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.722 2.281 . . . . 64.109999999999999 112.329 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -178.22 74.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 65.140000000000001 110.841 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 53.91 -172.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.154 -0.475 . . . . 64.209999999999994 110.861 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 95.5 m -120.45 -54.8 2.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 72.549999999999997 110.904 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.32 -57.43 13.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.743 . . . . 73.439999999999998 112.502 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -52.08 -34.97 46.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.361 . . . . 65.329999999999998 110.846 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.97 -48.21 67.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 74.340000000000003 110.92 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 29.4 ttm -62.34 -52.06 65.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 74.25 110.866 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.7 p -58.02 -27.06 63.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 63.340000000000003 111.107 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.648 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -75.87 -34.19 60.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.29 -0.413 . . . . 73.209999999999994 110.886 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 90.2 m -70.96 -51.89 23.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 54.119999999999997 110.845 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 15.8 tt -63.24 -35.29 71.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 65.329999999999998 111.134 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.5 t -63.54 -25.46 68.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 74.329999999999998 110.847 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 62' ' ' LEU . 83.6 t -57.95 -36.15 54.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 62.140000000000001 111.08 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.87 -28.83 24.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 73.310000000000002 110.926 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.493 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.24 -38.98 78.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 73.340000000000003 110.924 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.56 -29.95 70.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 54.340000000000003 111.136 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.607 HD13 HG11 ' A' ' 102' ' ' VAL . 9.4 mt -65.16 -54.71 25.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 73.319999999999993 110.945 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.7 -38.56 88.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 74.120000000000005 111.149 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 68' ' ' LEU . 82.2 t -71.5 -32.91 47.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 74.120000000000005 111.105 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.446 ' O ' HG22 ' A' ' 77' ' ' ILE . 28.0 t80 -51.86 -30.55 24.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 70.209999999999994 110.859 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.624 HD11 HD11 ' A' ' 95' ' ' LEU . 0.3 OUTLIER -75.02 -39.24 61.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 74.329999999999998 110.892 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.07 -39.38 65.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 72.340000000000003 110.901 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.4 tt -66.46 -55.06 17.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 72.129999999999995 110.918 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 73' ' ' PHE . 1.1 tt -57.04 -30.6 34.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 73.430000000000007 111.13 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.5 t -80.22 -23.36 40.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 74.030000000000001 110.83 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.685 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.4 OUTLIER -69.63 -12.9 62.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 72.319999999999993 110.895 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.455 HG21 HD21 ' A' ' 35' ' ' LEU . 2.2 pp -56.41 -24.53 18.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 75.209999999999994 111.088 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 79' ' ' LYS . 21.8 t 63.68 75.21 0.4 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.649 0.737 . . . . 60.520000000000003 111.173 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 167.55 24.2 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.638 2.226 . . . . 60.520000000000003 112.352 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -48.63 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.694 2.263 . . . . 61.530000000000001 112.356 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.4 t -117.22 -19.88 9.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 70.019999999999996 111.07 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.76 47.02 3.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 72.540000000000006 110.858 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 tp -99.27 26.05 6.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 71.219999999999999 110.91 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.631 ' HA ' HD23 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -99.91 23.68 9.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 74.519999999999996 110.845 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.542 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.74 -57.79 9.32 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.66 0.743 . . . . 71.049999999999997 111.152 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.7 Cg_endo -69.81 -20.0 35.18 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.664 2.243 . . . . 72.519999999999996 112.35 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.631 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.19 -53.09 10.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 63.43 110.911 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.519 HG12 HD21 ' A' ' 95' ' ' LEU . 24.9 t -80.68 -33.69 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 70.219999999999999 111.125 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.82 -52.21 35.63 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.734 -0.746 . . . . 75.030000000000001 112.466 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -35.35 80.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 73.409999999999997 110.882 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -60.32 -36.98 79.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.438 . . . . 75.099999999999994 110.923 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.624 HD11 HD11 ' A' ' 74' ' ' LEU . 9.5 mt -51.91 -29.75 21.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 75.030000000000001 110.915 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 4.1 mmt -67.67 -42.86 81.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 73.430000000000007 110.921 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.501 ' O ' HG22 ' A' ' 100' ' ' VAL . 4.4 t80 -75.29 -52.47 10.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 61.200000000000003 110.849 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.785 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.1 -29.87 33.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 75.109999999999999 111.135 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.71 -30.08 70.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 73.340000000000003 110.913 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.73 -30.05 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 73.450000000000003 111.103 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.785 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -74.96 -33.25 61.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 54.25 110.893 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.607 HG11 HD13 ' A' ' 70' ' ' LEU . 31.1 m -76.93 -37.96 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 72.239999999999995 111.095 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.603 ' HA ' HD12 ' A' ' 106' ' ' ILE . 61.3 m -72.45 -41.37 66.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 72.400000000000006 111.116 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -61.67 -32.02 72.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 72.329999999999998 110.873 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -32.58 69.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 63.329999999999998 110.843 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' A' ' 103' ' ' THR . 12.3 mt -74.41 -51.77 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 74.310000000000002 111.165 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.558 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.3 p -53.95 -33.93 24.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 73.310000000000002 111.158 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 91.8 m -52.36 -32.4 38.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 63.439999999999998 111.131 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.34 -31.74 15.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 74.120000000000005 110.874 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.5 p -52.72 -32.83 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.492 . . . . 62.439999999999998 111.114 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 47.5 m -65.23 -43.53 91.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 64.230000000000004 110.881 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.5 t -76.82 -35.77 24.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 71.439999999999998 111.161 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.425 HD13 ' HD2' ' A' ' 118' ' ' ARG . 90.3 mt -72.14 -31.13 65.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 75.109999999999999 110.882 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -64.73 -29.46 70.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 64.230000000000004 110.87 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.76 HG11 ' HB2' ' A' ' 133' ' ' ALA . 10.8 p -102.24 -20.91 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 73.120000000000005 111.102 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -79.18 -74.55 0.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 72.140000000000001 110.853 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -177.26 110.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 74.409999999999997 110.876 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.425 ' HD2' HD13 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -178.03 -178.55 0.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 70.019999999999996 110.876 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.1 160.63 1.15 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.699 0.761 . . . . 65.409999999999997 110.855 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 79.61 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.67 2.247 . . . . 71.310000000000002 112.342 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.78 -179.42 5.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 74.519999999999996 111.135 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.98 128.74 15.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 70.439999999999998 111.126 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.61 -58.52 0.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 73.040000000000006 110.884 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.88 159.64 39.98 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.554 0.692 . . . . 74.450000000000003 111.117 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -12.47 32.88 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.725 2.284 . . . . 55.439999999999998 112.318 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -63.54 151.5 41.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 72.510000000000005 110.897 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -176.6 -164.53 30.72 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.741 -0.742 . . . . 70.530000000000001 112.496 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 129.26 -136.7 9.12 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 70.019999999999996 112.457 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.58 -133.07 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.756 -0.735 . . . . 74.549999999999997 112.505 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -112.43 -51.62 0.54 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.732 -0.746 . . . . 74.340000000000003 112.523 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -71.43 -26.93 62.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.897 0.379 . . . . 71.409999999999997 110.915 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.62 ' O ' HG22 ' A' ' 135' ' ' VAL . 34.8 m -55.8 -26.96 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 52.539999999999999 111.139 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.76 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -55.99 -24.84 41.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 61.200000000000003 111.069 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.1 mtt -52.66 -31.0 34.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 63.32 110.889 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 132' ' ' VAL . 17.7 m -59.55 -30.55 44.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 74.219999999999999 111.156 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 28.2 mt -74.15 -47.38 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 73.319999999999993 111.163 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -69.66 -29.95 67.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 65.310000000000002 110.839 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.1 mtm-85 -55.87 -25.64 43.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 71.530000000000001 110.838 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.6 mt -71.02 -50.99 28.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 60.329999999999998 110.887 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -73.82 -27.13 60.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 55.32 110.853 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.678 HD13 ' CZ ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -51.93 -36.8 50.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.17 -0.468 . . . . 65.010000000000005 110.884 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -53.03 -52.01 59.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 63.329999999999998 110.905 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.735 ' O ' HG23 ' A' ' 147' ' ' VAL . 3.4 mt -77.02 -37.74 26.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 72.109999999999999 111.17 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -56.01 -56.96 14.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 73.109999999999999 110.915 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 141' ' ' LEU . 42.7 t -56.67 -34.97 43.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 73.439999999999998 111.165 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -68.48 -34.95 76.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 75.439999999999998 110.882 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 143' ' ' ILE . 93.5 t -55.58 -41.62 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 73.310000000000002 111.133 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 98.6 m -52.02 -48.23 64.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 74.340000000000003 110.9 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.461 ' O ' HG22 ' A' ' 153' ' ' ILE . 43.6 t -75.69 -36.9 34.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 54.130000000000003 111.122 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.31 -26.85 61.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 75.200000000000003 110.903 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.15 -59.07 2.48 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.696 -0.764 . . . . 50.109999999999999 112.455 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 4.6 t -55.3 -41.78 72.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.741 0.305 . . . . 22.440000000000001 111.092 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.461 HG22 ' O ' ' A' ' 149' ' ' VAL . 18.7 tt -63.06 -26.29 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 74.420000000000002 111.141 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -51.98 -49.82 47.36 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.767 -0.73 . . . . 63.409999999999997 112.47 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 22.7 mmt -71.57 -31.9 67.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.828 0.347 . . . . 74.409999999999997 110.878 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -67.97 -20.28 65.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 72.340000000000003 110.903 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.6 mt -74.43 -28.96 61.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 73.120000000000005 110.849 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.487 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 1.0 OUTLIER -53.27 -60.56 6.58 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.618 0.723 . . . . 72.329999999999998 110.952 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.4 Cg_endo -69.82 -21.56 33.04 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.674 2.249 . . . . 63.509999999999998 112.31 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.449 HD13 ' O ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -55.82 -25.65 42.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 72.299999999999997 110.903 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -51.99 -30.3 24.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 74.299999999999997 110.88 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.16 104.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 75.299999999999997 110.905 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -115.92 27.36 9.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 61.399999999999999 110.918 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 78.2 t80 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 72.450000000000003 110.888 -179.913 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.81 0.338 . . . . 64.120000000000005 110.852 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.2 mmt-85 -68.2 -60.75 2.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 50.219999999999999 110.876 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -120.64 68.3 15.09 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.63 0.729 . . . . 74.010000000000005 110.904 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.74 78.47 1.0 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.688 2.258 . . . . 64.340000000000003 112.376 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.92 -30.94 65.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 74.310000000000002 110.873 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -78.18 -31.84 49.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 74.200000000000003 110.84 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.668 ' CE1' HG22 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -73.66 -44.91 55.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 74.510000000000005 110.926 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.6 t -60.56 -39.78 89.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 53.130000000000003 111.14 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.12 -29.12 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 74.010000000000005 111.118 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.13 -27.05 52.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 55.210000000000001 110.909 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.522 ' CD1' HD22 ' A' ' 76' ' ' LEU . 4.1 mm? -91.25 -19.28 23.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 70.239999999999995 110.925 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.3 mm -76.84 -34.58 22.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 63.119999999999997 111.118 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.551 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.75 -57.18 22.9 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.629 0.728 . . . . 74.120000000000005 111.112 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.8 Cg_endo -69.74 -20.47 34.9 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.663 2.242 . . . . 60.130000000000003 112.356 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.631 ' O ' HG22 ' A' ' 42' ' ' ILE . 49.3 t -75.94 -44.42 40.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 61.329999999999998 110.87 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.2 p -81.57 -28.93 10.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 73.010000000000005 111.104 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.5 mt -50.99 -33.94 26.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 75.230000000000004 110.917 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.631 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.74 -34.69 52.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 64.329999999999998 111.1 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.82 -36.79 84.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 71.209999999999994 111.121 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.07 -52.65 60.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 71.510000000000005 110.862 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.1 tp -68.91 -40.51 79.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 73.239999999999995 110.922 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.93 -51.38 69.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 70.239999999999995 111.101 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.13 -31.85 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 74.25 111.141 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.558 ' O ' HD13 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -51.68 -38.1 53.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 73.239999999999995 110.926 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.7 p -101.6 -37.17 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 74.340000000000003 111.175 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -67.43 -63.28 1.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 71.209999999999994 110.86 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.39 -26.01 38.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 75.420000000000002 110.946 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 48' ' ' LEU . 4.2 mp -76.78 160.65 76.29 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.596 0.712 . . . . 54.530000000000001 110.907 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 78.84 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.704 2.27 . . . . 73.019999999999996 112.339 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.7 t -165.8 151.69 9.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 54.520000000000003 110.848 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -161.16 26.14 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 74.310000000000002 110.85 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 30.3 p -65.97 -170.24 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 54.210000000000001 110.86 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.99 -43.73 72.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.723 -0.751 . . . . 64.200000000000003 112.488 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -53.04 -41.27 64.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.93 0.395 . . . . 72.040000000000006 110.929 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -59.28 -45.21 91.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 73.510000000000005 110.894 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 33.4 ttm -63.92 -51.68 63.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 53.229999999999997 110.902 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 80.8 p -54.08 -34.82 61.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 71.519999999999996 111.135 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.533 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -65.64 -50.33 65.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 74.310000000000002 110.921 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 59.4 m -53.87 -51.96 62.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 62.030000000000001 110.886 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.6 tt -67.37 -35.06 72.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 73.329999999999998 111.095 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 m -60.26 -26.01 66.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 75.019999999999996 110.911 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 62' ' ' LEU . 41.6 t -57.97 -38.52 67.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 51.340000000000003 111.139 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.88 -28.9 25.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 71.200000000000003 110.913 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.493 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.03 -39.34 79.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 74.040000000000006 110.945 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.27 -29.98 70.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 74.5 111.081 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.529 HD22 HG11 ' A' ' 102' ' ' VAL . 10.1 mt -64.82 -54.74 26.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 62.039999999999999 110.908 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.97 -38.08 87.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 63.409999999999997 111.127 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 68' ' ' LEU . 75.0 t -71.45 -32.91 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 54.420000000000002 111.094 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -60.13 -29.88 68.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 75.409999999999997 110.901 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.568 HD11 HD13 ' A' ' 95' ' ' LEU . 1.7 tt -73.25 -44.17 59.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.124 -0.489 . . . . 74.450000000000003 110.89 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.4 mt -73.35 -33.04 64.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 72.120000000000005 110.918 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.545 HD23 ' HD2' ' A' ' 79' ' ' LYS . 1.6 tt -68.87 -55.14 12.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 73.319999999999993 110.882 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.442 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.6 OUTLIER -56.93 -23.38 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 74.25 111.16 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.5 t -70.03 -14.69 62.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 71.420000000000002 110.882 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.745 ' O ' HG23 ' A' ' 81' ' ' VAL . 12.6 ptmt -62.17 -17.04 56.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 53.530000000000001 110.893 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.668 HG22 ' CE1' ' A' ' 31' ' ' TYR . 24.7 pt -50.37 -31.4 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 75.349999999999994 111.099 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 79' ' ' LYS . 66.7 t 56.73 80.33 0.29 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.635 0.731 . . . . 63.420000000000002 111.137 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 166.8 26.3 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.735 2.29 . . . . 75.310000000000002 112.358 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -49.14 0.59 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.658 2.239 . . . . 74.049999999999997 112.374 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.1 t -135.67 22.2 3.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 63.340000000000003 111.153 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.7 t 52.17 48.57 22.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 64.200000000000003 110.856 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tp -95.55 24.65 5.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 61.219999999999999 110.915 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.635 ' HA ' HD23 ' A' ' 90' ' ' LEU . 3.3 m-20 -110.92 25.85 11.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 73.230000000000004 110.894 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.533 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.03 -57.82 10.45 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.664 0.745 . . . . 72.129999999999995 111.092 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.539 ' HG2' HD22 ' A' ' 90' ' ' LEU . 53.9 Cg_endo -69.72 -20.59 34.84 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.661 2.241 . . . . 63.539999999999999 112.392 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.635 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.19 -53.07 10.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 74.099999999999994 110.978 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.07 -36.54 16.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 74.540000000000006 111.096 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.21 -40.43 52.35 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.768 -0.729 . . . . 61.149999999999999 112.475 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -67.66 -24.6 65.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 65.209999999999994 110.865 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -78.04 -44.3 26.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 75.340000000000003 110.971 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.568 HD13 HD11 ' A' ' 74' ' ' LEU . 10.0 mt -55.45 -29.72 59.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 73.140000000000001 110.923 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.38 -43.26 77.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 74.239999999999995 110.847 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.503 ' O ' HG22 ' A' ' 100' ' ' VAL . 39.1 t80 -75.29 -51.85 12.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 75.319999999999993 110.941 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.776 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.12 -29.87 33.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 72.200000000000003 111.165 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.1 mmt -66.69 -30.11 70.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 73.109999999999999 110.875 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.76 -30.09 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 75.049999999999997 111.116 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.776 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.89 -33.27 62.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 75.430000000000007 110.884 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.529 HG11 HD22 ' A' ' 70' ' ' LEU . 31.1 m -76.87 -38.1 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 63.350000000000001 111.159 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 73.9 m -72.46 -39.77 67.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 53.240000000000002 111.143 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -64.87 -31.99 73.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 73.510000000000005 110.843 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.9 t -72.57 -35.25 67.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 60.210000000000001 110.857 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 36.8 mt -72.55 -51.36 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 72.420000000000002 111.099 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.549 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.5 p -53.97 -36.41 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 74.540000000000006 111.097 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 94.7 m -52.42 -32.4 39.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 74.310000000000002 111.099 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.9 p -50.44 -31.4 14.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 55.539999999999999 110.826 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.4 p -52.45 -32.82 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 63.219999999999999 111.106 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 31.0 m -65.81 -43.17 89.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 73.409999999999997 110.895 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.8 t -77.02 -35.45 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 74.439999999999998 111.145 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 87.5 mt -71.99 -32.98 67.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 74.109999999999999 110.906 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -59.71 -31.24 69.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 65.400000000000006 110.881 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.769 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.7 p -102.29 -23.96 4.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 74.510000000000005 111.135 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -77.04 -26.17 53.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 71.439999999999998 110.833 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -173.27 -169.94 0.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 75.310000000000002 110.827 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 56.71 -174.24 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 74.510000000000005 110.903 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.5 160.62 29.74 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.665 0.745 . . . . 64.120000000000005 110.844 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 125.3 11.97 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.68 2.253 . . . . 74.329999999999998 112.33 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.97 -73.22 0.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 52.009999999999998 111.127 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 48.8 m -93.54 -42.89 8.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 63.439999999999998 111.147 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -91.24 -169.93 2.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 73.430000000000007 110.841 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.36 147.55 43.47 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.577 0.704 . . . . 74.140000000000001 111.141 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -173.93 0.81 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.667 2.245 . . . . 74.219999999999999 112.372 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.04 120.15 1.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 75.409999999999997 110.866 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -53.98 102.52 0.12 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.746 -0.74 . . . . 24.210000000000001 112.479 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -176.21 -109.24 0.24 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.771 -0.728 . . . . 44.140000000000001 112.496 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -166.68 -37.24 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.701 -0.761 . . . . 63.340000000000003 112.449 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 167.63 -30.59 0.18 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.768 -0.73 . . . . 32.420000000000002 112.524 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -86.37 -26.79 24.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 70.019999999999996 110.882 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.6 m -54.4 -26.91 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 71.409999999999997 111.124 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.769 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -55.22 -26.04 36.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 54.229999999999997 111.066 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 6.4 ptm -52.99 -30.94 38.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 74.439999999999998 110.89 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 62.8 t -56.96 -58.95 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 72.230000000000004 111.092 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.8 mt -73.96 -37.78 48.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 71.319999999999993 111.14 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -61.25 -30.01 70.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 62.210000000000001 110.851 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.01 -29.02 26.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 61.420000000000002 110.9 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.52 -48.3 70.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 72.319999999999993 110.925 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -73.69 -41.77 62.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 42.450000000000003 110.824 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.615 ' O ' HG23 ' A' ' 145' ' ' VAL . 0.4 OUTLIER -52.07 -32.7 35.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 54.450000000000003 110.933 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 23.7 m0 -61.85 -51.98 65.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 54.43 110.906 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.681 ' O ' HG23 ' A' ' 147' ' ' VAL . 66.6 mt -71.21 -32.05 46.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 55.43 111.175 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -56.33 -40.76 74.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 65.340000000000003 110.858 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 141' ' ' LEU . 21.8 t -73.63 -44.97 52.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 72.019999999999996 111.101 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.4 -40.73 62.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 72.219999999999999 110.851 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 143' ' ' ILE . 65.5 t -54.34 -33.96 27.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 60.409999999999997 111.119 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 72.0 m -52.06 -51.96 54.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.191 -0.459 . . . . 54.25 110.871 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.91 -33.7 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 72.010000000000005 111.143 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -52.38 -40.57 62.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 74.109999999999999 110.902 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.76 -44.24 8.52 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.771 -0.728 . . . . 72.349999999999994 112.506 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 35.1 m -51.85 -52.85 46.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 51.32 111.163 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 47.5 mm -76.52 -24.92 16.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 52.43 111.16 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -53.92 -49.9 56.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 74.439999999999998 112.513 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -31.95 73.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.825 0.345 . . . . 64.340000000000003 110.894 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -76.97 -23.77 52.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 65.040000000000006 110.881 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.571 HD23 HD23 ' A' ' 160' ' ' LEU . 2.3 mt -78.51 -26.79 45.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 73.310000000000002 110.889 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.527 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 4.6 tt0 -51.98 -58.69 10.36 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.577 0.703 . . . . 73.25 110.854 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.9 Cg_endo -69.79 -17.17 37.59 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.697 2.265 . . . . 75.109999999999999 112.327 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.571 HD23 HD23 ' A' ' 157' ' ' LEU . 26.0 tp -83.76 -26.45 29.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 75.019999999999996 110.879 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -53.86 -71.63 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 72.140000000000001 110.904 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 63.06 104.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 73.400000000000006 110.911 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -75.9 79.74 2.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 73.099999999999994 110.887 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 13.2 p90 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 74.120000000000005 110.956 -179.898 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.83 0.348 . . . . 64.140000000000001 110.829 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.97 -167.89 2.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 74.209999999999994 110.894 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.9 mtpp 55.83 73.62 0.82 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.564 0.697 . . . . 61.409999999999997 110.894 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 -11.64 31.36 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.735 2.29 . . . . 72.329999999999998 112.343 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 pp -52.06 -30.91 27.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 71.5 110.92 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -79.08 -33.17 44.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 61.020000000000003 110.9 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.45 -46.0 56.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 74.409999999999997 110.938 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -60.03 -39.97 87.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 71.140000000000001 111.182 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.442 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.24 -29.05 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 53.020000000000003 111.132 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.87 -27.19 50.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 72.129999999999995 110.89 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.23 -19.14 23.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 64.219999999999999 110.894 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.52 HD12 HG23 ' A' ' 152' ' ' THR . 45.7 mm -76.77 -34.73 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 62.119999999999997 111.138 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.545 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.7 -57.15 22.91 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.62 0.724 . . . . 73.409999999999997 111.09 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.9 Cg_endo -69.73 -22.83 31.68 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.655 2.237 . . . . 50.210000000000001 112.377 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.627 ' O ' HG22 ' A' ' 42' ' ' ILE . 49.6 t -76.08 -46.49 28.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 72.349999999999994 110.825 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 36' ' ' ILE . 8.7 p -81.6 -28.78 10.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 72.25 111.117 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.6 mt -50.93 -33.99 26.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 72.230000000000004 110.932 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.627 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.68 -34.71 52.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 71.140000000000001 111.119 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.7 p -66.04 -38.55 88.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 74.530000000000001 111.147 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.8 m -52.92 -53.77 44.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.229 -0.442 . . . . 75.439999999999998 110.897 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tp -67.55 -39.47 84.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 52.420000000000002 110.954 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.99 74.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 43.329999999999998 111.142 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.422 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.3 mp -64.93 -32.47 58.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 72.230000000000004 111.104 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.6 tp -53.76 -34.61 59.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 75.140000000000001 110.887 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.585 HG23 ' HB2' ' A' ' 55' ' ' ASP . 7.1 p -102.26 -36.59 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 74.439999999999998 111.145 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.48 -64.92 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 74.540000000000006 110.891 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.629 ' CD2' HD22 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -69.27 -62.3 1.44 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.099 -0.5 . . . . 74.019999999999996 110.956 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.6 mp -63.47 160.09 45.54 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.587 0.708 . . . . 61.240000000000002 110.932 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -168.54 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.687 2.258 . . . . 73.519999999999996 112.349 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.88 154.53 0.07 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 72.510000000000005 110.856 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.585 ' HB2' HG23 ' A' ' 49' ' ' VAL . 43.8 m-20 53.01 88.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 73.129999999999995 110.813 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 94.5 m -88.71 -69.61 0.7 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 62.240000000000002 110.831 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.95 -32.0 59.0 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.708 -0.758 . . . . 41.32 112.493 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -51.97 -34.97 44.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.9 0.381 . . . . 75.409999999999997 110.924 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -52.98 -48.79 67.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 73.030000000000001 110.906 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.4 ttm -57.83 -51.78 68.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 75.099999999999994 110.892 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.4 p -61.95 -28.34 69.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 64.010000000000005 111.111 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.747 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -75.81 -50.78 14.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 74.239999999999995 110.931 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 71.4 m -52.96 -42.19 65.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 73.329999999999998 110.895 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.7 tt -73.37 -34.95 44.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 51.200000000000003 111.127 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.9 t -69.14 -25.85 64.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 71.319999999999993 110.841 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 62' ' ' LEU . 99.5 t -57.95 -34.6 49.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 72.420000000000002 111.12 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -52.89 -28.91 25.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 71.420000000000002 110.891 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.493 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.37 -38.92 78.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 72.200000000000003 110.95 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.6 -29.94 70.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 72.5 111.105 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.766 HD22 HG11 ' A' ' 102' ' ' VAL . 9.5 mt -65.08 -54.79 24.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 72.109999999999999 110.86 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.71 -38.38 87.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 74.25 111.173 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 68' ' ' LEU . 79.3 t -71.48 -32.83 47.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 55.109999999999999 111.109 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -51.94 -30.0 22.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 74.420000000000002 110.855 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.08 -41.71 61.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 74.450000000000003 110.88 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.9 mt -73.2 -34.78 66.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 70.530000000000001 110.91 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.443 HD13 ' HD2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -69.31 -55.09 11.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 74.319999999999993 110.885 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.6 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -56.19 -25.0 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 52.109999999999999 111.117 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.6 -14.9 63.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 63.119999999999997 110.851 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.757 ' O ' HG23 ' A' ' 81' ' ' VAL . 2.2 ptmm? -59.23 -20.76 56.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 72.25 110.884 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 77' ' ' ILE . 36.8 pt -51.55 -29.38 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 74.319999999999993 111.108 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 79' ' ' LYS . 60.2 t 60.87 77.54 0.36 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.589 0.709 . . . . 55.200000000000003 111.112 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 167.57 24.06 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.714 2.276 . . . . 75.310000000000002 112.356 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -48.76 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.657 2.238 . . . . 71.540000000000006 112.33 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.5 t -131.73 9.89 4.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 73.420000000000002 111.179 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.73 52.74 13.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 61.409999999999997 110.82 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.89 25.65 4.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 73.25 110.91 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.636 ' HA ' HD23 ' A' ' 90' ' ' LEU . 1.5 m-20 -104.3 23.71 12.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 75.439999999999998 110.87 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.542 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.37 -57.84 9.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.63 0.728 . . . . 63.030000000000001 111.133 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.3 Cg_endo -69.75 -20.35 35.01 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.716 2.277 . . . . 73.239999999999995 112.337 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.636 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.17 -53.02 10.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 72.219999999999999 110.937 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.573 HG12 HD21 ' A' ' 95' ' ' LEU . 24.6 t -80.75 -32.87 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 70.140000000000001 111.114 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.72 -52.1 35.69 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.707 -0.759 . . . . 55.549999999999997 112.476 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -35.01 79.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.778 0.323 . . . . 75.129999999999995 110.883 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -61.22 -36.61 80.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 75.129999999999995 110.906 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.573 HD21 HG12 ' A' ' 91' ' ' VAL . 9.2 mt -51.82 -29.87 21.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 71.25 110.924 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -69.25 -43.63 73.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 75.040000000000006 110.864 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.506 ' O ' HG22 ' A' ' 100' ' ' VAL . 72.4 t80 -75.26 -51.26 13.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 75.140000000000001 110.867 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.808 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.05 -29.86 32.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 74.420000000000002 111.157 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.8 mmt -66.6 -30.24 70.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 71.439999999999998 110.859 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.67 -29.97 13.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 61.229999999999997 111.097 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.808 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -75.23 -33.49 61.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 72.109999999999999 110.903 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.766 HG11 HD22 ' A' ' 70' ' ' LEU . 29.3 m -77.53 -39.65 27.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 74.519999999999996 111.104 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.719 ' HA ' HD12 ' A' ' 106' ' ' ILE . 2.9 t -72.55 -32.3 65.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 70.329999999999998 111.082 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -56.83 -35.14 68.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 62.219999999999999 110.861 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.4 t -75.02 -32.59 61.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 73.120000000000005 110.882 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.719 HD12 ' HA ' ' A' ' 103' ' ' THR . 9.3 mt -75.16 -51.3 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 71.319999999999993 111.092 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.542 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.5 p -53.99 -35.87 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 75.430000000000007 111.101 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.7 m -52.42 -32.36 38.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 74.319999999999993 111.135 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.2 t -50.33 -31.58 14.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 74.450000000000003 110.822 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.2 p -52.5 -32.77 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 71.409999999999997 111.124 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 35.5 m -66.2 -47.55 73.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 52.200000000000003 110.915 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.2 t -72.1 -36.09 55.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.475 . . . . 75.230000000000004 111.137 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.5 mt -72.04 -33.31 67.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 75.329999999999998 110.927 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -59.82 -30.72 69.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 74.400000000000006 110.906 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.777 HG11 ' HB2' ' A' ' 133' ' ' ALA . 9.4 p -102.26 -23.83 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 73.329999999999998 111.15 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 -85.44 -70.37 0.59 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 64.349999999999994 110.858 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -178.88 121.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 73.230000000000004 110.869 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.3 ttp85 -153.45 159.12 42.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 73.109999999999999 110.849 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.11 160.62 0.99 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.646 0.736 . . . . 74.540000000000006 110.862 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.527 ' O ' HG23 ' A' ' 121' ' ' THR . 53.4 Cg_endo -69.78 78.7 1.0 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.709 2.273 . . . . 63.299999999999997 112.315 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -171.11 177.55 3.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 61.219999999999999 111.172 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.55 69.29 1.4 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 70.519999999999996 111.102 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.495 ' O ' HG23 ' A' ' 124' ' ' THR . 11.5 t-160 -81.48 -74.44 0.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.456 . . . . 73.010000000000005 110.888 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 123' ' ' HIS . 0.1 OUTLIER -171.56 159.69 4.9 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.607 0.718 . . . . 72.129999999999995 111.131 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.448 ' HD2' HG22 ' A' ' 124' ' ' THR . 53.1 Cg_endo -69.81 -12.45 32.82 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.642 2.228 . . . . 71.109999999999999 112.34 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -52.35 127.48 22.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 64.040000000000006 110.89 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.36 133.25 1.57 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.771 -0.728 . . . . 50.340000000000003 112.529 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -135.8 151.68 20.74 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.733 . . . . 64.299999999999997 112.487 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 112.38 94.45 2.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.769 -0.729 . . . . 41.340000000000003 112.506 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 156.26 51.27 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.733 -0.746 . . . . 75.5 112.478 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -87.89 -26.07 22.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.964 0.412 . . . . 73.420000000000002 110.947 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.3 m -54.35 -26.93 16.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.077 -0.511 . . . . 75.329999999999998 111.083 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.777 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -55.96 -25.05 41.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 73.319999999999993 111.091 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.94 -30.84 36.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 70.129999999999995 110.912 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 91.5 t -57.09 -59.31 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 75.450000000000003 111.08 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 65.1 mt -73.97 -35.26 41.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 73.140000000000001 111.137 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -62.98 -30.16 71.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 54.140000000000001 110.843 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -53.78 -28.23 33.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 61.240000000000002 110.881 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.8 mp -67.36 -48.91 66.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 73.120000000000005 110.888 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -73.67 -47.47 39.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 73.319999999999993 110.892 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.629 HD22 ' CD2' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -51.92 -49.74 62.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.483 . . . . 61.329999999999998 110.944 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -53.22 -32.3 47.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 75.420000000000002 110.94 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.697 ' O ' HG23 ' A' ' 147' ' ' VAL . 63.8 mt -76.99 -42.33 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 74.439999999999998 111.118 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -56.17 -57.01 13.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 75.099999999999994 110.938 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 31.1 t -54.15 -37.08 34.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 74.319999999999993 111.118 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -70.01 -44.04 70.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 73.219999999999999 110.854 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 143' ' ' ILE . 91.1 t -63.52 -34.09 65.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 73.150000000000006 111.158 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 17.2 m -51.85 -44.23 63.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 72.409999999999997 110.907 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.459 HG12 HD12 ' A' ' 153' ' ' ILE . 26.5 t -75.84 -33.19 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 70.409999999999997 111.097 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -58.8 -54.63 44.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 73.439999999999998 110.882 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -68.42 -19.4 72.58 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 50.229999999999997 112.512 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.52 HG23 HD12 ' A' ' 36' ' ' ILE . 33.1 m -75.64 -52.83 9.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.754 0.311 . . . . 62.409999999999997 111.172 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.459 HD12 HG12 ' A' ' 149' ' ' VAL . 49.3 mt -76.5 -27.5 17.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 65.109999999999999 111.132 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -53.65 -49.55 57.27 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.725 -0.75 . . . . 62.100000000000001 112.533 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -31.89 67.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 75.129999999999995 110.906 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -72.75 -20.98 61.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 73.329999999999998 110.877 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.44 ' CD1' HG22 ' A' ' 153' ' ' ILE . 20.1 mt -79.37 -26.79 41.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 63.439999999999998 110.942 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.53 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 14.4 tp60 -52.0 -58.17 12.28 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.577 0.703 . . . . 62.200000000000003 110.88 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 54.1 Cg_endo -69.68 -15.73 37.53 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.695 2.263 . . . . 54.5 112.348 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.91 40.84 1.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 75.099999999999994 110.94 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -73.3 -26.17 60.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 74.420000000000002 110.874 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 63.27 105.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 65.450000000000003 110.905 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -91.05 -64.5 1.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 72.310000000000002 110.909 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 69.0 t80 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 71.310000000000002 110.942 -179.921 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.817 0.341 . . . . 71.150000000000006 110.921 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.6 mtm-85 -59.29 -28.41 66.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 74.219999999999999 110.865 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -123.06 79.01 51.47 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.532 0.682 . . . . 54.420000000000002 110.882 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 -5.07 15.28 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.688 2.258 . . . . 72.129999999999995 112.358 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 pp -52.16 -31.0 29.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 70.230000000000004 110.93 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -81.0 -31.95 34.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 75.140000000000001 110.865 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -72.51 -46.1 56.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 71.409999999999997 110.896 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 t -59.83 -40.17 87.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 73.409999999999997 111.146 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.26 -29.11 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 71.239999999999995 111.105 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -55.59 -27.0 46.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 73.409999999999997 110.899 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.672 ' HG ' HD12 ' A' ' 77' ' ' ILE . 4.1 mm? -91.51 -18.95 23.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 53.039999999999999 110.947 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.8 mm -76.53 -35.17 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 72.430000000000007 111.103 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.53 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.3 mm -55.68 -57.15 22.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.609 0.718 . . . . 71.430000000000007 111.125 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.78 -21.4 33.45 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.67 2.247 . . . . 73.030000000000001 112.323 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.641 ' O ' HG22 ' A' ' 42' ' ' ILE . 43.0 t -71.33 -45.36 63.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 65.400000000000006 110.912 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 p -81.62 -28.94 10.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 74.25 111.091 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 mt -50.95 -33.91 26.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 74.439999999999998 110.915 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.641 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.77 -34.68 52.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 74.409999999999997 111.145 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.72 -39.81 91.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 54.229999999999997 111.145 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.95 -51.23 62.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 62.340000000000003 110.885 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.7 tp -70.68 -35.96 73.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 64.409999999999997 110.908 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.73 -38.84 82.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 42.140000000000001 111.075 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.3 mp -64.25 -32.03 55.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 53.039999999999999 111.15 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 tp -51.42 -38.74 55.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 74.030000000000001 110.944 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.747 HG21 ' HA ' ' A' ' 59' ' ' LYS . 7.8 p -101.48 -36.79 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 61.210000000000001 111.145 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -66.97 -64.59 0.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 73.409999999999997 110.926 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.732 ' CZ ' HD13 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -71.22 -25.98 62.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 74.439999999999998 110.924 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.6 mp -125.08 71.65 63.22 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.622 0.725 . . . . 74.420000000000002 110.9 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 173.27 11.19 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.748 2.299 . . . . 64.219999999999999 112.3 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.0 p -167.8 -170.27 1.34 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 70.209999999999994 110.876 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.0 95.71 10.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 72.140000000000001 110.839 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -179.1 138.78 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 71.109999999999999 110.841 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.33 -22.96 77.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.741 -0.743 . . . . 64.319999999999993 112.452 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -52.06 -34.94 45.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.932 0.396 . . . . 71.409999999999997 110.87 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.747 ' HA ' HG21 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -52.98 -51.57 61.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 72.420000000000002 110.905 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.8 ttm -65.41 -28.02 68.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 62.329999999999998 110.835 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.4 m -75.49 -31.65 60.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 44.140000000000001 111.148 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.606 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -68.45 -51.07 47.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 70.310000000000002 110.912 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -53.88 -48.01 70.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 62.229999999999997 110.887 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.6 tt -70.68 -34.95 58.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 71.420000000000002 111.119 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -61.52 -27.96 68.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 64.409999999999997 110.885 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 62' ' ' LEU . 60.2 t -57.93 -39.48 71.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 62.140000000000001 111.099 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -29.13 27.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 62.130000000000003 110.915 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.487 ' O ' HD22 ' A' ' 68' ' ' LEU . 2.1 tm? -74.56 -45.77 43.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 73.540000000000006 110.94 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.91 -29.59 20.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 70.219999999999999 111.086 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.517 HD22 HG11 ' A' ' 102' ' ' VAL . 37.3 mt -58.69 -54.46 46.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 62.229999999999997 110.91 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 68' ' ' LEU . 1.0 OUTLIER -62.31 -27.21 68.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 71.010000000000005 111.126 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 97.8 t -70.69 -33.05 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 75.400000000000006 111.154 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -64.7 -31.97 73.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 71.310000000000002 110.886 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.61 HD11 ' CD1' ' A' ' 95' ' ' LEU . 1.3 tp -75.1 -50.73 15.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 72.430000000000007 110.897 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.2 mp -65.84 -37.58 86.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 74.439999999999998 110.908 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.4 tt -62.63 -55.07 30.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 74.310000000000002 110.93 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.672 HD12 ' HG ' ' A' ' 35' ' ' LEU . 1.6 tt -66.31 -29.51 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 71.510000000000005 111.097 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.3 t -81.55 -14.78 56.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 110.822 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.461 ' O ' HG23 ' A' ' 81' ' ' VAL . 1.3 mmmt -93.67 -9.72 36.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 64.439999999999998 110.89 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.52 -16.88 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 71.319999999999993 111.122 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 79' ' ' LYS . 21.2 t 64.28 78.01 0.29 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.561 0.696 . . . . 54.420000000000002 111.118 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.402 ' HB3' ' HB2' ' A' ' 86' ' ' LEU . 53.3 Cg_endo -69.84 164.11 35.84 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.659 2.24 . . . . 62.109999999999999 112.355 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -49.3 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.745 2.296 . . . . 74.030000000000001 112.36 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 t -124.9 -35.32 2.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 73.129999999999995 111.153 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.24 -39.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 60.340000000000003 110.865 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 82' ' ' PRO . 8.2 tp 64.53 70.6 0.49 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 74.129999999999995 110.917 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.519 ' O ' HG23 ' A' ' 91' ' ' VAL . 4.0 m-20 50.15 60.17 4.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 55.409999999999997 110.894 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.533 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -68.62 -58.21 7.26 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.625 0.726 . . . . 60.329999999999998 111.114 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.587 ' HG2' HD22 ' A' ' 90' ' ' LEU . 53.4 Cg_endo -69.77 -26.02 27.98 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.673 2.248 . . . . 50.43 112.342 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.587 HD22 ' HG2' ' A' ' 89' ' ' PRO . 3.3 mm? -71.83 -39.81 69.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 60.409999999999997 110.916 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 87' ' ' ASP . 84.3 t -80.53 -41.85 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 72.200000000000003 111.164 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.0 -46.39 55.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.769 -0.729 . . . . 53.509999999999998 112.464 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -32.95 69.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.816 0.341 . . . . 73.209999999999994 110.896 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -62.25 -31.97 72.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 72.400000000000006 110.879 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.61 ' CD1' HD11 ' A' ' 74' ' ' LEU . 11.3 mt -53.17 -29.8 33.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 55.119999999999997 110.903 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -42.48 86.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 72.430000000000007 110.859 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.49 ' O ' HG22 ' A' ' 100' ' ' VAL . 24.5 t80 -75.26 -53.19 9.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 74.340000000000003 110.892 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.789 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.03 -29.93 32.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 75.400000000000006 111.165 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.1 mmt -66.61 -30.13 70.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 72.430000000000007 110.901 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.76 -30.1 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 64.409999999999997 111.116 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.789 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.92 -33.12 61.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 74.140000000000001 110.953 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.517 HG11 HD22 ' A' ' 70' ' ' LEU . 31.6 m -76.96 -37.99 27.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 73.299999999999997 111.118 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.437 ' O ' HG13 ' A' ' 107' ' ' VAL . 70.5 m -72.53 -39.68 67.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 74.400000000000006 111.153 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -64.73 -31.93 73.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 53.520000000000003 110.847 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.6 t -74.3 -33.92 63.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.461 . . . . 42.039999999999999 110.852 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.3 mt -74.93 -50.65 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 72.5 111.151 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 110' ' ' VAL . 34.7 m -54.15 -34.12 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 64.040000000000006 111.111 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.0 m -52.41 -32.45 39.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 74.010000000000005 111.188 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.4 m -50.42 -31.54 15.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 73.430000000000007 110.857 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.4 p -52.47 -32.8 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.496 . . . . 71.340000000000003 111.143 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 31.5 m -65.46 -43.17 91.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.143 -0.481 . . . . 63.039999999999999 110.846 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.3 t -77.12 -34.81 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 74.239999999999995 111.106 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.546 HD22 ' O ' ' A' ' 117' ' ' HIS . 85.1 mt -72.05 -33.11 67.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 73.099999999999994 110.917 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -59.68 -31.03 69.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 73.310000000000002 110.888 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.776 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.8 p -102.32 -24.24 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 74.340000000000003 111.139 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -94.24 -74.68 0.53 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.472 . . . . 75.129999999999995 110.897 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.546 ' O ' HD22 ' A' ' 113' ' ' LEU . 4.2 t-80 -158.94 96.58 1.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 44.310000000000002 110.897 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.36 -26.0 13.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 74.099999999999994 110.877 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.13 160.59 1.17 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.711 0.767 . . . . 74.349999999999994 110.806 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.537 ' O ' HG23 ' A' ' 121' ' ' THR . 53.8 Cg_endo -69.75 134.94 29.23 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.687 2.258 . . . . 70.340000000000003 112.385 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -171.07 83.67 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 64.019999999999996 111.13 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.6 p -95.53 25.5 4.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.436 . . . . 73.150000000000006 111.142 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -135.3 -51.44 0.76 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 73.409999999999997 110.814 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 30.6 m -144.78 68.44 14.42 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.57 0.7 . . . . 75.530000000000001 111.156 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -12.45 32.85 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.638 2.225 . . . . 54.350000000000001 112.356 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.12 136.67 29.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 73.530000000000001 110.887 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.7 110.54 0.78 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 32.200000000000003 112.471 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 112.14 -159.16 13.87 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.78 -0.724 . . . . 65.129999999999995 112.525 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.91 -84.21 0.17 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.745 -0.741 . . . . 54.240000000000002 112.494 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.12 19.88 7.4 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 71.329999999999998 112.47 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -87.87 -26.11 22.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.914 0.388 . . . . 71.409999999999997 110.932 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.8 -36.92 77.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 63.130000000000003 111.08 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.776 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -67.04 -25.8 66.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 74.010000000000005 111.123 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 30.4 mmt -52.96 -30.95 37.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 63.039999999999999 110.91 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 74.8 t -56.97 -59.02 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 42.43 111.134 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 136' ' ' ILE . 3.6 mp -74.01 -37.74 47.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 71.420000000000002 111.136 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -61.26 -29.94 70.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 73.420000000000002 110.896 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.08 -30.14 24.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 73.430000000000007 110.872 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.42 -42.24 68.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 74.319999999999993 110.933 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -74.0 -51.43 15.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 72.040000000000006 110.881 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.732 HD13 ' CZ ' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -52.03 -33.31 38.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 61.229999999999997 110.893 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 45.6 t-105 -61.8 -45.42 93.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.236 -0.438 . . . . 64.140000000000001 110.924 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.751 ' O ' HG23 ' A' ' 147' ' ' VAL . 50.8 mm -76.96 -32.87 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 72.129999999999995 111.135 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -56.07 -56.96 14.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 72.129999999999995 110.867 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.7 m -55.6 -35.0 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 72.239999999999995 111.146 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -69.72 -33.11 72.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 73.310000000000002 110.883 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 143' ' ' ILE . 82.0 t -67.62 -33.99 65.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 52.299999999999997 111.144 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 67.9 m -66.32 -46.41 77.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 61.219999999999999 110.874 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.532 ' O ' HG22 ' A' ' 152' ' ' THR . 43.4 t -76.03 -36.82 32.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 72.120000000000005 111.104 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.573 ' O ' HG22 ' A' ' 153' ' ' ILE . 68.5 t80 -71.87 -28.6 63.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 74.310000000000002 110.861 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -52.24 -27.75 24.81 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.754 -0.736 . . . . 54.140000000000001 112.468 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 149' ' ' VAL . 14.8 t -53.81 -32.01 51.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 63.109999999999999 111.155 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 150' ' ' PHE . 20.0 tt -55.89 -25.7 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 75.0 111.163 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -51.9 -49.93 46.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.723 -0.751 . . . . 61.020000000000003 112.507 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -73.92 -31.8 63.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.785 0.326 . . . . 72.450000000000003 110.825 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -68.91 -21.49 64.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.429 . . . . 75.109999999999999 110.906 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.4 mt -74.74 -29.05 61.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 44.109999999999999 110.884 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.48 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.7 OUTLIER -51.95 -60.62 5.74 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.592 0.71 . . . . 72.519999999999996 110.877 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.9 Cg_endo -69.7 -16.53 37.84 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.753 2.302 . . . . 74.239999999999995 112.331 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -93.96 40.72 1.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 63.329999999999998 110.925 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -72.76 -26.32 61.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.442 . . . . 64.409999999999997 110.903 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 63.32 103.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.487 . . . . 73.299999999999997 110.867 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -78.88 -72.27 0.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 70.310000000000002 110.897 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 16.5 t80 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 73.439999999999998 110.88 -179.898 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 27.3 mmt-85 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.814 0.34 . . . . 74.129999999999995 110.845 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -96.16 26.16 4.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 64.430000000000007 110.848 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.97 73.73 2.46 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.536 0.684 . . . . 72.140000000000001 110.896 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -11.84 31.6 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.661 2.24 . . . . 72.430000000000007 112.292 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.409 HD11 ' CE1' ' A' ' 30' ' ' PHE . 2.4 pp -52.0 -30.96 27.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 74.420000000000002 110.904 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.409 ' CE1' HD11 ' A' ' 29' ' ' LEU . 42.8 m-85 -78.98 -33.31 45.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 63.340000000000003 110.901 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -72.5 -46.19 55.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 74.510000000000005 110.922 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -59.98 -40.03 87.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.511 . . . . 75.239999999999995 111.125 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.11 -29.1 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 64.409999999999997 111.141 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.1 -26.87 51.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 60.210000000000001 110.866 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.616 ' HG ' HD12 ' A' ' 77' ' ' ILE . 4.1 mm? -91.51 -19.2 23.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 73.129999999999995 110.9 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mm -76.76 -34.86 23.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 63.329999999999998 111.087 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.539 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 5.1 mt -55.72 -57.12 23.15 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.6 0.714 . . . . 73.150000000000006 111.109 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.4 Cg_endo -69.8 -20.34 34.77 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.683 2.255 . . . . 72.019999999999996 112.337 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.635 ' O ' HG22 ' A' ' 42' ' ' ILE . 48.4 t -75.51 -44.26 44.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 62.109999999999999 110.869 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 p -81.54 -28.95 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 74.310000000000002 111.144 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.3 mt -50.97 -33.97 26.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 75.120000000000005 110.872 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.635 HG22 ' O ' ' A' ' 39' ' ' CYS . 0.7 OUTLIER -58.76 -34.66 52.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 64.510000000000005 111.121 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.83 -38.43 88.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.19 -0.459 . . . . 71.510000000000005 111.132 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.07 -49.08 67.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 65.409999999999997 110.849 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.0 tp -74.31 -36.02 63.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 73.439999999999998 110.938 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.48 -37.99 76.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 61.130000000000003 111.106 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.421 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.2 mp -64.9 -32.49 58.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 73.239999999999995 111.108 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 tp -55.07 -33.77 63.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 74.420000000000002 110.882 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.589 HG11 ' HG ' ' A' ' 62' ' ' LEU . 27.5 m -101.76 -36.73 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 73.319999999999993 111.126 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -71.43 -64.91 0.83 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 71.099999999999994 110.903 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.739 ' CZ ' HD13 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -68.98 -23.27 64.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 62.439999999999998 110.875 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.7 mp -128.05 73.6 79.3 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.634 0.73 . . . . 73.510000000000005 110.889 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 133.18 24.89 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.721 2.28 . . . . 75.329999999999998 112.351 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.2 m -87.08 -67.73 0.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 53.210000000000001 110.824 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.53 -75.14 0.59 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 73.030000000000001 110.841 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.45 -62.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 72.219999999999999 110.859 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.16 -62.93 5.26 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.751 -0.737 . . . . 71.200000000000003 112.477 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -51.94 -36.93 50.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 64.349999999999994 110.881 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -62.93 -44.06 97.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 75.109999999999999 110.882 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.0 tpt -72.06 -48.47 44.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 74.219999999999999 110.842 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 82.0 p -54.99 -26.15 34.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.424 . . . . 71.400000000000006 111.101 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.589 ' HG ' HG11 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -75.65 -37.4 59.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 63.329999999999998 110.874 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 35.0 m -74.01 -48.19 31.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 74.540000000000006 110.914 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.6 pt -54.92 -32.21 26.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 73.510000000000005 111.115 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.0 t -70.84 -25.14 62.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 71.239999999999995 110.838 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.1 t -57.94 -37.13 59.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 75.510000000000005 111.137 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mt -55.37 -29.7 58.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 50.140000000000001 110.907 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.485 ' O ' HD22 ' A' ' 68' ' ' LEU . 2.1 tm? -69.85 -45.44 67.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 73.329999999999998 110.872 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.07 -29.7 22.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 30.300000000000001 111.082 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.774 HD22 HG11 ' A' ' 102' ' ' VAL . 23.9 mt -59.81 -54.53 45.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 63.43 110.932 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 68' ' ' LEU . 0.8 OUTLIER -60.76 -27.16 67.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 62.5 111.148 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.1 t -70.32 -32.94 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 72.299999999999997 111.127 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.535 ' O ' HG22 ' A' ' 77' ' ' ILE . 1.8 t80 -61.66 -29.84 70.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 74.510000000000005 110.911 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.888 HD11 HD13 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -66.73 -50.3 63.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 73.25 110.903 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.4 -38.25 65.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 73.329999999999998 110.866 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.5 tt -58.03 -55.05 40.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 74.310000000000002 110.969 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.616 HD12 ' HG ' ' A' ' 35' ' ' LEU . 1.3 tt -66.62 -23.95 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 74.519999999999996 111.162 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.6 t -80.32 -17.96 50.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 64.019999999999996 110.817 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.752 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -68.55 -12.18 60.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 73.409999999999997 110.925 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.492 HG23 ' O ' ' A' ' 77' ' ' ILE . 47.7 pt -52.77 -28.04 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 73.239999999999995 111.151 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.752 HG23 ' O ' ' A' ' 79' ' ' LYS . 57.5 t 61.48 77.14 0.37 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.664 0.745 . . . . 72.510000000000005 111.117 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 167.28 24.89 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.681 2.254 . . . . 74.519999999999996 112.318 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -48.99 0.6 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.656 2.237 . . . . 63.420000000000002 112.369 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 t -134.82 18.49 3.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 73.140000000000001 111.106 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.2 m 51.73 64.55 1.8 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 52.420000000000002 110.845 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.15 24.96 11.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 74.430000000000007 110.877 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -115.05 25.48 10.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 71.209999999999994 110.861 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.537 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -65.15 -57.61 14.92 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.643 0.735 . . . . 74.519999999999996 111.121 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.6 Cg_endo -69.76 -21.4 33.53 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.676 2.25 . . . . 55.450000000000003 112.326 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.0 mp -73.41 -52.97 11.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 64.450000000000003 110.935 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.1 t -80.03 -42.86 22.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.458 . . . . 63.030000000000001 111.14 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.41 -38.05 49.83 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.784 -0.722 . . . . 50.030000000000001 112.46 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.35 -23.7 60.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.789 0.328 . . . . 52.329999999999998 110.9 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -76.15 -39.34 55.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 72.340000000000003 110.951 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.888 HD13 HD11 ' A' ' 74' ' ' LEU . 12.0 mt -55.68 -29.74 59.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.108 -0.496 . . . . 72.239999999999995 110.924 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.9 mmt -70.23 -42.57 72.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 72.219999999999999 110.896 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.506 ' O ' HG22 ' A' ' 100' ' ' VAL . 4.7 t80 -75.26 -51.09 14.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 74.209999999999994 110.863 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.804 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.23 -29.84 34.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 74.129999999999995 111.127 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.6 mmt -66.77 -30.01 70.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 72.120000000000005 110.877 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.81 -30.01 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 62.210000000000001 111.137 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.804 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -74.91 -33.12 61.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 52.520000000000003 110.916 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.774 HG11 HD22 ' A' ' 70' ' ' LEU . 30.2 m -76.55 -37.73 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 64.109999999999999 111.118 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.728 ' O ' HG23 ' A' ' 107' ' ' VAL . 53.7 m -72.7 -46.6 52.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 72.120000000000005 111.097 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.444 ' CE2' HG21 ' A' ' 147' ' ' VAL . 69.9 t80 -51.86 -31.26 27.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 71.319999999999993 110.894 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 m -73.86 -51.09 17.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 70.409999999999997 110.842 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 103' ' ' THR . 7.6 mt -54.76 -34.68 30.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 61.509999999999998 111.117 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 103' ' ' THR . 25.6 t -54.02 -45.73 64.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 63.039999999999999 111.103 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.6 m -52.3 -32.45 37.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 71.400000000000006 111.152 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.1 p -50.41 -31.36 14.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 65.319999999999993 110.855 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.6 p -52.45 -32.86 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 70.299999999999997 111.154 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 28.9 m -65.86 -47.35 75.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.468 . . . . 71.25 110.897 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.42 HG23 ' OD1' ' A' ' 137' ' ' ASP . 84.6 t -72.46 -36.28 54.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 73.340000000000003 111.121 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.612 HD13 HH21 ' A' ' 118' ' ' ARG . 95.1 mt -72.05 -32.72 67.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 65.129999999999995 110.93 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -60.98 -30.59 70.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 73.530000000000001 110.852 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.778 HG11 ' HB2' ' A' ' 133' ' ' ALA . 9.8 p -102.3 -23.2 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 72.120000000000005 111.126 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -109.37 117.7 34.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 73.510000000000005 110.886 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -52.96 169.98 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.456 . . . . 73.120000000000005 110.855 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.612 HH21 HD13 ' A' ' 113' ' ' LEU . 2.0 ttm180 -173.1 -173.88 0.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 73.510000000000005 110.861 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.04 160.61 1.14 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.654 0.74 . . . . 74.010000000000005 110.833 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 78.95 0.98 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.662 2.241 . . . . 71.319999999999993 112.319 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.11 -172.68 3.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 72.319999999999993 111.159 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.8 t -116.81 -24.58 7.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 64.010000000000005 111.178 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -51.88 -74.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 74.310000000000002 110.864 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 64.4 m -160.62 73.8 2.82 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.588 0.708 . . . . 72.549999999999997 111.145 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 100.05 0.79 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.667 2.245 . . . . 75.120000000000005 112.37 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -146.2 156.09 43.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 50.030000000000001 110.855 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -136.1 -162.5 9.57 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.762 -0.733 . . . . 71.319999999999993 112.491 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 103.41 57.42 0.75 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.714 -0.755 . . . . 64.400000000000006 112.46 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 130.38 -164.9 22.8 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.752 -0.737 . . . . 33.240000000000002 112.471 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 176.14 -64.01 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 63.32 112.501 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -66.29 -39.96 89.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.944 0.402 . . . . 74.219999999999999 110.952 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 135' ' ' VAL . 34.7 m -54.72 -27.04 17.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 43.049999999999997 111.079 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.778 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -56.31 -25.33 48.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 61.32 111.094 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 37.1 mmt -53.01 -30.98 38.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 70.230000000000004 110.849 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 132' ' ' VAL . 52.6 t -56.94 -58.26 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 64.109999999999999 111.114 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 45.5 mm -74.06 -37.94 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 73.019999999999996 111.101 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.42 ' OD1' HG23 ' A' ' 112' ' ' VAL . 0.8 OUTLIER -58.73 -32.86 69.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 61.409999999999997 110.869 179.839 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.07 -26.02 59.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 73.349999999999994 110.895 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 16.1 tp -68.51 -50.88 48.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 74.150000000000006 110.939 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -73.23 -37.01 66.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 73.439999999999998 110.895 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.739 HD13 ' CZ ' ' A' ' 51' ' ' TYR . 3.5 mt -52.02 -33.31 37.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 73.400000000000006 110.885 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -74.31 -34.53 63.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.213 -0.449 . . . . 75.439999999999998 110.905 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.556 ' O ' HG23 ' A' ' 147' ' ' VAL . 36.0 mt -76.94 -32.01 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 72.150000000000006 111.101 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -56.05 -56.96 14.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 74.129999999999995 110.861 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.3 m -54.19 -34.99 28.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 41.240000000000002 111.132 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -67.34 -41.18 85.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 74.409999999999997 110.895 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 143' ' ' ILE . 87.9 t -62.18 -34.04 61.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 44.32 111.121 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 98.9 m -53.8 -39.07 65.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.14 -0.482 . . . . 74.450000000000003 110.89 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.9 t -75.46 -33.0 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 74.510000000000005 111.122 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.98 -54.7 26.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 63.140000000000001 110.92 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.42 -19.35 79.87 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.794 -0.717 . . . . 73.040000000000006 112.461 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 34.6 m -73.61 -52.83 12.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.806 0.336 . . . . 70.519999999999996 111.176 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 45.4 mm -76.51 -24.26 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 71.040000000000006 111.128 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -53.95 -48.51 62.26 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.767 -0.73 . . . . 71.120000000000005 112.472 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.21 -33.14 50.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.762 0.315 . . . . 72.439999999999998 110.881 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.69 -21.14 64.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 72.099999999999994 110.867 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.9 mt -74.85 -29.18 60.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 64.140000000000001 110.868 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.484 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -51.93 -60.55 5.86 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.645 0.735 . . . . 75.439999999999998 110.879 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.5 Cg_endo -69.76 -31.12 21.13 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.668 2.246 . . . . 61.109999999999999 112.345 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.532 HD12 ' HB2' ' A' ' 162' ' ' GLN . 0.1 OUTLIER -52.1 -53.5 41.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 71.329999999999998 110.933 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 5.1 t80 64.75 14.05 8.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 73.230000000000004 110.885 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.532 ' HB2' HD12 ' A' ' 160' ' ' LEU . 3.5 tt0 -56.13 -65.38 0.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 72.400000000000006 110.905 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 62.6 t30 53.07 30.98 10.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 75.209999999999994 110.876 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 3.3 t80 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 72.5 110.946 -179.887 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.801 0.334 . . . . 72.109999999999999 110.836 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.95 -67.98 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 74.239999999999995 110.891 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? -119.56 68.44 11.07 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.551 0.691 . . . . 73.540000000000006 110.909 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 78.7 0.99 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.716 2.278 . . . . 74.109999999999999 112.388 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.99 -30.94 65.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 62.140000000000001 110.886 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -77.7 -32.24 52.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 62.25 110.873 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -73.45 -44.98 56.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 72.349999999999994 110.91 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 t -60.71 -39.71 89.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.102 -0.499 . . . . 62.219999999999999 111.183 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.446 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.18 -29.07 21.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 51.200000000000003 111.097 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -56.0 -27.58 53.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 75.019999999999996 110.892 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.756 ' HG ' HD12 ' A' ' 77' ' ' ILE . 4.1 mm? -90.69 -18.42 25.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 52.210000000000001 110.908 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mm -76.79 -34.79 23.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 73.25 111.165 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.55 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.73 -57.16 22.94 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.61 0.719 . . . . 75.540000000000006 111.092 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.8 Cg_endo -69.75 -20.85 34.35 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.718 2.279 . . . . 52.539999999999999 112.335 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.626 ' O ' HG22 ' A' ' 42' ' ' ILE . 48.6 t -76.0 -44.69 38.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 71.349999999999994 110.859 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.5 -28.88 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 75.450000000000003 111.183 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mt -51.01 -34.01 27.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 73.430000000000007 110.909 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.626 HG22 ' O ' ' A' ' 39' ' ' CYS . 0.7 OUTLIER -58.64 -34.73 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 41.140000000000001 111.143 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.75 -41.15 92.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 74.519999999999996 111.13 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.01 -43.01 66.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 72.010000000000005 110.865 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 tp -76.59 -40.03 50.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 74.299999999999997 110.938 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.72 -51.46 69.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 61.439999999999998 111.075 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.442 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.4 mp -49.73 -31.44 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 73.540000000000006 111.136 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.0 tp -50.76 -42.22 57.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 74.219999999999999 110.943 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.7 HG23 ' CB ' ' A' ' 54' ' ' SER . 7.2 p -101.49 -37.48 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 75.230000000000004 111.145 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.493 ' HB3' HD21 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -63.68 -64.53 0.87 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 65.219999999999999 110.871 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.581 ' CD2' HD22 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -72.85 -62.0 1.61 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.484 . . . . 75.329999999999998 110.907 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.2 mp -67.89 160.67 72.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.599 0.714 . . . . 72.140000000000001 110.874 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 143.68 51.77 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.73 2.287 . . . . 51.310000000000002 112.329 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.7 ' CB ' HG23 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -155.17 -176.83 6.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 50.43 110.846 -179.864 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -173.41 -169.99 0.57 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.5 . . . . 71.25 110.872 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 63.35 172.5 0.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 64.129999999999995 110.893 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.4 -22.93 39.91 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.712 -0.756 . . . . 64.409999999999997 112.48 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.654 ' O ' HD12 ' A' ' 62' ' ' LEU . 5.4 tt0 -51.97 -35.01 44.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.917 0.389 . . . . 73.409999999999997 110.887 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.527 ' HA ' HG21 ' A' ' 49' ' ' VAL . 6.3 ttpp -52.96 -52.0 59.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 64.420000000000002 110.897 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 6.8 tpt -72.01 -42.09 66.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 74.120000000000005 110.87 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.6 m -53.08 -28.4 24.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 62.420000000000002 111.13 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 58' ' ' GLU . 0.2 OUTLIER -71.53 -40.21 70.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 54.119999999999997 110.899 179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 28.7 m -66.04 -45.65 80.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 63.32 110.908 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 12.4 tt -72.37 -35.05 50.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 70.530000000000001 111.145 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.14 -43.25 70.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 72.430000000000007 110.898 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.5 ' HA ' HD11 ' A' ' 42' ' ' ILE . 99.7 t -58.01 -34.83 49.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 65.450000000000003 111.134 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.87 -28.98 25.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 71.439999999999998 110.895 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.487 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -68.99 -39.25 79.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 74.310000000000002 110.896 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.39 -30.05 70.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 64.5 111.086 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.761 HD13 HG11 ' A' ' 102' ' ' VAL . 9.9 mt -64.85 -54.67 27.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 70.239999999999995 110.947 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.97 -38.22 87.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 70.230000000000004 111.172 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 68' ' ' LEU . 77.5 t -71.37 -32.9 48.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 74.510000000000005 111.151 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.525 ' O ' HG22 ' A' ' 77' ' ' ILE . 64.2 t80 -66.68 -29.88 69.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 75.25 110.853 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.489 HD11 HD13 ' A' ' 95' ' ' LEU . 4.3 tt -72.06 -47.61 50.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 44.399999999999999 110.896 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.5 mt -73.04 -39.63 65.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 65.140000000000001 110.915 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.9 tt -58.22 -51.3 70.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 62.119999999999997 110.932 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.756 HD12 ' HG ' ' A' ' 35' ' ' LEU . 1.6 tt -71.68 -26.2 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 62.539999999999999 111.145 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 25.5 t -80.53 -13.8 58.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 62.140000000000001 110.868 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.616 ' O ' HG23 ' A' ' 81' ' ' VAL . 5.5 mmmt -50.71 -29.21 10.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 74.329999999999998 110.878 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.9 pt -50.53 -37.43 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 55.409999999999997 111.111 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 79' ' ' LYS . 53.0 t 51.37 81.68 0.26 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.59 0.709 . . . . 74.349999999999994 111.178 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 167.47 24.43 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.657 2.238 . . . . 60.439999999999998 112.335 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -49.96 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.701 2.267 . . . . 73.040000000000006 112.342 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.2 t -136.75 -38.92 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 74.430000000000007 111.179 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.64 83.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 70.030000000000001 110.886 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.8 -18.04 16.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 54.119999999999997 110.893 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.582 ' HA ' HD23 ' A' ' 90' ' ' LEU . 5.5 m-20 -153.7 24.1 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 71.209999999999994 110.873 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.538 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -66.9 -57.9 10.56 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.649 0.738 . . . . 73.040000000000006 111.159 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.554 ' HG2' HD22 ' A' ' 90' ' ' LEU . 54.1 Cg_endo -69.75 -21.54 33.38 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.709 2.273 . . . . 74.430000000000007 112.372 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.582 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.4 mm? -74.12 -53.17 10.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 64.420000000000002 110.938 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.7 -46.65 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 43.520000000000003 111.134 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.87 -39.46 47.94 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.754 -0.736 . . . . 32.219999999999999 112.47 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -73.22 -24.37 60.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.331 . . . . 70.310000000000002 110.922 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -74.43 -37.95 63.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 64.219999999999999 110.916 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.489 HD13 HD11 ' A' ' 74' ' ' LEU . 11.6 mt -57.38 -29.71 64.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.076 -0.511 . . . . 74.409999999999997 110.938 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 5.2 mmt -69.51 -43.57 72.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 74.030000000000001 110.866 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.49 ' O ' HG22 ' A' ' 100' ' ' VAL . 64.5 t80 -75.16 -51.22 13.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 60.520000000000003 110.854 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.793 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.08 -29.9 33.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 65.329999999999998 111.097 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 9.0 mmt -66.65 -30.13 70.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 61.140000000000001 110.887 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.77 -30.18 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 62.200000000000003 111.114 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.793 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.79 -33.29 62.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 74.219999999999999 110.931 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.761 HG11 HD13 ' A' ' 70' ' ' LEU . 30.9 m -76.93 -38.06 28.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 73.200000000000003 111.097 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 76.7 m -72.4 -38.91 68.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 71.0 111.162 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -66.17 -31.93 73.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 61.149999999999999 110.874 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.0 t -73.41 -37.12 66.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 63.329999999999998 110.841 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.0 mt -70.29 -51.45 38.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 51.409999999999997 111.157 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.55 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.1 p -54.06 -35.53 29.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 42.219999999999999 111.15 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.3 m -52.41 -32.42 39.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 70.230000000000004 111.162 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.6 m -50.36 -31.54 14.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 74.040000000000006 110.847 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.55 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.3 p -52.51 -32.83 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 74.349999999999994 111.092 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 33.6 m -65.69 -43.56 88.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.199 -0.455 . . . . 61.119999999999997 110.863 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.9 t -76.74 -35.64 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 65.340000000000003 111.11 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 89.6 mt -72.1 -31.57 66.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 75.409999999999997 110.903 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -62.51 -30.26 71.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 64.209999999999994 110.896 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.803 HG11 ' HB2' ' A' ' 133' ' ' ALA . 9.9 p -102.31 -22.78 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 31.399999999999999 111.173 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -60.91 -74.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 73.030000000000001 110.903 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -174.97 76.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 73.150000000000006 110.86 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.12 -170.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 72.310000000000002 110.862 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 63.2 69.12 0.86 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.65 0.738 . . . . 41.109999999999999 110.814 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -170.97 0.43 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.703 2.269 . . . . 64.120000000000005 112.332 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.93 -73.53 0.58 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 62.240000000000002 111.163 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.68 150.2 49.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 73.040000000000006 111.146 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 56.46 -169.87 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 73.430000000000007 110.853 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.0 t -114.07 72.4 2.24 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.55 0.691 . . . . 74.010000000000005 111.129 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 139.55 40.55 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.667 2.245 . . . . 53.109999999999999 112.309 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.8 158.36 44.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 74.450000000000003 110.866 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 109.54 156.44 16.66 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.797 -0.716 . . . . 75.340000000000003 112.472 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 132.23 -158.06 22.77 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.729 -0.748 . . . . 62.43 112.471 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.84 -146.64 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.724 -0.75 . . . . 74.150000000000006 112.469 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.04 45.69 0.8 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.714 -0.755 . . . . 63.32 112.481 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -87.9 -43.0 12.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.919 0.39 . . . . 70.230000000000004 110.951 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.2 m -54.97 -31.84 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 62.119999999999997 111.119 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.803 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -71.81 -24.99 61.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 65.519999999999996 111.069 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 18.2 mmt -52.93 -31.05 38.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 71.310000000000002 110.894 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 32.2 t -57.0 -49.44 79.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 63.549999999999997 111.105 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 30.8 mm -74.03 -40.65 52.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 72.420000000000002 111.121 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -61.97 -30.02 70.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 64.519999999999996 110.848 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.0 mtm-85 -54.32 -27.53 36.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 65.409999999999997 110.857 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 tp -67.66 -50.85 55.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 73.400000000000006 110.931 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -74.05 -31.44 62.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 74.5 110.847 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.581 HD22 ' CD2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -52.15 -32.04 33.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 54.310000000000002 110.906 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -35.16 61.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 72.049999999999997 110.923 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.511 ' O ' HG23 ' A' ' 147' ' ' VAL . 36.9 mm -76.91 -32.16 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 63.210000000000001 111.11 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -56.02 -56.74 17.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 74.439999999999998 110.923 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.27 -35.46 62.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 64.140000000000001 111.142 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.32 -33.07 67.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 75.310000000000002 110.851 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 143' ' ' ILE . 28.8 t -65.96 -37.04 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 74.140000000000001 111.118 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.1 t -57.09 -51.69 68.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 73.409999999999997 110.854 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.9 t -69.17 -33.47 58.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 71.019999999999996 111.094 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -52.32 -53.5 43.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 74.549999999999997 110.895 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.04 -19.63 77.06 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.702 -0.761 . . . . 60.409999999999997 112.486 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 35.1 m -65.82 -52.83 47.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.74 0.305 . . . . 53.119999999999997 111.174 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.425 HG22 ' CD1' ' A' ' 157' ' ' LEU . 20.6 mt -76.58 -25.26 16.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 70.239999999999995 111.142 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -58.5 -49.92 72.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 32.030000000000001 112.462 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 9.6 mmt -70.13 -31.99 69.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.782 0.325 . . . . 75.019999999999996 110.854 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -71.64 -24.32 61.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 71.299999999999997 110.882 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.425 ' CD1' HG22 ' A' ' 153' ' ' ILE . 10.7 mt -75.35 -26.74 58.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 54.409999999999997 110.932 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.478 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.9 OUTLIER -52.13 -60.61 5.83 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.592 0.71 . . . . 75.439999999999998 110.894 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 54.0 Cg_endo -69.71 -36.26 11.26 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.705 2.27 . . . . 75.140000000000001 112.38 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.407 ' O ' ' CB ' ' A' ' 161' ' ' PHE . 4.5 tp 48.72 34.96 5.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 62.310000000000002 110.91 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.407 ' CB ' ' O ' ' A' ' 160' ' ' LEU . 8.9 t80 76.39 -52.22 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 70.019999999999996 110.868 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -170.4 -72.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 74.25 110.933 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -174.92 118.07 0.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 64.099999999999994 110.917 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 3.7 t80 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 74.299999999999997 110.917 -179.873 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.824 0.345 . . . . 63.43 110.859 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.471 ' O ' ' C ' ' A' ' 27' ' ' LYS . 8.6 mtt-85 -78.74 67.3 4.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 71.25 110.85 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER 31.85 77.0 0.36 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.622 0.725 . . . . 53.020000000000003 110.902 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -3.32 11.79 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.714 2.276 . . . . 51.32 112.3 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 pp -52.36 -30.98 31.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 74.109999999999999 110.905 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -80.99 -31.69 34.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.468 . . . . 75.219999999999999 110.902 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -72.88 -46.29 53.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 72.230000000000004 110.951 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 t -59.49 -40.09 85.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 65.230000000000004 111.145 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.442 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.16 -29.05 21.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 74.150000000000006 111.149 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.0 -26.87 50.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 71.209999999999994 110.91 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.411 HD21 HG21 ' A' ' 80' ' ' ILE . 4.1 mm? -91.5 -19.24 23.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 72.439999999999998 110.891 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mm -76.66 -34.95 24.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 65.329999999999998 111.131 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.54 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.65 -57.16 22.74 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.62 0.724 . . . . 74.099999999999994 111.12 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.4 Cg_endo -69.73 -20.45 34.95 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.743 2.295 . . . . 64.040000000000006 112.318 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.629 ' O ' HG22 ' A' ' 42' ' ' ILE . 48.0 t -75.98 -44.54 39.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 73.540000000000006 110.885 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.2 p -81.57 -28.93 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 74.120000000000005 111.131 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 mt -50.98 -33.94 26.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.459 . . . . 71.340000000000003 110.93 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.629 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.1 tp -58.76 -34.64 52.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 55.32 111.122 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 p -65.79 -38.8 90.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 72.340000000000003 111.111 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 t -53.0 -46.46 68.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 75.329999999999998 110.866 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.63 -41.41 60.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 50.350000000000001 110.938 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.4 -35.74 68.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 71.109999999999999 111.089 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.423 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.2 mp -64.81 -32.54 58.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 71.430000000000007 111.122 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.8 tp -55.04 -33.64 62.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 72.219999999999999 110.916 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.7 m -102.04 -35.57 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 71.099999999999994 111.102 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -72.58 -64.87 0.87 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 70.349999999999994 110.87 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.528 ' CE2' HD22 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -64.76 -41.14 96.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 74.209999999999994 110.911 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.49 74.78 2.29 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.639 0.733 . . . . 71.319999999999993 110.942 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 125.89 12.67 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.723 2.282 . . . . 74.400000000000006 112.312 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.8 t -116.31 -26.78 7.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 61.43 110.826 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -161.96 125.87 3.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.107 -0.497 . . . . 72.319999999999993 110.853 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.7 p -57.72 -26.0 61.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 73.209999999999994 110.871 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.607 ' O ' HG23 ' A' ' 61' ' ' THR . . . -52.95 -62.97 5.43 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.76 -0.733 . . . . 44.200000000000003 112.462 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.535 ' O ' HD23 ' A' ' 62' ' ' LEU . 1.5 tt0 -74.89 -35.46 62.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.889 0.376 . . . . 72.409999999999997 110.876 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -55.76 -50.49 70.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 73.420000000000002 110.869 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.5 ttm -64.96 -51.7 60.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 71.230000000000004 110.877 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 57' ' ' GLY . 70.9 p -56.22 -28.63 59.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 73.049999999999997 111.175 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.684 ' O ' HG23 ' A' ' 66' ' ' VAL . 1.6 mm? -72.78 -51.0 20.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 71.109999999999999 110.908 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.01 -49.67 65.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 65.0 110.887 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.6 tt -68.29 -35.01 69.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 72.340000000000003 111.125 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 m -65.71 -25.07 67.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 63.520000000000003 110.837 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 62' ' ' LEU . 61.0 t -57.96 -37.57 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.494 . . . . 43.310000000000002 111.107 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -28.95 26.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 73.150000000000006 110.884 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.49 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.36 -38.86 78.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 73.25 110.917 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.53 -30.02 70.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 51.100000000000001 111.128 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.589 HD13 HG11 ' A' ' 102' ' ' VAL . 9.6 mt -65.08 -54.7 26.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 63.100000000000001 110.897 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.69 -38.49 88.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 71.140000000000001 111.152 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 68' ' ' LEU . 80.0 t -71.43 -32.93 48.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 53.039999999999999 111.127 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.406 ' O ' HG22 ' A' ' 77' ' ' ILE . 90.3 t80 -51.84 -30.18 22.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 72.5 110.917 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.588 HD11 HD11 ' A' ' 95' ' ' LEU . 0.3 OUTLIER -73.22 -42.36 62.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.491 . . . . 75.040000000000006 110.936 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.6 mt -73.21 -33.91 65.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 74.109999999999999 110.897 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 tt -70.22 -55.07 10.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 73.209999999999994 110.973 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 80' ' ' ILE . 1.2 tt -57.08 -30.43 34.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 74.319999999999993 111.104 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.1 m -80.17 -23.42 41.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 72.25 110.858 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.69 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.4 OUTLIER -69.79 -12.75 61.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.477 . . . . 74.129999999999995 110.895 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.43 HG23 ' O ' ' A' ' 77' ' ' ILE . 2.2 pp -56.31 -24.57 18.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 73.120000000000005 111.123 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 79' ' ' LYS . 22.0 t 63.7 75.27 0.4 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.641 0.734 . . . . 72.129999999999995 111.151 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 167.53 24.22 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.658 2.238 . . . . 51.210000000000001 112.342 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 -48.66 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.69 2.26 . . . . 70.420000000000002 112.354 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.0 t -117.2 -19.79 9.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 73.010000000000005 111.143 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.69 45.08 4.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 72.510000000000005 110.872 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.6 tp -95.7 25.9 4.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 75.230000000000004 110.909 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.646 ' HA ' HD23 ' A' ' 90' ' ' LEU . 4.0 m-20 -104.57 24.39 11.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 72.200000000000003 110.862 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.19 -57.79 10.23 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.642 0.735 . . . . 61.25 111.145 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.537 ' HG2' HD22 ' A' ' 90' ' ' LEU . 54.3 Cg_endo -69.79 -20.48 34.62 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.696 2.264 . . . . 74.230000000000004 112.359 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.646 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.12 -45.6 47.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 75.400000000000006 110.955 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.493 HG12 HD21 ' A' ' 95' ' ' LEU . 38.4 t -80.67 -37.85 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 51.43 111.121 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.92 -52.1 36.66 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.724 -0.751 . . . . 73.400000000000006 112.542 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -35.19 79.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.828 0.347 . . . . 70.540000000000006 110.895 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -60.77 -36.75 79.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 60.109999999999999 110.952 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.588 HD11 HD11 ' A' ' 74' ' ' LEU . 9.7 mt -51.89 -29.8 21.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 54.399999999999999 110.934 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 13.4 mmt -67.85 -43.12 80.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 74.510000000000005 110.916 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.5 ' O ' HG22 ' A' ' 100' ' ' VAL . 67.2 t80 -75.28 -52.25 11.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 74.219999999999999 110.888 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.781 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.02 -29.91 32.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 74.510000000000005 111.165 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.72 -30.05 70.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 72.140000000000001 110.858 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.8 -30.04 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 65.129999999999995 111.134 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.781 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -74.91 -33.21 61.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 75.409999999999997 110.929 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.589 HG11 HD13 ' A' ' 70' ' ' LEU . 31.3 m -76.91 -38.09 28.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 72.319999999999993 111.156 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.484 ' HA ' HD12 ' A' ' 106' ' ' ILE . 73.0 m -72.46 -40.73 66.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 70.200000000000003 111.203 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -63.51 -32.17 73.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 63.229999999999997 110.88 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.0 t -71.38 -32.04 68.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 74.299999999999997 110.828 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.484 HD12 ' HA ' ' A' ' 103' ' ' THR . 22.3 mt -75.01 -52.1 19.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 64.129999999999995 111.163 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.547 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.1 p -54.16 -36.65 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 55.509999999999998 111.139 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.7 m -52.38 -32.4 38.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 62.310000000000002 111.173 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.7 m -50.46 -31.29 14.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.463 . . . . 71.099999999999994 110.835 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.2 p -52.51 -32.73 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 75.530000000000001 111.109 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 17.9 m -64.15 -43.87 93.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 45.039999999999999 110.878 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 84.1 t -76.89 -34.74 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 62.329999999999998 111.087 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.432 HD22 ' O ' ' A' ' 117' ' ' HIS . 83.4 mt -71.99 -32.25 67.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 71.409999999999997 110.895 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -59.18 -31.97 69.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 72.319999999999993 110.858 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.788 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.0 p -102.32 -24.84 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 42.409999999999997 111.166 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 -90.25 -73.73 0.51 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.123 -0.49 . . . . 74.430000000000007 110.828 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.432 ' O ' HD22 ' A' ' 113' ' ' LEU . 9.5 t-80 -172.72 99.14 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 75.319999999999993 110.816 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.432 HH11 ' N ' ' A' ' 119' ' ' SER . 52.3 tpt85 -98.76 118.1 34.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 70.239999999999995 110.909 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.432 ' N ' HH11 ' A' ' 118' ' ' ARG . 0.1 OUTLIER -179.12 160.59 0.99 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.689 0.757 . . . . 73.400000000000006 110.826 -179.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.519 ' O ' HG23 ' A' ' 121' ' ' THR . 54.0 Cg_endo -69.74 135.93 31.75 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.647 2.231 . . . . 72.019999999999996 112.384 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -170.4 145.85 2.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 54.409999999999997 111.18 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.5 m -160.47 69.02 0.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 51.219999999999999 111.132 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -156.28 26.21 0.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 55.219999999999999 110.879 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 27.2 m 60.62 73.95 0.58 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.574 0.702 . . . . 73.129999999999995 111.173 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -170.99 0.43 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.702 2.268 . . . . 71.109999999999999 112.349 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.0 mmt-85 -126.04 -74.29 0.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 74.129999999999995 110.862 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 52.4 -144.38 20.26 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.759 -0.734 . . . . 61.240000000000002 112.49 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 144.83 125.89 1.85 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.768 -0.73 . . . . 71.239999999999995 112.525 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 131.04 -154.53 20.84 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.747 -0.74 . . . . 71.319999999999993 112.495 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 90.31 28.75 16.26 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 44.039999999999999 112.464 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -87.97 -29.81 20.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.987 0.422 . . . . 74.150000000000006 110.922 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.9 m -66.44 -35.93 76.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 61.420000000000002 111.105 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.788 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -64.46 -25.02 67.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 75.040000000000006 111.094 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 39.1 mmt -53.0 -31.02 38.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 73.019999999999996 110.872 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 64.5 t -56.99 -58.17 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.281 -0.418 . . . . 74.519999999999996 111.082 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.9 mt -73.95 -36.93 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 73.219999999999999 111.12 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -62.09 -29.94 70.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 63.5 110.884 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.18 -29.86 24.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 73.319999999999993 110.886 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.31 -39.48 74.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 74.200000000000003 110.879 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -73.86 -53.38 10.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 64.030000000000001 110.897 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.538 ' O ' HG23 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -52.39 -33.6 44.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 63.219999999999999 110.913 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 20.7 t90 -55.51 -50.6 69.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 75.200000000000003 110.937 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.715 ' O ' HG23 ' A' ' 147' ' ' VAL . 57.8 mt -76.01 -33.49 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 50.210000000000001 111.121 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -56.16 -56.02 25.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 63.109999999999999 110.867 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 141' ' ' LEU . 23.2 t -59.95 -35.01 58.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 62.109999999999999 111.089 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -66.06 -33.27 75.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 70.209999999999994 110.895 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 143' ' ' ILE . 78.7 t -54.25 -50.64 54.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 74.510000000000005 111.155 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.39 -47.7 66.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 74.439999999999998 110.921 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.7 t -63.67 -33.03 59.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 74.329999999999998 111.132 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -52.07 -54.94 24.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 73.439999999999998 110.893 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.32 -19.55 74.05 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 44.439999999999998 112.486 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.2 m -60.11 -52.82 63.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.733 0.301 . . . . 65.519999999999996 111.136 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.587 HG22 ' CD1' ' A' ' 157' ' ' LEU . 47.3 mm -76.48 -33.65 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 73.209999999999994 111.132 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -55.2 -49.98 61.31 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.741 -0.742 . . . . 55.32 112.51 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 3.3 mmt -72.43 -31.99 65.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.822 0.344 . . . . 75.319999999999993 110.91 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -71.22 -24.18 62.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 74.430000000000007 110.856 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.587 ' CD1' HG22 ' A' ' 153' ' ' ILE . 5.8 mt -75.28 -26.97 59.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 65.030000000000001 110.963 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.475 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.8 OUTLIER -52.0 -60.55 5.91 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.629 0.728 . . . . 75.510000000000005 110.915 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.4 Cg_endo -69.81 -15.61 36.96 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.701 2.267 . . . . 65.230000000000004 112.339 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.96 40.87 1.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 73.099999999999994 110.949 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -67.93 -26.09 65.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 72.400000000000006 110.854 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 72.21 -69.01 0.2 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 62.329999999999998 110.968 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 22.8 t30 52.02 87.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 55.030000000000001 110.904 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 35.1 t80 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 73.120000000000005 110.927 -179.9 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.819 0.342 . . . . 70.230000000000004 110.865 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -146.96 -168.0 2.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 45.219999999999999 110.876 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 28' ' ' PRO . 8.9 ptpt -49.66 108.1 0.92 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.583 0.706 . . . . 75.510000000000005 110.933 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 27' ' ' LYS . 54.0 Cg_endo -69.71 -13.46 34.82 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.652 2.235 . . . . 74.430000000000007 112.375 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.0 pp -52.08 -30.99 28.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 71.310000000000002 110.913 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -78.04 -33.59 50.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 72.420000000000002 110.882 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -72.64 -45.89 56.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 74.129999999999995 110.904 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -60.31 -39.96 88.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 63.43 111.14 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.455 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.17 -29.08 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 64.519999999999996 111.145 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.88 -27.26 51.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.420000000000002 110.861 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.558 HD21 HG21 ' A' ' 80' ' ' ILE . 4.1 mm? -91.1 -18.8 23.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 70.420000000000002 110.957 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.7 mm -76.54 -34.97 25.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 64.420000000000002 111.173 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.545 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.72 -57.15 22.97 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.583 0.706 . . . . 72.540000000000006 111.107 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.5 Cg_endo -69.77 -21.35 33.54 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.683 2.255 . . . . 72.530000000000001 112.285 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.622 ' O ' HG22 ' A' ' 42' ' ' ILE . 47.3 t -75.87 -44.52 40.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 72.510000000000005 110.882 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.508 HG23 ' SG ' ' A' ' 148' ' ' CYS . 9.7 p -81.57 -28.93 10.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 63.210000000000001 111.139 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 mt -50.97 -34.01 27.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 72.25 110.907 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.1 tp -58.68 -34.68 52.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 65.25 111.141 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 p -65.69 -40.48 92.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.458 . . . . 72.340000000000003 111.138 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.97 -43.08 66.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 71.420000000000002 110.876 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.9 tp -76.96 -40.79 45.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.12 -0.491 . . . . 61.340000000000003 110.914 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.1 -36.52 68.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 61.240000000000002 111.103 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.426 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.3 mp -64.28 -32.02 55.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 75.420000000000002 111.112 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.9 tp -51.43 -38.76 55.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 71.239999999999995 110.916 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.674 HG21 HD13 ' A' ' 62' ' ' LEU . 7.9 p -101.47 -36.69 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 70.239999999999995 111.154 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -67.02 -64.65 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 72.340000000000003 110.871 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.547 ' CE2' HD22 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -71.34 -60.8 2.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 74.129999999999995 110.907 -179.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.0 mp -71.0 160.63 81.85 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.598 0.713 . . . . 65.540000000000006 110.921 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 144.63 54.77 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.701 2.267 . . . . 55.100000000000001 112.313 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.76 95.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 72.400000000000006 110.877 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 53.85 -172.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 54.420000000000002 110.862 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.4 m -114.81 -74.49 0.61 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 62.310000000000002 110.862 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.41 -27.74 66.18 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.726 . . . . 44.100000000000001 112.515 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.489 ' HG2' HD12 ' A' ' 62' ' ' LEU . 11.6 tt0 -52.1 -34.92 46.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.852 0.358 . . . . 70.349999999999994 110.821 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.6 mttt -52.98 -51.92 59.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 71.349999999999994 110.894 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 9.7 ttm -64.3 -45.44 87.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 51.32 110.882 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.7 m -58.28 -36.96 74.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.446 . . . . 75.25 111.177 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.674 HD13 HG21 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -75.62 -32.6 60.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 71.430000000000007 110.939 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 6.8 m -65.26 -52.01 57.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 71.129999999999995 110.897 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.4 tt -60.26 -34.95 59.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 62.520000000000003 111.112 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -24.98 66.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 73.129999999999995 110.853 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.3 t -57.95 -35.59 52.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 74.400000000000006 111.137 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mp -52.98 -28.88 25.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 71.510000000000005 110.893 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.495 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.37 -38.99 78.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 65.409999999999997 110.925 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.45 -30.05 70.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 53.109999999999999 111.093 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.842 HD22 HG11 ' A' ' 102' ' ' VAL . 9.9 mt -64.7 -54.72 27.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 41.310000000000002 110.944 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.97 -38.17 87.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 53.32 111.112 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 68' ' ' LEU . 76.4 t -71.44 -32.83 47.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 53.130000000000003 111.111 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -51.51 -30.67 21.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 73.329999999999998 110.909 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.456 HD11 HD11 ' A' ' 95' ' ' LEU . 8.9 tp -75.0 -40.06 60.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 75.510000000000005 110.915 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.9 mt -73.22 -34.8 66.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 70.319999999999993 110.916 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.11 -53.87 13.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.456 . . . . 70.129999999999995 110.906 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 80' ' ' ILE . 1.6 tt -56.43 -26.17 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 70.010000000000005 111.104 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.5 m -80.15 -22.4 42.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 71.109999999999999 110.862 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.684 ' O ' HG23 ' A' ' 81' ' ' VAL . 7.1 mttp -70.77 -10.5 59.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 74.329999999999998 110.873 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.558 HG21 HD21 ' A' ' 35' ' ' LEU . 2.4 pp -56.61 -23.72 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 64.549999999999997 111.133 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 79' ' ' LYS . 21.4 t 64.11 75.49 0.38 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.598 0.713 . . . . 65.219999999999999 111.127 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 167.26 24.93 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.656 2.237 . . . . 63.25 112.348 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -48.8 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.713 2.275 . . . . 71.219999999999999 112.331 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.75 HG23 ' H ' ' A' ' 86' ' ' LEU . 8.4 t -116.6 -19.93 9.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 74.439999999999998 111.148 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 p 63.46 23.27 13.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 64.540000000000006 110.873 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.75 ' H ' HG23 ' A' ' 84' ' ' THR . 0.1 OUTLIER -95.72 31.21 2.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 63.310000000000002 110.915 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.66 ' HA ' HD23 ' A' ' 90' ' ' LEU . 75.7 m-20 -94.63 47.16 1.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.457 . . . . 72.329999999999998 110.875 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.536 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -66.74 -57.72 11.22 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.586 0.708 . . . . 73.329999999999998 111.142 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.7 Cg_endo -69.77 -20.0 35.34 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.679 2.252 . . . . 73.319999999999993 112.322 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.66 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.15 -53.16 10.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.246 -0.434 . . . . 71.340000000000003 110.875 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.11 -38.01 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 71.299999999999997 111.085 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.1 -43.43 56.18 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.752 -0.737 . . . . 75.299999999999997 112.448 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -21.92 64.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.806 0.336 . . . . 73.540000000000006 110.911 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -78.13 -41.88 33.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 61.310000000000002 110.902 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.469 ' HA ' HG22 ' A' ' 98' ' ' THR . 10.9 mt -55.69 -29.71 59.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 73.349999999999994 110.875 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -43.42 76.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 74.450000000000003 110.876 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.504 ' O ' HG22 ' A' ' 100' ' ' VAL . 50.9 t80 -75.27 -51.69 12.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 75.230000000000004 110.871 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.791 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.16 -29.88 33.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 74.340000000000003 111.113 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.8 mmt -66.63 -30.12 70.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 72.019999999999996 110.878 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.7 -30.08 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 51.049999999999997 111.153 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -75.0 -33.2 61.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 74.109999999999999 110.906 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.842 HG11 HD22 ' A' ' 70' ' ' LEU . 31.2 m -76.91 -38.12 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 73.040000000000006 111.155 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.45 ' O ' HG13 ' A' ' 107' ' ' VAL . 74.1 m -72.47 -40.05 67.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.472 . . . . 74.329999999999998 111.135 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -64.49 -31.92 73.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 63.329999999999998 110.852 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.6 t -74.4 -34.51 63.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 61.200000000000003 110.859 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.5 mt -74.43 -50.72 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 72.409999999999997 111.135 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.555 ' O ' HG12 ' A' ' 110' ' ' VAL . 34.5 m -54.05 -33.99 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 70.219999999999999 111.111 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.0 m -52.41 -32.53 39.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 63.229999999999997 111.164 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.1 m -50.45 -31.46 15.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 73.239999999999995 110.891 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.4 p -52.5 -32.73 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 72.150000000000006 111.115 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 35.5 m -66.94 -48.74 67.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 64.530000000000001 110.868 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 77.7 t -70.49 -35.37 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 64.219999999999999 111.124 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.452 HD13 HH11 ' A' ' 118' ' ' ARG . 90.0 mt -72.09 -40.31 68.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 64.5 110.911 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -52.12 -31.66 31.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 72.230000000000004 110.863 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.775 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.3 p -102.31 -24.18 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 65.519999999999996 111.139 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -54.02 -74.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 72.510000000000005 110.879 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -179.15 35.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 75.540000000000006 110.857 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.452 HH11 HD13 ' A' ' 113' ' ' LEU . 3.2 ttp180 -119.93 -173.62 2.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 74.409999999999997 110.846 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.58 160.58 47.34 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.652 0.739 . . . . 54.109999999999999 110.851 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -171.25 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.717 2.278 . . . . 75.329999999999998 112.3 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.0 -72.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.468 . . . . 73.25 111.129 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -143.54 -62.49 0.4 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.211 -0.45 . . . . 72.450000000000003 111.14 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -109.76 -176.2 2.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 74.239999999999995 110.867 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.5 m 64.27 73.64 0.45 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.615 0.721 . . . . 71.239999999999995 111.162 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -170.96 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.672 2.248 . . . . 63.43 112.351 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.5 ttm-85 63.22 161.7 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 73.120000000000005 110.853 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -164.27 64.26 0.24 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.751 . . . . 64.549999999999997 112.497 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -136.74 112.84 0.98 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.689 -0.767 . . . . 72.310000000000002 112.484 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 112.19 -147.62 18.21 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.781 -0.724 . . . . 71.25 112.462 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -165.7 -60.42 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.797 -0.716 . . . . 71.319999999999993 112.518 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -69.32 -26.35 64.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.969 0.414 . . . . 75.25 110.946 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.1 m -54.72 -27.1 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.054 -0.521 . . . . 75.310000000000002 111.113 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.775 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -54.83 -27.66 43.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 51.240000000000002 111.117 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 37.0 mmt -53.0 -31.01 38.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 71.420000000000002 110.876 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 62.4 t -56.94 -56.02 16.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.267 -0.424 . . . . 73.430000000000007 111.105 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.8 mp -73.94 -38.66 50.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 73.010000000000005 111.116 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -61.13 -30.46 70.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 73.349999999999994 110.899 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.76 -27.28 40.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.478 . . . . 71.150000000000006 110.88 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.01 -50.63 21.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 72.040000000000006 110.909 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -69.06 -53.59 19.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 72.140000000000001 110.887 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.621 ' O ' HG23 ' A' ' 145' ' ' VAL . 0.2 OUTLIER -52.08 -32.4 34.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 74.540000000000006 110.907 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -61.45 -51.48 68.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 74.540000000000006 110.884 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.748 ' O ' HG23 ' A' ' 147' ' ' VAL . 62.1 mt -74.35 -32.0 29.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 75.120000000000005 111.156 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -56.0 -56.46 20.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 70.129999999999995 110.847 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 141' ' ' LEU . 30.6 t -54.3 -35.56 30.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 62.210000000000001 111.138 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -69.96 -37.86 75.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 64.209999999999994 110.884 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 143' ' ' ILE . 63.0 t -54.9 -34.06 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 71.109999999999999 111.145 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.508 ' SG ' HG23 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -52.78 -47.99 67.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 71.530000000000001 110.91 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.788 HG12 HD11 ' A' ' 153' ' ' ILE . 22.0 t -74.5 -36.69 42.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 51.450000000000003 111.126 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -54.89 -26.92 38.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 63.140000000000001 110.92 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.58 -59.05 4.26 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 73.349999999999994 112.423 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 4.4 t -54.59 -34.09 61.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.788 0.328 . . . . 64.450000000000003 111.162 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.788 HD11 HG12 ' A' ' 149' ' ' VAL . 47.6 mt -70.24 -25.21 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 62.140000000000001 111.091 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.83 -49.92 32.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.704 -0.76 . . . . 54.030000000000001 112.514 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.65 -32.01 57.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.345 . . . . 55.340000000000003 110.928 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -72.68 -20.84 61.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 74.010000000000005 110.879 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.412 ' CD1' HG22 ' A' ' 153' ' ' ILE . 7.3 mt -79.34 -27.11 42.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 73.120000000000005 110.917 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.537 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 11.5 tp60 -51.75 -58.17 12.02 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.584 0.706 . . . . 61.530000000000001 110.884 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 54.1 Cg_endo -69.74 -29.38 24.07 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.745 2.296 . . . . 72.219999999999999 112.334 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.97 -53.52 40.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 72.150000000000006 110.909 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 4.8 t80 64.46 14.45 8.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 72.239999999999995 110.858 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 60.19 47.48 9.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 60.32 110.928 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -162.7 -60.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 73.219999999999999 110.923 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 64.209999999999994 110.899 -179.927 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.783 0.325 . . . . 71.099999999999994 110.841 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -65.68 91.07 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 74.510000000000005 110.883 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.31 79.23 44.88 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.582 0.706 . . . . 54.240000000000002 110.889 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 -5.07 15.33 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.704 2.269 . . . . 55.219999999999999 112.313 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.0 pp -52.29 -30.95 30.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 75.409999999999997 110.923 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -80.26 -32.01 38.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 72.409999999999997 110.914 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -73.12 -46.16 52.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 72.209999999999994 110.926 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 t -59.67 -39.99 86.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 72.430000000000007 111.157 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.447 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.19 -29.1 21.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 64.400000000000006 111.132 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -55.58 -27.24 48.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 63.310000000000002 110.869 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.56 ' HG ' HD12 ' A' ' 77' ' ' ILE . 4.1 mm? -91.27 -19.08 23.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.201 -0.454 . . . . 74.109999999999999 110.93 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.8 mm -76.51 -35.03 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 74.219999999999999 111.138 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.547 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.68 -57.14 22.91 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.609 0.719 . . . . 74.519999999999996 111.127 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.9 Cg_endo -69.75 -21.58 33.32 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.683 2.255 . . . . 63.539999999999999 112.308 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.621 ' O ' HG22 ' A' ' 42' ' ' ILE . 36.2 t -73.09 -46.91 48.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 63.229999999999997 110.871 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.5 p -81.53 -29.01 10.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 62.399999999999999 111.117 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.1 mt -50.89 -34.01 26.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 72.420000000000002 110.949 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.621 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.76 -34.64 52.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 74.549999999999997 111.113 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.3 p -65.66 -34.53 78.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 63.210000000000001 111.141 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.06 -49.01 72.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 72.019999999999996 110.864 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.0 tp -73.17 -43.21 61.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 61.009999999999998 110.922 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.94 -39.99 75.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 52.100000000000001 111.13 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.07 -32.45 58.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 73.310000000000002 111.102 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.523 ' O ' HD23 ' A' ' 52' ' ' LEU . 4.0 tp -51.57 -37.15 48.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 65.200000000000003 110.915 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.01 -35.78 4.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 51.299999999999997 111.09 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -67.08 -62.86 1.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 73.549999999999997 110.881 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.23 -40.33 70.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 75.430000000000007 110.922 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.523 HD23 ' O ' ' A' ' 48' ' ' LEU . 4.5 mm? -70.43 159.18 85.73 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.602 0.715 . . . . 73.019999999999996 110.887 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -172.28 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.615 2.21 . . . . 72.0 112.389 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.9 t 63.28 87.75 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 71.329999999999998 110.865 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -89.86 50.4 1.88 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 73.030000000000001 110.875 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.7 p -63.21 -173.38 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 71.319999999999993 110.898 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.738 ' O ' HG23 ' A' ' 61' ' ' THR . . . -52.2 -30.02 30.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.754 -0.736 . . . . 50.530000000000001 112.492 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -60.89 -34.88 75.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.977 0.417 . . . . 73.099999999999994 110.932 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -46.07 82.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 71.439999999999998 110.873 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 23.9 ttm -71.64 -46.49 58.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 62.130000000000003 110.889 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.738 HG23 ' O ' ' A' ' 57' ' ' GLY . 30.4 p -54.38 -27.18 34.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 72.430000000000007 111.109 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.24 -51.0 34.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 73.140000000000001 110.906 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 7.3 m -54.66 -46.53 74.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.429 . . . . 64.329999999999998 110.931 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 15.8 tt -71.22 -34.96 56.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 74.209999999999994 111.148 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 m -53.85 -28.07 33.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 63.210000000000001 110.898 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.0 t -58.08 -38.37 67.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.487 . . . . 61.340000000000003 111.169 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.91 -28.87 25.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 70.010000000000005 110.962 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.482 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.01 -39.04 79.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 75.310000000000002 110.927 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.48 -29.97 70.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 60.100000000000001 111.084 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.015 HD11 HG11 ' A' ' 102' ' ' VAL . 8.5 mt -66.04 -54.81 21.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 62.329999999999998 110.903 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -60.94 -38.37 85.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 71.140000000000001 111.148 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 68' ' ' LEU . 81.9 t -71.5 -37.19 63.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 73.319999999999993 111.124 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.514 ' CE2' HD12 ' A' ' 35' ' ' LEU . 49.7 t80 -68.55 -31.87 71.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 73.310000000000002 110.853 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.401 HD11 ' CD1' ' A' ' 95' ' ' LEU . 2.8 tt -75.03 -43.62 52.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 60.450000000000003 110.904 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.8 mp -73.32 -44.06 59.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 72.030000000000001 110.893 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.3 tt -55.55 -55.16 35.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 52.200000000000003 110.936 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.56 HD12 ' HG ' ' A' ' 35' ' ' LEU . 1.4 tt -62.91 -25.08 37.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 73.409999999999997 111.074 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.4 m -80.14 -14.62 58.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 75.329999999999998 110.848 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -54.43 -26.42 30.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 63.229999999999997 110.891 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.423 ' O ' ' C ' ' A' ' 81' ' ' VAL . 1.0 OUTLIER -62.42 -16.78 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 73.219999999999999 111.084 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 81' ' ' VAL . 2.4 p 35.53 80.95 0.25 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.601 0.715 . . . . 70.319999999999993 111.097 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 165.76 29.87 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.714 2.276 . . . . 73.120000000000005 112.376 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 -50.13 0.5 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.704 2.269 . . . . 54.350000000000001 112.388 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.5 t -136.98 -38.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 71.530000000000001 111.14 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 178.7 82.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 74.349999999999994 110.85 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -96.21 -17.82 20.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 64.099999999999994 110.914 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.593 ' HA ' HD23 ' A' ' 90' ' ' LEU . 4.3 m-20 -152.56 23.88 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 71.400000000000006 110.879 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.538 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -66.86 -57.8 10.82 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.63 0.728 . . . . 72.299999999999997 111.113 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.551 ' HG2' HD22 ' A' ' 90' ' ' LEU . 53.4 Cg_endo -69.79 -21.55 33.21 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.67 2.247 . . . . 72.219999999999999 112.322 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.593 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.4 mm? -74.15 -53.1 10.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.44 . . . . 71.5 110.934 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.32 -44.89 24.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 74.230000000000004 111.164 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.04 -39.2 48.83 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.736 -0.745 . . . . 53.210000000000001 112.446 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -73.75 -23.56 59.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.798 0.333 . . . . 73.450000000000003 110.936 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -75.35 -37.82 60.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 75.420000000000002 110.931 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.439 ' HA ' HG22 ' A' ' 98' ' ' THR . 12.9 mt -54.45 -29.85 50.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 73.510000000000005 110.89 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.36 -43.65 73.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 55.210000000000001 110.885 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.501 ' O ' HG22 ' A' ' 100' ' ' VAL . 39.0 t80 -75.17 -51.12 14.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 73.030000000000001 110.884 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.805 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.15 -29.74 33.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 73.030000000000001 111.129 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.78 -30.18 70.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.44 . . . . 73.319999999999993 110.909 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.85 -29.95 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 64.310000000000002 111.154 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.805 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -75.06 -33.22 61.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 63.149999999999999 110.915 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 1.015 HG11 HD11 ' A' ' 70' ' ' LEU . 30.1 m -76.91 -38.06 28.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 72.430000000000007 111.164 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.447 ' O ' HG13 ' A' ' 107' ' ' VAL . 74.5 m -72.51 -38.54 68.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 74.140000000000001 111.113 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -66.41 -31.84 72.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 73.299999999999997 110.87 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.01 -34.76 64.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 73.239999999999995 110.872 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.3 mt -73.83 -51.03 25.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 51.229999999999997 111.177 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.552 ' O ' HG12 ' A' ' 110' ' ' VAL . 35.2 m -53.94 -34.21 25.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 65.319999999999993 111.133 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.3 m -52.39 -32.51 39.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 32.020000000000003 111.144 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.0 p -50.41 -31.45 14.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 64.439999999999998 110.862 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.5 p -52.56 -32.8 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 75.209999999999994 111.118 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 27.3 m -66.2 -48.14 71.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 53.240000000000002 110.905 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.6 t -71.44 -35.98 59.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 63.219999999999999 111.144 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.8 mt -72.03 -34.68 68.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 75.109999999999999 110.912 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -55.44 -32.73 62.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 72.329999999999998 110.886 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.782 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.6 p -102.34 -24.28 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 64.540000000000006 111.121 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -81.48 -70.08 0.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 75.400000000000006 110.812 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -123.2 77.64 1.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 75.230000000000004 110.871 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.0 -50.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 73.439999999999998 110.846 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.5 t -165.47 73.38 1.37 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.631 0.729 . . . . 61.119999999999997 110.851 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 107.02 1.77 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.663 2.242 . . . . 61.439999999999998 112.333 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 17.2 m -76.22 -25.96 55.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 73.420000000000002 111.119 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.38 102.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.445 . . . . 70.019999999999996 111.161 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.501 ' O ' HG23 ' A' ' 124' ' ' THR . 19.3 t-160 -119.81 -71.95 0.71 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 74.430000000000007 110.903 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 123' ' ' HIS . 0.9 OUTLIER -160.18 67.93 2.79 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.592 0.71 . . . . 51.520000000000003 111.142 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -172.31 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.72 2.28 . . . . 63.100000000000001 112.373 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.66 -57.66 1.72 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 73.230000000000004 110.889 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -104.23 -41.77 2.02 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.724 -0.75 . . . . 71.340000000000003 112.452 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 129.63 92.42 0.66 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.758 -0.734 . . . . 65.109999999999999 112.47 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 169.29 -76.53 0.11 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.673 -0.775 . . . . 35.340000000000003 112.489 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.63 61.12 0.28 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.753 -0.737 . . . . 73.109999999999999 112.518 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -87.17 -30.78 20.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.893 0.378 . . . . 54.240000000000002 110.882 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.479 HG11 ' HB3' ' A' ' 123' ' ' HIS . 23.4 m -73.66 -28.26 24.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 54.130000000000003 111.16 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.782 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -55.95 -25.12 42.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 54.420000000000002 111.146 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -52.96 -30.88 37.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 63.240000000000002 110.89 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 64.9 t -56.97 -56.66 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 51.439999999999998 111.141 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 31.9 mm -74.09 -36.42 44.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 75.219999999999999 111.133 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -62.84 -29.88 71.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 71.319999999999993 110.864 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.18 -27.6 35.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 60.439999999999998 110.909 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.9 tt -70.47 -50.22 40.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 73.409999999999997 110.928 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -72.09 -28.95 63.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 44.539999999999999 110.925 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.8 tt -56.77 -40.74 76.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 52.409999999999997 110.918 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -72.44 -51.07 21.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 73.140000000000001 110.976 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.746 ' O ' HG23 ' A' ' 147' ' ' VAL . 51.0 mm -57.96 -32.21 42.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 63.399999999999999 111.164 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -56.27 -57.14 13.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 73.439999999999998 110.878 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 21.7 t -66.73 -36.31 76.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.48 . . . . 74.439999999999998 111.108 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.34 -36.13 68.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 62.329999999999998 110.851 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 143' ' ' ILE . 94.4 t -58.82 -53.22 50.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 64.540000000000006 111.117 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -56.23 -32.6 64.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 73.430000000000007 110.893 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 67.5 t -71.07 -34.2 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 74.329999999999998 111.097 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -71.88 -27.44 62.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 73.219999999999999 110.939 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.07 -48.58 5.99 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.705 -0.76 . . . . 71.329999999999998 112.482 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.4 t -51.81 -39.39 58.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.751 0.31 . . . . 61.030000000000001 111.14 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.524 HG22 ' CD1' ' A' ' 157' ' ' LEU . 41.1 mt -63.09 -43.18 98.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 43.030000000000001 111.135 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -52.88 -48.55 57.27 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.747 -0.74 . . . . 74.049999999999997 112.495 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -31.94 66.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.792 0.329 . . . . 74.420000000000002 110.887 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -71.32 -24.58 62.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.443 . . . . 72.409999999999997 110.902 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.524 ' CD1' HG22 ' A' ' 153' ' ' ILE . 3.7 mt -75.7 -26.46 57.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 72.219999999999999 110.939 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.485 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 1.3 mm-40 -51.91 -60.5 5.97 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.581 0.705 . . . . 65.099999999999994 110.865 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.9 Cg_endo -69.77 -15.68 37.14 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.668 2.246 . . . . 73.420000000000002 112.349 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 30.8 mt -92.1 44.94 1.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 61.310000000000002 110.904 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.88 -26.14 17.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 61.210000000000001 110.84 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 61.92 58.5 1.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 74.439999999999998 110.906 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -122.63 96.28 4.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 64.340000000000003 110.89 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 75.0 t80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 74.329999999999998 110.904 -179.903 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 77.1 mmt-85 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.799 0.333 . . . . 65.400000000000006 110.873 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -96.22 26.6 4.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 72.230000000000004 110.842 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -118.88 73.09 11.86 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.61 0.719 . . . . 72.120000000000005 110.922 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -12.19 32.37 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.659 2.239 . . . . 60.039999999999999 112.369 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 pp -51.99 -30.95 27.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 64.25 110.927 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -78.82 -33.49 46.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 75.099999999999994 110.879 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -72.46 -46.23 55.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 72.040000000000006 110.94 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -60.08 -40.02 88.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.511 . . . . 54.149999999999999 111.11 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.445 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.19 -29.11 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 74.200000000000003 111.101 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -55.8 -27.12 49.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 72.040000000000006 110.856 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.43 ' HB3' HD12 ' A' ' 77' ' ' ILE . 4.1 mm? -91.29 -19.19 23.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 71.310000000000002 110.942 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.6 mm -76.6 -34.94 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 65.030000000000001 111.134 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.543 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.3 mm -55.61 -57.21 22.35 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.659 0.742 . . . . 50.210000000000001 111.136 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.6 Cg_endo -69.82 -20.91 33.95 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.661 2.24 . . . . 64.109999999999999 112.336 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.633 ' O ' HG22 ' A' ' 42' ' ' ILE . 48.6 t -75.98 -44.65 38.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 75.409999999999997 110.908 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.61 -28.86 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 64.430000000000007 111.128 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.3 mt -50.97 -33.97 26.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 42.130000000000003 110.919 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 39' ' ' CYS . 0.7 OUTLIER -58.76 -34.65 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 44.210000000000001 111.131 179.844 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 p -65.81 -39.73 91.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 53.32 111.188 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.99 -51.11 62.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 74.310000000000002 110.809 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.9 tp -69.48 -38.81 77.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 74.310000000000002 110.896 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.7 -39.64 77.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 54.009999999999998 111.106 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.447 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.3 mp -64.33 -31.93 55.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 45.109999999999999 111.125 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.5 -38.7 55.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 74.209999999999994 110.927 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -101.45 -36.73 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 73.219999999999999 111.139 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -67.1 -64.62 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 71.129999999999995 110.894 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.447 ' HB2' HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -71.22 -61.96 1.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 74.129999999999995 110.944 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.2 mp -67.62 160.65 71.58 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.617 0.723 . . . . 75.219999999999999 110.928 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 161.53 45.56 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.722 2.282 . . . . 64.219999999999999 112.336 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -174.88 -69.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 72.099999999999994 110.895 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -178.37 -171.73 0.27 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 71.109999999999999 110.887 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 50.2 t -94.83 -74.39 0.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 64.310000000000002 110.892 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.75 -47.1 59.2 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 70.409999999999997 112.506 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.56 -35.54 70.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.916 0.389 . . . . 60.210000000000001 110.862 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -66.02 -44.58 84.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 75.409999999999997 110.885 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.605 ' O ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.35 -45.76 71.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 72.430000000000007 110.863 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 77.3 p -62.45 -26.09 68.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 73.409999999999997 111.131 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.24 -37.34 61.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 52.509999999999998 110.913 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 82.5 m -74.0 -48.65 28.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 74.319999999999993 110.839 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 60' ' ' MET . 24.7 pt -54.85 -32.26 25.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 73.409999999999997 111.121 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.1 -28.45 67.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 65.310000000000002 110.9 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.13 -38.25 66.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 74.049999999999997 111.141 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tp -52.89 -28.92 25.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 63.450000000000003 110.876 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.491 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.23 -38.94 78.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 74.319999999999993 110.933 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.65 -30.01 70.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 74.299999999999997 111.093 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.794 HD13 HG11 ' A' ' 102' ' ' VAL . 9.2 mt -65.31 -54.81 23.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 72.209999999999994 110.87 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.47 -38.63 87.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 65.510000000000005 111.151 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 68' ' ' LEU . 84.2 t -71.52 -32.96 47.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 61.210000000000001 111.13 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.582 ' O ' HG22 ' A' ' 77' ' ' ILE . 72.4 t80 -52.03 -34.09 41.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 73.140000000000001 110.889 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.1 tp -60.96 -51.11 70.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 74.409999999999997 110.939 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.5 mt -73.14 -32.13 64.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.47 . . . . 53.520000000000003 110.87 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.7 tt -66.69 -52.33 45.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 64.349999999999994 110.895 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 73' ' ' PHE . 1.5 tt -69.17 -30.55 46.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 74.129999999999995 111.117 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.0 m -80.19 -21.3 43.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 54.520000000000003 110.862 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.651 ' O ' HG23 ' A' ' 81' ' ' VAL . 4.8 mttt -60.38 -19.95 57.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.107 -0.497 . . . . 73.120000000000005 110.947 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -59.17 -20.71 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 72.129999999999995 111.132 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 79' ' ' LYS . 23.8 t 51.56 76.62 0.52 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.609 0.719 . . . . 65.099999999999994 111.118 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.429 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 54.0 Cg_endo -69.77 112.08 2.99 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.711 2.274 . . . . 63.130000000000003 112.35 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 82' ' ' PRO . 53.1 Cg_endo -69.82 -48.61 0.67 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.716 2.277 . . . . 72.120000000000005 112.309 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.5 t -117.05 -21.86 8.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 73.120000000000005 111.13 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.18 -48.74 61.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 73.430000000000007 110.86 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.3 tp 51.0 56.14 8.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.108 -0.496 . . . . 74.129999999999995 110.918 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.625 ' HA ' HD23 ' A' ' 90' ' ' LEU . 3.7 m-20 -95.36 24.03 5.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 75.310000000000002 110.875 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.536 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.2 -57.82 10.16 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.609 0.719 . . . . 60.420000000000002 111.132 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.9 Cg_endo -69.76 -20.8 34.35 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.706 2.27 . . . . 73.25 112.324 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.625 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.07 -53.13 10.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 74.329999999999998 110.939 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.526 HG12 HD21 ' A' ' 95' ' ' LEU . 60.6 t -65.37 -36.43 77.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 52.420000000000002 111.135 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.94 -41.46 52.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.761 -0.733 . . . . 52.119999999999997 112.464 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.6 mmpm? -75.21 -22.07 58.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.748 0.308 . . . . 74.239999999999995 110.867 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -75.68 -33.4 60.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.259 -0.428 . . . . 75.140000000000001 110.954 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.526 HD21 HG12 ' A' ' 91' ' ' VAL . 13.2 mt -53.39 -29.83 36.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 72.299999999999997 110.937 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.26 -43.65 73.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 64.450000000000003 110.923 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.489 ' O ' HG22 ' A' ' 100' ' ' VAL . 65.9 t80 -75.23 -51.16 14.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 74.420000000000002 110.901 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.786 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.17 -29.93 34.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 43.450000000000003 111.126 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.0 mmt -66.53 -30.15 70.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 74.310000000000002 110.892 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.85 -30.07 13.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 74.430000000000007 111.135 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.786 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.88 -33.2 62.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 63.409999999999997 110.94 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.794 HG11 HD13 ' A' ' 70' ' ' LEU . 31.1 m -76.92 -38.08 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 71.299999999999997 111.129 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 78.8 m -72.48 -38.55 68.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 75.329999999999998 111.107 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -66.86 -32.03 73.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 74.040000000000006 110.888 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.0 t -71.56 -35.55 70.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 75.230000000000004 110.831 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.4 mt -71.7 -51.92 29.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 71.040000000000006 111.112 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.548 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.7 p -54.05 -36.36 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 61.539999999999999 111.139 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.1 m -52.34 -32.41 37.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 62.32 111.182 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.0 m -50.46 -31.32 14.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 72.510000000000005 110.836 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.548 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.3 p -52.49 -32.83 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 61.200000000000003 111.089 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 23.6 m -65.51 -44.35 87.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 64.319999999999993 110.926 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 82.1 t -75.96 -35.83 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 75.340000000000003 111.067 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.449 HD22 ' O ' ' A' ' 117' ' ' HIS . 90.0 mt -71.95 -31.79 66.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 75.219999999999999 110.95 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -60.03 -31.71 70.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 74.510000000000005 110.919 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.765 HG11 ' HB2' ' A' ' 133' ' ' ALA . 8.3 p -102.32 -24.77 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 64.430000000000007 111.151 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -90.47 -74.14 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 62.420000000000002 110.869 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.449 ' O ' HD22 ' A' ' 113' ' ' LEU . 0.5 OUTLIER -179.14 105.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 73.219999999999999 110.896 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -97.12 104.75 16.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 64.109999999999999 110.883 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -178.45 160.59 1.15 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.664 0.745 . . . . 74.150000000000006 110.845 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.507 ' O ' HG23 ' A' ' 121' ' ' THR . 53.4 Cg_endo -69.76 126.2 13.03 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.749 2.299 . . . . 62.409999999999997 112.343 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 120' ' ' PRO . 0.1 OUTLIER -169.78 94.36 0.26 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 71.129999999999995 111.135 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.5 t -116.64 -25.01 7.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 64.409999999999997 111.169 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -100.36 -26.8 13.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 75.140000000000001 110.835 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.5 m -116.88 69.15 4.59 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.542 0.687 . . . . 74.420000000000002 111.136 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 157.19 61.25 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.645 2.23 . . . . 71.120000000000005 112.364 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -145.56 -74.25 0.23 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 71.319999999999993 110.87 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.31 168.74 7.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.804 -0.713 . . . . 74.230000000000004 112.47 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 151.65 63.46 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.711 -0.756 . . . . 33.109999999999999 112.444 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 111.79 -149.47 18.11 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.725 -0.75 . . . . 61.240000000000002 112.491 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.79 19.52 19.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.744 -0.741 . . . . 73.150000000000006 112.516 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -87.9 -26.48 22.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.924 0.392 . . . . 72.129999999999995 110.911 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.5 m -55.59 -30.79 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 55.130000000000003 111.122 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.765 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -70.02 -26.08 63.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 51.0 111.101 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 31.8 mmt -52.95 -30.99 37.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 72.010000000000005 110.904 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 52.4 t -57.01 -58.43 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 73.200000000000003 111.109 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 44.5 mm -73.98 -37.77 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 71.140000000000001 111.135 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -61.17 -30.4 70.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 71.140000000000001 110.9 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.78 -28.19 33.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 74.319999999999993 110.903 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.0 tp -65.4 -50.81 64.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 75.239999999999995 110.916 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -73.78 -42.89 60.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 74.329999999999998 110.876 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 tt -52.01 -32.78 35.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 54.200000000000003 110.892 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -66.63 -43.01 85.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 74.030000000000001 110.931 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.751 ' O ' HG23 ' A' ' 147' ' ' VAL . 4.9 mt -76.43 -32.15 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 71.420000000000002 111.099 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -55.96 -56.41 21.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 65.040000000000006 110.884 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.2 m -60.72 -35.22 62.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 63.229999999999997 111.072 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -64.68 -41.52 95.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 63.049999999999997 110.855 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 143' ' ' ILE . 88.9 t -58.39 -34.23 49.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 61.009999999999998 111.106 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 89.8 m -57.79 -51.98 67.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 41.100000000000001 110.842 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.454 ' O ' HG22 ' A' ' 153' ' ' ILE . 57.0 t -75.99 -35.23 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 72.129999999999995 111.089 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -63.42 -37.73 88.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 65.439999999999998 110.919 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.25 -46.14 9.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.792 -0.718 . . . . 71.340000000000003 112.445 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 95.4 m -59.96 -51.99 67.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.785 0.326 . . . . 71.540000000000006 111.16 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 149' ' ' VAL . 20.4 tt -55.9 -26.63 21.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 73.329999999999998 111.129 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -52.0 -49.99 46.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.764 -0.732 . . . . 42.229999999999997 112.447 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.2 mmt -71.65 -31.81 67.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 64.400000000000006 110.919 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -68.83 -21.45 64.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 75.040000000000006 110.904 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.3 mt -74.68 -29.13 61.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 72.420000000000002 110.932 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.483 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -51.93 -60.56 5.83 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.602 0.715 . . . . 65.409999999999997 110.884 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 54.1 Cg_endo -69.74 -16.95 37.9 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.68 2.253 . . . . 51.409999999999997 112.341 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.1 tp -94.16 40.66 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 74.019999999999996 110.924 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -55.22 -26.85 42.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 74.129999999999995 110.878 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 62.75 99.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 73.310000000000002 110.891 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 71.03 -70.18 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 54.439999999999998 110.917 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 72.239999999999995 110.901 -179.907 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.813 0.34 . . . . 75.120000000000005 110.865 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -95.74 -56.15 2.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 74.310000000000002 110.852 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.77 68.25 69.61 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.541 0.686 . . . . 71.5 110.907 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 78.52 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.717 2.278 . . . . 74.010000000000005 112.354 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.07 -30.96 65.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 72.310000000000002 110.86 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -78.26 -31.82 49.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 74.209999999999994 110.917 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.627 ' CE1' HG22 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -73.63 -44.87 55.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 74.040000000000006 110.876 -179.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -60.55 -39.86 89.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 35.310000000000002 111.156 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.437 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.18 -29.07 21.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 52.350000000000001 111.135 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.03 -27.08 51.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 72.230000000000004 110.898 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.31 -19.19 23.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 71.140000000000001 110.904 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.4 mm -76.87 -34.62 22.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 55.200000000000003 111.112 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.537 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.78 -57.08 23.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.614 0.721 . . . . 70.010000000000005 111.13 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.4 Cg_endo -69.77 -19.34 36.21 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.709 2.273 . . . . 64.219999999999999 112.348 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.63 ' O ' HG22 ' A' ' 42' ' ' ILE . 37.4 t -70.12 -46.29 65.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 74.420000000000002 110.872 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 p -81.53 -28.91 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 74.049999999999997 111.16 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 38' ' ' PRO . 11.5 mt -51.04 -33.91 27.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 51.229999999999997 110.902 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.63 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.73 -34.64 52.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 63.409999999999997 111.146 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 p -65.73 -36.56 83.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 62.25 111.096 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.37 -44.77 72.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 71.430000000000007 110.881 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.01 -42.3 39.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 55.219999999999999 110.91 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.11 -34.63 66.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 73.299999999999997 111.126 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.409 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.1 mp -64.54 -32.39 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 75.040000000000006 111.121 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.4 tp -51.55 -37.43 49.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 74.200000000000003 110.932 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.69 HG23 ' HD3' ' A' ' 59' ' ' LYS . 7.9 p -101.98 -36.13 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 45.229999999999997 111.144 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -68.31 -64.96 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 75.420000000000002 110.885 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.458 ' CE2' HD22 ' A' ' 141' ' ' LEU . 0.3 OUTLIER -56.36 -39.15 72.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.148 -0.478 . . . . 74.329999999999998 110.916 -179.823 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.7 tp -57.61 139.0 81.79 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.613 0.72 . . . . 74.409999999999997 110.871 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 178.81 4.21 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.663 2.242 . . . . 50.240000000000002 112.349 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.23 161.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 64.219999999999999 110.859 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -160.88 175.9 12.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.102 -0.499 . . . . 74.549999999999997 110.87 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.5 p -176.19 -174.36 0.62 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 41.520000000000003 110.892 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 61' ' ' THR . . . -57.52 -31.45 63.32 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.737 -0.744 . . . . 62.409999999999997 112.486 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -75.09 -54.74 6.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.882 0.372 . . . . 74.510000000000005 110.904 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.69 ' HD3' HG23 ' A' ' 49' ' ' VAL . 3.3 mttm -53.2 -45.33 68.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 71.519999999999996 110.919 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -57.68 -51.74 68.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 73.450000000000003 110.844 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 57' ' ' GLY . 60.4 p -65.37 -28.43 69.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.264 -0.425 . . . . 75.349999999999994 111.136 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.51 -34.57 67.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 74.450000000000003 110.934 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.481 ' O ' HG12 ' A' ' 66' ' ' VAL . 80.2 m -72.78 -51.99 16.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 63.140000000000001 110.913 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.5 tt -54.39 -33.06 25.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 71.129999999999995 111.112 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.69 -25.24 6.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 74.049999999999997 110.858 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 63' ' ' CYS . 9.9 p -57.13 -32.62 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.485 . . . . 72.099999999999994 111.127 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.93 -35.36 61.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 72.409999999999997 110.917 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.503 ' O ' HD22 ' A' ' 68' ' ' LEU . 2.0 tm? -68.96 -46.7 67.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 63.200000000000003 110.891 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.8 -29.53 19.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 60.109999999999999 111.089 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.773 HD22 HG11 ' A' ' 102' ' ' VAL . 40.9 mt -57.83 -54.51 46.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 75.450000000000003 110.918 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 68' ' ' LEU . 1.2 t -63.45 -27.28 69.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 61.350000000000001 111.156 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.6 t -71.35 -34.11 52.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 70.230000000000004 111.169 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -52.07 -30.11 24.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 75.099999999999994 110.865 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.608 HD11 HD11 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -74.93 -39.49 61.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 72.450000000000003 110.923 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.0 mp -73.24 -40.13 64.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 73.120000000000005 110.902 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.6 -55.05 22.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 73.239999999999995 110.937 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 tt -56.22 -24.69 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 73.209999999999994 111.17 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.1 p -68.1 -15.0 63.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 74.319999999999993 110.876 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.729 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -60.11 -19.83 55.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 54.100000000000001 110.94 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.627 HG22 ' CE1' ' A' ' 31' ' ' TYR . 1.1 pt -53.57 -27.17 14.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 61.219999999999999 111.134 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 79' ' ' LYS . 50.2 t 61.41 75.23 0.45 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.661 0.743 . . . . 70.239999999999995 111.101 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 167.46 24.35 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.663 2.242 . . . . 64.540000000000006 112.395 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -48.64 0.67 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.671 2.247 . . . . 71.420000000000002 112.35 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 86' ' ' LEU . 9.6 t -117.26 -19.63 9.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 71.010000000000005 111.15 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.3 t 63.72 38.37 9.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.451 . . . . 72.349999999999994 110.822 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.456 ' H ' HG23 ' A' ' 84' ' ' THR . 1.2 tp -99.72 35.33 2.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.144 -0.48 . . . . 61.240000000000002 110.94 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.634 ' HA ' HD23 ' A' ' 90' ' ' LEU . 1.8 m-20 -95.58 24.37 5.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 64.450000000000003 110.887 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.521 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.31 -57.73 10.13 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.623 0.725 . . . . 40.229999999999997 111.195 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.535 ' HG2' HD22 ' A' ' 90' ' ' LEU . 53.6 Cg_endo -69.82 -20.32 34.71 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.664 2.242 . . . . 63.109999999999999 112.329 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.634 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.14 -53.09 10.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 71.519999999999996 110.949 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.48 HG12 HD21 ' A' ' 95' ' ' LEU . 39.7 t -80.31 -20.53 11.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 74.409999999999997 111.116 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.28 -31.49 27.45 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.775 -0.726 . . . . 71.340000000000003 112.494 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -35.39 59.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.8 0.333 . . . . 51.219999999999999 110.883 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -65.69 -44.84 84.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 75.129999999999995 110.872 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.608 HD11 HD11 ' A' ' 74' ' ' LEU . 7.5 mt -51.94 -29.81 21.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 71.140000000000001 110.953 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -43.38 76.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 72.209999999999994 110.892 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.498 ' O ' HG22 ' A' ' 100' ' ' VAL . 33.7 t80 -75.22 -51.83 12.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 74.420000000000002 110.9 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.792 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.07 -29.97 33.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 74.25 111.185 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.2 mmt -66.61 -30.04 70.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 65.200000000000003 110.923 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.83 -30.04 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 73.230000000000004 111.111 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.792 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -74.92 -33.31 61.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 73.109999999999999 110.947 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.773 HG11 HD22 ' A' ' 70' ' ' LEU . 31.3 m -76.8 -38.07 29.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 74.329999999999998 111.115 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.489 ' HA ' HD12 ' A' ' 106' ' ' ILE . 71.4 m -72.49 -39.81 67.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 71.430000000000007 111.149 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -64.69 -31.96 73.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 74.129999999999995 110.898 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.4 t -71.54 -35.75 70.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 51.409999999999997 110.859 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 103' ' ' THR . 11.7 mt -71.58 -51.83 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 73.5 111.116 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.556 ' O ' HG12 ' A' ' 110' ' ' VAL . 7.5 p -53.97 -35.1 27.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 72.310000000000002 111.13 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.6 m -52.34 -32.43 38.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 75.25 111.146 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.4 m -50.42 -31.52 15.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 50.039999999999999 110.871 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.5 p -52.49 -32.79 17.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.102 -0.499 . . . . 71.430000000000007 111.153 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 42.1 m -66.59 -45.66 78.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 63.539999999999999 110.868 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 88.4 t -73.91 -34.7 40.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 75.420000000000002 111.128 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.07 -42.02 66.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 75.109999999999999 110.906 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -52.02 -30.71 26.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 75.319999999999993 110.901 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.77 HG11 ' HB2' ' A' ' 133' ' ' ALA . 9.4 p -102.31 -23.07 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 71.340000000000003 111.13 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -52.49 -66.22 0.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 73.120000000000005 110.896 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -162.15 28.48 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 74.310000000000002 110.876 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.2 mtt85 -117.72 -178.91 3.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 73.0 110.86 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.1 p -55.27 160.6 3.32 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.694 0.759 . . . . 63.450000000000003 110.839 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 168.46 21.52 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.707 2.272 . . . . 73.409999999999997 112.335 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.59 -172.76 2.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 71.540000000000006 111.105 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.0 m -75.86 69.14 2.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 73.530000000000001 111.138 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 61.29 89.54 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 64.420000000000002 110.853 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.83 159.64 32.81 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.585 0.707 . . . . 74.230000000000004 111.096 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -12.52 33.06 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.697 2.265 . . . . 51.329999999999998 112.326 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 ttm-85 -52.29 123.81 11.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 74.439999999999998 110.885 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -177.12 106.6 0.22 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.771 -0.728 . . . . 70.239999999999995 112.526 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.412 ' HA3' HG11 ' A' ' 132' ' ' VAL . . . -177.39 -136.04 2.36 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.703 -0.76 . . . . 51.009999999999998 112.457 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -112.61 -19.3 7.05 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.773 -0.727 . . . . 71.530000000000001 112.515 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 153.35 -51.2 0.49 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.729 -0.748 . . . . 72.200000000000003 112.467 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -63.29 -26.12 68.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.961 0.41 . . . . 71.25 110.953 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.412 HG11 ' HA3' ' A' ' 128' ' ' GLY . 29.8 m -56.9 -33.68 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.116 -0.493 . . . . 62.210000000000001 111.15 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.77 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -65.2 -25.22 67.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 41.420000000000002 111.091 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 16.7 mmt -53.0 -30.92 38.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 62.119999999999997 110.833 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 49.2 t -56.96 -63.86 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 62.039999999999999 111.11 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.0 mp -70.46 -38.35 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 65.129999999999995 111.134 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -60.56 -30.02 69.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 73.409999999999997 110.879 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.5 mtt-85 -56.18 -26.03 49.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 75.400000000000006 110.881 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.01 -50.99 35.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 74.140000000000001 110.941 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -73.97 -28.44 61.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 64.430000000000007 110.862 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.492 ' O ' HG23 ' A' ' 145' ' ' VAL . 0.2 OUTLIER -64.02 -36.4 83.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 71.420000000000002 110.913 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -58.99 -48.74 80.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 73.109999999999999 110.883 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.724 ' O ' HG23 ' A' ' 147' ' ' VAL . 58.5 mt -77.04 -32.29 19.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 63.229999999999997 111.159 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.0 -56.88 15.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 75.030000000000001 110.89 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 141' ' ' LEU . 21.6 t -60.42 -35.06 60.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 70.420000000000002 111.155 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.06 -32.97 74.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 51.450000000000003 110.892 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 143' ' ' ILE . 92.9 t -53.98 -34.11 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 62.25 111.139 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 4.8 t -52.03 -42.98 63.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 73.140000000000001 110.878 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 25.5 t -75.99 -33.03 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 73.530000000000001 111.124 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -52.44 -49.9 63.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 73.230000000000004 110.93 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.2 -19.78 73.87 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.71 -0.757 . . . . 74.409999999999997 112.53 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.4 m -63.46 -52.85 59.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.783 0.325 . . . . 43.229999999999997 111.167 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 89.2 mt -76.49 -25.89 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 71.140000000000001 111.149 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -52.19 -29.39 29.15 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 31.039999999999999 112.502 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.92 -31.9 51.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.737 0.303 . . . . 63.420000000000002 110.883 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.33 -15.75 61.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 74.099999999999994 110.843 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.54 -38.04 74.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 65.209999999999994 110.942 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.477 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 1.6 mm-40 -51.61 -60.74 5.29 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.62 0.724 . . . . 63.200000000000003 110.915 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 54.1 Cg_endo -69.69 -33.74 16.25 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.738 2.292 . . . . 73.209999999999994 112.363 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.7 mt -53.68 -45.5 70.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 70.319999999999993 110.968 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 5.9 t80 64.31 14.5 8.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 74.109999999999999 110.902 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -68.41 -26.97 65.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 65.140000000000001 110.912 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -72.95 78.79 1.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 73.340000000000003 110.908 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 77.1 t80 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 73.420000000000002 110.917 -179.906 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.832 0.348 . . . . 54.43 110.876 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -65.46 91.26 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 73.510000000000005 110.901 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.34 79.0 53.52 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.554 0.692 . . . . 53.210000000000001 110.88 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -5.03 15.24 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.71 2.273 . . . . 73.540000000000006 112.319 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 pp -52.08 -30.99 28.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 73.209999999999994 110.933 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -80.08 -32.52 39.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 64.519999999999996 110.838 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -72.66 -46.25 54.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.206 -0.452 . . . . 71.040000000000006 110.892 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -59.81 -39.95 86.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.492 . . . . 54.109999999999999 111.148 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.431 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -75.13 -29.06 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 53.25 111.135 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.65 -27.59 50.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 73.400000000000006 110.886 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.557 ' HG ' HD12 ' A' ' 77' ' ' ILE . 4.1 mm? -90.78 -18.14 25.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 60.240000000000002 110.896 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.9 mm -76.33 -35.31 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 71.010000000000005 111.083 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.549 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.77 -57.13 23.23 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.605 0.717 . . . . 75.230000000000004 111.098 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.9 Cg_endo -69.8 -21.83 32.74 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.689 2.259 . . . . 74.519999999999996 112.374 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.618 ' O ' HG22 ' A' ' 42' ' ' ILE . 43.6 t -73.86 -44.43 55.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 73.540000000000006 110.826 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.57 -28.91 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 74.319999999999993 111.138 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mt -50.97 -33.93 26.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 73.349999999999994 110.948 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 tp -58.73 -34.68 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 74.540000000000006 111.122 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.2 p -65.69 -42.84 90.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 72.329999999999998 111.093 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.99 -41.74 64.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.425 . . . . 74.349999999999994 110.829 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.4 tp -77.03 -38.43 52.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 72.209999999999994 110.946 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.8 -52.14 67.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 54.229999999999997 111.056 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.43 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.4 mp -49.72 -31.44 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 71.150000000000006 111.079 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.2 tp -50.79 -42.3 57.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 65.400000000000006 110.926 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.421 HG11 HD23 ' A' ' 62' ' ' LEU . 7.1 p -101.46 -37.5 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 63.100000000000001 111.12 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -63.68 -64.46 0.89 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 75.400000000000006 110.85 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.647 ' CZ ' HD23 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -72.89 -60.73 2.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 73.430000000000007 110.897 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -78.39 159.22 75.35 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.549 0.69 . . . . 75.420000000000002 110.943 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 138.68 38.31 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.657 2.238 . . . . 73.450000000000003 112.321 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.3 112.67 0.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 43.409999999999997 110.854 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 56.32 -176.06 0.05 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.145 -0.479 . . . . 74.219999999999999 110.859 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 50.0 t -113.7 -74.51 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 54.229999999999997 110.859 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.428 ' O ' HG23 ' A' ' 61' ' ' THR . . . -61.71 -23.01 62.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.742 . . . . 42.439999999999998 112.493 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -52.11 -34.96 46.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.914 0.387 . . . . 70.319999999999993 110.932 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -51.96 60.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 70.400000000000006 110.911 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -48.56 68.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 65.420000000000002 110.852 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 57' ' ' GLY . 29.3 p -53.07 -31.88 44.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 74.319999999999993 111.134 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.516 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -69.2 -50.84 43.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 63.420000000000002 110.93 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 68.1 m -52.97 -47.75 67.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 71.409999999999997 110.861 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.3 tt -72.31 -35.04 51.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 72.450000000000003 111.141 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.67 -25.61 60.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 61.240000000000002 110.879 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 62' ' ' LEU . 21.7 t -63.09 -41.39 92.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.101 -0.5 . . . . 63.409999999999997 111.119 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 tt -52.88 -28.87 25.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 63.119999999999997 110.991 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.489 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.26 -39.1 78.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 55.329999999999998 110.872 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.41 -30.03 70.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 75.209999999999994 111.099 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.503 HD13 HG11 ' A' ' 102' ' ' VAL . 9.8 mt -64.78 -54.7 27.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 74.049999999999997 110.957 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.94 -38.26 87.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 55.229999999999997 111.147 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 68' ' ' LEU . 77.0 t -71.44 -32.82 47.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 65.200000000000003 111.134 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.499 ' O ' HG22 ' A' ' 77' ' ' ILE . 73.6 t80 -61.85 -29.85 70.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 64.209999999999994 110.89 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.739 HD11 HD13 ' A' ' 95' ' ' LEU . 3.1 tt -71.99 -44.93 62.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 74.420000000000002 110.941 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.7 mp -73.22 -39.31 65.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 71.430000000000007 110.931 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.28 -51.67 67.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.129999999999995 110.907 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.557 HD12 ' HG ' ' A' ' 35' ' ' LEU . 1.8 tt -68.17 -30.2 47.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 75.200000000000003 111.092 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.1 t -80.53 -14.93 57.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 75.150000000000006 110.821 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.29 -9.9 58.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.151 -0.477 . . . . 74.409999999999997 110.903 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 77' ' ' ILE . 1.1 pp -63.84 -15.37 16.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.422 . . . . 73.340000000000003 111.147 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 81' ' ' VAL . 2.4 p 35.79 81.21 0.25 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.609 0.718 . . . . 64.0 111.137 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 167.3 24.78 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.704 2.269 . . . . 74.019999999999996 112.364 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 -48.61 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.657 2.238 . . . . 73.510000000000005 112.313 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.0 t -117.26 -19.48 9.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 74.319999999999993 111.125 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.54 46.99 3.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 55.439999999999998 110.866 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.1 -11.1 60.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 62.240000000000002 110.901 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.634 ' HA ' HD23 ' A' ' 90' ' ' LEU . 3.7 m-20 -95.36 23.96 5.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 75.219999999999999 110.892 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -67.58 -57.8 9.56 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.626 0.727 . . . . 60.240000000000002 111.161 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.5 Cg_endo -69.77 -20.02 35.31 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.679 2.253 . . . . 64.200000000000003 112.358 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.634 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.22 -53.1 10.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 74.430000000000007 110.863 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 87' ' ' ASP . 40.3 t -68.6 -43.42 83.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 73.120000000000005 111.146 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.07 -38.86 48.43 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.76 . . . . 65.040000000000006 112.497 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.66 -24.39 59.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.783 0.325 . . . . 72.549999999999997 110.902 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -74.5 -37.92 62.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 72.310000000000002 110.897 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.739 HD13 HD11 ' A' ' 74' ' ' LEU . 12.5 mt -54.79 -29.57 54.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 75.140000000000001 110.927 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.0 mmt -71.28 -41.56 69.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 72.439999999999998 110.884 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.494 ' O ' HG22 ' A' ' 100' ' ' VAL . 23.3 t80 -75.28 -51.06 14.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 64.010000000000005 110.888 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.786 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.8 t -53.09 -29.87 32.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.474 . . . . 60.140000000000001 111.18 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.68 -30.09 70.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 63.329999999999998 110.85 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.8 -30.05 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.443 . . . . 72.219999999999999 111.113 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.786 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.93 -32.99 61.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 74.340000000000003 110.924 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.503 HG11 HD13 ' A' ' 70' ' ' LEU . 29.4 m -76.6 -37.46 29.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 72.439999999999998 111.091 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.716 ' O ' HG23 ' A' ' 107' ' ' VAL . 55.3 m -72.98 -46.6 51.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 72.049999999999997 111.154 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -51.96 -31.7 30.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 43.420000000000002 110.916 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.8 p -74.59 -48.73 24.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 72.230000000000004 110.813 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.643 HD12 ' HA ' ' A' ' 103' ' ' THR . 9.8 mt -56.15 -34.52 39.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 63.32 111.148 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 103' ' ' THR . 22.1 t -53.85 -45.55 62.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 62.32 111.083 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.9 m -52.3 -32.38 37.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 64.319999999999993 111.153 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.5 t -50.28 -31.49 14.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 74.340000000000003 110.857 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.5 p -52.51 -32.83 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 74.340000000000003 111.159 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.47 ' SG ' HG21 ' A' ' 124' ' ' THR . 34.7 m -65.89 -44.52 85.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 73.219999999999999 110.874 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 83.8 t -75.52 -35.78 33.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 74.439999999999998 111.154 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.8 mt -72.21 -33.62 67.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 71.120000000000005 110.916 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -62.6 -28.95 70.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 64.540000000000006 110.93 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.8 HG11 ' HB2' ' A' ' 133' ' ' ALA . 11.2 p -102.39 -20.94 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 54.340000000000003 111.084 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -76.08 73.69 2.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 70.329999999999998 110.833 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 52.15 63.33 2.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 73.230000000000004 110.836 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -150.14 169.31 21.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 74.510000000000005 110.89 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.5 m -100.48 160.55 26.64 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.707 0.765 . . . . 72.430000000000007 110.818 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 111.46 2.81 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.674 2.249 . . . . 53.409999999999997 112.327 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -71.14 0.5 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 71.409999999999997 111.147 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.19 128.29 1.9 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 72.150000000000006 111.146 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 54.3 t60 63.29 161.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 64.439999999999998 110.868 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.47 HG21 ' SG ' ' A' ' 111' ' ' CYS . 23.6 m 61.25 68.2 1.26 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.574 0.702 . . . . 70.140000000000001 111.137 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 83.72 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.695 2.264 . . . . 74.329999999999998 112.357 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.03 172.66 8.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 71.430000000000007 110.907 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -173.8 147.04 9.14 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.715 -0.755 . . . . 64.329999999999998 112.48 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 145.43 -134.08 5.34 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 45.539999999999999 112.504 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -112.03 -64.84 0.49 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.738 -0.744 . . . . 64.329999999999998 112.517 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -174.05 -68.95 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.778 -0.725 . . . . 42.229999999999997 112.543 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -62.14 -26.39 68.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.968 0.413 . . . . 74.239999999999995 110.945 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.4 m -54.14 -27.2 16.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 42.229999999999997 111.147 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.8 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -56.62 -26.25 55.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 55.340000000000003 111.136 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 11.3 ptm -53.04 -30.79 37.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 62.43 110.846 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 58.6 t -56.9 -61.55 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 73.140000000000001 111.159 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.481 ' H ' HD12 ' A' ' 136' ' ' ILE . 4.5 mp -74.06 -25.96 20.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 74.109999999999999 111.136 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.442 ' OD2' HD13 ' A' ' 141' ' ' LEU . 25.5 t0 -58.5 -29.96 66.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.462 . . . . 72.430000000000007 110.884 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -30.1 23.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 73.439999999999998 110.863 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 7.0 tp -63.22 -50.73 69.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 61.439999999999998 110.916 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -74.03 -41.22 62.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 62.240000000000002 110.882 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.647 HD23 ' CZ ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -51.93 -31.98 31.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 73.209999999999994 110.915 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.18 -46.25 84.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.192 -0.458 . . . . 73.310000000000002 110.913 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.745 ' O ' HG23 ' A' ' 147' ' ' VAL . 3.9 mt -76.98 -31.96 19.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 70.120000000000005 111.155 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -56.01 -55.89 27.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 71.239999999999995 110.873 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 141' ' ' LEU . 31.8 t -54.01 -36.68 32.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 73.439999999999998 111.153 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -70.05 -41.38 74.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 73.209999999999994 110.867 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 143' ' ' ILE . 96.7 t -54.07 -34.45 26.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 45.219999999999999 111.087 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 95.6 m -51.9 -52.08 52.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 63.310000000000002 110.873 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.46 ' O ' HG22 ' A' ' 153' ' ' ILE . 31.5 t -76.06 -33.26 24.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 74.140000000000001 111.14 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.72 -27.05 37.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 75.140000000000001 110.846 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.97 -57.67 3.42 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.733 -0.746 . . . . 71.010000000000005 112.485 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 92.5 m -61.35 -45.01 96.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.779 0.323 . . . . 72.140000000000001 111.185 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.46 HG22 ' O ' ' A' ' 149' ' ' VAL . 20.3 tt -55.9 -25.86 19.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 73.400000000000006 111.128 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -51.93 -50.07 45.99 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.746 -0.74 . . . . 74.099999999999994 112.454 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.66 -31.84 63.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.773 0.32 . . . . 71.530000000000001 110.85 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -68.61 -21.24 64.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 75.540000000000006 110.9 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.3 mt -74.72 -29.19 61.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 75.319999999999993 110.895 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.488 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.9 OUTLIER -51.9 -60.6 5.74 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.636 0.731 . . . . 72.310000000000002 110.917 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.8 Cg_endo -69.77 -26.84 27.1 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.667 2.245 . . . . 73.329999999999998 112.326 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.6 -54.17 36.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 71.150000000000006 110.906 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 5.1 t80 64.55 14.42 8.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 65.230000000000004 110.878 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 72.18 -68.83 0.21 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 75.299999999999997 110.957 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 53.71 77.77 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 63.5 110.933 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 71.310000000000002 110.917 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.782 0.325 . . . . 75.519999999999996 110.855 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.88 26.55 6.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 74.129999999999995 110.863 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.66 78.99 48.12 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.574 0.702 . . . . 55.299999999999997 110.88 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -5.04 15.25 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.66 2.24 . . . . 61.329999999999998 112.354 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 pp -53.57 -30.93 44.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 63.530000000000001 110.917 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -80.58 -28.56 37.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 60.5 110.898 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.475 ' CE1' HG21 ' A' ' 80' ' ' ILE . 7.5 t80 -76.74 -44.79 31.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 74.420000000000002 110.913 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.4 t -62.87 -39.54 94.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 73.140000000000001 111.182 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.442 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -73.79 -29.03 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 74.299999999999997 111.12 179.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -68.87 -25.31 64.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 72.230000000000004 110.922 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.51 ' CD1' HD12 ' A' ' 77' ' ' ILE . 3.6 mm? -92.0 -27.81 17.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 73.230000000000004 110.884 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.532 ' O ' HG12 ' A' ' 40' ' ' VAL . 26.2 mm -79.51 -28.38 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 74.349999999999994 111.145 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.549 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -55.96 -57.15 23.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.575 0.702 . . . . 72.299999999999997 111.086 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.79 -24.82 29.1 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.676 2.251 . . . . 72.409999999999997 112.356 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.636 ' O ' HG22 ' A' ' 42' ' ' ILE . 3.1 t -74.57 -45.4 45.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 60.109999999999999 110.892 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 36' ' ' ILE . 8.9 p -81.45 -28.91 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 53.329999999999998 111.161 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mt -51.02 -33.96 27.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 64.319999999999993 110.898 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 39' ' ' CYS . 0.8 OUTLIER -58.68 -34.6 52.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 72.109999999999999 111.138 179.85 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.9 p -65.69 -34.98 79.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 64.549999999999997 111.094 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 m -57.33 -52.6 64.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 75.140000000000001 110.836 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.8 tp -70.16 -34.45 73.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 54.210000000000001 110.922 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.24 -44.89 90.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.452 . . . . 10.23 111.11 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.432 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.3 mp -64.26 -31.98 55.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 63.229999999999997 111.137 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mp -51.39 -38.88 55.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 73.450000000000003 110.916 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.782 HG22 ' HD3' ' A' ' 59' ' ' LYS . 7.9 p -101.45 -36.7 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 63.030000000000001 111.107 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -67.05 -64.65 0.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 63.109999999999999 110.861 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.432 ' HB2' HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -71.4 -60.08 2.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 54.530000000000001 110.936 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.1 mp -78.2 160.67 72.82 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.609 0.719 . . . . 64.019999999999996 110.92 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 157.25 61.14 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.711 2.274 . . . . 73.239999999999995 112.329 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.486 ' HB3' HG23 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -179.32 -170.19 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 71.430000000000007 110.845 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.33 171.21 1.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 71.209999999999994 110.859 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 5.6 t -81.51 -68.11 0.72 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 71.150000000000006 110.922 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.53 -23.64 43.66 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.782 -0.723 . . . . 70.319999999999993 112.495 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -52.36 -42.89 64.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.933 0.397 . . . . 72.430000000000007 110.908 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.782 ' HD3' HG22 ' A' ' 49' ' ' VAL . 1.1 mmmt -53.53 -43.45 68.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 73.0 110.868 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.93 -50.77 26.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 51.130000000000003 110.867 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.2 p -53.39 -44.64 68.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 64.540000000000006 111.136 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.93 -28.93 64.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 71.299999999999997 110.93 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.468 ' HB3' HG23 ' A' ' 106' ' ' ILE . 1.3 m -71.43 -44.96 63.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 63.25 110.889 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.8 tt -72.41 -35.09 50.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 61.119999999999997 111.118 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -55.96 -26.25 47.27 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.174 -0.466 . . . . 70.5 110.809 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.2 t -58.68 -38.63 72.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 74.219999999999999 111.113 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.89 -28.93 25.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 55.109999999999999 110.918 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.492 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -69.16 -39.14 78.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 75.129999999999995 110.893 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.4 -30.12 70.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 50.539999999999999 111.079 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.685 HD22 HG11 ' A' ' 102' ' ' VAL . 9.7 mt -64.93 -54.66 27.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.448 . . . . 72.239999999999995 110.93 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -61.92 -38.25 87.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 62.030000000000001 111.139 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 68' ' ' LEU . 77.3 t -71.44 -32.85 47.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 63.399999999999999 111.165 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -51.87 -38.39 55.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 71.129999999999995 110.864 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.3 tp -75.12 -30.87 60.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.487 . . . . 70.420000000000002 110.905 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 65.5 mt -73.26 -54.03 9.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 64.200000000000003 110.888 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.61 -54.16 47.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 75.310000000000002 110.928 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.51 HD12 ' CD1' ' A' ' 35' ' ' LEU . 3.4 tt -55.49 -27.59 21.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 71.030000000000001 111.135 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.5 m -80.03 -24.8 40.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 62.509999999999998 110.895 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.686 ' O ' HG23 ' A' ' 81' ' ' VAL . 14.7 mttp -64.74 -15.27 61.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 74.439999999999998 110.853 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.475 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.2 pp -56.16 -24.38 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 64.400000000000006 111.136 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 79' ' ' LYS . 22.1 t 63.81 75.11 0.4 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.595 0.712 . . . . 64.209999999999994 111.118 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 166.69 26.77 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.71 2.273 . . . . 74.530000000000001 112.302 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -49.1 0.6 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.679 2.253 . . . . 62.539999999999999 112.347 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.9 t -118.88 -25.61 6.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 70.329999999999998 111.136 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 64.26 47.99 3.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 61.310000000000002 110.831 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.18 37.15 1.59 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 72.140000000000001 110.902 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.623 ' HA ' HD23 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -112.44 22.76 14.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 72.109999999999999 110.856 179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.54 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -68.05 -57.89 8.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.578 0.704 . . . . 52.140000000000001 111.106 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.7 Cg_endo -69.74 -19.93 35.6 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.653 2.236 . . . . 43.530000000000001 112.341 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.623 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.09 -51.54 15.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 72.519999999999996 110.964 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.569 HG12 HD21 ' A' ' 95' ' ' LEU . 39.1 t -80.17 -24.38 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 75.030000000000001 111.089 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.7 -50.0 44.86 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.729 -0.748 . . . . 74.140000000000001 112.496 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -35.46 80.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.78 0.324 . . . . 75.219999999999999 110.879 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -60.51 -40.1 90.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.218 -0.446 . . . . 64.420000000000002 110.906 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.569 HD21 HG12 ' A' ' 91' ' ' VAL . 8.5 mt -51.79 -29.87 20.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 71.109999999999999 110.918 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.21 -43.62 73.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 73.140000000000001 110.859 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.508 ' O ' HG22 ' A' ' 100' ' ' VAL . 51.7 t80 -75.19 -51.34 13.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 75.0 110.863 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.783 ' HA ' HD23 ' A' ' 101' ' ' LEU . 1.9 t -53.07 -29.91 32.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 64.409999999999997 111.169 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.9 mmt -66.69 -30.11 70.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 74.540000000000006 110.834 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.73 -30.12 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 72.129999999999995 111.123 179.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.783 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.89 -33.26 62.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 71.219999999999999 110.944 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.685 HG11 HD22 ' A' ' 70' ' ' LEU . 30.9 m -76.95 -38.04 27.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 70.319999999999993 111.141 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.503 ' HA ' HD12 ' A' ' 106' ' ' ILE . 69.8 m -72.51 -40.67 66.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 73.209999999999994 111.158 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -63.41 -31.98 73.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 72.129999999999995 110.87 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.29 -32.98 69.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 60.509999999999998 110.841 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 103' ' ' THR . 20.3 mt -73.96 -51.69 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 63.240000000000002 111.131 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -54.21 -34.29 27.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 71.230000000000004 111.164 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.5 m -53.0 -34.97 58.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 64.430000000000007 111.119 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.0 t -52.24 -48.34 65.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 72.400000000000006 110.845 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.7 t -52.91 -33.83 19.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.493 . . . . 61.350000000000001 111.155 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.46 ' O ' HG12 ' A' ' 115' ' ' VAL . 31.2 m -65.09 -39.9 93.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 55.140000000000001 110.875 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 65.6 t -79.98 -36.14 16.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 74.409999999999997 111.175 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.611 HD21 ' HE2' ' A' ' 59' ' ' LYS . 87.6 mt -72.86 -51.7 17.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 74.430000000000007 110.886 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -51.73 -29.5 18.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 72.299999999999997 110.901 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.82 HG11 ' HB2' ' A' ' 133' ' ' ALA . 12.9 p -99.43 -16.81 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 63.450000000000003 111.157 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -54.26 -52.53 61.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 73.450000000000003 110.924 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -163.04 32.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 74.140000000000001 110.86 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -131.92 -178.38 4.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 74.239999999999995 110.845 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.51 160.58 41.8 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.641 0.734 . . . . 72.340000000000003 110.885 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 161.06 47.4 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.667 2.245 . . . . 61.130000000000003 112.315 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.23 -176.96 3.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 53.109999999999999 111.161 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 15.0 t -118.41 28.55 8.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.251 -0.432 . . . . 61.399999999999999 111.147 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -148.18 95.14 2.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 75.430000000000007 110.893 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 8.6 m 53.37 68.34 3.0 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.587 0.708 . . . . 75.310000000000002 111.175 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 179.72 3.49 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.701 2.268 . . . . 65.140000000000001 112.382 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -142.53 -42.78 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 74.209999999999994 110.902 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.4 141.27 0.12 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.712 -0.756 . . . . 75.010000000000005 112.524 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.672 ' HA3' HG11 ' A' ' 132' ' ' VAL . . . 111.39 -166.49 12.26 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.756 -0.735 . . . . 72.310000000000002 112.473 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.75 -138.65 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.719 -0.753 . . . . 31.109999999999999 112.475 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -99.8 -20.3 17.16 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.743 -0.742 . . . . 61.240000000000002 112.503 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -76.37 -27.0 56.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.938 0.399 . . . . 64.450000000000003 110.911 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.672 HG11 ' HA3' ' A' ' 128' ' ' GLY . 21.8 m -58.62 -37.39 64.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 71.329999999999998 111.158 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.82 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -72.8 -29.3 63.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 51.450000000000003 111.074 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 14.6 mmt -56.66 -31.02 63.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 73.340000000000003 110.806 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 65.9 t -56.99 -65.9 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 74.120000000000005 111.146 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 38.9 mm -69.17 -33.07 56.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 63.509999999999998 111.12 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -64.27 -29.97 71.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 64.140000000000001 110.859 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.09 -29.1 39.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 64.230000000000004 110.873 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.96 -44.54 61.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 64.099999999999994 110.926 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -74.0 -53.96 8.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 53.100000000000001 110.895 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.596 ' O ' HG23 ' A' ' 145' ' ' VAL . 0.8 OUTLIER -52.23 -36.98 53.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 73.129999999999995 110.96 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 32.9 t-105 -52.98 -51.48 61.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 73.340000000000003 110.905 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.621 ' O ' HG23 ' A' ' 147' ' ' VAL . 74.3 mt -76.99 -38.81 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 75.150000000000006 111.127 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -56.14 -57.15 13.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 53.340000000000003 110.839 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 141' ' ' LEU . 46.2 t -56.74 -34.96 44.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 73.030000000000001 111.128 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -66.58 -32.95 74.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 74.409999999999997 110.864 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 143' ' ' ILE . 94.5 t -53.99 -33.96 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 73.299999999999997 111.128 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.97 -36.77 50.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 72.430000000000007 110.845 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 83.1 t -75.95 -35.93 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 65.299999999999997 111.102 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -71.9 -27.01 62.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 73.230000000000004 110.863 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -52.2 -58.9 9.67 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.753 -0.737 . . . . 71.310000000000002 112.462 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.5 t -54.06 -35.08 61.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.78 0.324 . . . . 74.0 111.192 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 51.0 mm -66.67 -57.98 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 74.319999999999993 111.158 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -54.13 -26.07 34.15 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.764 -0.731 . . . . 63.210000000000001 112.488 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -32.0 73.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 41.049999999999997 110.903 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -80.5 -26.15 38.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 73.349999999999994 110.89 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 95.9 mt -79.75 -25.87 40.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 71.299999999999997 110.941 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.523 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 1.4 tp-100 -52.07 -58.05 12.83 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.608 0.718 . . . . 72.120000000000005 110.922 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 54.2 Cg_endo -69.76 -16.33 37.52 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.684 2.256 . . . . 73.109999999999999 112.334 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.8 tp -93.96 40.73 1.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 73.450000000000003 110.903 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.89 -59.65 2.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 72.010000000000005 110.876 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 72.22 -68.96 0.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 74.319999999999993 110.872 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 38.9 t30 52.15 42.3 30.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 72.129999999999995 110.856 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 74.349999999999994 110.931 -179.948 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.828 0.346 . . . . 61.130000000000003 110.845 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.27 -32.76 74.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 71.010000000000005 110.87 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.09 78.91 51.67 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.639 0.733 . . . . 61.0 110.919 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -4.96 15.1 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.707 2.271 . . . . 63.25 112.312 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 pp -52.9 -31.5 40.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 72.329999999999998 110.927 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -80.35 -29.88 37.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 64.239999999999995 110.896 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -76.81 -42.35 40.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.13 -0.486 . . . . 74.109999999999999 110.935 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.1 t -62.21 -38.52 89.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 73.040000000000006 111.179 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.446 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -74.96 -29.12 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 65.540000000000006 111.124 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -57.53 -27.73 62.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 74.230000000000004 110.887 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.422 HD11 ' HG ' ' A' ' 76' ' ' LEU . 4.3 mm? -90.55 -20.13 22.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 63.030000000000001 110.924 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.4 mm -76.96 -34.22 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 50.219999999999999 111.131 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.543 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.3 mm -54.95 -57.32 20.08 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.634 0.731 . . . . 71.040000000000006 111.143 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.654 ' HA ' HD23 ' A' ' 41' ' ' LEU . 53.5 Cg_endo -69.72 -11.8 31.65 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.657 2.238 . . . . 43.299999999999997 112.363 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.622 ' O ' HG22 ' A' ' 42' ' ' ILE . 3.1 t -62.07 -43.41 98.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 73.120000000000005 110.895 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 37' ' ' ILE . 14.3 p -79.47 -27.28 12.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 71.129999999999995 111.073 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.654 HD23 ' HA ' ' A' ' 38' ' ' PRO . 2.9 mm? -50.39 -34.31 23.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 71.310000000000002 110.909 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 39' ' ' CYS . 0.8 OUTLIER -58.7 -34.94 53.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 74.319999999999993 111.115 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.3 p -64.95 -36.59 84.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 72.099999999999994 111.105 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.1 t -54.17 -46.35 72.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 41.229999999999997 110.847 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tp -77.13 -38.08 52.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 75.209999999999994 110.936 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.65 -52.12 67.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 50.200000000000003 111.07 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.426 HG23 ' HB2' ' A' ' 51' ' ' TYR . 1.4 mp -49.82 -31.51 6.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 74.299999999999997 111.11 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 tt -50.78 -41.91 57.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 73.319999999999993 110.92 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.762 HG13 HD22 ' A' ' 62' ' ' LEU . 7.2 p -101.61 -36.77 4.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 45.340000000000003 111.117 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -64.47 -64.56 0.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 73.530000000000001 110.888 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.426 ' HB2' HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -71.71 -62.01 1.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 74.239999999999995 110.965 -179.856 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.4 mp -67.04 160.75 68.51 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.61 0.719 . . . . 74.109999999999999 110.896 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 143.12 49.55 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.692 2.262 . . . . 64.540000000000006 112.316 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.686 ' CB ' HG23 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -153.42 -170.1 3.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 72.310000000000002 110.816 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.14 172.67 11.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 73.510000000000005 110.851 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 22.5 m -68.29 -62.07 1.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 71.319999999999993 110.869 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.25 -22.94 38.82 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.709 -0.757 . . . . 40.25 112.526 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -35.01 41.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.919 0.39 . . . . 64.120000000000005 110.915 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -56.24 -46.48 79.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 73.319999999999993 110.93 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -52.01 51.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 55.299999999999997 110.923 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 55.3 p -55.28 -25.95 37.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 75.310000000000002 111.129 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.762 HD22 HG13 ' A' ' 49' ' ' VAL . 22.4 tp -72.99 -37.27 67.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 74.140000000000001 110.896 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 39.4 t -73.85 -48.52 30.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 61.119999999999997 110.893 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.6 pt -58.09 -32.59 44.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 65.450000000000003 111.096 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.13 -57.15 4.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 74.420000000000002 110.848 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.558 HG23 ' CD1' ' A' ' 42' ' ' ILE . 13.2 p -60.64 -33.61 55.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 63.340000000000003 111.128 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 tt -52.67 -31.08 35.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 75.140000000000001 110.906 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.499 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.6 tm? -68.36 -37.78 80.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 71.519999999999996 110.944 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.0 -29.96 69.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 64.310000000000002 111.07 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.429 HD13 HG11 ' A' ' 102' ' ' VAL . 7.4 mt -66.78 -54.86 18.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.236 -0.438 . . . . 71.200000000000003 110.928 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.576 ' O ' HD13 ' A' ' 75' ' ' LEU . 4.7 t -59.95 -38.81 83.54 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.17 -0.468 . . . . 75.25 111.167 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 68' ' ' LEU . 84.6 t -71.42 -33.0 48.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 75.129999999999995 111.124 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -65.46 -38.44 89.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 71.329999999999998 110.916 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.782 HD23 HD13 ' A' ' 95' ' ' LEU . 7.6 mp -74.99 -35.41 62.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.117 -0.492 . . . . 73.209999999999994 110.932 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.576 HD13 ' O ' ' A' ' 71' ' ' THR . 8.1 mp -73.42 -47.84 38.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 60.350000000000001 110.902 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.437 ' O ' HD13 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -57.98 -48.33 80.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 62.020000000000003 110.924 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 tt -65.96 -28.83 44.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 73.140000000000001 111.122 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 t -80.85 -23.87 38.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 70.549999999999997 110.833 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.723 ' O ' HG23 ' A' ' 81' ' ' VAL . 7.6 mmtp -58.81 -22.04 57.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.484 . . . . 62.229999999999997 110.914 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 26.0 pt -51.25 -30.87 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 74.239999999999995 111.097 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 79' ' ' LYS . 58.4 t 55.71 80.13 0.31 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.655 0.74 . . . . 74.319999999999993 111.158 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 53.6 Cg_endo -69.79 112.11 3.0 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.652 2.235 . . . . 75.019999999999996 112.359 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 82' ' ' PRO . 53.6 Cg_endo -69.72 -48.56 0.7 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.713 2.275 . . . . 74.319999999999993 112.363 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.0 t -116.84 -22.07 8.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 74.420000000000002 111.131 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.71 -47.5 63.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 60.399999999999999 110.841 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.6 tp 51.73 49.8 20.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 74.109999999999999 110.951 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.639 ' HA ' HD23 ' A' ' 90' ' ' LEU . 9.7 m-20 -95.99 29.19 2.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 75.120000000000005 110.893 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.539 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 2.1 t -66.98 -57.77 10.65 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.612 0.72 . . . . 54.450000000000003 111.136 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 53.5 Cg_endo -69.78 -20.87 34.19 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.663 2.242 . . . . 73.209999999999994 112.337 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.639 HD23 ' HA ' ' A' ' 87' ' ' ASP . 3.5 mm? -74.25 -43.87 55.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 75.439999999999998 110.959 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.477 HG12 HD21 ' A' ' 95' ' ' LEU . 61.7 t -80.7 -38.84 17.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 42.539999999999999 111.106 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.89 -51.21 40.97 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.689 -0.767 . . . . 71.019999999999996 112.509 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -34.71 78.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.81 0.338 . . . . 73.400000000000006 110.891 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -61.26 -36.03 78.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 72.140000000000001 110.913 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.782 HD13 HD23 ' A' ' 74' ' ' LEU . 10.4 mt -51.82 -33.0 33.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 64.329999999999998 110.894 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.85 -28.05 33.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 64.010000000000005 110.891 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.491 ' O ' HG22 ' A' ' 100' ' ' VAL . 5.2 t80 -72.98 -54.68 7.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 63.109999999999999 110.89 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.803 ' HA ' HD23 ' A' ' 101' ' ' LEU . 0.6 OUTLIER -53.4 -28.54 30.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.494 . . . . 72.239999999999995 111.142 -179.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 27.4 mmt -68.59 -30.04 68.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 72.150000000000006 110.875 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.91 -29.74 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 73.030000000000001 111.107 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.803 HD23 ' HA ' ' A' ' 98' ' ' THR . 0.3 OUTLIER -74.74 -32.73 62.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 62.409999999999997 110.876 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.429 HG11 HD13 ' A' ' 70' ' ' LEU . 27.7 m -77.08 -38.18 27.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 44.119999999999997 111.178 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 84.4 m -72.66 -37.7 67.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 72.230000000000004 111.126 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -68.54 -32.19 71.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 75.5 110.851 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.0 t -70.42 -33.62 71.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 74.209999999999994 110.833 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 30.8 mt -72.6 -51.39 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 72.129999999999995 111.127 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.554 ' O ' HG12 ' A' ' 110' ' ' VAL . 6.3 p -56.18 -35.35 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 74.439999999999998 111.121 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 98.3 m -52.48 -32.32 39.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.156 -0.475 . . . . 51.140000000000001 111.104 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.41 -31.54 15.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 71.120000000000005 110.875 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.554 HG12 ' O ' ' A' ' 107' ' ' VAL . 8.3 p -52.57 -32.87 17.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 73.129999999999995 111.129 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 43.0 m -66.11 -47.67 73.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 62.210000000000001 110.877 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.7 t -71.99 -36.04 56.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 71.349999999999994 111.141 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.5 mt -72.02 -33.48 68.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 63.119999999999997 110.961 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -59.64 -30.73 68.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 73.409999999999997 110.907 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.815 HG11 ' HB2' ' A' ' 133' ' ' ALA . 9.5 p -102.34 -24.21 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 65.219999999999999 111.127 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -90.72 -73.23 0.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 72.450000000000003 110.857 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.57 99.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 72.439999999999998 110.833 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 47.0 tpt85 -86.22 -73.94 0.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 74.409999999999997 110.885 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.3 160.56 4.89 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.665 0.745 . . . . 63.520000000000003 110.875 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 131.57 21.52 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.726 2.284 . . . . 64.329999999999998 112.371 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.7 p -150.42 80.45 1.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 41.219999999999999 111.106 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.9 m 63.63 106.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 53.210000000000001 111.127 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -52.18 103.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 63.32 110.859 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.1 p -141.1 73.92 25.82 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.629 0.728 . . . . 73.219999999999999 111.157 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 155.25 66.45 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.695 2.263 . . . . 74.140000000000001 112.356 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.7 mtm180 63.05 103.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 73.439999999999998 110.885 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.01 130.57 5.52 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.74 -0.743 . . . . 50.130000000000003 112.479 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 162.82 -165.85 36.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.788 -0.72 . . . . 53.5 112.488 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -143.99 119.13 1.26 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.686 -0.769 . . . . 64.340000000000003 112.431 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 179.18 38.04 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.704 -0.76 . . . . 72.219999999999999 112.455 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -87.87 -24.93 23.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.912 0.387 . . . . 73.329999999999998 110.901 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 23.8 m -53.98 -30.51 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 72.120000000000005 111.066 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.815 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . -57.25 -25.05 58.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 73.439999999999998 111.082 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.8 ptm -52.94 -30.94 37.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 71.430000000000007 110.892 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 59.1 t -56.92 -53.64 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.284 -0.416 . . . . 73.420000000000002 111.128 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 64.9 mt -73.93 -38.56 50.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 64.230000000000004 111.156 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.97 -30.03 70.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 74.120000000000005 110.909 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -30.14 23.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 74.200000000000003 110.863 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.4 tt -63.47 -50.91 67.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 74.400000000000006 110.868 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -73.99 -36.97 64.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 71.540000000000006 110.901 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.0 -34.33 42.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 64.319999999999993 110.957 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 21.4 t90 -64.17 -50.68 67.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 74.310000000000002 110.915 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.633 ' O ' HG23 ' A' ' 147' ' ' VAL . 51.2 mm -68.35 -32.12 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 72.310000000000002 111.148 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -56.02 -56.72 17.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 70.409999999999997 110.859 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 21.7 t -65.95 -35.91 76.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 61.109999999999999 111.147 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.51 -33.2 65.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 71.129999999999995 110.842 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 143' ' ' ILE . 58.0 t -54.07 -34.11 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 54.409999999999997 111.126 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 71.8 m -51.95 -43.55 63.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.167 -0.47 . . . . 71.510000000000005 110.849 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 64.3 t -75.22 -35.06 32.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 54.420000000000002 111.112 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -54.74 -28.71 50.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 75.430000000000007 110.873 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -70.8 -22.43 78.19 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.734 -0.745 . . . . 62.149999999999999 112.493 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.1 m -79.46 -52.8 7.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.76 0.314 . . . . 54.310000000000002 111.15 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 47.6 mm -76.5 -24.15 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 73.219999999999999 111.147 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -52.13 -50.04 47.37 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.728 -0.748 . . . . 34.200000000000003 112.463 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -31.98 67.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 71.549999999999997 110.899 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.76 -23.57 62.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 72.519999999999996 110.899 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.5 mt -75.25 -27.41 59.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 72.230000000000004 110.905 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.483 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.8 OUTLIER -51.94 -60.55 5.88 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.607 0.717 . . . . 71.109999999999999 110.947 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 158' ' ' GLN . 53.7 Cg_endo -69.74 -16.47 37.64 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.647 2.231 . . . . 75.310000000000002 112.347 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.1 tp -93.96 40.73 1.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.441 . . . . 75.430000000000007 110.951 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.85 -59.06 2.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 71.049999999999997 110.873 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -179.15 -74.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 71.319999999999993 110.959 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 26.2 t30 59.68 97.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 64.0 110.86 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 2.2 t80 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 73.329999999999998 110.959 -179.967 . . . . . . . . 0 0 . 1 stop_ save_